data_2ka7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ka7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.6 tpp . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.56 109.55 8.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.575 0.75 . . . . 0.0 110.075 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -104.81 178.09 4.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.046 0.938 . . . . 0.0 110.104 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -144.07 157.35 44.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.509 1.924 . . . . 0.0 108.891 -171.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 p -110.92 177.28 4.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 123.04 1.4 . . . . 0.0 109.463 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -78.64 -9.43 59.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.978 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -109.18 42.0 1.52 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.794 -1.191 . . . . 0.0 109.107 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 p80 44.87 54.47 6.75 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.084 1.353 . . . . 0.0 110.674 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -130.21 145.25 51.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.212 2.205 . . . . 0.0 107.479 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.447 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.2 p-90 -117.87 159.89 22.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.56 1.944 . . . . 0.0 110.21 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.99 152.74 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.646 1.978 . . . . 0.0 107.468 -173.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.85 84.33 1.84 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 119.766 1.166 . . . . 0.0 112.771 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mp -70.37 132.39 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -120.15 -99.47 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 164.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.25 -88.65 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.911 2.084 . . . . 0.0 110.368 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -127.71 3.88 6.09 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.8 -1.188 . . . . 0.0 113.382 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.71 133.56 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.35 110.29 21.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.038 2.135 . . . . 0.0 109.529 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.5 m -75.96 116.51 16.73 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.653 1.181 . . . . 0.0 110.743 171.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.99 149.85 3.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 112.415 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.98 163.64 31.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 156.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 pt -82.09 151.42 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.4 1.6 . . . . 0.0 109.511 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.3 p -82.05 174.48 11.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.705 1.202 . . . . 0.0 112.828 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.81 -41.81 71.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.2 -0.937 . . . . 0.0 112.3 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -57.85 -21.1 40.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.093 0.86 . . . . 0.0 112.935 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.28 -47.83 9.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.034 -1.041 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -64.18 -21.38 66.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.7 0.682 . . . . 0.0 111.806 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.09 -37.95 81.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.627 1.571 . . . . 0.0 110.888 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -88.21 -35.9 17.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.2 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.7 -70.99 0.47 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.703 1.138 . . . . 0.0 109.824 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.19 -130.25 10.11 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.19 0.9 . . . . 0.0 111.041 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -71.85 34.18 0.06 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.242 3.017 . . . . 0.0 117.029 -159.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 t -21.97 -113.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 114.091 -2.861 . . . . 0.0 113.049 -135.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 164.38 -41.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 128.924 2.89 . . . . 0.0 110.082 -170.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -157.39 164.4 37.56 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.644 0.656 . . . . 0.0 109.721 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -139.12 142.18 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 163.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.79 87.46 3.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.341 1.457 . . . . 0.0 107.218 -177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -90.28 153.1 46.4 Favored Pre-proline 0 C--O 1.234 0.245 0 O-C-N 121.656 -0.652 . . . . 0.0 109.885 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.96 174.7 12.32 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.448 2.099 . . . . 0.0 112.205 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.89 142.11 31.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.13 19.88 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 128.835 2.854 . . . . 0.0 114.839 -172.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.82 17.89 0.65 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.063 1.792 . . . . 0.0 112.501 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -90.18 142.63 27.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.889 1.345 . . . . 0.0 110.319 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.43 144.69 27.84 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.124 1.329 . . . . 0.0 110.669 170.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.3 m -137.17 177.98 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.793 1.237 . . . . 0.0 111.22 -175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -132.01 166.61 21.32 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.172 1.789 . . . . 0.0 108.821 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -72.94 37.21 0.08 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.076 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.56 76.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.01 120.34 7.86 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.696 1.598 . . . . 0.0 106.8 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.287 0.1 OUTLIER -69.84 33.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 127.716 2.406 . . . . 0.0 113.683 -171.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.17 8.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 118.501 -2.624 . . . . 0.0 114.804 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 48.01 1.77 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 121.063 1.756 . . . . 0.0 111.031 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 161.64 8.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.918 0.866 . . . . 0.0 110.767 -173.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mt -137.78 101.77 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.49 148.97 25.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 164.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -124.2 179.8 4.74 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.391 1.077 . . . . 0.0 110.167 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -40.8 -35.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 126.172 1.789 . . . . 0.0 113.379 175.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -160.97 59.19 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.62 1.554 . . . . 0.0 113.655 156.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.93 -175.57 5.5 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.75 . . . . 0.0 109.48 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.64 166.5 23.41 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.865 1.666 . . . . 0.0 110.635 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.64 127.19 6.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.714 2.006 . . . . 0.0 106.902 167.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.3 118.05 28.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.67 93.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.53 106.88 9.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.655 0.382 . . . . 0.0 111.565 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.39 153.36 0.57 Allowed Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 127.606 2.362 . . . . 0.0 115.615 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -86.11 -41.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.343 1.362 . . . . 0.0 114.866 -162.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -129.93 168.17 17.07 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -76.94 168.95 19.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 156.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.95 -167.38 24.65 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -171.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -135.07 129.48 34.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -169.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.0 mm -62.47 141.76 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 107.585 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.79 -1.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 124.383 1.052 . . . . 0.0 112.828 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -151.99 157.08 41.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.583 1.538 . . . . 0.0 106.898 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.7 m -142.56 154.0 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.72 85.16 5.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.588 0.631 . . . . 0.0 110.722 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.23 -9.56 5.19 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -55.09 -46.24 75.46 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.654 -1.279 . . . . 0.0 110.463 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -13.03 60.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.23 1.012 . . . . 0.0 110.069 -168.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.65 -35.2 73.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.415 1.486 . . . . 0.0 110.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -123.59 -22.32 5.02 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.243 1.417 . . . . 0.0 112.854 -167.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -131.18 68.83 82.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 127.426 2.291 . . . . 0.0 107.847 171.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.69 -11.29 28.29 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.39 2.727 . . . . 0.0 111.588 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.65 -3.14 19.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.632 1.573 . . . . 0.0 112.675 171.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mt -70.37 -22.49 62.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.623 1.556 . . . . 0.0 113.527 -172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.0 mt -65.34 -29.32 46.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.46 -52.03 60.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 120.42 1.464 . . . . 0.0 109.038 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -56.17 -55.59 31.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.727 2.411 . . . . 0.0 110.169 -169.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -151.95 89.7 3.97 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -57.36 -29.49 84.41 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.586 1.524 . . . . 0.0 111.934 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.447 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 13.1 mt-10 -122.73 31.21 6.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.624 1.969 . . . . 0.0 108.701 -167.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.38 -74.45 0.07 OUTLIER Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.409 1.481 . . . . 0.0 111.404 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -117.17 -11.3 10.7 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.129 -0.939 . . . . 0.0 113.307 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.84 29.6 1.55 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.449 1.022 . . . . 0.0 113.328 168.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 59.0 p-90 -60.31 149.6 33.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.579 1.189 . . . . 0.0 109.755 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.85 -69.4 0.76 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 116.589 -1.672 . . . . 0.0 106.814 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.31 -174.95 3.71 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 122.114 2.234 . . . . 0.0 112.033 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -135.86 153.53 51.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.831 167.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.07 139.15 25.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.847 0.859 . . . . 0.0 109.271 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.38 120.31 12.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 163.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -73.24 152.97 7.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 m -110.12 -31.93 7.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.699 0.8 . . . . 0.0 111.58 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 76.48 1.61 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -160.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -11.46 57.35 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.445 -0.784 . . . . 0.0 111.324 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.01 -15.17 81.22 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.927 -1.108 . . . . 0.0 112.586 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -86.34 -15.95 38.93 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.549 1.175 . . . . 0.0 111.572 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.22 -43.37 98.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.497 1.044 . . . . 0.0 109.543 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -60.65 -24.76 65.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 111.28 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.5 -4.52 58.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.247 1.019 . . . . 0.0 112.45 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.54 -171.95 2.5 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.591 1.956 . . . . 0.0 108.958 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -96.99 135.53 38.86 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.675 1.19 . . . . 0.0 108.215 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.38 179.93 3.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.828 0.823 . . . . 0.0 110.041 163.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.53 -47.53 72.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.612 1.965 . . . . 0.0 111.732 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -74.22 -39.99 62.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.191 0.596 . . . . 0.0 109.419 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.78 76.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.417 0.687 . . . . 0.0 111.262 172.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -70.7 -44.22 67.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.969 0.908 . . . . 0.0 111.187 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.27 -45.57 72.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.125 0.875 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 . . . . . 0 N--CA 1.437 -1.116 0 C-N-CA 123.815 0.846 . . . . 0.0 110.879 176.174 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.464 ' SD ' ' HE3' ' A' ' 5' ' ' LYS . 2.9 ptp . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.411 ' HB3' ' HZ3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -150.54 122.89 8.4 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 120.669 -1.27 . . . . 0.0 109.324 171.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.464 ' HE3' ' SD ' ' A' ' 3' ' ' MET . 22.2 mmtt -114.38 175.44 5.48 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.662 0.602 . . . . 0.0 109.864 168.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -133.36 154.22 50.92 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.654 1.581 . . . . 0.0 109.179 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -91.48 -176.92 4.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 122.226 1.013 . . . . 0.0 108.641 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -101.66 20.48 16.12 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 0.0 110.296 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -127.02 30.1 5.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.402 1.881 . . . . 0.0 110.817 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 59.72 40.69 19.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.801 -1.187 . . . . 0.0 112.193 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -126.24 145.11 50.53 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.45 1.5 . . . . 0.0 107.887 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.405 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.1 p-90 -116.94 162.02 18.43 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.714 1.605 . . . . 0.0 109.534 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.35 100.79 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -167.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -82.15 89.12 6.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.74 -1.225 . . . . 0.0 109.034 173.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.04 104.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 120.224 1.374 . . . . 0.0 107.595 174.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.3 tp10 -80.9 -138.78 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 167.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.441 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 1.2 t0 -64.69 -61.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.098 -1.001 . . . . 0.0 109.414 -172.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.5 2.21 2.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.031 0.933 . . . . 0.0 113.019 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.3 t -124.28 132.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -100.2 140.0 35.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 169.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -85.15 139.05 31.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 t -113.5 126.22 70.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.654 1.581 . . . . 0.0 107.584 170.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.97 168.55 23.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 160.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 pt -85.62 156.57 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.8 p -82.55 179.09 7.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -39.52 94.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.408 -1.433 . . . . 0.0 111.541 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -61.02 -26.48 67.64 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.398 -1.439 . . . . 0.0 111.668 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.79 -56.43 7.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.977 -1.077 . . . . 0.0 110.088 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -55.14 -30.89 60.74 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.662 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.03 -42.43 94.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.381 0.672 . . . . 0.0 110.545 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -79.96 -24.26 41.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 113.202 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.68 -42.05 35.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.747 1.158 . . . . 0.0 110.346 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.9 53.27 Favored Glycine 0 N--CA 1.443 -0.859 0 O-C-N 124.188 0.93 . . . . 0.0 110.939 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.95 122.6 3.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.748 2.019 . . . . 0.0 108.515 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 36' ' ' VAL 0.425 9.8 p -118.47 158.07 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 122.493 1.139 . . . . 0.0 112.387 -177.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.479 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -146.85 -26.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 C-N-CA 126.148 1.779 . . . . 0.0 108.974 -150.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -150.53 151.93 33.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 123.741 0.651 . . . . 0.0 111.17 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.0 t -145.46 127.81 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 136.42 38.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.606 171.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.8 mt -129.88 128.52 22.92 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.2 -178.95 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.44 2.76 . . . . 0.0 112.59 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -80.61 140.88 35.51 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.828 -1.17 . . . . 0.0 108.923 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.0 12.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 128.567 2.747 . . . . 0.0 115.71 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.2 9.16 1.1 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.044 1.783 . . . . 0.0 111.615 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -71.92 137.57 47.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.086 -1.243 . . . . 0.0 110.106 -171.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG2' ' CG ' ' A' ' 72' ' ' LYS . 10.5 mt-10 -85.35 149.44 25.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.623 -0.673 . . . . 0.0 110.285 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.76 177.35 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.174 0.99 . . . . 0.0 109.527 -172.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -126.25 170.98 11.31 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 125.659 1.584 . . . . 0.0 109.589 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.81 10.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.77 66.74 0.24 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.55 115.81 13.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.06 114.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.476 1.111 . . . . 0.0 108.257 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -146.09 0.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.754 1.222 . . . . 0.0 112.718 -168.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.96 39.63 0.94 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.216 1.006 . . . . 0.0 108.385 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -50.66 165.66 0.1 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.992 1.717 . . . . 0.0 111.538 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mt -139.45 145.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.99 116.6 17.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.936 1.694 . . . . 0.0 107.234 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -105.6 -167.71 1.36 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.615 1.566 . . . . 0.0 111.02 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 m -44.86 -39.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 114.152 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -165.75 72.57 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 149.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.07 167.24 22.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.8 154.85 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 159.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.26 109.02 4.37 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.255 1.022 . . . . 0.0 109.701 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.2 114.54 4.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.575 1.55 . . . . 0.0 108.371 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.46 104.31 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.33 105.55 17.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.954 0.797 . . . . 0.0 110.341 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.66 142.33 1.07 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.434 1.894 . . . . 0.0 112.876 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.08 -35.32 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.18 1.92 . . . . 0.0 113.259 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -138.84 145.75 40.4 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.958 2.103 . . . . 0.0 107.147 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -64.44 137.86 58.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 167.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.48 -177.91 44.09 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -155.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' CG ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -129.9 140.62 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 173.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -65.67 145.46 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.51 -3.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 O-C-N 123.359 0.412 . . . . 0.0 111.753 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.14 151.47 30.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.2 m -141.54 149.6 20.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -99.47 75.8 1.98 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.0 -14.89 2.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -53.01 -34.64 57.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.066 1.347 . . . . 0.0 111.919 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -9.05 41.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 112.024 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.07 -28.68 69.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.786 1.634 . . . . 0.0 112.912 166.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -126.93 -27.55 3.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.947 1.699 . . . . 0.0 110.818 -167.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -125.94 65.03 53.82 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.202 1.801 . . . . 0.0 108.511 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -72.26 -51.62 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.594 2.863 . . . . 0.0 108.654 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -15.65 0.39 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.226 2.21 . . . . 0.0 111.322 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.04 41.23 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 122.632 2.469 . . . . 0.0 110.999 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.0 mt -51.33 -30.34 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 120.814 -1.179 . . . . 0.0 110.4 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -73.45 -51.73 16.16 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.71 -1.244 . . . . 0.0 111.581 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -70.23 -38.73 75.29 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.098 1.759 . . . . 0.0 110.76 -163.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -156.11 67.58 4.66 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 123.03 0.532 . . . . 0.0 111.332 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.88 -20.99 69.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.53 2.82 . . . . 0.0 113.535 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.405 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 5.1 mt-10 -123.11 20.05 9.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.593 0.757 . . . . 0.0 110.535 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -123.83 -93.0 1.04 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -79.92 -32.14 40.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.264 1.032 . . . . 0.0 112.869 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.35 37.73 2.03 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 120.23 1.377 . . . . 0.0 114.58 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -68.87 165.02 20.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.871 1.835 . . . . 0.0 109.732 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -108.93 -61.37 1.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -148.85 172.23 15.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.769 0.827 . . . . 0.0 111.068 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -134.95 152.32 51.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.48 1.512 . . . . 0.0 108.795 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.44 144.82 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.912 0.485 . . . . 0.0 110.68 -166.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.16 128.25 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.266 1.826 . . . . 0.0 107.029 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 pt -86.95 95.86 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.794 0.807 . . . . 0.0 109.987 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 m -81.67 -11.33 59.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.762 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.49 96.51 3.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 171.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -4.98 57.68 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.304 -0.248 . . . . 0.0 110.671 171.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.79 -55.22 9.92 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -18.4 47.0 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 125.822 1.649 . . . . 0.0 113.486 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.7 mt -44.14 -37.16 2.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.893 1.679 . . . . 0.0 111.48 169.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.24 -13.23 60.42 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.601 0.637 . . . . 0.0 112.265 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.38 -35.22 68.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.299 1.04 . . . . 0.0 109.574 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.83 167.88 19.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.327 1.451 . . . . 0.0 108.256 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 mt -77.82 131.59 37.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -55.55 171.64 0.19 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 122.491 1.138 . . . . 0.0 108.647 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.96 -39.45 79.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 111.414 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -64.57 -45.64 86.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.509 -0.745 . . . . 0.0 109.417 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.4 86.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.314 0.646 . . . . 0.0 111.038 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.1 -45.04 96.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.761 1.624 . . . . 0.0 110.832 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -48.16 73.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.972 0.509 . . . . 0.0 110.179 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 CA--C 1.541 0.602 0 O-C-N 122.034 -0.416 . . . . 0.0 111.479 -179.317 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.78 113.54 11.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.271 1.396 . . . . 0.0 110.545 169.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.07 174.34 5.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 167.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.93 179.0 5.41 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.722 2.809 . . . . 0.0 110.958 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -139.53 167.06 22.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.4 1.88 . . . . 0.0 109.214 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.73 -7.87 56.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.24 0.616 . . . . 0.0 112.489 168.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -94.37 19.12 9.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.481 -1.387 . . . . 0.0 112.173 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 58.32 43.94 19.29 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.289 1.836 . . . . 0.0 111.566 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -124.11 149.86 45.72 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.739 -1.226 . . . . 0.0 109.91 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.517 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.1 p-90 -111.55 163.76 13.72 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.3 1.84 . . . . 0.0 109.109 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.53 100.81 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -168.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -85.25 95.17 9.1 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 119.609 1.095 . . . . 0.0 109.441 172.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 mp -74.43 141.62 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 119.897 1.226 . . . . 0.0 107.834 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.54 -101.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.607 1.163 . . . . 0.0 108.147 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.24 -77.57 0.46 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -126.51 16.72 7.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.49 1.516 . . . . 0.0 111.095 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.84 155.36 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -129.43 136.57 50.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.989 1.316 . . . . 0.0 108.305 166.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.0 m -83.65 138.54 33.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.85 134.54 55.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.691 1.996 . . . . 0.0 108.632 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.78 164.62 28.83 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 163.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 pt -73.77 154.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 O-C-N 122.029 -0.689 . . . . 0.0 109.325 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 79.3 p -75.42 166.34 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.334 -0.854 . . . . 0.0 109.802 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.67 -34.43 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.939 -1.101 . . . . 0.0 112.674 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -59.89 -28.09 67.26 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.0 -1.063 . . . . 0.0 111.959 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.71 -57.31 4.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.546 0.738 . . . . 0.0 111.21 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -56.59 -27.88 59.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.693 1.133 . . . . 0.0 112.326 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.99 -32.26 61.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.039 1.336 . . . . 0.0 111.047 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -88.92 -46.52 8.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.906 -0.569 . . . . 0.0 109.787 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -34.92 78.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 118.158 -0.925 . . . . 0.0 113.176 -174.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.94 -126.58 41.1 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -169.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.69 34.05 0.33 Allowed 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -145.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.439 ' HA ' ' HB2' ' A' ' 58' ' ' SER 0.398 2.2 p -23.06 -111.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 115.683 -2.103 . . . . 0.0 112.846 -122.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 166.38 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.112 2.165 . . . . 0.0 109.032 -168.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.412 ' H ' HG21 ' A' ' 35' ' ' VAL . 83.3 t80 -161.8 166.68 26.11 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.494 0.717 . . . . 0.0 110.165 -165.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.17 134.34 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.915 1.686 . . . . 0.0 107.757 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.64 143.18 28.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.416 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.11 151.5 70.0 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 123.671 0.789 . . . . 0.0 109.326 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -72.12 174.32 11.55 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.959 1.773 . . . . 0.0 111.396 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 44' ' ' GLY . 2.3 tt0 -78.64 150.9 32.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 167.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.81 17.2 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 127.713 2.405 . . . . 0.0 114.098 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 42' ' ' GLU . . . -154.08 6.44 0.35 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 128.623 3.011 . . . . 0.0 111.922 -176.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -67.18 125.73 26.96 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.019 1.41 . . . . 0.0 108.267 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.62 143.65 40.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 m -144.29 -176.73 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.667 0.787 . . . . 0.0 109.647 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -138.95 167.78 21.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.539 1.536 . . . . 0.0 109.772 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -67.83 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -172.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.9 66.5 0.24 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 161.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.48 123.19 47.93 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.184 1.393 . . . . 0.0 113.083 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 0.1 OUTLIER -65.5 21.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 129.149 2.98 . . . . 0.0 115.113 -174.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -62.84 8.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 119.142 -2.224 . . . . 0.0 116.273 -168.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.68 51.48 1.05 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.026 1.285 . . . . 0.0 110.706 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.19 148.29 36.87 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 123.155 1.455 . . . . 0.0 110.783 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.29 142.56 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -118.88 142.33 47.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 155.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' ' 35' ' ' VAL . 82.6 p -111.51 -173.85 2.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.237 1.381 . . . . 0.0 108.344 155.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -40.65 -37.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.99 1.716 . . . . 0.0 113.174 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.13 0.11 1.03 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 159.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.804 2.093 . . . . 0.0 110.464 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.4 162.56 35.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.097 1.359 . . . . 0.0 108.545 160.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.04 112.28 2.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.733 0.813 . . . . 0.0 109.919 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.56 127.92 33.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.033 1.733 . . . . 0.0 107.989 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.8 t -102.48 109.29 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 120.697 1.589 . . . . 0.0 106.996 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.32 99.47 10.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.465 1.03 . . . . 0.0 112.125 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -35.66 124.84 0.64 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.514 1.925 . . . . 0.0 112.843 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.54 -24.57 10.36 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.694 2.262 . . . . 0.0 114.845 -160.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -133.5 158.64 42.59 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.243 1.817 . . . . 0.0 108.619 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -75.57 153.85 37.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.886 0.85 . . . . 0.0 109.842 165.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.74 -174.54 30.04 Favored Glycine 0 C--O 1.237 0.293 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -160.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.49 141.35 51.68 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.7 mm -67.7 146.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 173.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.19 -11.28 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.0 151.6 42.65 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.6 159.99 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.384 1.474 . . . . 0.0 107.177 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.469 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 39.2 t30 -104.43 90.03 3.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -172.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.47 -14.6 30.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.924 1.29 . . . . 0.0 112.585 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.469 ' HE2' ' OD1' ' A' ' 77' ' ' ASN . 25.4 mtmm -55.96 -42.09 75.7 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.802 1.241 . . . . 0.0 111.787 167.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -21.9 61.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.947 0.794 . . . . 0.0 109.937 -170.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -57.63 -49.51 76.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.634 1.574 . . . . 0.0 109.063 167.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.8 p -82.98 -30.83 27.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.645 0.778 . . . . 0.0 112.364 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -149.86 71.8 9.57 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.2 1.0 . . . . 0.0 109.048 -166.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -50.82 -41.54 54.68 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.232 3.288 . . . . 0.0 112.651 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.412 ' HA ' ' CG1' ' A' ' 35' ' ' VAL . 11.1 pt-20 -65.54 -2.88 3.75 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.664 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.66 -22.61 64.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 123.657 2.935 . . . . 0.0 112.169 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -61.02 -23.83 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.292 0.637 . . . . 0.0 109.819 174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -71.77 -58.16 3.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.811 -1.181 . . . . 0.0 109.647 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.09 -35.31 59.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 126.397 1.879 . . . . 0.0 111.474 -172.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.16 100.43 0.49 Allowed Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 168.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.43 -12.45 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.317 1.345 . . . . 0.0 113.14 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.517 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -118.37 -19.54 8.85 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.662 1.119 . . . . 0.0 113.779 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -77.97 -90.24 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -99.05 -17.17 18.39 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.98 0.912 . . . . 0.0 111.738 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.66 30.94 3.37 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.043 1.306 . . . . 0.0 114.197 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -72.24 164.82 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.293 1.546 . . . . 0.0 110.559 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mt -100.3 -66.93 0.88 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -142.39 172.82 12.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.941 0.897 . . . . 0.0 110.789 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -124.98 154.62 40.94 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.843 0.857 . . . . 0.0 109.47 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.71 142.42 34.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.871 0.869 . . . . 0.0 110.442 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -81.32 113.95 19.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.231 1.812 . . . . 0.0 107.45 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 pt -76.44 103.0 3.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.965 0.906 . . . . 0.0 110.416 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -60.02 -37.78 80.75 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.123 0.569 . . . . 0.0 111.84 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.6 93.45 2.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.06 -12.48 55.65 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.839 0.828 . . . . 0.0 109.95 168.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.45 72.48 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 120.701 -1.249 . . . . 0.0 110.983 173.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -72.55 -7.79 51.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.424 1.112 . . . . 0.0 111.586 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.19 -26.94 66.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.382 1.446 . . . . 0.0 111.384 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -78.39 -29.14 47.12 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 110.38 -167.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.94 -19.22 64.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 129.135 2.974 . . . . 0.0 112.364 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.3 mt -73.2 -170.41 0.77 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.368 1.467 . . . . 0.0 109.673 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.34 132.59 54.29 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.343 -0.848 . . . . 0.0 108.943 -171.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -60.13 165.4 3.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 157.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.21 -46.87 72.55 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -62.8 -33.38 75.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.08 0.4 . . . . 0.0 111.487 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.84 77.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.471 0.708 . . . . 0.0 110.433 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.85 -32.5 73.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.648 -0.657 . . . . 0.0 112.111 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.0 -56.53 17.04 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.728 1.611 . . . . 0.0 108.806 168.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 N--CA 1.452 -0.371 0 C-N-CA 124.548 1.139 . . . . 0.0 110.161 -171.927 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.6 ttp . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -155.21 98.41 1.99 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.164 1.347 . . . . 0.0 113.295 -167.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -95.02 -177.03 4.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.314 0.578 . . . . 0.0 111.865 168.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -138.1 172.99 12.1 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 127.684 2.393 . . . . 0.0 109.867 -170.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.9 p -121.49 173.34 7.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.822 1.649 . . . . 0.0 108.733 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -34.58 46.29 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.36 163.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 p -75.22 23.49 0.11 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.818 1.247 . . . . 0.0 112.541 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.273 0.0 OUTLIER 60.84 52.81 4.08 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 128.076 2.55 . . . . 0.0 112.799 165.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -125.15 140.97 52.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.517 1.927 . . . . 0.0 108.572 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.471 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 63.5 p-90 -94.85 159.83 14.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.13 100.32 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -85.03 85.67 7.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.945 -1.097 . . . . 0.0 109.55 175.154 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 mp -69.5 134.95 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -122.17 -68.76 0.87 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.851 0.46 . . . . 0.0 110.068 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -120.76 -83.95 0.66 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -125.82 12.84 7.93 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.712 1.205 . . . . 0.0 110.57 170.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.8 t -128.58 149.92 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -118.77 140.36 50.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 166.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.8 m -91.57 133.25 35.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 t -110.6 138.58 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.203 1.401 . . . . 0.0 109.946 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.34 169.03 29.01 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.05 2.262 . . . . 0.0 108.207 164.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.55 159.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.934 1.367 . . . . 0.0 110.256 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.0 p -85.18 167.51 15.64 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.297 -0.877 . . . . 0.0 112.683 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.28 -42.36 69.91 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.566 -1.334 . . . . 0.0 112.728 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -57.63 -9.36 1.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.321 1.048 . . . . 0.0 113.145 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.94 -46.79 4.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.553 -1.342 . . . . 0.0 111.53 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -58.94 -26.58 64.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.923 1.238 . . . . 0.0 110.862 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -38.4 75.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.42 1.088 . . . . 0.0 111.516 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -82.61 -19.92 37.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.048 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.68 -31.91 9.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.697 0.681 . . . . 0.0 111.51 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.53 -123.77 29.89 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.09 114.96 4.04 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.548 HG13 ' H ' ' A' ' 36' ' ' VAL . 1.3 t -94.61 -170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 160.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.548 ' H ' HG13 ' A' ' 35' ' ' VAL . 1.1 p -172.84 -30.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.78 1.232 . . . . 0.0 108.04 -147.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -153.43 160.37 42.58 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.746 0.654 . . . . 0.0 112.3 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.75 145.88 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 156.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.64 150.21 22.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.993 -1.003 . . . . 0.0 108.749 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -134.68 155.46 79.46 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 120.708 1.595 . . . . 0.0 111.045 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.34 -163.63 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 125.231 3.954 . . . . 0.0 109.563 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -108.66 148.92 29.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.582 1.153 . . . . 0.0 110.972 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.29 11.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 131.47 3.908 . . . . 0.0 117.633 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.62 17.43 0.57 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.556 2.027 . . . . 0.0 112.178 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -79.16 141.31 37.34 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.318 -1.107 . . . . 0.0 108.218 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -82.06 156.01 24.81 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.4 m -139.08 160.74 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.401 1.48 . . . . 0.0 110.236 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -124.09 162.64 23.11 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.106 2.162 . . . . 0.0 107.095 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -74.99 23.33 0.1 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -159.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -152.54 18.44 0.78 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.731 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -78.17 143.31 37.33 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 120.162 1.981 . . . . 0.0 111.218 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.0 106.95 18.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.6 m -133.84 -2.71 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -163.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.07 46.31 0.24 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.427 0.691 . . . . 0.0 110.007 -162.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -51.27 160.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.854 0.862 . . . . 0.0 111.694 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mt -128.45 111.69 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -109.01 130.99 55.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.6 p -112.62 -172.45 2.05 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.95 1.3 . . . . 0.0 110.22 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -48.77 -43.76 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.107 1.363 . . . . 0.0 111.736 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -155.77 88.05 1.1 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.163 1.385 . . . . 0.0 108.989 158.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 177.38 178.61 0.28 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.512 1.925 . . . . 0.0 108.699 161.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.75 147.66 52.32 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.507 1.523 . . . . 0.0 110.818 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.68 99.87 4.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.433 2.293 . . . . 0.0 106.444 170.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.29 121.85 15.26 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -80.79 123.53 37.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -103.62 105.32 15.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.787 0.835 . . . . 0.0 108.849 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -27.09 113.0 0.24 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 128.704 2.801 . . . . 0.0 112.314 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.85 -34.2 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.73 1.62 . . . . 0.0 113.164 -164.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.18 165.65 20.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.486 1.914 . . . . 0.0 107.231 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -67.4 152.23 46.05 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 108.103 155.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.41 -167.59 31.95 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 132.3 23.4 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.66 143.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.83 -3.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.869 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.1 159.81 36.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.062 0.846 . . . . 0.0 109.978 166.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -141.16 152.23 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.913 1.685 . . . . 0.0 107.663 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -98.78 76.21 2.16 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.59 -11.66 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.856 1.662 . . . . 0.0 113.349 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -36.79 68.38 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.663 1.585 . . . . 0.0 112.86 167.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -10.39 59.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.51 1.05 . . . . 0.0 111.761 -165.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -41.81 -55.15 3.14 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 128.098 2.559 . . . . 0.0 111.93 155.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 79.2 p -118.69 -3.98 10.78 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.754 1.222 . . . . 0.0 111.863 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -132.04 56.45 23.63 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.324 1.45 . . . . 0.0 110.879 170.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 -28.42 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.507 2.138 . . . . 0.0 109.407 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.88 -17.41 64.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.529 1.132 . . . . 0.0 111.111 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -21.92 65.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 120.619 1.554 . . . . 0.0 111.831 173.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.41 -14.8 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 120.167 -1.583 . . . . 0.0 110.538 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -84.86 -55.01 4.3 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 120.022 -1.674 . . . . 0.0 110.556 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -62.98 -31.41 72.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.273 1.029 . . . . 0.0 112.091 -168.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -162.59 77.22 1.97 Allowed Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 123.907 0.883 . . . . 0.0 110.463 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.69 -18.06 45.94 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 113.194 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.471 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 4.2 mt-10 -123.43 11.84 9.33 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.829 0.852 . . . . 0.0 111.465 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.39 -108.4 2.07 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.15 -18.44 63.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.475 0.71 . . . . 0.0 112.644 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.44 27.04 4.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.225 1.393 . . . . 0.0 114.489 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -64.85 165.81 10.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.8 1.8 . . . . 0.0 110.164 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 mt -110.01 -60.91 1.73 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.76 168.83 21.87 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.3 -0.875 . . . . 0.0 110.88 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -123.59 141.68 51.77 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.318 1.447 . . . . 0.0 108.425 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.7 ptm -141.65 140.18 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.842 0.857 . . . . 0.0 110.275 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.27 136.42 40.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 34.3 pt -87.02 117.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 t -83.59 -18.22 38.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.857 167.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -143.12 86.57 1.92 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -157.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.22 -12.17 60.49 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 0.0 111.079 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.03 -57.66 18.11 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -69.43 -1.88 9.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.568 1.147 . . . . 0.0 113.019 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.48 -38.44 87.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.312 -0.867 . . . . 0.0 110.115 164.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.59 -5.31 59.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.295 1.438 . . . . 0.0 111.323 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.07 -18.77 60.78 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.427 -0.796 . . . . 0.0 110.132 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.6 mt -87.18 -159.17 0.49 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.04 1.336 . . . . 0.0 112.477 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.9 mt -110.29 135.78 50.49 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.094 2.157 . . . . 0.0 109.761 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.3 172.65 1.84 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 162.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -63.32 -48.05 79.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.861 1.664 . . . . 0.0 110.086 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.28 -40.68 96.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.181 0.992 . . . . 0.0 111.644 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.23 75.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.77 0.828 . . . . 0.0 110.152 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.79 -43.42 69.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.858 0.863 . . . . 0.0 110.419 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 . . . . . 0 N--CA 1.449 -0.522 0 C-N-CA 123.189 0.596 . . . . 0.0 111.042 175.072 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ptm . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -160.07 125.05 3.92 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 121.041 -1.037 . . . . 0.0 109.985 -167.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HE2' ' OD1' ' A' ' 113' ' ' ASP . 6.6 mmtp -128.12 -177.45 4.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.334 1.054 . . . . 0.0 109.821 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 179.62 6.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.5 1.92 . . . . 0.0 111.042 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -138.4 173.32 11.73 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.711 1.596 . . . . 0.0 111.912 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.02 -2.89 53.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.253 2.221 . . . . 0.0 112.9 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -102.14 48.37 0.88 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 p80 45.54 57.01 5.25 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.431 168.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -132.64 152.73 51.58 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.618 1.167 . . . . 0.0 108.33 -167.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.1 p-90 -124.43 162.53 23.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.081 0.952 . . . . 0.0 111.699 170.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.81 161.72 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.85 2.46 . . . . 0.0 107.705 172.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.73 94.57 1.9 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.464 1.906 . . . . 0.0 107.469 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.7 mt -98.54 95.03 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -78.11 -49.89 13.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.898 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.07 -71.68 0.68 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.259 0.936 . . . . 0.0 110.128 -171.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -138.94 10.31 2.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.627 1.571 . . . . 0.0 111.85 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.32 121.13 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -162.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 119.31 22.68 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.4 m -68.17 137.06 54.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 152.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.41 142.7 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.256 1.422 . . . . 0.0 109.772 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.71 176.73 34.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 pt -97.14 156.57 3.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 121.531 0.682 . . . . 0.0 110.697 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 169.59 17.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 112.57 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -24.28 62.52 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.64 -1.288 . . . . 0.0 111.367 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.65 -30.42 71.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.958 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.99 66.06 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.037 -1.039 . . . . 0.0 112.468 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -63.3 -19.82 64.94 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.66 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.01 -0.59 7.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.337 1.455 . . . . 0.0 113.434 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -115.04 -31.01 6.19 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 160.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.42 -46.49 54.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.44 -147.0 43.22 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.81 112.5 0.62 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.566 2.346 . . . . 0.0 110.51 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 36' ' ' VAL 0.345 9.0 p -108.31 165.7 4.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 123.309 1.528 . . . . 0.0 111.275 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -152.43 -28.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.839 -154.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -146.3 143.57 29.24 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.433 0.56 . . . . 0.0 110.846 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.57 125.91 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.656 1.582 . . . . 0.0 107.915 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.89 139.86 43.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.382 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.1 mt -133.04 139.25 33.82 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.73 1.212 . . . . 0.0 107.932 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.45 -179.63 5.36 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.269 2.646 . . . . 0.0 112.041 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.25 145.67 43.87 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.9 18.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 129.178 2.991 . . . . 0.0 115.36 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.17 13.46 0.46 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.183 1.849 . . . . 0.0 112.138 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -76.58 132.73 39.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.789 1.294 . . . . 0.0 108.96 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.98 152.41 33.14 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.983 0.81 . . . . 0.0 109.212 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.82 174.08 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 122.354 1.073 . . . . 0.0 111.07 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -112.28 170.2 8.34 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.317 2.247 . . . . 0.0 107.9 165.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.87 18.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.616 2.366 . . . . 0.0 115.221 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.08 59.14 0.24 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.2 131.12 56.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.742 1.217 . . . . 0.0 108.112 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 52' ' ' VAL 0.297 0.1 OUTLIER -77.69 27.51 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.877 2.871 . . . . 0.0 114.232 -168.032 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.06 12.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.76 54.26 1.17 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 171.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.83 159.3 2.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mt -139.85 135.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -127.76 110.99 13.16 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -99.15 -164.24 1.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.456 1.902 . . . . 0.0 110.775 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -45.89 -34.86 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.338 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -165.91 15.87 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 160.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.33 138.37 31.57 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.4 124.66 52.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 161.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.06 92.49 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.126 0.97 . . . . 0.0 109.303 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -58.72 108.06 0.6 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 108.8 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.22 93.75 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -82.41 109.74 16.92 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.666 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.87 150.01 0.39 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.922 2.489 . . . . 0.0 114.329 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.23 -36.53 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.819 1.679 . . . . 0.0 115.801 -161.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -148.03 139.57 23.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.114 1.365 . . . . 0.0 108.806 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -51.17 129.4 24.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.404 0.621 . . . . 0.0 109.393 170.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.03 -174.52 44.79 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 107.061 -2.416 . . . . 0.0 107.061 -161.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -142.56 127.95 18.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -166.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -59.52 142.46 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -145.99 -2.51 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -147.24 156.66 43.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 121.097 1.771 . . . . 0.0 108.44 165.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.83 153.47 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.045 0.938 . . . . 0.0 109.168 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -104.73 78.83 1.47 Allowed 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.446 0.698 . . . . 0.0 109.398 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -57.03 -14.88 4.12 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.979 0.912 . . . . 0.0 112.76 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -50.68 -39.56 51.46 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.989 1.716 . . . . 0.0 111.955 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -3.25 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.56 0.744 . . . . 0.0 112.501 -170.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.86 -49.96 53.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.011 1.278 . . . . 0.0 109.16 160.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.0 p -92.34 -39.31 11.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.069 -162.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -117.33 67.39 4.86 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.097 1.759 . . . . 0.0 109.517 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.51 -44.83 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.953 3.769 . . . . 0.0 110.837 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -61.69 -4.45 1.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.125 1.37 . . . . 0.0 109.905 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -58.15 -13.58 5.19 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 121.426 1.921 . . . . 0.0 114.076 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.2 mm -53.33 -39.68 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 118.619 0.645 . . . . 0.0 109.78 164.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -69.61 -55.79 9.11 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.046 1.339 . . . . 0.0 109.42 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.82 78.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 -164.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -153.32 74.01 6.76 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -57.32 -23.5 54.96 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.776 2.317 . . . . 0.0 112.381 -172.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.2 mp0 -118.67 9.42 12.16 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.263 1.025 . . . . 0.0 112.147 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.93 -110.29 2.7 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.244 1.878 . . . . 0.0 109.597 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.96 -28.29 69.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.458 1.129 . . . . 0.0 111.093 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.54 25.22 1.4 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-N 119.721 1.146 . . . . 0.0 115.76 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.425 ' CH2' ' HE3' ' A' ' 99' ' ' LYS . 46.0 p-90 -67.57 163.06 22.05 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.288 1.544 . . . . 0.0 110.404 171.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mt -106.16 -66.96 0.96 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -140.92 175.95 9.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.569 1.147 . . . . 0.0 109.387 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.425 ' HE3' ' CH2' ' A' ' 96' ' ' TRP . 65.9 mttt -131.88 152.45 51.03 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 124.307 1.043 . . . . 0.0 108.297 171.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.32 134.89 23.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.342 0.657 . . . . 0.0 110.04 -172.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.66 127.37 31.68 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 167.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 pt -76.53 109.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.1 m -65.97 -21.55 66.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.949 -0.47 . . . . 0.0 111.198 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -151.63 88.33 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -157.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -11.92 59.93 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.933 0.788 . . . . 0.0 111.662 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.78 -41.16 95.84 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.92 -22.66 66.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 117.416 -1.278 . . . . 0.0 111.928 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.4 mt -52.62 -30.96 34.2 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -79.21 -11.38 59.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.596 0.635 . . . . 0.0 112.069 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -74.89 -34.44 62.19 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.815 -0.553 . . . . 0.0 110.928 168.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.65 158.98 34.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.743 1.259 . . . . 0.0 108.132 -173.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.42 130.85 40.42 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.472 ' OD1' ' HE2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -69.82 -167.81 0.16 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 164.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.14 -39.69 65.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 119.768 -1.832 . . . . 0.0 113.544 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.73 -48.44 31.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.45 81.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.139 0.274 . . . . 0.0 111.408 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -53.99 -54.77 34.48 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.101 0.961 . . . . 0.0 109.866 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -39.4 74.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.103 0.961 . . . . 0.0 111.652 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 N--CA 1.448 -0.569 0 C-N-CA 124.51 1.124 . . . . 0.0 111.677 178.396 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.6 ttm . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 116.8 13.96 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 119.977 -1.702 . . . . 0.0 110.842 157.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -112.99 -179.76 3.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -130.65 170.66 14.01 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 127.191 2.196 . . . . 0.0 110.855 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -117.79 -174.67 2.68 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.665 1.586 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -106.71 10.68 30.86 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.816 1.246 . . . . 0.0 112.271 163.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -105.64 17.7 23.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.477 1.111 . . . . 0.0 111.26 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 72.23 42.5 0.56 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.892 2.077 . . . . 0.0 111.379 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -131.82 139.36 48.84 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.898 1.679 . . . . 0.0 110.879 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.477 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 69.9 p-90 -103.24 164.36 11.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.765 1.626 . . . . 0.0 109.583 171.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.57 99.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -86.84 91.88 8.8 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.741 -1.224 . . . . 0.0 110.668 173.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.54 119.17 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 6.9 pt-20 -97.83 -72.94 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.412 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 8.0 t70 -116.49 -105.65 0.39 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -93.62 14.04 20.19 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.51 1.124 . . . . 0.0 110.698 166.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.27 152.06 35.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -123.16 137.07 54.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.784 1.633 . . . . 0.0 108.521 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -77.84 138.31 38.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 160.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.2 143.79 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.951 0.9 . . . . 0.0 109.669 171.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.75 165.93 29.23 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.979 -2.049 . . . . 0.0 107.979 164.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.6 pt -76.6 160.1 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.806 -0.82 . . . . 0.0 109.576 168.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.2 p -84.58 166.51 17.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.07 0.948 . . . . 0.0 111.304 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -34.63 67.07 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.652 -1.28 . . . . 0.0 111.267 175.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -58.36 -23.4 56.79 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.955 -1.09 . . . . 0.0 112.724 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.78 -49.64 8.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.414 -1.429 . . . . 0.0 111.349 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -56.09 -28.54 58.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.116 0.871 . . . . 0.0 110.899 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -55.83 -23.29 29.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.821 1.648 . . . . 0.0 113.288 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -109.63 -11.63 14.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.96 1.304 . . . . 0.0 112.776 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.52 -43.86 11.71 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.097 0.862 . . . . 0.0 111.0 173.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.75 -149.65 51.61 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.85 114.7 2.43 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.023 1.329 . . . . 0.0 109.228 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.549 HG23 ' H ' ' A' ' 36' ' ' VAL 0.344 8.4 p -105.65 167.57 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 124.192 1.949 . . . . 0.0 110.36 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.549 ' H ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.29 -30.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 112.316 -2.22 . . . . 0.0 107.396 -148.202 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -149.08 153.81 38.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.782 0.719 . . . . 0.0 111.329 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.1 t -145.3 118.73 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 127.304 2.242 . . . . 0.0 106.579 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -69.29 140.06 54.39 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.73 136.55 29.32 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.05 -172.74 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.157 3.238 . . . . 0.0 111.391 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.83 156.28 19.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.53 0.732 . . . . 0.0 111.897 171.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.78 13.63 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.031 1.732 . . . . 0.0 113.34 -172.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.21 12.94 0.61 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.654 2.073 . . . . 0.0 111.566 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -66.13 119.75 11.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.85 141.99 40.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 174.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.24 157.32 25.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.978 0.911 . . . . 0.0 110.352 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 50' ' ' GLY . 55.0 mmtt -104.95 171.01 7.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.499 1.52 . . . . 0.0 109.446 167.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -65.38 13.88 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -154.39 25.93 0.68 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.55 1.072 . . . . 0.0 112.24 177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.62 124.79 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 108.793 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.27 109.03 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.28 8.79 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.868 0.867 . . . . 0.0 111.646 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.28 51.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.806 -0.559 . . . . 0.0 110.173 -171.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.83 161.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.293 1.037 . . . . 0.0 112.709 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mt -143.49 108.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.61 98.95 9.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.047 1.339 . . . . 0.0 107.924 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.2 p -84.55 -163.2 0.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.31 0.644 . . . . 0.0 110.487 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.01 -41.5 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.411 1.484 . . . . 0.0 112.538 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -167.6 20.53 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.009 0.923 . . . . 0.0 113.277 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.78 160.36 14.41 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 120.031 -1.668 . . . . 0.0 108.546 161.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.42 84.72 1.97 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 171.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.22 118.32 22.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -77.04 111.48 12.66 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 167.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.0 t -79.21 118.0 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -100.33 98.51 9.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.092 1.357 . . . . 0.0 111.759 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.75 135.62 1.25 Allowed Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.031 1.733 . . . . 0.0 113.301 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.55 -37.47 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.486 2.124 . . . . 0.0 114.707 -161.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.42 164.59 16.88 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 m -69.12 137.16 53.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 155.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.61 33.79 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -135.27 129.55 33.76 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.9 145.74 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.49 -2.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.749 0.82 . . . . 0.0 113.07 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -154.3 153.79 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.62 150.35 30.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.44 85.74 5.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -16.35 51.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -51.62 -36.34 45.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.272 1.829 . . . . 0.0 111.79 168.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -10.43 59.79 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.721 0.809 . . . . 0.0 111.567 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.26 -42.26 79.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.915 1.234 . . . . 0.0 109.552 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.6 p -95.64 -41.03 9.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.704 0.802 . . . . 0.0 111.25 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.19 72.54 9.47 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.431 1.892 . . . . 0.0 109.72 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.13 -38.8 4.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.06 3.173 . . . . 0.0 110.38 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.18 -13.46 12.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.574 1.15 . . . . 0.0 111.363 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -19.83 41.1 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.261 1.391 . . . . 0.0 112.815 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.8 mt -63.88 -26.22 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 121.519 -0.738 . . . . 0.0 110.893 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.35 -57.14 13.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.299 1.047 . . . . 0.0 109.263 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.19 -64.08 0.95 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.623 2.769 . . . . 0.0 110.355 -165.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -136.88 60.66 30.86 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -165.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.96 -15.48 39.13 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.151 2.567 . . . . 0.0 113.682 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.477 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -125.5 7.57 7.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.632 2.373 . . . . 0.0 110.747 -170.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.42 -96.77 1.79 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 168.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.18 -20.28 32.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.204 0.602 . . . . 0.0 112.003 -171.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.0 32.85 4.19 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.43 1.014 . . . . 0.0 113.344 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -65.5 160.6 21.87 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 1.373 . . . . 0.0 109.859 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mt -104.71 -62.0 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -141.82 167.63 21.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.503 0.721 . . . . 0.0 111.459 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -117.5 150.57 38.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.282 1.033 . . . . 0.0 108.67 165.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.3 ptm -145.32 140.69 27.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.351 0.661 . . . . 0.0 109.864 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -64.0 121.51 14.29 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.559 1.144 . . . . 0.0 107.921 168.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.0 pt -71.51 98.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -75.37 -10.03 59.09 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.81 -0.557 . . . . 0.0 111.59 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -151.49 95.14 2.1 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.379 1.871 . . . . 0.0 107.068 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -8.61 55.33 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.63 -1.294 . . . . 0.0 111.507 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.92 -40.44 98.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -67.05 -9.97 44.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.728 1.611 . . . . 0.0 112.049 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.15 -20.27 65.72 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.756 1.162 . . . . 0.0 110.557 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -72.29 -18.0 61.83 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.894 1.224 . . . . 0.0 111.537 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.19 -19.81 49.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.052 0.842 . . . . 0.0 111.091 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.52 175.17 8.78 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.951 1.301 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.3 mt -106.44 149.63 26.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.863 1.265 . . . . 0.0 110.823 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.99 169.12 10.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.383 1.073 . . . . 0.0 108.294 163.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.67 -49.65 61.73 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.948 1.299 . . . . 0.0 109.843 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -60.56 -41.79 95.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.705 0.802 . . . . 0.0 110.612 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.88 -37.18 83.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.121 0.568 . . . . 0.0 110.718 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.03 -39.09 86.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.548 0.739 . . . . 0.0 110.692 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -47.66 84.37 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.272 0.629 . . . . 0.0 110.694 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 CA--C 1.54 0.574 0 CA-C-N 118.547 0.612 . . . . 0.0 111.421 -179.449 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.811 0.339 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -159.82 70.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 110.143 -170.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -81.42 176.72 9.47 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.71 -1.244 . . . . 0.0 112.956 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -132.91 161.68 33.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.555 2.342 . . . . 0.0 111.723 -171.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -103.4 177.23 4.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 123.181 1.467 . . . . 0.0 109.68 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -101.39 19.16 18.32 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.504 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -134.04 44.14 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.816 1.647 . . . . 0.0 109.894 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 p80 41.47 55.07 3.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.534 1.534 . . . . 0.0 113.118 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -143.81 134.39 24.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.751 2.021 . . . . 0.0 107.479 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -92.65 172.72 8.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.234 1.414 . . . . 0.0 109.29 167.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.53 148.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.46 90.98 2.51 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.027 0.531 . . . . 0.0 111.696 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.0 mt -95.76 102.87 14.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.991 1.316 . . . . 0.0 107.468 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -79.02 -76.49 0.2 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.245 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -106.07 -82.71 0.53 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.081 0.855 . . . . 0.0 109.219 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.18 13.72 11.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.834 0.854 . . . . 0.0 111.339 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -137.41 126.08 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.45 154.86 20.03 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.938 0.875 . . . . 0.0 108.843 162.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.9 m -106.5 155.4 19.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.994 157.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.63 142.64 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.239 3.416 . . . . 0.0 104.765 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 96' ' ' TRP . . . -160.37 32.66 0.4 Allowed Glycine 0 N--CA 1.477 1.376 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.6 pt 44.07 162.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 131.215 3.806 . . . . 0.0 114.663 -169.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.9 p -93.46 170.78 9.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.496 -2.003 . . . . 0.0 110.92 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -31.36 70.98 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.629 -1.294 . . . . 0.0 111.659 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -59.45 -24.21 63.35 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.043 0.937 . . . . 0.0 111.66 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.71 -54.22 6.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.945 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.11 -26.8 51.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.424 0.69 . . . . 0.0 111.947 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.56 -54.62 41.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.138 1.775 . . . . 0.0 110.928 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -62.18 -49.01 77.51 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.245 1.018 . . . . 0.0 110.63 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.82 -38.57 83.42 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.363 1.065 . . . . 0.0 109.515 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.74 -118.77 10.14 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.192 1.853 . . . . 0.0 108.928 -168.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.6 159.59 21.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.685 0.755 . . . . 0.0 109.681 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.661 ' CG1' ' H ' ' A' ' 36' ' ' VAL . 6.4 t -132.74 -172.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.014 1.325 . . . . 0.0 107.914 171.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.661 ' H ' ' CG1' ' A' ' 35' ' ' VAL . 3.1 m -159.35 -34.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 129.307 3.043 . . . . 0.0 109.583 -168.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -151.4 164.99 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.49 124.47 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 127.045 2.138 . . . . 0.0 107.379 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.68 140.17 38.4 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.807 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.6 mt -138.98 144.76 42.54 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.223 0.609 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.4 178.19 7.69 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.941 3.094 . . . . 0.0 111.454 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -86.58 160.41 18.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 0.0 110.581 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.11 17.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 127.177 2.191 . . . . 0.0 114.487 -167.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.4 11.4 0.47 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.977 2.227 . . . . 0.0 113.025 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -71.0 127.96 34.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.132 1.466 . . . . 0.0 109.929 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.69 146.21 46.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.762 1.165 . . . . 0.0 110.924 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.53 144.47 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.905 1.682 . . . . 0.0 108.991 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -83.25 172.31 12.72 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.109 -0.995 . . . . 0.0 111.414 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 12.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.254 2.221 . . . . 0.0 116.182 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.25 65.48 0.22 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.92 121.98 15.72 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.2 OUTLIER -72.76 35.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 132.003 4.121 . . . . 0.0 113.308 -166.834 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 m -70.12 6.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 118.827 -2.421 . . . . 0.0 115.291 -168.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.7 55.76 1.2 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.897 1.226 . . . . 0.0 111.465 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.69 163.81 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.769 1.271 . . . . 0.0 112.532 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 mt -131.91 114.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -166.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.53 126.52 51.69 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 167.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -165.62 1.06 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.04 2.536 . . . . 0.0 108.388 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.26 -24.74 32.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 127.701 2.4 . . . . 0.0 112.375 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.23 12.6 0.19 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.604 1.093 . . . . 0.0 113.93 166.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.02 155.42 27.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.143 -0.973 . . . . 0.0 109.944 173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.66 100.03 3.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.05 179.21 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.469 1.508 . . . . 0.0 111.078 -166.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.18 139.06 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.586 1.955 . . . . 0.0 108.475 -163.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.35 108.59 25.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 167.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.0 107.67 20.21 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.808 0.731 . . . . 0.0 109.895 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -43.48 142.39 1.77 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.451 1.101 . . . . 0.0 112.485 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.13 -28.1 2.6 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.85 2.366 . . . . 0.0 114.596 -158.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mt -153.19 145.34 23.83 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.496 2.718 . . . . 0.0 104.906 -162.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 m -68.11 128.03 35.04 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 103' ' ' SER . . . -175.01 -166.53 32.96 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 124.496 1.046 . . . . 0.0 111.559 -170.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -137.02 130.3 31.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.9 mm -58.78 144.63 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.515 1.126 . . . . 0.0 108.287 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.9 m -146.98 3.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -155.14 156.01 34.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.614 1.552 . . . . 0.0 108.535 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.09 157.68 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.788 1.235 . . . . 0.0 109.081 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -101.15 84.73 2.69 Favored 'General case' 0 C--O 1.23 0.057 0 C-N-CA 123.347 0.659 . . . . 0.0 109.455 -174.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -60.1 -3.38 0.57 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.803 1.241 . . . . 0.0 113.586 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -54.86 -52.77 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.301 -1.499 . . . . 0.0 109.982 160.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.94 -25.39 68.12 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.018 1.727 . . . . 0.0 112.111 -163.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -59.72 -23.81 63.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.641 1.176 . . . . 0.0 111.827 173.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.2 p -125.69 -20.82 4.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.678 1.591 . . . . 0.0 112.107 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -133.62 70.01 76.13 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 126.304 1.841 . . . . 0.0 108.4 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.48 -4.75 15.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.576 3.517 . . . . 0.0 111.689 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.82 -8.44 43.56 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.091 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.94 -22.97 62.16 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.06 -1.65 . . . . 0.0 111.543 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.5 mt -58.17 -26.29 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.297 169.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -72.11 -55.29 7.57 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.684 1.584 . . . . 0.0 110.585 164.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -35.22 80.46 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.115 0.966 . . . . 0.0 111.884 -161.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.35 78.72 1.1 Allowed Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.57 -34.45 95.37 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 CA-C-N 120.948 1.374 . . . . 0.0 110.328 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -100.09 -5.69 27.53 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.959 1.304 . . . . 0.0 111.946 -171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.69 -69.19 0.96 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -119.68 -21.13 7.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.541 1.136 . . . . 0.0 112.769 -167.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.91 26.07 3.87 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.805 1.669 . . . . 0.0 115.351 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.411 ' HA ' ' HA3' ' A' ' 23' ' ' GLY . 45.0 p-90 -63.53 158.92 19.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 119.388 1.594 . . . . 0.0 111.642 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.46 -67.43 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -172.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -142.22 166.1 25.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.264 1.826 . . . . 0.0 110.617 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -113.84 154.68 27.06 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.023 1.329 . . . . 0.0 108.933 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.0 ptm -145.48 143.32 29.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.084 0.553 . . . . 0.0 110.688 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.31 137.23 57.4 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.902 1.281 . . . . 0.0 107.881 168.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.5 pt -76.29 155.92 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 123.444 0.465 . . . . 0.0 109.96 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.434 ' HB2' ' HA2' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -133.53 -13.03 2.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.56 112.68 3.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 168.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -83.95 -15.68 46.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.089 1.755 . . . . 0.0 110.622 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.36 71.79 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.085 1.326 . . . . 0.0 111.437 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.61 -7.89 58.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 112.609 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.02 -41.23 82.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.442 1.474 . . . . 0.0 110.639 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.23 -19.09 63.95 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.493 0.588 . . . . 0.0 111.065 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -70.91 -17.11 62.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.097 1.359 . . . . 0.0 111.702 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.81 169.59 13.22 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.37 153.42 20.44 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.641 0.776 . . . . 0.0 109.89 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.63 171.14 6.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 163.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.78 -45.64 70.81 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.11 -40.11 96.66 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.651 1.18 . . . . 0.0 111.005 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.56 82.7 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.082 0.401 . . . . 0.0 111.308 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -64.48 -36.51 84.42 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.527 0.731 . . . . 0.0 111.766 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.04 -47.85 71.14 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.491 0.587 . . . . 0.0 110.343 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 N--CA 1.438 -1.051 0 CA-C-N 118.183 0.447 . . . . 0.0 110.149 177.77 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.4 ttm . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.455 ' HB3' ' HZ1' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -138.39 110.53 7.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -111.34 -179.94 3.86 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.415 1.086 . . . . 0.0 109.946 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.58 163.56 32.53 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.032 0.933 . . . . 0.0 110.361 -170.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.1 p -114.68 -179.79 3.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.552 1.644 . . . . 0.0 110.642 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -63.63 -24.48 67.81 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.072 2.149 . . . . 0.0 115.226 160.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -84.05 24.01 0.98 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.732 1.151 . . . . 0.0 111.67 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 52.89 56.42 7.6 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 125.391 1.476 . . . . 0.0 109.569 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -140.28 148.85 42.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.856 2.063 . . . . 0.0 108.236 -167.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -128.03 153.55 46.64 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.99 1.716 . . . . 0.0 110.956 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.14 151.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 C-N-CA 127.188 2.195 . . . . 0.0 106.499 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.4 72.3 1.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.282 1.433 . . . . 0.0 108.807 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mp -70.57 134.1 30.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.064 2.145 . . . . 0.0 106.427 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -125.78 -61.44 1.25 Allowed 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.315 -0.866 . . . . 0.0 110.981 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.03 -76.65 0.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -126.79 4.44 6.66 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.041 1.336 . . . . 0.0 112.635 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.76 135.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.11 142.35 29.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.8 m -75.87 147.51 39.01 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 151.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.14 130.29 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 129.003 2.921 . . . . 0.0 107.187 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.41 172.68 26.92 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 167.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.2 pt -91.66 152.54 3.37 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.38 0.672 . . . . 0.0 109.863 173.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.7 p -82.29 170.85 14.91 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.973 -1.08 . . . . 0.0 111.206 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -21.82 66.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.926 -1.109 . . . . 0.0 113.345 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -61.59 -29.46 70.05 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.0 -1.062 . . . . 0.0 111.56 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.16 56.46 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.974 -1.079 . . . . 0.0 111.432 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -64.93 -24.25 67.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.198 0.599 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.49 -47.84 68.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.553 1.941 . . . . 0.0 108.389 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -70.7 -52.6 19.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mt -73.13 -33.03 65.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.286 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -133.46 15.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.46 147.71 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.694 1.198 . . . . 0.0 107.804 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.527 ' CG1' ' H ' ' A' ' 36' ' ' VAL . 21.4 t -121.48 -149.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.969 1.707 . . . . 0.0 106.559 178.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.527 ' H ' ' CG1' ' A' ' 35' ' ' VAL . 0.2 OUTLIER 179.8 -40.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 130.34 3.456 . . . . 0.0 108.406 -166.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -150.43 154.52 37.88 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.267 1.394 . . . . 0.0 113.776 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.06 131.33 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 125.189 1.396 . . . . 0.0 107.767 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.9 147.76 26.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.686 2.394 . . . . 0.0 108.777 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -144.61 148.88 41.64 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.048 1.339 . . . . 0.0 109.6 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.06 179.98 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.212 2.608 . . . . 0.0 114.377 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 152.04 21.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.109 0.963 . . . . 0.0 110.518 170.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.93 11.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 128.349 2.66 . . . . 0.0 115.037 -168.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.16 10.83 1.36 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.111 1.815 . . . . 0.0 112.47 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -70.14 128.68 37.12 Favored 'General case' 0 CA--C 1.527 0.088 0 O-C-N 121.288 -1.124 . . . . 0.0 108.027 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.85 153.79 30.31 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.94 170.88 10.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.893 1.277 . . . . 0.0 109.849 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 50' ' ' GLY . 34.4 mmtt -122.56 166.24 15.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.014 1.326 . . . . 0.0 109.597 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -62.13 7.87 0.05 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -155.34 75.61 0.22 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 167.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 114.36 13.73 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.579 1.151 . . . . 0.0 109.558 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.48 93.29 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.944 1.697 . . . . 0.0 108.145 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.27 -3.5 10.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.852 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.99 53.21 1.21 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.763 0.664 . . . . 0.0 111.925 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.66 155.44 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.787 0.835 . . . . 0.0 111.348 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mt -129.42 94.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.04 108.34 15.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.1 p -88.92 -169.52 2.56 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.604 1.162 . . . . 0.0 110.559 172.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.1 m -53.78 -29.35 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.684 1.193 . . . . 0.0 111.905 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -163.73 29.69 0.08 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -149.9 161.54 42.09 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.483 -0.761 . . . . 0.0 109.504 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.56 105.4 8.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.601 1.561 . . . . 0.0 107.606 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.01 119.78 22.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' CG ' ' HH ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -76.35 131.03 38.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 163.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.49 106.72 21.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.414 ' HH ' ' CG ' ' A' ' 64' ' ' ASP . 51.2 m-85 -99.72 107.4 19.48 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 110.629 -162.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -36.37 122.89 0.75 Allowed Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 126.747 2.019 . . . . 0.0 111.284 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 -23.55 7.27 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.637 1.558 . . . . 0.0 114.848 -161.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.74 161.61 32.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.418 1.887 . . . . 0.0 105.911 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.4 m -77.98 149.67 34.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.7 -162.97 34.39 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 120.101 -1.624 . . . . 0.0 110.167 -172.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -132.53 131.89 42.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.114 0.957 . . . . 0.0 109.844 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.3 mm -61.3 137.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.708 1.603 . . . . 0.0 108.167 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.71 1.12 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 123.955 0.784 . . . . 0.0 112.966 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -150.75 153.32 35.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 162.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.45 166.07 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.159 1.345 . . . . 0.0 109.827 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -110.4 82.01 1.53 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -59.86 -15.09 18.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.79 0.836 . . . . 0.0 112.255 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -55.87 -31.63 62.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.339 1.055 . . . . 0.0 112.416 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -13.93 62.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.191 0.905 . . . . 0.0 109.828 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.49 -16.91 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.87 1.268 . . . . 0.0 111.953 171.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -129.95 -17.85 3.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.773 0.829 . . . . 0.0 112.267 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.06 71.71 72.96 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.941 1.697 . . . . 0.0 107.904 167.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.52 -17.53 59.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 108.949 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.51 -4.75 59.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.268 1.027 . . . . 0.0 112.734 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 mt -66.08 -18.15 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.468 -1.395 . . . . 0.0 111.993 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.7 mt -62.94 -34.85 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.223 1.009 . . . . 0.0 109.561 171.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.08 -52.4 49.18 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.138 -1.602 . . . . 0.0 109.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -37.3 86.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.505 -162.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.18 79.92 0.52 Allowed Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.42 -14.95 41.22 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.135 1.89 . . . . 0.0 112.168 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -125.15 43.76 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.579 1.552 . . . . 0.0 108.316 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.34 -100.26 0.34 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 162.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -76.38 -26.57 55.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.96 -1.019 . . . . 0.0 112.505 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 39.52 2.92 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.347 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -69.39 164.02 23.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.871 1.336 . . . . 0.0 110.344 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.28 -65.16 0.98 Allowed 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -148.78 173.51 13.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.2 1.0 . . . . 0.0 110.04 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -127.21 153.8 45.63 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.658 1.183 . . . . 0.0 109.022 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.4 ptm -149.9 135.88 18.68 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.159 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.76 125.56 20.54 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.061 1.744 . . . . 0.0 107.357 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 21.4 pt -73.28 129.84 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.3 p -75.62 -41.92 53.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 166.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 106' ' ' GLY . 22.9 m-20 -142.83 90.53 2.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.981 0.913 . . . . 0.0 108.648 -160.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -10.1 0.98 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.319 1.048 . . . . 0.0 111.904 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 104' ' ' ASP . . . -90.47 -15.97 56.05 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.571 1.558 . . . . 0.0 112.591 -177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.87 -16.29 60.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.561 1.181 . . . . 0.0 110.29 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.64 -29.17 69.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.437 0.695 . . . . 0.0 110.927 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -95.38 27.63 3.25 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.011 -1.056 . . . . 0.0 111.36 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -116.71 0.5 12.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.381 147.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -84.41 -177.62 6.68 Favored 'General case' 0 C--N 1.34 0.186 0 O-C-N 120.683 -1.261 . . . . 0.0 109.837 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -91.3 127.92 36.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 107.656 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.93 178.29 1.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.374 1.083 . . . . 0.0 109.472 160.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -69.65 -49.53 52.86 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.273 1.029 . . . . 0.0 112.02 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.28 -44.28 95.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.905 0.882 . . . . 0.0 109.037 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.71 90.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.138 0.575 . . . . 0.0 111.148 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.76 -41.72 78.48 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.242 -0.911 . . . . 0.0 111.118 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -44.01 68.04 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.649 1.58 . . . . 0.0 109.97 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 . . . . . 0 N--CA 1.441 -0.923 0 C-N-CA 124.094 0.957 . . . . 0.0 110.49 176.254 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 ttp . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 14' ' ' SER . 21.0 ttmt -145.09 148.2 33.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.669 -1.269 . . . . 0.0 107.733 155.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -127.01 176.1 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.43 168.08 20.62 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.549 1.94 . . . . 0.0 108.827 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -130.53 177.16 7.57 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.938 1.352 . . . . 0.0 111.311 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -76.25 -25.46 55.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.518 1.527 . . . . 0.0 110.856 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 0.6 OUTLIER -82.28 17.33 1.71 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.68 1.127 . . . . 0.0 111.272 171.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 65.34 59.18 0.82 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.23 1.812 . . . . 0.0 110.663 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -111.58 165.45 12.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.167 0.987 . . . . 0.0 110.388 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.406 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 50.4 p-90 -131.37 152.81 50.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.865 1.666 . . . . 0.0 109.227 168.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 t -135.78 89.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.961 1.704 . . . . 0.0 107.407 -168.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.44 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 5.7 m -72.86 82.37 1.19 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.25 1.82 . . . . 0.0 112.986 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mm -87.41 127.29 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -141.61 -21.57 0.74 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.124 -0.985 . . . . 0.0 112.945 -170.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -141.19 -105.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 157.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -111.49 9.66 21.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.82 1.648 . . . . 0.0 111.015 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.05 144.24 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 168.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -109.06 141.88 40.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 108.565 160.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 m -85.67 136.06 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 156.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.5 124.18 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 130.249 3.42 . . . . 0.0 110.67 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.62 170.96 33.6 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.007 1.289 . . . . 0.0 110.49 168.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 pt -90.7 148.27 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.784 -0.833 . . . . 0.0 108.818 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 27' ' ' HIS . 41.9 p -76.28 157.92 32.06 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.32 -0.862 . . . . 0.0 111.144 176.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -58.44 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 1 C-N-CA 135.451 5.5 . . . . 0.0 116.054 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 25' ' ' THR . 11.0 t60 -107.5 -40.08 5.45 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 127.566 2.346 . . . . 0.0 112.402 164.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.79 -51.66 21.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.215 2.206 . . . . 0.0 116.07 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -42.08 -45.7 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.385 3.074 . . . . 0.0 109.75 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.597 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -51.69 -48.07 63.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.271 1.428 . . . . 0.0 112.284 176.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -68.75 -23.13 64.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.571 1.148 . . . . 0.0 111.517 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -89.05 -28.48 20.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.607 0.64 . . . . 0.0 112.385 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.43 -137.36 37.39 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 126.178 1.847 . . . . 0.0 110.555 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.28 112.98 2.93 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -86.28 -171.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 122.596 1.189 . . . . 0.0 109.038 170.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.55 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.7 p -173.15 -40.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.267 2.227 . . . . 0.0 106.348 -150.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -154.48 149.68 27.02 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.73 135.43 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.668 1.587 . . . . 0.0 107.967 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -91.54 143.99 26.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.551 2.341 . . . . 0.0 108.155 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -141.66 138.36 17.2 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.936 0.894 . . . . 0.0 109.031 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.75 175.71 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.088 2.525 . . . . 0.0 112.325 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.19 147.93 29.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.925 -1.11 . . . . 0.0 109.718 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.19 17.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 128.464 2.706 . . . . 0.0 115.528 -168.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.77 3.85 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.311 2.386 . . . . 0.0 112.319 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -60.71 138.87 58.05 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.571 1.186 . . . . 0.0 108.388 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.61 141.36 28.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.71 170.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.952 0.901 . . . . 0.0 110.182 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 50' ' ' GLY . 32.9 mtmm -127.57 159.75 33.67 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.996 0.918 . . . . 0.0 110.672 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 10.55 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.914 2.486 . . . . 0.0 115.151 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -166.12 68.19 0.19 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 173.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -140.42 129.28 23.22 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.2 t -79.35 110.7 15.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -173.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -2.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.767 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.35 45.29 0.72 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.417 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.3 m -48.29 145.86 3.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.246 1.419 . . . . 0.0 113.156 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.8 mt -122.2 107.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.3 128.84 41.04 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.3 p -105.03 -172.68 2.14 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.299 0.954 . . . . 0.0 109.967 172.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 m -52.36 -27.17 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.37 1.468 . . . . 0.0 112.616 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -158.29 29.77 0.24 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.918 1.235 . . . . 0.0 113.76 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.54 -179.31 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.007 -1.058 . . . . 0.0 109.993 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.34 44.43 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 126.746 2.018 . . . . 0.0 108.35 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.31 111.65 8.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.596 1.959 . . . . 0.0 107.01 160.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 114.95 7.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -77.78 101.44 3.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -68.15 124.15 22.66 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.08 132.95 30.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.995 0.918 . . . . 0.0 109.728 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -81.01 -31.84 1.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.221 1.947 . . . . 0.0 114.285 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.67 157.99 35.89 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.538 1.935 . . . . 0.0 106.981 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 m -77.16 153.62 33.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.45 -171.05 31.68 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -165.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -136.38 130.88 33.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -63.62 150.21 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.432 1.093 . . . . 0.0 108.374 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.68 3.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.689 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -156.73 160.12 38.99 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 121.373 1.897 . . . . 0.0 109.501 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.68 168.0 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.728 1.611 . . . . 0.0 109.59 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -117.71 78.71 1.26 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.641 1.177 . . . . 0.0 109.035 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.55 -11.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.169 0.987 . . . . 0.0 112.958 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -53.14 -31.68 43.68 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.683 -1.26 . . . . 0.0 111.042 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -21.36 59.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.241 1.017 . . . . 0.0 110.079 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.38 -5.95 16.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.549 1.939 . . . . 0.0 113.293 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -137.42 -34.35 0.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.552 -0.718 . . . . 0.0 110.229 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.1 62.07 19.19 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.323 2.249 . . . . 0.0 109.113 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.16 -20.49 28.34 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 124.177 3.251 . . . . 0.0 110.263 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.83 -17.32 49.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.699 1.2 . . . . 0.0 110.587 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.5 mt -67.86 -16.76 64.24 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.653 1.57 . . . . 0.0 114.383 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 mt -67.4 -23.72 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.26 0.936 . . . . 0.0 109.816 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -76.16 -53.73 7.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 119.967 -1.708 . . . . 0.0 109.918 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -59.99 -40.5 89.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.151 0.981 . . . . 0.0 112.084 -167.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.75 76.63 2.26 Favored Pre-proline 0 C--N 1.333 -0.136 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.15 -19.71 67.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.407 2.072 . . . . 0.0 113.315 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.406 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.3 mt-10 -124.19 22.32 8.66 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.43 1.013 . . . . 0.0 111.288 -171.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.06 -82.14 0.17 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 166.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -83.36 -38.83 21.5 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.49 46.32 3.24 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.793 1.179 . . . . 0.0 114.15 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -81.3 168.37 18.51 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.249 1.024 . . . . 0.0 109.704 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.63 -69.25 0.84 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -138.48 173.18 11.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.557 0.743 . . . . 0.0 111.349 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -128.38 150.36 50.14 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -144.84 148.69 34.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.054 0.542 . . . . 0.0 110.141 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.94 117.48 11.57 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.258 1.823 . . . . 0.0 107.778 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 pt -70.1 97.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.587 1.184 . . . . 0.0 107.963 163.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 m -60.67 -34.73 74.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.028 167.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -134.95 82.72 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -163.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -12.81 55.0 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.464 -0.772 . . . . 0.0 110.235 172.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.31 73.19 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 117.549 -1.695 . . . . 0.0 112.202 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -80.43 -29.22 37.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.958 1.879 . . . . 0.0 110.61 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.8 mt -41.81 -46.08 3.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.142 1.792 . . . . 0.0 111.83 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.49 -11.34 60.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.05 -35.62 59.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 165.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.88 171.02 3.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 123.693 1.711 . . . . 0.0 110.979 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.7 mt -70.54 120.82 16.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.022 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.4 -179.47 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.266 1.426 . . . . 0.0 110.231 163.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.64 -37.96 70.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.271 -1.518 . . . . 0.0 110.986 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -69.73 -46.1 66.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.27 1.428 . . . . 0.0 109.024 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.44 66.5 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.013 0.925 . . . . 0.0 111.875 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -63.47 -48.14 78.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.573 1.149 . . . . 0.0 109.506 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.0 -41.85 79.23 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 123.817 0.847 . . . . 0.0 110.084 175.784 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 31.1 tpp . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -142.09 112.47 7.1 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.964 -1.085 . . . . 0.0 109.892 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -105.63 -179.23 3.88 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.732 0.645 . . . . 0.0 111.56 162.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -136.69 176.75 8.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.408 1.883 . . . . 0.0 111.568 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -134.96 166.09 23.82 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.894 1.277 . . . . 0.0 111.512 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -71.91 -34.54 69.18 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.769 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -71.58 42.33 0.08 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.35 0.977 . . . . 0.0 109.611 165.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 p80 38.97 63.97 0.85 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 127.726 2.411 . . . . 0.0 112.509 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -128.17 169.14 14.47 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.0 109.361 168.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -113.35 172.27 7.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.833 2.053 . . . . 0.0 109.435 161.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.4 142.89 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.757 2.423 . . . . 0.0 105.279 174.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.77 80.11 1.78 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 119.557 1.071 . . . . 0.0 110.893 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -62.39 140.02 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 168.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -117.23 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 160.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.68 -94.83 0.44 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -123.22 33.35 5.4 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 128.152 2.581 . . . . 0.0 110.849 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.16 119.43 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 164.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.06 107.04 18.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.856 1.663 . . . . 0.0 107.607 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -70.23 126.39 29.52 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.824 0.85 . . . . 0.0 109.145 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.12 148.52 5.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 128.545 2.738 . . . . 0.0 112.618 169.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.19 161.39 32.0 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 157.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 pt -84.49 139.4 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 118.939 1.37 . . . . 0.0 108.6 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.7 p -73.51 172.99 10.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.564 -0.71 . . . . 0.0 111.466 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -59.19 -33.81 71.4 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.618 -1.301 . . . . 0.0 113.245 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -54.25 -24.1 17.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.893 1.277 . . . . 0.0 111.616 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.52 -48.75 10.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.264 1.025 . . . . 0.0 112.152 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -62.45 -20.02 64.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.084 0.856 . . . . 0.0 110.302 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -58.67 -26.52 63.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.647 1.979 . . . . 0.0 112.958 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -90.04 -42.01 11.38 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 120.155 1.343 . . . . 0.0 113.387 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mt -89.14 -33.0 17.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -170.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.44 -118.78 7.26 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.848 1.69 . . . . 0.0 111.606 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.79 112.88 3.07 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.213 1.805 . . . . 0.0 107.81 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -98.11 -165.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.047 0.927 . . . . 0.0 109.849 179.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.517 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -172.85 -31.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 129.62 3.168 . . . . 0.0 109.545 -168.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -150.12 147.41 27.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 111.326 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.8 t -138.99 115.88 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.21 140.71 58.9 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.998 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.3 mt -134.17 137.01 27.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 125.486 1.515 . . . . 0.0 107.576 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.87 -163.69 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.546 2.831 . . . . 0.0 112.643 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -113.69 145.32 41.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.854 1.662 . . . . 0.0 108.288 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.41 16.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -165.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.54 13.84 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.92 1.724 . . . . 0.0 112.671 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -79.39 137.38 37.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.524 1.662 . . . . 0.0 109.491 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -77.13 154.48 33.19 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.996 0.816 . . . . 0.0 109.872 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 m -140.46 164.71 21.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.515 1.126 . . . . 0.0 110.566 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 50' ' ' GLY . 20.2 mmtm -111.08 165.45 11.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 126.427 1.891 . . . . 0.0 107.983 167.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -60.77 10.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.729 2.012 . . . . 0.0 115.78 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -159.3 92.13 0.12 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 162.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.07 126.83 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -72.27 20.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 126.47 1.908 . . . . 0.0 113.976 -166.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.03 11.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 127.118 2.167 . . . . 0.0 116.196 -165.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.1 49.08 0.84 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.899 1.28 . . . . 0.0 108.79 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.8 m -49.43 157.22 0.53 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.402 1.096 . . . . 0.0 111.123 169.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mt -142.0 100.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -86.2 118.93 25.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -90.37 -167.94 1.97 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.484 1.514 . . . . 0.0 109.511 168.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -39.53 -52.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.054 1.742 . . . . 0.0 112.392 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -155.04 52.4 0.62 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.883 1.219 . . . . 0.0 111.81 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.3 177.37 10.64 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.179 -0.951 . . . . 0.0 109.194 163.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.19 114.04 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.506 1.523 . . . . 0.0 108.34 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.77 100.04 11.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.21 111.16 2.47 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.11 109.69 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -81.97 108.05 15.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.721 -0.612 . . . . 0.0 109.767 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -38.49 142.63 0.48 Allowed Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 126.826 2.05 . . . . 0.0 113.067 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.8 -35.9 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 119.617 0.899 . . . . 0.0 113.783 -161.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -123.46 160.32 27.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -80.67 151.61 28.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.54 -157.28 27.44 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -168.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -142.54 137.44 30.15 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.899 0.85 . . . . 0.0 109.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.0 mm -63.96 146.27 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 124.372 1.069 . . . . 0.0 108.817 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.4 -0.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.202 1.001 . . . . 0.0 111.116 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -161.43 157.64 25.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.22 146.13 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -173.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -86.51 74.73 9.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 118.57 0.623 . . . . 0.0 110.204 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.35 -15.11 14.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -54.51 -45.9 73.39 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.076 165.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.11 -18.88 64.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 0.0 112.281 -173.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -63.75 -15.66 59.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.207 1.403 . . . . 0.0 111.232 169.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 p -131.97 -27.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.67 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.23 64.55 61.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.143 1.777 . . . . 0.0 110.496 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.85 -10.25 27.65 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.146 3.231 . . . . 0.0 111.792 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.37 -14.16 61.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.197 -0.94 . . . . 0.0 112.908 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.5 mt -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.113 1.324 . . . . 0.0 113.464 -169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -63.83 -33.87 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.44 1.018 . . . . 0.0 110.667 169.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -59.07 -46.35 88.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.785 1.755 . . . . 0.0 109.965 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -72.73 -59.99 2.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 127.694 2.398 . . . . 0.0 110.579 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -140.54 65.07 25.24 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -167.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.78 -18.31 55.33 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 120.811 1.007 . . . . 0.0 111.475 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.33 28.18 7.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 109.021 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.6 -113.85 0.99 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.44 -14.33 62.83 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.269 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.71 32.48 2.15 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 120.678 1.581 . . . . 0.0 112.513 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.86 161.25 13.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.171 0.985 . . . . 0.0 108.741 165.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.46 -58.29 2.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.931 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -140.03 -176.79 4.72 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 115.022 -2.671 . . . . 0.0 111.934 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -136.42 129.84 31.79 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 ptm -131.92 139.13 48.63 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.5 141.91 58.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.9 pt -95.91 149.97 4.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -133.65 -13.06 2.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.904 1.681 . . . . 0.0 112.391 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -146.27 74.36 1.36 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -66.52 -10.26 43.04 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.618 -1.301 . . . . 0.0 111.009 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.28 -39.26 95.82 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 120.531 -1.355 . . . . 0.0 110.703 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -63.85 -28.94 70.19 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.568 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.0 mt -47.41 -36.67 10.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 120.184 1.356 . . . . 0.0 111.883 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.72 -16.62 55.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.887 1.676 . . . . 0.0 112.657 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.6 -31.24 66.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.346 1.459 . . . . 0.0 109.96 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.08 169.08 5.78 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.673 -0.642 . . . . 0.0 109.525 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.21 127.04 31.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.57 171.94 0.76 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 154.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -67.88 -36.57 80.47 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.509 -1.995 . . . . 0.0 112.126 -173.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.71 -51.55 58.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.21 71.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.255 0.222 . . . . 0.0 111.192 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -61.58 -52.37 64.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.728 1.211 . . . . 0.0 109.933 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -41.0 72.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.295 0.638 . . . . 0.0 109.651 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 . . . . . 0 N--CA 1.443 -0.803 0 C-N-CA 123.906 0.882 . . . . 0.0 110.968 -176.336 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.51 ' SD ' ' HE2' ' A' ' 5' ' ' LYS . 3.8 ptp . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 64.94 0.74 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.66 -1.275 . . . . 0.0 111.372 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.51 ' HE2' ' SD ' ' A' ' 3' ' ' MET . 2.0 mptp? -66.9 -178.65 0.78 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.97 149.42 47.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.487 1.915 . . . . 0.0 110.003 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.0 p -93.14 171.21 9.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 123.518 1.628 . . . . 0.0 109.574 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -71.99 -33.4 68.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.016 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -89.84 43.53 1.15 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.63 2.372 . . . . 0.0 111.564 -176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p80 48.5 46.53 20.79 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.361 1.864 . . . . 0.0 114.234 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.25 158.21 28.61 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 109.275 170.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.8 p-90 -108.79 163.15 13.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.472 1.509 . . . . 0.0 107.358 165.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.18 154.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.34 80.66 1.68 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.122 1.369 . . . . 0.0 109.632 -172.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.56 117.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.454 1.502 . . . . 0.0 108.82 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.287 5.1 pt-20 -114.11 -101.18 0.42 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 116.732 -1.604 . . . . 0.0 108.988 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -64.08 1.1 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 122.321 2.328 . . . . 0.0 111.806 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -153.66 8.54 0.38 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.487 2.715 . . . . 0.0 109.873 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.5 t -127.92 126.45 66.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.71 141.81 28.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.695 0.398 . . . . 0.0 109.962 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.4 m -87.99 151.71 22.58 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.15 142.33 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.752 1.221 . . . . 0.0 109.327 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.47 170.39 35.11 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 163.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.7 pt -77.46 152.08 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 118.415 1.108 . . . . 0.0 110.695 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -80.8 171.81 14.54 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.916 -1.115 . . . . 0.0 112.508 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -21.52 62.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.37 1.068 . . . . 0.0 113.025 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -67.02 -31.21 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 119.765 -1.835 . . . . 0.0 111.859 169.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.2 -42.7 20.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.953 -1.092 . . . . 0.0 111.705 -172.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -56.31 -22.32 29.72 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.372 0.533 . . . . 0.0 111.374 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -46.13 81.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.194 0.998 . . . . 0.0 109.371 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.577 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -81.01 -27.83 35.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.254 1.422 . . . . 0.0 112.515 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.02 -43.96 27.91 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.91 -150.03 51.6 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 124.517 1.056 . . . . 0.0 110.801 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -46.23 114.57 0.82 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.954 2.502 . . . . 0.0 108.081 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.55 HG22 ' H ' ' A' ' 36' ' ' VAL 0.276 8.9 p -111.08 173.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-O 122.774 1.273 . . . . 0.0 110.112 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.55 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.07 -23.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.413 -153.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -147.79 142.05 26.21 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.802 0.274 . . . . 0.0 111.237 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.25 132.47 55.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 159.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.5 137.63 42.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.805 168.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.2 mt -131.47 131.44 22.91 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.66 179.7 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.568 2.845 . . . . 0.0 113.149 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.39 156.77 24.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.549 -0.719 . . . . 0.0 111.146 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.99 19.21 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 0.0 113.457 -164.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.88 33.43 0.56 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -106.85 133.89 50.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.332 1.066 . . . . 0.0 110.829 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 150.72 48.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.378 0.99 . . . . 0.0 110.353 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -142.22 167.13 15.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.755 1.622 . . . . 0.0 110.624 169.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -116.85 170.49 8.58 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 127.758 2.423 . . . . 0.0 110.895 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 6.61 0.25 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.6 59.25 0.35 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -106.79 115.35 30.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.922 1.289 . . . . 0.0 108.994 -173.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.1 OUTLIER -70.28 33.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 127.736 2.414 . . . . 0.0 113.922 -173.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.69 10.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 O-C-N 117.956 -2.965 . . . . 0.0 115.958 -167.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.85 51.85 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.221 0.918 . . . . 0.0 109.554 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.69 157.21 7.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.81 0.814 . . . . 0.0 111.034 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.2 mt -133.6 108.03 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -101.49 117.27 34.59 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.2 p -99.61 -159.95 0.77 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.335 1.454 . . . . 0.0 111.7 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -43.55 -44.1 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.07 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -158.56 13.29 0.18 Allowed 'General case' 0 C--N 1.346 0.453 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 165.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.82 159.16 15.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.911 1.687 . . . . 0.0 108.148 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.32 96.59 3.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.385 1.474 . . . . 0.0 107.517 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.65 107.38 19.14 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.998 0.919 . . . . 0.0 110.311 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.31 117.33 4.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.238 1.815 . . . . 0.0 107.37 163.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.74 103.63 14.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -94.51 98.55 10.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -168.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.9 130.97 0.3 Allowed Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.924 2.09 . . . . 0.0 113.917 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.1 -29.68 39.54 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.279 2.653 . . . . 0.0 114.546 -167.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.9 mt -148.34 158.59 44.19 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.963 1.305 . . . . 0.0 108.079 -167.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -66.48 145.43 55.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.4 38.8 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -129.53 130.92 46.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.13 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.5 mm -63.66 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.2 m -145.71 -3.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.245 1.018 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -148.03 158.77 44.24 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.969 1.259 . . . . 0.0 107.845 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -142.45 158.38 19.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.333 1.453 . . . . 0.0 107.948 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -108.72 74.09 0.9 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.988 0.515 . . . . 0.0 110.141 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.65 -11.4 7.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -44.78 -42.34 7.71 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.313 1.445 . . . . 0.0 111.357 164.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -12.14 61.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.063 0.945 . . . . 0.0 110.893 -170.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.66 -11.21 57.75 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.707 1.203 . . . . 0.0 112.173 167.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -131.28 -36.18 1.31 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.828 . . . . 0.0 111.235 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -121.2 73.92 28.39 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.869 2.068 . . . . 0.0 107.233 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.89 -43.86 1.54 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.987 1.791 . . . . 0.0 107.657 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.07 -11.36 1.07 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.653 1.581 . . . . 0.0 112.285 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -57.43 -18.11 16.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.664 1.985 . . . . 0.0 111.99 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.8 mm -53.05 -37.95 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -68.02 -48.59 65.28 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 120.93 -1.106 . . . . 0.0 111.334 174.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 5.0 mtpt -77.74 -28.26 50.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 125.755 1.622 . . . . 0.0 113.126 -162.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.75 65.19 0.72 Allowed Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -177.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.98 -30.22 89.47 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.295 1.997 . . . . 0.0 112.756 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.1 mp0 -119.12 21.57 12.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.642 0.777 . . . . 0.0 110.046 177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.79 -121.53 4.86 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 105.874 -2.89 . . . . 0.0 105.874 157.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.54 -3.01 28.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.05 23.3 5.31 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 120.706 1.594 . . . . 0.0 112.7 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -63.2 162.02 12.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.722 1.761 . . . . 0.0 109.886 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.71 -56.16 2.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.03 173.81 12.12 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.209 -0.932 . . . . 0.0 112.014 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -124.72 152.54 43.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.788 0.835 . . . . 0.0 110.209 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -142.89 141.71 31.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.753 1.221 . . . . 0.0 110.493 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -64.63 133.51 52.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 pt -87.45 103.13 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 122.846 0.458 . . . . 0.0 110.322 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.5 m -66.86 -7.69 23.54 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -143.56 135.08 26.19 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -99.46 2.02 44.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.527 2.331 . . . . 0.0 108.158 162.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.81 -39.12 5.02 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.804 -1.185 . . . . 0.0 112.573 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -65.27 -24.13 67.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.42 1.11 . . . . 0.0 110.527 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.402 ' H ' ' CD1' ' A' ' 108' ' ' LEU . 2.7 mp -38.0 -44.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.533 2.733 . . . . 0.0 112.206 163.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -79.86 -7.34 58.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.272 1.396 . . . . 0.0 112.506 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -88.23 -12.75 42.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 111.639 168.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.27 169.52 7.1 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.053 -1.655 . . . . 0.0 109.155 167.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.42 139.44 42.33 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.84 171.66 0.88 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.553 1.168 . . . . 0.0 109.232 159.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.13 -34.45 78.08 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.388 1.875 . . . . 0.0 111.251 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -80.55 -44.16 19.49 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.571 1.148 . . . . 0.0 109.514 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.16 72.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.106 0.479 . . . . 0.0 111.307 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -59.31 -39.9 84.55 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.175 0.99 . . . . 0.0 110.947 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.67 -45.32 72.02 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.178 0.591 . . . . 0.0 109.881 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 123.662 0.785 . . . . 0.0 110.45 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.6 ttm . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -138.64 121.18 16.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.949 154.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -113.42 179.97 3.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.316 1.847 . . . . 0.0 110.011 172.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -150.55 167.94 25.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.0 1.32 . . . . 0.0 110.508 -164.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -136.74 170.08 16.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.23 1.377 . . . . 0.0 111.371 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.5 -14.64 63.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 176.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -89.33 34.89 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.151 -1.593 . . . . 0.0 108.282 175.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 p80 41.73 64.16 1.13 Allowed 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.173 2.589 . . . . 0.0 110.723 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.492 1.517 . . . . 0.0 107.562 -166.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.9 p-90 -116.92 150.69 38.09 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.19 1.796 . . . . 0.0 110.043 176.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.57 122.91 15.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -161.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.38 97.79 5.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.449 1.022 . . . . 0.0 111.295 -163.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -108.49 102.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.484 1.113 . . . . 0.0 109.529 -164.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.46 -74.5 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.885 0.874 . . . . 0.0 110.11 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -74.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 108.066 -170.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -126.93 7.85 6.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.233 0.924 . . . . 0.0 113.344 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -134.69 142.66 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.79 137.54 38.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.029 1.332 . . . . 0.0 109.187 163.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 m -78.94 132.02 36.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 155.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.49 132.05 49.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.683 1.993 . . . . 0.0 108.762 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.69 168.82 29.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.548 1.071 . . . . 0.0 110.904 159.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.4 pt -89.06 159.19 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.334 0.653 . . . . 0.0 109.875 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -90.72 175.08 7.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.711 -1.243 . . . . 0.0 112.049 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -39.52 62.45 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.01 -1.056 . . . . 0.0 111.599 171.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -58.18 -22.5 51.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.398 1.079 . . . . 0.0 111.85 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.56 -46.65 8.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.751 1.62 . . . . 0.0 112.172 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -64.03 -22.83 67.09 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.12 0.418 . . . . 0.0 111.396 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -27.52 69.0 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.193 1.397 . . . . 0.0 111.716 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -90.11 -43.78 10.24 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.733 -0.605 . . . . 0.0 110.967 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.58 -35.75 14.08 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.954 -170.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.2 -119.42 8.68 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 125.373 1.464 . . . . 0.0 111.043 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.73 91.63 0.63 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.405 1.882 . . . . 0.0 106.728 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.68 HG11 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -74.88 -162.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.68 ' H ' HG11 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -165.6 -35.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 130.249 3.42 . . . . 0.0 109.37 -169.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -158.17 161.21 37.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.128 0.876 . . . . 0.0 112.667 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.45 132.37 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.574 1.15 . . . . 0.0 110.951 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.78 136.02 36.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 108.869 170.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.3 mt -130.95 144.39 53.35 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.062 1.745 . . . . 0.0 109.135 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.72 -179.25 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.586 2.857 . . . . 0.0 112.658 -169.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -73.49 148.11 43.45 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 110.065 166.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.71 9.18 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.642 2.377 . . . . 0.0 114.743 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.19 12.17 0.92 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 126.76 2.124 . . . . 0.0 110.503 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -66.52 145.14 55.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.212 1.006 . . . . 0.0 108.921 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -84.33 150.48 25.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.429 1.585 . . . . 0.0 110.575 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.377 11.6 t -142.58 173.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.174 0 C-N-CA 129.782 3.233 . . . . 0.0 108.621 -175.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 50' ' ' GLY . 20.0 mttm -141.89 169.46 17.54 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 129.362 3.065 . . . . 0.0 103.831 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 14.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -167.68 92.57 0.1 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 103.9 -3.68 . . . . 0.0 103.9 162.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.26 142.45 31.37 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.1 t -79.12 32.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 130.341 3.456 . . . . 0.0 111.344 -164.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.5 m -68.41 1.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 119.431 -2.043 . . . . 0.0 111.788 -169.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.6 73.2 1.17 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.886 1.675 . . . . 0.0 110.015 172.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.99 164.33 6.74 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 120.028 -1.67 . . . . 0.0 110.592 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mt -135.24 151.88 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.0 123.68 21.1 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.835 -1.165 . . . . 0.0 108.286 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.4 t -107.21 -169.61 1.57 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.957 1.303 . . . . 0.0 107.952 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.93 -33.82 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.86 1.264 . . . . 0.0 111.794 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -169.13 18.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.96 1.704 . . . . 0.0 112.827 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.48 152.64 29.89 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.269 0.941 . . . . 0.0 111.361 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.83 129.58 15.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.119 1.368 . . . . 0.0 109.254 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.3 107.93 2.27 Favored 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.634 4.374 . . . . 0.0 105.27 -163.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -67.35 134.75 52.11 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -78.46 120.12 28.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 164.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -102.86 105.58 15.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.57 132.58 1.34 Allowed Pre-proline 0 N--CA 1.452 -0.36 0 O-C-N 124.488 1.117 . . . . 0.0 112.331 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.02 -26.0 31.5 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.711 2.274 . . . . 0.0 113.491 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.4 151.26 34.97 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.261 1.425 . . . . 0.0 107.568 -163.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -72.48 128.38 35.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.16 40.62 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.626 -0.671 . . . . 0.0 111.919 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -128.52 131.09 48.28 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.328 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.2 mm -57.78 148.31 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 120.132 1.333 . . . . 0.0 108.368 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.81 -4.27 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.029 0.932 . . . . 0.0 112.747 164.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -150.5 156.51 41.57 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.349 1.432 . . . . 0.0 107.796 171.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.0 m -133.55 165.44 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.765 1.226 . . . . 0.0 108.017 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.98 83.03 1.69 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.253 0.621 . . . . 0.0 110.617 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.1 1.9 0.4 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -62.53 -43.02 99.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 119.802 -1.811 . . . . 0.0 108.49 166.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.1 mt -57.09 -14.29 3.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 113.704 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.1 -36.85 78.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.832 2.053 . . . . 0.0 110.698 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 p -127.5 -11.84 5.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.518 1.127 . . . . 0.0 112.413 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -117.31 58.3 2.29 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.254 1.822 . . . . 0.0 111.235 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.45 -18.16 18.02 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.641 2.227 . . . . 0.0 110.222 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.04 -13.89 60.92 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.382 0.992 . . . . 0.0 111.6 171.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -24.91 66.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.725 -1.859 . . . . 0.0 110.863 -172.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.5 mt -62.65 -18.27 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 O-C-N 120.557 -1.339 . . . . 0.0 110.507 172.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -74.3 -53.57 9.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 119.171 -2.206 . . . . 0.0 111.33 161.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -52.6 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.296 1.439 . . . . 0.0 109.958 -159.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.4 70.72 12.93 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 125.803 1.641 . . . . 0.0 106.7 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.99 -23.35 72.69 Favored 'Trans proline' 0 CA--C 1.511 -0.63 0 C-N-CA 123.059 2.506 . . . . 0.0 112.351 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP 0.294 0.4 OUTLIER -119.1 31.54 6.58 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.773 1.629 . . . . 0.0 109.27 -175.256 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -110.87 0.85 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.256 1.884 . . . . 0.0 109.03 166.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -72.96 -9.17 58.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.828 0.851 . . . . 0.0 113.104 -175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.74 21.92 33.68 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.854 1.216 . . . . 0.0 113.567 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -57.66 169.12 0.74 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.126 1.463 . . . . 0.0 110.309 165.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.6 -52.58 2.13 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -152.05 170.09 20.77 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 121.557 -0.714 . . . . 0.0 110.144 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -129.84 141.13 50.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.59 142.29 39.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.845 0.858 . . . . 0.0 110.105 -171.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.56 125.69 27.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.89 2.076 . . . . 0.0 106.935 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -81.77 97.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 124.328 1.018 . . . . 0.0 108.69 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -72.15 -16.12 61.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.39 172.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -137.93 79.2 1.73 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -15.61 62.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.62 -0.675 . . . . 0.0 111.609 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.55 4.64 77.48 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 116.925 -2.042 . . . . 0.0 114.067 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -97.81 -28.91 13.64 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.691 1.745 . . . . 0.0 112.614 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -34.06 76.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.652 1.569 . . . . 0.0 112.135 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -56.0 -29.29 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 124.841 1.257 . . . . 0.0 112.698 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -84.97 -17.16 38.51 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 111.36 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -76.68 -174.08 2.85 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.589 1.155 . . . . 0.0 109.623 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.58 128.1 32.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.96 169.93 0.2 Allowed 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 122.023 0.916 . . . . 0.0 109.957 160.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.01 -43.06 75.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.732 1.613 . . . . 0.0 110.995 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -65.31 -50.97 63.64 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.475 1.51 . . . . 0.0 109.107 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.84 70.19 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.592 -0.692 . . . . 0.0 111.824 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -63.16 -44.0 96.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.009 0.924 . . . . 0.0 110.407 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.38 71.91 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.981 0.42 . . . . 0.0 109.909 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ptm . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -125.9 88.4 2.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.278 0.944 . . . . 0.0 109.947 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -92.49 174.73 7.13 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.697 -0.627 . . . . 0.0 111.707 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.16 177.24 7.99 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.288 1.435 . . . . 0.0 112.035 -169.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -130.67 168.03 17.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.1 1.36 . . . . 0.0 110.882 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.27 18.21 0.42 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.019 1.328 . . . . 0.0 111.414 159.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -125.23 26.67 6.83 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.458 -1.401 . . . . 0.0 110.496 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.6 p80 45.02 50.97 9.03 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 111.506 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -121.97 143.22 49.61 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -99.51 159.53 14.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 160.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.26 107.9 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.35 74.79 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.495 1.118 . . . . 0.0 110.503 -170.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.0 mp -64.7 146.16 13.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.718 1.207 . . . . 0.0 108.501 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -139.06 -70.6 0.41 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.083 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.4 -62.47 1.26 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.984 1.266 . . . . 0.0 111.006 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.05 15.36 2.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.01 1.324 . . . . 0.0 110.526 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.45 150.89 33.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.07 133.43 54.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.736 1.614 . . . . 0.0 107.261 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -77.47 113.59 15.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 164.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.12 135.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.3 170.32 31.56 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 165.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 pt -90.33 153.35 3.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 117.974 0.887 . . . . 0.0 110.466 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 p -91.25 164.58 13.83 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.211 -1.555 . . . . 0.0 109.654 171.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.581 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 13.4 p-10 -50.9 -37.18 42.29 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 114.151 -2.833 . . . . 0.0 115.308 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -49.24 -34.52 15.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 121.604 2.002 . . . . 0.0 109.46 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.57 -68.9 0.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.26 1.824 . . . . 0.0 112.9 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.581 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 6.1 pm0 -66.04 -24.58 66.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.695 1.589 . . . . 0.0 110.699 -171.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.99 -40.29 96.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.272 6.3 pt20 -75.05 -56.69 4.48 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.328 0.651 . . . . 0.0 112.248 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -35.62 81.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.682 0.674 . . . . 0.0 111.926 -170.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.53 -137.07 36.86 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.85 110.73 0.77 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 128.39 2.676 . . . . 0.0 110.105 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.627 HG13 ' H ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -93.1 172.82 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 124.693 2.187 . . . . 0.0 109.649 171.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.627 ' H ' HG13 ' A' ' 35' ' ' VAL . 2.5 m -151.2 -37.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 129.432 3.093 . . . . 0.0 109.201 -160.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -155.52 153.61 30.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.759 0.424 . . . . 0.0 110.776 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.44 135.43 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.843 0.83 . . . . 0.0 109.602 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.93 122.74 23.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 163.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.33 141.83 31.34 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 124.626 1.17 . . . . 0.0 107.907 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -76.3 179.45 6.36 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.717 2.278 . . . . 0.0 111.97 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -79.59 157.93 27.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.29 1.036 . . . . 0.0 110.232 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.41 15.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.291 1.437 . . . . 0.0 113.317 -171.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.34 15.29 0.39 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 128.41 2.91 . . . . 0.0 111.41 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -73.38 128.17 34.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.11 1.455 . . . . 0.0 109.051 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.26 146.76 45.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.21 168.41 14.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 110.391 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' H ' ' HB2' ' A' ' 51' ' ' GLU . 26.3 mtpt -126.21 170.68 11.6 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.741 1.616 . . . . 0.0 108.427 172.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 24.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -152.16 15.17 0.77 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.931 1.253 . . . . 0.0 113.012 167.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.43 113.78 13.23 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.06 1.93 . . . . 0.0 110.679 -168.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.79 94.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.81 5.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.545 1.538 . . . . 0.0 112.153 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.37 38.96 1.16 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.786 0.435 . . . . 0.0 110.643 -168.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.33 151.98 6.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 123.183 1.468 . . . . 0.0 111.067 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.79 134.78 53.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -115.22 124.34 51.15 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 161.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.8 p -99.14 -173.84 2.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.191 0.996 . . . . 0.0 109.647 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 m -42.9 -48.6 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.997 0.919 . . . . 0.0 111.381 171.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -160.25 85.13 0.73 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.069 0.85 . . . . 0.0 109.55 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -178.47 147.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.878 2.471 . . . . 0.0 106.23 157.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.34 152.83 18.04 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.25 120.13 14.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 130.5 47.24 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.983 2.113 . . . . 0.0 107.392 165.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.82 116.15 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -106.27 100.71 10.23 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.893 0.877 . . . . 0.0 110.738 -166.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.54 127.09 0.5 Allowed Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 126.801 2.04 . . . . 0.0 112.584 -172.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.52 -27.71 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.569 1.513 . . . . 0.0 114.129 -159.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.23 172.44 12.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.485 1.914 . . . . 0.0 108.634 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 49.7 m -93.48 123.02 36.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.093 1.357 . . . . 0.0 110.862 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.33 -158.27 20.7 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -164.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -139.76 142.12 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.079 -1.247 . . . . 0.0 108.304 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.3 mm -62.17 148.66 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.693 1.197 . . . . 0.0 108.226 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -146.46 -5.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -156.36 140.79 16.74 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.51 147.67 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -89.02 81.64 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.1 -15.71 4.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.122 0.969 . . . . 0.0 113.193 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -53.34 -39.6 64.23 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.988 2.115 . . . . 0.0 112.692 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -11.17 60.56 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.377 1.444 . . . . 0.0 111.313 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -69.3 -38.3 78.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.358 1.463 . . . . 0.0 111.164 171.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.4 p -110.86 -25.99 9.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.32 1.448 . . . . 0.0 112.847 -171.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -132.09 61.79 59.83 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 128.513 2.725 . . . . 0.0 109.449 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.67 -30.07 84.82 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.021 3.148 . . . . 0.0 111.502 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.83 -11.42 27.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.87 2.068 . . . . 0.0 111.896 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mt -64.46 -15.7 61.15 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 120.281 1.401 . . . . 0.0 113.043 168.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.8 mt -58.6 -32.34 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.502 1.046 . . . . 0.0 110.054 167.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -73.86 -55.02 6.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 119.709 -1.87 . . . . 0.0 109.082 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -63.85 -56.46 15.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.391 1.476 . . . . 0.0 110.722 -168.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -138.63 57.17 11.11 Favored Pre-proline 0 C--O 1.239 0.523 0 O-C-N 124.691 1.245 . . . . 0.0 110.459 -165.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.74 -13.74 36.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.147 2.565 . . . . 0.0 112.116 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -109.22 -0.8 19.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.574 2.35 . . . . 0.0 110.756 -163.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.79 -81.09 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 125.947 1.737 . . . . 0.0 110.719 -174.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.12 -24.8 20.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.847 1.324 . . . . 0.0 113.212 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.63 31.89 1.44 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.372 1.463 . . . . 0.0 111.996 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -67.97 155.15 40.09 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.343 1.072 . . . . 0.0 109.229 173.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.15 -72.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -143.82 149.63 37.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.258 1.423 . . . . 0.0 108.371 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -99.25 150.71 21.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.67 142.76 43.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.47 138.16 48.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.076 1.35 . . . . 0.0 107.444 169.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 pt -96.02 111.92 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.513 0.725 . . . . 0.0 110.703 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 m -70.36 -38.03 74.7 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.073 -0.392 . . . . 0.0 111.346 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.62 81.07 1.98 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.154 0.982 . . . . 0.0 109.032 -164.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -7.31 24.11 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.97 -1.081 . . . . 0.0 111.748 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.66 -31.76 23.47 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.778 -1.201 . . . . 0.0 111.583 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -66.42 -8.98 29.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.7 -28.03 69.62 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.242 0.928 . . . . 0.0 110.946 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.16 -14.25 60.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.979 1.263 . . . . 0.0 111.391 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.85 -10.31 58.9 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.828 0.851 . . . . 0.0 111.616 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.9 mt -78.95 176.43 9.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.457 1.122 . . . . 0.0 110.534 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.7 133.14 34.31 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.149 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.79 166.44 13.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.379 1.561 . . . . 0.0 108.651 153.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -68.89 -35.93 77.45 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 125.447 1.499 . . . . 0.0 111.154 -168.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -67.38 -40.19 85.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.14 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.848 -0.533 . . . . 0.0 110.621 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.85 -44.04 97.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.603 0.361 . . . . 0.0 110.198 171.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -47.0 81.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.855 0.862 . . . . 0.0 110.698 172.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 118.145 0.43 . . . . 0.0 110.389 -178.257 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 83.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.267 -0.896 . . . . 0.0 110.119 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.551 ' H ' ' HE3' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -82.93 176.81 8.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 119.436 -0.905 . . . . 0.0 113.202 178.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -131.44 152.92 50.25 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.897 1.679 . . . . 0.0 109.222 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.8 p -101.84 -173.67 2.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.442 1.115 . . . . 0.0 109.716 -172.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -98.03 10.36 40.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.662 1.985 . . . . 0.0 111.244 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.0 p -119.92 32.73 5.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.726 1.61 . . . . 0.0 111.572 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.11 38.86 26.54 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.355 -1.466 . . . . 0.0 111.844 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.28 137.29 44.15 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.378 1.871 . . . . 0.0 108.724 -165.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.516 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 60.4 p-90 -106.25 166.48 10.49 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.62 1.168 . . . . 0.0 109.774 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.04 144.67 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 83.81 1.9 Allowed 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.351 1.061 . . . . 0.0 109.855 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.79 132.39 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 107.744 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -137.96 -12.92 1.45 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.82 -70.86 0.07 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -144.41 17.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.899 1.28 . . . . 0.0 111.225 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.0 t -143.56 128.34 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.96 131.34 34.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 158.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 m -73.25 132.19 42.86 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 152.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.62 139.38 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 126.756 2.022 . . . . 0.0 107.656 171.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.21 164.69 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 163.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.9 pt -80.24 152.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 122.598 1.19 . . . . 0.0 109.168 167.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.1 p -77.32 166.07 23.64 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.519 1.128 . . . . 0.0 109.599 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -36.2 68.99 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.92 -33.24 61.93 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.644 -1.285 . . . . 0.0 112.381 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.58 61.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.164 176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.17 -27.11 68.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.512 1.051 . . . . 0.0 111.427 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -49.13 64.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.902 0.481 . . . . 0.0 109.867 -173.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -49.83 55.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.417 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -34.61 78.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.57 0.623 . . . . 0.0 110.169 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 -119.43 9.23 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.82 111.12 4.12 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.585 HG13 ' H ' ' A' ' 36' ' ' VAL . 1.9 t -77.11 -168.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 152.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.585 ' H ' HG13 ' A' ' 35' ' ' VAL . 2.6 p -176.75 -40.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -157.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -153.69 151.26 29.45 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.794 1.179 . . . . 0.0 110.832 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.5 t -134.13 133.59 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.66 137.32 32.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.361 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -136.28 149.18 67.14 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 124.319 1.048 . . . . 0.0 109.135 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -79.37 -174.02 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.821 3.014 . . . . 0.0 114.428 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.46 162.03 20.07 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 119.837 -1.789 . . . . 0.0 112.928 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.27 16.13 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 126.997 2.119 . . . . 0.0 111.773 -171.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.75 10.26 0.79 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.764 2.126 . . . . 0.0 112.329 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.9 ttt85 -81.12 130.12 34.88 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.314 1.057 . . . . 0.0 108.678 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.8 151.23 37.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.25 165.77 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.768 1.227 . . . . 0.0 109.443 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.464 ' C ' ' H ' ' A' ' 50' ' ' GLY . 53.6 mtpt -118.56 170.34 9.03 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.132 1.373 . . . . 0.0 107.599 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -62.82 15.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -169.36 86.62 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 166.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.54 128.58 25.47 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.96 1.704 . . . . 0.0 107.534 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 t -72.01 38.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 127.56 2.344 . . . . 0.0 111.627 -174.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 m -83.86 28.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 118.421 -2.674 . . . . 0.0 112.786 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -167.72 66.54 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.41 1.004 . . . . 0.0 108.915 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.5 m -58.16 148.83 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.058 -1.026 . . . . 0.0 110.176 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.9 mt -122.37 109.03 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 124.37 34.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 36' ' ' VAL . 80.4 p -102.47 -179.91 4.11 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.361 1.077 . . . . 0.0 109.532 171.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -48.32 -33.59 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.519 -1.673 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -148.19 5.67 0.75 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.92 170.41 9.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.627 1.558 . . . . 0.0 108.747 171.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.39 149.2 38.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 149.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.52 88.69 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -39.8 120.36 1.11 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 128.408 2.683 . . . . 0.0 107.999 161.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.43 136.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -113.39 98.73 7.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.416 0.686 . . . . 0.0 109.798 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -33.42 124.29 0.45 Allowed Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 124.765 1.29 . . . . 0.0 112.065 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.34 -23.96 11.19 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.653 1.568 . . . . 0.0 114.358 -157.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -141.36 156.98 45.77 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 127.505 2.322 . . . . 0.0 107.047 -174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.6 m -74.23 138.43 43.68 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.316 1.417 . . . . 0.0 110.347 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.0 36.57 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.669 0.652 . . . . 0.0 111.803 -165.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -138.43 136.7 36.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.409 -1.054 . . . . 0.0 109.458 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.1 mm -65.3 146.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 108.941 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.39 4.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 110.909 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -162.25 151.1 15.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.26 158.57 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.315 1.046 . . . . 0.0 108.46 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.72 76.78 1.41 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -57.91 -11.73 2.62 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.639 -0.663 . . . . 0.0 112.218 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -51.21 -31.55 20.87 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 111.699 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.16 -9.05 59.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.257 1.023 . . . . 0.0 110.514 -173.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.0 -30.41 70.52 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.41 1.084 . . . . 0.0 111.424 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.7 p -118.98 -20.36 8.14 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.732 0.813 . . . . 0.0 112.42 -171.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -136.85 67.14 56.99 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.759 2.023 . . . . 0.0 108.721 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.71 -26.17 60.94 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.345 2.697 . . . . 0.0 110.03 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.64 -15.66 53.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.332 1.053 . . . . 0.0 112.382 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -16.46 64.04 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.312 -1.493 . . . . 0.0 111.929 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.7 mt -64.28 -28.89 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.978 0.808 . . . . 0.0 109.832 169.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -71.44 -55.19 8.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.083 -1.636 . . . . 0.0 108.972 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.01 -43.1 99.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.429 -169.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.33 87.14 2.95 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-O 119.178 -0.439 . . . . 0.0 110.234 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.1 -11.28 29.17 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.095 1.863 . . . . 0.0 112.737 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.516 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -125.98 8.42 7.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.407 1.483 . . . . 0.0 112.201 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -124.19 -71.15 0.22 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 124.397 0.998 . . . . 0.0 111.474 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.2 -25.36 7.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.341 1.056 . . . . 0.0 110.611 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.03 35.59 1.47 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.057 1.789 . . . . 0.0 112.865 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -64.98 159.29 23.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.214 1.507 . . . . 0.0 108.626 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 mt -99.32 -66.91 0.87 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -146.27 171.98 14.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.202 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -135.14 145.62 48.0 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 124.323 1.049 . . . . 0.0 109.392 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.6 ptm -149.07 140.11 22.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.029 -172.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.78 143.89 57.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.492 1.117 . . . . 0.0 109.412 172.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.9 pt -90.4 109.03 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 123.928 0.767 . . . . 0.0 109.139 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -67.38 -35.55 79.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.166 0.439 . . . . 0.0 110.558 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -135.42 70.73 1.43 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -156.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.537 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -57.65 -17.62 15.75 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 172.651 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.46 -21.95 74.04 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.696 1.589 . . . . 0.0 113.294 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -72.43 -12.75 61.24 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 119.235 1.517 . . . . 0.0 111.338 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 105' ' ' GLU . 0.6 OUTLIER -56.09 -36.13 67.79 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.881 173.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.23 -7.83 49.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.097 0.862 . . . . 0.0 112.34 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.96 -19.06 41.41 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.705 1.202 . . . . 0.0 109.983 172.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.95 161.32 23.1 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 123.32 1.534 . . . . 0.0 109.87 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.91 140.69 43.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.941 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.24 167.72 2.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 163.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.24 -47.02 78.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.544 1.537 . . . . 0.0 110.777 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -61.91 -50.8 70.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.84 -32.16 72.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.144 0.578 . . . . 0.0 110.2 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.73 -44.93 96.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.978 0.911 . . . . 0.0 111.26 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.32 -46.8 72.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.61 0.641 . . . . 0.0 109.992 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 CA--C 1.535 0.379 0 C-N-CA 124.747 1.219 . . . . 0.0 111.141 175.47 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 tpp . . . . . 0 C--O 1.23 0.079 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -133.98 69.96 1.46 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.866 0.841 . . . . 0.0 109.204 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -80.87 175.59 10.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.895 171.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -137.57 169.08 18.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.741 2.417 . . . . 0.0 108.921 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -107.36 174.03 6.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.425 1.49 . . . . 0.0 108.955 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -77.22 -32.37 55.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.804 174.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -88.94 29.21 1.06 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.323 1.849 . . . . 0.0 113.229 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.02 41.89 3.49 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.224 -1.548 . . . . 0.0 112.59 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -124.8 150.29 46.5 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.445 1.098 . . . . 0.0 109.794 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 67.4 p-90 -105.08 172.54 6.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.863 0.839 . . . . 0.0 111.114 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.09 152.74 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.651 1.58 . . . . 0.0 107.071 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -143.29 81.47 1.71 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.649 1.179 . . . . 0.0 109.748 175.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 mp -65.99 150.07 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.662 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 3.4 pt-20 -142.71 -65.5 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.333 1.453 . . . . 0.0 108.797 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.429 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 13.3 t70 -126.52 -77.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.118 2.567 . . . . 0.0 108.222 -170.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.75 9.78 2.41 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 128.16 2.584 . . . . 0.0 110.963 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.63 155.68 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.755 1.622 . . . . 0.0 107.051 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -124.67 139.57 53.74 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 125.343 1.457 . . . . 0.0 108.294 165.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.1 m -83.97 143.57 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 t -122.11 143.03 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.54 2.336 . . . . 0.0 109.911 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -154.44 174.22 32.84 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 158.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 pt -74.2 165.12 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 117.837 0.819 . . . . 0.0 108.838 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -90.06 173.28 8.28 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.001 -1.062 . . . . 0.0 113.234 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.422 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -74.36 9.39 1.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 175.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -100.72 0.21 38.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.038 2.135 . . . . 0.0 112.624 167.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.43 -58.62 1.9 Allowed 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.571 -1.331 . . . . 0.0 110.573 -163.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.422 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -41.46 -42.17 2.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.72 2.808 . . . . 0.0 111.997 166.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.63 -52.99 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.394 3.078 . . . . 0.0 110.223 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -72.32 -35.47 68.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.719 -0.613 . . . . 0.0 111.453 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.13 -48.34 73.92 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.586 1.154 . . . . 0.0 110.162 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.79 -158.63 41.14 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.96 128.42 15.92 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.806 2.043 . . . . 0.0 109.147 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 85' ' ' GLU 0.446 6.0 p -123.89 154.88 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.437 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 1.0 OUTLIER -153.43 -31.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.632 -142.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -146.95 150.5 35.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.636 0.653 . . . . 0.0 111.843 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.27 133.02 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.514 1.15 . . . . 0.0 109.902 168.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.02 145.7 51.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.452 170.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.77 151.87 79.56 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 163.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.43 176.14 8.25 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.197 2.598 . . . . 0.0 111.702 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.16 141.88 35.28 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.41 22.06 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 129.024 2.929 . . . . 0.0 115.173 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.37 6.84 0.7 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.091 1.329 . . . . 0.0 113.308 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -79.84 141.86 35.8 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.829 1.815 . . . . 0.0 110.116 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -79.42 149.38 31.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.014 0.825 . . . . 0.0 109.098 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.0 171.0 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 110.062 -176.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 50' ' ' GLY . 1.1 mtmm -116.15 166.01 12.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.227 1.411 . . . . 0.0 110.537 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -64.82 14.82 0.02 OUTLIER 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.063 2.145 . . . . 0.0 116.131 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -163.66 67.07 0.23 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 173.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -134.13 128.07 33.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.84 53.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 127.46 2.304 . . . . 0.0 110.042 -161.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -86.52 9.01 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 120.014 -1.679 . . . . 0.0 113.631 -158.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.35 50.26 0.28 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.879 0.872 . . . . 0.0 110.221 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 148.72 20.46 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.631 -0.668 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 mt -117.92 135.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.11 117.11 29.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.979 1.312 . . . . 0.0 107.925 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -99.18 -165.89 1.29 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.756 0.707 . . . . 0.0 110.679 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -46.75 -38.91 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.731 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.84 55.81 0.2 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.454 1.479 . . . . 0.0 111.559 155.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.79 167.8 16.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.512 -0.742 . . . . 0.0 109.961 165.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.2 151.45 39.11 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 152.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.39 112.9 13.13 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.964 1.706 . . . . 0.0 106.585 160.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -70.78 107.98 4.24 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 170.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -76.0 111.04 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -86.22 116.51 24.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.42 135.15 5.73 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.107 0.963 . . . . 0.0 110.078 169.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.55 -32.38 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.116 1.877 . . . . 0.0 113.845 -161.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.08 166.69 19.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.555 2.342 . . . . 0.0 106.397 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 m -81.46 134.39 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -171.94 44.9 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 120.759 -1.213 . . . . 0.0 111.132 -166.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -121.63 132.61 54.76 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 117.655 -1.164 . . . . 0.0 109.647 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -60.95 140.18 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -147.35 1.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.802 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -148.62 160.65 42.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.685 1.584 . . . . 0.0 109.066 162.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.7 155.69 14.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.369 1.468 . . . . 0.0 108.438 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -108.02 70.96 0.78 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.45 -15.16 15.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 112.477 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -53.28 -29.89 35.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 116.855 -1.545 . . . . 0.0 112.991 166.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.3 mt -57.01 -14.7 3.9 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 121.186 1.812 . . . . 0.0 113.269 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.2 1.818 . . . . 0.0 112.903 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.0 p -124.13 -27.15 3.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.094 1.358 . . . . 0.0 110.858 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.34 64.21 14.19 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 128.042 2.537 . . . . 0.0 110.11 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -73.72 -52.08 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.728 2.952 . . . . 0.0 109.858 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HA ' ' CG1' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -53.64 -17.63 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.179 1.791 . . . . 0.0 110.524 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -30.48 34.96 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.454 1.934 . . . . 0.0 111.518 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -58.6 -25.69 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 121.825 -0.547 . . . . 0.0 110.047 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -64.83 -53.51 45.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.444 -2.035 . . . . 0.0 110.814 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -49.31 70.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.777 . . . . 0.0 110.342 -164.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -148.73 79.62 8.56 Favored Pre-proline 0 N--CA 1.451 -0.393 0 O-C-N 123.899 0.75 . . . . 0.0 110.151 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.57 -17.44 59.97 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.802 1.668 . . . . 0.0 112.444 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 3.6 mp0 -114.75 14.4 17.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.264 0.626 . . . . 0.0 112.592 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.34 -89.95 0.28 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.81 -32.25 35.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 122.94 0.496 . . . . 0.0 111.899 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.41 36.34 2.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.245 0.926 . . . . 0.0 112.698 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -66.42 169.33 7.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.025 1.412 . . . . 0.0 109.452 166.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.88 -59.76 1.77 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.72 168.31 20.49 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.711 -1.243 . . . . 0.0 111.023 -171.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -125.72 155.32 41.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.288 1.035 . . . . 0.0 108.47 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -146.46 143.99 29.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.215 0.606 . . . . 0.0 110.727 -177.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.9 139.04 58.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.651 1.18 . . . . 0.0 108.025 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 pt -88.21 104.72 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 122.578 0.351 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -33.99 70.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.85 0.46 . . . . 0.0 110.391 171.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -147.36 103.39 3.56 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 125.931 1.692 . . . . 0.0 107.216 -171.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.501 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -71.46 -1.95 14.98 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.807 1.243 . . . . 0.0 109.712 160.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.1 -64.46 4.32 Favored Glycine 0 C--N 1.338 0.653 0 O-C-N 120.789 -1.194 . . . . 0.0 111.959 168.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -71.4 -10.04 59.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -164.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.501 ' CD1' ' HA ' ' A' ' 105' ' ' GLU . 1.1 mp -46.48 -48.33 19.14 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.29 1.436 . . . . 0.0 110.455 163.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -75.82 -15.24 60.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.668 0.667 . . . . 0.0 111.024 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -86.66 -18.01 32.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.121 1.368 . . . . 0.0 110.943 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mt -80.32 -178.78 6.79 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.233 2.213 . . . . 0.0 110.975 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.3 mt -87.78 121.05 29.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.165 0.986 . . . . 0.0 110.249 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.99 166.8 15.07 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.112 0.965 . . . . 0.0 110.786 163.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.57 -57.72 4.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.184 1.794 . . . . 0.0 112.091 -160.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -50.21 -46.61 54.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.512 1.525 . . . . 0.0 110.01 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.58 -25.21 41.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.943 1.297 . . . . 0.0 111.901 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.91 -40.6 91.64 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 127.778 2.431 . . . . 0.0 109.844 167.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.42 -52.2 59.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 125.083 1.353 . . . . 0.0 111.066 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -142.78 114.82 8.27 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.519 1.128 . . . . 0.0 111.453 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -113.0 179.77 3.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.82 161.56 37.26 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.367 1.867 . . . . 0.0 110.194 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -125.62 173.38 9.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.437 1.113 . . . . 0.0 110.182 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -89.91 17.01 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.898 1.679 . . . . 0.0 110.849 -169.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -135.53 57.72 1.78 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.5 p80 44.42 52.77 7.27 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.807 1.643 . . . . 0.0 112.984 172.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -128.99 149.96 50.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.412 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 54.5 p-90 -121.35 162.53 20.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.648 1.579 . . . . 0.0 110.19 170.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.8 t -141.77 126.15 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.477 1.511 . . . . 0.0 107.995 -166.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -117.01 75.47 0.97 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.7 2.4 . . . . 0.0 110.004 -170.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 mp -74.0 97.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.108 1.363 . . . . 0.0 108.485 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.05 -56.02 3.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 118.112 -0.946 . . . . 0.0 111.541 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.16 -76.15 0.45 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.41 0.55 . . . . 0.0 110.173 -166.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -125.52 2.95 7.64 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.834 1.254 . . . . 0.0 111.086 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.25 143.14 41.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.62 109.05 16.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.174 1.789 . . . . 0.0 108.971 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.0 m -68.76 143.75 54.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.32 152.44 16.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 127.647 2.379 . . . . 0.0 112.512 176.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.18 161.09 32.25 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 160.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 pt -73.52 149.23 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.072 -1.252 . . . . 0.0 108.506 170.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 p -76.41 170.35 16.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.967 0.889 . . . . 0.0 111.657 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -62.63 -33.66 75.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.885 -1.134 . . . . 0.0 112.794 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -58.92 -25.7 63.69 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.264 -0.898 . . . . 0.0 112.056 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.27 -47.63 41.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.386 -0.822 . . . . 0.0 111.211 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -64.42 -27.79 69.24 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.837 -0.539 . . . . 0.0 110.56 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -63.43 -28.4 69.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.701 1.2 . . . . 0.0 111.47 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.75 -54.67 4.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.843 0.857 . . . . 0.0 111.959 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.81 -43.7 98.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.371 0.532 . . . . 0.0 110.118 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.52 -114.17 4.55 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.57 96.08 0.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.686 1.594 . . . . 0.0 109.057 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG13 ' H ' ' A' ' 36' ' ' VAL . 3.4 t -78.62 -178.77 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 162.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.539 ' H ' HG13 ' A' ' 35' ' ' VAL . 2.8 p -169.2 -33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 126.431 1.892 . . . . 0.0 108.487 -146.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -166.44 157.61 12.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.222 0.951 . . . . 0.0 111.008 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -138.15 146.93 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.86 148.11 22.71 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.176 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -137.72 142.98 38.52 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 123.897 0.879 . . . . 0.0 111.161 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.37 175.44 10.75 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.029 2.486 . . . . 0.0 111.077 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -87.85 147.67 25.01 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.348 0.659 . . . . 0.0 110.107 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.77 16.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 129.816 3.246 . . . . 0.0 116.436 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.72 6.32 0.87 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.655 1.598 . . . . 0.0 113.222 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -76.55 135.97 39.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.878 1.339 . . . . 0.0 110.487 -171.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -78.11 143.04 37.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.344 1.429 . . . . 0.0 108.902 167.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.07 -177.08 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.795 1.238 . . . . 0.0 108.645 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 50' ' ' GLY . 5.6 mtpm? -131.55 160.75 34.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.062 1.345 . . . . 0.0 108.547 -174.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 10.28 0.23 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -162.64 102.61 0.21 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 105.472 -3.051 . . . . 0.0 105.472 160.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.88 131.71 14.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.992 1.717 . . . . 0.0 107.097 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.1 t -69.92 16.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.805 2.042 . . . . 0.0 114.33 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.38 -0.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 119.317 -2.114 . . . . 0.0 115.528 -163.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -142.51 60.08 1.44 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.677 1.126 . . . . 0.0 108.375 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 m -56.74 163.04 2.03 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.597 1.189 . . . . 0.0 111.346 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.8 mt -132.85 144.77 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -122.27 165.86 15.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -139.62 -177.49 4.98 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.9 m -51.45 -23.83 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 125.504 1.522 . . . . 0.0 112.118 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.53 13.58 0.23 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.39 168.78 19.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.79 1.632 . . . . 0.0 110.04 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.78 164.94 27.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.205 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.65 118.44 5.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.77 1.228 . . . . 0.0 110.031 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.86 117.21 9.45 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.59 121.63 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.535 1.516 . . . . 0.0 106.976 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -88.98 111.16 21.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.692 0.678 . . . . 0.0 109.533 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.32 156.64 0.23 Allowed Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 128.078 2.551 . . . . 0.0 114.528 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -96.62 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 116.157 1.56 . . . . 0.0 116.157 -163.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -136.41 169.73 17.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.577 1.551 . . . . 0.0 107.606 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 m -101.26 65.56 1.07 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.839 1.256 . . . . 0.0 111.761 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.63 -165.84 12.54 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.199 1.857 . . . . 0.0 111.774 -164.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -119.17 123.69 44.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 118.1 0.95 . . . . 0.0 110.81 -176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 mm -59.77 142.01 15.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.3 m -146.75 -5.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.43 163.68 39.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.658 1.117 . . . . 0.0 108.792 169.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 m -149.83 144.18 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -95.12 81.2 3.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.76 1.618 . . . . 0.0 108.846 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.78 -11.52 27.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -26.79 65.91 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.375 1.07 . . . . 0.0 111.812 169.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -8.69 58.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.535 1.061 . . . . 0.0 109.941 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -80.09 -4.87 54.62 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 112.269 170.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -137.75 -25.07 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.595 0.758 . . . . 0.0 112.589 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.81 67.44 42.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.905 2.082 . . . . 0.0 109.512 168.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.81 -20.15 58.72 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.203 2.602 . . . . 0.0 111.186 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.97 -16.12 48.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.911 -1.042 . . . . 0.0 111.935 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 5.3 mt -60.88 -20.63 62.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.972 1.715 . . . . 0.0 113.414 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.3 mt -59.71 -32.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -66.13 -47.46 74.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 122.654 1.216 . . . . 0.0 110.123 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 15.5 mttt -69.65 -47.37 63.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.604 -1.635 . . . . 0.0 111.425 -165.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.32 83.17 4.18 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 172.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -62.89 -20.64 71.89 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.179 1.253 . . . . 0.0 111.135 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 1.2 mt-10 -112.65 21.53 15.49 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.818 1.247 . . . . 0.0 111.58 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.92 -101.87 0.97 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -86.62 -20.86 27.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.5 0.72 . . . . 0.0 111.308 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.52 37.05 2.03 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-N 120.001 1.273 . . . . 0.0 113.658 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -68.62 157.5 36.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.83 1.252 . . . . 0.0 110.242 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.66 -67.36 0.87 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-O 116.904 -1.522 . . . . 0.0 108.486 176.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -133.49 -176.94 4.32 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.191 2.269 . . . . 0.0 111.762 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -136.87 141.58 42.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -141.71 138.32 32.31 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.278 0.631 . . . . 0.0 109.494 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -62.51 126.11 26.23 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.695 1.998 . . . . 0.0 106.243 168.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.9 pt -75.78 135.81 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.7 m -117.26 -11.12 10.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.017 1.727 . . . . 0.0 113.421 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -145.23 81.37 1.63 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -6.33 44.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.517 -1.364 . . . . 0.0 112.365 -177.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.51 66.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.02 -7.02 14.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.83 -42.1 98.62 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.209 0.913 . . . . 0.0 109.023 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -71.86 -0.2 10.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.398 0.679 . . . . 0.0 111.32 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -85.69 -19.15 31.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.87 0.759 . . . . 0.0 111.497 168.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.41 174.59 8.43 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.174 1.79 . . . . 0.0 111.413 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.46 142.97 38.89 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.418 1.087 . . . . 0.0 110.158 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.484 ' HB2' ' H ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -59.81 170.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 109.086 158.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -68.47 -51.36 44.37 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.046 -1.033 . . . . 0.0 110.187 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.37 -47.8 84.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.484 ' H ' ' HB2' ' A' ' 113' ' ' ASP . . . -63.96 -30.31 71.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.68 0.673 . . . . 0.0 112.09 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -67.29 -40.94 86.16 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.402 0.547 . . . . 0.0 110.956 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.64 -53.07 60.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.244 169.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 120.176 1.353 . . . . 0.0 109.948 -172.211 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ttp . . . . . 0 C--O 1.23 0.051 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -140.71 100.24 3.8 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.76 179.3 4.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -143.54 174.98 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.686 1.594 . . . . 0.0 108.669 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.8 p -133.82 -165.14 1.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.129 0.966 . . . . 0.0 112.624 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -30.96 42.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.631 2.372 . . . . 0.0 111.135 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.13 30.21 0.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.249 -0.907 . . . . 0.0 111.502 -167.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 p80 45.33 27.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.121 1.769 . . . . 0.0 115.026 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.9 mt-10 -82.8 165.34 19.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.744 3.218 . . . . 0.0 112.628 160.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.488 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 61.2 p-90 -124.46 170.09 11.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.218 2.207 . . . . 0.0 109.014 163.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.12 142.39 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.59 88.33 2.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.479 1.112 . . . . 0.0 109.738 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.88 89.48 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -175.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -69.88 0.31 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.28 -98.32 0.39 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -122.23 11.01 10.06 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.235 1.414 . . . . 0.0 110.79 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.72 119.71 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.4 124.53 36.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 m -76.63 128.44 34.71 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 162.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.57 134.81 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 108.016 167.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.12 172.01 27.67 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 162.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 6.1 pt -88.6 148.92 4.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 118.586 1.193 . . . . 0.0 109.367 169.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.1 p -77.04 169.6 18.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.062 0.945 . . . . 0.0 110.954 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.85 63.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.169 0.988 . . . . 0.0 111.883 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -59.33 -18.5 38.63 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.356 -0.84 . . . . 0.0 113.149 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.33 -51.0 7.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.997 -1.065 . . . . 0.0 111.189 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -60.89 -21.48 63.36 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.668 0.667 . . . . 0.0 111.574 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.13 -16.12 40.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.866 2.066 . . . . 0.0 113.731 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -112.22 -51.3 2.85 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.737 0.699 . . . . 0.0 110.022 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mt -65.01 -36.32 84.03 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.59 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.88 -125.45 27.87 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 125.339 1.447 . . . . 0.0 110.002 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.69 113.13 3.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.579 HG13 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -87.63 -164.0 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.579 ' H ' HG13 ' A' ' 35' ' ' VAL . 2.2 p -173.19 -38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.22 1.808 . . . . 0.0 107.124 -153.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -154.21 152.55 30.49 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 123.561 0.538 . . . . 0.0 111.524 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.6 t -139.17 128.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -72.63 134.72 45.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.921 166.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.7 mt -128.88 138.7 33.73 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.08 179.18 6.01 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.387 2.725 . . . . 0.0 113.772 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.48 166.78 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.137 0.975 . . . . 0.0 110.119 169.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.62 21.38 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 124.484 2.088 . . . . 0.0 112.786 -162.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.57 10.86 0.52 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 129.269 3.318 . . . . 0.0 111.315 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -76.95 132.45 39.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.085 -1.244 . . . . 0.0 108.238 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -86.35 145.24 26.97 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.67 164.22 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.563 1.545 . . . . 0.0 110.061 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' H ' ' HB2' ' A' ' 51' ' ' GLU . 59.3 mtmt -116.56 170.19 8.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.116 1.766 . . . . 0.0 108.401 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.72 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.023 2.929 . . . . 0.0 117.96 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.54 35.8 0.43 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.512 165.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -86.04 115.71 23.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.949 1.874 . . . . 0.0 109.683 -173.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.416 0.2 OUTLIER -63.43 25.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 129.962 3.305 . . . . 0.0 115.609 -175.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.92 13.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 118.573 -2.58 . . . . 0.0 116.133 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.36 43.93 0.61 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 120.517 1.508 . . . . 0.0 111.163 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -46.82 145.07 2.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.875 1.27 . . . . 0.0 112.223 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.3 mt -126.98 104.9 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -173.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.88 131.96 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -104.91 -173.7 2.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.893 0.877 . . . . 0.0 109.936 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 m -47.87 -27.82 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.62 15.45 0.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.54 -179.28 5.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.561 1.528 . . . . 0.0 110.504 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.11 137.61 27.64 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.53 107.38 7.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.882 1.673 . . . . 0.0 108.683 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.64 144.0 28.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.716 1.206 . . . . 0.0 107.946 170.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.1 t -116.42 113.27 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -106.01 99.06 8.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.277 1.031 . . . . 0.0 110.297 -166.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.76 134.69 2.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 O-C-N 124.58 1.175 . . . . 0.0 111.718 -164.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.1 -24.85 16.69 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.365 1.376 . . . . 0.0 113.409 -165.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mp -142.58 166.86 23.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.193 1.397 . . . . 0.0 108.935 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -89.3 122.9 33.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.723 1.209 . . . . 0.0 108.262 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.15 -161.37 24.03 Favored Glycine 0 C--O 1.235 0.193 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -172.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -132.93 130.3 39.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.298 1.049 . . . . 0.0 109.686 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.9 mm -58.39 151.72 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 108.165 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -167.29 -14.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.192 -165.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.432 ' CD ' ' HZ3' ' A' ' 99' ' ' LYS . 2.2 mt-10 -146.13 153.57 40.82 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 168.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.92 138.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.413 ' HB2' ' CD2' ' A' ' 96' ' ' TRP . 61.4 t30 -87.16 89.52 8.02 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.99 -9.24 9.26 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.708 0.803 . . . . 0.0 111.745 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -62.4 -45.28 93.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.024 1.33 . . . . 0.0 108.825 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.32 -14.6 63.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 120.249 1.386 . . . . 0.0 114.141 -170.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -62.17 -30.67 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.421 1.088 . . . . 0.0 111.529 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.8 p -134.38 -7.96 2.56 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.38 70.46 81.86 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.423 1.089 . . . . 0.0 108.238 159.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.15 -16.11 52.33 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.546 2.83 . . . . 0.0 110.086 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 -19.75 64.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 118.018 -0.992 . . . . 0.0 112.065 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -65.4 -17.17 64.33 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 121.025 1.739 . . . . 0.0 112.787 -173.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 mt -64.52 -29.13 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 118.801 -0.619 . . . . 0.0 110.724 169.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -70.29 -53.87 15.03 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 120.814 1.643 . . . . 0.0 109.779 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -60.63 -43.49 97.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.825 1.65 . . . . 0.0 112.063 -171.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.91 74.75 5.04 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 124.39 1.076 . . . . 0.0 108.269 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -55.29 -29.64 68.33 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.822 1.681 . . . . 0.0 111.734 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.488 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 7.6 mp0 -104.62 3.43 31.68 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.358 1.463 . . . . 0.0 112.769 -169.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.89 -86.56 0.57 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -172.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.49 -7.48 38.0 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.751 -0.852 . . . . 0.0 111.848 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.66 25.53 18.42 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.416 1.484 . . . . 0.0 112.344 172.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.413 ' CD2' ' HB2' ' A' ' 77' ' ' ASN . 16.8 p-90 -60.98 159.54 11.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.595 1.198 . . . . 0.0 109.229 166.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.63 -54.07 2.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 109.681 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -148.43 168.15 23.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 42.0 mtpt -128.3 151.5 49.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.6 ptm -143.48 145.86 32.94 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.069 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.52 128.76 37.3 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 160.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt -81.44 136.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.61 -21.56 14.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.76 1.224 . . . . 0.0 111.349 167.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 106' ' ' GLY . 2.0 p30 -138.08 64.35 1.51 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.904 1.335 . . . . 0.0 111.595 -171.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -5.48 0.07 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.486 1.915 . . . . 0.0 112.846 160.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 104' ' ' ASP . . . -92.87 -25.94 18.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.685 1.612 . . . . 0.0 112.065 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.76 -5.54 46.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.614 1.707 . . . . 0.0 111.122 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 74.8 mt -54.09 -21.87 9.57 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.528 0.731 . . . . 0.0 111.261 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.063 1.345 . . . . 0.0 113.188 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.95 -24.31 35.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.284 1.434 . . . . 0.0 110.423 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 mt -85.1 156.18 21.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.363 1.078 . . . . 0.0 108.577 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.404 HD21 ' H ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -75.75 134.6 40.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -176.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.17 179.06 0.32 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 123.442 1.592 . . . . 0.0 110.386 155.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -73.35 -39.89 64.83 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.291 -168.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -67.16 -49.19 65.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.84 69.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.021 1.728 . . . . 0.0 111.421 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -61.83 -38.12 86.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.271 1.028 . . . . 0.0 112.692 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -46.16 48.81 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 125.105 1.362 . . . . 0.0 111.265 177.145 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 C--O 1.238 0.467 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.04 95.76 4.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -170.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -75.49 179.93 4.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 110.399 165.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -142.23 178.5 7.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.25 1.42 . . . . 0.0 110.898 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 p -135.89 174.61 10.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.959 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' H ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -75.32 -35.23 61.25 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.88 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.25 51.71 2.03 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.77 1.623 . . . . 0.0 108.816 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 p80 42.85 52.28 5.13 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.8 -1.187 . . . . 0.0 113.423 165.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.8 mt-10 -114.21 154.37 27.99 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.337 1.455 . . . . 0.0 108.06 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.428 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 54.7 p-90 -108.11 162.41 14.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 157.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -124.88 164.08 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.47 77.02 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.818 1.19 . . . . 0.0 109.508 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 mt -72.37 93.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -71.56 -64.51 0.91 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.95 -86.49 0.42 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.159 0.584 . . . . 0.0 109.809 -169.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -119.47 -2.0 10.62 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.0 2.12 . . . . 0.0 110.073 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -116.25 141.58 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.25 161.7 13.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 162.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.3 m -111.19 148.91 31.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 163.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.92 145.83 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.1 3.36 . . . . 0.0 113.134 169.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.49 169.44 34.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 107.271 -2.331 . . . . 0.0 107.271 155.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 41.7 pt -81.69 157.16 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 O-C-N 121.837 -0.802 . . . . 0.0 109.829 170.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -78.16 166.4 22.8 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.219 0.533 . . . . 0.0 110.428 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -25.66 68.2 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.018 -1.051 . . . . 0.0 111.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -49.37 -47.88 47.27 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.807 -1.183 . . . . 0.0 110.537 165.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.65 -42.93 81.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.445 -1.409 . . . . 0.0 112.393 -170.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -62.43 -23.58 66.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.752 0.251 . . . . 0.0 111.084 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.58 -24.19 67.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.248 2.219 . . . . 0.0 112.035 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -98.37 -41.06 8.0 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.349 -0.844 . . . . 0.0 111.878 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.81 -27.55 28.71 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.753 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.59 -133.64 38.28 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 119.24 0.927 . . . . 0.0 111.28 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -62.4 117.43 6.14 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.682 HG13 ' H ' ' A' ' 36' ' ' VAL . 1.6 t -87.39 -171.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.682 ' H ' HG13 ' A' ' 35' ' ' VAL . 1.4 m -153.92 -35.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 130.485 3.514 . . . . 0.0 108.495 -169.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -155.85 156.61 35.0 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.231 0.469 . . . . 0.0 111.191 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.34 136.79 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.98 144.71 25.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.354 2.262 . . . . 0.0 108.451 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -138.77 154.48 73.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.784 0.834 . . . . 0.0 109.262 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -72.72 -171.23 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.154 2.569 . . . . 0.0 112.647 174.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -107.03 158.26 17.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.77 1.628 . . . . 0.0 110.685 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.52 9.42 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 126.946 2.099 . . . . 0.0 115.238 -165.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.25 11.68 1.81 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.028 1.775 . . . . 0.0 111.917 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -69.35 125.35 26.44 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.334 1.567 . . . . 0.0 108.957 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -76.15 145.6 39.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.7 m -142.39 163.12 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.014 1.326 . . . . 0.0 109.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 50' ' ' GLY . 30.8 mtmt -111.67 169.29 8.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.573 0.349 . . . . 0.0 110.858 168.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -57.55 17.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 1 C-N-CA 131.834 4.053 . . . . 0.0 114.944 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -163.35 23.76 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 120.045 -1.659 . . . . 0.0 114.856 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.63 143.86 32.2 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.254 2.027 . . . . 0.0 111.923 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.3 t -77.65 38.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 129.241 3.016 . . . . 0.0 112.852 -168.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.59 4.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 118.472 -2.643 . . . . 0.0 115.048 -166.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.3 54.82 0.86 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.633 1.106 . . . . 0.0 111.542 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -61.85 165.48 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.194 0.997 . . . . 0.0 112.838 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.66 100.55 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.03 125.89 32.52 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.4 p -103.83 -174.8 2.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.213 1.405 . . . . 0.0 109.853 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 m -50.82 -32.09 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.142 1.377 . . . . 0.0 113.015 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.72 37.7 0.27 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 120.506 1.503 . . . . 0.0 113.289 168.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.03 170.58 19.02 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.44 -1.412 . . . . 0.0 109.832 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.46 122.4 24.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.596 1.558 . . . . 0.0 107.832 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.75 143.49 26.24 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 160.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.58 117.19 34.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.105 -2.924 . . . . 0.0 103.105 167.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.36 119.6 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 169.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.36 97.95 7.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.125 0.875 . . . . 0.0 109.624 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.09 0.46 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.664 1.985 . . . . 0.0 115.198 -157.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.06 -32.57 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 N-CA-C 114.593 0.959 . . . . 0.0 114.593 -159.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -127.58 170.21 12.89 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.293 2.237 . . . . 0.0 104.975 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -86.03 157.56 20.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 157.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.47 -165.7 31.49 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 120.006 -1.684 . . . . 0.0 111.091 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -130.83 125.7 34.35 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.8 mm -63.29 140.07 20.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.1 m -149.63 6.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.858 0.863 . . . . 0.0 111.231 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -159.79 153.91 23.42 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 166.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.86 174.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.226 1.81 . . . . 0.0 108.25 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -118.37 84.06 2.11 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.706 0.685 . . . . 0.0 109.683 -172.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.9 -15.54 9.0 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.093 0.957 . . . . 0.0 112.123 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -54.52 -38.68 66.83 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.755 1.622 . . . . 0.0 111.105 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.866 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -68.96 -18.87 64.14 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.613 -0.679 . . . . 0.0 111.412 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 p -127.6 -16.44 4.79 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -129.59 71.62 82.07 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.182 1.793 . . . . 0.0 107.415 165.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -67.53 -22.75 44.27 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.219 1.946 . . . . 0.0 109.746 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.7 -9.75 58.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.087 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -17.87 63.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 122.5 2.409 . . . . 0.0 111.779 -177.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.5 mt -60.68 -30.52 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.115 0.966 . . . . 0.0 109.654 171.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -69.47 -47.98 62.22 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 120.851 -1.156 . . . . 0.0 109.18 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -29.92 30.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.463 -160.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -160.06 65.06 2.4 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 120.414 1.461 . . . . 0.0 110.601 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.06 -19.6 49.54 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.9 2.4 . . . . 0.0 114.547 -167.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.2 mp0 -115.23 -1.57 12.91 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.849 0.86 . . . . 0.0 112.405 -173.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.64 -84.53 1.67 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -98.55 -26.64 14.35 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.557 1.143 . . . . 0.0 111.956 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.98 40.28 2.65 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.058 0.845 . . . . 0.0 111.594 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -73.78 164.92 26.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.652 1.581 . . . . 0.0 110.448 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.26 -66.5 1.0 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-O 116.468 -1.73 . . . . 0.0 108.845 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -138.04 -177.62 4.9 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.016 -2.273 . . . . 0.0 112.703 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -134.1 154.08 51.41 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 124.123 0.969 . . . . 0.0 109.321 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.72 138.72 21.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.246 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -58.66 126.63 28.41 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 162.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 pt -82.25 96.15 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 172.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -66.42 -29.69 69.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.021 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -143.81 79.84 1.64 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.931 1.348 . . . . 0.0 109.998 -167.3 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.617 ' HA ' ' CD1' ' A' ' 108' ' ' LEU 0.293 0.0 OUTLIER -81.44 26.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 124.582 2.134 . . . . 0.0 111.504 173.9 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 104' ' ' ASP . . . -92.03 -22.07 31.31 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.511 -1.222 . . . . 0.0 114.052 155.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -76.32 -6.96 53.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.181 1.491 . . . . 0.0 112.678 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.617 ' CD1' ' HA ' ' A' ' 105' ' ' GLU . 4.8 mp -61.88 -21.94 65.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.219 1.008 . . . . 0.0 110.955 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.47 -20.42 58.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.111 . . . . 0.0 112.057 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -82.57 -15.88 50.61 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.238 0.926 . . . . 0.0 110.535 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.82 165.74 20.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.975 -1.078 . . . . 0.0 108.364 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.57 125.07 28.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 172.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.86 171.68 7.61 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 152.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.48 -41.99 88.15 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 120.452 -1.405 . . . . 0.0 113.569 -156.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -62.49 -41.51 98.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.332 1.053 . . . . 0.0 110.114 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.72 -32.92 66.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.578 0.751 . . . . 0.0 111.034 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.5 -48.7 80.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 120.957 -1.089 . . . . 0.0 109.015 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.23 -47.92 71.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 125.602 1.561 . . . . 0.0 111.805 173.834 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.7 ptm . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.7 95.88 2.66 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.836 -0.54 . . . . 0.0 110.569 -162.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 109' ' ' GLU . 15.2 mmtm -93.53 174.26 7.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.68 0.792 . . . . 0.0 111.391 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.69 -173.09 2.66 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.772 2.429 . . . . 0.0 109.486 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -138.41 179.54 6.4 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.947 1.299 . . . . 0.0 109.918 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -82.3 7.53 13.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.424 1.089 . . . . 0.0 111.447 167.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -121.93 40.8 3.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.605 1.548 . . . . 0.0 109.909 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 p80 43.27 59.62 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.967 1.707 . . . . 0.0 111.908 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -152.21 133.25 14.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 108.612 -158.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.408 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.2 p-90 -110.62 160.69 16.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.361 1.465 . . . . 0.0 109.514 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 136.37 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.77 77.32 1.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.913 0.885 . . . . 0.0 109.462 -172.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mp -71.47 139.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.7 pt-20 -126.46 -93.58 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.654 1.182 . . . . 0.0 110.101 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 9.1 t0 -83.4 -81.42 0.16 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -131.05 7.93 4.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.699 2.0 . . . . 0.0 110.426 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.77 149.78 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.05 140.83 47.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 159.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.3 m -79.78 137.02 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 153.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.9 t -103.11 136.62 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 128.0 2.52 . . . . 0.0 110.367 167.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.4 173.67 36.21 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.521 -0.737 . . . . 0.0 111.598 161.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.0 pt -86.56 153.99 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 118.073 0.936 . . . . 0.0 110.683 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -84.06 171.91 12.48 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.677 0.791 . . . . 0.0 111.454 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.73 -35.94 71.37 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.408 0.623 . . . . 0.0 111.938 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -54.39 -33.74 59.86 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.734 -1.229 . . . . 0.0 112.279 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.8 -44.0 51.77 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.356 -0.84 . . . . 0.0 112.145 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.13 -25.81 68.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.497 0.59 . . . . 0.0 110.75 176.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.62 -21.09 66.63 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.115 1.366 . . . . 0.0 111.042 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -102.45 -41.58 6.25 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.763 0.711 . . . . 0.0 111.254 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 mt -82.99 -19.75 36.43 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.55 -123.13 29.25 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 119.45 1.023 . . . . 0.0 111.183 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -80.29 33.91 0.3 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.745 2.018 . . . . 0.0 116.212 -151.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -22.19 -115.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 115.121 -2.371 . . . . 0.0 111.428 -131.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 170.93 -47.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 128.455 2.702 . . . . 0.0 110.813 -170.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -169.86 158.85 7.56 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.31 0.381 . . . . 0.0 111.446 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.09 144.05 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 125.561 1.544 . . . . 0.0 110.711 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.04 139.56 37.51 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.712 2.405 . . . . 0.0 108.984 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -135.79 155.9 77.71 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.973 0.909 . . . . 0.0 110.713 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -84.47 -179.05 3.63 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.374 3.382 . . . . 0.0 114.207 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -84.96 155.76 21.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 163.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.39 18.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 127.086 2.155 . . . . 0.0 113.927 -163.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.42 13.75 0.2 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 127.903 2.668 . . . . 0.0 111.938 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -73.92 135.89 43.31 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.067 -1.255 . . . . 0.0 109.564 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -82.88 139.16 33.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.03 175.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.238 1.415 . . . . 0.0 110.453 -174.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -118.66 169.67 9.62 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.417 1.487 . . . . 0.0 109.48 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 107' ' ' GLU . 24.9 tttt -62.99 14.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.27 2.228 . . . . 0.0 114.915 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.0 78.2 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.52 116.58 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -169.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.6 71.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 128.005 2.522 . . . . 0.0 108.835 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.51 6.42 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.502 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.24 59.8 0.9 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.551 1.069 . . . . 0.0 112.438 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 m -59.85 160.61 7.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.763 1.268 . . . . 0.0 111.324 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mt -134.27 105.73 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.7 166.19 23.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 163.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.9 p -140.8 177.78 7.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.487 1.494 . . . . 0.0 107.89 164.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -49.04 -19.58 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 128.055 2.542 . . . . 0.0 115.978 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -160.65 41.6 0.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.934 1.697 . . . . 0.0 114.164 155.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -154.37 -172.32 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.216 -0.928 . . . . 0.0 109.188 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.91 14.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.994 0.918 . . . . 0.0 108.771 159.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.75 131.96 32.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 143.62 37.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 164.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.54 114.18 46.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.44 107.03 18.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -170.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.62 125.39 0.94 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.038 1.335 . . . . 0.0 113.551 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.9 -21.86 24.04 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.218 2.612 . . . . 0.0 115.187 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -134.93 149.02 50.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 129.501 3.12 . . . . 0.0 108.644 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -66.49 149.72 50.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 158.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.67 -165.97 36.5 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -130.67 134.86 47.29 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.36 0.664 . . . . 0.0 109.43 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.22 143.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.93 1.292 . . . . 0.0 108.861 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.59 -8.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -153.18 150.52 29.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.588 1.54 . . . . 0.0 108.342 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.26 168.01 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.818 1.19 . . . . 0.0 110.21 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 79' ' ' LYS . 51.6 t30 -119.86 73.98 1.0 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.72 -1.04 0.33 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.05 -0.407 . . . . 0.0 112.077 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 77' ' ' ASN . 14.3 mmmm -54.92 -43.77 73.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.128 -1.415 . . . . 0.0 110.2 162.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.37 -9.81 50.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.639 1.563 . . . . 0.0 113.774 -177.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.8 -24.28 65.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.476 1.035 . . . . 0.0 111.636 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.2 p -129.18 -19.29 3.54 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.577 -0.702 . . . . 0.0 112.548 -172.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -122.03 59.86 11.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.351 2.66 . . . . 0.0 108.788 166.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.82 -19.04 47.32 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.691 1.594 . . . . 0.0 109.601 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.23 -11.54 59.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.464 1.906 . . . . 0.0 112.094 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -27.83 68.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 119.454 -2.029 . . . . 0.0 111.519 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.75 -19.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.157 0.583 . . . . 0.0 109.932 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -65.0 -56.02 15.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.3 1.048 . . . . 0.0 109.696 165.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -63.05 -53.89 46.73 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.067 2.547 . . . . 0.0 108.791 -162.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 85.79 5.5 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -59.11 -22.04 62.24 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.512 2.141 . . . . 0.0 112.455 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -127.41 9.01 6.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 127.858 2.463 . . . . 0.0 110.764 -163.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.33 -80.26 0.87 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 126.277 1.894 . . . . 0.0 109.716 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -93.6 -25.25 17.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.18 31.88 4.9 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.649 1.119 . . . . 0.0 113.367 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.544 ' CZ3' ' HE3' ' A' ' 99' ' ' LYS . 34.4 p-90 -70.06 159.4 33.91 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.89 -46.66 3.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.5 1.046 . . . . 0.0 109.136 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -154.33 171.02 19.95 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.339 -0.851 . . . . 0.0 111.378 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.544 ' HE3' ' CZ3' ' A' ' 96' ' ' TRP . 77.1 mttt -131.59 152.49 50.76 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.504 1.522 . . . . 0.0 108.1 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.0 ptm -154.8 148.3 25.2 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.202 -175.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -65.67 133.35 50.91 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.1 pt -79.23 103.41 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -73.77 -17.41 61.1 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.808 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -144.15 79.29 1.61 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.191 1.397 . . . . 0.0 107.364 -164.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.55 -10.46 55.91 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.767 -1.208 . . . . 0.0 113.298 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -81.97 -4.85 90.15 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.72 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.465 ' HB3' ' HE3' ' A' ' 49' ' ' LYS . 49.0 mt-10 -81.38 -36.55 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.87 1.335 . . . . 0.0 112.169 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -35.41 80.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.656 1.116 . . . . 0.0 112.193 -170.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.437 ' HA ' ' HE2' ' A' ' 5' ' ' LYS . 17.6 mm-40 -62.51 -20.37 64.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -87.26 -11.0 50.94 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.588 0.755 . . . . 0.0 112.589 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.5 mt -75.04 -179.1 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.539 1.136 . . . . 0.0 110.252 167.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.9 mt -88.33 131.96 34.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.733 0.813 . . . . 0.0 109.996 -170.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.84 171.74 1.55 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.263 1.425 . . . . 0.0 109.846 163.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.74 -51.53 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.286 1.035 . . . . 0.0 111.151 -175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -56.7 -47.47 79.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.024 0.53 . . . . 0.0 109.776 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.48 67.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.332 0.653 . . . . 0.0 112.098 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -79.72 -43.35 22.81 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.656 0.662 . . . . 0.0 111.631 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 109.579 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 169.901 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ttp . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.27 101.73 3.75 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.442 -0.786 . . . . 0.0 109.763 -171.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -112.77 -178.6 3.43 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.97 153.49 43.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.373 1.069 . . . . 0.0 112.061 -167.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -101.33 171.39 7.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 123.306 1.527 . . . . 0.0 110.346 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -83.59 -1.01 52.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.989 170.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 p -120.65 44.25 2.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.129 1.772 . . . . 0.0 109.376 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.2 p80 43.96 61.11 2.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 113.807 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -134.86 152.18 51.53 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.299 1.84 . . . . 0.0 109.155 171.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 64.0 p-90 -109.81 172.66 6.72 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.947 1.299 . . . . 0.0 109.373 169.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.1 134.45 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -116.43 84.92 2.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mp -75.67 118.07 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -106.33 -120.82 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 167.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.61 -60.49 2.29 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.849 1.204 . . . . 0.0 110.666 -167.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.1 7.53 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.973 0.909 . . . . 0.0 111.523 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.4 t -130.38 140.79 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -110.33 134.22 52.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 163.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -77.15 142.05 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 158.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.72 139.86 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.083 1.353 . . . . 0.0 109.559 166.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.29 161.4 28.75 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 161.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.06 159.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -79.6 -172.31 3.22 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.493 -0.755 . . . . 0.0 111.726 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.04 19.74 13.48 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.896 2.478 . . . . 0.0 112.549 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -113.48 0.57 14.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 126.009 1.724 . . . . 0.0 113.999 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.288 . . -119.76 -52.26 2.23 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.823 3.249 . . . . 0.0 112.585 -156.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.91 -42.97 1.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.777 2.431 . . . . 0.0 110.178 158.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.28 -25.05 67.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.694 1.598 . . . . 0.0 113.722 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -75.02 -45.31 42.67 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.015 -1.053 . . . . 0.0 109.542 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -72.47 -57.51 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.31 -132.29 11.19 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.15 126.82 28.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 36' ' ' VAL . 3.1 t -97.83 -154.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 169.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.512 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.2 m -174.42 -38.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 129.582 3.153 . . . . 0.0 106.973 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -144.93 145.6 31.62 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.553 0.615 . . . . 0.0 111.27 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -128.81 121.07 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 168.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.48 140.79 37.2 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.033 173.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.43 149.09 63.5 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -175.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -71.0 -175.52 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.18 2.587 . . . . 0.0 112.308 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.44 158.98 15.35 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.893 1.677 . . . . 0.0 109.918 162.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.13 19.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 126.378 1.871 . . . . 0.0 115.014 -167.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.33 9.34 0.6 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.627 2.06 . . . . 0.0 112.887 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -73.04 135.82 44.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.723 1.261 . . . . 0.0 109.678 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.01 157.95 18.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.315 1.055 . . . . 0.0 111.665 177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.331 11.1 t -146.22 171.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.29 0 C-N-CA 131.653 3.981 . . . . 0.0 108.852 -162.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 50' ' ' GLY . 64.9 mttm -146.13 166.11 27.12 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.768 4.027 . . . . 0.0 106.338 -171.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -74.73 27.85 0.09 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -178.85 57.78 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 126.469 1.985 . . . . 0.0 108.372 171.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.01 143.25 45.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 117.583 0.692 . . . . 0.0 110.491 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.1 t -92.72 103.89 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.76 -0.24 8.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 125.919 1.687 . . . . 0.0 109.9 -177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -166.95 66.51 0.09 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.488 1.115 . . . . 0.0 109.432 -163.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -65.23 166.59 9.56 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.515 -1.366 . . . . 0.0 110.963 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.2 mt -143.65 103.78 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 O-C-N 120.145 -1.597 . . . . 0.0 107.612 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.43 117.67 29.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.4 p -97.98 -168.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.187 1.795 . . . . 0.0 110.645 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -52.79 -28.84 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.473 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.11 40.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.393 1.451 . . . . 0.0 113.003 166.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.17 39.46 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 120.78 -1.2 . . . . 0.0 109.721 171.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.34 152.38 31.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.739 1.616 . . . . 0.0 106.7 168.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.73 76.1 1.42 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -33.01 107.49 0.05 OUTLIER 'General case' 0 C--O 1.237 0.439 0 C-N-CA 128.777 2.831 . . . . 0.0 108.928 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.79 120.53 30.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.18 94.77 6.13 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.696 0.398 . . . . 0.0 111.804 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.09 132.74 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.559 0 C-N-CA 125.947 1.699 . . . . 0.0 114.647 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.2 -32.74 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.068 1.845 . . . . 0.0 111.874 -165.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.24 160.93 37.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.235 1.814 . . . . 0.0 108.209 -175.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.14 132.18 46.75 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.226 1.811 . . . . 0.0 107.328 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -172.89 45.88 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.2 131.23 40.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.81 151.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.93 -11.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 124.044 0.937 . . . . 0.0 109.744 -167.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.58 152.07 39.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 163.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.68 152.38 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -99.99 84.66 2.91 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.27 -15.29 23.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.779 0.8 . . . . 0.0 111.859 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -59.56 -22.41 61.67 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.273 1.829 . . . . 0.0 113.24 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.29 -15.55 46.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.271 1.396 . . . . 0.0 112.113 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -62.66 -31.33 72.19 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 165.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.9 -20.36 12.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.113 -0.992 . . . . 0.0 111.9 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.11 74.95 76.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.79 1.236 . . . . 0.0 110.312 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -65.64 -25.55 54.35 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.633 2.222 . . . . 0.0 110.456 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.64 -16.84 64.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.938 0.79 . . . . 0.0 110.99 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -21.62 66.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.911 2.141 . . . . 0.0 112.204 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.0 mt -64.52 -28.78 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.353 0.661 . . . . 0.0 110.289 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -67.1 -55.31 14.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.22 -1.55 . . . . 0.0 108.527 167.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -51.13 68.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.25 -160.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.86 76.76 5.88 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.13 0.972 . . . . 0.0 108.427 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.51 -25.16 62.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.016 1.81 . . . . 0.0 113.028 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -116.0 15.09 16.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.064 0.945 . . . . 0.0 110.781 -175.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.4 -65.91 0.34 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.248 1.88 . . . . 0.0 111.289 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -124.86 -23.9 4.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.516 1.158 . . . . 0.0 114.072 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.51 2.65 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 111.879 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -67.59 152.58 45.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -93.63 -59.9 1.89 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -149.31 168.62 22.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.719 1.207 . . . . 0.0 109.857 -172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -132.99 155.11 49.76 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.386 1.474 . . . . 0.0 107.545 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.8 ptm -148.58 144.59 27.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.388 -168.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.56 114.66 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.351 2.26 . . . . 0.0 107.912 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt -71.34 117.59 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.606 0.717 . . . . 0.0 111.472 -170.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -78.06 -25.85 47.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.371 -0.83 . . . . 0.0 112.718 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.08 84.76 1.59 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -8.55 36.27 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 173.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.53 -31.85 8.06 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.748 -1.029 . . . . 0.0 112.872 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.57 -5.47 11.56 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.085 1.443 . . . . 0.0 111.212 170.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.99 -34.57 73.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.45 1.023 . . . . 0.0 110.868 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.69 -20.74 61.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.253 1.421 . . . . 0.0 111.441 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -83.41 -6.08 59.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.886 0.874 . . . . 0.0 111.456 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.08 176.07 5.27 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.643 1.211 . . . . 0.0 111.915 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.97 143.78 41.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.8 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.75 171.98 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.395 162.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -73.9 -34.68 64.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.524 1.93 . . . . 0.0 111.903 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.82 -48.92 33.79 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.22 70.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.445 0.698 . . . . 0.0 110.839 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -53.48 -47.64 69.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.626 1.571 . . . . 0.0 111.884 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.61 -35.72 65.4 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.7 -0.625 . . . . 0.0 110.205 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.807 . . . . 0.0 110.101 175.001 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.31 145.37 47.17 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 157.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.6 tpp -157.54 125.62 5.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -168.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.56 109.55 8.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.575 0.75 . . . . 0.0 110.075 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -104.81 178.09 4.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.046 0.938 . . . . 0.0 110.104 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -144.07 157.35 44.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.509 1.924 . . . . 0.0 108.891 -171.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 p -110.92 177.28 4.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 123.04 1.4 . . . . 0.0 109.463 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -78.64 -9.43 59.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.978 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -109.18 42.0 1.52 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.794 -1.191 . . . . 0.0 109.107 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 p80 44.87 54.47 6.75 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.084 1.353 . . . . 0.0 110.674 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -130.21 145.25 51.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.212 2.205 . . . . 0.0 107.479 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.447 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.2 p-90 -117.87 159.89 22.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.56 1.944 . . . . 0.0 110.21 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.99 152.74 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.646 1.978 . . . . 0.0 107.468 -173.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.85 84.33 1.84 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 119.766 1.166 . . . . 0.0 112.771 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mp -70.37 132.39 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -120.15 -99.47 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 164.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.25 -88.65 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.911 2.084 . . . . 0.0 110.368 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -127.71 3.88 6.09 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.8 -1.188 . . . . 0.0 113.382 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.71 133.56 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.35 110.29 21.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.038 2.135 . . . . 0.0 109.529 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.5 m -75.96 116.51 16.73 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.653 1.181 . . . . 0.0 110.743 171.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.99 149.85 3.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 112.415 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.98 163.64 31.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 156.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 pt -82.09 151.42 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.4 1.6 . . . . 0.0 109.511 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.3 p -82.05 174.48 11.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.705 1.202 . . . . 0.0 112.828 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.81 -41.81 71.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.2 -0.937 . . . . 0.0 112.3 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -57.85 -21.1 40.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.093 0.86 . . . . 0.0 112.935 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.28 -47.83 9.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.034 -1.041 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -64.18 -21.38 66.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.7 0.682 . . . . 0.0 111.806 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.09 -37.95 81.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.627 1.571 . . . . 0.0 110.888 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -88.21 -35.9 17.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.2 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.7 -70.99 0.47 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.703 1.138 . . . . 0.0 109.824 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.19 -130.25 10.11 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.19 0.9 . . . . 0.0 111.041 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -71.85 34.18 0.06 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.242 3.017 . . . . 0.0 117.029 -159.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 t -21.97 -113.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 114.091 -2.861 . . . . 0.0 113.049 -135.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 164.38 -41.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 128.924 2.89 . . . . 0.0 110.082 -170.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -157.39 164.4 37.56 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.644 0.656 . . . . 0.0 109.721 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -139.12 142.18 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 163.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.79 87.46 3.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.341 1.457 . . . . 0.0 107.218 -177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -90.28 153.1 46.4 Favored Pre-proline 0 C--O 1.234 0.245 0 O-C-N 121.656 -0.652 . . . . 0.0 109.885 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.96 174.7 12.32 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.448 2.099 . . . . 0.0 112.205 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.89 142.11 31.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.13 19.88 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 128.835 2.854 . . . . 0.0 114.839 -172.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.82 17.89 0.65 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.063 1.792 . . . . 0.0 112.501 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -90.18 142.63 27.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.889 1.345 . . . . 0.0 110.319 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.43 144.69 27.84 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.124 1.329 . . . . 0.0 110.669 170.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.3 m -137.17 177.98 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.793 1.237 . . . . 0.0 111.22 -175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -132.01 166.61 21.32 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.172 1.789 . . . . 0.0 108.821 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -72.94 37.21 0.08 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.076 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.56 76.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.01 120.34 7.86 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.696 1.598 . . . . 0.0 106.8 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.287 0.1 OUTLIER -69.84 33.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 127.716 2.406 . . . . 0.0 113.683 -171.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.17 8.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 118.501 -2.624 . . . . 0.0 114.804 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 48.01 1.77 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 121.063 1.756 . . . . 0.0 111.031 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 161.64 8.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.918 0.866 . . . . 0.0 110.767 -173.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mt -137.78 101.77 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.49 148.97 25.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 164.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -124.2 179.8 4.74 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.391 1.077 . . . . 0.0 110.167 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -40.8 -35.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 126.172 1.789 . . . . 0.0 113.379 175.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -160.97 59.19 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.62 1.554 . . . . 0.0 113.655 156.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.93 -175.57 5.5 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.75 . . . . 0.0 109.48 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.64 166.5 23.41 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.865 1.666 . . . . 0.0 110.635 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.64 127.19 6.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.714 2.006 . . . . 0.0 106.902 167.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.3 118.05 28.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.67 93.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.53 106.88 9.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.655 0.382 . . . . 0.0 111.565 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.39 153.36 0.57 Allowed Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 127.606 2.362 . . . . 0.0 115.615 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -86.11 -41.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.343 1.362 . . . . 0.0 114.866 -162.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -129.93 168.17 17.07 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -76.94 168.95 19.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 156.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.95 -167.38 24.65 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -171.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -135.07 129.48 34.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -169.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.0 mm -62.47 141.76 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 107.585 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.79 -1.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 124.383 1.052 . . . . 0.0 112.828 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -151.99 157.08 41.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.583 1.538 . . . . 0.0 106.898 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.7 m -142.56 154.0 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.72 85.16 5.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.588 0.631 . . . . 0.0 110.722 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.23 -9.56 5.19 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -55.09 -46.24 75.46 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.654 -1.279 . . . . 0.0 110.463 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -13.03 60.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.23 1.012 . . . . 0.0 110.069 -168.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.65 -35.2 73.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.415 1.486 . . . . 0.0 110.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -123.59 -22.32 5.02 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.243 1.417 . . . . 0.0 112.854 -167.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -131.18 68.83 82.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 127.426 2.291 . . . . 0.0 107.847 171.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.69 -11.29 28.29 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.39 2.727 . . . . 0.0 111.588 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.65 -3.14 19.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.632 1.573 . . . . 0.0 112.675 171.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mt -70.37 -22.49 62.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.623 1.556 . . . . 0.0 113.527 -172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.0 mt -65.34 -29.32 46.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.46 -52.03 60.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 120.42 1.464 . . . . 0.0 109.038 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -56.17 -55.59 31.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.727 2.411 . . . . 0.0 110.169 -169.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -151.95 89.7 3.97 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -57.36 -29.49 84.41 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.586 1.524 . . . . 0.0 111.934 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.447 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 13.1 mt-10 -122.73 31.21 6.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.624 1.969 . . . . 0.0 108.701 -167.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.38 -74.45 0.07 OUTLIER Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.409 1.481 . . . . 0.0 111.404 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -117.17 -11.3 10.7 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.129 -0.939 . . . . 0.0 113.307 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.84 29.6 1.55 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.449 1.022 . . . . 0.0 113.328 168.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 59.0 p-90 -60.31 149.6 33.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.579 1.189 . . . . 0.0 109.755 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.85 -69.4 0.76 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 116.589 -1.672 . . . . 0.0 106.814 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.31 -174.95 3.71 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 122.114 2.234 . . . . 0.0 112.033 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -135.86 153.53 51.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.831 167.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.07 139.15 25.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.847 0.859 . . . . 0.0 109.271 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.38 120.31 12.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 163.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -73.24 152.97 7.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 m -110.12 -31.93 7.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.699 0.8 . . . . 0.0 111.58 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 76.48 1.61 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -160.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -11.46 57.35 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.445 -0.784 . . . . 0.0 111.324 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.01 -15.17 81.22 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.927 -1.108 . . . . 0.0 112.586 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -86.34 -15.95 38.93 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.549 1.175 . . . . 0.0 111.572 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.22 -43.37 98.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.497 1.044 . . . . 0.0 109.543 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -60.65 -24.76 65.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 111.28 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.5 -4.52 58.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.247 1.019 . . . . 0.0 112.45 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.54 -171.95 2.5 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.591 1.956 . . . . 0.0 108.958 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -96.99 135.53 38.86 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.675 1.19 . . . . 0.0 108.215 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.38 179.93 3.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.828 0.823 . . . . 0.0 110.041 163.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.53 -47.53 72.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.612 1.965 . . . . 0.0 111.732 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -74.22 -39.99 62.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.191 0.596 . . . . 0.0 109.419 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.78 76.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.417 0.687 . . . . 0.0 111.262 172.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -70.7 -44.22 67.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.969 0.908 . . . . 0.0 111.187 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.27 -45.57 72.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.125 0.875 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -63.4 -38.76 92.38 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.815 0.846 . . . . 0.0 110.879 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -59.14 -32.34 69.78 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.159 -0.963 . . . . 0.0 111.408 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.6 m -77.06 -26.04 53.09 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.078 -1.013 . . . . 0.0 112.982 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.9 0.56 17.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.446 1.098 . . . . 0.0 111.485 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.8 17.92 21.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.001 0.92 . . . . 0.0 110.202 169.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.669 164.129 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt 48.41 64.71 1.57 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 127.253 2.221 . . . . 0.0 112.464 157.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.464 ' SD ' ' HE3' ' A' ' 5' ' ' LYS . 2.9 ptp -152.66 -175.8 5.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.129 1.772 . . . . 0.0 109.027 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.411 ' HB3' ' HZ3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -150.54 122.89 8.4 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 120.669 -1.27 . . . . 0.0 109.324 171.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' HE3' ' SD ' ' A' ' 3' ' ' MET . 22.2 mmtt -114.38 175.44 5.48 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.662 0.602 . . . . 0.0 109.864 168.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -133.36 154.22 50.92 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.654 1.581 . . . . 0.0 109.179 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -91.48 -176.92 4.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 122.226 1.013 . . . . 0.0 108.641 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -101.66 20.48 16.12 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 0.0 110.296 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -127.02 30.1 5.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.402 1.881 . . . . 0.0 110.817 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 59.72 40.69 19.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.801 -1.187 . . . . 0.0 112.193 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -126.24 145.11 50.53 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.45 1.5 . . . . 0.0 107.887 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.405 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.1 p-90 -116.94 162.02 18.43 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.714 1.605 . . . . 0.0 109.534 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.35 100.79 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -167.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -82.15 89.12 6.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.74 -1.225 . . . . 0.0 109.034 173.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.04 104.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 120.224 1.374 . . . . 0.0 107.595 174.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.3 tp10 -80.9 -138.78 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 167.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.441 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 1.2 t0 -64.69 -61.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.098 -1.001 . . . . 0.0 109.414 -172.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.5 2.21 2.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.031 0.933 . . . . 0.0 113.019 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.3 t -124.28 132.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -100.2 140.0 35.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 169.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -85.15 139.05 31.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 t -113.5 126.22 70.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.654 1.581 . . . . 0.0 107.584 170.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.97 168.55 23.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 160.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 pt -85.62 156.57 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.8 p -82.55 179.09 7.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -39.52 94.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.408 -1.433 . . . . 0.0 111.541 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -61.02 -26.48 67.64 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.398 -1.439 . . . . 0.0 111.668 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.79 -56.43 7.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.977 -1.077 . . . . 0.0 110.088 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -55.14 -30.89 60.74 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.662 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.03 -42.43 94.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.381 0.672 . . . . 0.0 110.545 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -79.96 -24.26 41.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 113.202 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.68 -42.05 35.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.747 1.158 . . . . 0.0 110.346 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.9 53.27 Favored Glycine 0 N--CA 1.443 -0.859 0 O-C-N 124.188 0.93 . . . . 0.0 110.939 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.95 122.6 3.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.748 2.019 . . . . 0.0 108.515 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 36' ' ' VAL 0.425 9.8 p -118.47 158.07 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 122.493 1.139 . . . . 0.0 112.387 -177.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.479 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -146.85 -26.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 C-N-CA 126.148 1.779 . . . . 0.0 108.974 -150.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -150.53 151.93 33.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 123.741 0.651 . . . . 0.0 111.17 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.0 t -145.46 127.81 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 136.42 38.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.606 171.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.8 mt -129.88 128.52 22.92 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.2 -178.95 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.44 2.76 . . . . 0.0 112.59 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -80.61 140.88 35.51 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.828 -1.17 . . . . 0.0 108.923 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.0 12.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 128.567 2.747 . . . . 0.0 115.71 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.2 9.16 1.1 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.044 1.783 . . . . 0.0 111.615 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -71.92 137.57 47.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.086 -1.243 . . . . 0.0 110.106 -171.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HG2' ' CG ' ' A' ' 72' ' ' LYS . 10.5 mt-10 -85.35 149.44 25.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.623 -0.673 . . . . 0.0 110.285 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.76 177.35 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.174 0.99 . . . . 0.0 109.527 -172.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -126.25 170.98 11.31 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 125.659 1.584 . . . . 0.0 109.589 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.81 10.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.77 66.74 0.24 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.55 115.81 13.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.06 114.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.476 1.111 . . . . 0.0 108.257 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -146.09 0.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.754 1.222 . . . . 0.0 112.718 -168.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.96 39.63 0.94 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.216 1.006 . . . . 0.0 108.385 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -50.66 165.66 0.1 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.992 1.717 . . . . 0.0 111.538 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mt -139.45 145.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.99 116.6 17.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.936 1.694 . . . . 0.0 107.234 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -105.6 -167.71 1.36 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.615 1.566 . . . . 0.0 111.02 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 m -44.86 -39.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 114.152 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -165.75 72.57 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 149.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.07 167.24 22.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.8 154.85 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 159.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.26 109.02 4.37 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.255 1.022 . . . . 0.0 109.701 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.2 114.54 4.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.575 1.55 . . . . 0.0 108.371 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.46 104.31 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.33 105.55 17.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.954 0.797 . . . . 0.0 110.341 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.66 142.33 1.07 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.434 1.894 . . . . 0.0 112.876 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.08 -35.32 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.18 1.92 . . . . 0.0 113.259 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -138.84 145.75 40.4 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.958 2.103 . . . . 0.0 107.147 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -64.44 137.86 58.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 167.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.48 -177.91 44.09 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -155.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' CG ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -129.9 140.62 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 173.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -65.67 145.46 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.51 -3.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 O-C-N 123.359 0.412 . . . . 0.0 111.753 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.14 151.47 30.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.2 m -141.54 149.6 20.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -99.47 75.8 1.98 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.0 -14.89 2.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -53.01 -34.64 57.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.066 1.347 . . . . 0.0 111.919 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -9.05 41.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 112.024 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.07 -28.68 69.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.786 1.634 . . . . 0.0 112.912 166.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -126.93 -27.55 3.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.947 1.699 . . . . 0.0 110.818 -167.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -125.94 65.03 53.82 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.202 1.801 . . . . 0.0 108.511 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -72.26 -51.62 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.594 2.863 . . . . 0.0 108.654 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -15.65 0.39 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.226 2.21 . . . . 0.0 111.322 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.04 41.23 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 122.632 2.469 . . . . 0.0 110.999 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 70.0 mt -51.33 -30.34 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 120.814 -1.179 . . . . 0.0 110.4 171.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -73.45 -51.73 16.16 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.71 -1.244 . . . . 0.0 111.581 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -70.23 -38.73 75.29 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.098 1.759 . . . . 0.0 110.76 -163.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -156.11 67.58 4.66 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 123.03 0.532 . . . . 0.0 111.332 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.88 -20.99 69.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.53 2.82 . . . . 0.0 113.535 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.405 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 5.1 mt-10 -123.11 20.05 9.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.593 0.757 . . . . 0.0 110.535 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -123.83 -93.0 1.04 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -79.92 -32.14 40.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.264 1.032 . . . . 0.0 112.869 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.35 37.73 2.03 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 120.23 1.377 . . . . 0.0 114.58 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -68.87 165.02 20.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.871 1.835 . . . . 0.0 109.732 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -108.93 -61.37 1.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -148.85 172.23 15.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.769 0.827 . . . . 0.0 111.068 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -134.95 152.32 51.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.48 1.512 . . . . 0.0 108.795 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.44 144.82 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.912 0.485 . . . . 0.0 110.68 -166.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.16 128.25 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.266 1.826 . . . . 0.0 107.029 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 pt -86.95 95.86 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.794 0.807 . . . . 0.0 109.987 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 m -81.67 -11.33 59.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.762 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.49 96.51 3.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 171.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -4.98 57.68 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.304 -0.248 . . . . 0.0 110.671 171.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.79 -55.22 9.92 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -18.4 47.0 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 125.822 1.649 . . . . 0.0 113.486 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.7 mt -44.14 -37.16 2.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.893 1.679 . . . . 0.0 111.48 169.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.24 -13.23 60.42 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.601 0.637 . . . . 0.0 112.265 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.38 -35.22 68.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.299 1.04 . . . . 0.0 109.574 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.83 167.88 19.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.327 1.451 . . . . 0.0 108.256 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 mt -77.82 131.59 37.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -55.55 171.64 0.19 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 122.491 1.138 . . . . 0.0 108.647 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.96 -39.45 79.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 111.414 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -64.57 -45.64 86.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.509 -0.745 . . . . 0.0 109.417 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.4 86.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.314 0.646 . . . . 0.0 111.038 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.1 -45.04 96.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.761 1.624 . . . . 0.0 110.832 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -48.16 73.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.972 0.509 . . . . 0.0 110.179 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -64.51 -31.94 73.37 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.034 -0.416 . . . . 0.0 111.479 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -70.65 -32.89 70.34 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.727 -1.233 . . . . 0.0 110.622 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.3 t -66.13 -39.79 90.14 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.027 0.376 . . . . 0.0 110.272 171.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.13 -25.68 67.87 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.64 -0.662 . . . . 0.0 112.154 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -101.45 4.87 41.69 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.987 1.715 . . . . 0.0 111.511 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.248 1.013 0 CA-C-N 119.596 1.089 . . . . 0.0 109.959 -178.578 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.9 ttm . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 153.59 126.59 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 1 C-N-CA 133.485 4.714 . . . . 0.0 105.131 173.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 ttm -152.61 157.79 41.51 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.78 113.54 11.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.271 1.396 . . . . 0.0 110.545 169.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.07 174.34 5.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 167.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.93 179.0 5.41 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.722 2.809 . . . . 0.0 110.958 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -139.53 167.06 22.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.4 1.88 . . . . 0.0 109.214 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.73 -7.87 56.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.24 0.616 . . . . 0.0 112.489 168.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -94.37 19.12 9.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.481 -1.387 . . . . 0.0 112.173 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 58.32 43.94 19.29 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.289 1.836 . . . . 0.0 111.566 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -124.11 149.86 45.72 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.739 -1.226 . . . . 0.0 109.91 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.517 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.1 p-90 -111.55 163.76 13.72 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.3 1.84 . . . . 0.0 109.109 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.53 100.81 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -168.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -85.25 95.17 9.1 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 119.609 1.095 . . . . 0.0 109.441 172.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 mp -74.43 141.62 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 119.897 1.226 . . . . 0.0 107.834 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.54 -101.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.607 1.163 . . . . 0.0 108.147 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.24 -77.57 0.46 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -126.51 16.72 7.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.49 1.516 . . . . 0.0 111.095 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.84 155.36 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -129.43 136.57 50.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.989 1.316 . . . . 0.0 108.305 166.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.0 m -83.65 138.54 33.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.85 134.54 55.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.691 1.996 . . . . 0.0 108.632 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.78 164.62 28.83 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 163.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 pt -73.77 154.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 O-C-N 122.029 -0.689 . . . . 0.0 109.325 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 79.3 p -75.42 166.34 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.334 -0.854 . . . . 0.0 109.802 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.67 -34.43 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.939 -1.101 . . . . 0.0 112.674 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -59.89 -28.09 67.26 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.0 -1.063 . . . . 0.0 111.959 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.71 -57.31 4.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.546 0.738 . . . . 0.0 111.21 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -56.59 -27.88 59.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.693 1.133 . . . . 0.0 112.326 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.99 -32.26 61.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.039 1.336 . . . . 0.0 111.047 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -88.92 -46.52 8.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.906 -0.569 . . . . 0.0 109.787 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -34.92 78.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 118.158 -0.925 . . . . 0.0 113.176 -174.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.94 -126.58 41.1 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -169.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.69 34.05 0.33 Allowed 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -145.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.439 ' HA ' ' HB2' ' A' ' 58' ' ' SER 0.398 2.2 p -23.06 -111.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 115.683 -2.103 . . . . 0.0 112.846 -122.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 166.38 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.112 2.165 . . . . 0.0 109.032 -168.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.412 ' H ' HG21 ' A' ' 35' ' ' VAL . 83.3 t80 -161.8 166.68 26.11 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.494 0.717 . . . . 0.0 110.165 -165.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.17 134.34 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.915 1.686 . . . . 0.0 107.757 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.64 143.18 28.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.416 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.11 151.5 70.0 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 123.671 0.789 . . . . 0.0 109.326 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -72.12 174.32 11.55 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.959 1.773 . . . . 0.0 111.396 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 44' ' ' GLY . 2.3 tt0 -78.64 150.9 32.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 167.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.81 17.2 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 127.713 2.405 . . . . 0.0 114.098 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 42' ' ' GLU . . . -154.08 6.44 0.35 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 128.623 3.011 . . . . 0.0 111.922 -176.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -67.18 125.73 26.96 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.019 1.41 . . . . 0.0 108.267 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.62 143.65 40.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 m -144.29 -176.73 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.667 0.787 . . . . 0.0 109.647 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -138.95 167.78 21.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.539 1.536 . . . . 0.0 109.772 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -67.83 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -172.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.9 66.5 0.24 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 161.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.48 123.19 47.93 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.184 1.393 . . . . 0.0 113.083 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 0.1 OUTLIER -65.5 21.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 129.149 2.98 . . . . 0.0 115.113 -174.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -62.84 8.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 119.142 -2.224 . . . . 0.0 116.273 -168.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.68 51.48 1.05 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.026 1.285 . . . . 0.0 110.706 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.19 148.29 36.87 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 123.155 1.455 . . . . 0.0 110.783 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.29 142.56 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -118.88 142.33 47.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 155.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' ' 35' ' ' VAL . 82.6 p -111.51 -173.85 2.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.237 1.381 . . . . 0.0 108.344 155.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -40.65 -37.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.99 1.716 . . . . 0.0 113.174 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.13 0.11 1.03 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 159.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.804 2.093 . . . . 0.0 110.464 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.4 162.56 35.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.097 1.359 . . . . 0.0 108.545 160.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.04 112.28 2.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.733 0.813 . . . . 0.0 109.919 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.56 127.92 33.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.033 1.733 . . . . 0.0 107.989 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.8 t -102.48 109.29 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 120.697 1.589 . . . . 0.0 106.996 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.32 99.47 10.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.465 1.03 . . . . 0.0 112.125 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -35.66 124.84 0.64 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.514 1.925 . . . . 0.0 112.843 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.54 -24.57 10.36 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.694 2.262 . . . . 0.0 114.845 -160.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -133.5 158.64 42.59 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.243 1.817 . . . . 0.0 108.619 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -75.57 153.85 37.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.886 0.85 . . . . 0.0 109.842 165.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.74 -174.54 30.04 Favored Glycine 0 C--O 1.237 0.293 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -160.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.49 141.35 51.68 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.7 mm -67.7 146.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 173.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.19 -11.28 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.0 151.6 42.65 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.6 159.99 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.384 1.474 . . . . 0.0 107.177 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.469 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 39.2 t30 -104.43 90.03 3.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -172.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.47 -14.6 30.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.924 1.29 . . . . 0.0 112.585 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.469 ' HE2' ' OD1' ' A' ' 77' ' ' ASN . 25.4 mtmm -55.96 -42.09 75.7 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.802 1.241 . . . . 0.0 111.787 167.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -21.9 61.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.947 0.794 . . . . 0.0 109.937 -170.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -57.63 -49.51 76.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.634 1.574 . . . . 0.0 109.063 167.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.8 p -82.98 -30.83 27.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.645 0.778 . . . . 0.0 112.364 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -149.86 71.8 9.57 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.2 1.0 . . . . 0.0 109.048 -166.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -50.82 -41.54 54.68 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.232 3.288 . . . . 0.0 112.651 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.412 ' HA ' ' CG1' ' A' ' 35' ' ' VAL . 11.1 pt-20 -65.54 -2.88 3.75 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.664 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.66 -22.61 64.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 123.657 2.935 . . . . 0.0 112.169 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -61.02 -23.83 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.292 0.637 . . . . 0.0 109.819 174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -71.77 -58.16 3.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.811 -1.181 . . . . 0.0 109.647 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.09 -35.31 59.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 126.397 1.879 . . . . 0.0 111.474 -172.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.16 100.43 0.49 Allowed Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 168.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.43 -12.45 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.317 1.345 . . . . 0.0 113.14 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.517 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -118.37 -19.54 8.85 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.662 1.119 . . . . 0.0 113.779 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -77.97 -90.24 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -99.05 -17.17 18.39 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.98 0.912 . . . . 0.0 111.738 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.66 30.94 3.37 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.043 1.306 . . . . 0.0 114.197 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -72.24 164.82 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.293 1.546 . . . . 0.0 110.559 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mt -100.3 -66.93 0.88 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -142.39 172.82 12.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.941 0.897 . . . . 0.0 110.789 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -124.98 154.62 40.94 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.843 0.857 . . . . 0.0 109.47 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.71 142.42 34.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.871 0.869 . . . . 0.0 110.442 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -81.32 113.95 19.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.231 1.812 . . . . 0.0 107.45 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 pt -76.44 103.0 3.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.965 0.906 . . . . 0.0 110.416 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -60.02 -37.78 80.75 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.123 0.569 . . . . 0.0 111.84 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.6 93.45 2.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.06 -12.48 55.65 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.839 0.828 . . . . 0.0 109.95 168.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.45 72.48 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 120.701 -1.249 . . . . 0.0 110.983 173.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -72.55 -7.79 51.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.424 1.112 . . . . 0.0 111.586 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.19 -26.94 66.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.382 1.446 . . . . 0.0 111.384 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -78.39 -29.14 47.12 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 110.38 -167.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.94 -19.22 64.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 129.135 2.974 . . . . 0.0 112.364 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.3 mt -73.2 -170.41 0.77 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.368 1.467 . . . . 0.0 109.673 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.34 132.59 54.29 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.343 -0.848 . . . . 0.0 108.943 -171.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -60.13 165.4 3.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 157.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.21 -46.87 72.55 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -62.8 -33.38 75.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.08 0.4 . . . . 0.0 111.487 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.84 77.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.471 0.708 . . . . 0.0 110.433 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.85 -32.5 73.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.648 -0.657 . . . . 0.0 112.111 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.0 -56.53 17.04 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.728 1.611 . . . . 0.0 108.806 168.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.63 -44.57 93.5 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.548 1.139 . . . . 0.0 110.161 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.31 -50.8 64.2 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.545 0.738 . . . . 0.0 110.509 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.3 t -60.05 -35.35 74.94 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.691 -0.631 . . . . 0.0 112.249 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.45 -23.6 66.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.315 0.646 . . . . 0.0 111.533 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -96.36 -3.66 43.34 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.126 1.37 . . . . 0.0 111.917 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.457 -176.177 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 tpp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.66 120.43 11.78 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 162.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.6 ttp -165.26 162.26 19.72 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -155.21 98.41 1.99 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.164 1.347 . . . . 0.0 113.295 -167.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -95.02 -177.03 4.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.314 0.578 . . . . 0.0 111.865 168.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -138.1 172.99 12.1 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 127.684 2.393 . . . . 0.0 109.867 -170.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.9 p -121.49 173.34 7.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.822 1.649 . . . . 0.0 108.733 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -34.58 46.29 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.36 163.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 p -75.22 23.49 0.11 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.818 1.247 . . . . 0.0 112.541 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.273 0.0 OUTLIER 60.84 52.81 4.08 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 128.076 2.55 . . . . 0.0 112.799 165.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -125.15 140.97 52.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.517 1.927 . . . . 0.0 108.572 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.471 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 63.5 p-90 -94.85 159.83 14.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.13 100.32 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -85.03 85.67 7.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.945 -1.097 . . . . 0.0 109.55 175.154 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 mp -69.5 134.95 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -122.17 -68.76 0.87 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.851 0.46 . . . . 0.0 110.068 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -120.76 -83.95 0.66 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -125.82 12.84 7.93 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.712 1.205 . . . . 0.0 110.57 170.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.8 t -128.58 149.92 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -118.77 140.36 50.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 166.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.8 m -91.57 133.25 35.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 t -110.6 138.58 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.203 1.401 . . . . 0.0 109.946 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.34 169.03 29.01 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.05 2.262 . . . . 0.0 108.207 164.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.55 159.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.934 1.367 . . . . 0.0 110.256 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.0 p -85.18 167.51 15.64 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.297 -0.877 . . . . 0.0 112.683 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.28 -42.36 69.91 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.566 -1.334 . . . . 0.0 112.728 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -57.63 -9.36 1.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.321 1.048 . . . . 0.0 113.145 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.94 -46.79 4.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.553 -1.342 . . . . 0.0 111.53 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -58.94 -26.58 64.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.923 1.238 . . . . 0.0 110.862 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -38.4 75.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.42 1.088 . . . . 0.0 111.516 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -82.61 -19.92 37.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.048 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.68 -31.91 9.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.697 0.681 . . . . 0.0 111.51 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.53 -123.77 29.89 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.09 114.96 4.04 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.548 HG13 ' H ' ' A' ' 36' ' ' VAL . 1.3 t -94.61 -170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 160.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.548 ' H ' HG13 ' A' ' 35' ' ' VAL . 1.1 p -172.84 -30.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.78 1.232 . . . . 0.0 108.04 -147.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -153.43 160.37 42.58 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.746 0.654 . . . . 0.0 112.3 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.75 145.88 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 156.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.64 150.21 22.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.993 -1.003 . . . . 0.0 108.749 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -134.68 155.46 79.46 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 120.708 1.595 . . . . 0.0 111.045 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.34 -163.63 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 125.231 3.954 . . . . 0.0 109.563 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -108.66 148.92 29.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.582 1.153 . . . . 0.0 110.972 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.29 11.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 131.47 3.908 . . . . 0.0 117.633 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.62 17.43 0.57 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.556 2.027 . . . . 0.0 112.178 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -79.16 141.31 37.34 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.318 -1.107 . . . . 0.0 108.218 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -82.06 156.01 24.81 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.4 m -139.08 160.74 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.401 1.48 . . . . 0.0 110.236 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -124.09 162.64 23.11 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.106 2.162 . . . . 0.0 107.095 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -74.99 23.33 0.1 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -159.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -152.54 18.44 0.78 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.731 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -78.17 143.31 37.33 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 120.162 1.981 . . . . 0.0 111.218 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.0 106.95 18.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.6 m -133.84 -2.71 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -163.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.07 46.31 0.24 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.427 0.691 . . . . 0.0 110.007 -162.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -51.27 160.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.854 0.862 . . . . 0.0 111.694 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mt -128.45 111.69 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -109.01 130.99 55.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.6 p -112.62 -172.45 2.05 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.95 1.3 . . . . 0.0 110.22 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -48.77 -43.76 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.107 1.363 . . . . 0.0 111.736 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -155.77 88.05 1.1 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.163 1.385 . . . . 0.0 108.989 158.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 177.38 178.61 0.28 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.512 1.925 . . . . 0.0 108.699 161.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.75 147.66 52.32 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.507 1.523 . . . . 0.0 110.818 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.68 99.87 4.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.433 2.293 . . . . 0.0 106.444 170.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.29 121.85 15.26 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -80.79 123.53 37.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -103.62 105.32 15.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.787 0.835 . . . . 0.0 108.849 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -27.09 113.0 0.24 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 128.704 2.801 . . . . 0.0 112.314 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.85 -34.2 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.73 1.62 . . . . 0.0 113.164 -164.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.18 165.65 20.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.486 1.914 . . . . 0.0 107.231 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -67.4 152.23 46.05 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 108.103 155.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.41 -167.59 31.95 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 132.3 23.4 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.66 143.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.83 -3.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.869 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.1 159.81 36.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.062 0.846 . . . . 0.0 109.978 166.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -141.16 152.23 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.913 1.685 . . . . 0.0 107.663 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -98.78 76.21 2.16 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.59 -11.66 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.856 1.662 . . . . 0.0 113.349 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -36.79 68.38 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.663 1.585 . . . . 0.0 112.86 167.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -10.39 59.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.51 1.05 . . . . 0.0 111.761 -165.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -41.81 -55.15 3.14 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 128.098 2.559 . . . . 0.0 111.93 155.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 79.2 p -118.69 -3.98 10.78 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.754 1.222 . . . . 0.0 111.863 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -132.04 56.45 23.63 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.324 1.45 . . . . 0.0 110.879 170.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 -28.42 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.507 2.138 . . . . 0.0 109.407 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.88 -17.41 64.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.529 1.132 . . . . 0.0 111.111 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -21.92 65.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 120.619 1.554 . . . . 0.0 111.831 173.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.41 -14.8 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 120.167 -1.583 . . . . 0.0 110.538 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -84.86 -55.01 4.3 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 120.022 -1.674 . . . . 0.0 110.556 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -62.98 -31.41 72.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.273 1.029 . . . . 0.0 112.091 -168.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -162.59 77.22 1.97 Allowed Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 123.907 0.883 . . . . 0.0 110.463 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.69 -18.06 45.94 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 113.194 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.471 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 4.2 mt-10 -123.43 11.84 9.33 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.829 0.852 . . . . 0.0 111.465 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.39 -108.4 2.07 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.15 -18.44 63.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.475 0.71 . . . . 0.0 112.644 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.44 27.04 4.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.225 1.393 . . . . 0.0 114.489 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -64.85 165.81 10.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.8 1.8 . . . . 0.0 110.164 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 mt -110.01 -60.91 1.73 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.76 168.83 21.87 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.3 -0.875 . . . . 0.0 110.88 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -123.59 141.68 51.77 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.318 1.447 . . . . 0.0 108.425 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.7 ptm -141.65 140.18 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.842 0.857 . . . . 0.0 110.275 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.27 136.42 40.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 34.3 pt -87.02 117.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 t -83.59 -18.22 38.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.857 167.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -143.12 86.57 1.92 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -157.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.22 -12.17 60.49 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 0.0 111.079 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.03 -57.66 18.11 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -69.43 -1.88 9.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.568 1.147 . . . . 0.0 113.019 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.48 -38.44 87.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.312 -0.867 . . . . 0.0 110.115 164.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.59 -5.31 59.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.295 1.438 . . . . 0.0 111.323 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.07 -18.77 60.78 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.427 -0.796 . . . . 0.0 110.132 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.6 mt -87.18 -159.17 0.49 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.04 1.336 . . . . 0.0 112.477 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.9 mt -110.29 135.78 50.49 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.094 2.157 . . . . 0.0 109.761 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.3 172.65 1.84 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 162.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -63.32 -48.05 79.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.861 1.664 . . . . 0.0 110.086 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.28 -40.68 96.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.181 0.992 . . . . 0.0 111.644 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.23 75.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.77 0.828 . . . . 0.0 110.152 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.79 -43.42 69.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.858 0.863 . . . . 0.0 110.419 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -57.57 -48.74 78.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.189 0.596 . . . . 0.0 111.042 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -64.58 -26.54 68.45 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.232 0.539 . . . . 0.0 112.085 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -7.2 46.63 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.391 1.476 . . . . 0.0 112.806 172.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.93 -14.46 23.07 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.32 1.048 . . . . 0.0 112.125 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -87.76 -1.95 58.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.43 1.092 . . . . 0.0 112.75 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.245 0.835 0 CA-C-N 120.167 1.349 . . . . 0.0 112.166 -163.451 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 mtt . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm 176.43 134.86 0.05 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 128.53 2.732 . . . . 0.0 104.266 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ptm -162.31 158.3 23.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.103 0.865 . . . . 0.0 109.961 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -160.07 125.05 3.92 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 121.041 -1.037 . . . . 0.0 109.985 -167.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HE2' ' OD1' ' A' ' 113' ' ' ASP . 6.6 mmtp -128.12 -177.45 4.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.334 1.054 . . . . 0.0 109.821 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 179.62 6.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.5 1.92 . . . . 0.0 111.042 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -138.4 173.32 11.73 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.711 1.596 . . . . 0.0 111.912 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.02 -2.89 53.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.253 2.221 . . . . 0.0 112.9 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -102.14 48.37 0.88 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 p80 45.54 57.01 5.25 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.431 168.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -132.64 152.73 51.58 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.618 1.167 . . . . 0.0 108.33 -167.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.1 p-90 -124.43 162.53 23.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.081 0.952 . . . . 0.0 111.699 170.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.81 161.72 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.85 2.46 . . . . 0.0 107.705 172.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.73 94.57 1.9 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.464 1.906 . . . . 0.0 107.469 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.7 mt -98.54 95.03 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -78.11 -49.89 13.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.898 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.07 -71.68 0.68 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.259 0.936 . . . . 0.0 110.128 -171.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -138.94 10.31 2.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.627 1.571 . . . . 0.0 111.85 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.32 121.13 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -162.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 119.31 22.68 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.4 m -68.17 137.06 54.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 152.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.41 142.7 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.256 1.422 . . . . 0.0 109.772 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.71 176.73 34.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 pt -97.14 156.57 3.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 121.531 0.682 . . . . 0.0 110.697 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 169.59 17.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 112.57 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -24.28 62.52 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.64 -1.288 . . . . 0.0 111.367 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.65 -30.42 71.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.958 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.99 66.06 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.037 -1.039 . . . . 0.0 112.468 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -63.3 -19.82 64.94 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.66 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.01 -0.59 7.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.337 1.455 . . . . 0.0 113.434 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -115.04 -31.01 6.19 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 160.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.42 -46.49 54.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.44 -147.0 43.22 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.81 112.5 0.62 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.566 2.346 . . . . 0.0 110.51 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 36' ' ' VAL 0.345 9.0 p -108.31 165.7 4.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 123.309 1.528 . . . . 0.0 111.275 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -152.43 -28.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.839 -154.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -146.3 143.57 29.24 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.433 0.56 . . . . 0.0 110.846 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.57 125.91 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.656 1.582 . . . . 0.0 107.915 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.89 139.86 43.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.382 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.1 mt -133.04 139.25 33.82 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.73 1.212 . . . . 0.0 107.932 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.45 -179.63 5.36 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.269 2.646 . . . . 0.0 112.041 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.25 145.67 43.87 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.9 18.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 129.178 2.991 . . . . 0.0 115.36 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.17 13.46 0.46 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.183 1.849 . . . . 0.0 112.138 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -76.58 132.73 39.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.789 1.294 . . . . 0.0 108.96 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.98 152.41 33.14 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.983 0.81 . . . . 0.0 109.212 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.82 174.08 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 122.354 1.073 . . . . 0.0 111.07 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -112.28 170.2 8.34 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.317 2.247 . . . . 0.0 107.9 165.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.87 18.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.616 2.366 . . . . 0.0 115.221 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.08 59.14 0.24 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.2 131.12 56.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.742 1.217 . . . . 0.0 108.112 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 52' ' ' VAL 0.297 0.1 OUTLIER -77.69 27.51 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.877 2.871 . . . . 0.0 114.232 -168.032 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.06 12.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.76 54.26 1.17 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 171.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.83 159.3 2.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mt -139.85 135.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -127.76 110.99 13.16 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -99.15 -164.24 1.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.456 1.902 . . . . 0.0 110.775 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -45.89 -34.86 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.338 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -165.91 15.87 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 160.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.33 138.37 31.57 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.4 124.66 52.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 161.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.06 92.49 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.126 0.97 . . . . 0.0 109.303 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -58.72 108.06 0.6 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 108.8 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.22 93.75 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -82.41 109.74 16.92 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.666 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.87 150.01 0.39 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.922 2.489 . . . . 0.0 114.329 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.23 -36.53 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.819 1.679 . . . . 0.0 115.801 -161.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -148.03 139.57 23.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.114 1.365 . . . . 0.0 108.806 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -51.17 129.4 24.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.404 0.621 . . . . 0.0 109.393 170.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.03 -174.52 44.79 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 107.061 -2.416 . . . . 0.0 107.061 -161.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -142.56 127.95 18.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -166.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -59.52 142.46 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -145.99 -2.51 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -147.24 156.66 43.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 121.097 1.771 . . . . 0.0 108.44 165.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.83 153.47 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.045 0.938 . . . . 0.0 109.168 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -104.73 78.83 1.47 Allowed 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.446 0.698 . . . . 0.0 109.398 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -57.03 -14.88 4.12 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.979 0.912 . . . . 0.0 112.76 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -50.68 -39.56 51.46 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.989 1.716 . . . . 0.0 111.955 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -3.25 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.56 0.744 . . . . 0.0 112.501 -170.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.86 -49.96 53.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.011 1.278 . . . . 0.0 109.16 160.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.0 p -92.34 -39.31 11.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.069 -162.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -117.33 67.39 4.86 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.097 1.759 . . . . 0.0 109.517 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.51 -44.83 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.953 3.769 . . . . 0.0 110.837 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -61.69 -4.45 1.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.125 1.37 . . . . 0.0 109.905 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -58.15 -13.58 5.19 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 121.426 1.921 . . . . 0.0 114.076 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.2 mm -53.33 -39.68 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 118.619 0.645 . . . . 0.0 109.78 164.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -69.61 -55.79 9.11 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.046 1.339 . . . . 0.0 109.42 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.82 78.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 -164.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -153.32 74.01 6.76 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -57.32 -23.5 54.96 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.776 2.317 . . . . 0.0 112.381 -172.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.2 mp0 -118.67 9.42 12.16 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.263 1.025 . . . . 0.0 112.147 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.93 -110.29 2.7 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.244 1.878 . . . . 0.0 109.597 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.96 -28.29 69.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.458 1.129 . . . . 0.0 111.093 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.54 25.22 1.4 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-N 119.721 1.146 . . . . 0.0 115.76 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.425 ' CH2' ' HE3' ' A' ' 99' ' ' LYS . 46.0 p-90 -67.57 163.06 22.05 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.288 1.544 . . . . 0.0 110.404 171.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mt -106.16 -66.96 0.96 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -140.92 175.95 9.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.569 1.147 . . . . 0.0 109.387 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.425 ' HE3' ' CH2' ' A' ' 96' ' ' TRP . 65.9 mttt -131.88 152.45 51.03 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 124.307 1.043 . . . . 0.0 108.297 171.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.32 134.89 23.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.342 0.657 . . . . 0.0 110.04 -172.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.66 127.37 31.68 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 167.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 pt -76.53 109.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.1 m -65.97 -21.55 66.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.949 -0.47 . . . . 0.0 111.198 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -151.63 88.33 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -157.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -11.92 59.93 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.933 0.788 . . . . 0.0 111.662 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.78 -41.16 95.84 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.92 -22.66 66.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 117.416 -1.278 . . . . 0.0 111.928 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.4 mt -52.62 -30.96 34.2 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -79.21 -11.38 59.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.596 0.635 . . . . 0.0 112.069 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -74.89 -34.44 62.19 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.815 -0.553 . . . . 0.0 110.928 168.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.65 158.98 34.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.743 1.259 . . . . 0.0 108.132 -173.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.42 130.85 40.42 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.472 ' OD1' ' HE2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -69.82 -167.81 0.16 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 164.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.14 -39.69 65.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 119.768 -1.832 . . . . 0.0 113.544 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.73 -48.44 31.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.45 81.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.139 0.274 . . . . 0.0 111.408 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -53.99 -54.77 34.48 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.101 0.961 . . . . 0.0 109.866 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -39.4 74.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.103 0.961 . . . . 0.0 111.652 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.86 -35.38 79.9 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.51 1.124 . . . . 0.0 111.677 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -72.76 -38.39 67.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.25 0.932 . . . . 0.0 110.592 167.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.6 t -69.18 5.07 1.34 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.214 1.805 . . . . 0.0 113.739 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.75 -42.91 11.04 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.357 1.063 . . . . 0.0 110.944 161.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -94.84 1.41 55.36 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.832 2.053 . . . . 0.0 113.868 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--O 1.246 0.917 0 C-N-CA 124.736 1.214 . . . . 0.0 109.077 174.116 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.1 tttp 50.11 72.9 0.29 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.607 1.563 . . . . 0.0 112.627 170.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.6 ttm -146.42 159.38 43.46 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.103 1.761 . . . . 0.0 107.168 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 116.8 13.96 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 119.977 -1.702 . . . . 0.0 110.842 157.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -112.99 -179.76 3.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -130.65 170.66 14.01 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 127.191 2.196 . . . . 0.0 110.855 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -117.79 -174.67 2.68 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.665 1.586 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -106.71 10.68 30.86 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.816 1.246 . . . . 0.0 112.271 163.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -105.64 17.7 23.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.477 1.111 . . . . 0.0 111.26 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 72.23 42.5 0.56 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.892 2.077 . . . . 0.0 111.379 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -131.82 139.36 48.84 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.898 1.679 . . . . 0.0 110.879 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.477 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 69.9 p-90 -103.24 164.36 11.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.765 1.626 . . . . 0.0 109.583 171.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.57 99.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -86.84 91.88 8.8 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.741 -1.224 . . . . 0.0 110.668 173.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.54 119.17 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 6.9 pt-20 -97.83 -72.94 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.412 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 8.0 t70 -116.49 -105.65 0.39 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -93.62 14.04 20.19 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.51 1.124 . . . . 0.0 110.698 166.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.27 152.06 35.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -123.16 137.07 54.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.784 1.633 . . . . 0.0 108.521 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -77.84 138.31 38.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 160.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.2 143.79 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.951 0.9 . . . . 0.0 109.669 171.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.75 165.93 29.23 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.979 -2.049 . . . . 0.0 107.979 164.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.6 pt -76.6 160.1 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.806 -0.82 . . . . 0.0 109.576 168.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.2 p -84.58 166.51 17.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.07 0.948 . . . . 0.0 111.304 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -34.63 67.07 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.652 -1.28 . . . . 0.0 111.267 175.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -58.36 -23.4 56.79 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.955 -1.09 . . . . 0.0 112.724 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.78 -49.64 8.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.414 -1.429 . . . . 0.0 111.349 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -56.09 -28.54 58.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.116 0.871 . . . . 0.0 110.899 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -55.83 -23.29 29.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.821 1.648 . . . . 0.0 113.288 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -109.63 -11.63 14.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.96 1.304 . . . . 0.0 112.776 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.52 -43.86 11.71 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.097 0.862 . . . . 0.0 111.0 173.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.75 -149.65 51.61 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.85 114.7 2.43 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.023 1.329 . . . . 0.0 109.228 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.549 HG23 ' H ' ' A' ' 36' ' ' VAL 0.344 8.4 p -105.65 167.57 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 124.192 1.949 . . . . 0.0 110.36 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.549 ' H ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.29 -30.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 112.316 -2.22 . . . . 0.0 107.396 -148.202 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -149.08 153.81 38.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.782 0.719 . . . . 0.0 111.329 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.1 t -145.3 118.73 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 127.304 2.242 . . . . 0.0 106.579 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -69.29 140.06 54.39 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.73 136.55 29.32 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.05 -172.74 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.157 3.238 . . . . 0.0 111.391 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.83 156.28 19.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.53 0.732 . . . . 0.0 111.897 171.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.78 13.63 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.031 1.732 . . . . 0.0 113.34 -172.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.21 12.94 0.61 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.654 2.073 . . . . 0.0 111.566 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -66.13 119.75 11.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.85 141.99 40.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 174.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.24 157.32 25.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.978 0.911 . . . . 0.0 110.352 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 50' ' ' GLY . 55.0 mmtt -104.95 171.01 7.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.499 1.52 . . . . 0.0 109.446 167.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -65.38 13.88 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -154.39 25.93 0.68 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.55 1.072 . . . . 0.0 112.24 177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.62 124.79 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 108.793 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.27 109.03 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.28 8.79 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.868 0.867 . . . . 0.0 111.646 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.28 51.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.806 -0.559 . . . . 0.0 110.173 -171.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.83 161.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.293 1.037 . . . . 0.0 112.709 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mt -143.49 108.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.61 98.95 9.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.047 1.339 . . . . 0.0 107.924 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.2 p -84.55 -163.2 0.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.31 0.644 . . . . 0.0 110.487 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.01 -41.5 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.411 1.484 . . . . 0.0 112.538 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -167.6 20.53 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.009 0.923 . . . . 0.0 113.277 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.78 160.36 14.41 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 120.031 -1.668 . . . . 0.0 108.546 161.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.42 84.72 1.97 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 171.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.22 118.32 22.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -77.04 111.48 12.66 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 167.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.0 t -79.21 118.0 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -100.33 98.51 9.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.092 1.357 . . . . 0.0 111.759 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.75 135.62 1.25 Allowed Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.031 1.733 . . . . 0.0 113.301 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.55 -37.47 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.486 2.124 . . . . 0.0 114.707 -161.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.42 164.59 16.88 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 m -69.12 137.16 53.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 155.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.61 33.79 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -135.27 129.55 33.76 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.9 145.74 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.49 -2.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.749 0.82 . . . . 0.0 113.07 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -154.3 153.79 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.62 150.35 30.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.44 85.74 5.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -16.35 51.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -51.62 -36.34 45.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.272 1.829 . . . . 0.0 111.79 168.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -10.43 59.79 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.721 0.809 . . . . 0.0 111.567 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.26 -42.26 79.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.915 1.234 . . . . 0.0 109.552 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.6 p -95.64 -41.03 9.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.704 0.802 . . . . 0.0 111.25 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.19 72.54 9.47 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.431 1.892 . . . . 0.0 109.72 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.13 -38.8 4.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.06 3.173 . . . . 0.0 110.38 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.18 -13.46 12.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.574 1.15 . . . . 0.0 111.363 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -19.83 41.1 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.261 1.391 . . . . 0.0 112.815 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.8 mt -63.88 -26.22 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 121.519 -0.738 . . . . 0.0 110.893 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.35 -57.14 13.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.299 1.047 . . . . 0.0 109.263 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.19 -64.08 0.95 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.623 2.769 . . . . 0.0 110.355 -165.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -136.88 60.66 30.86 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -165.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.96 -15.48 39.13 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.151 2.567 . . . . 0.0 113.682 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.477 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -125.5 7.57 7.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.632 2.373 . . . . 0.0 110.747 -170.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.42 -96.77 1.79 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 168.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.18 -20.28 32.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.204 0.602 . . . . 0.0 112.003 -171.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.0 32.85 4.19 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.43 1.014 . . . . 0.0 113.344 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -65.5 160.6 21.87 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 1.373 . . . . 0.0 109.859 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mt -104.71 -62.0 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -141.82 167.63 21.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.503 0.721 . . . . 0.0 111.459 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -117.5 150.57 38.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.282 1.033 . . . . 0.0 108.67 165.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.3 ptm -145.32 140.69 27.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.351 0.661 . . . . 0.0 109.864 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -64.0 121.51 14.29 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.559 1.144 . . . . 0.0 107.921 168.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.0 pt -71.51 98.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -75.37 -10.03 59.09 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.81 -0.557 . . . . 0.0 111.59 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -151.49 95.14 2.1 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.379 1.871 . . . . 0.0 107.068 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -8.61 55.33 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.63 -1.294 . . . . 0.0 111.507 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.92 -40.44 98.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -67.05 -9.97 44.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.728 1.611 . . . . 0.0 112.049 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.15 -20.27 65.72 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.756 1.162 . . . . 0.0 110.557 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -72.29 -18.0 61.83 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.894 1.224 . . . . 0.0 111.537 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.19 -19.81 49.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.052 0.842 . . . . 0.0 111.091 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.52 175.17 8.78 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.951 1.301 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.3 mt -106.44 149.63 26.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.863 1.265 . . . . 0.0 110.823 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.99 169.12 10.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.383 1.073 . . . . 0.0 108.294 163.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.67 -49.65 61.73 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.948 1.299 . . . . 0.0 109.843 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -60.56 -41.79 95.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.705 0.802 . . . . 0.0 110.612 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.88 -37.18 83.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.121 0.568 . . . . 0.0 110.718 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.03 -39.09 86.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.548 0.739 . . . . 0.0 110.692 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -47.66 84.37 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.272 0.629 . . . . 0.0 110.694 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.17 -26.07 65.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.547 0.612 . . . . 0.0 111.421 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -65.86 -27.19 68.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.2 -0.938 . . . . 0.0 111.861 167.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.94 -48.44 68.58 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.056 -1.027 . . . . 0.0 109.018 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.17 -20.61 64.32 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.522 0.601 . . . . 0.0 112.578 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -83.78 -15.45 48.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.716 1.606 . . . . 0.0 112.79 172.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.324 -172.271 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp 65.18 158.0 0.1 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.138 1.775 . . . . 0.0 110.136 -168.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 ptp -160.41 168.44 25.17 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.246 -1.534 . . . . 0.0 111.502 -167.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -159.82 70.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 110.143 -170.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -81.42 176.72 9.47 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.71 -1.244 . . . . 0.0 112.956 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -132.91 161.68 33.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.555 2.342 . . . . 0.0 111.723 -171.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -103.4 177.23 4.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 123.181 1.467 . . . . 0.0 109.68 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -101.39 19.16 18.32 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.504 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -134.04 44.14 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.816 1.647 . . . . 0.0 109.894 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 p80 41.47 55.07 3.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.534 1.534 . . . . 0.0 113.118 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -143.81 134.39 24.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.751 2.021 . . . . 0.0 107.479 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -92.65 172.72 8.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.234 1.414 . . . . 0.0 109.29 167.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.53 148.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.46 90.98 2.51 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.027 0.531 . . . . 0.0 111.696 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.0 mt -95.76 102.87 14.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.991 1.316 . . . . 0.0 107.468 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -79.02 -76.49 0.2 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.245 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -106.07 -82.71 0.53 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.081 0.855 . . . . 0.0 109.219 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.18 13.72 11.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.834 0.854 . . . . 0.0 111.339 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -137.41 126.08 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.45 154.86 20.03 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.938 0.875 . . . . 0.0 108.843 162.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.9 m -106.5 155.4 19.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.994 157.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.63 142.64 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.239 3.416 . . . . 0.0 104.765 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 96' ' ' TRP . . . -160.37 32.66 0.4 Allowed Glycine 0 N--CA 1.477 1.376 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.6 pt 44.07 162.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 131.215 3.806 . . . . 0.0 114.663 -169.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.9 p -93.46 170.78 9.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.496 -2.003 . . . . 0.0 110.92 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -31.36 70.98 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.629 -1.294 . . . . 0.0 111.659 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -59.45 -24.21 63.35 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.043 0.937 . . . . 0.0 111.66 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.71 -54.22 6.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.945 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.11 -26.8 51.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.424 0.69 . . . . 0.0 111.947 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.56 -54.62 41.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.138 1.775 . . . . 0.0 110.928 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -62.18 -49.01 77.51 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.245 1.018 . . . . 0.0 110.63 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.82 -38.57 83.42 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.363 1.065 . . . . 0.0 109.515 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.74 -118.77 10.14 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.192 1.853 . . . . 0.0 108.928 -168.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.6 159.59 21.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.685 0.755 . . . . 0.0 109.681 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.661 ' CG1' ' H ' ' A' ' 36' ' ' VAL . 6.4 t -132.74 -172.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.014 1.325 . . . . 0.0 107.914 171.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.661 ' H ' ' CG1' ' A' ' 35' ' ' VAL . 3.1 m -159.35 -34.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 129.307 3.043 . . . . 0.0 109.583 -168.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -151.4 164.99 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.49 124.47 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 127.045 2.138 . . . . 0.0 107.379 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.68 140.17 38.4 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.807 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.6 mt -138.98 144.76 42.54 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.223 0.609 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.4 178.19 7.69 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.941 3.094 . . . . 0.0 111.454 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -86.58 160.41 18.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 0.0 110.581 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.11 17.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 127.177 2.191 . . . . 0.0 114.487 -167.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.4 11.4 0.47 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.977 2.227 . . . . 0.0 113.025 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -71.0 127.96 34.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.132 1.466 . . . . 0.0 109.929 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.69 146.21 46.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.762 1.165 . . . . 0.0 110.924 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.53 144.47 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.905 1.682 . . . . 0.0 108.991 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -83.25 172.31 12.72 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.109 -0.995 . . . . 0.0 111.414 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 12.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.254 2.221 . . . . 0.0 116.182 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.25 65.48 0.22 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.92 121.98 15.72 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.2 OUTLIER -72.76 35.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 132.003 4.121 . . . . 0.0 113.308 -166.834 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 m -70.12 6.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 118.827 -2.421 . . . . 0.0 115.291 -168.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.7 55.76 1.2 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.897 1.226 . . . . 0.0 111.465 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.69 163.81 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.769 1.271 . . . . 0.0 112.532 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 mt -131.91 114.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -166.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.53 126.52 51.69 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 167.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -165.62 1.06 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.04 2.536 . . . . 0.0 108.388 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.26 -24.74 32.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 127.701 2.4 . . . . 0.0 112.375 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.23 12.6 0.19 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.604 1.093 . . . . 0.0 113.93 166.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.02 155.42 27.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.143 -0.973 . . . . 0.0 109.944 173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.66 100.03 3.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.05 179.21 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.469 1.508 . . . . 0.0 111.078 -166.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.18 139.06 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.586 1.955 . . . . 0.0 108.475 -163.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.35 108.59 25.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 167.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.0 107.67 20.21 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.808 0.731 . . . . 0.0 109.895 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -43.48 142.39 1.77 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.451 1.101 . . . . 0.0 112.485 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.13 -28.1 2.6 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.85 2.366 . . . . 0.0 114.596 -158.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mt -153.19 145.34 23.83 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.496 2.718 . . . . 0.0 104.906 -162.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 m -68.11 128.03 35.04 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 103' ' ' SER . . . -175.01 -166.53 32.96 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 124.496 1.046 . . . . 0.0 111.559 -170.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -137.02 130.3 31.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.9 mm -58.78 144.63 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.515 1.126 . . . . 0.0 108.287 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.9 m -146.98 3.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -155.14 156.01 34.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.614 1.552 . . . . 0.0 108.535 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.09 157.68 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.788 1.235 . . . . 0.0 109.081 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -101.15 84.73 2.69 Favored 'General case' 0 C--O 1.23 0.057 0 C-N-CA 123.347 0.659 . . . . 0.0 109.455 -174.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -60.1 -3.38 0.57 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.803 1.241 . . . . 0.0 113.586 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -54.86 -52.77 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.301 -1.499 . . . . 0.0 109.982 160.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.94 -25.39 68.12 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.018 1.727 . . . . 0.0 112.111 -163.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -59.72 -23.81 63.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.641 1.176 . . . . 0.0 111.827 173.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.2 p -125.69 -20.82 4.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.678 1.591 . . . . 0.0 112.107 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -133.62 70.01 76.13 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 126.304 1.841 . . . . 0.0 108.4 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.48 -4.75 15.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.576 3.517 . . . . 0.0 111.689 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.82 -8.44 43.56 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.091 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.94 -22.97 62.16 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.06 -1.65 . . . . 0.0 111.543 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.5 mt -58.17 -26.29 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.297 169.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -72.11 -55.29 7.57 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.684 1.584 . . . . 0.0 110.585 164.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -35.22 80.46 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.115 0.966 . . . . 0.0 111.884 -161.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.35 78.72 1.1 Allowed Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.57 -34.45 95.37 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 CA-C-N 120.948 1.374 . . . . 0.0 110.328 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -100.09 -5.69 27.53 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.959 1.304 . . . . 0.0 111.946 -171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.69 -69.19 0.96 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -119.68 -21.13 7.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.541 1.136 . . . . 0.0 112.769 -167.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.91 26.07 3.87 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.805 1.669 . . . . 0.0 115.351 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.411 ' HA ' ' HA3' ' A' ' 23' ' ' GLY . 45.0 p-90 -63.53 158.92 19.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 119.388 1.594 . . . . 0.0 111.642 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.46 -67.43 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -172.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -142.22 166.1 25.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.264 1.826 . . . . 0.0 110.617 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -113.84 154.68 27.06 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.023 1.329 . . . . 0.0 108.933 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.0 ptm -145.48 143.32 29.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.084 0.553 . . . . 0.0 110.688 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.31 137.23 57.4 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.902 1.281 . . . . 0.0 107.881 168.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.5 pt -76.29 155.92 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 123.444 0.465 . . . . 0.0 109.96 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.434 ' HB2' ' HA2' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -133.53 -13.03 2.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.56 112.68 3.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 168.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -83.95 -15.68 46.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.089 1.755 . . . . 0.0 110.622 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.36 71.79 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.085 1.326 . . . . 0.0 111.437 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.61 -7.89 58.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 112.609 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.02 -41.23 82.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.442 1.474 . . . . 0.0 110.639 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.23 -19.09 63.95 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.493 0.588 . . . . 0.0 111.065 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -70.91 -17.11 62.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.097 1.359 . . . . 0.0 111.702 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.81 169.59 13.22 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.37 153.42 20.44 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.641 0.776 . . . . 0.0 109.89 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.63 171.14 6.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 163.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.78 -45.64 70.81 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.11 -40.11 96.66 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.651 1.18 . . . . 0.0 111.005 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.56 82.7 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.082 0.401 . . . . 0.0 111.308 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -64.48 -36.51 84.42 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.527 0.731 . . . . 0.0 111.766 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.04 -47.85 71.14 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.491 0.587 . . . . 0.0 110.343 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -62.0 -39.54 92.56 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 118.183 0.447 . . . . 0.0 110.149 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -62.15 -27.22 68.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.45 0.568 . . . . 0.0 111.862 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 55.5 m -82.66 -5.46 58.85 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.825 -1.172 . . . . 0.0 113.873 171.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.96 -2.24 53.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.949 1.249 . . . . 0.0 111.4 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.05 24.93 9.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.863 2.065 . . . . 0.0 108.986 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 127.2 2.2 . . . . 0.0 107.456 -175.505 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 tttp 30.86 77.36 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.818 2.447 . . . . 0.0 112.534 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.4 ttm -142.86 150.5 39.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -173.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.455 ' HB3' ' HZ1' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -138.39 110.53 7.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -111.34 -179.94 3.86 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.415 1.086 . . . . 0.0 109.946 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.58 163.56 32.53 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.032 0.933 . . . . 0.0 110.361 -170.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.1 p -114.68 -179.79 3.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.552 1.644 . . . . 0.0 110.642 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -63.63 -24.48 67.81 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.072 2.149 . . . . 0.0 115.226 160.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -84.05 24.01 0.98 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.732 1.151 . . . . 0.0 111.67 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 52.89 56.42 7.6 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 125.391 1.476 . . . . 0.0 109.569 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -140.28 148.85 42.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.856 2.063 . . . . 0.0 108.236 -167.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -128.03 153.55 46.64 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.99 1.716 . . . . 0.0 110.956 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.14 151.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 C-N-CA 127.188 2.195 . . . . 0.0 106.499 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.4 72.3 1.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.282 1.433 . . . . 0.0 108.807 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mp -70.57 134.1 30.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.064 2.145 . . . . 0.0 106.427 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -125.78 -61.44 1.25 Allowed 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.315 -0.866 . . . . 0.0 110.981 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.03 -76.65 0.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -126.79 4.44 6.66 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.041 1.336 . . . . 0.0 112.635 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.76 135.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.11 142.35 29.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.8 m -75.87 147.51 39.01 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 151.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.14 130.29 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 129.003 2.921 . . . . 0.0 107.187 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.41 172.68 26.92 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 167.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.2 pt -91.66 152.54 3.37 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.38 0.672 . . . . 0.0 109.863 173.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.7 p -82.29 170.85 14.91 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.973 -1.08 . . . . 0.0 111.206 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -21.82 66.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.926 -1.109 . . . . 0.0 113.345 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -61.59 -29.46 70.05 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.0 -1.062 . . . . 0.0 111.56 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.16 56.46 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.974 -1.079 . . . . 0.0 111.432 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -64.93 -24.25 67.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.198 0.599 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.49 -47.84 68.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.553 1.941 . . . . 0.0 108.389 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -70.7 -52.6 19.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mt -73.13 -33.03 65.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.286 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -133.46 15.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.46 147.71 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.694 1.198 . . . . 0.0 107.804 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.527 ' CG1' ' H ' ' A' ' 36' ' ' VAL . 21.4 t -121.48 -149.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.969 1.707 . . . . 0.0 106.559 178.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.527 ' H ' ' CG1' ' A' ' 35' ' ' VAL . 0.2 OUTLIER 179.8 -40.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 130.34 3.456 . . . . 0.0 108.406 -166.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -150.43 154.52 37.88 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.267 1.394 . . . . 0.0 113.776 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.06 131.33 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 125.189 1.396 . . . . 0.0 107.767 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.9 147.76 26.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.686 2.394 . . . . 0.0 108.777 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -144.61 148.88 41.64 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.048 1.339 . . . . 0.0 109.6 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.06 179.98 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.212 2.608 . . . . 0.0 114.377 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 152.04 21.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.109 0.963 . . . . 0.0 110.518 170.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.93 11.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 128.349 2.66 . . . . 0.0 115.037 -168.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.16 10.83 1.36 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.111 1.815 . . . . 0.0 112.47 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -70.14 128.68 37.12 Favored 'General case' 0 CA--C 1.527 0.088 0 O-C-N 121.288 -1.124 . . . . 0.0 108.027 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.85 153.79 30.31 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.94 170.88 10.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.893 1.277 . . . . 0.0 109.849 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 50' ' ' GLY . 34.4 mmtt -122.56 166.24 15.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.014 1.326 . . . . 0.0 109.597 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -62.13 7.87 0.05 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -155.34 75.61 0.22 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 167.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 114.36 13.73 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.579 1.151 . . . . 0.0 109.558 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.48 93.29 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.944 1.697 . . . . 0.0 108.145 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.27 -3.5 10.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.852 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.99 53.21 1.21 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.763 0.664 . . . . 0.0 111.925 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.66 155.44 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.787 0.835 . . . . 0.0 111.348 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mt -129.42 94.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.04 108.34 15.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.1 p -88.92 -169.52 2.56 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.604 1.162 . . . . 0.0 110.559 172.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.1 m -53.78 -29.35 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.684 1.193 . . . . 0.0 111.905 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -163.73 29.69 0.08 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -149.9 161.54 42.09 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.483 -0.761 . . . . 0.0 109.504 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.56 105.4 8.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.601 1.561 . . . . 0.0 107.606 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.01 119.78 22.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' CG ' ' HH ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -76.35 131.03 38.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 163.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.49 106.72 21.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.414 ' HH ' ' CG ' ' A' ' 64' ' ' ASP . 51.2 m-85 -99.72 107.4 19.48 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 110.629 -162.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -36.37 122.89 0.75 Allowed Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 126.747 2.019 . . . . 0.0 111.284 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 -23.55 7.27 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.637 1.558 . . . . 0.0 114.848 -161.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.74 161.61 32.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.418 1.887 . . . . 0.0 105.911 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.4 m -77.98 149.67 34.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.7 -162.97 34.39 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 120.101 -1.624 . . . . 0.0 110.167 -172.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -132.53 131.89 42.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.114 0.957 . . . . 0.0 109.844 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.3 mm -61.3 137.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.708 1.603 . . . . 0.0 108.167 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.71 1.12 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 123.955 0.784 . . . . 0.0 112.966 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -150.75 153.32 35.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 162.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.45 166.07 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.159 1.345 . . . . 0.0 109.827 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -110.4 82.01 1.53 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -59.86 -15.09 18.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.79 0.836 . . . . 0.0 112.255 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -55.87 -31.63 62.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.339 1.055 . . . . 0.0 112.416 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -13.93 62.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.191 0.905 . . . . 0.0 109.828 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.49 -16.91 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.87 1.268 . . . . 0.0 111.953 171.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -129.95 -17.85 3.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.773 0.829 . . . . 0.0 112.267 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.06 71.71 72.96 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.941 1.697 . . . . 0.0 107.904 167.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.52 -17.53 59.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 108.949 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.51 -4.75 59.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.268 1.027 . . . . 0.0 112.734 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 mt -66.08 -18.15 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.468 -1.395 . . . . 0.0 111.993 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.7 mt -62.94 -34.85 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.223 1.009 . . . . 0.0 109.561 171.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.08 -52.4 49.18 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.138 -1.602 . . . . 0.0 109.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -37.3 86.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.505 -162.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.18 79.92 0.52 Allowed Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.42 -14.95 41.22 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.135 1.89 . . . . 0.0 112.168 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -125.15 43.76 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.579 1.552 . . . . 0.0 108.316 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.34 -100.26 0.34 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 162.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -76.38 -26.57 55.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.96 -1.019 . . . . 0.0 112.505 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 39.52 2.92 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.347 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -69.39 164.02 23.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.871 1.336 . . . . 0.0 110.344 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.28 -65.16 0.98 Allowed 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -148.78 173.51 13.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.2 1.0 . . . . 0.0 110.04 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -127.21 153.8 45.63 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.658 1.183 . . . . 0.0 109.022 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.4 ptm -149.9 135.88 18.68 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.159 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.76 125.56 20.54 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.061 1.744 . . . . 0.0 107.357 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 21.4 pt -73.28 129.84 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.3 p -75.62 -41.92 53.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 166.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 106' ' ' GLY . 22.9 m-20 -142.83 90.53 2.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.981 0.913 . . . . 0.0 108.648 -160.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -10.1 0.98 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.319 1.048 . . . . 0.0 111.904 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 104' ' ' ASP . . . -90.47 -15.97 56.05 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.571 1.558 . . . . 0.0 112.591 -177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.87 -16.29 60.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.561 1.181 . . . . 0.0 110.29 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.64 -29.17 69.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.437 0.695 . . . . 0.0 110.927 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -95.38 27.63 3.25 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.011 -1.056 . . . . 0.0 111.36 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -116.71 0.5 12.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.381 147.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -84.41 -177.62 6.68 Favored 'General case' 0 C--N 1.34 0.186 0 O-C-N 120.683 -1.261 . . . . 0.0 109.837 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -91.3 127.92 36.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 107.656 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.93 178.29 1.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.374 1.083 . . . . 0.0 109.472 160.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -69.65 -49.53 52.86 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.273 1.029 . . . . 0.0 112.02 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.28 -44.28 95.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.905 0.882 . . . . 0.0 109.037 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.71 90.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.138 0.575 . . . . 0.0 111.148 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.76 -41.72 78.48 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.242 -0.911 . . . . 0.0 111.118 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -44.01 68.04 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.649 1.58 . . . . 0.0 109.97 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -52.1 -56.54 13.81 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.094 0.957 . . . . 0.0 110.49 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.04 -46.21 78.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.558 0.343 . . . . 0.0 110.283 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 4.3 t -66.43 -13.95 61.5 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.912 -1.118 . . . . 0.0 113.074 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.94 15.12 18.57 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.21 1.404 . . . . 0.0 111.117 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -4.31 25.6 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.183 -0.948 . . . . 0.0 111.334 169.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 . . . . . 0 C--O 1.248 0.978 0 C-N-CA 124.948 1.299 . . . . 0.0 109.047 -166.68 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -161.17 124.69 3.31 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 159.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 ttp -136.03 162.14 33.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.6 1.56 . . . . 0.0 107.958 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 14' ' ' SER . 21.0 ttmt -145.09 148.2 33.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.669 -1.269 . . . . 0.0 107.733 155.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -127.01 176.1 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.43 168.08 20.62 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.549 1.94 . . . . 0.0 108.827 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -130.53 177.16 7.57 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.938 1.352 . . . . 0.0 111.311 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -76.25 -25.46 55.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.518 1.527 . . . . 0.0 110.856 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 0.6 OUTLIER -82.28 17.33 1.71 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.68 1.127 . . . . 0.0 111.272 171.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 65.34 59.18 0.82 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.23 1.812 . . . . 0.0 110.663 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -111.58 165.45 12.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.167 0.987 . . . . 0.0 110.388 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.406 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 50.4 p-90 -131.37 152.81 50.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.865 1.666 . . . . 0.0 109.227 168.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 t -135.78 89.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.961 1.704 . . . . 0.0 107.407 -168.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.44 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 5.7 m -72.86 82.37 1.19 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.25 1.82 . . . . 0.0 112.986 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 mm -87.41 127.29 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -141.61 -21.57 0.74 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.124 -0.985 . . . . 0.0 112.945 -170.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -141.19 -105.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 157.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -111.49 9.66 21.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.82 1.648 . . . . 0.0 111.015 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.05 144.24 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 168.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -109.06 141.88 40.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 108.565 160.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 m -85.67 136.06 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 156.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.5 124.18 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 130.249 3.42 . . . . 0.0 110.67 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.62 170.96 33.6 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.007 1.289 . . . . 0.0 110.49 168.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 pt -90.7 148.27 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.784 -0.833 . . . . 0.0 108.818 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 27' ' ' HIS . 41.9 p -76.28 157.92 32.06 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.32 -0.862 . . . . 0.0 111.144 176.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -58.44 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 1 C-N-CA 135.451 5.5 . . . . 0.0 116.054 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 25' ' ' THR . 11.0 t60 -107.5 -40.08 5.45 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 127.566 2.346 . . . . 0.0 112.402 164.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.79 -51.66 21.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.215 2.206 . . . . 0.0 116.07 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -42.08 -45.7 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.385 3.074 . . . . 0.0 109.75 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.597 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -51.69 -48.07 63.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.271 1.428 . . . . 0.0 112.284 176.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -68.75 -23.13 64.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.571 1.148 . . . . 0.0 111.517 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -89.05 -28.48 20.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.607 0.64 . . . . 0.0 112.385 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.43 -137.36 37.39 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 126.178 1.847 . . . . 0.0 110.555 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.28 112.98 2.93 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -86.28 -171.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 122.596 1.189 . . . . 0.0 109.038 170.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.55 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.7 p -173.15 -40.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.267 2.227 . . . . 0.0 106.348 -150.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -154.48 149.68 27.02 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.73 135.43 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.668 1.587 . . . . 0.0 107.967 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -91.54 143.99 26.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.551 2.341 . . . . 0.0 108.155 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -141.66 138.36 17.2 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.936 0.894 . . . . 0.0 109.031 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.75 175.71 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.088 2.525 . . . . 0.0 112.325 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.19 147.93 29.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.925 -1.11 . . . . 0.0 109.718 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.19 17.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 128.464 2.706 . . . . 0.0 115.528 -168.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.77 3.85 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.311 2.386 . . . . 0.0 112.319 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -60.71 138.87 58.05 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.571 1.186 . . . . 0.0 108.388 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.61 141.36 28.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.71 170.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.952 0.901 . . . . 0.0 110.182 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 50' ' ' GLY . 32.9 mtmm -127.57 159.75 33.67 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.996 0.918 . . . . 0.0 110.672 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 10.55 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.914 2.486 . . . . 0.0 115.151 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -166.12 68.19 0.19 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 173.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -140.42 129.28 23.22 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.2 t -79.35 110.7 15.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -173.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -2.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.767 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.35 45.29 0.72 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.417 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.3 m -48.29 145.86 3.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.246 1.419 . . . . 0.0 113.156 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.8 mt -122.2 107.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.3 128.84 41.04 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.3 p -105.03 -172.68 2.14 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.299 0.954 . . . . 0.0 109.967 172.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 m -52.36 -27.17 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.37 1.468 . . . . 0.0 112.616 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -158.29 29.77 0.24 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.918 1.235 . . . . 0.0 113.76 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.54 -179.31 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.007 -1.058 . . . . 0.0 109.993 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.34 44.43 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 126.746 2.018 . . . . 0.0 108.35 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.31 111.65 8.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.596 1.959 . . . . 0.0 107.01 160.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 114.95 7.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -77.78 101.44 3.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -68.15 124.15 22.66 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.08 132.95 30.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.995 0.918 . . . . 0.0 109.728 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -81.01 -31.84 1.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.221 1.947 . . . . 0.0 114.285 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.67 157.99 35.89 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.538 1.935 . . . . 0.0 106.981 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 m -77.16 153.62 33.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.45 -171.05 31.68 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -165.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -136.38 130.88 33.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -63.62 150.21 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.432 1.093 . . . . 0.0 108.374 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.68 3.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.689 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -156.73 160.12 38.99 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 121.373 1.897 . . . . 0.0 109.501 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.68 168.0 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.728 1.611 . . . . 0.0 109.59 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -117.71 78.71 1.26 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.641 1.177 . . . . 0.0 109.035 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.55 -11.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.169 0.987 . . . . 0.0 112.958 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -53.14 -31.68 43.68 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.683 -1.26 . . . . 0.0 111.042 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -21.36 59.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.241 1.017 . . . . 0.0 110.079 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.38 -5.95 16.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.549 1.939 . . . . 0.0 113.293 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -137.42 -34.35 0.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.552 -0.718 . . . . 0.0 110.229 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.1 62.07 19.19 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.323 2.249 . . . . 0.0 109.113 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.16 -20.49 28.34 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 124.177 3.251 . . . . 0.0 110.263 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.83 -17.32 49.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.699 1.2 . . . . 0.0 110.587 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.5 mt -67.86 -16.76 64.24 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.653 1.57 . . . . 0.0 114.383 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 mt -67.4 -23.72 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.26 0.936 . . . . 0.0 109.816 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -76.16 -53.73 7.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 119.967 -1.708 . . . . 0.0 109.918 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -59.99 -40.5 89.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.151 0.981 . . . . 0.0 112.084 -167.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.75 76.63 2.26 Favored Pre-proline 0 C--N 1.333 -0.136 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.15 -19.71 67.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.407 2.072 . . . . 0.0 113.315 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.406 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.3 mt-10 -124.19 22.32 8.66 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.43 1.013 . . . . 0.0 111.288 -171.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.06 -82.14 0.17 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 166.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -83.36 -38.83 21.5 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.49 46.32 3.24 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.793 1.179 . . . . 0.0 114.15 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -81.3 168.37 18.51 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.249 1.024 . . . . 0.0 109.704 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.63 -69.25 0.84 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -138.48 173.18 11.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.557 0.743 . . . . 0.0 111.349 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -128.38 150.36 50.14 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -144.84 148.69 34.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.054 0.542 . . . . 0.0 110.141 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.94 117.48 11.57 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.258 1.823 . . . . 0.0 107.778 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 pt -70.1 97.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.587 1.184 . . . . 0.0 107.963 163.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 m -60.67 -34.73 74.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.028 167.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -134.95 82.72 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -163.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -12.81 55.0 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.464 -0.772 . . . . 0.0 110.235 172.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.31 73.19 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 117.549 -1.695 . . . . 0.0 112.202 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -80.43 -29.22 37.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.958 1.879 . . . . 0.0 110.61 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.8 mt -41.81 -46.08 3.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.142 1.792 . . . . 0.0 111.83 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.49 -11.34 60.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.05 -35.62 59.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 165.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.88 171.02 3.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 123.693 1.711 . . . . 0.0 110.979 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.7 mt -70.54 120.82 16.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.022 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.4 -179.47 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.266 1.426 . . . . 0.0 110.231 163.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.64 -37.96 70.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.271 -1.518 . . . . 0.0 110.986 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -69.73 -46.1 66.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.27 1.428 . . . . 0.0 109.024 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.44 66.5 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.013 0.925 . . . . 0.0 111.875 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -63.47 -48.14 78.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.573 1.149 . . . . 0.0 109.506 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.0 -41.85 79.23 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -56.17 -46.95 79.14 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.817 0.847 . . . . 0.0 110.084 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -61.46 -40.92 96.27 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.24 -0.913 . . . . 0.0 111.671 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.49 -14.89 8.95 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.56 -17.77 29.51 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 120.523 1.51 . . . . 0.0 111.757 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -115.81 32.35 6.14 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.701 2.401 . . . . 0.0 108.601 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.61 -1.662 . . . . 0.0 111.891 -175.812 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.7 mtt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.83 150.46 1.47 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 31.1 tpp -147.43 154.23 40.58 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.126 1.37 . . . . 0.0 108.767 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -142.09 112.47 7.1 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.964 -1.085 . . . . 0.0 109.892 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -105.63 -179.23 3.88 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.732 0.645 . . . . 0.0 111.56 162.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -136.69 176.75 8.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.408 1.883 . . . . 0.0 111.568 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -134.96 166.09 23.82 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.894 1.277 . . . . 0.0 111.512 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -71.91 -34.54 69.18 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.769 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -71.58 42.33 0.08 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.35 0.977 . . . . 0.0 109.611 165.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 p80 38.97 63.97 0.85 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 127.726 2.411 . . . . 0.0 112.509 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -128.17 169.14 14.47 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.0 109.361 168.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -113.35 172.27 7.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.833 2.053 . . . . 0.0 109.435 161.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.4 142.89 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.757 2.423 . . . . 0.0 105.279 174.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.77 80.11 1.78 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 119.557 1.071 . . . . 0.0 110.893 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 mp -62.39 140.02 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 168.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -117.23 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 160.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.68 -94.83 0.44 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -123.22 33.35 5.4 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 128.152 2.581 . . . . 0.0 110.849 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.16 119.43 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 164.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.06 107.04 18.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.856 1.663 . . . . 0.0 107.607 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -70.23 126.39 29.52 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.824 0.85 . . . . 0.0 109.145 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.12 148.52 5.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 128.545 2.738 . . . . 0.0 112.618 169.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.19 161.39 32.0 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 157.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 pt -84.49 139.4 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 118.939 1.37 . . . . 0.0 108.6 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.7 p -73.51 172.99 10.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.564 -0.71 . . . . 0.0 111.466 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -59.19 -33.81 71.4 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.618 -1.301 . . . . 0.0 113.245 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -54.25 -24.1 17.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.893 1.277 . . . . 0.0 111.616 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.52 -48.75 10.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.264 1.025 . . . . 0.0 112.152 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -62.45 -20.02 64.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.084 0.856 . . . . 0.0 110.302 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -58.67 -26.52 63.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.647 1.979 . . . . 0.0 112.958 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -90.04 -42.01 11.38 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 120.155 1.343 . . . . 0.0 113.387 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mt -89.14 -33.0 17.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -170.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.44 -118.78 7.26 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.848 1.69 . . . . 0.0 111.606 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.79 112.88 3.07 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.213 1.805 . . . . 0.0 107.81 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -98.11 -165.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.047 0.927 . . . . 0.0 109.849 179.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.517 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -172.85 -31.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 129.62 3.168 . . . . 0.0 109.545 -168.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -150.12 147.41 27.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 111.326 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.8 t -138.99 115.88 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.21 140.71 58.9 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.998 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.3 mt -134.17 137.01 27.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 125.486 1.515 . . . . 0.0 107.576 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.87 -163.69 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.546 2.831 . . . . 0.0 112.643 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -113.69 145.32 41.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.854 1.662 . . . . 0.0 108.288 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.41 16.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -165.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.54 13.84 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.92 1.724 . . . . 0.0 112.671 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -79.39 137.38 37.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.524 1.662 . . . . 0.0 109.491 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -77.13 154.48 33.19 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.996 0.816 . . . . 0.0 109.872 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 m -140.46 164.71 21.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.515 1.126 . . . . 0.0 110.566 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 50' ' ' GLY . 20.2 mmtm -111.08 165.45 11.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 126.427 1.891 . . . . 0.0 107.983 167.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -60.77 10.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.729 2.012 . . . . 0.0 115.78 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -159.3 92.13 0.12 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 162.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.07 126.83 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -72.27 20.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 126.47 1.908 . . . . 0.0 113.976 -166.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.03 11.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 127.118 2.167 . . . . 0.0 116.196 -165.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.1 49.08 0.84 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.899 1.28 . . . . 0.0 108.79 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.8 m -49.43 157.22 0.53 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.402 1.096 . . . . 0.0 111.123 169.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mt -142.0 100.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -86.2 118.93 25.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -90.37 -167.94 1.97 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.484 1.514 . . . . 0.0 109.511 168.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -39.53 -52.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.054 1.742 . . . . 0.0 112.392 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -155.04 52.4 0.62 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.883 1.219 . . . . 0.0 111.81 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.3 177.37 10.64 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.179 -0.951 . . . . 0.0 109.194 163.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.19 114.04 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.506 1.523 . . . . 0.0 108.34 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.77 100.04 11.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.21 111.16 2.47 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.11 109.69 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -81.97 108.05 15.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.721 -0.612 . . . . 0.0 109.767 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -38.49 142.63 0.48 Allowed Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 126.826 2.05 . . . . 0.0 113.067 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.8 -35.9 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 119.617 0.899 . . . . 0.0 113.783 -161.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -123.46 160.32 27.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -80.67 151.61 28.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.54 -157.28 27.44 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -168.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -142.54 137.44 30.15 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.899 0.85 . . . . 0.0 109.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.0 mm -63.96 146.27 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 124.372 1.069 . . . . 0.0 108.817 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.4 -0.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.202 1.001 . . . . 0.0 111.116 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -161.43 157.64 25.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.22 146.13 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -173.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -86.51 74.73 9.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 118.57 0.623 . . . . 0.0 110.204 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.35 -15.11 14.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -54.51 -45.9 73.39 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.076 165.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.11 -18.88 64.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 0.0 112.281 -173.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -63.75 -15.66 59.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.207 1.403 . . . . 0.0 111.232 169.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 p -131.97 -27.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.67 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.23 64.55 61.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.143 1.777 . . . . 0.0 110.496 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.85 -10.25 27.65 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.146 3.231 . . . . 0.0 111.792 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.37 -14.16 61.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.197 -0.94 . . . . 0.0 112.908 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.5 mt -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.113 1.324 . . . . 0.0 113.464 -169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -63.83 -33.87 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.44 1.018 . . . . 0.0 110.667 169.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -59.07 -46.35 88.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.785 1.755 . . . . 0.0 109.965 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -72.73 -59.99 2.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 127.694 2.398 . . . . 0.0 110.579 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -140.54 65.07 25.24 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -167.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.78 -18.31 55.33 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 120.811 1.007 . . . . 0.0 111.475 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.33 28.18 7.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 109.021 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.6 -113.85 0.99 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.44 -14.33 62.83 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.269 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.71 32.48 2.15 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 120.678 1.581 . . . . 0.0 112.513 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.86 161.25 13.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.171 0.985 . . . . 0.0 108.741 165.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.46 -58.29 2.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.931 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -140.03 -176.79 4.72 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 115.022 -2.671 . . . . 0.0 111.934 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -136.42 129.84 31.79 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 ptm -131.92 139.13 48.63 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.5 141.91 58.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.9 pt -95.91 149.97 4.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -133.65 -13.06 2.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.904 1.681 . . . . 0.0 112.391 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -146.27 74.36 1.36 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -66.52 -10.26 43.04 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.618 -1.301 . . . . 0.0 111.009 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.28 -39.26 95.82 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 120.531 -1.355 . . . . 0.0 110.703 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -63.85 -28.94 70.19 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.568 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.0 mt -47.41 -36.67 10.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 120.184 1.356 . . . . 0.0 111.883 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.72 -16.62 55.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.887 1.676 . . . . 0.0 112.657 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.6 -31.24 66.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.346 1.459 . . . . 0.0 109.96 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.08 169.08 5.78 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.673 -0.642 . . . . 0.0 109.525 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.21 127.04 31.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.57 171.94 0.76 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 154.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -67.88 -36.57 80.47 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.509 -1.995 . . . . 0.0 112.126 -173.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.71 -51.55 58.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.21 71.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.255 0.222 . . . . 0.0 111.192 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -61.58 -52.37 64.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.728 1.211 . . . . 0.0 109.933 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -41.0 72.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.295 0.638 . . . . 0.0 109.651 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.97 -41.41 91.22 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.906 0.882 . . . . 0.0 110.968 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -68.11 -51.67 43.6 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.54 -0.725 . . . . 0.0 109.435 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.5 m -72.76 15.26 0.2 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.803 1.241 . . . . 0.0 113.404 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.34 -15.67 14.58 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.231 2.212 . . . . 0.0 112.266 164.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -114.21 -13.85 12.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.717 1.607 . . . . 0.0 112.664 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.465 1.906 . . . . 0.0 109.55 -174.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mtm . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.919 0.39 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.5 mttt 70.43 130.15 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 128.569 2.748 . . . . 0.0 111.43 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.51 ' SD ' ' HE2' ' A' ' 5' ' ' LYS . 3.8 ptp -165.61 178.28 6.78 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.44 1.496 . . . . 0.0 109.512 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 64.94 0.74 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.66 -1.275 . . . . 0.0 111.372 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.51 ' HE2' ' SD ' ' A' ' 3' ' ' MET . 2.0 mptp? -66.9 -178.65 0.78 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.97 149.42 47.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.487 1.915 . . . . 0.0 110.003 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.0 p -93.14 171.21 9.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 123.518 1.628 . . . . 0.0 109.574 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -71.99 -33.4 68.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.016 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -89.84 43.53 1.15 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.63 2.372 . . . . 0.0 111.564 -176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p80 48.5 46.53 20.79 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.361 1.864 . . . . 0.0 114.234 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.25 158.21 28.61 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 109.275 170.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.8 p-90 -108.79 163.15 13.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.472 1.509 . . . . 0.0 107.358 165.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.18 154.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.34 80.66 1.68 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.122 1.369 . . . . 0.0 109.632 -172.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.56 117.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.454 1.502 . . . . 0.0 108.82 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.287 5.1 pt-20 -114.11 -101.18 0.42 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 116.732 -1.604 . . . . 0.0 108.988 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -64.08 1.1 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 122.321 2.328 . . . . 0.0 111.806 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -153.66 8.54 0.38 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.487 2.715 . . . . 0.0 109.873 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.5 t -127.92 126.45 66.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.71 141.81 28.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.695 0.398 . . . . 0.0 109.962 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.4 m -87.99 151.71 22.58 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.15 142.33 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.752 1.221 . . . . 0.0 109.327 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.47 170.39 35.11 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 163.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.7 pt -77.46 152.08 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 118.415 1.108 . . . . 0.0 110.695 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -80.8 171.81 14.54 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.916 -1.115 . . . . 0.0 112.508 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -21.52 62.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.37 1.068 . . . . 0.0 113.025 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -67.02 -31.21 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 119.765 -1.835 . . . . 0.0 111.859 169.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.2 -42.7 20.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.953 -1.092 . . . . 0.0 111.705 -172.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -56.31 -22.32 29.72 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.372 0.533 . . . . 0.0 111.374 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -46.13 81.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.194 0.998 . . . . 0.0 109.371 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.577 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -81.01 -27.83 35.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.254 1.422 . . . . 0.0 112.515 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.02 -43.96 27.91 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.91 -150.03 51.6 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 124.517 1.056 . . . . 0.0 110.801 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -46.23 114.57 0.82 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.954 2.502 . . . . 0.0 108.081 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.55 HG22 ' H ' ' A' ' 36' ' ' VAL 0.276 8.9 p -111.08 173.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-O 122.774 1.273 . . . . 0.0 110.112 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.55 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.07 -23.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.413 -153.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -147.79 142.05 26.21 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.802 0.274 . . . . 0.0 111.237 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.25 132.47 55.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 159.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.5 137.63 42.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.805 168.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.2 mt -131.47 131.44 22.91 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.66 179.7 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.568 2.845 . . . . 0.0 113.149 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.39 156.77 24.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.549 -0.719 . . . . 0.0 111.146 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.99 19.21 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 0.0 113.457 -164.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.88 33.43 0.56 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -106.85 133.89 50.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.332 1.066 . . . . 0.0 110.829 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 150.72 48.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.378 0.99 . . . . 0.0 110.353 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -142.22 167.13 15.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.755 1.622 . . . . 0.0 110.624 169.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -116.85 170.49 8.58 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 127.758 2.423 . . . . 0.0 110.895 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 6.61 0.25 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.6 59.25 0.35 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -106.79 115.35 30.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.922 1.289 . . . . 0.0 108.994 -173.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.1 OUTLIER -70.28 33.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 127.736 2.414 . . . . 0.0 113.922 -173.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -72.69 10.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 O-C-N 117.956 -2.965 . . . . 0.0 115.958 -167.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.85 51.85 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.221 0.918 . . . . 0.0 109.554 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.69 157.21 7.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.81 0.814 . . . . 0.0 111.034 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.2 mt -133.6 108.03 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -101.49 117.27 34.59 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.2 p -99.61 -159.95 0.77 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.335 1.454 . . . . 0.0 111.7 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -43.55 -44.1 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.07 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -158.56 13.29 0.18 Allowed 'General case' 0 C--N 1.346 0.453 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 165.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.82 159.16 15.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.911 1.687 . . . . 0.0 108.148 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.32 96.59 3.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.385 1.474 . . . . 0.0 107.517 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.65 107.38 19.14 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.998 0.919 . . . . 0.0 110.311 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.31 117.33 4.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.238 1.815 . . . . 0.0 107.37 163.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.74 103.63 14.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -94.51 98.55 10.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -168.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.9 130.97 0.3 Allowed Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.924 2.09 . . . . 0.0 113.917 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.1 -29.68 39.54 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.279 2.653 . . . . 0.0 114.546 -167.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.9 mt -148.34 158.59 44.19 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.963 1.305 . . . . 0.0 108.079 -167.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -66.48 145.43 55.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.4 38.8 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -129.53 130.92 46.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.13 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.5 mm -63.66 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.2 m -145.71 -3.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.245 1.018 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -148.03 158.77 44.24 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.969 1.259 . . . . 0.0 107.845 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -142.45 158.38 19.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.333 1.453 . . . . 0.0 107.948 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -108.72 74.09 0.9 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.988 0.515 . . . . 0.0 110.141 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.65 -11.4 7.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -44.78 -42.34 7.71 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.313 1.445 . . . . 0.0 111.357 164.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -12.14 61.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.063 0.945 . . . . 0.0 110.893 -170.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.66 -11.21 57.75 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.707 1.203 . . . . 0.0 112.173 167.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -131.28 -36.18 1.31 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.828 . . . . 0.0 111.235 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -121.2 73.92 28.39 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.869 2.068 . . . . 0.0 107.233 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.89 -43.86 1.54 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.987 1.791 . . . . 0.0 107.657 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.07 -11.36 1.07 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.653 1.581 . . . . 0.0 112.285 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -57.43 -18.11 16.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.664 1.985 . . . . 0.0 111.99 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.8 mm -53.05 -37.95 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -68.02 -48.59 65.28 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 120.93 -1.106 . . . . 0.0 111.334 174.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 5.0 mtpt -77.74 -28.26 50.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 125.755 1.622 . . . . 0.0 113.126 -162.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.75 65.19 0.72 Allowed Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -177.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.98 -30.22 89.47 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.295 1.997 . . . . 0.0 112.756 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.1 mp0 -119.12 21.57 12.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.642 0.777 . . . . 0.0 110.046 177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.79 -121.53 4.86 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 105.874 -2.89 . . . . 0.0 105.874 157.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.54 -3.01 28.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.05 23.3 5.31 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 120.706 1.594 . . . . 0.0 112.7 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -63.2 162.02 12.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.722 1.761 . . . . 0.0 109.886 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.71 -56.16 2.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.03 173.81 12.12 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.209 -0.932 . . . . 0.0 112.014 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -124.72 152.54 43.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.788 0.835 . . . . 0.0 110.209 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -142.89 141.71 31.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.753 1.221 . . . . 0.0 110.493 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -64.63 133.51 52.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 pt -87.45 103.13 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 122.846 0.458 . . . . 0.0 110.322 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.5 m -66.86 -7.69 23.54 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -143.56 135.08 26.19 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -99.46 2.02 44.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.527 2.331 . . . . 0.0 108.158 162.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.81 -39.12 5.02 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.804 -1.185 . . . . 0.0 112.573 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -65.27 -24.13 67.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.42 1.11 . . . . 0.0 110.527 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.402 ' H ' ' CD1' ' A' ' 108' ' ' LEU . 2.7 mp -38.0 -44.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.533 2.733 . . . . 0.0 112.206 163.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -79.86 -7.34 58.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.272 1.396 . . . . 0.0 112.506 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -88.23 -12.75 42.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 111.639 168.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.27 169.52 7.1 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.053 -1.655 . . . . 0.0 109.155 167.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.42 139.44 42.33 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.84 171.66 0.88 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.553 1.168 . . . . 0.0 109.232 159.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.13 -34.45 78.08 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.388 1.875 . . . . 0.0 111.251 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -80.55 -44.16 19.49 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.571 1.148 . . . . 0.0 109.514 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.16 72.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.106 0.479 . . . . 0.0 111.307 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -59.31 -39.9 84.55 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.175 0.99 . . . . 0.0 110.947 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.67 -45.32 72.02 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.178 0.591 . . . . 0.0 109.881 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -46.52 76.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.662 0.785 . . . . 0.0 110.45 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -53.82 -49.26 68.76 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.798 1.639 . . . . 0.0 110.895 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.3 t -66.5 -21.71 66.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.985 0.914 . . . . 0.0 112.346 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.88 -6.59 58.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.287 1.035 . . . . 0.0 112.721 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -103.21 -13.67 16.66 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.088 0.858 . . . . 0.0 111.902 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.895 -169.298 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 58.04 61.47 2.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.129 1.372 . . . . 0.0 111.21 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.6 ttm -115.85 157.81 23.88 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.437 1.095 . . . . 0.0 108.141 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -138.64 121.18 16.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.949 154.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -113.42 179.97 3.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.316 1.847 . . . . 0.0 110.011 172.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -150.55 167.94 25.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.0 1.32 . . . . 0.0 110.508 -164.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -136.74 170.08 16.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.23 1.377 . . . . 0.0 111.371 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 120' ' ' PHE . 0.7 OUTLIER -68.5 -14.64 63.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 176.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -89.33 34.89 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.151 -1.593 . . . . 0.0 108.282 175.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 p80 41.73 64.16 1.13 Allowed 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.173 2.589 . . . . 0.0 110.723 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.492 1.517 . . . . 0.0 107.562 -166.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.9 p-90 -116.92 150.69 38.09 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.19 1.796 . . . . 0.0 110.043 176.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.57 122.91 15.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -161.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.38 97.79 5.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.449 1.022 . . . . 0.0 111.295 -163.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -108.49 102.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.484 1.113 . . . . 0.0 109.529 -164.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.46 -74.5 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.885 0.874 . . . . 0.0 110.11 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -74.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 108.066 -170.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -126.93 7.85 6.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.233 0.924 . . . . 0.0 113.344 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -134.69 142.66 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.79 137.54 38.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.029 1.332 . . . . 0.0 109.187 163.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 m -78.94 132.02 36.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 155.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.49 132.05 49.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.683 1.993 . . . . 0.0 108.762 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.69 168.82 29.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.548 1.071 . . . . 0.0 110.904 159.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.4 pt -89.06 159.19 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.334 0.653 . . . . 0.0 109.875 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -90.72 175.08 7.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.711 -1.243 . . . . 0.0 112.049 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -39.52 62.45 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.01 -1.056 . . . . 0.0 111.599 171.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -58.18 -22.5 51.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.398 1.079 . . . . 0.0 111.85 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.56 -46.65 8.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.751 1.62 . . . . 0.0 112.172 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -64.03 -22.83 67.09 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.12 0.418 . . . . 0.0 111.396 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -27.52 69.0 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.193 1.397 . . . . 0.0 111.716 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -90.11 -43.78 10.24 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.733 -0.605 . . . . 0.0 110.967 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.58 -35.75 14.08 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.954 -170.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.2 -119.42 8.68 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 125.373 1.464 . . . . 0.0 111.043 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.73 91.63 0.63 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.405 1.882 . . . . 0.0 106.728 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.68 HG11 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -74.88 -162.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.68 ' H ' HG11 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -165.6 -35.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 130.249 3.42 . . . . 0.0 109.37 -169.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -158.17 161.21 37.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.128 0.876 . . . . 0.0 112.667 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.45 132.37 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.574 1.15 . . . . 0.0 110.951 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.78 136.02 36.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 108.869 170.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.3 mt -130.95 144.39 53.35 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.062 1.745 . . . . 0.0 109.135 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.72 -179.25 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.586 2.857 . . . . 0.0 112.658 -169.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -73.49 148.11 43.45 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 110.065 166.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.71 9.18 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.642 2.377 . . . . 0.0 114.743 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.19 12.17 0.92 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 126.76 2.124 . . . . 0.0 110.503 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -66.52 145.14 55.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.212 1.006 . . . . 0.0 108.921 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -84.33 150.48 25.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.429 1.585 . . . . 0.0 110.575 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.377 11.6 t -142.58 173.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.174 0 C-N-CA 129.782 3.233 . . . . 0.0 108.621 -175.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 50' ' ' GLY . 20.0 mttm -141.89 169.46 17.54 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 129.362 3.065 . . . . 0.0 103.831 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 14.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -167.68 92.57 0.1 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 103.9 -3.68 . . . . 0.0 103.9 162.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.26 142.45 31.37 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.1 t -79.12 32.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 130.341 3.456 . . . . 0.0 111.344 -164.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.5 m -68.41 1.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 119.431 -2.043 . . . . 0.0 111.788 -169.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.6 73.2 1.17 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.886 1.675 . . . . 0.0 110.015 172.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.99 164.33 6.74 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 120.028 -1.67 . . . . 0.0 110.592 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mt -135.24 151.88 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.0 123.68 21.1 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.835 -1.165 . . . . 0.0 108.286 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.4 t -107.21 -169.61 1.57 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.957 1.303 . . . . 0.0 107.952 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.93 -33.82 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.86 1.264 . . . . 0.0 111.794 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -169.13 18.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.96 1.704 . . . . 0.0 112.827 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.48 152.64 29.89 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.269 0.941 . . . . 0.0 111.361 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.83 129.58 15.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.119 1.368 . . . . 0.0 109.254 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.3 107.93 2.27 Favored 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.634 4.374 . . . . 0.0 105.27 -163.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -67.35 134.75 52.11 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -78.46 120.12 28.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 164.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -102.86 105.58 15.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.57 132.58 1.34 Allowed Pre-proline 0 N--CA 1.452 -0.36 0 O-C-N 124.488 1.117 . . . . 0.0 112.331 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.02 -26.0 31.5 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.711 2.274 . . . . 0.0 113.491 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.4 151.26 34.97 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.261 1.425 . . . . 0.0 107.568 -163.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -72.48 128.38 35.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.16 40.62 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.626 -0.671 . . . . 0.0 111.919 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -128.52 131.09 48.28 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.328 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.2 mm -57.78 148.31 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 120.132 1.333 . . . . 0.0 108.368 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.81 -4.27 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.029 0.932 . . . . 0.0 112.747 164.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -150.5 156.51 41.57 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.349 1.432 . . . . 0.0 107.796 171.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.0 m -133.55 165.44 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.765 1.226 . . . . 0.0 108.017 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.98 83.03 1.69 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.253 0.621 . . . . 0.0 110.617 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.1 1.9 0.4 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -62.53 -43.02 99.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 119.802 -1.811 . . . . 0.0 108.49 166.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.1 mt -57.09 -14.29 3.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 113.704 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.1 -36.85 78.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.832 2.053 . . . . 0.0 110.698 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 p -127.5 -11.84 5.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.518 1.127 . . . . 0.0 112.413 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -117.31 58.3 2.29 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.254 1.822 . . . . 0.0 111.235 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.45 -18.16 18.02 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.641 2.227 . . . . 0.0 110.222 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.04 -13.89 60.92 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.382 0.992 . . . . 0.0 111.6 171.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -24.91 66.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.725 -1.859 . . . . 0.0 110.863 -172.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.5 mt -62.65 -18.27 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 O-C-N 120.557 -1.339 . . . . 0.0 110.507 172.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -74.3 -53.57 9.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 119.171 -2.206 . . . . 0.0 111.33 161.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -52.6 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.296 1.439 . . . . 0.0 109.958 -159.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.4 70.72 12.93 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 125.803 1.641 . . . . 0.0 106.7 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.99 -23.35 72.69 Favored 'Trans proline' 0 CA--C 1.511 -0.63 0 C-N-CA 123.059 2.506 . . . . 0.0 112.351 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP 0.294 0.4 OUTLIER -119.1 31.54 6.58 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.773 1.629 . . . . 0.0 109.27 -175.256 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -110.87 0.85 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.256 1.884 . . . . 0.0 109.03 166.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -72.96 -9.17 58.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.828 0.851 . . . . 0.0 113.104 -175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.74 21.92 33.68 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.854 1.216 . . . . 0.0 113.567 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -57.66 169.12 0.74 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.126 1.463 . . . . 0.0 110.309 165.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.6 -52.58 2.13 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -152.05 170.09 20.77 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 121.557 -0.714 . . . . 0.0 110.144 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -129.84 141.13 50.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.59 142.29 39.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.845 0.858 . . . . 0.0 110.105 -171.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.56 125.69 27.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.89 2.076 . . . . 0.0 106.935 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -81.77 97.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 124.328 1.018 . . . . 0.0 108.69 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -72.15 -16.12 61.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.39 172.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -137.93 79.2 1.73 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -15.61 62.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.62 -0.675 . . . . 0.0 111.609 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.55 4.64 77.48 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 116.925 -2.042 . . . . 0.0 114.067 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -97.81 -28.91 13.64 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.691 1.745 . . . . 0.0 112.614 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -34.06 76.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.652 1.569 . . . . 0.0 112.135 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -56.0 -29.29 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 124.841 1.257 . . . . 0.0 112.698 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -84.97 -17.16 38.51 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 111.36 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -76.68 -174.08 2.85 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.589 1.155 . . . . 0.0 109.623 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.58 128.1 32.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.96 169.93 0.2 Allowed 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 122.023 0.916 . . . . 0.0 109.957 160.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.01 -43.06 75.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.732 1.613 . . . . 0.0 110.995 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -65.31 -50.97 63.64 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.475 1.51 . . . . 0.0 109.107 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.84 70.19 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.592 -0.692 . . . . 0.0 111.824 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -63.16 -44.0 96.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.009 0.924 . . . . 0.0 110.407 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.38 71.91 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -45.6 86.55 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.981 0.42 . . . . 0.0 109.909 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 8' ' ' LYS . 34.3 t80 -66.18 -34.65 78.52 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.249 -0.907 . . . . 0.0 111.456 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 90.7 m -69.68 -12.6 61.76 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.237 -0.914 . . . . 0.0 113.337 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.94 9.65 42.59 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.199 1.8 . . . . 0.0 111.171 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -104.48 20.13 19.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.043 0.537 . . . . 0.0 110.234 160.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 C--O 1.243 0.72 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.189 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 mmm . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -74.83 129.15 37.17 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.665 -1.272 . . . . 0.0 108.511 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ptm -160.38 152.5 20.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.311 1.045 . . . . 0.0 108.93 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -125.9 88.4 2.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.278 0.944 . . . . 0.0 109.947 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -92.49 174.73 7.13 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.697 -0.627 . . . . 0.0 111.707 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.16 177.24 7.99 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.288 1.435 . . . . 0.0 112.035 -169.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -130.67 168.03 17.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.1 1.36 . . . . 0.0 110.882 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.27 18.21 0.42 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.019 1.328 . . . . 0.0 111.414 159.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -125.23 26.67 6.83 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.458 -1.401 . . . . 0.0 110.496 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.6 p80 45.02 50.97 9.03 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 111.506 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -121.97 143.22 49.61 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -99.51 159.53 14.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 160.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.26 107.9 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.35 74.79 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.495 1.118 . . . . 0.0 110.503 -170.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.0 mp -64.7 146.16 13.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.718 1.207 . . . . 0.0 108.501 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -139.06 -70.6 0.41 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.083 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.4 -62.47 1.26 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.984 1.266 . . . . 0.0 111.006 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.05 15.36 2.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.01 1.324 . . . . 0.0 110.526 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.45 150.89 33.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.07 133.43 54.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.736 1.614 . . . . 0.0 107.261 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -77.47 113.59 15.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 164.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.12 135.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.3 170.32 31.56 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 165.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.7 pt -90.33 153.35 3.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 117.974 0.887 . . . . 0.0 110.466 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 p -91.25 164.58 13.83 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.211 -1.555 . . . . 0.0 109.654 171.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.581 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 13.4 p-10 -50.9 -37.18 42.29 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 114.151 -2.833 . . . . 0.0 115.308 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -49.24 -34.52 15.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 121.604 2.002 . . . . 0.0 109.46 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.57 -68.9 0.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.26 1.824 . . . . 0.0 112.9 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.581 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 6.1 pm0 -66.04 -24.58 66.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.695 1.589 . . . . 0.0 110.699 -171.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.99 -40.29 96.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.272 6.3 pt20 -75.05 -56.69 4.48 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.328 0.651 . . . . 0.0 112.248 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -35.62 81.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.682 0.674 . . . . 0.0 111.926 -170.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.53 -137.07 36.86 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.85 110.73 0.77 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 128.39 2.676 . . . . 0.0 110.105 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.627 HG13 ' H ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -93.1 172.82 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 124.693 2.187 . . . . 0.0 109.649 171.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.627 ' H ' HG13 ' A' ' 35' ' ' VAL . 2.5 m -151.2 -37.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 129.432 3.093 . . . . 0.0 109.201 -160.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -155.52 153.61 30.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.759 0.424 . . . . 0.0 110.776 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.44 135.43 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.843 0.83 . . . . 0.0 109.602 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.93 122.74 23.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 163.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.33 141.83 31.34 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 124.626 1.17 . . . . 0.0 107.907 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -76.3 179.45 6.36 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.717 2.278 . . . . 0.0 111.97 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -79.59 157.93 27.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.29 1.036 . . . . 0.0 110.232 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.41 15.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.291 1.437 . . . . 0.0 113.317 -171.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.34 15.29 0.39 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 128.41 2.91 . . . . 0.0 111.41 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -73.38 128.17 34.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.11 1.455 . . . . 0.0 109.051 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.26 146.76 45.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.21 168.41 14.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 110.391 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' H ' ' HB2' ' A' ' 51' ' ' GLU . 26.3 mtpt -126.21 170.68 11.6 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.741 1.616 . . . . 0.0 108.427 172.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 24.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -152.16 15.17 0.77 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.931 1.253 . . . . 0.0 113.012 167.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -75.43 113.78 13.23 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.06 1.93 . . . . 0.0 110.679 -168.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.79 94.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.81 5.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.545 1.538 . . . . 0.0 112.153 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.37 38.96 1.16 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.786 0.435 . . . . 0.0 110.643 -168.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.33 151.98 6.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 123.183 1.468 . . . . 0.0 111.067 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.79 134.78 53.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -115.22 124.34 51.15 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 161.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.8 p -99.14 -173.84 2.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.191 0.996 . . . . 0.0 109.647 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 m -42.9 -48.6 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.997 0.919 . . . . 0.0 111.381 171.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -160.25 85.13 0.73 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.069 0.85 . . . . 0.0 109.55 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -178.47 147.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.878 2.471 . . . . 0.0 106.23 157.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.34 152.83 18.04 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.25 120.13 14.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 130.5 47.24 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.983 2.113 . . . . 0.0 107.392 165.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.82 116.15 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -106.27 100.71 10.23 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.893 0.877 . . . . 0.0 110.738 -166.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.54 127.09 0.5 Allowed Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 126.801 2.04 . . . . 0.0 112.584 -172.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.52 -27.71 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.569 1.513 . . . . 0.0 114.129 -159.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.23 172.44 12.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.485 1.914 . . . . 0.0 108.634 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 49.7 m -93.48 123.02 36.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.093 1.357 . . . . 0.0 110.862 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.33 -158.27 20.7 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -164.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -139.76 142.12 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.079 -1.247 . . . . 0.0 108.304 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.3 mm -62.17 148.66 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.693 1.197 . . . . 0.0 108.226 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -146.46 -5.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -156.36 140.79 16.74 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.51 147.67 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -89.02 81.64 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.1 -15.71 4.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.122 0.969 . . . . 0.0 113.193 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -53.34 -39.6 64.23 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.988 2.115 . . . . 0.0 112.692 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -11.17 60.56 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.377 1.444 . . . . 0.0 111.313 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -69.3 -38.3 78.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.358 1.463 . . . . 0.0 111.164 171.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.4 p -110.86 -25.99 9.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.32 1.448 . . . . 0.0 112.847 -171.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -132.09 61.79 59.83 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 128.513 2.725 . . . . 0.0 109.449 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.67 -30.07 84.82 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.021 3.148 . . . . 0.0 111.502 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.83 -11.42 27.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.87 2.068 . . . . 0.0 111.896 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mt -64.46 -15.7 61.15 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 120.281 1.401 . . . . 0.0 113.043 168.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.8 mt -58.6 -32.34 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.502 1.046 . . . . 0.0 110.054 167.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -73.86 -55.02 6.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 119.709 -1.87 . . . . 0.0 109.082 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -63.85 -56.46 15.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.391 1.476 . . . . 0.0 110.722 -168.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -138.63 57.17 11.11 Favored Pre-proline 0 C--O 1.239 0.523 0 O-C-N 124.691 1.245 . . . . 0.0 110.459 -165.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.74 -13.74 36.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.147 2.565 . . . . 0.0 112.116 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -109.22 -0.8 19.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.574 2.35 . . . . 0.0 110.756 -163.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.79 -81.09 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 125.947 1.737 . . . . 0.0 110.719 -174.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.12 -24.8 20.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.847 1.324 . . . . 0.0 113.212 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.63 31.89 1.44 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.372 1.463 . . . . 0.0 111.996 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -67.97 155.15 40.09 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.343 1.072 . . . . 0.0 109.229 173.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.15 -72.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -143.82 149.63 37.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.258 1.423 . . . . 0.0 108.371 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -99.25 150.71 21.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.67 142.76 43.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.47 138.16 48.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.076 1.35 . . . . 0.0 107.444 169.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 pt -96.02 111.92 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.513 0.725 . . . . 0.0 110.703 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 m -70.36 -38.03 74.7 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.073 -0.392 . . . . 0.0 111.346 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.62 81.07 1.98 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.154 0.982 . . . . 0.0 109.032 -164.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -7.31 24.11 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.97 -1.081 . . . . 0.0 111.748 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.66 -31.76 23.47 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.778 -1.201 . . . . 0.0 111.583 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -66.42 -8.98 29.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.7 -28.03 69.62 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.242 0.928 . . . . 0.0 110.946 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.16 -14.25 60.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.979 1.263 . . . . 0.0 111.391 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.85 -10.31 58.9 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.828 0.851 . . . . 0.0 111.616 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.9 mt -78.95 176.43 9.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.457 1.122 . . . . 0.0 110.534 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.7 133.14 34.31 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.149 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.79 166.44 13.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.379 1.561 . . . . 0.0 108.651 153.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -68.89 -35.93 77.45 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 125.447 1.499 . . . . 0.0 111.154 -168.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -67.38 -40.19 85.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.14 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.848 -0.533 . . . . 0.0 110.621 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.85 -44.04 97.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.603 0.361 . . . . 0.0 110.198 171.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -47.0 81.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.855 0.862 . . . . 0.0 110.698 172.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -60.41 -46.34 90.35 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.145 0.43 . . . . 0.0 110.389 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -59.77 -39.18 84.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.301 0.641 . . . . 0.0 110.953 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 37.8 t -62.27 -29.25 70.28 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.26 -0.9 . . . . 0.0 112.494 176.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.61 -36.88 76.59 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.895 1.225 . . . . 0.0 110.729 173.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -77.63 -3.1 39.21 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.546 1.138 . . . . 0.0 113.07 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.227 -1.368 . . . . 0.0 107.744 173.01 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 mtt . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -168.26 116.33 0.72 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -153.42 140.49 19.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 83.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.267 -0.896 . . . . 0.0 110.119 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.551 ' H ' ' HE3' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -82.93 176.81 8.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 119.436 -0.905 . . . . 0.0 113.202 178.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -131.44 152.92 50.25 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.897 1.679 . . . . 0.0 109.222 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.8 p -101.84 -173.67 2.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.442 1.115 . . . . 0.0 109.716 -172.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -98.03 10.36 40.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.662 1.985 . . . . 0.0 111.244 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.0 p -119.92 32.73 5.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.726 1.61 . . . . 0.0 111.572 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.11 38.86 26.54 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.355 -1.466 . . . . 0.0 111.844 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.28 137.29 44.15 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.378 1.871 . . . . 0.0 108.724 -165.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.516 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 60.4 p-90 -106.25 166.48 10.49 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.62 1.168 . . . . 0.0 109.774 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.04 144.67 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 83.81 1.9 Allowed 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.351 1.061 . . . . 0.0 109.855 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.79 132.39 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 107.744 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -137.96 -12.92 1.45 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.82 -70.86 0.07 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -144.41 17.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.899 1.28 . . . . 0.0 111.225 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.0 t -143.56 128.34 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.96 131.34 34.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 158.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 m -73.25 132.19 42.86 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 152.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.62 139.38 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 126.756 2.022 . . . . 0.0 107.656 171.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.21 164.69 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 163.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.9 pt -80.24 152.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 122.598 1.19 . . . . 0.0 109.168 167.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.1 p -77.32 166.07 23.64 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.519 1.128 . . . . 0.0 109.599 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -36.2 68.99 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.92 -33.24 61.93 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.644 -1.285 . . . . 0.0 112.381 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.58 61.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.164 176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.17 -27.11 68.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.512 1.051 . . . . 0.0 111.427 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -49.13 64.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.902 0.481 . . . . 0.0 109.867 -173.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -49.83 55.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.417 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -34.61 78.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.57 0.623 . . . . 0.0 110.169 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 -119.43 9.23 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.82 111.12 4.12 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.585 HG13 ' H ' ' A' ' 36' ' ' VAL . 1.9 t -77.11 -168.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 152.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.585 ' H ' HG13 ' A' ' 35' ' ' VAL . 2.6 p -176.75 -40.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -157.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -153.69 151.26 29.45 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.794 1.179 . . . . 0.0 110.832 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.5 t -134.13 133.59 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.66 137.32 32.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.361 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -136.28 149.18 67.14 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 124.319 1.048 . . . . 0.0 109.135 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -79.37 -174.02 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.821 3.014 . . . . 0.0 114.428 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.46 162.03 20.07 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 119.837 -1.789 . . . . 0.0 112.928 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.27 16.13 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 126.997 2.119 . . . . 0.0 111.773 -171.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.75 10.26 0.79 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.764 2.126 . . . . 0.0 112.329 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.9 ttt85 -81.12 130.12 34.88 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.314 1.057 . . . . 0.0 108.678 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.8 151.23 37.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.25 165.77 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.768 1.227 . . . . 0.0 109.443 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.464 ' C ' ' H ' ' A' ' 50' ' ' GLY . 53.6 mtpt -118.56 170.34 9.03 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.132 1.373 . . . . 0.0 107.599 176.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -62.82 15.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -169.36 86.62 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 166.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.54 128.58 25.47 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.96 1.704 . . . . 0.0 107.534 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 t -72.01 38.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 127.56 2.344 . . . . 0.0 111.627 -174.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 m -83.86 28.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 118.421 -2.674 . . . . 0.0 112.786 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -167.72 66.54 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.41 1.004 . . . . 0.0 108.915 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.5 m -58.16 148.83 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.058 -1.026 . . . . 0.0 110.176 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.9 mt -122.37 109.03 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 124.37 34.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 36' ' ' VAL . 80.4 p -102.47 -179.91 4.11 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.361 1.077 . . . . 0.0 109.532 171.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -48.32 -33.59 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.519 -1.673 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -148.19 5.67 0.75 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.92 170.41 9.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.627 1.558 . . . . 0.0 108.747 171.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.39 149.2 38.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 149.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.52 88.69 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -39.8 120.36 1.11 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 128.408 2.683 . . . . 0.0 107.999 161.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.43 136.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -113.39 98.73 7.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.416 0.686 . . . . 0.0 109.798 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -33.42 124.29 0.45 Allowed Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 124.765 1.29 . . . . 0.0 112.065 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.34 -23.96 11.19 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.653 1.568 . . . . 0.0 114.358 -157.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -141.36 156.98 45.77 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 127.505 2.322 . . . . 0.0 107.047 -174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.6 m -74.23 138.43 43.68 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.316 1.417 . . . . 0.0 110.347 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.0 36.57 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.669 0.652 . . . . 0.0 111.803 -165.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -138.43 136.7 36.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.409 -1.054 . . . . 0.0 109.458 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.1 mm -65.3 146.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 108.941 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.39 4.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 110.909 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -162.25 151.1 15.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.26 158.57 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.315 1.046 . . . . 0.0 108.46 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.72 76.78 1.41 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -57.91 -11.73 2.62 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.639 -0.663 . . . . 0.0 112.218 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -51.21 -31.55 20.87 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 111.699 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.16 -9.05 59.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.257 1.023 . . . . 0.0 110.514 -173.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.0 -30.41 70.52 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.41 1.084 . . . . 0.0 111.424 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.7 p -118.98 -20.36 8.14 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.732 0.813 . . . . 0.0 112.42 -171.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -136.85 67.14 56.99 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.759 2.023 . . . . 0.0 108.721 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.71 -26.17 60.94 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.345 2.697 . . . . 0.0 110.03 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.64 -15.66 53.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.332 1.053 . . . . 0.0 112.382 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -16.46 64.04 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.312 -1.493 . . . . 0.0 111.929 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.7 mt -64.28 -28.89 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.978 0.808 . . . . 0.0 109.832 169.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -71.44 -55.19 8.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.083 -1.636 . . . . 0.0 108.972 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.01 -43.1 99.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.429 -169.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.33 87.14 2.95 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-O 119.178 -0.439 . . . . 0.0 110.234 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.1 -11.28 29.17 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.095 1.863 . . . . 0.0 112.737 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.516 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -125.98 8.42 7.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.407 1.483 . . . . 0.0 112.201 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -124.19 -71.15 0.22 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 124.397 0.998 . . . . 0.0 111.474 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.2 -25.36 7.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.341 1.056 . . . . 0.0 110.611 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.03 35.59 1.47 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.057 1.789 . . . . 0.0 112.865 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -64.98 159.29 23.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.214 1.507 . . . . 0.0 108.626 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 mt -99.32 -66.91 0.87 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -146.27 171.98 14.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.202 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -135.14 145.62 48.0 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 124.323 1.049 . . . . 0.0 109.392 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.6 ptm -149.07 140.11 22.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.029 -172.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.78 143.89 57.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.492 1.117 . . . . 0.0 109.412 172.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.9 pt -90.4 109.03 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 123.928 0.767 . . . . 0.0 109.139 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -67.38 -35.55 79.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.166 0.439 . . . . 0.0 110.558 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -135.42 70.73 1.43 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -156.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.537 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -57.65 -17.62 15.75 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 172.651 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.46 -21.95 74.04 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.696 1.589 . . . . 0.0 113.294 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -72.43 -12.75 61.24 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 119.235 1.517 . . . . 0.0 111.338 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 105' ' ' GLU . 0.6 OUTLIER -56.09 -36.13 67.79 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.881 173.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.23 -7.83 49.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.097 0.862 . . . . 0.0 112.34 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.96 -19.06 41.41 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.705 1.202 . . . . 0.0 109.983 172.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.95 161.32 23.1 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 123.32 1.534 . . . . 0.0 109.87 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.91 140.69 43.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.941 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.24 167.72 2.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 163.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.24 -47.02 78.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.544 1.537 . . . . 0.0 110.777 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -61.91 -50.8 70.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.84 -32.16 72.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.144 0.578 . . . . 0.0 110.2 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.73 -44.93 96.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.978 0.911 . . . . 0.0 111.26 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.32 -46.8 72.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.61 0.641 . . . . 0.0 109.992 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -53.65 -43.78 69.08 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.747 1.219 . . . . 0.0 111.141 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -58.02 -48.53 79.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.462 1.105 . . . . 0.0 111.339 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 61.4 m -70.17 -24.33 63.13 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.708 -0.62 . . . . 0.0 112.239 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.91 -31.59 63.16 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.613 0.642 . . . . 0.0 111.874 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -63.04 -10.74 15.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.249 1.42 . . . . 0.0 112.82 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 117.009 -1.472 . . . . 0.0 110.975 -175.798 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm 27.91 80.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.35 2.26 . . . . 0.0 114.628 151.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 tpp -137.24 145.71 43.9 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.658 1.183 . . . . 0.0 108.015 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -133.98 69.96 1.46 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.866 0.841 . . . . 0.0 109.204 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -80.87 175.59 10.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.895 171.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -137.57 169.08 18.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.741 2.417 . . . . 0.0 108.921 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -107.36 174.03 6.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.425 1.49 . . . . 0.0 108.955 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HE3' ' CZ ' ' A' ' 120' ' ' PHE . 8.3 mtpt -77.22 -32.37 55.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.804 174.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -88.94 29.21 1.06 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.323 1.849 . . . . 0.0 113.229 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.02 41.89 3.49 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.224 -1.548 . . . . 0.0 112.59 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -124.8 150.29 46.5 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.445 1.098 . . . . 0.0 109.794 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 67.4 p-90 -105.08 172.54 6.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.863 0.839 . . . . 0.0 111.114 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.09 152.74 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.651 1.58 . . . . 0.0 107.071 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -143.29 81.47 1.71 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.649 1.179 . . . . 0.0 109.748 175.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 mp -65.99 150.07 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.662 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 3.4 pt-20 -142.71 -65.5 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.333 1.453 . . . . 0.0 108.797 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.429 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 13.3 t70 -126.52 -77.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.118 2.567 . . . . 0.0 108.222 -170.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.75 9.78 2.41 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 128.16 2.584 . . . . 0.0 110.963 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.63 155.68 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.755 1.622 . . . . 0.0 107.051 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -124.67 139.57 53.74 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 125.343 1.457 . . . . 0.0 108.294 165.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.1 m -83.97 143.57 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 t -122.11 143.03 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.54 2.336 . . . . 0.0 109.911 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -154.44 174.22 32.84 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 158.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 pt -74.2 165.12 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 117.837 0.819 . . . . 0.0 108.838 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -90.06 173.28 8.28 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.001 -1.062 . . . . 0.0 113.234 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.422 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -74.36 9.39 1.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 175.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -100.72 0.21 38.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.038 2.135 . . . . 0.0 112.624 167.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.43 -58.62 1.9 Allowed 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.571 -1.331 . . . . 0.0 110.573 -163.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.422 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -41.46 -42.17 2.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.72 2.808 . . . . 0.0 111.997 166.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.63 -52.99 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.394 3.078 . . . . 0.0 110.223 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -72.32 -35.47 68.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.719 -0.613 . . . . 0.0 111.453 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.13 -48.34 73.92 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.586 1.154 . . . . 0.0 110.162 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.79 -158.63 41.14 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.96 128.42 15.92 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.806 2.043 . . . . 0.0 109.147 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 85' ' ' GLU 0.446 6.0 p -123.89 154.88 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.437 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 1.0 OUTLIER -153.43 -31.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.632 -142.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -146.95 150.5 35.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.636 0.653 . . . . 0.0 111.843 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.27 133.02 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.514 1.15 . . . . 0.0 109.902 168.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.02 145.7 51.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.452 170.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.77 151.87 79.56 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 163.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.43 176.14 8.25 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.197 2.598 . . . . 0.0 111.702 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.16 141.88 35.28 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.41 22.06 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 129.024 2.929 . . . . 0.0 115.173 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.37 6.84 0.7 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.091 1.329 . . . . 0.0 113.308 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -79.84 141.86 35.8 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.829 1.815 . . . . 0.0 110.116 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -79.42 149.38 31.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.014 0.825 . . . . 0.0 109.098 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.0 171.0 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 110.062 -176.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 50' ' ' GLY . 1.1 mtmm -116.15 166.01 12.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.227 1.411 . . . . 0.0 110.537 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -64.82 14.82 0.02 OUTLIER 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.063 2.145 . . . . 0.0 116.131 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -163.66 67.07 0.23 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 173.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -134.13 128.07 33.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.84 53.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 127.46 2.304 . . . . 0.0 110.042 -161.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -86.52 9.01 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 120.014 -1.679 . . . . 0.0 113.631 -158.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.35 50.26 0.28 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.879 0.872 . . . . 0.0 110.221 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 148.72 20.46 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.631 -0.668 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 mt -117.92 135.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.11 117.11 29.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.979 1.312 . . . . 0.0 107.925 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -99.18 -165.89 1.29 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.756 0.707 . . . . 0.0 110.679 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -46.75 -38.91 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.731 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.84 55.81 0.2 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.454 1.479 . . . . 0.0 111.559 155.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.79 167.8 16.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.512 -0.742 . . . . 0.0 109.961 165.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.2 151.45 39.11 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 152.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.39 112.9 13.13 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.964 1.706 . . . . 0.0 106.585 160.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -70.78 107.98 4.24 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 170.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -76.0 111.04 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -86.22 116.51 24.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.42 135.15 5.73 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.107 0.963 . . . . 0.0 110.078 169.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.55 -32.38 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.116 1.877 . . . . 0.0 113.845 -161.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.08 166.69 19.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.555 2.342 . . . . 0.0 106.397 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 m -81.46 134.39 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -171.94 44.9 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 120.759 -1.213 . . . . 0.0 111.132 -166.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -121.63 132.61 54.76 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 117.655 -1.164 . . . . 0.0 109.647 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -60.95 140.18 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -147.35 1.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.802 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -148.62 160.65 42.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.685 1.584 . . . . 0.0 109.066 162.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.7 155.69 14.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.369 1.468 . . . . 0.0 108.438 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -108.02 70.96 0.78 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.45 -15.16 15.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 112.477 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -53.28 -29.89 35.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 116.855 -1.545 . . . . 0.0 112.991 166.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.3 mt -57.01 -14.7 3.9 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 121.186 1.812 . . . . 0.0 113.269 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.2 1.818 . . . . 0.0 112.903 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.0 p -124.13 -27.15 3.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.094 1.358 . . . . 0.0 110.858 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.34 64.21 14.19 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 128.042 2.537 . . . . 0.0 110.11 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -73.72 -52.08 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.728 2.952 . . . . 0.0 109.858 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HA ' ' CG1' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -53.64 -17.63 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.179 1.791 . . . . 0.0 110.524 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -30.48 34.96 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.454 1.934 . . . . 0.0 111.518 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -58.6 -25.69 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 121.825 -0.547 . . . . 0.0 110.047 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -64.83 -53.51 45.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.444 -2.035 . . . . 0.0 110.814 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -49.31 70.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.777 . . . . 0.0 110.342 -164.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -148.73 79.62 8.56 Favored Pre-proline 0 N--CA 1.451 -0.393 0 O-C-N 123.899 0.75 . . . . 0.0 110.151 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.57 -17.44 59.97 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.802 1.668 . . . . 0.0 112.444 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 3.6 mp0 -114.75 14.4 17.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.264 0.626 . . . . 0.0 112.592 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.34 -89.95 0.28 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.81 -32.25 35.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 122.94 0.496 . . . . 0.0 111.899 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.41 36.34 2.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.245 0.926 . . . . 0.0 112.698 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -66.42 169.33 7.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.025 1.412 . . . . 0.0 109.452 166.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.88 -59.76 1.77 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.72 168.31 20.49 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.711 -1.243 . . . . 0.0 111.023 -171.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -125.72 155.32 41.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.288 1.035 . . . . 0.0 108.47 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -146.46 143.99 29.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.215 0.606 . . . . 0.0 110.727 -177.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.9 139.04 58.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.651 1.18 . . . . 0.0 108.025 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 pt -88.21 104.72 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 122.578 0.351 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -33.99 70.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.85 0.46 . . . . 0.0 110.391 171.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -147.36 103.39 3.56 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 125.931 1.692 . . . . 0.0 107.216 -171.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.501 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -71.46 -1.95 14.98 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.807 1.243 . . . . 0.0 109.712 160.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.1 -64.46 4.32 Favored Glycine 0 C--N 1.338 0.653 0 O-C-N 120.789 -1.194 . . . . 0.0 111.959 168.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -71.4 -10.04 59.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -164.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.501 ' CD1' ' HA ' ' A' ' 105' ' ' GLU . 1.1 mp -46.48 -48.33 19.14 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.29 1.436 . . . . 0.0 110.455 163.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -75.82 -15.24 60.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.668 0.667 . . . . 0.0 111.024 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -86.66 -18.01 32.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.121 1.368 . . . . 0.0 110.943 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mt -80.32 -178.78 6.79 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.233 2.213 . . . . 0.0 110.975 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.3 mt -87.78 121.05 29.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.165 0.986 . . . . 0.0 110.249 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.99 166.8 15.07 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.112 0.965 . . . . 0.0 110.786 163.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.57 -57.72 4.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.184 1.794 . . . . 0.0 112.091 -160.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -50.21 -46.61 54.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.512 1.525 . . . . 0.0 110.01 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.58 -25.21 41.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.943 1.297 . . . . 0.0 111.901 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.91 -40.6 91.64 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 127.778 2.431 . . . . 0.0 109.844 167.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.42 -52.2 59.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -43.26 -46.7 6.32 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.083 1.353 . . . . 0.0 111.066 171.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.523 ' CZ ' ' HE3' ' A' ' 8' ' ' LYS . 9.0 t80 -51.17 -36.54 41.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.381 1.472 . . . . 0.0 112.8 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.09 -21.51 50.37 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.382 1.473 . . . . 0.0 113.844 -177.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.58 -43.27 23.29 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 166.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -73.85 26.64 0.07 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.428 2.291 . . . . 0.0 110.734 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.911 2.085 . . . . 0.0 107.929 -178.838 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt 42.83 100.0 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.963 2.505 . . . . 0.0 116.378 166.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ptp -150.68 168.82 23.21 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.804 1.641 . . . . 0.0 112.53 -165.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -142.78 114.82 8.27 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.519 1.128 . . . . 0.0 111.453 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -113.0 179.77 3.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.82 161.56 37.26 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.367 1.867 . . . . 0.0 110.194 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -125.62 173.38 9.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.437 1.113 . . . . 0.0 110.182 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 120' ' ' PHE . 6.1 mmmt -89.91 17.01 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.898 1.679 . . . . 0.0 110.849 -169.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -135.53 57.72 1.78 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.5 p80 44.42 52.77 7.27 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.807 1.643 . . . . 0.0 112.984 172.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -128.99 149.96 50.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.412 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 54.5 p-90 -121.35 162.53 20.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.648 1.579 . . . . 0.0 110.19 170.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.8 t -141.77 126.15 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.477 1.511 . . . . 0.0 107.995 -166.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -117.01 75.47 0.97 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.7 2.4 . . . . 0.0 110.004 -170.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 mp -74.0 97.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.108 1.363 . . . . 0.0 108.485 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.05 -56.02 3.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 118.112 -0.946 . . . . 0.0 111.541 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.16 -76.15 0.45 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.41 0.55 . . . . 0.0 110.173 -166.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -125.52 2.95 7.64 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.834 1.254 . . . . 0.0 111.086 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.25 143.14 41.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.62 109.05 16.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.174 1.789 . . . . 0.0 108.971 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.0 m -68.76 143.75 54.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.32 152.44 16.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 127.647 2.379 . . . . 0.0 112.512 176.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.18 161.09 32.25 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 160.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 pt -73.52 149.23 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.072 -1.252 . . . . 0.0 108.506 170.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 p -76.41 170.35 16.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.967 0.889 . . . . 0.0 111.657 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -62.63 -33.66 75.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.885 -1.134 . . . . 0.0 112.794 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -58.92 -25.7 63.69 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.264 -0.898 . . . . 0.0 112.056 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.27 -47.63 41.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.386 -0.822 . . . . 0.0 111.211 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -64.42 -27.79 69.24 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.837 -0.539 . . . . 0.0 110.56 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -63.43 -28.4 69.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.701 1.2 . . . . 0.0 111.47 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.75 -54.67 4.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.843 0.857 . . . . 0.0 111.959 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.81 -43.7 98.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.371 0.532 . . . . 0.0 110.118 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.52 -114.17 4.55 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.57 96.08 0.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.686 1.594 . . . . 0.0 109.057 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG13 ' H ' ' A' ' 36' ' ' VAL . 3.4 t -78.62 -178.77 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 162.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.539 ' H ' HG13 ' A' ' 35' ' ' VAL . 2.8 p -169.2 -33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 126.431 1.892 . . . . 0.0 108.487 -146.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -166.44 157.61 12.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.222 0.951 . . . . 0.0 111.008 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -138.15 146.93 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.86 148.11 22.71 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.176 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -137.72 142.98 38.52 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 123.897 0.879 . . . . 0.0 111.161 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.37 175.44 10.75 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.029 2.486 . . . . 0.0 111.077 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -87.85 147.67 25.01 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.348 0.659 . . . . 0.0 110.107 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.77 16.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 129.816 3.246 . . . . 0.0 116.436 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.72 6.32 0.87 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.655 1.598 . . . . 0.0 113.222 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -76.55 135.97 39.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.878 1.339 . . . . 0.0 110.487 -171.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -78.11 143.04 37.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.344 1.429 . . . . 0.0 108.902 167.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.07 -177.08 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.795 1.238 . . . . 0.0 108.645 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 50' ' ' GLY . 5.6 mtpm? -131.55 160.75 34.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.062 1.345 . . . . 0.0 108.547 -174.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 10.28 0.23 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -162.64 102.61 0.21 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 105.472 -3.051 . . . . 0.0 105.472 160.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.88 131.71 14.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.992 1.717 . . . . 0.0 107.097 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.1 t -69.92 16.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.805 2.042 . . . . 0.0 114.33 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.38 -0.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 119.317 -2.114 . . . . 0.0 115.528 -163.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -142.51 60.08 1.44 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.677 1.126 . . . . 0.0 108.375 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 m -56.74 163.04 2.03 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.597 1.189 . . . . 0.0 111.346 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.8 mt -132.85 144.77 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -122.27 165.86 15.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -139.62 -177.49 4.98 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.9 m -51.45 -23.83 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 125.504 1.522 . . . . 0.0 112.118 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.53 13.58 0.23 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.39 168.78 19.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.79 1.632 . . . . 0.0 110.04 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.78 164.94 27.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.205 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.65 118.44 5.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.77 1.228 . . . . 0.0 110.031 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.86 117.21 9.45 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.59 121.63 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.535 1.516 . . . . 0.0 106.976 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -88.98 111.16 21.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.692 0.678 . . . . 0.0 109.533 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.32 156.64 0.23 Allowed Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 128.078 2.551 . . . . 0.0 114.528 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -96.62 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 116.157 1.56 . . . . 0.0 116.157 -163.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -136.41 169.73 17.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.577 1.551 . . . . 0.0 107.606 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 m -101.26 65.56 1.07 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.839 1.256 . . . . 0.0 111.761 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.63 -165.84 12.54 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.199 1.857 . . . . 0.0 111.774 -164.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -119.17 123.69 44.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 118.1 0.95 . . . . 0.0 110.81 -176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 mm -59.77 142.01 15.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.3 m -146.75 -5.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.43 163.68 39.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.658 1.117 . . . . 0.0 108.792 169.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 m -149.83 144.18 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -95.12 81.2 3.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.76 1.618 . . . . 0.0 108.846 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.78 -11.52 27.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -26.79 65.91 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.375 1.07 . . . . 0.0 111.812 169.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -8.69 58.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.535 1.061 . . . . 0.0 109.941 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -80.09 -4.87 54.62 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 112.269 170.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -137.75 -25.07 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.595 0.758 . . . . 0.0 112.589 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.81 67.44 42.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.905 2.082 . . . . 0.0 109.512 168.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.81 -20.15 58.72 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.203 2.602 . . . . 0.0 111.186 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.97 -16.12 48.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.911 -1.042 . . . . 0.0 111.935 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 5.3 mt -60.88 -20.63 62.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.972 1.715 . . . . 0.0 113.414 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.3 mt -59.71 -32.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -66.13 -47.46 74.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 122.654 1.216 . . . . 0.0 110.123 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 15.5 mttt -69.65 -47.37 63.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.604 -1.635 . . . . 0.0 111.425 -165.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.32 83.17 4.18 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 172.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -62.89 -20.64 71.89 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.179 1.253 . . . . 0.0 111.135 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 1.2 mt-10 -112.65 21.53 15.49 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.818 1.247 . . . . 0.0 111.58 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.92 -101.87 0.97 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -86.62 -20.86 27.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.5 0.72 . . . . 0.0 111.308 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.52 37.05 2.03 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-N 120.001 1.273 . . . . 0.0 113.658 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -68.62 157.5 36.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.83 1.252 . . . . 0.0 110.242 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.66 -67.36 0.87 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-O 116.904 -1.522 . . . . 0.0 108.486 176.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -133.49 -176.94 4.32 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.191 2.269 . . . . 0.0 111.762 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -136.87 141.58 42.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -141.71 138.32 32.31 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.278 0.631 . . . . 0.0 109.494 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -62.51 126.11 26.23 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.695 1.998 . . . . 0.0 106.243 168.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.9 pt -75.78 135.81 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.7 m -117.26 -11.12 10.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.017 1.727 . . . . 0.0 113.421 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -145.23 81.37 1.63 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -6.33 44.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.517 -1.364 . . . . 0.0 112.365 -177.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.51 66.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.02 -7.02 14.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.83 -42.1 98.62 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.209 0.913 . . . . 0.0 109.023 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -71.86 -0.2 10.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.398 0.679 . . . . 0.0 111.32 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -85.69 -19.15 31.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.87 0.759 . . . . 0.0 111.497 168.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.41 174.59 8.43 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.174 1.79 . . . . 0.0 111.413 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.46 142.97 38.89 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.418 1.087 . . . . 0.0 110.158 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.484 ' HB2' ' H ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -59.81 170.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 109.086 158.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -68.47 -51.36 44.37 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.046 -1.033 . . . . 0.0 110.187 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.37 -47.8 84.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.484 ' H ' ' HB2' ' A' ' 113' ' ' ASP . . . -63.96 -30.31 71.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.68 0.673 . . . . 0.0 112.09 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -67.29 -40.94 86.16 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.402 0.547 . . . . 0.0 110.956 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.64 -53.07 60.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.244 169.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -68.66 -24.66 64.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.176 1.353 . . . . 0.0 109.948 -172.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 8' ' ' LYS . 32.4 t80 -63.02 -29.75 71.07 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.996 -1.065 . . . . 0.0 111.698 171.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -31.66 72.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 118.425 0.557 . . . . 0.0 110.778 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.07 -18.71 65.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.224 0.609 . . . . 0.0 111.856 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -97.28 -0.03 47.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.238 2.215 . . . . 0.0 111.803 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.251 1.155 0 O-C-N 120.227 -1.546 . . . . 0.0 110.01 -178.105 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.66 119.4 5.24 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.536 0.734 . . . . 0.0 111.497 -175.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ttp -131.8 145.54 51.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.704 1.202 . . . . 0.0 108.489 -173.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -140.71 100.24 3.8 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.76 179.3 4.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -143.54 174.98 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.686 1.594 . . . . 0.0 108.669 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.8 p -133.82 -165.14 1.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.129 0.966 . . . . 0.0 112.624 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -30.96 42.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.631 2.372 . . . . 0.0 111.135 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.13 30.21 0.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.249 -0.907 . . . . 0.0 111.502 -167.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 p80 45.33 27.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.121 1.769 . . . . 0.0 115.026 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.9 mt-10 -82.8 165.34 19.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.744 3.218 . . . . 0.0 112.628 160.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.488 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 61.2 p-90 -124.46 170.09 11.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.218 2.207 . . . . 0.0 109.014 163.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.12 142.39 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.59 88.33 2.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.479 1.112 . . . . 0.0 109.738 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.88 89.48 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -175.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -69.88 0.31 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.28 -98.32 0.39 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -122.23 11.01 10.06 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.235 1.414 . . . . 0.0 110.79 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.72 119.71 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.4 124.53 36.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 m -76.63 128.44 34.71 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 162.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.57 134.81 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 108.016 167.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.12 172.01 27.67 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 162.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 6.1 pt -88.6 148.92 4.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 118.586 1.193 . . . . 0.0 109.367 169.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.1 p -77.04 169.6 18.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.062 0.945 . . . . 0.0 110.954 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.85 63.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.169 0.988 . . . . 0.0 111.883 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -59.33 -18.5 38.63 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.356 -0.84 . . . . 0.0 113.149 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.33 -51.0 7.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.997 -1.065 . . . . 0.0 111.189 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -60.89 -21.48 63.36 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.668 0.667 . . . . 0.0 111.574 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.13 -16.12 40.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.866 2.066 . . . . 0.0 113.731 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -112.22 -51.3 2.85 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.737 0.699 . . . . 0.0 110.022 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mt -65.01 -36.32 84.03 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.59 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.88 -125.45 27.87 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 125.339 1.447 . . . . 0.0 110.002 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.69 113.13 3.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.579 HG13 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -87.63 -164.0 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.579 ' H ' HG13 ' A' ' 35' ' ' VAL . 2.2 p -173.19 -38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.22 1.808 . . . . 0.0 107.124 -153.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -154.21 152.55 30.49 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 123.561 0.538 . . . . 0.0 111.524 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.6 t -139.17 128.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -72.63 134.72 45.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.921 166.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.7 mt -128.88 138.7 33.73 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.08 179.18 6.01 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.387 2.725 . . . . 0.0 113.772 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.48 166.78 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.137 0.975 . . . . 0.0 110.119 169.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.62 21.38 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 124.484 2.088 . . . . 0.0 112.786 -162.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.57 10.86 0.52 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 129.269 3.318 . . . . 0.0 111.315 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -76.95 132.45 39.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.085 -1.244 . . . . 0.0 108.238 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -86.35 145.24 26.97 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.67 164.22 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.563 1.545 . . . . 0.0 110.061 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' H ' ' HB2' ' A' ' 51' ' ' GLU . 59.3 mtmt -116.56 170.19 8.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.116 1.766 . . . . 0.0 108.401 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.72 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.023 2.929 . . . . 0.0 117.96 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.54 35.8 0.43 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.512 165.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -86.04 115.71 23.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.949 1.874 . . . . 0.0 109.683 -173.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.416 0.2 OUTLIER -63.43 25.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 129.962 3.305 . . . . 0.0 115.609 -175.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.92 13.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 118.573 -2.58 . . . . 0.0 116.133 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.36 43.93 0.61 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 120.517 1.508 . . . . 0.0 111.163 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -46.82 145.07 2.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.875 1.27 . . . . 0.0 112.223 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.3 mt -126.98 104.9 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -173.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.88 131.96 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -104.91 -173.7 2.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.893 0.877 . . . . 0.0 109.936 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 m -47.87 -27.82 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.62 15.45 0.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.54 -179.28 5.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.561 1.528 . . . . 0.0 110.504 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.11 137.61 27.64 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.53 107.38 7.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.882 1.673 . . . . 0.0 108.683 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.64 144.0 28.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.716 1.206 . . . . 0.0 107.946 170.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.1 t -116.42 113.27 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -106.01 99.06 8.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.277 1.031 . . . . 0.0 110.297 -166.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.76 134.69 2.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 O-C-N 124.58 1.175 . . . . 0.0 111.718 -164.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.1 -24.85 16.69 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.365 1.376 . . . . 0.0 113.409 -165.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mp -142.58 166.86 23.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.193 1.397 . . . . 0.0 108.935 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -89.3 122.9 33.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.723 1.209 . . . . 0.0 108.262 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.15 -161.37 24.03 Favored Glycine 0 C--O 1.235 0.193 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -172.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -132.93 130.3 39.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.298 1.049 . . . . 0.0 109.686 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.9 mm -58.39 151.72 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 108.165 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -167.29 -14.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.192 -165.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.432 ' CD ' ' HZ3' ' A' ' 99' ' ' LYS . 2.2 mt-10 -146.13 153.57 40.82 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 168.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.92 138.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.413 ' HB2' ' CD2' ' A' ' 96' ' ' TRP . 61.4 t30 -87.16 89.52 8.02 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.99 -9.24 9.26 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.708 0.803 . . . . 0.0 111.745 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -62.4 -45.28 93.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.024 1.33 . . . . 0.0 108.825 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.32 -14.6 63.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 120.249 1.386 . . . . 0.0 114.141 -170.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -62.17 -30.67 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.421 1.088 . . . . 0.0 111.529 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.8 p -134.38 -7.96 2.56 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.38 70.46 81.86 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.423 1.089 . . . . 0.0 108.238 159.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.15 -16.11 52.33 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.546 2.83 . . . . 0.0 110.086 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 -19.75 64.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 118.018 -0.992 . . . . 0.0 112.065 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mt -65.4 -17.17 64.33 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 121.025 1.739 . . . . 0.0 112.787 -173.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 mt -64.52 -29.13 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 118.801 -0.619 . . . . 0.0 110.724 169.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -70.29 -53.87 15.03 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 120.814 1.643 . . . . 0.0 109.779 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -60.63 -43.49 97.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.825 1.65 . . . . 0.0 112.063 -171.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.91 74.75 5.04 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 124.39 1.076 . . . . 0.0 108.269 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -55.29 -29.64 68.33 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.822 1.681 . . . . 0.0 111.734 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.488 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 7.6 mp0 -104.62 3.43 31.68 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.358 1.463 . . . . 0.0 112.769 -169.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.89 -86.56 0.57 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -172.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.49 -7.48 38.0 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.751 -0.852 . . . . 0.0 111.848 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.66 25.53 18.42 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.416 1.484 . . . . 0.0 112.344 172.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.413 ' CD2' ' HB2' ' A' ' 77' ' ' ASN . 16.8 p-90 -60.98 159.54 11.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.595 1.198 . . . . 0.0 109.229 166.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.63 -54.07 2.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 109.681 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -148.43 168.15 23.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 42.0 mtpt -128.3 151.5 49.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.6 ptm -143.48 145.86 32.94 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.069 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.52 128.76 37.3 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 160.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt -81.44 136.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.61 -21.56 14.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.76 1.224 . . . . 0.0 111.349 167.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 106' ' ' GLY . 2.0 p30 -138.08 64.35 1.51 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.904 1.335 . . . . 0.0 111.595 -171.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -5.48 0.07 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.486 1.915 . . . . 0.0 112.846 160.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 104' ' ' ASP . . . -92.87 -25.94 18.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.685 1.612 . . . . 0.0 112.065 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.76 -5.54 46.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.614 1.707 . . . . 0.0 111.122 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 74.8 mt -54.09 -21.87 9.57 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.528 0.731 . . . . 0.0 111.261 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.063 1.345 . . . . 0.0 113.188 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.95 -24.31 35.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.284 1.434 . . . . 0.0 110.423 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 mt -85.1 156.18 21.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.363 1.078 . . . . 0.0 108.577 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.404 HD21 ' H ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -75.75 134.6 40.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -176.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.17 179.06 0.32 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 123.442 1.592 . . . . 0.0 110.386 155.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -73.35 -39.89 64.83 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.291 -168.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -67.16 -49.19 65.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.84 69.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.021 1.728 . . . . 0.0 111.421 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -61.83 -38.12 86.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.271 1.028 . . . . 0.0 112.692 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -46.16 48.81 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -48.28 -46.9 36.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.105 1.362 . . . . 0.0 111.265 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -60.82 -43.42 98.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 122.8 0.44 . . . . 0.0 112.027 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.43 -17.42 64.77 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.692 -1.255 . . . . 0.0 112.951 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.52 -20.85 53.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.846 -1.159 . . . . 0.0 112.096 171.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.68 27.78 8.34 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.552 1.541 . . . . 0.0 112.056 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.116 1.766 . . . . 0.0 110.512 -179.523 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.528 0.204 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 tttt 50.85 51.51 16.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.595 2.358 . . . . 0.0 113.889 172.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.9 ttm -137.5 131.57 32.01 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.869 1.267 . . . . 0.0 111.981 -163.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.04 95.76 4.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -170.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -75.49 179.93 4.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 110.399 165.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -142.23 178.5 7.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.25 1.42 . . . . 0.0 110.898 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 p -135.89 174.61 10.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.959 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' H ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -75.32 -35.23 61.25 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.88 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.25 51.71 2.03 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.77 1.623 . . . . 0.0 108.816 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 p80 42.85 52.28 5.13 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.8 -1.187 . . . . 0.0 113.423 165.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.8 mt-10 -114.21 154.37 27.99 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.337 1.455 . . . . 0.0 108.06 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.428 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 54.7 p-90 -108.11 162.41 14.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 157.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -124.88 164.08 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.47 77.02 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.818 1.19 . . . . 0.0 109.508 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 mt -72.37 93.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -71.56 -64.51 0.91 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.95 -86.49 0.42 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.159 0.584 . . . . 0.0 109.809 -169.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -119.47 -2.0 10.62 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.0 2.12 . . . . 0.0 110.073 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -116.25 141.58 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.25 161.7 13.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 162.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.3 m -111.19 148.91 31.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 163.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.92 145.83 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.1 3.36 . . . . 0.0 113.134 169.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.49 169.44 34.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 107.271 -2.331 . . . . 0.0 107.271 155.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 41.7 pt -81.69 157.16 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 O-C-N 121.837 -0.802 . . . . 0.0 109.829 170.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -78.16 166.4 22.8 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.219 0.533 . . . . 0.0 110.428 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -25.66 68.2 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.018 -1.051 . . . . 0.0 111.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -49.37 -47.88 47.27 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.807 -1.183 . . . . 0.0 110.537 165.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.65 -42.93 81.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.445 -1.409 . . . . 0.0 112.393 -170.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -62.43 -23.58 66.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.752 0.251 . . . . 0.0 111.084 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.58 -24.19 67.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.248 2.219 . . . . 0.0 112.035 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -98.37 -41.06 8.0 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.349 -0.844 . . . . 0.0 111.878 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.81 -27.55 28.71 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.753 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.59 -133.64 38.28 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 119.24 0.927 . . . . 0.0 111.28 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -62.4 117.43 6.14 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.682 HG13 ' H ' ' A' ' 36' ' ' VAL . 1.6 t -87.39 -171.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.682 ' H ' HG13 ' A' ' 35' ' ' VAL . 1.4 m -153.92 -35.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 130.485 3.514 . . . . 0.0 108.495 -169.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -155.85 156.61 35.0 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.231 0.469 . . . . 0.0 111.191 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.34 136.79 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.98 144.71 25.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.354 2.262 . . . . 0.0 108.451 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -138.77 154.48 73.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.784 0.834 . . . . 0.0 109.262 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -72.72 -171.23 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.154 2.569 . . . . 0.0 112.647 174.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -107.03 158.26 17.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.77 1.628 . . . . 0.0 110.685 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.52 9.42 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 126.946 2.099 . . . . 0.0 115.238 -165.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.25 11.68 1.81 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.028 1.775 . . . . 0.0 111.917 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -69.35 125.35 26.44 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.334 1.567 . . . . 0.0 108.957 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -76.15 145.6 39.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.7 m -142.39 163.12 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.014 1.326 . . . . 0.0 109.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 50' ' ' GLY . 30.8 mtmt -111.67 169.29 8.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.573 0.349 . . . . 0.0 110.858 168.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -57.55 17.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 1 C-N-CA 131.834 4.053 . . . . 0.0 114.944 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -163.35 23.76 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 120.045 -1.659 . . . . 0.0 114.856 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.63 143.86 32.2 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.254 2.027 . . . . 0.0 111.923 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.3 t -77.65 38.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 129.241 3.016 . . . . 0.0 112.852 -168.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.59 4.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 118.472 -2.643 . . . . 0.0 115.048 -166.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.3 54.82 0.86 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.633 1.106 . . . . 0.0 111.542 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -61.85 165.48 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.194 0.997 . . . . 0.0 112.838 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.66 100.55 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.03 125.89 32.52 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.4 p -103.83 -174.8 2.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.213 1.405 . . . . 0.0 109.853 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 m -50.82 -32.09 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.142 1.377 . . . . 0.0 113.015 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.72 37.7 0.27 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 120.506 1.503 . . . . 0.0 113.289 168.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.03 170.58 19.02 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.44 -1.412 . . . . 0.0 109.832 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.46 122.4 24.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.596 1.558 . . . . 0.0 107.832 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.75 143.49 26.24 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 160.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.58 117.19 34.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.105 -2.924 . . . . 0.0 103.105 167.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.36 119.6 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 169.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.36 97.95 7.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.125 0.875 . . . . 0.0 109.624 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.09 0.46 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.664 1.985 . . . . 0.0 115.198 -157.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.06 -32.57 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 N-CA-C 114.593 0.959 . . . . 0.0 114.593 -159.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -127.58 170.21 12.89 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.293 2.237 . . . . 0.0 104.975 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -86.03 157.56 20.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 157.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.47 -165.7 31.49 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 120.006 -1.684 . . . . 0.0 111.091 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -130.83 125.7 34.35 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.8 mm -63.29 140.07 20.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.1 m -149.63 6.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.858 0.863 . . . . 0.0 111.231 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -159.79 153.91 23.42 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 166.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.86 174.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.226 1.81 . . . . 0.0 108.25 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -118.37 84.06 2.11 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.706 0.685 . . . . 0.0 109.683 -172.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.9 -15.54 9.0 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.093 0.957 . . . . 0.0 112.123 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -54.52 -38.68 66.83 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.755 1.622 . . . . 0.0 111.105 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.866 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -68.96 -18.87 64.14 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.613 -0.679 . . . . 0.0 111.412 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 p -127.6 -16.44 4.79 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -129.59 71.62 82.07 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.182 1.793 . . . . 0.0 107.415 165.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -67.53 -22.75 44.27 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.219 1.946 . . . . 0.0 109.746 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.7 -9.75 58.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.087 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -17.87 63.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 122.5 2.409 . . . . 0.0 111.779 -177.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.5 mt -60.68 -30.52 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.115 0.966 . . . . 0.0 109.654 171.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -69.47 -47.98 62.22 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 120.851 -1.156 . . . . 0.0 109.18 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -29.92 30.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.463 -160.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -160.06 65.06 2.4 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 120.414 1.461 . . . . 0.0 110.601 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.06 -19.6 49.54 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.9 2.4 . . . . 0.0 114.547 -167.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.2 mp0 -115.23 -1.57 12.91 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.849 0.86 . . . . 0.0 112.405 -173.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.64 -84.53 1.67 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -98.55 -26.64 14.35 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.557 1.143 . . . . 0.0 111.956 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.98 40.28 2.65 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.058 0.845 . . . . 0.0 111.594 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -73.78 164.92 26.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.652 1.581 . . . . 0.0 110.448 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.26 -66.5 1.0 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-O 116.468 -1.73 . . . . 0.0 108.845 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -138.04 -177.62 4.9 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.016 -2.273 . . . . 0.0 112.703 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -134.1 154.08 51.41 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 124.123 0.969 . . . . 0.0 109.321 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.72 138.72 21.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.246 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -58.66 126.63 28.41 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 162.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 pt -82.25 96.15 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 172.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -66.42 -29.69 69.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.021 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -143.81 79.84 1.64 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.931 1.348 . . . . 0.0 109.998 -167.3 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.617 ' HA ' ' CD1' ' A' ' 108' ' ' LEU 0.293 0.0 OUTLIER -81.44 26.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 124.582 2.134 . . . . 0.0 111.504 173.9 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 104' ' ' ASP . . . -92.03 -22.07 31.31 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.511 -1.222 . . . . 0.0 114.052 155.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -76.32 -6.96 53.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.181 1.491 . . . . 0.0 112.678 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.617 ' CD1' ' HA ' ' A' ' 105' ' ' GLU . 4.8 mp -61.88 -21.94 65.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.219 1.008 . . . . 0.0 110.955 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.47 -20.42 58.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.111 . . . . 0.0 112.057 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -82.57 -15.88 50.61 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.238 0.926 . . . . 0.0 110.535 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.82 165.74 20.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.975 -1.078 . . . . 0.0 108.364 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.57 125.07 28.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 172.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.86 171.68 7.61 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 152.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.48 -41.99 88.15 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 120.452 -1.405 . . . . 0.0 113.569 -156.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -62.49 -41.51 98.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.332 1.053 . . . . 0.0 110.114 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.72 -32.92 66.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.578 0.751 . . . . 0.0 111.034 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.5 -48.7 80.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 120.957 -1.089 . . . . 0.0 109.015 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.23 -47.92 71.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -51.7 -55.89 16.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.602 1.561 . . . . 0.0 111.805 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -65.12 -36.46 84.34 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.443 0.565 . . . . 0.0 111.282 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.85 -33.73 75.33 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.993 1.317 . . . . 0.0 110.833 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.73 -2.95 32.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.029 1.331 . . . . 0.0 111.767 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -87.23 -2.84 58.92 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.271 0.941 . . . . 0.0 111.729 166.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.242 0.682 0 CA-C-O 116.388 -1.768 . . . . 0.0 108.286 174.64 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtp . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -64.88 95.66 0.16 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.896 1.226 . . . . 0.0 108.646 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.7 ptm -154.93 152.94 30.32 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.467 1.107 . . . . 0.0 109.987 -175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.7 95.88 2.66 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.836 -0.54 . . . . 0.0 110.569 -162.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 109' ' ' GLU . 15.2 mmtm -93.53 174.26 7.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.68 0.792 . . . . 0.0 111.391 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.69 -173.09 2.66 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.772 2.429 . . . . 0.0 109.486 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -138.41 179.54 6.4 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.947 1.299 . . . . 0.0 109.918 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -82.3 7.53 13.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.424 1.089 . . . . 0.0 111.447 167.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -121.93 40.8 3.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.605 1.548 . . . . 0.0 109.909 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 p80 43.27 59.62 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.967 1.707 . . . . 0.0 111.908 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -152.21 133.25 14.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 108.612 -158.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.408 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.2 p-90 -110.62 160.69 16.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.361 1.465 . . . . 0.0 109.514 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 136.37 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.77 77.32 1.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.913 0.885 . . . . 0.0 109.462 -172.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mp -71.47 139.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.7 pt-20 -126.46 -93.58 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.654 1.182 . . . . 0.0 110.101 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 9.1 t0 -83.4 -81.42 0.16 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -131.05 7.93 4.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.699 2.0 . . . . 0.0 110.426 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.77 149.78 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.05 140.83 47.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 159.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.3 m -79.78 137.02 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 153.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.9 t -103.11 136.62 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 128.0 2.52 . . . . 0.0 110.367 167.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.4 173.67 36.21 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.521 -0.737 . . . . 0.0 111.598 161.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.0 pt -86.56 153.99 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 118.073 0.936 . . . . 0.0 110.683 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -84.06 171.91 12.48 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.677 0.791 . . . . 0.0 111.454 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.73 -35.94 71.37 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.408 0.623 . . . . 0.0 111.938 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -54.39 -33.74 59.86 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.734 -1.229 . . . . 0.0 112.279 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.8 -44.0 51.77 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.356 -0.84 . . . . 0.0 112.145 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.13 -25.81 68.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.497 0.59 . . . . 0.0 110.75 176.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.62 -21.09 66.63 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.115 1.366 . . . . 0.0 111.042 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -102.45 -41.58 6.25 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.763 0.711 . . . . 0.0 111.254 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 mt -82.99 -19.75 36.43 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.55 -123.13 29.25 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 119.45 1.023 . . . . 0.0 111.183 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -80.29 33.91 0.3 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.745 2.018 . . . . 0.0 116.212 -151.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -22.19 -115.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 115.121 -2.371 . . . . 0.0 111.428 -131.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 170.93 -47.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 128.455 2.702 . . . . 0.0 110.813 -170.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -169.86 158.85 7.56 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.31 0.381 . . . . 0.0 111.446 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 t -144.09 144.05 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 125.561 1.544 . . . . 0.0 110.711 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.04 139.56 37.51 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.712 2.405 . . . . 0.0 108.984 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -135.79 155.9 77.71 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.973 0.909 . . . . 0.0 110.713 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -84.47 -179.05 3.63 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.374 3.382 . . . . 0.0 114.207 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -84.96 155.76 21.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 163.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.39 18.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 127.086 2.155 . . . . 0.0 113.927 -163.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.42 13.75 0.2 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 127.903 2.668 . . . . 0.0 111.938 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -73.92 135.89 43.31 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.067 -1.255 . . . . 0.0 109.564 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -82.88 139.16 33.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.03 175.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.238 1.415 . . . . 0.0 110.453 -174.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -118.66 169.67 9.62 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.417 1.487 . . . . 0.0 109.48 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 107' ' ' GLU . 24.9 tttt -62.99 14.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.27 2.228 . . . . 0.0 114.915 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.0 78.2 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.52 116.58 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -169.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.6 71.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 128.005 2.522 . . . . 0.0 108.835 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.51 6.42 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.502 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.24 59.8 0.9 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.551 1.069 . . . . 0.0 112.438 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 m -59.85 160.61 7.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.763 1.268 . . . . 0.0 111.324 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mt -134.27 105.73 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.7 166.19 23.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 163.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.9 p -140.8 177.78 7.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.487 1.494 . . . . 0.0 107.89 164.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -49.04 -19.58 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 128.055 2.542 . . . . 0.0 115.978 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -160.65 41.6 0.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.934 1.697 . . . . 0.0 114.164 155.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -154.37 -172.32 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.216 -0.928 . . . . 0.0 109.188 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.91 14.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.994 0.918 . . . . 0.0 108.771 159.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.75 131.96 32.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 143.62 37.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 164.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.54 114.18 46.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.44 107.03 18.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -170.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.62 125.39 0.94 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.038 1.335 . . . . 0.0 113.551 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.9 -21.86 24.04 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.218 2.612 . . . . 0.0 115.187 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -134.93 149.02 50.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 129.501 3.12 . . . . 0.0 108.644 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -66.49 149.72 50.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 158.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.67 -165.97 36.5 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -130.67 134.86 47.29 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.36 0.664 . . . . 0.0 109.43 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.22 143.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.93 1.292 . . . . 0.0 108.861 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.59 -8.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -153.18 150.52 29.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.588 1.54 . . . . 0.0 108.342 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.26 168.01 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.818 1.19 . . . . 0.0 110.21 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 79' ' ' LYS . 51.6 t30 -119.86 73.98 1.0 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.72 -1.04 0.33 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.05 -0.407 . . . . 0.0 112.077 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 77' ' ' ASN . 14.3 mmmm -54.92 -43.77 73.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.128 -1.415 . . . . 0.0 110.2 162.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.37 -9.81 50.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.639 1.563 . . . . 0.0 113.774 -177.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.8 -24.28 65.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.476 1.035 . . . . 0.0 111.636 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.2 p -129.18 -19.29 3.54 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.577 -0.702 . . . . 0.0 112.548 -172.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -122.03 59.86 11.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.351 2.66 . . . . 0.0 108.788 166.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.82 -19.04 47.32 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.691 1.594 . . . . 0.0 109.601 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.23 -11.54 59.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.464 1.906 . . . . 0.0 112.094 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -27.83 68.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 119.454 -2.029 . . . . 0.0 111.519 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.75 -19.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.157 0.583 . . . . 0.0 109.932 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -65.0 -56.02 15.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.3 1.048 . . . . 0.0 109.696 165.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -63.05 -53.89 46.73 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.067 2.547 . . . . 0.0 108.791 -162.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 85.79 5.5 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -59.11 -22.04 62.24 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.512 2.141 . . . . 0.0 112.455 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -127.41 9.01 6.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 127.858 2.463 . . . . 0.0 110.764 -163.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.33 -80.26 0.87 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 126.277 1.894 . . . . 0.0 109.716 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -93.6 -25.25 17.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.18 31.88 4.9 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.649 1.119 . . . . 0.0 113.367 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.544 ' CZ3' ' HE3' ' A' ' 99' ' ' LYS . 34.4 p-90 -70.06 159.4 33.91 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.89 -46.66 3.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.5 1.046 . . . . 0.0 109.136 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -154.33 171.02 19.95 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.339 -0.851 . . . . 0.0 111.378 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.544 ' HE3' ' CZ3' ' A' ' 96' ' ' TRP . 77.1 mttt -131.59 152.49 50.76 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.504 1.522 . . . . 0.0 108.1 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.0 ptm -154.8 148.3 25.2 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.202 -175.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -65.67 133.35 50.91 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.1 pt -79.23 103.41 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -73.77 -17.41 61.1 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.808 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -144.15 79.29 1.61 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.191 1.397 . . . . 0.0 107.364 -164.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.55 -10.46 55.91 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.767 -1.208 . . . . 0.0 113.298 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -81.97 -4.85 90.15 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.72 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.465 ' HB3' ' HE3' ' A' ' 49' ' ' LYS . 49.0 mt-10 -81.38 -36.55 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.87 1.335 . . . . 0.0 112.169 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -35.41 80.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.656 1.116 . . . . 0.0 112.193 -170.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.437 ' HA ' ' HE2' ' A' ' 5' ' ' LYS . 17.6 mm-40 -62.51 -20.37 64.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -87.26 -11.0 50.94 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.588 0.755 . . . . 0.0 112.589 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.5 mt -75.04 -179.1 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.539 1.136 . . . . 0.0 110.252 167.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.9 mt -88.33 131.96 34.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.733 0.813 . . . . 0.0 109.996 -170.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.84 171.74 1.55 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.263 1.425 . . . . 0.0 109.846 163.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.74 -51.53 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.286 1.035 . . . . 0.0 111.151 -175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -56.7 -47.47 79.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.024 0.53 . . . . 0.0 109.776 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.48 67.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.332 0.653 . . . . 0.0 112.098 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -79.72 -43.35 22.81 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.656 0.662 . . . . 0.0 111.631 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 109.579 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -45.75 -49.13 15.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -68.36 -24.96 64.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.287 1.035 . . . . 0.0 112.061 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.6 m -87.38 -3.32 59.02 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.665 1.186 . . . . 0.0 112.738 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -112.75 3.24 16.39 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.35 1.46 . . . . 0.0 111.332 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.76 18.54 13.34 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.677 1.591 . . . . 0.0 110.73 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.203 1.401 . . . . 0.0 110.16 -166.274 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 ttm . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -169.02 127.75 1.03 Allowed 'General case' 0 C--O 1.231 0.121 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -167.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ttp -162.54 153.46 17.35 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.318 1.447 . . . . 0.0 107.973 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.27 101.73 3.75 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.442 -0.786 . . . . 0.0 109.763 -171.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -112.77 -178.6 3.43 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.97 153.49 43.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.373 1.069 . . . . 0.0 112.061 -167.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -101.33 171.39 7.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 123.306 1.527 . . . . 0.0 110.346 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HE3' ' CZ ' ' A' ' 120' ' ' PHE . 9.4 mtpt -83.59 -1.01 52.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.989 170.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 p -120.65 44.25 2.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.129 1.772 . . . . 0.0 109.376 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.2 p80 43.96 61.11 2.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 113.807 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -134.86 152.18 51.53 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.299 1.84 . . . . 0.0 109.155 171.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 64.0 p-90 -109.81 172.66 6.72 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.947 1.299 . . . . 0.0 109.373 169.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.1 134.45 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -116.43 84.92 2.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mp -75.67 118.07 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -106.33 -120.82 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 167.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.61 -60.49 2.29 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.849 1.204 . . . . 0.0 110.666 -167.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.1 7.53 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.973 0.909 . . . . 0.0 111.523 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.4 t -130.38 140.79 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -110.33 134.22 52.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 163.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -77.15 142.05 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 158.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.72 139.86 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.083 1.353 . . . . 0.0 109.559 166.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.29 161.4 28.75 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 161.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.06 159.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -79.6 -172.31 3.22 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.493 -0.755 . . . . 0.0 111.726 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.04 19.74 13.48 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.896 2.478 . . . . 0.0 112.549 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -113.48 0.57 14.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 126.009 1.724 . . . . 0.0 113.999 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.288 . . -119.76 -52.26 2.23 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.823 3.249 . . . . 0.0 112.585 -156.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.91 -42.97 1.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.777 2.431 . . . . 0.0 110.178 158.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.28 -25.05 67.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.694 1.598 . . . . 0.0 113.722 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -75.02 -45.31 42.67 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.015 -1.053 . . . . 0.0 109.542 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -72.47 -57.51 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.31 -132.29 11.19 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.15 126.82 28.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 36' ' ' VAL . 3.1 t -97.83 -154.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 169.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.512 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.2 m -174.42 -38.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 129.582 3.153 . . . . 0.0 106.973 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -144.93 145.6 31.62 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.553 0.615 . . . . 0.0 111.27 -176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -128.81 121.07 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 168.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.48 140.79 37.2 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.033 173.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.43 149.09 63.5 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -175.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -71.0 -175.52 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.18 2.587 . . . . 0.0 112.308 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.44 158.98 15.35 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.893 1.677 . . . . 0.0 109.918 162.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.13 19.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 126.378 1.871 . . . . 0.0 115.014 -167.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.33 9.34 0.6 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.627 2.06 . . . . 0.0 112.887 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -73.04 135.82 44.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.723 1.261 . . . . 0.0 109.678 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.01 157.95 18.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.315 1.055 . . . . 0.0 111.665 177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.331 11.1 t -146.22 171.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.29 0 C-N-CA 131.653 3.981 . . . . 0.0 108.852 -162.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 50' ' ' GLY . 64.9 mttm -146.13 166.11 27.12 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.768 4.027 . . . . 0.0 106.338 -171.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -74.73 27.85 0.09 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 48' ' ' LYS . . . -178.85 57.78 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 126.469 1.985 . . . . 0.0 108.372 171.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.01 143.25 45.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 117.583 0.692 . . . . 0.0 110.491 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.1 t -92.72 103.89 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.76 -0.24 8.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 125.919 1.687 . . . . 0.0 109.9 -177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -166.95 66.51 0.09 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.488 1.115 . . . . 0.0 109.432 -163.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -65.23 166.59 9.56 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.515 -1.366 . . . . 0.0 110.963 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.2 mt -143.65 103.78 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 O-C-N 120.145 -1.597 . . . . 0.0 107.612 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.43 117.67 29.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.4 p -97.98 -168.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.187 1.795 . . . . 0.0 110.645 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -52.79 -28.84 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.473 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.11 40.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.393 1.451 . . . . 0.0 113.003 166.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.17 39.46 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 120.78 -1.2 . . . . 0.0 109.721 171.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.34 152.38 31.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.739 1.616 . . . . 0.0 106.7 168.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.73 76.1 1.42 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -33.01 107.49 0.05 OUTLIER 'General case' 0 C--O 1.237 0.439 0 C-N-CA 128.777 2.831 . . . . 0.0 108.928 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.79 120.53 30.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.18 94.77 6.13 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.696 0.398 . . . . 0.0 111.804 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.09 132.74 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.559 0 C-N-CA 125.947 1.699 . . . . 0.0 114.647 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.2 -32.74 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.068 1.845 . . . . 0.0 111.874 -165.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.24 160.93 37.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.235 1.814 . . . . 0.0 108.209 -175.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.14 132.18 46.75 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.226 1.811 . . . . 0.0 107.328 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -172.89 45.88 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.2 131.23 40.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.81 151.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.93 -11.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 124.044 0.937 . . . . 0.0 109.744 -167.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.58 152.07 39.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 163.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.68 152.38 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -99.99 84.66 2.91 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.27 -15.29 23.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.779 0.8 . . . . 0.0 111.859 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -59.56 -22.41 61.67 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.273 1.829 . . . . 0.0 113.24 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.29 -15.55 46.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.271 1.396 . . . . 0.0 112.113 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -62.66 -31.33 72.19 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 165.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.9 -20.36 12.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.113 -0.992 . . . . 0.0 111.9 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.11 74.95 76.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.79 1.236 . . . . 0.0 110.312 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -65.64 -25.55 54.35 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.633 2.222 . . . . 0.0 110.456 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.64 -16.84 64.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.938 0.79 . . . . 0.0 110.99 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -21.62 66.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.911 2.141 . . . . 0.0 112.204 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.0 mt -64.52 -28.78 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.353 0.661 . . . . 0.0 110.289 172.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -67.1 -55.31 14.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.22 -1.55 . . . . 0.0 108.527 167.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -51.13 68.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.25 -160.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.86 76.76 5.88 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.13 0.972 . . . . 0.0 108.427 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.51 -25.16 62.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.016 1.81 . . . . 0.0 113.028 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -116.0 15.09 16.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.064 0.945 . . . . 0.0 110.781 -175.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.4 -65.91 0.34 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.248 1.88 . . . . 0.0 111.289 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -124.86 -23.9 4.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.516 1.158 . . . . 0.0 114.072 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.51 2.65 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 111.879 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -67.59 152.58 45.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -93.63 -59.9 1.89 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -149.31 168.62 22.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.719 1.207 . . . . 0.0 109.857 -172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -132.99 155.11 49.76 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.386 1.474 . . . . 0.0 107.545 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.8 ptm -148.58 144.59 27.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.388 -168.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.56 114.66 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.351 2.26 . . . . 0.0 107.912 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt -71.34 117.59 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.606 0.717 . . . . 0.0 111.472 -170.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -78.06 -25.85 47.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.371 -0.83 . . . . 0.0 112.718 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.08 84.76 1.59 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -8.55 36.27 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 173.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.53 -31.85 8.06 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.748 -1.029 . . . . 0.0 112.872 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.57 -5.47 11.56 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.085 1.443 . . . . 0.0 111.212 170.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.99 -34.57 73.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.45 1.023 . . . . 0.0 110.868 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.69 -20.74 61.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.253 1.421 . . . . 0.0 111.441 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -83.41 -6.08 59.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.886 0.874 . . . . 0.0 111.456 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.08 176.07 5.27 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.643 1.211 . . . . 0.0 111.915 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.97 143.78 41.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.8 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.75 171.98 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.395 162.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -73.9 -34.68 64.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.524 1.93 . . . . 0.0 111.903 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.82 -48.92 33.79 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.22 70.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.445 0.698 . . . . 0.0 110.839 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -53.48 -47.64 69.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.626 1.571 . . . . 0.0 111.884 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.61 -35.72 65.4 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.7 -0.625 . . . . 0.0 110.205 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.53 -46.03 90.04 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.807 . . . . 0.0 110.101 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.429 ' CZ ' ' HE3' ' A' ' 8' ' ' LYS . 31.4 t80 -57.19 -19.25 19.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.596 1.559 . . . . 0.0 112.918 175.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.4 t -87.89 -15.08 37.66 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.71 0.804 . . . . 0.0 112.7 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.5 -50.73 5.63 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.603 1.161 . . . . 0.0 109.08 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.52 45.54 0.68 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.969 0.89 . . . . 0.0 110.725 172.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 167.009 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.6 tpp . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.56 109.55 8.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.575 0.75 . . . . 0.0 110.075 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -104.81 178.09 4.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.046 0.938 . . . . 0.0 110.104 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -144.07 157.35 44.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.509 1.924 . . . . 0.0 108.891 -171.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 p -110.92 177.28 4.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 123.04 1.4 . . . . 0.0 109.463 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -78.64 -9.43 59.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.978 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -109.18 42.0 1.52 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.794 -1.191 . . . . 0.0 109.107 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 p80 44.87 54.47 6.75 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.084 1.353 . . . . 0.0 110.674 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 4.2 tt0 -130.21 145.25 51.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.212 2.205 . . . . 0.0 107.479 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.47 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.2 p-90 -117.87 159.89 22.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.56 1.944 . . . . 0.0 110.21 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.555 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.2 t -128.99 152.74 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.646 1.978 . . . . 0.0 107.468 -173.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.85 84.33 1.84 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 119.766 1.166 . . . . 0.0 112.771 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mp -70.37 132.39 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -120.15 -99.47 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 164.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.25 -88.65 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.911 2.084 . . . . 0.0 110.368 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -127.71 3.88 6.09 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.8 -1.188 . . . . 0.0 113.382 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.71 133.56 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -108.35 110.29 21.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.038 2.135 . . . . 0.0 109.529 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.5 m -75.96 116.51 16.73 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.653 1.181 . . . . 0.0 110.743 171.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.5 OUTLIER -87.99 149.85 3.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 112.415 174.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.98 163.64 31.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 156.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.407 ' CD1' HG21 ' A' ' 87' ' ' ILE . 2.3 pt -82.09 151.42 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.4 1.6 . . . . 0.0 109.511 169.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.3 p -82.05 174.48 11.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.705 1.202 . . . . 0.0 112.828 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.81 -41.81 71.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.2 -0.937 . . . . 0.0 112.3 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -57.85 -21.1 40.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.093 0.86 . . . . 0.0 112.935 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.28 -47.83 9.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.034 -1.041 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -64.18 -21.38 66.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.7 0.682 . . . . 0.0 111.806 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.09 -37.95 81.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.627 1.571 . . . . 0.0 110.888 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -88.21 -35.9 17.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.2 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.7 -70.99 0.47 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.703 1.138 . . . . 0.0 109.824 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.19 -130.25 10.11 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.19 0.9 . . . . 0.0 111.041 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -71.85 34.18 0.06 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.242 3.017 . . . . 0.0 117.029 -159.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 59' ' ' VAL . 14.2 t -21.97 -113.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 114.091 -2.861 . . . . 0.0 113.049 -135.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER 164.38 -41.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 128.924 2.89 . . . . 0.0 110.082 -170.307 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -157.39 164.4 37.56 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.644 0.656 . . . . 0.0 109.721 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -139.12 142.18 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 163.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.79 87.46 3.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.341 1.457 . . . . 0.0 107.218 -177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -90.28 153.1 46.4 Favored Pre-proline 0 C--O 1.234 0.245 0 O-C-N 121.656 -0.652 . . . . 0.0 109.885 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.96 174.7 12.32 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.448 2.099 . . . . 0.0 112.205 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.89 142.11 31.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.13 19.88 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 128.835 2.854 . . . . 0.0 114.839 -172.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.82 17.89 0.65 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.063 1.792 . . . . 0.0 112.501 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -90.18 142.63 27.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.889 1.345 . . . . 0.0 110.319 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.43 144.69 27.84 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.124 1.329 . . . . 0.0 110.669 170.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.44 HG11 HD11 ' A' ' 73' ' ' ILE . 20.3 m -137.17 177.98 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.793 1.237 . . . . 0.0 111.22 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -132.01 166.61 21.32 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.172 1.789 . . . . 0.0 108.821 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -72.94 37.21 0.08 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.076 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.56 76.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.01 120.34 7.86 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.696 1.598 . . . . 0.0 106.8 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.287 0.1 OUTLIER -69.84 33.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 127.716 2.406 . . . . 0.0 113.683 -171.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.17 8.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 118.501 -2.624 . . . . 0.0 114.804 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 48.01 1.77 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 121.063 1.756 . . . . 0.0 111.031 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 161.64 8.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.918 0.866 . . . . 0.0 110.767 -173.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mt -137.78 101.77 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.49 148.97 25.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 164.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -124.2 179.8 4.74 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.391 1.077 . . . . 0.0 110.167 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 35' ' ' VAL . 2.7 m -40.8 -35.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 126.172 1.789 . . . . 0.0 113.379 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -160.97 59.19 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.62 1.554 . . . . 0.0 113.655 156.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.93 -175.57 5.5 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.75 . . . . 0.0 109.48 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.64 166.5 23.41 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.865 1.666 . . . . 0.0 110.635 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.64 127.19 6.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.714 2.006 . . . . 0.0 106.902 167.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.3 118.05 28.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.67 93.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.53 106.88 9.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.655 0.382 . . . . 0.0 111.565 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.39 153.36 0.57 Allowed Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 127.606 2.362 . . . . 0.0 115.615 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -86.11 -41.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.343 1.362 . . . . 0.0 114.866 -162.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -129.93 168.17 17.07 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -76.94 168.95 19.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 156.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.95 -167.38 24.65 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -171.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -135.07 129.48 34.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -169.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.452 HD12 ' CD2' ' A' ' 98' ' ' PHE . 6.0 mm -62.47 141.76 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 107.585 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.79 -1.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 124.383 1.052 . . . . 0.0 112.828 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -151.99 157.08 41.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.583 1.538 . . . . 0.0 106.898 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.7 m -142.56 154.0 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.72 85.16 5.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.588 0.631 . . . . 0.0 110.722 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.23 -9.56 5.19 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -55.09 -46.24 75.46 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.654 -1.279 . . . . 0.0 110.463 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -13.03 60.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.23 1.012 . . . . 0.0 110.069 -168.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.65 -35.2 73.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.415 1.486 . . . . 0.0 110.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -123.59 -22.32 5.02 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.243 1.417 . . . . 0.0 112.854 -167.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -131.18 68.83 82.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 127.426 2.291 . . . . 0.0 107.847 171.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.69 -11.29 28.29 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.39 2.727 . . . . 0.0 111.588 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.65 -3.14 19.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.632 1.573 . . . . 0.0 112.675 171.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 86' ' ' LEU . 1.9 mt -70.37 -22.49 62.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.623 1.556 . . . . 0.0 113.527 -172.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.407 HG21 ' CD1' ' A' ' 24' ' ' ILE . 3.0 mt -65.34 -29.32 46.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.46 -52.03 60.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 120.42 1.464 . . . . 0.0 109.038 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -56.17 -55.59 31.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.727 2.411 . . . . 0.0 110.169 -169.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -151.95 89.7 3.97 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -57.36 -29.49 84.41 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.586 1.524 . . . . 0.0 111.934 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 13.1 mt-10 -122.73 31.21 6.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.624 1.969 . . . . 0.0 108.701 -167.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.38 -74.45 0.07 OUTLIER Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.409 1.481 . . . . 0.0 111.404 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -117.17 -11.3 10.7 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.129 -0.939 . . . . 0.0 113.307 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.84 29.6 1.55 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.449 1.022 . . . . 0.0 113.328 168.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 59.0 p-90 -60.31 149.6 33.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.579 1.189 . . . . 0.0 109.755 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.85 -69.4 0.76 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 116.589 -1.672 . . . . 0.0 106.814 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CD2' HD12 ' A' ' 73' ' ' ILE . 48.4 p90 -134.31 -174.95 3.71 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 122.114 2.234 . . . . 0.0 112.033 -172.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -135.86 153.53 51.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.831 167.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.07 139.15 25.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.847 0.859 . . . . 0.0 109.271 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.38 120.31 12.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 163.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -73.24 152.97 7.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 m -110.12 -31.93 7.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.699 0.8 . . . . 0.0 111.58 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 76.48 1.61 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -160.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -11.46 57.35 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.445 -0.784 . . . . 0.0 111.324 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.01 -15.17 81.22 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.927 -1.108 . . . . 0.0 112.586 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -86.34 -15.95 38.93 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.549 1.175 . . . . 0.0 111.572 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.22 -43.37 98.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.497 1.044 . . . . 0.0 109.543 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -60.65 -24.76 65.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 111.28 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.5 -4.52 58.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.247 1.019 . . . . 0.0 112.45 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.54 -171.95 2.5 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.591 1.956 . . . . 0.0 108.958 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -96.99 135.53 38.86 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.675 1.19 . . . . 0.0 108.215 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.38 179.93 3.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.828 0.823 . . . . 0.0 110.041 163.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.53 -47.53 72.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.612 1.965 . . . . 0.0 111.732 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -74.22 -39.99 62.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.191 0.596 . . . . 0.0 109.419 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.78 76.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.417 0.687 . . . . 0.0 111.262 172.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -70.7 -44.22 67.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.969 0.908 . . . . 0.0 111.187 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.27 -45.57 72.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.125 0.875 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 . . . . . 0 N--CA 1.437 -1.116 0 C-N-CA 123.815 0.846 . . . . 0.0 110.879 176.174 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.496 ' SD ' ' HE3' ' A' ' 5' ' ' LYS . 2.9 ptp . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.54 122.89 8.4 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 120.669 -1.27 . . . . 0.0 109.324 171.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.496 ' HE3' ' SD ' ' A' ' 3' ' ' MET . 22.2 mmtt -114.38 175.44 5.48 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.662 0.602 . . . . 0.0 109.864 168.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -133.36 154.22 50.92 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.654 1.581 . . . . 0.0 109.179 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -91.48 -176.92 4.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 122.226 1.013 . . . . 0.0 108.641 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -101.66 20.48 16.12 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 0.0 110.296 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -127.02 30.1 5.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.402 1.881 . . . . 0.0 110.817 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 59.72 40.69 19.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.801 -1.187 . . . . 0.0 112.193 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 24' ' ' ILE . 20.5 mt-10 -126.24 145.11 50.53 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.45 1.5 . . . . 0.0 107.887 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.418 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.1 p-90 -116.94 162.02 18.43 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.714 1.605 . . . . 0.0 109.534 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.5 t -142.35 100.79 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -167.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -82.15 89.12 6.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.74 -1.225 . . . . 0.0 109.034 173.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.2 mp -74.04 104.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 120.224 1.374 . . . . 0.0 107.595 174.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.3 tp10 -80.9 -138.78 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 167.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.414 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 1.2 t0 -64.69 -61.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.098 -1.001 . . . . 0.0 109.414 -172.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.5 2.21 2.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.031 0.933 . . . . 0.0 113.019 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.3 t -124.28 132.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -100.2 140.0 35.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 169.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -85.15 139.05 31.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 t -113.5 126.22 70.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.654 1.581 . . . . 0.0 107.584 170.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -134.97 168.55 23.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 160.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 87' ' ' ILE . 19.6 pt -85.62 156.57 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.8 p -82.55 179.09 7.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.35 -39.52 94.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.408 -1.433 . . . . 0.0 111.541 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -61.02 -26.48 67.64 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.398 -1.439 . . . . 0.0 111.668 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.434 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -69.79 -56.43 7.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.977 -1.077 . . . . 0.0 110.088 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -55.14 -30.89 60.74 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.662 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.03 -42.43 94.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.381 0.672 . . . . 0.0 110.545 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -79.96 -24.26 41.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 113.202 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.68 -42.05 35.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.747 1.158 . . . . 0.0 110.346 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.9 53.27 Favored Glycine 0 N--CA 1.443 -0.859 0 O-C-N 124.188 0.93 . . . . 0.0 110.939 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.95 122.6 3.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.748 2.019 . . . . 0.0 108.515 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 36' ' ' VAL 0.425 9.8 p -118.47 158.07 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 122.493 1.139 . . . . 0.0 112.387 -177.309 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.584 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -146.85 -26.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 C-N-CA 126.148 1.779 . . . . 0.0 108.974 -150.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -150.53 151.93 33.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 123.741 0.651 . . . . 0.0 111.17 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 56' ' ' ILE . 60.0 t -145.46 127.81 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 136.42 38.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.606 171.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.8 mt -129.88 128.52 22.92 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.2 -178.95 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.44 2.76 . . . . 0.0 112.59 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -80.61 140.88 35.51 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.828 -1.17 . . . . 0.0 108.923 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.0 12.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 128.567 2.747 . . . . 0.0 115.71 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.2 9.16 1.1 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.044 1.783 . . . . 0.0 111.615 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -71.92 137.57 47.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.086 -1.243 . . . . 0.0 110.106 -171.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HG2' ' CG ' ' A' ' 72' ' ' LYS . 10.5 mt-10 -85.35 149.44 25.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.623 -0.673 . . . . 0.0 110.285 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.76 177.35 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.174 0.99 . . . . 0.0 109.527 -172.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -126.25 170.98 11.31 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 125.659 1.584 . . . . 0.0 109.589 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.81 10.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.77 66.74 0.24 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.55 115.81 13.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.06 114.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.476 1.111 . . . . 0.0 108.257 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -146.09 0.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.754 1.222 . . . . 0.0 112.718 -168.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.96 39.63 0.94 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.216 1.006 . . . . 0.0 108.385 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -50.66 165.66 0.1 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.992 1.717 . . . . 0.0 111.538 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.489 HG23 HG22 ' A' ' 38' ' ' VAL . 2.2 mt -139.45 145.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.99 116.6 17.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.936 1.694 . . . . 0.0 107.234 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' HG23 ' A' ' 35' ' ' VAL . 84.5 p -105.6 -167.71 1.36 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.615 1.566 . . . . 0.0 111.02 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 m -44.86 -39.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 114.152 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -165.75 72.57 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 149.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.07 167.24 22.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.8 154.85 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 159.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.26 109.02 4.37 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.255 1.022 . . . . 0.0 109.701 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.2 114.54 4.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.575 1.55 . . . . 0.0 108.371 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.622 HG11 HD13 ' A' ' 97' ' ' LEU . 53.2 t -87.46 104.31 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.33 105.55 17.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.954 0.797 . . . . 0.0 110.341 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.66 142.33 1.07 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.434 1.894 . . . . 0.0 112.876 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.08 -35.32 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.18 1.92 . . . . 0.0 113.259 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -138.84 145.75 40.4 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.958 2.103 . . . . 0.0 107.147 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -64.44 137.86 58.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 167.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.48 -177.91 44.09 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -155.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.42 ' CG ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -129.9 140.62 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 173.202 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.479 HD12 ' CD2' ' A' ' 98' ' ' PHE . 7.1 mm -65.67 145.46 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 174.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.51 -3.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 O-C-N 123.359 0.412 . . . . 0.0 111.753 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.14 151.47 30.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.2 m -141.54 149.6 20.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -99.47 75.8 1.98 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.0 -14.89 2.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -53.01 -34.64 57.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.066 1.347 . . . . 0.0 111.919 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -9.05 41.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 112.024 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.07 -28.68 69.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.786 1.634 . . . . 0.0 112.912 166.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -126.93 -27.55 3.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.947 1.699 . . . . 0.0 110.818 -167.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -125.94 65.03 53.82 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.202 1.801 . . . . 0.0 108.511 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -72.26 -51.62 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.594 2.863 . . . . 0.0 108.654 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -15.65 0.39 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.226 2.21 . . . . 0.0 111.322 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.04 41.23 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 122.632 2.469 . . . . 0.0 110.999 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.533 ' CG2' HD11 ' A' ' 24' ' ' ILE . 70.0 mt -51.33 -30.34 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 120.814 -1.179 . . . . 0.0 110.4 171.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -73.45 -51.73 16.16 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.71 -1.244 . . . . 0.0 111.581 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -70.23 -38.73 75.29 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.098 1.759 . . . . 0.0 110.76 -163.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -156.11 67.58 4.66 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 123.03 0.532 . . . . 0.0 111.332 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.88 -20.99 69.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.53 2.82 . . . . 0.0 113.535 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.418 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 5.1 mt-10 -123.11 20.05 9.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.593 0.757 . . . . 0.0 110.535 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -123.83 -93.0 1.04 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -79.92 -32.14 40.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.264 1.032 . . . . 0.0 112.869 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.35 37.73 2.03 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 120.23 1.377 . . . . 0.0 114.58 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -68.87 165.02 20.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.871 1.835 . . . . 0.0 109.732 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 65' ' ' VAL . 1.7 mt -108.93 -61.37 1.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.479 ' CD2' HD12 ' A' ' 73' ' ' ILE . 43.6 p90 -148.85 172.23 15.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.769 0.827 . . . . 0.0 111.068 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -134.95 152.32 51.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.48 1.512 . . . . 0.0 108.795 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.44 144.82 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.912 0.485 . . . . 0.0 110.68 -166.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.16 128.25 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.266 1.826 . . . . 0.0 107.029 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 pt -86.95 95.86 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.794 0.807 . . . . 0.0 109.987 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 m -81.67 -11.33 59.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.762 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.49 96.51 3.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 171.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -4.98 57.68 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.304 -0.248 . . . . 0.0 110.671 171.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.79 -55.22 9.92 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -18.4 47.0 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 125.822 1.649 . . . . 0.0 113.486 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 111' ' ' LEU . 13.7 mt -44.14 -37.16 2.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.893 1.679 . . . . 0.0 111.48 169.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.24 -13.23 60.42 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.601 0.637 . . . . 0.0 112.265 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.38 -35.22 68.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.299 1.04 . . . . 0.0 109.574 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -71.83 167.88 19.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.327 1.451 . . . . 0.0 108.256 -177.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 mt -77.82 131.59 37.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -55.55 171.64 0.19 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 122.491 1.138 . . . . 0.0 108.647 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.96 -39.45 79.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 111.414 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -64.57 -45.64 86.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.509 -0.745 . . . . 0.0 109.417 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.4 86.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.314 0.646 . . . . 0.0 111.038 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.1 -45.04 96.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.761 1.624 . . . . 0.0 110.832 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -48.16 73.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.972 0.509 . . . . 0.0 110.179 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 CA--C 1.541 0.602 0 O-C-N 122.034 -0.416 . . . . 0.0 111.479 -179.317 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.78 113.54 11.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.271 1.396 . . . . 0.0 110.545 169.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.07 174.34 5.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 167.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.93 179.0 5.41 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.722 2.809 . . . . 0.0 110.958 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -139.53 167.06 22.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.4 1.88 . . . . 0.0 109.214 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.73 -7.87 56.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.24 0.616 . . . . 0.0 112.489 168.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -94.37 19.12 9.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.481 -1.387 . . . . 0.0 112.173 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 58.32 43.94 19.29 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.289 1.836 . . . . 0.0 111.566 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -124.11 149.86 45.72 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.739 -1.226 . . . . 0.0 109.91 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.521 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.1 p-90 -111.55 163.76 13.72 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.3 1.84 . . . . 0.0 109.109 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.53 100.81 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -168.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -85.25 95.17 9.1 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 119.609 1.095 . . . . 0.0 109.441 172.656 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.9 mp -74.43 141.62 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 119.897 1.226 . . . . 0.0 107.834 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.54 -101.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.607 1.163 . . . . 0.0 108.147 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.24 -77.57 0.46 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -126.51 16.72 7.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.49 1.516 . . . . 0.0 111.095 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.84 155.36 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -129.43 136.57 50.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.989 1.316 . . . . 0.0 108.305 166.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.0 m -83.65 138.54 33.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.85 134.54 55.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.691 1.996 . . . . 0.0 108.632 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -147.78 164.62 28.83 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 163.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.542 HD12 ' HB3' ' A' ' 28' ' ' ALA . 8.6 pt -73.77 154.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 O-C-N 122.029 -0.689 . . . . 0.0 109.325 169.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 79.3 p -75.42 166.34 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.334 -0.854 . . . . 0.0 109.802 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.67 -34.43 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.939 -1.101 . . . . 0.0 112.674 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -59.89 -28.09 67.26 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.0 -1.063 . . . . 0.0 111.959 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.542 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -72.71 -57.31 4.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.546 0.738 . . . . 0.0 111.21 174.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -56.59 -27.88 59.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.693 1.133 . . . . 0.0 112.326 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.99 -32.26 61.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.039 1.336 . . . . 0.0 111.047 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -88.92 -46.52 8.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.906 -0.569 . . . . 0.0 109.787 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -34.92 78.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 118.158 -0.925 . . . . 0.0 113.176 -174.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.94 -126.58 41.1 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -169.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.69 34.05 0.33 Allowed 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -145.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 85' ' ' GLU 0.398 2.2 p -23.06 -111.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 115.683 -2.103 . . . . 0.0 112.846 -122.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.4 OUTLIER 166.38 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.112 2.165 . . . . 0.0 109.032 -168.227 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.433 ' H ' HG22 ' A' ' 35' ' ' VAL . 83.3 t80 -161.8 166.68 26.11 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.494 0.717 . . . . 0.0 110.165 -165.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.17 134.34 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.915 1.686 . . . . 0.0 107.757 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.64 143.18 28.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.416 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.11 151.5 70.0 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 123.671 0.789 . . . . 0.0 109.326 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -72.12 174.32 11.55 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.959 1.773 . . . . 0.0 111.396 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -78.64 150.9 32.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.81 17.2 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 127.713 2.405 . . . . 0.0 114.098 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.08 6.44 0.35 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 128.623 3.011 . . . . 0.0 111.922 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -67.18 125.73 26.96 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.019 1.41 . . . . 0.0 108.267 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.62 143.65 40.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 m -144.29 -176.73 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.667 0.787 . . . . 0.0 109.647 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -138.95 167.78 21.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.539 1.536 . . . . 0.0 109.772 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -67.83 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -172.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.9 66.5 0.24 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 161.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.48 123.19 47.93 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.184 1.393 . . . . 0.0 113.083 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 0.1 OUTLIER -65.5 21.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 129.149 2.98 . . . . 0.0 115.113 -174.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -62.84 8.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 119.142 -2.224 . . . . 0.0 116.273 -168.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.68 51.48 1.05 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.026 1.285 . . . . 0.0 110.706 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.19 148.29 36.87 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 123.155 1.455 . . . . 0.0 110.783 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.29 142.56 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -118.88 142.33 47.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 155.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.563 ' HB2' ' HA ' ' A' ' 35' ' ' VAL . 82.6 p -111.51 -173.85 2.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.237 1.381 . . . . 0.0 108.344 155.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -40.65 -37.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.99 1.716 . . . . 0.0 113.174 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.13 0.11 1.03 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 159.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.804 2.093 . . . . 0.0 110.464 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.4 162.56 35.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.097 1.359 . . . . 0.0 108.545 160.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.04 112.28 2.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.733 0.813 . . . . 0.0 109.919 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.56 127.92 33.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.033 1.733 . . . . 0.0 107.989 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.781 HG11 HD13 ' A' ' 97' ' ' LEU . 71.8 t -102.48 109.29 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 120.697 1.589 . . . . 0.0 106.996 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.32 99.47 10.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.465 1.03 . . . . 0.0 112.125 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -35.66 124.84 0.64 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.514 1.925 . . . . 0.0 112.843 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.54 -24.57 10.36 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.694 2.262 . . . . 0.0 114.845 -160.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -133.5 158.64 42.59 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.243 1.817 . . . . 0.0 108.619 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -75.57 153.85 37.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.886 0.85 . . . . 0.0 109.842 165.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.74 -174.54 30.04 Favored Glycine 0 C--O 1.237 0.293 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -160.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.49 141.35 51.68 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.451 HD12 ' CD1' ' A' ' 98' ' ' PHE . 18.7 mm -67.7 146.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 173.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.19 -11.28 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.0 151.6 42.65 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.6 159.99 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.384 1.474 . . . . 0.0 107.177 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.489 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 39.2 t30 -104.43 90.03 3.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -172.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.47 -14.6 30.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.924 1.29 . . . . 0.0 112.585 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HE2' ' OD1' ' A' ' 77' ' ' ASN . 25.4 mtmm -55.96 -42.09 75.7 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.802 1.241 . . . . 0.0 111.787 167.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -21.9 61.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.947 0.794 . . . . 0.0 109.937 -170.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -57.63 -49.51 76.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.634 1.574 . . . . 0.0 109.063 167.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.8 p -82.98 -30.83 27.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.645 0.778 . . . . 0.0 112.364 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -149.86 71.8 9.57 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.2 1.0 . . . . 0.0 109.048 -166.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.504 ' HB2' HG13 ' A' ' 35' ' ' VAL . 1.5 Cg_endo -50.82 -41.54 54.68 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.232 3.288 . . . . 0.0 112.651 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.74 ' HA ' HG12 ' A' ' 35' ' ' VAL . 11.1 pt-20 -65.54 -2.88 3.75 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.664 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -60.66 -22.61 64.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 123.657 2.935 . . . . 0.0 112.169 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -61.02 -23.83 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.292 0.637 . . . . 0.0 109.819 174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -71.77 -58.16 3.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.811 -1.181 . . . . 0.0 109.647 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -53.09 -35.31 59.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 126.397 1.879 . . . . 0.0 111.474 -172.041 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.16 100.43 0.49 Allowed Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 168.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.43 -12.45 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.317 1.345 . . . . 0.0 113.14 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.521 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -118.37 -19.54 8.85 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.662 1.119 . . . . 0.0 113.779 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -77.97 -90.24 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -99.05 -17.17 18.39 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.98 0.912 . . . . 0.0 111.738 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.66 30.94 3.37 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.043 1.306 . . . . 0.0 114.197 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -72.24 164.82 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.293 1.546 . . . . 0.0 110.559 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.781 HD13 HG11 ' A' ' 65' ' ' VAL . 3.9 mt -100.3 -66.93 0.88 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CD1' HD12 ' A' ' 73' ' ' ILE . 38.6 p90 -142.39 172.82 12.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.941 0.897 . . . . 0.0 110.789 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -124.98 154.62 40.94 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.843 0.857 . . . . 0.0 109.47 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.71 142.42 34.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.871 0.869 . . . . 0.0 110.442 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -81.32 113.95 19.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.231 1.812 . . . . 0.0 107.45 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 pt -76.44 103.0 3.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.965 0.906 . . . . 0.0 110.416 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -60.02 -37.78 80.75 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.123 0.569 . . . . 0.0 111.84 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.6 93.45 2.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.06 -12.48 55.65 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.839 0.828 . . . . 0.0 109.95 168.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.45 72.48 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 120.701 -1.249 . . . . 0.0 110.983 173.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -72.55 -7.79 51.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.424 1.112 . . . . 0.0 111.586 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.19 -26.94 66.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.382 1.446 . . . . 0.0 111.384 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -78.39 -29.14 47.12 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 110.38 -167.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.94 -19.22 64.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 129.135 2.974 . . . . 0.0 112.364 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.3 mt -73.2 -170.41 0.77 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.368 1.467 . . . . 0.0 109.673 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.34 132.59 54.29 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.343 -0.848 . . . . 0.0 108.943 -171.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -60.13 165.4 3.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 157.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.21 -46.87 72.55 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -62.8 -33.38 75.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.08 0.4 . . . . 0.0 111.487 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.84 77.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.471 0.708 . . . . 0.0 110.433 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.85 -32.5 73.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.648 -0.657 . . . . 0.0 112.111 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.0 -56.53 17.04 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.728 1.611 . . . . 0.0 108.806 168.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 N--CA 1.452 -0.371 0 C-N-CA 124.548 1.139 . . . . 0.0 110.161 -171.927 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.6 ttp . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -155.21 98.41 1.99 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.164 1.347 . . . . 0.0 113.295 -167.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -95.02 -177.03 4.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.314 0.578 . . . . 0.0 111.865 168.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -138.1 172.99 12.1 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 127.684 2.393 . . . . 0.0 109.867 -170.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.9 p -121.49 173.34 7.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.822 1.649 . . . . 0.0 108.733 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.65 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -78.65 -34.58 46.29 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.36 163.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 p -75.22 23.49 0.11 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.818 1.247 . . . . 0.0 112.541 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.273 0.0 OUTLIER 60.84 52.81 4.08 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 128.076 2.55 . . . . 0.0 112.799 165.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -125.15 140.97 52.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.517 1.927 . . . . 0.0 108.572 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.489 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 63.5 p-90 -94.85 159.83 14.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.13 100.32 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -85.03 85.67 7.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.945 -1.097 . . . . 0.0 109.55 175.154 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.2 mp -69.5 134.95 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 169.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -122.17 -68.76 0.87 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.851 0.46 . . . . 0.0 110.068 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -120.76 -83.95 0.66 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -125.82 12.84 7.93 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.712 1.205 . . . . 0.0 110.57 170.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.8 t -128.58 149.92 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -118.77 140.36 50.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 166.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.8 m -91.57 133.25 35.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 t -110.6 138.58 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.203 1.401 . . . . 0.0 109.946 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.34 169.03 29.01 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.05 2.262 . . . . 0.0 108.207 164.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.55 159.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.934 1.367 . . . . 0.0 110.256 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.0 p -85.18 167.51 15.64 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.297 -0.877 . . . . 0.0 112.683 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.28 -42.36 69.91 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.566 -1.334 . . . . 0.0 112.728 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -57.63 -9.36 1.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.321 1.048 . . . . 0.0 113.145 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.94 -46.79 4.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.553 -1.342 . . . . 0.0 111.53 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -58.94 -26.58 64.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.923 1.238 . . . . 0.0 110.862 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -38.4 75.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.42 1.088 . . . . 0.0 111.516 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -82.61 -19.92 37.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.048 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.68 -31.91 9.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.697 0.681 . . . . 0.0 111.51 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.53 -123.77 29.89 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.09 114.96 4.04 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.3 t -94.61 -170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 160.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.1 p -172.84 -30.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.78 1.232 . . . . 0.0 108.04 -147.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.442 ' H ' HG12 ' A' ' 35' ' ' VAL . 34.5 t80 -153.43 160.37 42.58 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.746 0.654 . . . . 0.0 112.3 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.75 145.88 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 156.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.64 150.21 22.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.993 -1.003 . . . . 0.0 108.749 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -134.68 155.46 79.46 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 120.708 1.595 . . . . 0.0 111.045 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.34 -163.63 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 125.231 3.954 . . . . 0.0 109.563 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -108.66 148.92 29.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.582 1.153 . . . . 0.0 110.972 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.29 11.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 131.47 3.908 . . . . 0.0 117.633 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.62 17.43 0.57 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.556 2.027 . . . . 0.0 112.178 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -79.16 141.31 37.34 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.318 -1.107 . . . . 0.0 108.218 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -82.06 156.01 24.81 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.4 m -139.08 160.74 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.401 1.48 . . . . 0.0 110.236 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -124.09 162.64 23.11 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.106 2.162 . . . . 0.0 107.095 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -74.99 23.33 0.1 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -159.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -152.54 18.44 0.78 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.731 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -78.17 143.31 37.33 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 120.162 1.981 . . . . 0.0 111.218 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.0 106.95 18.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.6 m -133.84 -2.71 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -163.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.07 46.31 0.24 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.427 0.691 . . . . 0.0 110.007 -162.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -51.27 160.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.854 0.862 . . . . 0.0 111.694 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mt -128.45 111.69 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -109.01 130.99 55.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.6 p -112.62 -172.45 2.05 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.95 1.3 . . . . 0.0 110.22 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -48.77 -43.76 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.107 1.363 . . . . 0.0 111.736 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -155.77 88.05 1.1 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.163 1.385 . . . . 0.0 108.989 158.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 177.38 178.61 0.28 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.512 1.925 . . . . 0.0 108.699 161.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.75 147.66 52.32 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.507 1.523 . . . . 0.0 110.818 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.68 99.87 4.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.433 2.293 . . . . 0.0 106.444 170.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.29 121.85 15.26 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -80.79 123.53 37.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -103.62 105.32 15.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.787 0.835 . . . . 0.0 108.849 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -27.09 113.0 0.24 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 128.704 2.801 . . . . 0.0 112.314 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.85 -34.2 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.73 1.62 . . . . 0.0 113.164 -164.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.18 165.65 20.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.486 1.914 . . . . 0.0 107.231 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -67.4 152.23 46.05 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 108.103 155.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.41 -167.59 31.95 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 132.3 23.4 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.66 143.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.83 -3.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.869 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.1 159.81 36.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.062 0.846 . . . . 0.0 109.978 166.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -141.16 152.23 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.913 1.685 . . . . 0.0 107.663 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -98.78 76.21 2.16 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.59 -11.66 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.856 1.662 . . . . 0.0 113.349 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -36.79 68.38 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.663 1.585 . . . . 0.0 112.86 167.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -10.39 59.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.51 1.05 . . . . 0.0 111.761 -165.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -41.81 -55.15 3.14 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 128.098 2.559 . . . . 0.0 111.93 155.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 79.2 p -118.69 -3.98 10.78 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.754 1.222 . . . . 0.0 111.863 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -132.04 56.45 23.63 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.324 1.45 . . . . 0.0 110.879 170.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 -28.42 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.507 2.138 . . . . 0.0 109.407 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.88 -17.41 64.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.529 1.132 . . . . 0.0 111.111 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -61.89 -21.92 65.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 120.619 1.554 . . . . 0.0 111.831 173.669 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.41 -14.8 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 120.167 -1.583 . . . . 0.0 110.538 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -84.86 -55.01 4.3 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 120.022 -1.674 . . . . 0.0 110.556 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 1.9 mmtp -62.98 -31.41 72.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.273 1.029 . . . . 0.0 112.091 -168.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -162.59 77.22 1.97 Allowed Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 123.907 0.883 . . . . 0.0 110.463 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.69 -18.06 45.94 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 113.194 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.489 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 4.2 mt-10 -123.43 11.84 9.33 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.829 0.852 . . . . 0.0 111.465 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.39 -108.4 2.07 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.15 -18.44 63.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.475 0.71 . . . . 0.0 112.644 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.44 27.04 4.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.225 1.393 . . . . 0.0 114.489 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -64.85 165.81 10.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.8 1.8 . . . . 0.0 110.164 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 mt -110.01 -60.91 1.73 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.76 168.83 21.87 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.3 -0.875 . . . . 0.0 110.88 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -123.59 141.68 51.77 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.318 1.447 . . . . 0.0 108.425 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.7 ptm -141.65 140.18 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.842 0.857 . . . . 0.0 110.275 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.27 136.42 40.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 34.3 pt -87.02 117.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 t -83.59 -18.22 38.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.857 167.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -143.12 86.57 1.92 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -157.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . 2.8 tt0 -74.22 -12.17 60.49 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 0.0 111.079 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.03 -57.66 18.11 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -69.43 -1.88 9.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.568 1.147 . . . . 0.0 113.019 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' ' 105' ' ' GLU . 14.9 mt -61.48 -38.44 87.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.312 -0.867 . . . . 0.0 110.115 164.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.59 -5.31 59.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.295 1.438 . . . . 0.0 111.323 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.07 -18.77 60.78 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.427 -0.796 . . . . 0.0 110.132 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.6 mt -87.18 -159.17 0.49 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.04 1.336 . . . . 0.0 112.477 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.9 mt -110.29 135.78 50.49 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.094 2.157 . . . . 0.0 109.761 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.3 172.65 1.84 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 162.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -63.32 -48.05 79.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.861 1.664 . . . . 0.0 110.086 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.28 -40.68 96.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.181 0.992 . . . . 0.0 111.644 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.23 75.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.77 0.828 . . . . 0.0 110.152 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.79 -43.42 69.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.858 0.863 . . . . 0.0 110.419 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 . . . . . 0 N--CA 1.449 -0.522 0 C-N-CA 123.189 0.596 . . . . 0.0 111.042 175.072 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ptm . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -160.07 125.05 3.92 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 121.041 -1.037 . . . . 0.0 109.985 -167.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' A' ' 113' ' ' ASP . 6.6 mmtp -128.12 -177.45 4.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.334 1.054 . . . . 0.0 109.821 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 179.62 6.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.5 1.92 . . . . 0.0 111.042 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -138.4 173.32 11.73 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.711 1.596 . . . . 0.0 111.912 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.473 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -82.02 -2.89 53.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.253 2.221 . . . . 0.0 112.9 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -102.14 48.37 0.88 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 p80 45.54 57.01 5.25 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.431 168.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -132.64 152.73 51.58 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.618 1.167 . . . . 0.0 108.33 -167.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.511 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.1 p-90 -124.43 162.53 23.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.081 0.952 . . . . 0.0 111.699 170.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.81 161.72 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.85 2.46 . . . . 0.0 107.705 172.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.73 94.57 1.9 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.464 1.906 . . . . 0.0 107.469 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.7 mt -98.54 95.03 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -78.11 -49.89 13.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.898 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.07 -71.68 0.68 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.259 0.936 . . . . 0.0 110.128 -171.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -138.94 10.31 2.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.627 1.571 . . . . 0.0 111.85 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.32 121.13 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -162.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 119.31 22.68 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.4 m -68.17 137.06 54.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 152.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.41 142.7 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.256 1.422 . . . . 0.0 109.772 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.71 176.73 34.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.728 HD11 HG21 ' A' ' 87' ' ' ILE . 13.8 pt -97.14 156.57 3.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 121.531 0.682 . . . . 0.0 110.697 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 169.59 17.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 112.57 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -24.28 62.52 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.64 -1.288 . . . . 0.0 111.367 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.65 -30.42 71.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.958 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.99 66.06 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.037 -1.039 . . . . 0.0 112.468 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.3 pp0? -63.3 -19.82 64.94 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.66 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.01 -0.59 7.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.337 1.455 . . . . 0.0 113.434 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -115.04 -31.01 6.19 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 160.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.42 -46.49 54.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.44 -147.0 43.22 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.81 112.5 0.62 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.566 2.346 . . . . 0.0 110.51 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.711 HG22 ' H ' ' A' ' 36' ' ' VAL 0.345 9.0 p -108.31 165.7 4.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 123.309 1.528 . . . . 0.0 111.275 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.711 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -152.43 -28.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.839 -154.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -146.3 143.57 29.24 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.433 0.56 . . . . 0.0 110.846 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.57 125.91 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.656 1.582 . . . . 0.0 107.915 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.89 139.86 43.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.382 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.1 mt -133.04 139.25 33.82 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.73 1.212 . . . . 0.0 107.932 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.45 -179.63 5.36 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.269 2.646 . . . . 0.0 112.041 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.25 145.67 43.87 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.9 18.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 129.178 2.991 . . . . 0.0 115.36 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.17 13.46 0.46 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.183 1.849 . . . . 0.0 112.138 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -76.58 132.73 39.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.789 1.294 . . . . 0.0 108.96 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.98 152.41 33.14 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.983 0.81 . . . . 0.0 109.212 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.82 174.08 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 122.354 1.073 . . . . 0.0 111.07 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -112.28 170.2 8.34 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.317 2.247 . . . . 0.0 107.9 165.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.87 18.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.616 2.366 . . . . 0.0 115.221 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.08 59.14 0.24 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.2 131.12 56.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.742 1.217 . . . . 0.0 108.112 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 52' ' ' VAL 0.297 0.1 OUTLIER -77.69 27.51 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.877 2.871 . . . . 0.0 114.232 -168.032 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.06 12.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.76 54.26 1.17 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 171.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.83 159.3 2.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.513 HG22 HG21 ' A' ' 35' ' ' VAL . 1.6 mt -139.85 135.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -127.76 110.99 13.16 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -99.15 -164.24 1.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.456 1.902 . . . . 0.0 110.775 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -45.89 -34.86 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.338 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -165.91 15.87 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 160.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.33 138.37 31.57 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.4 124.66 52.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 161.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.06 92.49 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.126 0.97 . . . . 0.0 109.303 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -58.72 108.06 0.6 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 108.8 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.22 93.75 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -82.41 109.74 16.92 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.666 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.87 150.01 0.39 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.922 2.489 . . . . 0.0 114.329 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.23 -36.53 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.819 1.679 . . . . 0.0 115.801 -161.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -148.03 139.57 23.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.114 1.365 . . . . 0.0 108.806 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -51.17 129.4 24.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.404 0.621 . . . . 0.0 109.393 170.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.03 -174.52 44.79 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 107.061 -2.416 . . . . 0.0 107.061 -161.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -142.56 127.95 18.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -166.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -59.52 142.46 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -145.99 -2.51 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -147.24 156.66 43.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 121.097 1.771 . . . . 0.0 108.44 165.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.83 153.47 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.045 0.938 . . . . 0.0 109.168 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -104.73 78.83 1.47 Allowed 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.446 0.698 . . . . 0.0 109.398 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -57.03 -14.88 4.12 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.979 0.912 . . . . 0.0 112.76 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -50.68 -39.56 51.46 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.989 1.716 . . . . 0.0 111.955 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -3.25 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.56 0.744 . . . . 0.0 112.501 -170.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.86 -49.96 53.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.011 1.278 . . . . 0.0 109.16 160.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.0 p -92.34 -39.31 11.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.069 -162.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -117.33 67.39 4.86 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.097 1.759 . . . . 0.0 109.517 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.51 -44.83 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.953 3.769 . . . . 0.0 110.837 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 35' ' ' VAL . 14.7 tt0 -61.69 -4.45 1.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.125 1.37 . . . . 0.0 109.905 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -58.15 -13.58 5.19 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 121.426 1.921 . . . . 0.0 114.076 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 24' ' ' ILE . 4.2 mm -53.33 -39.68 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 118.619 0.645 . . . . 0.0 109.78 164.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -69.61 -55.79 9.11 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.046 1.339 . . . . 0.0 109.42 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.82 78.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 -164.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -153.32 74.01 6.76 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -57.32 -23.5 54.96 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.776 2.317 . . . . 0.0 112.381 -172.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.511 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.2 mp0 -118.67 9.42 12.16 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.263 1.025 . . . . 0.0 112.147 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.93 -110.29 2.7 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.244 1.878 . . . . 0.0 109.597 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.96 -28.29 69.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.458 1.129 . . . . 0.0 111.093 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.54 25.22 1.4 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-N 119.721 1.146 . . . . 0.0 115.76 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.422 ' CZ3' ' HG3' ' A' ' 99' ' ' LYS . 46.0 p-90 -67.57 163.06 22.05 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.288 1.544 . . . . 0.0 110.404 171.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mt -106.16 -66.96 0.96 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -140.92 175.95 9.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.569 1.147 . . . . 0.0 109.387 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.422 ' HG3' ' CZ3' ' A' ' 96' ' ' TRP . 65.9 mttt -131.88 152.45 51.03 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 124.307 1.043 . . . . 0.0 108.297 171.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.32 134.89 23.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.342 0.657 . . . . 0.0 110.04 -172.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.66 127.37 31.68 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 167.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 pt -76.53 109.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.1 m -65.97 -21.55 66.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.949 -0.47 . . . . 0.0 111.198 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -151.63 88.33 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -157.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -11.92 59.93 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.933 0.788 . . . . 0.0 111.662 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.78 -41.16 95.84 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.92 -22.66 66.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 117.416 -1.278 . . . . 0.0 111.928 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 111' ' ' LEU . 12.4 mt -52.62 -30.96 34.2 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -79.21 -11.38 59.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.596 0.635 . . . . 0.0 112.069 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -74.89 -34.44 62.19 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.815 -0.553 . . . . 0.0 110.928 168.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -72.65 158.98 34.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.743 1.259 . . . . 0.0 108.132 -173.495 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.469 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -74.42 130.85 40.42 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.476 ' OD1' ' HE2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -69.82 -167.81 0.16 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 164.17 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.14 -39.69 65.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 119.768 -1.832 . . . . 0.0 113.544 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.73 -48.44 31.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.45 81.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.139 0.274 . . . . 0.0 111.408 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -53.99 -54.77 34.48 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.101 0.961 . . . . 0.0 109.866 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -39.4 74.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.103 0.961 . . . . 0.0 111.652 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 N--CA 1.448 -0.569 0 C-N-CA 124.51 1.124 . . . . 0.0 111.677 178.396 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.6 ttm . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 116.8 13.96 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 119.977 -1.702 . . . . 0.0 110.842 157.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -112.99 -179.76 3.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -130.65 170.66 14.01 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 127.191 2.196 . . . . 0.0 110.855 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -117.79 -174.67 2.68 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.665 1.586 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -106.71 10.68 30.86 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.816 1.246 . . . . 0.0 112.271 163.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -105.64 17.7 23.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.477 1.111 . . . . 0.0 111.26 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 72.23 42.5 0.56 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.892 2.077 . . . . 0.0 111.379 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -131.82 139.36 48.84 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.898 1.679 . . . . 0.0 110.879 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 69.9 p-90 -103.24 164.36 11.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.765 1.626 . . . . 0.0 109.583 171.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.57 99.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -86.84 91.88 8.8 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.741 -1.224 . . . . 0.0 110.668 173.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.548 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.2 mp -72.54 119.17 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -97.83 -72.94 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -116.49 -105.65 0.39 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -93.62 14.04 20.19 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.51 1.124 . . . . 0.0 110.698 166.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.27 152.06 35.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -123.16 137.07 54.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.784 1.633 . . . . 0.0 108.521 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -77.84 138.31 38.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 160.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.409 HG11 ' HD3' ' A' ' 68' ' ' PRO . 3.3 t -119.2 143.79 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.951 0.9 . . . . 0.0 109.669 171.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -148.75 165.93 29.23 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.979 -2.049 . . . . 0.0 107.979 164.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.6 pt -76.6 160.1 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.806 -0.82 . . . . 0.0 109.576 168.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.2 p -84.58 166.51 17.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.07 0.948 . . . . 0.0 111.304 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -56.47 -34.63 67.07 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.652 -1.28 . . . . 0.0 111.267 175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -58.36 -23.4 56.79 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.955 -1.09 . . . . 0.0 112.724 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.78 -49.64 8.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.414 -1.429 . . . . 0.0 111.349 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -56.09 -28.54 58.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.116 0.871 . . . . 0.0 110.899 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -55.83 -23.29 29.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.821 1.648 . . . . 0.0 113.288 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -109.63 -11.63 14.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.96 1.304 . . . . 0.0 112.776 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.52 -43.86 11.71 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.097 0.862 . . . . 0.0 111.0 173.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.75 -149.65 51.61 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.85 114.7 2.43 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.023 1.329 . . . . 0.0 109.228 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.658 HG22 ' H ' ' A' ' 36' ' ' VAL 0.344 8.4 p -105.65 167.57 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 124.192 1.949 . . . . 0.0 110.36 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.658 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.29 -30.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 112.316 -2.22 . . . . 0.0 107.396 -148.202 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -149.08 153.81 38.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.782 0.719 . . . . 0.0 111.329 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.571 HG22 HG23 ' A' ' 56' ' ' ILE . 69.1 t -145.3 118.73 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 127.304 2.242 . . . . 0.0 106.579 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -69.29 140.06 54.39 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.73 136.55 29.32 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.05 -172.74 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.157 3.238 . . . . 0.0 111.391 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.83 156.28 19.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.53 0.732 . . . . 0.0 111.897 171.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.78 13.63 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.031 1.732 . . . . 0.0 113.34 -172.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.21 12.94 0.61 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.654 2.073 . . . . 0.0 111.566 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -66.13 119.75 11.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.85 141.99 40.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 174.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.24 157.32 25.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.978 0.911 . . . . 0.0 110.352 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -104.95 171.01 7.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.499 1.52 . . . . 0.0 109.446 167.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -65.38 13.88 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.39 25.93 0.68 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.55 1.072 . . . . 0.0 112.24 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.62 124.79 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 108.793 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.27 109.03 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.28 8.79 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.868 0.867 . . . . 0.0 111.646 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.28 51.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.806 -0.559 . . . . 0.0 110.173 -171.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.83 161.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.293 1.037 . . . . 0.0 112.709 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.571 HG23 HG22 ' A' ' 38' ' ' VAL . 2.9 mt -143.49 108.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.61 98.95 9.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.047 1.339 . . . . 0.0 107.924 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.5 ' HA ' HG23 ' A' ' 35' ' ' VAL . 24.2 p -84.55 -163.2 0.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.31 0.644 . . . . 0.0 110.487 174.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.01 -41.5 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.411 1.484 . . . . 0.0 112.538 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -167.6 20.53 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.009 0.923 . . . . 0.0 113.277 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.78 160.36 14.41 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 120.031 -1.668 . . . . 0.0 108.546 161.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.42 84.72 1.97 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 171.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.22 118.32 22.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -77.04 111.48 12.66 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 167.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG11 HD13 ' A' ' 97' ' ' LEU . 75.0 t -79.21 118.0 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 170.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -100.33 98.51 9.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.092 1.357 . . . . 0.0 111.759 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.75 135.62 1.25 Allowed Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.031 1.733 . . . . 0.0 113.301 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD3' HG11 ' A' ' 22' ' ' VAL . 55.9 Cg_endo -76.55 -37.47 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.486 2.124 . . . . 0.0 114.707 -161.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.42 164.59 16.88 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 m -69.12 137.16 53.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 155.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.61 33.79 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -135.27 129.55 33.76 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.9 145.74 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.49 -2.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.749 0.82 . . . . 0.0 113.07 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -154.3 153.79 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.62 150.35 30.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.44 85.74 5.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -16.35 51.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -51.62 -36.34 45.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.272 1.829 . . . . 0.0 111.79 168.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -10.43 59.79 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.721 0.809 . . . . 0.0 111.567 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.26 -42.26 79.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.915 1.234 . . . . 0.0 109.552 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.6 p -95.64 -41.03 9.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.704 0.802 . . . . 0.0 111.25 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.19 72.54 9.47 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.431 1.892 . . . . 0.0 109.72 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.13 -38.8 4.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.06 3.173 . . . . 0.0 110.38 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HA ' HG12 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -60.18 -13.46 12.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.574 1.15 . . . . 0.0 111.363 -175.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -19.83 41.1 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.261 1.391 . . . . 0.0 112.815 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.8 mt -63.88 -26.22 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 121.519 -0.738 . . . . 0.0 110.893 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.35 -57.14 13.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.299 1.047 . . . . 0.0 109.263 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.19 -64.08 0.95 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.623 2.769 . . . . 0.0 110.355 -165.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -136.88 60.66 30.86 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -165.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.96 -15.48 39.13 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.151 2.567 . . . . 0.0 113.682 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -125.5 7.57 7.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.632 2.373 . . . . 0.0 110.747 -170.33 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.42 -96.77 1.79 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 168.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.18 -20.28 32.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.204 0.602 . . . . 0.0 112.003 -171.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.0 32.85 4.19 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.43 1.014 . . . . 0.0 113.344 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -65.5 160.6 21.87 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 1.373 . . . . 0.0 109.859 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 2.8 mt -104.71 -62.0 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -141.82 167.63 21.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.503 0.721 . . . . 0.0 111.459 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -117.5 150.57 38.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.282 1.033 . . . . 0.0 108.67 165.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.3 ptm -145.32 140.69 27.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.351 0.661 . . . . 0.0 109.864 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -64.0 121.51 14.29 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.559 1.144 . . . . 0.0 107.921 168.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.0 pt -71.51 98.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -75.37 -10.03 59.09 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.81 -0.557 . . . . 0.0 111.59 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -151.49 95.14 2.1 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.379 1.871 . . . . 0.0 107.068 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -8.61 55.33 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.63 -1.294 . . . . 0.0 111.507 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.92 -40.44 98.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -67.05 -9.97 44.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.728 1.611 . . . . 0.0 112.049 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.15 -20.27 65.72 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.756 1.162 . . . . 0.0 110.557 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -72.29 -18.0 61.83 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.894 1.224 . . . . 0.0 111.537 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.19 -19.81 49.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.052 0.842 . . . . 0.0 111.091 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.52 175.17 8.78 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.951 1.301 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.3 mt -106.44 149.63 26.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.863 1.265 . . . . 0.0 110.823 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.99 169.12 10.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.383 1.073 . . . . 0.0 108.294 163.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.67 -49.65 61.73 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.948 1.299 . . . . 0.0 109.843 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -60.56 -41.79 95.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.705 0.802 . . . . 0.0 110.612 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.88 -37.18 83.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.121 0.568 . . . . 0.0 110.718 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.03 -39.09 86.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.548 0.739 . . . . 0.0 110.692 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -47.66 84.37 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.272 0.629 . . . . 0.0 110.694 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 CA--C 1.54 0.574 0 CA-C-N 118.547 0.612 . . . . 0.0 111.421 -179.449 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.811 0.339 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -159.82 70.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 110.143 -170.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -81.42 176.72 9.47 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.71 -1.244 . . . . 0.0 112.956 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 12' ' ' TRP . 23.7 m-85 -132.91 161.68 33.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.555 2.342 . . . . 0.0 111.723 -171.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -103.4 177.23 4.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 123.181 1.467 . . . . 0.0 109.68 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -101.39 19.16 18.32 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.504 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -134.04 44.14 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.816 1.647 . . . . 0.0 109.894 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 p80 41.47 55.07 3.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.534 1.534 . . . . 0.0 113.118 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -143.81 134.39 24.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.751 2.021 . . . . 0.0 107.479 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 58.9 p-90 -92.65 172.72 8.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.234 1.414 . . . . 0.0 109.29 167.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.53 148.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.46 90.98 2.51 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.027 0.531 . . . . 0.0 111.696 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.0 mt -95.76 102.87 14.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.991 1.316 . . . . 0.0 107.468 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -79.02 -76.49 0.2 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.245 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -106.07 -82.71 0.53 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.081 0.855 . . . . 0.0 109.219 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.18 13.72 11.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.834 0.854 . . . . 0.0 111.339 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -137.41 126.08 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.45 154.86 20.03 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.938 0.875 . . . . 0.0 108.843 162.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.9 m -106.5 155.4 19.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.994 157.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.63 142.64 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.239 3.416 . . . . 0.0 104.765 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -160.37 32.66 0.4 Allowed Glycine 0 N--CA 1.477 1.376 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.541 HD11 ' CG2' ' A' ' 87' ' ' ILE . 27.6 pt 44.07 162.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 131.215 3.806 . . . . 0.0 114.663 -169.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.9 p -93.46 170.78 9.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.496 -2.003 . . . . 0.0 110.92 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -31.36 70.98 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.629 -1.294 . . . . 0.0 111.659 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -59.45 -24.21 63.35 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.043 0.937 . . . . 0.0 111.66 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.71 -54.22 6.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.945 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.11 -26.8 51.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.424 0.69 . . . . 0.0 111.947 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.56 -54.62 41.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.138 1.775 . . . . 0.0 110.928 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -62.18 -49.01 77.51 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.245 1.018 . . . . 0.0 110.63 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -67.82 -38.57 83.42 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.363 1.065 . . . . 0.0 109.515 179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.74 -118.77 10.14 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.192 1.853 . . . . 0.0 108.928 -168.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.6 159.59 21.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.685 0.755 . . . . 0.0 109.681 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.004 HG12 ' H ' ' A' ' 36' ' ' VAL . 6.4 t -132.74 -172.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.014 1.325 . . . . 0.0 107.914 171.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.004 ' H ' HG12 ' A' ' 35' ' ' VAL . 3.1 m -159.35 -34.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 129.307 3.043 . . . . 0.0 109.583 -168.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.445 ' H ' HG12 ' A' ' 35' ' ' VAL . 32.3 t80 -151.4 164.99 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.49 124.47 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 127.045 2.138 . . . . 0.0 107.379 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.68 140.17 38.4 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.807 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.6 mt -138.98 144.76 42.54 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.223 0.609 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.4 178.19 7.69 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.941 3.094 . . . . 0.0 111.454 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -86.58 160.41 18.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 0.0 110.581 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.11 17.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 127.177 2.191 . . . . 0.0 114.487 -167.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.4 11.4 0.47 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.977 2.227 . . . . 0.0 113.025 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -71.0 127.96 34.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.132 1.466 . . . . 0.0 109.929 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.69 146.21 46.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.762 1.165 . . . . 0.0 110.924 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.53 144.47 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.905 1.682 . . . . 0.0 108.991 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -83.25 172.31 12.72 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.109 -0.995 . . . . 0.0 111.414 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 12.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.254 2.221 . . . . 0.0 116.182 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.25 65.48 0.22 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.92 121.98 15.72 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.2 OUTLIER -72.76 35.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 132.003 4.121 . . . . 0.0 113.308 -166.834 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 m -70.12 6.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 118.827 -2.421 . . . . 0.0 115.291 -168.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.7 55.76 1.2 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.897 1.226 . . . . 0.0 111.465 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.69 163.81 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.769 1.271 . . . . 0.0 112.532 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 mt -131.91 114.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -166.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.53 126.52 51.69 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 167.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.469 ' HB3' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -108.0 -165.62 1.06 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.04 2.536 . . . . 0.0 108.388 178.336 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.26 -24.74 32.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 127.701 2.4 . . . . 0.0 112.375 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.23 12.6 0.19 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.604 1.093 . . . . 0.0 113.93 166.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.613 ' HB3' HD13 ' A' ' 32' ' ' LEU . . . -115.02 155.42 27.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.143 -0.973 . . . . 0.0 109.944 173.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.66 100.03 3.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.05 179.21 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.469 1.508 . . . . 0.0 111.078 -166.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.18 139.06 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.586 1.955 . . . . 0.0 108.475 -163.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.608 HG11 HD13 ' A' ' 97' ' ' LEU . 54.7 t -112.35 108.59 25.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 167.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.0 107.67 20.21 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.808 0.731 . . . . 0.0 109.895 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -43.48 142.39 1.77 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.451 1.101 . . . . 0.0 112.485 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.13 -28.1 2.6 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.85 2.366 . . . . 0.0 114.596 -158.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mt -153.19 145.34 23.83 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.496 2.718 . . . . 0.0 104.906 -162.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 m -68.11 128.03 35.04 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 103' ' ' SER . . . -175.01 -166.53 32.96 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 124.496 1.046 . . . . 0.0 111.559 -170.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -137.02 130.3 31.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.506 HD12 ' CD1' ' A' ' 98' ' ' PHE . 8.9 mm -58.78 144.63 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.515 1.126 . . . . 0.0 108.287 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.9 m -146.98 3.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -155.14 156.01 34.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.614 1.552 . . . . 0.0 108.535 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.09 157.68 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.788 1.235 . . . . 0.0 109.081 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -101.15 84.73 2.69 Favored 'General case' 0 C--O 1.23 0.057 0 C-N-CA 123.347 0.659 . . . . 0.0 109.455 -174.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -60.1 -3.38 0.57 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.803 1.241 . . . . 0.0 113.586 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -54.86 -52.77 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.301 -1.499 . . . . 0.0 109.982 160.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.53 ' CD1' HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -63.94 -25.39 68.12 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.018 1.727 . . . . 0.0 112.111 -163.135 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -59.72 -23.81 63.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.641 1.176 . . . . 0.0 111.827 173.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.2 p -125.69 -20.82 4.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.678 1.591 . . . . 0.0 112.107 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -133.62 70.01 76.13 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 126.304 1.841 . . . . 0.0 108.4 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.48 -4.75 15.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.576 3.517 . . . . 0.0 111.689 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.82 -8.44 43.56 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.091 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.7 mt -70.94 -22.97 62.16 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.06 -1.65 . . . . 0.0 111.543 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.541 ' CG2' HD11 ' A' ' 24' ' ' ILE . 8.5 mt -58.17 -26.29 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.297 169.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -72.11 -55.29 7.57 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.684 1.584 . . . . 0.0 110.585 164.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -35.22 80.46 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.115 0.966 . . . . 0.0 111.884 -161.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.35 78.72 1.1 Allowed Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.57 -34.45 95.37 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 CA-C-N 120.948 1.374 . . . . 0.0 110.328 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -100.09 -5.69 27.53 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.959 1.304 . . . . 0.0 111.946 -171.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.69 -69.19 0.96 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -119.68 -21.13 7.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.541 1.136 . . . . 0.0 112.769 -167.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.91 26.07 3.87 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.805 1.669 . . . . 0.0 115.351 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 45.0 p-90 -63.53 158.92 19.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 119.388 1.594 . . . . 0.0 111.642 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.608 HD13 HG11 ' A' ' 65' ' ' VAL . 1.1 mt -99.46 -67.43 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.506 ' CD1' HD12 ' A' ' 73' ' ' ILE . 15.2 p90 -142.22 166.1 25.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.264 1.826 . . . . 0.0 110.617 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -113.84 154.68 27.06 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.023 1.329 . . . . 0.0 108.933 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.0 ptm -145.48 143.32 29.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.084 0.553 . . . . 0.0 110.688 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.31 137.23 57.4 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.902 1.281 . . . . 0.0 107.881 168.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.5 pt -76.29 155.92 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 123.444 0.465 . . . . 0.0 109.96 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.505 ' HB2' ' HA2' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -133.53 -13.03 2.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.126 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.56 112.68 3.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 168.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -83.95 -15.68 46.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.089 1.755 . . . . 0.0 110.622 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.36 71.79 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.085 1.326 . . . . 0.0 111.437 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.61 -7.89 58.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 112.609 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.02 -41.23 82.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.442 1.474 . . . . 0.0 110.639 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.23 -19.09 63.95 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.493 0.588 . . . . 0.0 111.065 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -70.91 -17.11 62.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.097 1.359 . . . . 0.0 111.702 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.81 169.59 13.22 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.37 153.42 20.44 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.641 0.776 . . . . 0.0 109.89 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.63 171.14 6.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 163.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.78 -45.64 70.81 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.11 -40.11 96.66 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.651 1.18 . . . . 0.0 111.005 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.56 82.7 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.082 0.401 . . . . 0.0 111.308 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -64.48 -36.51 84.42 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.527 0.731 . . . . 0.0 111.766 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.04 -47.85 71.14 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.491 0.587 . . . . 0.0 110.343 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 N--CA 1.438 -1.051 0 CA-C-N 118.183 0.447 . . . . 0.0 110.149 177.77 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.4 ttm . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 110.53 7.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -111.34 -179.94 3.86 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.415 1.086 . . . . 0.0 109.946 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.58 163.56 32.53 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.032 0.933 . . . . 0.0 110.361 -170.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.1 p -114.68 -179.79 3.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.552 1.644 . . . . 0.0 110.642 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HG2' ' H ' ' A' ' 8' ' ' LYS . 11.1 ptpt -63.63 -24.48 67.81 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.072 2.149 . . . . 0.0 115.226 160.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -84.05 24.01 0.98 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.732 1.151 . . . . 0.0 111.67 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 52.89 56.42 7.6 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 125.391 1.476 . . . . 0.0 109.569 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -140.28 148.85 42.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.856 2.063 . . . . 0.0 108.236 -167.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -128.03 153.55 46.64 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.99 1.716 . . . . 0.0 110.956 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.14 151.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 C-N-CA 127.188 2.195 . . . . 0.0 106.499 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -141.4 72.3 1.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.282 1.433 . . . . 0.0 108.807 -178.368 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 15' ' ' ILE . 3.7 mp -70.57 134.1 30.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.064 2.145 . . . . 0.0 106.427 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -125.78 -61.44 1.25 Allowed 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.315 -0.866 . . . . 0.0 110.981 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.03 -76.65 0.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -126.79 4.44 6.66 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.041 1.336 . . . . 0.0 112.635 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.76 135.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.11 142.35 29.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 35.8 m -75.87 147.51 39.01 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 151.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.14 130.29 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 129.003 2.921 . . . . 0.0 107.187 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.41 172.68 26.92 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 167.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 87' ' ' ILE . 12.2 pt -91.66 152.54 3.37 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.38 0.672 . . . . 0.0 109.863 173.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.7 p -82.29 170.85 14.91 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.973 -1.08 . . . . 0.0 111.206 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -21.82 66.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.926 -1.109 . . . . 0.0 113.345 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -61.59 -29.46 70.05 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.0 -1.062 . . . . 0.0 111.56 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.412 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -72.4 -46.16 56.46 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.974 -1.079 . . . . 0.0 111.432 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -64.93 -24.25 67.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.198 0.599 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.49 -47.84 68.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.553 1.941 . . . . 0.0 108.389 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -70.7 -52.6 19.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mt -73.13 -33.03 65.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.286 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -133.46 15.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.46 147.71 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.694 1.198 . . . . 0.0 107.804 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.818 HG12 ' H ' ' A' ' 36' ' ' VAL . 21.4 t -121.48 -149.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.969 1.707 . . . . 0.0 106.559 178.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.818 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER 179.8 -40.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 130.34 3.456 . . . . 0.0 108.406 -166.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.456 ' H ' HG12 ' A' ' 35' ' ' VAL . 41.1 t80 -150.43 154.52 37.88 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.267 1.394 . . . . 0.0 113.776 -176.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.06 131.33 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 125.189 1.396 . . . . 0.0 107.767 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.9 147.76 26.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.686 2.394 . . . . 0.0 108.777 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -144.61 148.88 41.64 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.048 1.339 . . . . 0.0 109.6 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.06 179.98 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.212 2.608 . . . . 0.0 114.377 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 152.04 21.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.109 0.963 . . . . 0.0 110.518 170.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.93 11.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 128.349 2.66 . . . . 0.0 115.037 -168.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.16 10.83 1.36 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.111 1.815 . . . . 0.0 112.47 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.451 ' CZ ' HG12 ' A' ' 53' ' ' VAL . 72.2 ttt180 -70.14 128.68 37.12 Favored 'General case' 0 CA--C 1.527 0.088 0 O-C-N 121.288 -1.124 . . . . 0.0 108.027 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.85 153.79 30.31 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.405 HG12 HG11 ' A' ' 53' ' ' VAL . 35.3 m -142.94 170.88 10.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.893 1.277 . . . . 0.0 109.849 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -122.56 166.24 15.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.014 1.326 . . . . 0.0 109.597 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -62.13 7.87 0.05 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -155.34 75.61 0.22 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 167.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 114.36 13.73 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.579 1.151 . . . . 0.0 109.558 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.48 93.29 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.944 1.697 . . . . 0.0 108.145 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.451 HG12 ' CZ ' ' A' ' 45' ' ' ARG . 8.3 m -115.27 -3.5 10.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.852 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.99 53.21 1.21 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.763 0.664 . . . . 0.0 111.925 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.66 155.44 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.787 0.835 . . . . 0.0 111.348 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' CD1' HD13 ' A' ' 24' ' ' ILE . 8.4 mt -129.42 94.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.0 mt-10 -82.04 108.34 15.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 88.1 p -88.92 -169.52 2.56 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.604 1.162 . . . . 0.0 110.559 172.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.1 m -53.78 -29.35 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.684 1.193 . . . . 0.0 111.905 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -163.73 29.69 0.08 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -149.9 161.54 42.09 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.483 -0.761 . . . . 0.0 109.504 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.56 105.4 8.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.601 1.561 . . . . 0.0 107.606 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.01 119.78 22.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 131.03 38.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 163.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.49 106.72 21.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -99.72 107.4 19.48 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 110.629 -162.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -36.37 122.89 0.75 Allowed Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 126.747 2.019 . . . . 0.0 111.284 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 -23.55 7.27 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.637 1.558 . . . . 0.0 114.848 -161.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.74 161.61 32.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.418 1.887 . . . . 0.0 105.911 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.4 m -77.98 149.67 34.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.7 -162.97 34.39 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 120.101 -1.624 . . . . 0.0 110.167 -172.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -132.53 131.89 42.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.114 0.957 . . . . 0.0 109.844 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.49 HD12 ' CD1' ' A' ' 98' ' ' PHE . 13.3 mm -61.3 137.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.708 1.603 . . . . 0.0 108.167 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.71 1.12 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 123.955 0.784 . . . . 0.0 112.966 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -150.75 153.32 35.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 162.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.45 166.07 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.159 1.345 . . . . 0.0 109.827 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -110.4 82.01 1.53 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -59.86 -15.09 18.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.79 0.836 . . . . 0.0 112.255 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -55.87 -31.63 62.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.339 1.055 . . . . 0.0 112.416 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -13.93 62.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.191 0.905 . . . . 0.0 109.828 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.49 -16.91 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.87 1.268 . . . . 0.0 111.953 171.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -129.95 -17.85 3.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.773 0.829 . . . . 0.0 112.267 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.06 71.71 72.96 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.941 1.697 . . . . 0.0 107.904 167.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.52 -17.53 59.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 108.949 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.51 -4.75 59.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.268 1.027 . . . . 0.0 112.734 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.6 mt -66.08 -18.15 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.468 -1.395 . . . . 0.0 111.993 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.757 HG21 HD11 ' A' ' 24' ' ' ILE . 32.7 mt -62.94 -34.85 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.223 1.009 . . . . 0.0 109.561 171.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.08 -52.4 49.18 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.138 -1.602 . . . . 0.0 109.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -37.3 86.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.505 -162.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.18 79.92 0.52 Allowed Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.42 -14.95 41.22 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.135 1.89 . . . . 0.0 112.168 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -125.15 43.76 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.579 1.552 . . . . 0.0 108.316 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.34 -100.26 0.34 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 162.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -76.38 -26.57 55.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.96 -1.019 . . . . 0.0 112.505 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 39.52 2.92 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.347 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -69.39 164.02 23.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.871 1.336 . . . . 0.0 110.344 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.28 -65.16 0.98 Allowed 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.49 ' CD1' HD12 ' A' ' 73' ' ' ILE . 48.8 p90 -148.78 173.51 13.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.2 1.0 . . . . 0.0 110.04 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -127.21 153.8 45.63 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.658 1.183 . . . . 0.0 109.022 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.4 ptm -149.9 135.88 18.68 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.159 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.76 125.56 20.54 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.061 1.744 . . . . 0.0 107.357 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 21.4 pt -73.28 129.84 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.3 p -75.62 -41.92 53.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 166.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -142.83 90.53 2.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.981 0.913 . . . . 0.0 108.648 -160.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -10.1 0.98 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.319 1.048 . . . . 0.0 111.904 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -90.47 -15.97 56.05 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.571 1.558 . . . . 0.0 112.591 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.87 -16.29 60.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.561 1.181 . . . . 0.0 110.29 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.64 -29.17 69.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.437 0.695 . . . . 0.0 110.927 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -95.38 27.63 3.25 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.011 -1.056 . . . . 0.0 111.36 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -116.71 0.5 12.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.381 147.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -84.41 -177.62 6.68 Favored 'General case' 0 C--N 1.34 0.186 0 O-C-N 120.683 -1.261 . . . . 0.0 109.837 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -91.3 127.92 36.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 107.656 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.93 178.29 1.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.374 1.083 . . . . 0.0 109.472 160.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -69.65 -49.53 52.86 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.273 1.029 . . . . 0.0 112.02 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.28 -44.28 95.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.905 0.882 . . . . 0.0 109.037 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.71 90.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.138 0.575 . . . . 0.0 111.148 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.76 -41.72 78.48 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.242 -0.911 . . . . 0.0 111.118 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -44.01 68.04 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.649 1.58 . . . . 0.0 109.97 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 . . . . . 0 N--CA 1.441 -0.923 0 C-N-CA 124.094 0.957 . . . . 0.0 110.49 176.254 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 ttp . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 14' ' ' SER . 21.0 ttmt -145.09 148.2 33.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.669 -1.269 . . . . 0.0 107.733 155.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -127.01 176.1 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.43 168.08 20.62 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.549 1.94 . . . . 0.0 108.827 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 68' ' ' PRO . 7.7 p -130.53 177.16 7.57 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.938 1.352 . . . . 0.0 111.311 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -76.25 -25.46 55.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.518 1.527 . . . . 0.0 110.856 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 0.6 OUTLIER -82.28 17.33 1.71 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.68 1.127 . . . . 0.0 111.272 171.398 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 65.34 59.18 0.82 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.23 1.812 . . . . 0.0 110.663 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -111.58 165.45 12.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.167 0.987 . . . . 0.0 110.388 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.415 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 50.4 p-90 -131.37 152.81 50.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.865 1.666 . . . . 0.0 109.227 168.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 t -135.78 89.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.961 1.704 . . . . 0.0 107.407 -168.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 5.7 m -72.86 82.37 1.19 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.25 1.82 . . . . 0.0 112.986 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.789 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 13.5 mm -87.41 127.29 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -141.61 -21.57 0.74 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.124 -0.985 . . . . 0.0 112.945 -170.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -141.19 -105.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 157.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -111.49 9.66 21.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.82 1.648 . . . . 0.0 111.015 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.05 144.24 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 168.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . . . -109.06 141.88 40.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 108.565 160.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 m -85.67 136.06 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 156.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.5 124.18 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 130.249 3.42 . . . . 0.0 110.67 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.62 170.96 33.6 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.007 1.289 . . . . 0.0 110.49 168.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 pt -90.7 148.27 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.784 -0.833 . . . . 0.0 108.818 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.9 p -76.28 157.92 32.06 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.32 -0.862 . . . . 0.0 111.144 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.4 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 48.1 t30 -58.44 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 1 C-N-CA 135.451 5.5 . . . . 0.0 116.054 176.41 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -107.5 -40.08 5.45 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 127.566 2.346 . . . . 0.0 112.402 164.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.79 -51.66 21.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.215 2.206 . . . . 0.0 116.07 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.555 ' NE2' ' H ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -42.08 -45.7 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.385 3.074 . . . . 0.0 109.75 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.555 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -51.69 -48.07 63.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.271 1.428 . . . . 0.0 112.284 176.289 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -68.75 -23.13 64.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.571 1.148 . . . . 0.0 111.517 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -89.05 -28.48 20.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.607 0.64 . . . . 0.0 112.385 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.43 -137.36 37.39 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 126.178 1.847 . . . . 0.0 110.555 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.28 112.98 2.93 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -86.28 -171.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 122.596 1.189 . . . . 0.0 109.038 170.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.584 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.7 p -173.15 -40.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.267 2.227 . . . . 0.0 106.348 -150.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.505 ' H ' HG12 ' A' ' 35' ' ' VAL . 36.2 t80 -154.48 149.68 27.02 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.73 135.43 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.668 1.587 . . . . 0.0 107.967 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -91.54 143.99 26.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.551 2.341 . . . . 0.0 108.155 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -141.66 138.36 17.2 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.936 0.894 . . . . 0.0 109.031 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.75 175.71 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.088 2.525 . . . . 0.0 112.325 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.19 147.93 29.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.925 -1.11 . . . . 0.0 109.718 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.19 17.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 128.464 2.706 . . . . 0.0 115.528 -168.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.77 3.85 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.311 2.386 . . . . 0.0 112.319 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -60.71 138.87 58.05 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.571 1.186 . . . . 0.0 108.388 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.61 141.36 28.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.71 170.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.952 0.901 . . . . 0.0 110.182 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -127.57 159.75 33.67 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.996 0.918 . . . . 0.0 110.672 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 10.55 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.914 2.486 . . . . 0.0 115.151 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.12 68.19 0.19 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 173.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -140.42 129.28 23.22 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.2 t -79.35 110.7 15.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -173.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -2.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.767 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.35 45.29 0.72 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.417 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.3 m -48.29 145.86 3.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.246 1.419 . . . . 0.0 113.156 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.8 mt -122.2 107.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.3 128.84 41.04 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.3 p -105.03 -172.68 2.14 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.299 0.954 . . . . 0.0 109.967 172.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 m -52.36 -27.17 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.37 1.468 . . . . 0.0 112.616 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -158.29 29.77 0.24 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.918 1.235 . . . . 0.0 113.76 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.54 -179.31 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.007 -1.058 . . . . 0.0 109.993 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.34 44.43 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 126.746 2.018 . . . . 0.0 108.35 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.31 111.65 8.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.596 1.959 . . . . 0.0 107.01 160.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 114.95 7.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -77.78 101.44 3.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -68.15 124.15 22.66 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.08 132.95 30.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.995 0.918 . . . . 0.0 109.728 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HB3' HG21 ' A' ' 7' ' ' THR . 32.9 Cg_endo -81.01 -31.84 1.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.221 1.947 . . . . 0.0 114.285 -168.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.67 157.99 35.89 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.538 1.935 . . . . 0.0 106.981 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 m -77.16 153.62 33.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.45 -171.05 31.68 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -165.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -136.38 130.88 33.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -63.62 150.21 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.432 1.093 . . . . 0.0 108.374 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.68 3.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.689 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -156.73 160.12 38.99 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 121.373 1.897 . . . . 0.0 109.501 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.68 168.0 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.728 1.611 . . . . 0.0 109.59 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -117.71 78.71 1.26 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.641 1.177 . . . . 0.0 109.035 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.55 -11.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.169 0.987 . . . . 0.0 112.958 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -53.14 -31.68 43.68 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.683 -1.26 . . . . 0.0 111.042 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -21.36 59.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.241 1.017 . . . . 0.0 110.079 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.38 -5.95 16.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.549 1.939 . . . . 0.0 113.293 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -137.42 -34.35 0.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.552 -0.718 . . . . 0.0 110.229 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.1 62.07 19.19 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.323 2.249 . . . . 0.0 109.113 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.16 -20.49 28.34 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 124.177 3.251 . . . . 0.0 110.263 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.83 -17.32 49.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.699 1.2 . . . . 0.0 110.587 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.5 mt -67.86 -16.76 64.24 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.653 1.57 . . . . 0.0 114.383 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 mt -67.4 -23.72 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.26 0.936 . . . . 0.0 109.816 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -76.16 -53.73 7.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 119.967 -1.708 . . . . 0.0 109.918 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -59.99 -40.5 89.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.151 0.981 . . . . 0.0 112.084 -167.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.75 76.63 2.26 Favored Pre-proline 0 C--N 1.333 -0.136 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.15 -19.71 67.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.407 2.072 . . . . 0.0 113.315 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.3 mt-10 -124.19 22.32 8.66 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.43 1.013 . . . . 0.0 111.288 -171.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.06 -82.14 0.17 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 166.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -83.36 -38.83 21.5 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.49 46.32 3.24 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.793 1.179 . . . . 0.0 114.15 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -81.3 168.37 18.51 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.249 1.024 . . . . 0.0 109.704 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.63 -69.25 0.84 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -138.48 173.18 11.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.557 0.743 . . . . 0.0 111.349 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -128.38 150.36 50.14 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -144.84 148.69 34.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.054 0.542 . . . . 0.0 110.141 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.94 117.48 11.57 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.258 1.823 . . . . 0.0 107.778 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.412 HG21 ' CD1' ' A' ' 15' ' ' ILE . 2.9 pt -70.1 97.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.587 1.184 . . . . 0.0 107.963 163.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 m -60.67 -34.73 74.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.028 167.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -134.95 82.72 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -163.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.476 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -65.15 -12.81 55.0 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.464 -0.772 . . . . 0.0 110.235 172.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.31 73.19 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 117.549 -1.695 . . . . 0.0 112.202 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -80.43 -29.22 37.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.958 1.879 . . . . 0.0 110.61 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 105' ' ' GLU . 17.8 mt -41.81 -46.08 3.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.142 1.792 . . . . 0.0 111.83 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.49 -11.34 60.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.05 -35.62 59.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 165.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 108' ' ' LEU . 2.4 mm? -64.88 171.02 3.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 123.693 1.711 . . . . 0.0 110.979 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.7 mt -70.54 120.82 16.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.022 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.4 -179.47 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.266 1.426 . . . . 0.0 110.231 163.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.64 -37.96 70.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.271 -1.518 . . . . 0.0 110.986 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -69.73 -46.1 66.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.27 1.428 . . . . 0.0 109.024 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.44 66.5 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.013 0.925 . . . . 0.0 111.875 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -63.47 -48.14 78.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.573 1.149 . . . . 0.0 109.506 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.0 -41.85 79.23 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 123.817 0.847 . . . . 0.0 110.084 175.784 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 31.1 tpp . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -142.09 112.47 7.1 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.964 -1.085 . . . . 0.0 109.892 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -105.63 -179.23 3.88 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.732 0.645 . . . . 0.0 111.56 162.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -136.69 176.75 8.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.408 1.883 . . . . 0.0 111.568 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -134.96 166.09 23.82 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.894 1.277 . . . . 0.0 111.512 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 10' ' ' HIS . 2.1 mtmt -71.91 -34.54 69.18 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.769 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -71.58 42.33 0.08 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.35 0.977 . . . . 0.0 109.611 165.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 8' ' ' LYS . 5.1 p80 38.97 63.97 0.85 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 127.726 2.411 . . . . 0.0 112.509 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 11.1 mt-10 -128.17 169.14 14.47 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.0 109.361 168.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -113.35 172.27 7.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.833 2.053 . . . . 0.0 109.435 161.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.3 t -136.4 142.89 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.757 2.423 . . . . 0.0 105.279 174.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.77 80.11 1.78 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 119.557 1.071 . . . . 0.0 110.893 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.4 mp -62.39 140.02 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 168.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -117.23 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 160.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.68 -94.83 0.44 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -123.22 33.35 5.4 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 128.152 2.581 . . . . 0.0 110.849 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.16 119.43 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 164.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -102.06 107.04 18.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.856 1.663 . . . . 0.0 107.607 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -70.23 126.39 29.52 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.824 0.85 . . . . 0.0 109.145 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.54 HG11 ' CE1' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -95.12 148.52 5.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 128.545 2.738 . . . . 0.0 112.618 169.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.19 161.39 32.0 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 157.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.434 ' CD1' HG21 ' A' ' 87' ' ' ILE . 3.3 pt -84.49 139.4 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 118.939 1.37 . . . . 0.0 108.6 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.7 p -73.51 172.99 10.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.564 -0.71 . . . . 0.0 111.466 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -59.19 -33.81 71.4 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.618 -1.301 . . . . 0.0 113.245 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -54.25 -24.1 17.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.893 1.277 . . . . 0.0 111.616 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.52 -48.75 10.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.264 1.025 . . . . 0.0 112.152 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.0 pp0? -62.45 -20.02 64.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.084 0.856 . . . . 0.0 110.302 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -58.67 -26.52 63.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.647 1.979 . . . . 0.0 112.958 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -90.04 -42.01 11.38 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 120.155 1.343 . . . . 0.0 113.387 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mt -89.14 -33.0 17.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -170.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.44 -118.78 7.26 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.848 1.69 . . . . 0.0 111.606 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.79 112.88 3.07 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.213 1.805 . . . . 0.0 107.81 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -98.11 -165.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.047 0.927 . . . . 0.0 109.849 179.461 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.669 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -172.85 -31.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 129.62 3.168 . . . . 0.0 109.545 -168.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' H ' HG12 ' A' ' 35' ' ' VAL . 37.0 t80 -150.12 147.41 27.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 111.326 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 56' ' ' ILE . 22.8 t -138.99 115.88 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.21 140.71 58.9 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.998 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.3 mt -134.17 137.01 27.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 125.486 1.515 . . . . 0.0 107.576 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.87 -163.69 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.546 2.831 . . . . 0.0 112.643 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -113.69 145.32 41.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.854 1.662 . . . . 0.0 108.288 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.41 16.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -165.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.54 13.84 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.92 1.724 . . . . 0.0 112.671 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -79.39 137.38 37.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.524 1.662 . . . . 0.0 109.491 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -77.13 154.48 33.19 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.996 0.816 . . . . 0.0 109.872 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.448 HG11 HD11 ' A' ' 73' ' ' ILE . 35.6 m -140.46 164.71 21.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.515 1.126 . . . . 0.0 110.566 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -111.08 165.45 11.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 126.427 1.891 . . . . 0.0 107.983 167.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -60.77 10.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.729 2.012 . . . . 0.0 115.78 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.3 92.13 0.12 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 162.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.07 126.83 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -72.27 20.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 126.47 1.908 . . . . 0.0 113.976 -166.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.03 11.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 127.118 2.167 . . . . 0.0 116.196 -165.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.1 49.08 0.84 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.899 1.28 . . . . 0.0 108.79 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.8 m -49.43 157.22 0.53 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.402 1.096 . . . . 0.0 111.123 169.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.458 HG23 HG22 ' A' ' 38' ' ' VAL . 5.3 mt -142.0 100.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -86.2 118.93 25.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -90.37 -167.94 1.97 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.484 1.514 . . . . 0.0 109.511 168.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -39.53 -52.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.054 1.742 . . . . 0.0 112.392 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -155.04 52.4 0.62 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.883 1.219 . . . . 0.0 111.81 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.3 177.37 10.64 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.179 -0.951 . . . . 0.0 109.194 163.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.19 114.04 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.506 1.523 . . . . 0.0 108.34 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.77 100.04 11.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.21 111.16 2.47 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.11 109.69 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -81.97 108.05 15.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.721 -0.612 . . . . 0.0 109.767 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -38.49 142.63 0.48 Allowed Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 126.826 2.05 . . . . 0.0 113.067 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.8 -35.9 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 119.617 0.899 . . . . 0.0 113.783 -161.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.537 HD11 HD23 ' A' ' 108' ' ' LEU . 4.5 mm? -123.46 160.32 27.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -80.67 151.61 28.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.54 -157.28 27.44 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -168.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -142.54 137.44 30.15 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.899 0.85 . . . . 0.0 109.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.52 HD12 ' CD1' ' A' ' 98' ' ' PHE . 11.0 mm -63.96 146.27 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 124.372 1.069 . . . . 0.0 108.817 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.4 -0.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.202 1.001 . . . . 0.0 111.116 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -161.43 157.64 25.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.22 146.13 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -173.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -86.51 74.73 9.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 118.57 0.623 . . . . 0.0 110.204 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.35 -15.11 14.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -54.51 -45.9 73.39 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.076 165.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.11 -18.88 64.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 0.0 112.281 -173.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -63.75 -15.66 59.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.207 1.403 . . . . 0.0 111.232 169.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 p -131.97 -27.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.67 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.23 64.55 61.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.143 1.777 . . . . 0.0 110.496 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.85 -10.25 27.65 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.146 3.231 . . . . 0.0 111.792 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.37 -14.16 61.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.197 -0.94 . . . . 0.0 112.908 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 86' ' ' LEU . 5.5 mt -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.113 1.324 . . . . 0.0 113.464 -169.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 87' ' ' ILE . 4.6 mp -63.83 -33.87 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.44 1.018 . . . . 0.0 110.667 169.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -59.07 -46.35 88.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.785 1.755 . . . . 0.0 109.965 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -72.73 -59.99 2.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 127.694 2.398 . . . . 0.0 110.579 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -140.54 65.07 25.24 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -167.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.78 -18.31 55.33 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 120.811 1.007 . . . . 0.0 111.475 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.33 28.18 7.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 109.021 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.6 -113.85 0.99 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.44 -14.33 62.83 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.269 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.71 32.48 2.15 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 120.678 1.581 . . . . 0.0 112.513 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.86 161.25 13.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.171 0.985 . . . . 0.0 108.741 165.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.46 -58.29 2.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.931 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CE1' HG11 ' A' ' 22' ' ' VAL . 42.7 p90 -140.03 -176.79 4.72 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 115.022 -2.671 . . . . 0.0 111.934 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -136.42 129.84 31.79 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 ptm -131.92 139.13 48.63 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.5 141.91 58.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.9 pt -95.91 149.97 4.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -133.65 -13.06 2.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.904 1.681 . . . . 0.0 112.391 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -146.27 74.36 1.36 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -66.52 -10.26 43.04 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.618 -1.301 . . . . 0.0 111.009 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.28 -39.26 95.82 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 120.531 -1.355 . . . . 0.0 110.703 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -63.85 -28.94 70.19 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.568 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 69' ' ' LEU . 15.0 mt -47.41 -36.67 10.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 120.184 1.356 . . . . 0.0 111.883 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.72 -16.62 55.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.887 1.676 . . . . 0.0 112.657 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.6 -31.24 66.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.346 1.459 . . . . 0.0 109.96 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -65.08 169.08 5.78 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.673 -0.642 . . . . 0.0 109.525 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.561 HD22 ' H ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -68.21 127.04 31.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.57 171.94 0.76 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 154.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -67.88 -36.57 80.47 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.509 -1.995 . . . . 0.0 112.126 -173.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.71 -51.55 58.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.21 71.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.255 0.222 . . . . 0.0 111.192 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -61.58 -52.37 64.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.728 1.211 . . . . 0.0 109.933 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -41.0 72.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.295 0.638 . . . . 0.0 109.651 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 . . . . . 0 N--CA 1.443 -0.803 0 C-N-CA 123.906 0.882 . . . . 0.0 110.968 -176.336 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.519 ' SD ' ' HE2' ' A' ' 5' ' ' LYS . 3.8 ptp . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 64.94 0.74 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.66 -1.275 . . . . 0.0 111.372 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HE2' ' SD ' ' A' ' 3' ' ' MET . 2.0 mptp? -66.9 -178.65 0.78 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.97 149.42 47.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.487 1.915 . . . . 0.0 110.003 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.0 p -93.14 171.21 9.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 123.518 1.628 . . . . 0.0 109.574 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -71.99 -33.4 68.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.016 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -89.84 43.53 1.15 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.63 2.372 . . . . 0.0 111.564 -176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p80 48.5 46.53 20.79 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.361 1.864 . . . . 0.0 114.234 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.0 mt-10 -121.25 158.21 28.61 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 109.275 170.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.43 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.8 p-90 -108.79 163.15 13.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.472 1.509 . . . . 0.0 107.358 165.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.18 154.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -143.34 80.66 1.68 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.122 1.369 . . . . 0.0 109.632 -172.425 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 20' ' ' ALA . 1.2 mt -80.56 117.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.454 1.502 . . . . 0.0 108.82 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.287 5.1 pt-20 -114.11 -101.18 0.42 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 116.732 -1.604 . . . . 0.0 108.988 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -64.08 1.1 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 122.321 2.328 . . . . 0.0 111.806 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -153.66 8.54 0.38 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.487 2.715 . . . . 0.0 109.873 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.5 t -127.92 126.45 66.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -90.71 141.81 28.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.695 0.398 . . . . 0.0 109.962 168.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 16.4 m -87.99 151.71 22.58 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.15 142.33 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.752 1.221 . . . . 0.0 109.327 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -158.47 170.39 35.11 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 163.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.782 HD11 HG21 ' A' ' 87' ' ' ILE . 30.7 pt -77.46 152.08 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 118.415 1.108 . . . . 0.0 110.695 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -80.8 171.81 14.54 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.916 -1.115 . . . . 0.0 112.508 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -21.52 62.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.37 1.068 . . . . 0.0 113.025 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -67.02 -31.21 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 119.765 -1.835 . . . . 0.0 111.859 169.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.504 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -81.2 -42.7 20.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.953 -1.092 . . . . 0.0 111.705 -172.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.655 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.9 pp0? -56.31 -22.32 29.72 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.372 0.533 . . . . 0.0 111.374 175.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -46.13 81.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.194 0.998 . . . . 0.0 109.371 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -81.01 -27.83 35.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.254 1.422 . . . . 0.0 112.515 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.508 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -78.02 -43.96 27.91 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.91 -150.03 51.6 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 124.517 1.056 . . . . 0.0 110.801 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -46.23 114.57 0.82 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.954 2.502 . . . . 0.0 108.081 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 36' ' ' VAL 0.276 8.9 p -111.08 173.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-O 122.774 1.273 . . . . 0.0 110.112 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.709 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.07 -23.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.413 -153.221 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.419 ' H ' ' H ' ' A' ' 36' ' ' VAL . 45.3 t80 -147.79 142.05 26.21 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.802 0.274 . . . . 0.0 111.237 175.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.25 132.47 55.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 159.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.5 137.63 42.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.805 168.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.2 mt -131.47 131.44 22.91 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.66 179.7 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.568 2.845 . . . . 0.0 113.149 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.39 156.77 24.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.549 -0.719 . . . . 0.0 111.146 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.99 19.21 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 0.0 113.457 -164.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.88 33.43 0.56 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -106.85 133.89 50.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.332 1.066 . . . . 0.0 110.829 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 150.72 48.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.378 0.99 . . . . 0.0 110.353 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -142.22 167.13 15.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.755 1.622 . . . . 0.0 110.624 169.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -116.85 170.49 8.58 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 127.758 2.423 . . . . 0.0 110.895 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 6.61 0.25 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.6 59.25 0.35 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -106.79 115.35 30.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.922 1.289 . . . . 0.0 108.994 -173.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.1 OUTLIER -70.28 33.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 127.736 2.414 . . . . 0.0 113.922 -173.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 53' ' ' VAL . 17.0 m -72.69 10.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 O-C-N 117.956 -2.965 . . . . 0.0 115.958 -167.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.85 51.85 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.221 0.918 . . . . 0.0 109.554 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.69 157.21 7.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.81 0.814 . . . . 0.0 111.034 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.452 HD12 HD13 ' A' ' 24' ' ' ILE . 15.2 mt -133.6 108.03 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -101.49 117.27 34.59 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 35' ' ' VAL . 56.2 p -99.61 -159.95 0.77 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.335 1.454 . . . . 0.0 111.7 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -43.55 -44.1 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.07 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -158.56 13.29 0.18 Allowed 'General case' 0 C--N 1.346 0.453 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 165.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.82 159.16 15.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.911 1.687 . . . . 0.0 108.148 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.32 96.59 3.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.385 1.474 . . . . 0.0 107.517 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -90.65 107.38 19.14 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.998 0.919 . . . . 0.0 110.311 176.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.31 117.33 4.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.238 1.815 . . . . 0.0 107.37 163.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.74 103.63 14.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -94.51 98.55 10.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -168.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.9 130.97 0.3 Allowed Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.924 2.09 . . . . 0.0 113.917 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.1 -29.68 39.54 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.279 2.653 . . . . 0.0 114.546 -167.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.9 mt -148.34 158.59 44.19 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.963 1.305 . . . . 0.0 108.079 -167.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -66.48 145.43 55.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.4 38.8 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -129.53 130.92 46.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.13 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.5 mm -63.66 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.2 m -145.71 -3.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.245 1.018 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -148.03 158.77 44.24 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.969 1.259 . . . . 0.0 107.845 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -142.45 158.38 19.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.333 1.453 . . . . 0.0 107.948 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -108.72 74.09 0.9 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.988 0.515 . . . . 0.0 110.141 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.65 -11.4 7.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -44.78 -42.34 7.71 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.313 1.445 . . . . 0.0 111.357 164.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -12.14 61.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.063 0.945 . . . . 0.0 110.893 -170.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.66 -11.21 57.75 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.707 1.203 . . . . 0.0 112.173 167.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -131.28 -36.18 1.31 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.828 . . . . 0.0 111.235 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -121.2 73.92 28.39 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.869 2.068 . . . . 0.0 107.233 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.89 -43.86 1.54 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.987 1.791 . . . . 0.0 107.657 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.617 ' HA ' HG12 ' A' ' 35' ' ' VAL . 96.4 mt-10 -56.07 -11.36 1.07 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.653 1.581 . . . . 0.0 112.285 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -57.43 -18.11 16.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.664 1.985 . . . . 0.0 111.99 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.782 HG21 HD11 ' A' ' 24' ' ' ILE . 3.8 mm -53.05 -37.95 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -68.02 -48.59 65.28 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 120.93 -1.106 . . . . 0.0 111.334 174.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 5.0 mtpt -77.74 -28.26 50.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 125.755 1.622 . . . . 0.0 113.126 -162.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.75 65.19 0.72 Allowed Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -177.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.98 -30.22 89.47 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.295 1.997 . . . . 0.0 112.756 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.1 mp0 -119.12 21.57 12.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.642 0.777 . . . . 0.0 110.046 177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.79 -121.53 4.86 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 105.874 -2.89 . . . . 0.0 105.874 157.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.54 -3.01 28.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.05 23.3 5.31 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 120.706 1.594 . . . . 0.0 112.7 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -63.2 162.02 12.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.722 1.761 . . . . 0.0 109.886 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.42 HD12 ' HA2' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -104.71 -56.16 2.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.132 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.03 173.81 12.12 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.209 -0.932 . . . . 0.0 112.014 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -124.72 152.54 43.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.788 0.835 . . . . 0.0 110.209 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -142.89 141.71 31.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.753 1.221 . . . . 0.0 110.493 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -64.63 133.51 52.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 pt -87.45 103.13 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 122.846 0.458 . . . . 0.0 110.322 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.5 m -66.86 -7.69 23.54 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -143.56 135.08 26.19 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -99.46 2.02 44.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.527 2.331 . . . . 0.0 108.158 162.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.81 -39.12 5.02 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.804 -1.185 . . . . 0.0 112.573 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -65.27 -24.13 67.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.42 1.11 . . . . 0.0 110.527 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 111' ' ' LEU . 2.7 mp -38.0 -44.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.533 2.733 . . . . 0.0 112.206 163.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -79.86 -7.34 58.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.272 1.396 . . . . 0.0 112.506 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -88.23 -12.75 42.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 111.639 168.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 108' ' ' LEU . 1.1 mm? -66.27 169.52 7.1 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.053 -1.655 . . . . 0.0 109.155 167.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.42 139.44 42.33 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.84 171.66 0.88 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.553 1.168 . . . . 0.0 109.232 159.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.13 -34.45 78.08 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.388 1.875 . . . . 0.0 111.251 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -80.55 -44.16 19.49 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.571 1.148 . . . . 0.0 109.514 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.16 72.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.106 0.479 . . . . 0.0 111.307 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -59.31 -39.9 84.55 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.175 0.99 . . . . 0.0 110.947 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.67 -45.32 72.02 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.178 0.591 . . . . 0.0 109.881 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 123.662 0.785 . . . . 0.0 110.45 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.6 ttm . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -138.64 121.18 16.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.949 154.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -113.42 179.97 3.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.316 1.847 . . . . 0.0 110.011 172.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 117' ' ' TYR . 70.6 m-85 -150.55 167.94 25.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.0 1.32 . . . . 0.0 110.508 -164.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -136.74 170.08 16.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.23 1.377 . . . . 0.0 111.371 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -68.5 -14.64 63.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 176.158 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -89.33 34.89 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.151 -1.593 . . . . 0.0 108.282 175.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 p80 41.73 64.16 1.13 Allowed 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.173 2.589 . . . . 0.0 110.723 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.492 1.517 . . . . 0.0 107.562 -166.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.9 p-90 -116.92 150.69 38.09 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.19 1.796 . . . . 0.0 110.043 176.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.57 122.91 15.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -161.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -120.38 97.79 5.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.449 1.022 . . . . 0.0 111.295 -163.606 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -108.49 102.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.484 1.113 . . . . 0.0 109.529 -164.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.46 -74.5 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.885 0.874 . . . . 0.0 110.11 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -74.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 108.066 -170.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -126.93 7.85 6.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.233 0.924 . . . . 0.0 113.344 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -134.69 142.66 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.79 137.54 38.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.029 1.332 . . . . 0.0 109.187 163.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 5.8 m -78.94 132.02 36.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 155.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.49 132.05 49.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.683 1.993 . . . . 0.0 108.762 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.493 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -149.69 168.82 29.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.548 1.071 . . . . 0.0 110.904 159.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.601 HD12 ' HB1' ' A' ' 28' ' ' ALA . 16.4 pt -89.06 159.19 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.334 0.653 . . . . 0.0 109.875 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -90.72 175.08 7.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.711 -1.243 . . . . 0.0 112.049 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -39.52 62.45 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.01 -1.056 . . . . 0.0 111.599 171.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -58.18 -22.5 51.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.398 1.079 . . . . 0.0 111.85 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 24' ' ' ILE . . . -89.56 -46.65 8.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.751 1.62 . . . . 0.0 112.172 -175.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -64.03 -22.83 67.09 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.12 0.418 . . . . 0.0 111.396 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -27.52 69.0 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.193 1.397 . . . . 0.0 111.716 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -90.11 -43.78 10.24 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.733 -0.605 . . . . 0.0 110.967 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.58 -35.75 14.08 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.954 -170.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.2 -119.42 8.68 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 125.373 1.464 . . . . 0.0 111.043 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.73 91.63 0.63 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.405 1.882 . . . . 0.0 106.728 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -74.88 -162.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.8 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -165.6 -35.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 130.249 3.42 . . . . 0.0 109.37 -169.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.478 ' H ' HG12 ' A' ' 35' ' ' VAL . 59.7 t80 -158.17 161.21 37.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.128 0.876 . . . . 0.0 112.667 -174.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.45 132.37 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.574 1.15 . . . . 0.0 110.951 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.78 136.02 36.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 108.869 170.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 80' ' ' LEU . 68.3 mt -130.95 144.39 53.35 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.062 1.745 . . . . 0.0 109.135 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.72 -179.25 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.586 2.857 . . . . 0.0 112.658 -169.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -73.49 148.11 43.45 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 110.065 166.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.71 9.18 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.642 2.377 . . . . 0.0 114.743 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.19 12.17 0.92 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 126.76 2.124 . . . . 0.0 110.503 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -66.52 145.14 55.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.212 1.006 . . . . 0.0 108.921 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -84.33 150.48 25.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.429 1.585 . . . . 0.0 110.575 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.562 HG22 HG11 ' A' ' 53' ' ' VAL 0.377 11.6 t -142.58 173.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.174 0 C-N-CA 129.782 3.233 . . . . 0.0 108.621 -175.257 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -141.89 169.46 17.54 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 129.362 3.065 . . . . 0.0 103.831 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 14.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.68 92.57 0.1 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 103.9 -3.68 . . . . 0.0 103.9 162.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.26 142.45 31.37 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 52' ' ' VAL . 46.1 t -79.12 32.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 130.341 3.456 . . . . 0.0 111.344 -164.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG11 HG22 ' A' ' 47' ' ' VAL . 23.5 m -68.41 1.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 119.431 -2.043 . . . . 0.0 111.788 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.6 73.2 1.17 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.886 1.675 . . . . 0.0 110.015 172.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.99 164.33 6.74 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 120.028 -1.67 . . . . 0.0 110.592 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mt -135.24 151.88 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.0 123.68 21.1 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.835 -1.165 . . . . 0.0 108.286 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 61' ' ' ALA . 48.4 t -107.21 -169.61 1.57 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.957 1.303 . . . . 0.0 107.952 -172.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.93 -33.82 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.86 1.264 . . . . 0.0 111.794 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -169.13 18.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.96 1.704 . . . . 0.0 112.827 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 58' ' ' SER . . . -113.48 152.64 29.89 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.269 0.941 . . . . 0.0 111.361 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.83 129.58 15.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.119 1.368 . . . . 0.0 109.254 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.3 107.93 2.27 Favored 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.634 4.374 . . . . 0.0 105.27 -163.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -67.35 134.75 52.11 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -78.46 120.12 28.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 164.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -102.86 105.58 15.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.57 132.58 1.34 Allowed Pre-proline 0 N--CA 1.452 -0.36 0 O-C-N 124.488 1.117 . . . . 0.0 112.331 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.02 -26.0 31.5 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.711 2.274 . . . . 0.0 113.491 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.4 151.26 34.97 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.261 1.425 . . . . 0.0 107.568 -163.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -72.48 128.38 35.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.16 40.62 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.626 -0.671 . . . . 0.0 111.919 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -128.52 131.09 48.28 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.328 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.2 mm -57.78 148.31 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 120.132 1.333 . . . . 0.0 108.368 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.81 -4.27 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.029 0.932 . . . . 0.0 112.747 164.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -150.5 156.51 41.57 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.349 1.432 . . . . 0.0 107.796 171.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.0 m -133.55 165.44 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.765 1.226 . . . . 0.0 108.017 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.98 83.03 1.69 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.253 0.621 . . . . 0.0 110.617 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.1 1.9 0.4 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -62.53 -43.02 99.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 119.802 -1.811 . . . . 0.0 108.49 166.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.554 ' CD1' HD23 ' A' ' 97' ' ' LEU . 92.1 mt -57.09 -14.29 3.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 113.704 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.1 -36.85 78.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.832 2.053 . . . . 0.0 110.698 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 p -127.5 -11.84 5.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.518 1.127 . . . . 0.0 112.413 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -117.31 58.3 2.29 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.254 1.822 . . . . 0.0 111.235 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.45 -18.16 18.02 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.641 2.227 . . . . 0.0 110.222 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.04 -13.89 60.92 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.382 0.992 . . . . 0.0 111.6 171.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -24.91 66.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.725 -1.859 . . . . 0.0 110.863 -172.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 80' ' ' LEU . 3.5 mt -62.65 -18.27 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 O-C-N 120.557 -1.339 . . . . 0.0 110.507 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -74.3 -53.57 9.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 119.171 -2.206 . . . . 0.0 111.33 161.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -68.73 -52.6 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.296 1.439 . . . . 0.0 109.958 -159.551 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.4 70.72 12.93 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 125.803 1.641 . . . . 0.0 106.7 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.99 -23.35 72.69 Favored 'Trans proline' 0 CA--C 1.511 -0.63 0 C-N-CA 123.059 2.506 . . . . 0.0 112.351 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP 0.294 0.4 OUTLIER -119.1 31.54 6.58 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.773 1.629 . . . . 0.0 109.27 -175.256 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -110.87 0.85 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.256 1.884 . . . . 0.0 109.03 166.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -72.96 -9.17 58.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.828 0.851 . . . . 0.0 113.104 -175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.74 21.92 33.68 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.854 1.216 . . . . 0.0 113.567 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -57.66 169.12 0.74 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.126 1.463 . . . . 0.0 110.309 165.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.554 HD23 ' CD1' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -120.6 -52.58 2.13 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.642 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -152.05 170.09 20.77 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 121.557 -0.714 . . . . 0.0 110.144 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -129.84 141.13 50.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.59 142.29 39.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.845 0.858 . . . . 0.0 110.105 -171.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.56 125.69 27.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.89 2.076 . . . . 0.0 106.935 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -81.77 97.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 124.328 1.018 . . . . 0.0 108.69 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -72.15 -16.12 61.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.39 172.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -137.93 79.2 1.73 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.597 ' HA ' HD21 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -65.25 -15.61 62.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.62 -0.675 . . . . 0.0 111.609 176.261 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.55 4.64 77.48 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 116.925 -2.042 . . . . 0.0 114.067 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -97.81 -28.91 13.64 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.691 1.745 . . . . 0.0 112.614 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -62.95 -34.06 76.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.652 1.569 . . . . 0.0 112.135 -173.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -56.0 -29.29 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 124.841 1.257 . . . . 0.0 112.698 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -84.97 -17.16 38.51 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 111.36 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -76.68 -174.08 2.85 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.589 1.155 . . . . 0.0 109.623 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.58 128.1 32.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.96 169.93 0.2 Allowed 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 122.023 0.916 . . . . 0.0 109.957 160.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.01 -43.06 75.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.732 1.613 . . . . 0.0 110.995 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -65.31 -50.97 63.64 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.475 1.51 . . . . 0.0 109.107 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.84 70.19 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.592 -0.692 . . . . 0.0 111.824 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 4.3 t80 -63.16 -44.0 96.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.009 0.924 . . . . 0.0 110.407 174.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.38 71.91 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.981 0.42 . . . . 0.0 109.909 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ptm . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -125.9 88.4 2.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.278 0.944 . . . . 0.0 109.947 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -92.49 174.73 7.13 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.697 -0.627 . . . . 0.0 111.707 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.16 177.24 7.99 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.288 1.435 . . . . 0.0 112.035 -169.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -130.67 168.03 17.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.1 1.36 . . . . 0.0 110.882 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.474 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -77.27 18.21 0.42 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.019 1.328 . . . . 0.0 111.414 159.304 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -125.23 26.67 6.83 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.458 -1.401 . . . . 0.0 110.496 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.6 p80 45.02 50.97 9.03 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 111.506 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -121.97 143.22 49.61 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -99.51 159.53 14.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 160.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.26 107.9 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.35 74.79 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.495 1.118 . . . . 0.0 110.503 -170.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.0 mp -64.7 146.16 13.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.718 1.207 . . . . 0.0 108.501 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -139.06 -70.6 0.41 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.083 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.4 -62.47 1.26 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.984 1.266 . . . . 0.0 111.006 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.05 15.36 2.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.01 1.324 . . . . 0.0 110.526 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.45 150.89 33.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -123.07 133.43 54.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.736 1.614 . . . . 0.0 107.261 167.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -77.47 113.59 15.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 164.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.12 135.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.3 170.32 31.56 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 165.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.569 HD11 ' CG2' ' A' ' 87' ' ' ILE . 15.7 pt -90.33 153.35 3.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 117.974 0.887 . . . . 0.0 110.466 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 p -91.25 164.58 13.83 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.211 -1.555 . . . . 0.0 109.654 171.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.545 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 13.4 p-10 -50.9 -37.18 42.29 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 114.151 -2.833 . . . . 0.0 115.308 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -49.24 -34.52 15.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 121.604 2.002 . . . . 0.0 109.46 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' HB1' HD12 ' A' ' 24' ' ' ILE . . . -64.57 -68.9 0.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.26 1.824 . . . . 0.0 112.9 173.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.545 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 6.1 pm0 -66.04 -24.58 66.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.695 1.589 . . . . 0.0 110.699 -171.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.99 -40.29 96.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.272 17.8 pt20 -75.05 -56.69 4.48 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.328 0.651 . . . . 0.0 112.248 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -35.62 81.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.682 0.674 . . . . 0.0 111.926 -170.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.53 -137.07 36.86 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.85 110.73 0.77 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 128.39 2.676 . . . . 0.0 110.105 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -93.1 172.82 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 124.693 2.187 . . . . 0.0 109.649 171.361 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.715 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.5 m -151.2 -37.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 129.432 3.093 . . . . 0.0 109.201 -160.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.404 ' H ' HG12 ' A' ' 35' ' ' VAL . 46.3 t80 -155.52 153.61 30.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.759 0.424 . . . . 0.0 110.776 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.44 135.43 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.843 0.83 . . . . 0.0 109.602 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.93 122.74 23.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 163.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.33 141.83 31.34 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 124.626 1.17 . . . . 0.0 107.907 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -76.3 179.45 6.36 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.717 2.278 . . . . 0.0 111.97 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -79.59 157.93 27.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.29 1.036 . . . . 0.0 110.232 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.41 15.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.291 1.437 . . . . 0.0 113.317 -171.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.34 15.29 0.39 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 128.41 2.91 . . . . 0.0 111.41 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -73.38 128.17 34.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.11 1.455 . . . . 0.0 109.051 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.26 146.76 45.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 73' ' ' ILE . 34.2 m -142.21 168.41 14.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 110.391 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 26.3 mtpt -126.21 170.68 11.6 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.741 1.616 . . . . 0.0 108.427 172.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 24.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -152.16 15.17 0.77 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.931 1.253 . . . . 0.0 113.012 167.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.43 113.78 13.23 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.06 1.93 . . . . 0.0 110.679 -168.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.79 94.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.81 5.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.545 1.538 . . . . 0.0 112.153 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.37 38.96 1.16 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.786 0.435 . . . . 0.0 110.643 -168.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.33 151.98 6.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 123.183 1.468 . . . . 0.0 111.067 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.79 134.78 53.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -115.22 124.34 51.15 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 161.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.8 p -99.14 -173.84 2.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.191 0.996 . . . . 0.0 109.647 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 m -42.9 -48.6 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.997 0.919 . . . . 0.0 111.381 171.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -160.25 85.13 0.73 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.069 0.85 . . . . 0.0 109.55 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -178.47 147.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.878 2.471 . . . . 0.0 106.23 157.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.34 152.83 18.04 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.25 120.13 14.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 130.5 47.24 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.983 2.113 . . . . 0.0 107.392 165.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.82 116.15 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -106.27 100.71 10.23 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.893 0.877 . . . . 0.0 110.738 -166.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.54 127.09 0.5 Allowed Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 126.801 2.04 . . . . 0.0 112.584 -172.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.52 -27.71 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.569 1.513 . . . . 0.0 114.129 -159.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.481 HD21 HD11 ' A' ' 111' ' ' LEU . 3.5 mm? -133.23 172.44 12.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.485 1.914 . . . . 0.0 108.634 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 49.7 m -93.48 123.02 36.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.093 1.357 . . . . 0.0 110.862 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.33 -158.27 20.7 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -164.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -139.76 142.12 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.079 -1.247 . . . . 0.0 108.304 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.597 HD12 ' CD1' ' A' ' 98' ' ' PHE . 6.3 mm -62.17 148.66 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.693 1.197 . . . . 0.0 108.226 176.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -146.46 -5.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -156.36 140.79 16.74 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.51 147.67 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -89.02 81.64 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.1 -15.71 4.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.122 0.969 . . . . 0.0 113.193 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -53.34 -39.6 64.23 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.988 2.115 . . . . 0.0 112.692 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -11.17 60.56 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.377 1.444 . . . . 0.0 111.313 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -69.3 -38.3 78.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.358 1.463 . . . . 0.0 111.164 171.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.4 p -110.86 -25.99 9.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.32 1.448 . . . . 0.0 112.847 -171.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -132.09 61.79 59.83 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 128.513 2.725 . . . . 0.0 109.449 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.67 -30.07 84.82 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.021 3.148 . . . . 0.0 111.502 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.83 -11.42 27.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.87 2.068 . . . . 0.0 111.896 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 86' ' ' LEU . 6.6 mt -64.46 -15.7 61.15 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 120.281 1.401 . . . . 0.0 113.043 168.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.569 ' CG2' HD11 ' A' ' 24' ' ' ILE . 84.8 mt -58.6 -32.34 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.502 1.046 . . . . 0.0 110.054 167.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -73.86 -55.02 6.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 119.709 -1.87 . . . . 0.0 109.082 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.464 ' HB2' HD23 ' A' ' 86' ' ' LEU . 15.3 mmmt -63.85 -56.46 15.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.391 1.476 . . . . 0.0 110.722 -168.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -138.63 57.17 11.11 Favored Pre-proline 0 C--O 1.239 0.523 0 O-C-N 124.691 1.245 . . . . 0.0 110.459 -165.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.74 -13.74 36.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.147 2.565 . . . . 0.0 112.116 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -109.22 -0.8 19.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.574 2.35 . . . . 0.0 110.756 -163.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.79 -81.09 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 125.947 1.737 . . . . 0.0 110.719 -174.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.12 -24.8 20.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.847 1.324 . . . . 0.0 113.212 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.63 31.89 1.44 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.372 1.463 . . . . 0.0 111.996 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -67.97 155.15 40.09 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.343 1.072 . . . . 0.0 109.229 173.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.15 -72.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.597 ' CD1' HD12 ' A' ' 73' ' ' ILE . 25.4 p90 -143.82 149.63 37.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.258 1.423 . . . . 0.0 108.371 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -99.25 150.71 21.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.67 142.76 43.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.47 138.16 48.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.076 1.35 . . . . 0.0 107.444 169.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 pt -96.02 111.92 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.513 0.725 . . . . 0.0 110.703 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 m -70.36 -38.03 74.7 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.073 -0.392 . . . . 0.0 111.346 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.62 81.07 1.98 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.154 0.982 . . . . 0.0 109.032 -164.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -7.31 24.11 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.97 -1.081 . . . . 0.0 111.748 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.66 -31.76 23.47 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.778 -1.201 . . . . 0.0 111.583 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -66.42 -8.98 29.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.7 -28.03 69.62 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.242 0.928 . . . . 0.0 110.946 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.16 -14.25 60.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.979 1.263 . . . . 0.0 111.391 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.85 -10.31 58.9 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.828 0.851 . . . . 0.0 111.616 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.481 HD11 HD21 ' A' ' 69' ' ' LEU . 77.9 mt -78.95 176.43 9.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.457 1.122 . . . . 0.0 110.534 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.7 133.14 34.31 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.149 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.79 166.44 13.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.379 1.561 . . . . 0.0 108.651 153.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -68.89 -35.93 77.45 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 125.447 1.499 . . . . 0.0 111.154 -168.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -67.38 -40.19 85.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.14 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.848 -0.533 . . . . 0.0 110.621 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.85 -44.04 97.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.603 0.361 . . . . 0.0 110.198 171.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -47.0 81.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.855 0.862 . . . . 0.0 110.698 172.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 118.145 0.43 . . . . 0.0 110.389 -178.257 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 83.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.267 -0.896 . . . . 0.0 110.119 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.531 ' H ' ' HE3' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -82.93 176.81 8.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 119.436 -0.905 . . . . 0.0 113.202 178.185 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -131.44 152.92 50.25 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.897 1.679 . . . . 0.0 109.222 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.8 p -101.84 -173.67 2.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.442 1.115 . . . . 0.0 109.716 -172.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -98.03 10.36 40.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.662 1.985 . . . . 0.0 111.244 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.0 p -119.92 32.73 5.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.726 1.61 . . . . 0.0 111.572 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.11 38.86 26.54 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.355 -1.466 . . . . 0.0 111.844 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.28 137.29 44.15 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.378 1.871 . . . . 0.0 108.724 -165.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.541 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 60.4 p-90 -106.25 166.48 10.49 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.62 1.168 . . . . 0.0 109.774 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.04 144.67 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 83.81 1.9 Allowed 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.351 1.061 . . . . 0.0 109.855 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.79 132.39 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 107.744 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -137.96 -12.92 1.45 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.82 -70.86 0.07 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 29.7 mttt -144.41 17.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.899 1.28 . . . . 0.0 111.225 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.0 t -143.56 128.34 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.96 131.34 34.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 158.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 99' ' ' LYS . 21.0 m -73.25 132.19 42.86 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 152.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.62 139.38 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 126.756 2.022 . . . . 0.0 107.656 171.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.21 164.69 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 163.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.583 HD11 HG21 ' A' ' 87' ' ' ILE . 6.9 pt -80.24 152.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 122.598 1.19 . . . . 0.0 109.168 167.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.1 p -77.32 166.07 23.64 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.519 1.128 . . . . 0.0 109.599 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -36.2 68.99 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.92 -33.24 61.93 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.644 -1.285 . . . . 0.0 112.381 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -67.87 -49.58 61.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.164 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.17 -27.11 68.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.512 1.051 . . . . 0.0 111.427 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -49.13 64.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.902 0.481 . . . . 0.0 109.867 -173.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -49.83 55.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.417 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -34.61 78.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.57 0.623 . . . . 0.0 110.169 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 -119.43 9.23 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.82 111.12 4.12 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.9 t -77.11 -168.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 152.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.595 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.6 p -176.75 -40.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -157.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -153.69 151.26 29.45 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.794 1.179 . . . . 0.0 110.832 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.748 HG22 HG23 ' A' ' 56' ' ' ILE . 84.5 t -134.13 133.59 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.66 137.32 32.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.361 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -136.28 149.18 67.14 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 124.319 1.048 . . . . 0.0 109.135 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HG2' HG21 ' A' ' 73' ' ' ILE . 37.0 Cg_endo -79.37 -174.02 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.821 3.014 . . . . 0.0 114.428 -172.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.46 162.03 20.07 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 119.837 -1.789 . . . . 0.0 112.928 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.27 16.13 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 126.997 2.119 . . . . 0.0 111.773 -171.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.75 10.26 0.79 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.764 2.126 . . . . 0.0 112.329 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.9 ttt85 -81.12 130.12 34.88 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.314 1.057 . . . . 0.0 108.678 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.8 151.23 37.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.609 HG11 HD11 ' A' ' 73' ' ' ILE . 15.8 m -143.25 165.77 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.768 1.227 . . . . 0.0 109.443 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -118.56 170.34 9.03 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.132 1.373 . . . . 0.0 107.599 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -62.82 15.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.36 86.62 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 166.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.54 128.58 25.47 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.96 1.704 . . . . 0.0 107.534 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 52' ' ' VAL . 26.8 t -72.01 38.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 127.56 2.344 . . . . 0.0 111.627 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.573 HG21 HG11 ' A' ' 47' ' ' VAL . 21.4 m -83.86 28.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 118.421 -2.674 . . . . 0.0 112.786 -170.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -167.72 66.54 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.41 1.004 . . . . 0.0 108.915 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.5 m -58.16 148.83 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.058 -1.026 . . . . 0.0 110.176 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.748 HG23 HG22 ' A' ' 38' ' ' VAL . 10.9 mt -122.37 109.03 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 124.37 34.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.569 ' HA ' HG12 ' A' ' 36' ' ' VAL . 80.4 p -102.47 -179.91 4.11 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.361 1.077 . . . . 0.0 109.532 171.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -48.32 -33.59 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.519 -1.673 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -148.19 5.67 0.75 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.92 170.41 9.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.627 1.558 . . . . 0.0 108.747 171.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.39 149.2 38.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 149.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.52 88.69 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -39.8 120.36 1.11 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 128.408 2.683 . . . . 0.0 107.999 161.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.43 136.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -113.39 98.73 7.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.416 0.686 . . . . 0.0 109.798 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -33.42 124.29 0.45 Allowed Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 124.765 1.29 . . . . 0.0 112.065 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.34 -23.96 11.19 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.653 1.568 . . . . 0.0 114.358 -157.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' O ' ' HE1' ' A' ' 100' ' ' MET . 4.2 mm? -141.36 156.98 45.77 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 127.505 2.322 . . . . 0.0 107.047 -174.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.6 m -74.23 138.43 43.68 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.316 1.417 . . . . 0.0 110.347 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.0 36.57 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.669 0.652 . . . . 0.0 111.803 -165.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -138.43 136.7 36.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.409 -1.054 . . . . 0.0 109.458 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.609 HD11 HG11 ' A' ' 47' ' ' VAL . 9.1 mm -65.3 146.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 108.941 176.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.39 4.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 110.909 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -162.25 151.1 15.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 41' ' ' PRO . 35.4 m -139.26 158.57 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.315 1.046 . . . . 0.0 108.46 175.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.72 76.78 1.41 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -57.91 -11.73 2.62 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.639 -0.663 . . . . 0.0 112.218 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -51.21 -31.55 20.87 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 111.699 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.5 HD12 HG21 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -80.16 -9.05 59.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.257 1.023 . . . . 0.0 110.514 -173.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.0 -30.41 70.52 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.41 1.084 . . . . 0.0 111.424 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.7 p -118.98 -20.36 8.14 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.732 0.813 . . . . 0.0 112.42 -171.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -136.85 67.14 56.99 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.759 2.023 . . . . 0.0 108.721 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.71 -26.17 60.94 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.345 2.697 . . . . 0.0 110.03 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.64 -15.66 53.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.332 1.053 . . . . 0.0 112.382 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -16.46 64.04 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.312 -1.493 . . . . 0.0 111.929 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 24' ' ' ILE . 37.7 mt -64.28 -28.89 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.978 0.808 . . . . 0.0 109.832 169.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -71.44 -55.19 8.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.083 -1.636 . . . . 0.0 108.972 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.01 -43.1 99.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.429 -169.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.33 87.14 2.95 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-O 119.178 -0.439 . . . . 0.0 110.234 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.1 -11.28 29.17 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.095 1.863 . . . . 0.0 112.737 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -125.98 8.42 7.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.407 1.483 . . . . 0.0 112.201 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -124.19 -71.15 0.22 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 124.397 0.998 . . . . 0.0 111.474 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.2 -25.36 7.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.341 1.056 . . . . 0.0 110.611 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.03 35.59 1.47 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.057 1.789 . . . . 0.0 112.865 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -64.98 159.29 23.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.214 1.507 . . . . 0.0 108.626 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 mt -99.32 -66.91 0.87 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -146.27 171.98 14.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.202 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 18.2 mttt -135.14 145.62 48.0 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 124.323 1.049 . . . . 0.0 109.392 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.484 ' HB3' HD13 ' A' ' 73' ' ' ILE . 1.6 ptm -149.07 140.11 22.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.029 -172.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 18' ' ' LYS . 33.0 tt0 -62.78 143.89 57.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.492 1.117 . . . . 0.0 109.412 172.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.9 pt -90.4 109.03 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 123.928 0.767 . . . . 0.0 109.139 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -67.38 -35.55 79.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.166 0.439 . . . . 0.0 110.558 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -135.42 70.73 1.43 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -156.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.536 ' HA ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -57.65 -17.62 15.75 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 172.651 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.46 -21.95 74.04 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.696 1.589 . . . . 0.0 113.294 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -72.43 -12.75 61.24 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 119.235 1.517 . . . . 0.0 111.338 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.536 HD13 ' HA ' ' A' ' 105' ' ' GLU . 0.6 OUTLIER -56.09 -36.13 67.79 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.881 173.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.23 -7.83 49.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.097 0.862 . . . . 0.0 112.34 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.96 -19.06 41.41 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.705 1.202 . . . . 0.0 109.983 172.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.95 161.32 23.1 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 123.32 1.534 . . . . 0.0 109.87 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.91 140.69 43.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.941 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.24 167.72 2.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 163.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.24 -47.02 78.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.544 1.537 . . . . 0.0 110.777 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -61.91 -50.8 70.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.84 -32.16 72.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.144 0.578 . . . . 0.0 110.2 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.73 -44.93 96.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.978 0.911 . . . . 0.0 111.26 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.32 -46.8 72.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.61 0.641 . . . . 0.0 109.992 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 CA--C 1.535 0.379 0 C-N-CA 124.747 1.219 . . . . 0.0 111.141 175.47 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 tpp . . . . . 0 C--O 1.23 0.079 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -133.98 69.96 1.46 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.866 0.841 . . . . 0.0 109.204 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -80.87 175.59 10.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.895 171.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -137.57 169.08 18.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.741 2.417 . . . . 0.0 108.921 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -107.36 174.03 6.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.425 1.49 . . . . 0.0 108.955 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -77.22 -32.37 55.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.804 174.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -88.94 29.21 1.06 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.323 1.849 . . . . 0.0 113.229 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.02 41.89 3.49 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.224 -1.548 . . . . 0.0 112.59 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -124.8 150.29 46.5 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.445 1.098 . . . . 0.0 109.794 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.473 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 67.4 p-90 -105.08 172.54 6.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.863 0.839 . . . . 0.0 111.114 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.09 152.74 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.651 1.58 . . . . 0.0 107.071 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.29 81.47 1.71 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.649 1.179 . . . . 0.0 109.748 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 mp -65.99 150.07 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.662 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 3.4 pt-20 -142.71 -65.5 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.333 1.453 . . . . 0.0 108.797 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 13.3 t70 -126.52 -77.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.118 2.567 . . . . 0.0 108.222 -170.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.75 9.78 2.41 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 128.16 2.584 . . . . 0.0 110.963 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.63 155.68 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.755 1.622 . . . . 0.0 107.051 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.67 139.57 53.74 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 125.343 1.457 . . . . 0.0 108.294 165.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.1 m -83.97 143.57 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 t -122.11 143.03 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.54 2.336 . . . . 0.0 109.911 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.58 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -154.44 174.22 32.84 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 158.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 pt -74.2 165.12 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 117.837 0.819 . . . . 0.0 108.838 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -90.06 173.28 8.28 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.001 -1.062 . . . . 0.0 113.234 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.417 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -74.36 9.39 1.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 175.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -100.72 0.21 38.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.038 2.135 . . . . 0.0 112.624 167.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.43 -58.62 1.9 Allowed 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.571 -1.331 . . . . 0.0 110.573 -163.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.417 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -41.46 -42.17 2.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.72 2.808 . . . . 0.0 111.997 166.19 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.63 -52.99 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.394 3.078 . . . . 0.0 110.223 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -72.32 -35.47 68.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.719 -0.613 . . . . 0.0 111.453 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -65.13 -48.34 73.92 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.586 1.154 . . . . 0.0 110.162 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.79 -158.63 41.14 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.96 128.42 15.92 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.806 2.043 . . . . 0.0 109.147 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.595 HG22 ' H ' ' A' ' 36' ' ' VAL 0.446 6.0 p -123.89 154.88 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.595 ' H ' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -153.43 -31.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.632 -142.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -146.95 150.5 35.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.636 0.653 . . . . 0.0 111.843 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.27 133.02 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.514 1.15 . . . . 0.0 109.902 168.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.02 145.7 51.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.452 170.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.521 HD11 HD12 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -130.77 151.87 79.56 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 163.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.43 176.14 8.25 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.197 2.598 . . . . 0.0 111.702 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.16 141.88 35.28 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.41 22.06 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 129.024 2.929 . . . . 0.0 115.173 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.37 6.84 0.7 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.091 1.329 . . . . 0.0 113.308 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -79.84 141.86 35.8 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.829 1.815 . . . . 0.0 110.116 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -79.42 149.38 31.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.014 0.825 . . . . 0.0 109.098 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.0 171.0 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 110.062 -176.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -116.15 166.01 12.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.227 1.411 . . . . 0.0 110.537 174.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -64.82 14.82 0.02 OUTLIER 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.063 2.145 . . . . 0.0 116.131 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.66 67.07 0.23 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 173.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -134.13 128.07 33.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -175.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 52' ' ' VAL . 24.8 t -87.84 53.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 127.46 2.304 . . . . 0.0 110.042 -161.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -86.52 9.01 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 120.014 -1.679 . . . . 0.0 113.631 -158.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.35 50.26 0.28 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.879 0.872 . . . . 0.0 110.221 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 148.72 20.46 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.631 -0.668 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 mt -117.92 135.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.11 117.11 29.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.979 1.312 . . . . 0.0 107.925 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -99.18 -165.89 1.29 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.756 0.707 . . . . 0.0 110.679 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -46.75 -38.91 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.731 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.84 55.81 0.2 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.454 1.479 . . . . 0.0 111.559 155.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.79 167.8 16.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.512 -0.742 . . . . 0.0 109.961 165.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.2 151.45 39.11 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 152.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -131.39 112.9 13.13 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.964 1.706 . . . . 0.0 106.585 160.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -70.78 107.98 4.24 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 170.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -76.0 111.04 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -86.22 116.51 24.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.42 135.15 5.73 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.107 0.963 . . . . 0.0 110.078 169.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.55 -32.38 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.116 1.877 . . . . 0.0 113.845 -161.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.08 166.69 19.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.555 2.342 . . . . 0.0 106.397 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 m -81.46 134.39 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -171.94 44.9 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 120.759 -1.213 . . . . 0.0 111.132 -166.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -121.63 132.61 54.76 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 117.655 -1.164 . . . . 0.0 109.647 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -60.95 140.18 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -147.35 1.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.802 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -148.62 160.65 42.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.685 1.584 . . . . 0.0 109.066 162.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.7 155.69 14.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.369 1.468 . . . . 0.0 108.438 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -108.02 70.96 0.78 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.45 -15.16 15.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 112.477 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -53.28 -29.89 35.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 116.855 -1.545 . . . . 0.0 112.991 166.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 40' ' ' LEU . 76.3 mt -57.01 -14.7 3.9 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 121.186 1.812 . . . . 0.0 113.269 174.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.2 1.818 . . . . 0.0 112.903 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.0 p -124.13 -27.15 3.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.094 1.358 . . . . 0.0 110.858 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.34 64.21 14.19 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 128.042 2.537 . . . . 0.0 110.11 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -73.72 -52.08 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.728 2.952 . . . . 0.0 109.858 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -53.64 -17.63 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.179 1.791 . . . . 0.0 110.524 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -30.48 34.96 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.454 1.934 . . . . 0.0 111.518 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -58.6 -25.69 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 121.825 -0.547 . . . . 0.0 110.047 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -64.83 -53.51 45.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.444 -2.035 . . . . 0.0 110.814 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -49.31 70.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.777 . . . . 0.0 110.342 -164.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -148.73 79.62 8.56 Favored Pre-proline 0 N--CA 1.451 -0.393 0 O-C-N 123.899 0.75 . . . . 0.0 110.151 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.57 -17.44 59.97 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.802 1.668 . . . . 0.0 112.444 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.473 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 3.6 mp0 -114.75 14.4 17.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.264 0.626 . . . . 0.0 112.592 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.34 -89.95 0.28 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.81 -32.25 35.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 122.94 0.496 . . . . 0.0 111.899 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.41 36.34 2.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.245 0.926 . . . . 0.0 112.698 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -66.42 169.33 7.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.025 1.412 . . . . 0.0 109.452 166.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.58 HD12 ' HA2' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -119.88 -59.76 1.77 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.72 168.31 20.49 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.711 -1.243 . . . . 0.0 111.023 -171.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -125.72 155.32 41.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.288 1.035 . . . . 0.0 108.47 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -146.46 143.99 29.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.215 0.606 . . . . 0.0 110.727 -177.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.9 139.04 58.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.651 1.18 . . . . 0.0 108.025 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 pt -88.21 104.72 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 122.578 0.351 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -33.99 70.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.85 0.46 . . . . 0.0 110.391 171.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -147.36 103.39 3.56 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 125.931 1.692 . . . . 0.0 107.216 -171.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.538 ' HA ' HD13 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -71.46 -1.95 14.98 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.807 1.243 . . . . 0.0 109.712 160.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.1 -64.46 4.32 Favored Glycine 0 C--N 1.338 0.653 0 O-C-N 120.789 -1.194 . . . . 0.0 111.959 168.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -71.4 -10.04 59.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -164.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 105' ' ' GLU . 1.1 mp -46.48 -48.33 19.14 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.29 1.436 . . . . 0.0 110.455 163.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -75.82 -15.24 60.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.668 0.667 . . . . 0.0 111.024 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -86.66 -18.01 32.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.121 1.368 . . . . 0.0 110.943 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mt -80.32 -178.78 6.79 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.233 2.213 . . . . 0.0 110.975 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.3 mt -87.78 121.05 29.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.165 0.986 . . . . 0.0 110.249 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.99 166.8 15.07 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.112 0.965 . . . . 0.0 110.786 163.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.57 -57.72 4.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.184 1.794 . . . . 0.0 112.091 -160.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -50.21 -46.61 54.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.512 1.525 . . . . 0.0 110.01 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.58 -25.21 41.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.943 1.297 . . . . 0.0 111.901 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.91 -40.6 91.64 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 127.778 2.431 . . . . 0.0 109.844 167.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.42 -52.2 59.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 125.083 1.353 . . . . 0.0 111.066 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -142.78 114.82 8.27 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.519 1.128 . . . . 0.0 111.453 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -113.0 179.77 3.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.82 161.56 37.26 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.367 1.867 . . . . 0.0 110.194 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -125.62 173.38 9.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.437 1.113 . . . . 0.0 110.182 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -89.91 17.01 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.898 1.679 . . . . 0.0 110.849 -169.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.438 HG21 ' HB2' ' A' ' 66' ' ' TYR . 15.1 t -135.53 57.72 1.78 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.5 p80 44.42 52.77 7.27 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.807 1.643 . . . . 0.0 112.984 172.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -128.99 149.96 50.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.425 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 54.5 p-90 -121.35 162.53 20.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.648 1.579 . . . . 0.0 110.19 170.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.494 HG12 ' HB1' ' A' ' 20' ' ' ALA . 1.8 t -141.77 126.15 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.477 1.511 . . . . 0.0 107.995 -166.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.43 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.4 m -117.01 75.47 0.97 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.7 2.4 . . . . 0.0 110.004 -170.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.9 mp -74.0 97.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.108 1.363 . . . . 0.0 108.485 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.05 -56.02 3.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 118.112 -0.946 . . . . 0.0 111.541 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.16 -76.15 0.45 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.41 0.55 . . . . 0.0 110.173 -166.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -125.52 2.95 7.64 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.834 1.254 . . . . 0.0 111.086 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.25 143.14 41.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.494 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -117.62 109.05 16.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.174 1.789 . . . . 0.0 108.971 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 41.0 m -68.76 143.75 54.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.5 OUTLIER -115.32 152.44 16.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 127.647 2.379 . . . . 0.0 112.512 176.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.18 161.09 32.25 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 160.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.588 HD11 HG21 ' A' ' 87' ' ' ILE . 7.1 pt -73.52 149.23 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.072 -1.252 . . . . 0.0 108.506 170.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 p -76.41 170.35 16.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.967 0.889 . . . . 0.0 111.657 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -62.63 -33.66 75.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.885 -1.134 . . . . 0.0 112.794 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -58.92 -25.7 63.69 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.264 -0.898 . . . . 0.0 112.056 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.27 -47.63 41.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.386 -0.822 . . . . 0.0 111.211 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -64.42 -27.79 69.24 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.837 -0.539 . . . . 0.0 110.56 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -63.43 -28.4 69.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.701 1.2 . . . . 0.0 111.47 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.75 -54.67 4.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.843 0.857 . . . . 0.0 111.959 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.81 -43.7 98.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.371 0.532 . . . . 0.0 110.118 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.52 -114.17 4.55 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.57 96.08 0.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.686 1.594 . . . . 0.0 109.057 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.749 HG12 ' H ' ' A' ' 36' ' ' VAL . 3.4 t -78.62 -178.77 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 162.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.749 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.8 p -169.2 -33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 126.431 1.892 . . . . 0.0 108.487 -146.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.431 ' H ' HG12 ' A' ' 35' ' ' VAL . 40.3 t80 -166.44 157.61 12.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.222 0.951 . . . . 0.0 111.008 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -138.15 146.93 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.86 148.11 22.71 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.176 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -137.72 142.98 38.52 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 123.897 0.879 . . . . 0.0 111.161 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.37 175.44 10.75 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.029 2.486 . . . . 0.0 111.077 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -87.85 147.67 25.01 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.348 0.659 . . . . 0.0 110.107 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.77 16.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 129.816 3.246 . . . . 0.0 116.436 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.72 6.32 0.87 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.655 1.598 . . . . 0.0 113.222 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -76.55 135.97 39.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.878 1.339 . . . . 0.0 110.487 -171.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -78.11 143.04 37.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.344 1.429 . . . . 0.0 108.902 167.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.07 -177.08 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.795 1.238 . . . . 0.0 108.645 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -131.55 160.75 34.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.062 1.345 . . . . 0.0 108.547 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 10.28 0.23 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.64 102.61 0.21 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 105.472 -3.051 . . . . 0.0 105.472 160.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.88 131.71 14.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.992 1.717 . . . . 0.0 107.097 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.628 HG13 ' HB3' ' A' ' 64' ' ' ASP . 55.1 t -69.92 16.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.805 2.042 . . . . 0.0 114.33 -169.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.38 -0.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 119.317 -2.114 . . . . 0.0 115.528 -163.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -142.51 60.08 1.44 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.677 1.126 . . . . 0.0 108.375 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 m -56.74 163.04 2.03 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.597 1.189 . . . . 0.0 111.346 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.8 mt -132.85 144.77 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 35' ' ' VAL . 16.4 mt-10 -122.27 165.86 15.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -139.62 -177.49 4.98 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.9 m -51.45 -23.83 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 125.504 1.522 . . . . 0.0 112.118 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.53 13.58 0.23 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.39 168.78 19.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.79 1.632 . . . . 0.0 110.04 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.78 164.94 27.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.205 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.65 118.44 5.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.77 1.228 . . . . 0.0 110.031 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.628 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -67.86 117.21 9.45 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 167.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.59 121.63 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.535 1.516 . . . . 0.0 106.976 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.438 ' HB2' HG21 ' A' ' 9' ' ' THR . 38.4 m-85 -88.98 111.16 21.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.692 0.678 . . . . 0.0 109.533 171.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.32 156.64 0.23 Allowed Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 128.078 2.551 . . . . 0.0 114.528 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -96.62 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 116.157 1.56 . . . . 0.0 116.157 -163.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' CD2' HG11 ' A' ' 13' ' ' VAL . 3.5 mm? -136.41 169.73 17.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.577 1.551 . . . . 0.0 107.606 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 m -101.26 65.56 1.07 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.839 1.256 . . . . 0.0 111.761 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.63 -165.84 12.54 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.199 1.857 . . . . 0.0 111.774 -164.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -119.17 123.69 44.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 118.1 0.95 . . . . 0.0 110.81 -176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.437 HD12 ' CD1' ' A' ' 98' ' ' PHE . 20.7 mm -59.77 142.01 15.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.3 m -146.75 -5.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.43 163.68 39.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.658 1.117 . . . . 0.0 108.792 169.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 m -149.83 144.18 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -95.12 81.2 3.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.76 1.618 . . . . 0.0 108.846 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.78 -11.52 27.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -26.79 65.91 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.375 1.07 . . . . 0.0 111.812 169.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -8.69 58.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.535 1.061 . . . . 0.0 109.941 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -80.09 -4.87 54.62 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 112.269 170.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -137.75 -25.07 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.595 0.758 . . . . 0.0 112.589 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.81 67.44 42.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.905 2.082 . . . . 0.0 109.512 168.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.81 -20.15 58.72 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.203 2.602 . . . . 0.0 111.186 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.97 -16.12 48.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.911 -1.042 . . . . 0.0 111.935 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 86' ' ' LEU . 5.3 mt -60.88 -20.63 62.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.972 1.715 . . . . 0.0 113.414 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.588 HG21 HD11 ' A' ' 24' ' ' ILE . 15.3 mt -59.71 -32.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -66.13 -47.46 74.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 122.654 1.216 . . . . 0.0 110.123 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -69.65 -47.37 63.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.604 -1.635 . . . . 0.0 111.425 -165.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.32 83.17 4.18 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 172.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -62.89 -20.64 71.89 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.179 1.253 . . . . 0.0 111.135 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 1.2 mt-10 -112.65 21.53 15.49 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.818 1.247 . . . . 0.0 111.58 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.92 -101.87 0.97 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -86.62 -20.86 27.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.5 0.72 . . . . 0.0 111.308 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.52 37.05 2.03 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-N 120.001 1.273 . . . . 0.0 113.658 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -68.62 157.5 36.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.83 1.252 . . . . 0.0 110.242 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.66 -67.36 0.87 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-O 116.904 -1.522 . . . . 0.0 108.486 176.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.522 ' O ' HG13 ' A' ' 22' ' ' VAL . 53.1 p90 -133.49 -176.94 4.32 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.191 2.269 . . . . 0.0 111.762 -175.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -136.87 141.58 42.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -141.71 138.32 32.31 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.278 0.631 . . . . 0.0 109.494 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -62.51 126.11 26.23 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.695 1.998 . . . . 0.0 106.243 168.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.9 pt -75.78 135.81 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.7 m -117.26 -11.12 10.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.017 1.727 . . . . 0.0 113.421 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -145.23 81.37 1.63 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -6.33 44.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.517 -1.364 . . . . 0.0 112.365 -177.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.51 66.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.02 -7.02 14.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.83 -42.1 98.62 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.209 0.913 . . . . 0.0 109.023 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -71.86 -0.2 10.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.398 0.679 . . . . 0.0 111.32 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -85.69 -19.15 31.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.87 0.759 . . . . 0.0 111.497 168.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.41 174.59 8.43 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.174 1.79 . . . . 0.0 111.413 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.46 142.97 38.89 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.418 1.087 . . . . 0.0 110.158 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -59.81 170.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 109.086 158.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -68.47 -51.36 44.37 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.046 -1.033 . . . . 0.0 110.187 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.37 -47.8 84.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.533 ' H ' ' HB2' ' A' ' 113' ' ' ASP . . . -63.96 -30.31 71.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.68 0.673 . . . . 0.0 112.09 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -67.29 -40.94 86.16 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.402 0.547 . . . . 0.0 110.956 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.64 -53.07 60.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.244 169.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 120.176 1.353 . . . . 0.0 109.948 -172.211 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ttp . . . . . 0 C--O 1.23 0.051 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -140.71 100.24 3.8 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 113' ' ' ASP . 0.3 OUTLIER -101.76 179.3 4.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -143.54 174.98 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.686 1.594 . . . . 0.0 108.669 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.455 HG22 HD22 ' A' ' 111' ' ' LEU . 54.8 p -133.82 -165.14 1.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.129 0.966 . . . . 0.0 112.624 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -30.96 42.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.631 2.372 . . . . 0.0 111.135 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.13 30.21 0.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.249 -0.907 . . . . 0.0 111.502 -167.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 p80 45.33 27.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.121 1.769 . . . . 0.0 115.026 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.9 mt-10 -82.8 165.34 19.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.744 3.218 . . . . 0.0 112.628 160.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 61.2 p-90 -124.46 170.09 11.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.218 2.207 . . . . 0.0 109.014 163.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.12 142.39 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.59 88.33 2.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.479 1.112 . . . . 0.0 109.738 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.88 89.48 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -175.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -69.88 0.31 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.28 -98.32 0.39 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -122.23 11.01 10.06 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.235 1.414 . . . . 0.0 110.79 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.72 119.71 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.4 124.53 36.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 m -76.63 128.44 34.71 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 162.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.57 134.81 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 108.016 167.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.665 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -147.12 172.01 27.67 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 162.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HG21 ' A' ' 87' ' ' ILE . 6.1 pt -88.6 148.92 4.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 118.586 1.193 . . . . 0.0 109.367 169.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.1 p -77.04 169.6 18.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.062 0.945 . . . . 0.0 110.954 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.85 63.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.169 0.988 . . . . 0.0 111.883 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -59.33 -18.5 38.63 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.356 -0.84 . . . . 0.0 113.149 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -84.33 -51.0 7.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.997 -1.065 . . . . 0.0 111.189 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -60.89 -21.48 63.36 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.668 0.667 . . . . 0.0 111.574 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.13 -16.12 40.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.866 2.066 . . . . 0.0 113.731 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -112.22 -51.3 2.85 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.737 0.699 . . . . 0.0 110.022 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mt -65.01 -36.32 84.03 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.59 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.88 -125.45 27.87 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 125.339 1.447 . . . . 0.0 110.002 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.69 113.13 3.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -87.63 -164.0 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.693 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.2 p -173.19 -38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.22 1.808 . . . . 0.0 107.124 -153.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.473 ' H ' HG12 ' A' ' 35' ' ' VAL . 68.5 t80 -154.21 152.55 30.49 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 123.561 0.538 . . . . 0.0 111.524 -176.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.812 HG22 HG23 ' A' ' 56' ' ' ILE . 71.6 t -139.17 128.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -72.63 134.72 45.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.921 166.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.7 mt -128.88 138.7 33.73 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.08 179.18 6.01 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.387 2.725 . . . . 0.0 113.772 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.48 166.78 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.137 0.975 . . . . 0.0 110.119 169.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.62 21.38 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 124.484 2.088 . . . . 0.0 112.786 -162.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.57 10.86 0.52 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 129.269 3.318 . . . . 0.0 111.315 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -76.95 132.45 39.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.085 -1.244 . . . . 0.0 108.238 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -86.35 145.24 26.97 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 53' ' ' VAL . 30.7 m -131.67 164.22 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.563 1.545 . . . . 0.0 110.061 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' H ' ' HB2' ' A' ' 51' ' ' GLU . 59.3 mtmt -116.56 170.19 8.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.116 1.766 . . . . 0.0 108.401 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.72 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.023 2.929 . . . . 0.0 117.96 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.54 35.8 0.43 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.512 165.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -86.04 115.71 23.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.949 1.874 . . . . 0.0 109.683 -173.606 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' VAL 0.416 0.2 OUTLIER -63.43 25.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 129.962 3.305 . . . . 0.0 115.609 -175.703 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 47' ' ' VAL . 27.6 m -68.92 13.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 118.573 -2.58 . . . . 0.0 116.133 -169.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.36 43.93 0.61 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 120.517 1.508 . . . . 0.0 111.163 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -46.82 145.07 2.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.875 1.27 . . . . 0.0 112.223 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.812 HG23 HG22 ' A' ' 38' ' ' VAL . 7.3 mt -126.98 104.9 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -173.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.88 131.96 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -104.91 -173.7 2.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.893 0.877 . . . . 0.0 109.936 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 m -47.87 -27.82 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.62 15.45 0.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.54 -179.28 5.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.561 1.528 . . . . 0.0 110.504 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.11 137.61 27.64 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.53 107.38 7.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.882 1.673 . . . . 0.0 108.683 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB3' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -55.64 144.0 28.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.716 1.206 . . . . 0.0 107.946 170.383 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 97' ' ' LEU . 54.1 t -116.42 113.27 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -106.01 99.06 8.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.277 1.031 . . . . 0.0 110.297 -166.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.76 134.69 2.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 O-C-N 124.58 1.175 . . . . 0.0 111.718 -164.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.1 -24.85 16.69 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.365 1.376 . . . . 0.0 113.409 -165.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 108' ' ' LEU . 1.1 mp -142.58 166.86 23.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.193 1.397 . . . . 0.0 108.935 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -89.3 122.9 33.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.723 1.209 . . . . 0.0 108.262 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.15 -161.37 24.03 Favored Glycine 0 C--O 1.235 0.193 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -172.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -132.93 130.3 39.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.298 1.049 . . . . 0.0 109.686 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.514 HD12 ' CD1' ' A' ' 98' ' ' PHE . 8.9 mm -58.39 151.72 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 108.165 175.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -167.29 -14.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.192 -165.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -146.13 153.57 40.82 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 168.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.92 138.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.418 ' HB2' ' CD2' ' A' ' 96' ' ' TRP . 61.4 t30 -87.16 89.52 8.02 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.99 -9.24 9.26 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.708 0.803 . . . . 0.0 111.745 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -62.4 -45.28 93.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.024 1.33 . . . . 0.0 108.825 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.32 -14.6 63.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 120.249 1.386 . . . . 0.0 114.141 -170.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -62.17 -30.67 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.421 1.088 . . . . 0.0 111.529 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.8 p -134.38 -7.96 2.56 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.38 70.46 81.86 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.423 1.089 . . . . 0.0 108.238 159.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HB3' HG23 ' A' ' 38' ' ' VAL . 9.3 Cg_endo -63.15 -16.11 52.33 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.546 2.83 . . . . 0.0 110.086 169.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 -19.75 64.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 118.018 -0.992 . . . . 0.0 112.065 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.4 mt -65.4 -17.17 64.33 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 121.025 1.739 . . . . 0.0 112.787 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.509 HG21 HD11 ' A' ' 24' ' ' ILE . 2.8 mt -64.52 -29.13 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 118.801 -0.619 . . . . 0.0 110.724 169.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -70.29 -53.87 15.03 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 120.814 1.643 . . . . 0.0 109.779 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.427 ' HB2' HD23 ' A' ' 86' ' ' LEU . 1.2 mmtp -60.63 -43.49 97.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.825 1.65 . . . . 0.0 112.063 -171.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.91 74.75 5.04 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 124.39 1.076 . . . . 0.0 108.269 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -55.29 -29.64 68.33 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.822 1.681 . . . . 0.0 111.734 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 7.6 mp0 -104.62 3.43 31.68 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.358 1.463 . . . . 0.0 112.769 -169.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.89 -86.56 0.57 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -172.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.49 -7.48 38.0 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.751 -0.852 . . . . 0.0 111.848 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.66 25.53 18.42 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.416 1.484 . . . . 0.0 112.344 172.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.418 ' CD2' ' HB2' ' A' ' 77' ' ' ASN . 16.8 p-90 -60.98 159.54 11.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.595 1.198 . . . . 0.0 109.229 166.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.671 HD13 HG11 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -105.63 -54.07 2.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 109.681 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.514 ' CD1' HD12 ' A' ' 73' ' ' ILE . 41.3 p90 -148.43 168.15 23.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -128.3 151.5 49.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.6 ptm -143.48 145.86 32.94 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.069 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.52 128.76 37.3 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 160.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt -81.44 136.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.61 -21.56 14.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.76 1.224 . . . . 0.0 111.349 167.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -138.08 64.35 1.51 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.904 1.335 . . . . 0.0 111.595 -171.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -5.48 0.07 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.486 1.915 . . . . 0.0 112.846 160.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.87 -25.94 18.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.685 1.612 . . . . 0.0 112.065 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.76 -5.54 46.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.614 1.707 . . . . 0.0 111.122 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.442 HD23 HD21 ' A' ' 69' ' ' LEU . 74.8 mt -54.09 -21.87 9.57 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.528 0.731 . . . . 0.0 111.261 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.063 1.345 . . . . 0.0 113.188 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.95 -24.31 35.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.284 1.434 . . . . 0.0 110.423 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 HD22 HG22 ' A' ' 7' ' ' THR . 9.5 mt -85.1 156.18 21.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.363 1.078 . . . . 0.0 108.577 -175.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.49 ' H ' HD22 ' A' ' 112' ' ' LEU . 0.8 OUTLIER -75.75 134.6 40.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -176.536 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.414 ' HA ' ' HE2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -62.17 179.06 0.32 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 123.442 1.592 . . . . 0.0 110.386 155.365 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -73.35 -39.89 64.83 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.291 -168.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -67.16 -49.19 65.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.84 69.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.021 1.728 . . . . 0.0 111.421 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -61.83 -38.12 86.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.271 1.028 . . . . 0.0 112.692 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -73.59 -46.16 48.81 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 125.105 1.362 . . . . 0.0 111.265 177.145 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 C--O 1.238 0.467 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.04 95.76 4.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -170.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.499 ' CE ' HD23 ' A' ' 108' ' ' LEU . 1.8 mppt? -75.49 179.93 4.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 110.399 165.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -142.23 178.5 7.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.25 1.42 . . . . 0.0 110.898 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 p -135.89 174.61 10.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.959 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -75.32 -35.23 61.25 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.88 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.25 51.71 2.03 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.77 1.623 . . . . 0.0 108.816 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 p80 42.85 52.28 5.13 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.8 -1.187 . . . . 0.0 113.423 165.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.8 mt-10 -114.21 154.37 27.99 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.337 1.455 . . . . 0.0 108.06 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 54.7 p-90 -108.11 162.41 14.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 157.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 69' ' ' LEU . 1.5 t -124.88 164.08 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -149.47 77.02 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.818 1.19 . . . . 0.0 109.508 -177.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.47 HG13 ' HB2' ' A' ' 20' ' ' ALA . 9.6 mt -72.37 93.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -71.56 -64.51 0.91 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.95 -86.49 0.42 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.159 0.584 . . . . 0.0 109.809 -169.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -119.47 -2.0 10.62 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.0 2.12 . . . . 0.0 110.073 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -116.25 141.58 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -102.25 161.7 13.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 162.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 16.3 m -111.19 148.91 31.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 163.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -112.92 145.83 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.1 3.36 . . . . 0.0 113.134 169.299 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.49 169.44 34.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 107.271 -2.331 . . . . 0.0 107.271 155.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.737 HD11 HG21 ' A' ' 87' ' ' ILE . 41.7 pt -81.69 157.16 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 O-C-N 121.837 -0.802 . . . . 0.0 109.829 170.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -78.16 166.4 22.8 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.219 0.533 . . . . 0.0 110.428 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -25.66 68.2 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.018 -1.051 . . . . 0.0 111.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -47.88 47.27 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.807 -1.183 . . . . 0.0 110.537 165.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.526 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -67.65 -42.93 81.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.445 -1.409 . . . . 0.0 112.393 -170.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -62.43 -23.58 66.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.752 0.251 . . . . 0.0 111.084 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.58 -24.19 67.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.248 2.219 . . . . 0.0 112.035 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -98.37 -41.06 8.0 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.349 -0.844 . . . . 0.0 111.878 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.81 -27.55 28.71 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.753 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.59 -133.64 38.28 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 119.24 0.927 . . . . 0.0 111.28 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -62.4 117.43 6.14 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.6 t -87.39 -171.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.678 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.4 m -153.92 -35.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 130.485 3.514 . . . . 0.0 108.495 -169.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -155.85 156.61 35.0 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.231 0.469 . . . . 0.0 111.191 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.34 136.79 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.98 144.71 25.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.354 2.262 . . . . 0.0 108.451 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -138.77 154.48 73.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.784 0.834 . . . . 0.0 109.262 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -72.72 -171.23 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.154 2.569 . . . . 0.0 112.647 174.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -107.03 158.26 17.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.77 1.628 . . . . 0.0 110.685 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.52 9.42 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 126.946 2.099 . . . . 0.0 115.238 -165.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.25 11.68 1.81 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.028 1.775 . . . . 0.0 111.917 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -69.35 125.35 26.44 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.334 1.567 . . . . 0.0 108.957 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -76.15 145.6 39.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.7 m -142.39 163.12 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.014 1.326 . . . . 0.0 109.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -111.67 169.29 8.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.573 0.349 . . . . 0.0 110.858 168.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 49' ' ' LYS . 14.9 ttpt -57.55 17.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 1 C-N-CA 131.834 4.053 . . . . 0.0 114.944 178.093 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.35 23.76 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 120.045 -1.659 . . . . 0.0 114.856 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.63 143.86 32.2 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.254 2.027 . . . . 0.0 111.923 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 64' ' ' ASP . 52.3 t -77.65 38.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 129.241 3.016 . . . . 0.0 112.852 -168.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.59 4.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 118.472 -2.643 . . . . 0.0 115.048 -166.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.3 54.82 0.86 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.633 1.106 . . . . 0.0 111.542 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -61.85 165.48 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.194 0.997 . . . . 0.0 112.838 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.66 100.55 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.03 125.89 32.52 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.4 p -103.83 -174.8 2.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.213 1.405 . . . . 0.0 109.853 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 m -50.82 -32.09 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.142 1.377 . . . . 0.0 113.015 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.72 37.7 0.27 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 120.506 1.503 . . . . 0.0 113.289 168.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.03 170.58 19.02 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.44 -1.412 . . . . 0.0 109.832 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.46 122.4 24.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.596 1.558 . . . . 0.0 107.832 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.75 143.49 26.24 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 160.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.561 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -102.58 117.19 34.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.105 -2.924 . . . . 0.0 103.105 167.071 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.36 119.6 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 169.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.36 97.95 7.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.125 0.875 . . . . 0.0 109.624 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.09 0.46 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.664 1.985 . . . . 0.0 115.198 -157.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.06 -32.57 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 N-CA-C 114.593 0.959 . . . . 0.0 114.593 -159.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 13' ' ' VAL . 4.5 mm? -127.58 170.21 12.89 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.293 2.237 . . . . 0.0 104.975 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -86.03 157.56 20.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 157.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.47 -165.7 31.49 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 120.006 -1.684 . . . . 0.0 111.091 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -130.83 125.7 34.35 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.463 HD12 ' CD2' ' A' ' 98' ' ' PHE . 6.8 mm -63.29 140.07 20.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.1 m -149.63 6.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.858 0.863 . . . . 0.0 111.231 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -159.79 153.91 23.42 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 166.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.86 174.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.226 1.81 . . . . 0.0 108.25 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -118.37 84.06 2.11 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.706 0.685 . . . . 0.0 109.683 -172.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.9 -15.54 9.0 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.093 0.957 . . . . 0.0 112.123 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -54.52 -38.68 66.83 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.755 1.622 . . . . 0.0 111.105 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.866 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -68.96 -18.87 64.14 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.613 -0.679 . . . . 0.0 111.412 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 p -127.6 -16.44 4.79 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -129.59 71.62 82.07 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.182 1.793 . . . . 0.0 107.415 165.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -67.53 -22.75 44.27 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.219 1.946 . . . . 0.0 109.746 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.7 -9.75 58.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.087 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -17.87 63.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 122.5 2.409 . . . . 0.0 111.779 -177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.737 HG21 HD11 ' A' ' 24' ' ' ILE . 16.5 mt -60.68 -30.52 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.115 0.966 . . . . 0.0 109.654 171.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -69.47 -47.98 62.22 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 120.851 -1.156 . . . . 0.0 109.18 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -29.92 30.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.463 -160.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -160.06 65.06 2.4 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 120.414 1.461 . . . . 0.0 110.601 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.06 -19.6 49.54 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.9 2.4 . . . . 0.0 114.547 -167.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.2 mp0 -115.23 -1.57 12.91 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.849 0.86 . . . . 0.0 112.405 -173.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.64 -84.53 1.67 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -98.55 -26.64 14.35 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.557 1.143 . . . . 0.0 111.956 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.98 40.28 2.65 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.058 0.845 . . . . 0.0 111.594 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -73.78 164.92 26.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.652 1.581 . . . . 0.0 110.448 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.26 -66.5 1.0 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-O 116.468 -1.73 . . . . 0.0 108.845 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.494 ' O ' HG13 ' A' ' 22' ' ' VAL . 48.0 p90 -138.04 -177.62 4.9 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.016 -2.273 . . . . 0.0 112.703 -176.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -134.1 154.08 51.41 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 124.123 0.969 . . . . 0.0 109.321 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.72 138.72 21.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.246 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -58.66 126.63 28.41 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 162.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 pt -82.25 96.15 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 172.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -66.42 -29.69 69.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.021 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.81 79.84 1.64 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.931 1.348 . . . . 0.0 109.998 -167.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.746 ' HA ' ' CD1' ' A' ' 108' ' ' LEU 0.293 0.0 OUTLIER -81.44 26.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 124.582 2.134 . . . . 0.0 111.504 173.9 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.03 -22.07 31.31 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.511 -1.222 . . . . 0.0 114.052 155.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -76.32 -6.96 53.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.181 1.491 . . . . 0.0 112.678 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.746 ' CD1' ' HA ' ' A' ' 105' ' ' GLU . 4.8 mp -61.88 -21.94 65.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.219 1.008 . . . . 0.0 110.955 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.47 -20.42 58.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.111 . . . . 0.0 112.057 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -82.57 -15.88 50.61 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.238 0.926 . . . . 0.0 110.535 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.82 165.74 20.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.975 -1.078 . . . . 0.0 108.364 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.558 ' H ' HD22 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -77.57 125.07 28.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 172.049 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.86 171.68 7.61 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 152.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.48 -41.99 88.15 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 120.452 -1.405 . . . . 0.0 113.569 -156.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -62.49 -41.51 98.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.332 1.053 . . . . 0.0 110.114 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.72 -32.92 66.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.578 0.751 . . . . 0.0 111.034 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.5 -48.7 80.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 120.957 -1.089 . . . . 0.0 109.015 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.23 -47.92 71.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 125.602 1.561 . . . . 0.0 111.805 173.834 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.403 ' HG2' ' HB ' ' A' ' 15' ' ' ILE . 5.7 ptm . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.7 95.88 2.66 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.836 -0.54 . . . . 0.0 110.569 -162.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 109' ' ' GLU . 15.2 mmtm -93.53 174.26 7.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.68 0.792 . . . . 0.0 111.391 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.69 -173.09 2.66 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.772 2.429 . . . . 0.0 109.486 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -138.41 179.54 6.4 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.947 1.299 . . . . 0.0 109.918 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -82.3 7.53 13.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.424 1.089 . . . . 0.0 111.447 167.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -121.93 40.8 3.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.605 1.548 . . . . 0.0 109.909 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 p80 43.27 59.62 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.967 1.707 . . . . 0.0 111.908 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -152.21 133.25 14.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 108.612 -158.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.411 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.2 p-90 -110.62 160.69 16.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.361 1.465 . . . . 0.0 109.514 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 136.37 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.77 77.32 1.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.913 0.885 . . . . 0.0 109.462 -172.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.1 mp -71.47 139.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.7 pt-20 -126.46 -93.58 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.654 1.182 . . . . 0.0 110.101 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.484 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 9.1 t0 -83.4 -81.42 0.16 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -131.05 7.93 4.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.699 2.0 . . . . 0.0 110.426 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.77 149.78 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -113.05 140.83 47.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 159.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.3 m -79.78 137.02 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 153.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.9 t -103.11 136.62 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 128.0 2.52 . . . . 0.0 110.367 167.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.562 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -159.4 173.67 36.21 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.521 -0.737 . . . . 0.0 111.598 161.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 28' ' ' ALA . 9.0 pt -86.56 153.99 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 118.073 0.936 . . . . 0.0 110.683 177.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -84.06 171.91 12.48 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.677 0.791 . . . . 0.0 111.454 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.73 -35.94 71.37 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.408 0.623 . . . . 0.0 111.938 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -54.39 -33.74 59.86 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.734 -1.229 . . . . 0.0 112.279 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -74.8 -44.0 51.77 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.356 -0.84 . . . . 0.0 112.145 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.13 -25.81 68.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.497 0.59 . . . . 0.0 110.75 176.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.62 -21.09 66.63 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.115 1.366 . . . . 0.0 111.042 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -102.45 -41.58 6.25 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.763 0.711 . . . . 0.0 111.254 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 mt -82.99 -19.75 36.43 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.55 -123.13 29.25 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 119.45 1.023 . . . . 0.0 111.183 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -80.29 33.91 0.3 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.745 2.018 . . . . 0.0 116.212 -151.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 21.5 t -22.19 -115.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 115.121 -2.371 . . . . 0.0 111.428 -131.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.5 OUTLIER 170.93 -47.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 128.455 2.702 . . . . 0.0 110.813 -170.761 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -169.86 158.85 7.56 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.31 0.381 . . . . 0.0 111.446 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.755 HG22 HG23 ' A' ' 56' ' ' ILE . 4.5 t -144.09 144.05 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 125.561 1.544 . . . . 0.0 110.711 175.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.04 139.56 37.51 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.712 2.405 . . . . 0.0 108.984 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -135.79 155.9 77.71 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.973 0.909 . . . . 0.0 110.713 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -84.47 -179.05 3.63 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.374 3.382 . . . . 0.0 114.207 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -84.96 155.76 21.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 163.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.39 18.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 127.086 2.155 . . . . 0.0 113.927 -163.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.42 13.75 0.2 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 127.903 2.668 . . . . 0.0 111.938 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -73.92 135.89 43.31 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.067 -1.255 . . . . 0.0 109.564 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -82.88 139.16 33.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.03 175.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.238 1.415 . . . . 0.0 110.453 -174.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -118.66 169.67 9.62 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.417 1.487 . . . . 0.0 109.48 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HE2' HD21 ' A' ' 111' ' ' LEU . 24.9 tttt -62.99 14.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.27 2.228 . . . . 0.0 114.915 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.0 78.2 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.52 116.58 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -169.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.6 71.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 128.005 2.522 . . . . 0.0 108.835 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.51 6.42 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.502 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.24 59.8 0.9 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.551 1.069 . . . . 0.0 112.438 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 m -59.85 160.61 7.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.763 1.268 . . . . 0.0 111.324 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.755 HG23 HG22 ' A' ' 38' ' ' VAL . 1.6 mt -134.27 105.73 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.7 166.19 23.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 163.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.9 p -140.8 177.78 7.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.487 1.494 . . . . 0.0 107.89 164.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -49.04 -19.58 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 128.055 2.542 . . . . 0.0 115.978 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -160.65 41.6 0.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.934 1.697 . . . . 0.0 114.164 155.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -154.37 -172.32 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.216 -0.928 . . . . 0.0 109.188 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.91 14.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.994 0.918 . . . . 0.0 108.771 159.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.75 131.96 32.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 143.62 37.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 164.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.54 114.18 46.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.44 107.03 18.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -170.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.62 125.39 0.94 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.038 1.335 . . . . 0.0 113.551 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.9 -21.86 24.04 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.218 2.612 . . . . 0.0 115.187 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 49' ' ' LYS . 1.8 mm? -134.93 149.02 50.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 129.501 3.12 . . . . 0.0 108.644 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -66.49 149.72 50.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 158.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.67 -165.97 36.5 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -130.67 134.86 47.29 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.36 0.664 . . . . 0.0 109.43 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.429 ' HA ' ' HB3' ' A' ' 100' ' ' MET . 8.7 mm -60.22 143.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.93 1.292 . . . . 0.0 108.861 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.59 -8.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -153.18 150.52 29.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.588 1.54 . . . . 0.0 108.342 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.26 168.01 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.818 1.19 . . . . 0.0 110.21 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -119.86 73.98 1.0 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.72 -1.04 0.33 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.05 -0.407 . . . . 0.0 112.077 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -54.92 -43.77 73.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.128 -1.415 . . . . 0.0 110.2 162.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.439 HD12 HG11 ' A' ' 38' ' ' VAL . 43.7 mt -68.37 -9.81 50.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.639 1.563 . . . . 0.0 113.774 -177.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.8 -24.28 65.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.476 1.035 . . . . 0.0 111.636 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.2 p -129.18 -19.29 3.54 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.577 -0.702 . . . . 0.0 112.548 -172.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -122.03 59.86 11.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.351 2.66 . . . . 0.0 108.788 166.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.82 -19.04 47.32 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.691 1.594 . . . . 0.0 109.601 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.23 -11.54 59.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.464 1.906 . . . . 0.0 112.094 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -27.83 68.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 119.454 -2.029 . . . . 0.0 111.519 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.75 -19.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.157 0.583 . . . . 0.0 109.932 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -65.0 -56.02 15.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.3 1.048 . . . . 0.0 109.696 165.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -63.05 -53.89 46.73 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.067 2.547 . . . . 0.0 108.791 -162.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 85.79 5.5 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -59.11 -22.04 62.24 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.512 2.141 . . . . 0.0 112.455 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.411 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -127.41 9.01 6.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 127.858 2.463 . . . . 0.0 110.764 -163.42 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.33 -80.26 0.87 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 126.277 1.894 . . . . 0.0 109.716 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -93.6 -25.25 17.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.18 31.88 4.9 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.649 1.119 . . . . 0.0 113.367 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.564 ' CZ3' ' HE3' ' A' ' 99' ' ' LYS . 34.4 p-90 -70.06 159.4 33.91 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.562 HD12 ' HA2' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -108.89 -46.66 3.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.5 1.046 . . . . 0.0 109.136 -177.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.401 ' CD2' HD12 ' A' ' 73' ' ' ILE . 46.2 p90 -154.33 171.02 19.95 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.339 -0.851 . . . . 0.0 111.378 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.564 ' HE3' ' CZ3' ' A' ' 96' ' ' TRP . 77.1 mttt -131.59 152.49 50.76 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.504 1.522 . . . . 0.0 108.1 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.429 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 6.0 ptm -154.8 148.3 25.2 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.202 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -65.67 133.35 50.91 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.1 pt -79.23 103.41 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -73.77 -17.41 61.1 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.808 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -144.15 79.29 1.61 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.191 1.397 . . . . 0.0 107.364 -164.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.55 -10.46 55.91 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.767 -1.208 . . . . 0.0 113.298 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -81.97 -4.85 90.15 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.72 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 49' ' ' LYS . 49.0 mt-10 -81.38 -36.55 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.87 1.335 . . . . 0.0 112.169 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -35.41 80.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.656 1.116 . . . . 0.0 112.193 -170.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.468 ' HA ' ' HE2' ' A' ' 5' ' ' LYS . 17.6 mm-40 -62.51 -20.37 64.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -87.26 -11.0 50.94 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.588 0.755 . . . . 0.0 112.589 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.499 HD21 ' HE2' ' A' ' 49' ' ' LYS . 82.5 mt -75.04 -179.1 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.539 1.136 . . . . 0.0 110.252 167.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.9 mt -88.33 131.96 34.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.733 0.813 . . . . 0.0 109.996 -170.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.84 171.74 1.55 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.263 1.425 . . . . 0.0 109.846 163.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.74 -51.53 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.286 1.035 . . . . 0.0 111.151 -175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -56.7 -47.47 79.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.024 0.53 . . . . 0.0 109.776 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.48 67.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.332 0.653 . . . . 0.0 112.098 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -79.72 -43.35 22.81 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.656 0.662 . . . . 0.0 111.631 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 109.579 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 169.901 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ttp . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.27 101.73 3.75 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.442 -0.786 . . . . 0.0 109.763 -171.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -112.77 -178.6 3.43 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.97 153.49 43.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.373 1.069 . . . . 0.0 112.061 -167.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -101.33 171.39 7.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 123.306 1.527 . . . . 0.0 110.346 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -83.59 -1.01 52.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.989 170.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 p -120.65 44.25 2.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.129 1.772 . . . . 0.0 109.376 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.2 p80 43.96 61.11 2.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 113.807 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.8 mt-10 -134.86 152.18 51.53 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.299 1.84 . . . . 0.0 109.155 171.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.476 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 64.0 p-90 -109.81 172.66 6.72 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.947 1.299 . . . . 0.0 109.373 169.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.1 134.45 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -116.43 84.92 2.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.269 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.3 mp -75.67 118.07 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -106.33 -120.82 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 167.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.61 -60.49 2.29 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.849 1.204 . . . . 0.0 110.666 -167.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.1 7.53 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.973 0.909 . . . . 0.0 111.523 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.4 t -130.38 140.79 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -110.33 134.22 52.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 163.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -77.15 142.05 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 158.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.72 139.86 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.083 1.353 . . . . 0.0 109.559 166.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.29 161.4 28.75 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 161.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 87' ' ' ILE . 2.6 pp -70.06 159.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -79.6 -172.31 3.22 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.493 -0.755 . . . . 0.0 111.726 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.04 19.74 13.48 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.896 2.478 . . . . 0.0 112.549 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -113.48 0.57 14.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 126.009 1.724 . . . . 0.0 113.999 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.288 . . -119.76 -52.26 2.23 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.823 3.249 . . . . 0.0 112.585 -156.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.91 -42.97 1.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.777 2.431 . . . . 0.0 110.178 158.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.28 -25.05 67.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.694 1.598 . . . . 0.0 113.722 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -75.02 -45.31 42.67 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.015 -1.053 . . . . 0.0 109.542 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -72.47 -57.51 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.31 -132.29 11.19 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.15 126.82 28.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 36' ' ' VAL . 3.1 t -97.83 -154.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 169.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.644 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.2 m -174.42 -38.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 129.582 3.153 . . . . 0.0 106.973 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.487 ' H ' HG12 ' A' ' 35' ' ' VAL . 53.9 t80 -144.93 145.6 31.62 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.553 0.615 . . . . 0.0 111.27 -176.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 56' ' ' ILE . 39.6 t -128.81 121.07 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 168.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.48 140.79 37.2 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.033 173.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.43 149.09 63.5 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -175.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -71.0 -175.52 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.18 2.587 . . . . 0.0 112.308 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.44 158.98 15.35 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.893 1.677 . . . . 0.0 109.918 162.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.13 19.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 126.378 1.871 . . . . 0.0 115.014 -167.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.33 9.34 0.6 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.627 2.06 . . . . 0.0 112.887 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -73.04 135.82 44.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.723 1.261 . . . . 0.0 109.678 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.415 ' HG2' ' CG ' ' A' ' 72' ' ' LYS . 22.0 mt-10 -89.01 157.95 18.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.315 1.055 . . . . 0.0 111.665 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.519 HG22 HG11 ' A' ' 53' ' ' VAL 0.331 11.1 t -146.22 171.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.29 0 C-N-CA 131.653 3.981 . . . . 0.0 108.852 -162.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' H ' HG12 ' A' ' 47' ' ' VAL . 64.9 mttm -146.13 166.11 27.12 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.768 4.027 . . . . 0.0 106.338 -171.245 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -74.73 27.85 0.09 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.85 57.78 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 126.469 1.985 . . . . 0.0 108.372 171.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.01 143.25 45.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 117.583 0.692 . . . . 0.0 110.491 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.1 t -92.72 103.89 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.519 HG11 HG22 ' A' ' 47' ' ' VAL . 27.4 m -118.76 -0.24 8.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 125.919 1.687 . . . . 0.0 109.9 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -166.95 66.51 0.09 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.488 1.115 . . . . 0.0 109.432 -163.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -65.23 166.59 9.56 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.515 -1.366 . . . . 0.0 110.963 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.445 HG23 HG22 ' A' ' 38' ' ' VAL . 6.2 mt -143.65 103.78 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 O-C-N 120.145 -1.597 . . . . 0.0 107.612 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.43 117.67 29.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.4 p -97.98 -168.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.187 1.795 . . . . 0.0 110.645 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -52.79 -28.84 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.473 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.11 40.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.393 1.451 . . . . 0.0 113.003 166.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.17 39.46 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 120.78 -1.2 . . . . 0.0 109.721 171.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.34 152.38 31.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.739 1.616 . . . . 0.0 106.7 168.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.73 76.1 1.42 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -33.01 107.49 0.05 OUTLIER 'General case' 0 C--O 1.237 0.439 0 C-N-CA 128.777 2.831 . . . . 0.0 108.928 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.79 120.53 30.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.18 94.77 6.13 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.696 0.398 . . . . 0.0 111.804 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.09 132.74 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.559 0 C-N-CA 125.947 1.699 . . . . 0.0 114.647 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.2 -32.74 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.068 1.845 . . . . 0.0 111.874 -165.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.24 160.93 37.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.235 1.814 . . . . 0.0 108.209 -175.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.14 132.18 46.75 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.226 1.811 . . . . 0.0 107.328 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -172.89 45.88 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.415 ' CG ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -133.2 131.23 40.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 100' ' ' MET . 27.2 mm -62.81 151.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.93 -11.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 124.044 0.937 . . . . 0.0 109.744 -167.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.58 152.07 39.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 163.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.68 152.38 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -99.99 84.66 2.91 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.27 -15.29 23.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.779 0.8 . . . . 0.0 111.859 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -59.56 -22.41 61.67 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.273 1.829 . . . . 0.0 113.24 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.29 -15.55 46.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.271 1.396 . . . . 0.0 112.113 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -62.66 -31.33 72.19 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 165.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.9 -20.36 12.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.113 -0.992 . . . . 0.0 111.9 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.11 74.95 76.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.79 1.236 . . . . 0.0 110.312 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -65.64 -25.55 54.35 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.633 2.222 . . . . 0.0 110.456 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.64 -16.84 64.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.938 0.79 . . . . 0.0 110.99 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -21.62 66.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.911 2.141 . . . . 0.0 112.204 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.672 ' CG2' HD11 ' A' ' 24' ' ' ILE . 3.0 mt -64.52 -28.78 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.353 0.661 . . . . 0.0 110.289 172.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -67.1 -55.31 14.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.22 -1.55 . . . . 0.0 108.527 167.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -51.13 68.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.25 -160.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.86 76.76 5.88 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.13 0.972 . . . . 0.0 108.427 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.51 -25.16 62.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.016 1.81 . . . . 0.0 113.028 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -116.0 15.09 16.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.064 0.945 . . . . 0.0 110.781 -175.019 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.4 -65.91 0.34 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.248 1.88 . . . . 0.0 111.289 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -124.86 -23.9 4.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.516 1.158 . . . . 0.0 114.072 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.51 2.65 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 111.879 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -67.59 152.58 45.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -93.63 -59.9 1.89 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.441 ' CD1' HD12 ' A' ' 73' ' ' ILE . 44.4 p90 -149.31 168.62 22.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.719 1.207 . . . . 0.0 109.857 -172.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -132.99 155.11 49.76 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.386 1.474 . . . . 0.0 107.545 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.465 ' HB3' HD13 ' A' ' 73' ' ' ILE . 1.8 ptm -148.58 144.59 27.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.388 -168.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.56 114.66 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.351 2.26 . . . . 0.0 107.912 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt -71.34 117.59 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.606 0.717 . . . . 0.0 111.472 -170.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -78.06 -25.85 47.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.371 -0.83 . . . . 0.0 112.718 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.08 84.76 1.59 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -8.55 36.27 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 173.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.53 -31.85 8.06 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.748 -1.029 . . . . 0.0 112.872 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.57 -5.47 11.56 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.085 1.443 . . . . 0.0 111.212 170.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.99 -34.57 73.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.45 1.023 . . . . 0.0 110.868 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.69 -20.74 61.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.253 1.421 . . . . 0.0 111.441 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -83.41 -6.08 59.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.886 0.874 . . . . 0.0 111.456 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.08 176.07 5.27 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.643 1.211 . . . . 0.0 111.915 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.97 143.78 41.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.8 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.75 171.98 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.395 162.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -73.9 -34.68 64.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.524 1.93 . . . . 0.0 111.903 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.82 -48.92 33.79 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.22 70.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.445 0.698 . . . . 0.0 110.839 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -53.48 -47.64 69.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.626 1.571 . . . . 0.0 111.884 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.61 -35.72 65.4 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.7 -0.625 . . . . 0.0 110.205 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.807 . . . . 0.0 110.101 175.001 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.31 145.37 47.17 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 157.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.6 tpp -157.54 125.62 5.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -168.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.56 109.55 8.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.575 0.75 . . . . 0.0 110.075 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -104.81 178.09 4.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.046 0.938 . . . . 0.0 110.104 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -144.07 157.35 44.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.509 1.924 . . . . 0.0 108.891 -171.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 p -110.92 177.28 4.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 123.04 1.4 . . . . 0.0 109.463 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -78.64 -9.43 59.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.978 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -109.18 42.0 1.52 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.794 -1.191 . . . . 0.0 109.107 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 p80 44.87 54.47 6.75 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.084 1.353 . . . . 0.0 110.674 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 4.2 tt0 -130.21 145.25 51.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.212 2.205 . . . . 0.0 107.479 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.47 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.2 p-90 -117.87 159.89 22.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.56 1.944 . . . . 0.0 110.21 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.555 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.2 t -128.99 152.74 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.646 1.978 . . . . 0.0 107.468 -173.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.85 84.33 1.84 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 119.766 1.166 . . . . 0.0 112.771 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mp -70.37 132.39 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -120.15 -99.47 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 164.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.25 -88.65 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.911 2.084 . . . . 0.0 110.368 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -127.71 3.88 6.09 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.8 -1.188 . . . . 0.0 113.382 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.71 133.56 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -108.35 110.29 21.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.038 2.135 . . . . 0.0 109.529 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.5 m -75.96 116.51 16.73 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.653 1.181 . . . . 0.0 110.743 171.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.5 OUTLIER -87.99 149.85 3.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 112.415 174.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.98 163.64 31.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 156.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.407 ' CD1' HG21 ' A' ' 87' ' ' ILE . 2.3 pt -82.09 151.42 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.4 1.6 . . . . 0.0 109.511 169.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.3 p -82.05 174.48 11.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.705 1.202 . . . . 0.0 112.828 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.81 -41.81 71.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.2 -0.937 . . . . 0.0 112.3 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -57.85 -21.1 40.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.093 0.86 . . . . 0.0 112.935 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.28 -47.83 9.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.034 -1.041 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -64.18 -21.38 66.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.7 0.682 . . . . 0.0 111.806 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.09 -37.95 81.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.627 1.571 . . . . 0.0 110.888 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -88.21 -35.9 17.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.2 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.7 -70.99 0.47 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.703 1.138 . . . . 0.0 109.824 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.19 -130.25 10.11 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.19 0.9 . . . . 0.0 111.041 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -71.85 34.18 0.06 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.242 3.017 . . . . 0.0 117.029 -159.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 59' ' ' VAL . 14.2 t -21.97 -113.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 114.091 -2.861 . . . . 0.0 113.049 -135.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER 164.38 -41.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 128.924 2.89 . . . . 0.0 110.082 -170.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -157.39 164.4 37.56 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.644 0.656 . . . . 0.0 109.721 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -139.12 142.18 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 163.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.79 87.46 3.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.341 1.457 . . . . 0.0 107.218 -177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -90.28 153.1 46.4 Favored Pre-proline 0 C--O 1.234 0.245 0 O-C-N 121.656 -0.652 . . . . 0.0 109.885 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.96 174.7 12.32 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.448 2.099 . . . . 0.0 112.205 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.89 142.11 31.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.13 19.88 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 128.835 2.854 . . . . 0.0 114.839 -172.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.82 17.89 0.65 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.063 1.792 . . . . 0.0 112.501 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -90.18 142.63 27.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.889 1.345 . . . . 0.0 110.319 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.43 144.69 27.84 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.124 1.329 . . . . 0.0 110.669 170.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.44 HG11 HD11 ' A' ' 73' ' ' ILE . 20.3 m -137.17 177.98 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.793 1.237 . . . . 0.0 111.22 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -132.01 166.61 21.32 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.172 1.789 . . . . 0.0 108.821 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -72.94 37.21 0.08 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.076 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.56 76.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.01 120.34 7.86 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.696 1.598 . . . . 0.0 106.8 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.287 0.1 OUTLIER -69.84 33.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 127.716 2.406 . . . . 0.0 113.683 -171.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.17 8.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 118.501 -2.624 . . . . 0.0 114.804 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 48.01 1.77 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 121.063 1.756 . . . . 0.0 111.031 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 161.64 8.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.918 0.866 . . . . 0.0 110.767 -173.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mt -137.78 101.77 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.49 148.97 25.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 164.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -124.2 179.8 4.74 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.391 1.077 . . . . 0.0 110.167 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 35' ' ' VAL . 2.7 m -40.8 -35.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 126.172 1.789 . . . . 0.0 113.379 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -160.97 59.19 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.62 1.554 . . . . 0.0 113.655 156.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.93 -175.57 5.5 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.75 . . . . 0.0 109.48 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.64 166.5 23.41 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.865 1.666 . . . . 0.0 110.635 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.64 127.19 6.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.714 2.006 . . . . 0.0 106.902 167.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.3 118.05 28.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.67 93.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.53 106.88 9.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.655 0.382 . . . . 0.0 111.565 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.39 153.36 0.57 Allowed Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 127.606 2.362 . . . . 0.0 115.615 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -86.11 -41.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.343 1.362 . . . . 0.0 114.866 -162.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -129.93 168.17 17.07 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -76.94 168.95 19.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 156.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.95 -167.38 24.65 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -171.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -135.07 129.48 34.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -169.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.452 HD12 ' CD2' ' A' ' 98' ' ' PHE . 6.0 mm -62.47 141.76 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 107.585 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.79 -1.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 124.383 1.052 . . . . 0.0 112.828 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -151.99 157.08 41.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.583 1.538 . . . . 0.0 106.898 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.7 m -142.56 154.0 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.72 85.16 5.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.588 0.631 . . . . 0.0 110.722 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.23 -9.56 5.19 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -55.09 -46.24 75.46 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.654 -1.279 . . . . 0.0 110.463 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -13.03 60.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.23 1.012 . . . . 0.0 110.069 -168.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.65 -35.2 73.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.415 1.486 . . . . 0.0 110.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -123.59 -22.32 5.02 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.243 1.417 . . . . 0.0 112.854 -167.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -131.18 68.83 82.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 127.426 2.291 . . . . 0.0 107.847 171.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.69 -11.29 28.29 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.39 2.727 . . . . 0.0 111.588 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.65 -3.14 19.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.632 1.573 . . . . 0.0 112.675 171.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 86' ' ' LEU . 1.9 mt -70.37 -22.49 62.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.623 1.556 . . . . 0.0 113.527 -172.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.407 HG21 ' CD1' ' A' ' 24' ' ' ILE . 3.0 mt -65.34 -29.32 46.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.46 -52.03 60.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 120.42 1.464 . . . . 0.0 109.038 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -56.17 -55.59 31.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.727 2.411 . . . . 0.0 110.169 -169.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -151.95 89.7 3.97 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -57.36 -29.49 84.41 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.586 1.524 . . . . 0.0 111.934 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 13.1 mt-10 -122.73 31.21 6.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.624 1.969 . . . . 0.0 108.701 -167.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.38 -74.45 0.07 OUTLIER Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.409 1.481 . . . . 0.0 111.404 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -117.17 -11.3 10.7 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.129 -0.939 . . . . 0.0 113.307 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.84 29.6 1.55 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.449 1.022 . . . . 0.0 113.328 168.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 59.0 p-90 -60.31 149.6 33.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.579 1.189 . . . . 0.0 109.755 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.85 -69.4 0.76 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 116.589 -1.672 . . . . 0.0 106.814 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CD2' HD12 ' A' ' 73' ' ' ILE . 48.4 p90 -134.31 -174.95 3.71 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 122.114 2.234 . . . . 0.0 112.033 -172.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -135.86 153.53 51.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.831 167.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.07 139.15 25.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.847 0.859 . . . . 0.0 109.271 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.38 120.31 12.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 163.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -73.24 152.97 7.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 m -110.12 -31.93 7.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.699 0.8 . . . . 0.0 111.58 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 76.48 1.61 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -160.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -11.46 57.35 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.445 -0.784 . . . . 0.0 111.324 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.01 -15.17 81.22 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.927 -1.108 . . . . 0.0 112.586 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -86.34 -15.95 38.93 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.549 1.175 . . . . 0.0 111.572 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.22 -43.37 98.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.497 1.044 . . . . 0.0 109.543 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -60.65 -24.76 65.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 111.28 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.5 -4.52 58.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.247 1.019 . . . . 0.0 112.45 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.54 -171.95 2.5 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.591 1.956 . . . . 0.0 108.958 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -96.99 135.53 38.86 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.675 1.19 . . . . 0.0 108.215 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.38 179.93 3.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.828 0.823 . . . . 0.0 110.041 163.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.53 -47.53 72.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.612 1.965 . . . . 0.0 111.732 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -74.22 -39.99 62.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.191 0.596 . . . . 0.0 109.419 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.78 76.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.417 0.687 . . . . 0.0 111.262 172.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -70.7 -44.22 67.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.969 0.908 . . . . 0.0 111.187 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.27 -45.57 72.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.125 0.875 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -63.4 -38.76 92.38 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.815 0.846 . . . . 0.0 110.879 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -59.14 -32.34 69.78 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.159 -0.963 . . . . 0.0 111.408 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.6 m -77.06 -26.04 53.09 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.078 -1.013 . . . . 0.0 112.982 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.9 0.56 17.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.446 1.098 . . . . 0.0 111.485 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.8 17.92 21.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.001 0.92 . . . . 0.0 110.202 169.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.669 164.129 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt 48.41 64.71 1.57 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 127.253 2.221 . . . . 0.0 112.464 157.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.496 ' SD ' ' HE3' ' A' ' 5' ' ' LYS . 2.9 ptp -152.66 -175.8 5.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.129 1.772 . . . . 0.0 109.027 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.54 122.89 8.4 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 120.669 -1.27 . . . . 0.0 109.324 171.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.496 ' HE3' ' SD ' ' A' ' 3' ' ' MET . 22.2 mmtt -114.38 175.44 5.48 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.662 0.602 . . . . 0.0 109.864 168.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -133.36 154.22 50.92 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.654 1.581 . . . . 0.0 109.179 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -91.48 -176.92 4.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 122.226 1.013 . . . . 0.0 108.641 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -101.66 20.48 16.12 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 0.0 110.296 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -127.02 30.1 5.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.402 1.881 . . . . 0.0 110.817 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 59.72 40.69 19.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.801 -1.187 . . . . 0.0 112.193 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 24' ' ' ILE . 20.5 mt-10 -126.24 145.11 50.53 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.45 1.5 . . . . 0.0 107.887 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.418 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.1 p-90 -116.94 162.02 18.43 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.714 1.605 . . . . 0.0 109.534 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.5 t -142.35 100.79 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -167.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -82.15 89.12 6.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.74 -1.225 . . . . 0.0 109.034 173.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.2 mp -74.04 104.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 120.224 1.374 . . . . 0.0 107.595 174.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.3 tp10 -80.9 -138.78 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 167.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 1.2 t0 -64.69 -61.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.098 -1.001 . . . . 0.0 109.414 -172.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.5 2.21 2.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.031 0.933 . . . . 0.0 113.019 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.3 t -124.28 132.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -100.2 140.0 35.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 169.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -85.15 139.05 31.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 t -113.5 126.22 70.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.654 1.581 . . . . 0.0 107.584 170.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -134.97 168.55 23.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 160.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 87' ' ' ILE . 19.6 pt -85.62 156.57 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.8 p -82.55 179.09 7.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.35 -39.52 94.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.408 -1.433 . . . . 0.0 111.541 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -61.02 -26.48 67.64 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.398 -1.439 . . . . 0.0 111.668 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.434 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -69.79 -56.43 7.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.977 -1.077 . . . . 0.0 110.088 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -55.14 -30.89 60.74 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.662 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.03 -42.43 94.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.381 0.672 . . . . 0.0 110.545 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -79.96 -24.26 41.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 113.202 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.68 -42.05 35.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.747 1.158 . . . . 0.0 110.346 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.9 53.27 Favored Glycine 0 N--CA 1.443 -0.859 0 O-C-N 124.188 0.93 . . . . 0.0 110.939 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.95 122.6 3.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.748 2.019 . . . . 0.0 108.515 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 36' ' ' VAL 0.425 9.8 p -118.47 158.07 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 122.493 1.139 . . . . 0.0 112.387 -177.309 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.584 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -146.85 -26.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 C-N-CA 126.148 1.779 . . . . 0.0 108.974 -150.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -150.53 151.93 33.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 123.741 0.651 . . . . 0.0 111.17 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 56' ' ' ILE . 60.0 t -145.46 127.81 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 136.42 38.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.606 171.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.8 mt -129.88 128.52 22.92 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.2 -178.95 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.44 2.76 . . . . 0.0 112.59 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -80.61 140.88 35.51 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.828 -1.17 . . . . 0.0 108.923 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.0 12.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 128.567 2.747 . . . . 0.0 115.71 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.2 9.16 1.1 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.044 1.783 . . . . 0.0 111.615 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -71.92 137.57 47.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.086 -1.243 . . . . 0.0 110.106 -171.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HG2' ' CG ' ' A' ' 72' ' ' LYS . 10.5 mt-10 -85.35 149.44 25.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.623 -0.673 . . . . 0.0 110.285 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.76 177.35 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.174 0.99 . . . . 0.0 109.527 -172.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -126.25 170.98 11.31 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 125.659 1.584 . . . . 0.0 109.589 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.81 10.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.77 66.74 0.24 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.55 115.81 13.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.06 114.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.476 1.111 . . . . 0.0 108.257 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -146.09 0.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.754 1.222 . . . . 0.0 112.718 -168.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.96 39.63 0.94 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.216 1.006 . . . . 0.0 108.385 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -50.66 165.66 0.1 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.992 1.717 . . . . 0.0 111.538 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.489 HG23 HG22 ' A' ' 38' ' ' VAL . 2.2 mt -139.45 145.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.99 116.6 17.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.936 1.694 . . . . 0.0 107.234 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' HG23 ' A' ' 35' ' ' VAL . 84.5 p -105.6 -167.71 1.36 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.615 1.566 . . . . 0.0 111.02 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 m -44.86 -39.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 114.152 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -165.75 72.57 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 149.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.07 167.24 22.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.8 154.85 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 159.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.26 109.02 4.37 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.255 1.022 . . . . 0.0 109.701 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.2 114.54 4.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.575 1.55 . . . . 0.0 108.371 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.622 HG11 HD13 ' A' ' 97' ' ' LEU . 53.2 t -87.46 104.31 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.33 105.55 17.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.954 0.797 . . . . 0.0 110.341 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.66 142.33 1.07 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.434 1.894 . . . . 0.0 112.876 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.08 -35.32 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.18 1.92 . . . . 0.0 113.259 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -138.84 145.75 40.4 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.958 2.103 . . . . 0.0 107.147 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -64.44 137.86 58.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 167.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.48 -177.91 44.09 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -155.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' CG ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -129.9 140.62 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 173.202 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.479 HD12 ' CD2' ' A' ' 98' ' ' PHE . 7.1 mm -65.67 145.46 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 174.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.51 -3.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 O-C-N 123.359 0.412 . . . . 0.0 111.753 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.14 151.47 30.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.2 m -141.54 149.6 20.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -99.47 75.8 1.98 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.0 -14.89 2.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -53.01 -34.64 57.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.066 1.347 . . . . 0.0 111.919 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -9.05 41.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 112.024 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.07 -28.68 69.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.786 1.634 . . . . 0.0 112.912 166.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -126.93 -27.55 3.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.947 1.699 . . . . 0.0 110.818 -167.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -125.94 65.03 53.82 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.202 1.801 . . . . 0.0 108.511 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -72.26 -51.62 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.594 2.863 . . . . 0.0 108.654 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -15.65 0.39 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.226 2.21 . . . . 0.0 111.322 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.04 41.23 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 122.632 2.469 . . . . 0.0 110.999 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.533 ' CG2' HD11 ' A' ' 24' ' ' ILE . 70.0 mt -51.33 -30.34 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 120.814 -1.179 . . . . 0.0 110.4 171.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -73.45 -51.73 16.16 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.71 -1.244 . . . . 0.0 111.581 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -70.23 -38.73 75.29 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.098 1.759 . . . . 0.0 110.76 -163.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -156.11 67.58 4.66 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 123.03 0.532 . . . . 0.0 111.332 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.88 -20.99 69.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.53 2.82 . . . . 0.0 113.535 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.418 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 5.1 mt-10 -123.11 20.05 9.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.593 0.757 . . . . 0.0 110.535 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -123.83 -93.0 1.04 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -79.92 -32.14 40.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.264 1.032 . . . . 0.0 112.869 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.35 37.73 2.03 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 120.23 1.377 . . . . 0.0 114.58 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -68.87 165.02 20.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.871 1.835 . . . . 0.0 109.732 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 65' ' ' VAL . 1.7 mt -108.93 -61.37 1.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.479 ' CD2' HD12 ' A' ' 73' ' ' ILE . 43.6 p90 -148.85 172.23 15.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.769 0.827 . . . . 0.0 111.068 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -134.95 152.32 51.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.48 1.512 . . . . 0.0 108.795 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.44 144.82 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.912 0.485 . . . . 0.0 110.68 -166.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.16 128.25 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.266 1.826 . . . . 0.0 107.029 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 pt -86.95 95.86 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.794 0.807 . . . . 0.0 109.987 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 m -81.67 -11.33 59.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.762 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.49 96.51 3.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 171.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -4.98 57.68 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.304 -0.248 . . . . 0.0 110.671 171.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.79 -55.22 9.92 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -18.4 47.0 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 125.822 1.649 . . . . 0.0 113.486 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 111' ' ' LEU . 13.7 mt -44.14 -37.16 2.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.893 1.679 . . . . 0.0 111.48 169.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.24 -13.23 60.42 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.601 0.637 . . . . 0.0 112.265 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.38 -35.22 68.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.299 1.04 . . . . 0.0 109.574 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -71.83 167.88 19.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.327 1.451 . . . . 0.0 108.256 -177.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 mt -77.82 131.59 37.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -55.55 171.64 0.19 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 122.491 1.138 . . . . 0.0 108.647 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.96 -39.45 79.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 111.414 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -64.57 -45.64 86.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.509 -0.745 . . . . 0.0 109.417 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.4 86.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.314 0.646 . . . . 0.0 111.038 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.1 -45.04 96.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.761 1.624 . . . . 0.0 110.832 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -48.16 73.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.972 0.509 . . . . 0.0 110.179 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -64.51 -31.94 73.37 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.034 -0.416 . . . . 0.0 111.479 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -70.65 -32.89 70.34 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.727 -1.233 . . . . 0.0 110.622 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.3 t -66.13 -39.79 90.14 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.027 0.376 . . . . 0.0 110.272 171.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.13 -25.68 67.87 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.64 -0.662 . . . . 0.0 112.154 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -101.45 4.87 41.69 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.987 1.715 . . . . 0.0 111.511 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.248 1.013 0 CA-C-N 119.596 1.089 . . . . 0.0 109.959 -178.578 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.9 ttm . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 153.59 126.59 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 1 C-N-CA 133.485 4.714 . . . . 0.0 105.131 173.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 ttm -152.61 157.79 41.51 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.78 113.54 11.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.271 1.396 . . . . 0.0 110.545 169.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.07 174.34 5.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 167.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.93 179.0 5.41 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.722 2.809 . . . . 0.0 110.958 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -139.53 167.06 22.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.4 1.88 . . . . 0.0 109.214 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.73 -7.87 56.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.24 0.616 . . . . 0.0 112.489 168.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -94.37 19.12 9.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.481 -1.387 . . . . 0.0 112.173 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 58.32 43.94 19.29 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.289 1.836 . . . . 0.0 111.566 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -124.11 149.86 45.72 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.739 -1.226 . . . . 0.0 109.91 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.521 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.1 p-90 -111.55 163.76 13.72 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.3 1.84 . . . . 0.0 109.109 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.53 100.81 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -168.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -85.25 95.17 9.1 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 119.609 1.095 . . . . 0.0 109.441 172.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.9 mp -74.43 141.62 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 119.897 1.226 . . . . 0.0 107.834 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.54 -101.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.607 1.163 . . . . 0.0 108.147 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.24 -77.57 0.46 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -126.51 16.72 7.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.49 1.516 . . . . 0.0 111.095 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.84 155.36 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -129.43 136.57 50.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.989 1.316 . . . . 0.0 108.305 166.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.0 m -83.65 138.54 33.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.85 134.54 55.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.691 1.996 . . . . 0.0 108.632 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -147.78 164.62 28.83 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 163.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.542 HD12 ' HB3' ' A' ' 28' ' ' ALA . 8.6 pt -73.77 154.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 O-C-N 122.029 -0.689 . . . . 0.0 109.325 169.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 79.3 p -75.42 166.34 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.334 -0.854 . . . . 0.0 109.802 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.67 -34.43 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.939 -1.101 . . . . 0.0 112.674 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -59.89 -28.09 67.26 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.0 -1.063 . . . . 0.0 111.959 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.542 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -72.71 -57.31 4.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.546 0.738 . . . . 0.0 111.21 174.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -56.59 -27.88 59.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.693 1.133 . . . . 0.0 112.326 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.99 -32.26 61.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.039 1.336 . . . . 0.0 111.047 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -88.92 -46.52 8.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.906 -0.569 . . . . 0.0 109.787 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -34.92 78.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 118.158 -0.925 . . . . 0.0 113.176 -174.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.94 -126.58 41.1 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -169.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.69 34.05 0.33 Allowed 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -145.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 85' ' ' GLU 0.398 2.2 p -23.06 -111.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 115.683 -2.103 . . . . 0.0 112.846 -122.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.4 OUTLIER 166.38 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.112 2.165 . . . . 0.0 109.032 -168.227 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.433 ' H ' HG22 ' A' ' 35' ' ' VAL . 83.3 t80 -161.8 166.68 26.11 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.494 0.717 . . . . 0.0 110.165 -165.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.17 134.34 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.915 1.686 . . . . 0.0 107.757 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.64 143.18 28.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.416 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.11 151.5 70.0 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 123.671 0.789 . . . . 0.0 109.326 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -72.12 174.32 11.55 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.959 1.773 . . . . 0.0 111.396 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -78.64 150.9 32.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.81 17.2 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 127.713 2.405 . . . . 0.0 114.098 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.08 6.44 0.35 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 128.623 3.011 . . . . 0.0 111.922 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -67.18 125.73 26.96 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.019 1.41 . . . . 0.0 108.267 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.62 143.65 40.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 m -144.29 -176.73 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.667 0.787 . . . . 0.0 109.647 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -138.95 167.78 21.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.539 1.536 . . . . 0.0 109.772 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -67.83 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -172.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.9 66.5 0.24 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 161.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.48 123.19 47.93 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.184 1.393 . . . . 0.0 113.083 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 0.1 OUTLIER -65.5 21.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 129.149 2.98 . . . . 0.0 115.113 -174.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -62.84 8.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 119.142 -2.224 . . . . 0.0 116.273 -168.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.68 51.48 1.05 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.026 1.285 . . . . 0.0 110.706 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.19 148.29 36.87 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 123.155 1.455 . . . . 0.0 110.783 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.29 142.56 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -118.88 142.33 47.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 155.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.563 ' HB2' ' HA ' ' A' ' 35' ' ' VAL . 82.6 p -111.51 -173.85 2.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.237 1.381 . . . . 0.0 108.344 155.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -40.65 -37.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.99 1.716 . . . . 0.0 113.174 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.13 0.11 1.03 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 159.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.804 2.093 . . . . 0.0 110.464 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.4 162.56 35.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.097 1.359 . . . . 0.0 108.545 160.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.04 112.28 2.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.733 0.813 . . . . 0.0 109.919 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.56 127.92 33.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.033 1.733 . . . . 0.0 107.989 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.781 HG11 HD13 ' A' ' 97' ' ' LEU . 71.8 t -102.48 109.29 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 120.697 1.589 . . . . 0.0 106.996 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.32 99.47 10.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.465 1.03 . . . . 0.0 112.125 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -35.66 124.84 0.64 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.514 1.925 . . . . 0.0 112.843 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.54 -24.57 10.36 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.694 2.262 . . . . 0.0 114.845 -160.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -133.5 158.64 42.59 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.243 1.817 . . . . 0.0 108.619 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -75.57 153.85 37.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.886 0.85 . . . . 0.0 109.842 165.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.74 -174.54 30.04 Favored Glycine 0 C--O 1.237 0.293 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -160.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.49 141.35 51.68 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.451 HD12 ' CD1' ' A' ' 98' ' ' PHE . 18.7 mm -67.7 146.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 173.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.19 -11.28 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.0 151.6 42.65 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.6 159.99 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.384 1.474 . . . . 0.0 107.177 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.489 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 39.2 t30 -104.43 90.03 3.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -172.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.47 -14.6 30.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.924 1.29 . . . . 0.0 112.585 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HE2' ' OD1' ' A' ' 77' ' ' ASN . 25.4 mtmm -55.96 -42.09 75.7 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.802 1.241 . . . . 0.0 111.787 167.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -21.9 61.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.947 0.794 . . . . 0.0 109.937 -170.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -57.63 -49.51 76.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.634 1.574 . . . . 0.0 109.063 167.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.8 p -82.98 -30.83 27.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.645 0.778 . . . . 0.0 112.364 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -149.86 71.8 9.57 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.2 1.0 . . . . 0.0 109.048 -166.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.504 ' HB2' HG13 ' A' ' 35' ' ' VAL . 1.5 Cg_endo -50.82 -41.54 54.68 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.232 3.288 . . . . 0.0 112.651 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.74 ' HA ' HG12 ' A' ' 35' ' ' VAL . 11.1 pt-20 -65.54 -2.88 3.75 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.664 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -60.66 -22.61 64.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 123.657 2.935 . . . . 0.0 112.169 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -61.02 -23.83 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.292 0.637 . . . . 0.0 109.819 174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -71.77 -58.16 3.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.811 -1.181 . . . . 0.0 109.647 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -53.09 -35.31 59.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 126.397 1.879 . . . . 0.0 111.474 -172.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.16 100.43 0.49 Allowed Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 168.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.43 -12.45 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.317 1.345 . . . . 0.0 113.14 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.521 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -118.37 -19.54 8.85 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.662 1.119 . . . . 0.0 113.779 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -77.97 -90.24 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -99.05 -17.17 18.39 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.98 0.912 . . . . 0.0 111.738 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.66 30.94 3.37 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.043 1.306 . . . . 0.0 114.197 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -72.24 164.82 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.293 1.546 . . . . 0.0 110.559 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.781 HD13 HG11 ' A' ' 65' ' ' VAL . 3.9 mt -100.3 -66.93 0.88 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CD1' HD12 ' A' ' 73' ' ' ILE . 38.6 p90 -142.39 172.82 12.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.941 0.897 . . . . 0.0 110.789 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -124.98 154.62 40.94 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.843 0.857 . . . . 0.0 109.47 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.71 142.42 34.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.871 0.869 . . . . 0.0 110.442 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -81.32 113.95 19.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.231 1.812 . . . . 0.0 107.45 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 pt -76.44 103.0 3.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.965 0.906 . . . . 0.0 110.416 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -60.02 -37.78 80.75 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.123 0.569 . . . . 0.0 111.84 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.6 93.45 2.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.06 -12.48 55.65 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.839 0.828 . . . . 0.0 109.95 168.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.45 72.48 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 120.701 -1.249 . . . . 0.0 110.983 173.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -72.55 -7.79 51.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.424 1.112 . . . . 0.0 111.586 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.19 -26.94 66.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.382 1.446 . . . . 0.0 111.384 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -78.39 -29.14 47.12 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 110.38 -167.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.94 -19.22 64.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 129.135 2.974 . . . . 0.0 112.364 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.3 mt -73.2 -170.41 0.77 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.368 1.467 . . . . 0.0 109.673 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.34 132.59 54.29 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.343 -0.848 . . . . 0.0 108.943 -171.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -60.13 165.4 3.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 157.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.21 -46.87 72.55 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -62.8 -33.38 75.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.08 0.4 . . . . 0.0 111.487 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.84 77.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.471 0.708 . . . . 0.0 110.433 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.85 -32.5 73.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.648 -0.657 . . . . 0.0 112.111 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.0 -56.53 17.04 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.728 1.611 . . . . 0.0 108.806 168.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.63 -44.57 93.5 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.548 1.139 . . . . 0.0 110.161 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.31 -50.8 64.2 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.545 0.738 . . . . 0.0 110.509 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.3 t -60.05 -35.35 74.94 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.691 -0.631 . . . . 0.0 112.249 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.45 -23.6 66.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.315 0.646 . . . . 0.0 111.533 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -96.36 -3.66 43.34 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.126 1.37 . . . . 0.0 111.917 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.457 -176.177 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 tpp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.66 120.43 11.78 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 162.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.6 ttp -165.26 162.26 19.72 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -155.21 98.41 1.99 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.164 1.347 . . . . 0.0 113.295 -167.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -95.02 -177.03 4.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.314 0.578 . . . . 0.0 111.865 168.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -138.1 172.99 12.1 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 127.684 2.393 . . . . 0.0 109.867 -170.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.9 p -121.49 173.34 7.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.822 1.649 . . . . 0.0 108.733 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.65 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -78.65 -34.58 46.29 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.36 163.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 p -75.22 23.49 0.11 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.818 1.247 . . . . 0.0 112.541 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.273 0.0 OUTLIER 60.84 52.81 4.08 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 128.076 2.55 . . . . 0.0 112.799 165.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -125.15 140.97 52.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.517 1.927 . . . . 0.0 108.572 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.489 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 63.5 p-90 -94.85 159.83 14.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.13 100.32 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -85.03 85.67 7.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.945 -1.097 . . . . 0.0 109.55 175.154 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.2 mp -69.5 134.95 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 169.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -122.17 -68.76 0.87 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.851 0.46 . . . . 0.0 110.068 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -120.76 -83.95 0.66 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -125.82 12.84 7.93 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.712 1.205 . . . . 0.0 110.57 170.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.8 t -128.58 149.92 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -118.77 140.36 50.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 166.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.8 m -91.57 133.25 35.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 t -110.6 138.58 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.203 1.401 . . . . 0.0 109.946 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.34 169.03 29.01 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.05 2.262 . . . . 0.0 108.207 164.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.55 159.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.934 1.367 . . . . 0.0 110.256 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.0 p -85.18 167.51 15.64 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.297 -0.877 . . . . 0.0 112.683 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.28 -42.36 69.91 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.566 -1.334 . . . . 0.0 112.728 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -57.63 -9.36 1.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.321 1.048 . . . . 0.0 113.145 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.94 -46.79 4.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.553 -1.342 . . . . 0.0 111.53 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -58.94 -26.58 64.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.923 1.238 . . . . 0.0 110.862 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -38.4 75.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.42 1.088 . . . . 0.0 111.516 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -82.61 -19.92 37.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.048 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.68 -31.91 9.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.697 0.681 . . . . 0.0 111.51 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.53 -123.77 29.89 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.09 114.96 4.04 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.3 t -94.61 -170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 160.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.1 p -172.84 -30.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.78 1.232 . . . . 0.0 108.04 -147.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.442 ' H ' HG12 ' A' ' 35' ' ' VAL . 34.5 t80 -153.43 160.37 42.58 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.746 0.654 . . . . 0.0 112.3 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.75 145.88 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 156.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.64 150.21 22.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.993 -1.003 . . . . 0.0 108.749 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -134.68 155.46 79.46 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 120.708 1.595 . . . . 0.0 111.045 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.34 -163.63 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 125.231 3.954 . . . . 0.0 109.563 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -108.66 148.92 29.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.582 1.153 . . . . 0.0 110.972 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.29 11.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 131.47 3.908 . . . . 0.0 117.633 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.62 17.43 0.57 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.556 2.027 . . . . 0.0 112.178 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -79.16 141.31 37.34 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.318 -1.107 . . . . 0.0 108.218 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -82.06 156.01 24.81 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.4 m -139.08 160.74 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.401 1.48 . . . . 0.0 110.236 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -124.09 162.64 23.11 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.106 2.162 . . . . 0.0 107.095 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -74.99 23.33 0.1 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -159.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -152.54 18.44 0.78 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.731 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -78.17 143.31 37.33 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 120.162 1.981 . . . . 0.0 111.218 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.0 106.95 18.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.6 m -133.84 -2.71 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -163.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.07 46.31 0.24 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.427 0.691 . . . . 0.0 110.007 -162.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -51.27 160.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.854 0.862 . . . . 0.0 111.694 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mt -128.45 111.69 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -109.01 130.99 55.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.6 p -112.62 -172.45 2.05 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.95 1.3 . . . . 0.0 110.22 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -48.77 -43.76 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.107 1.363 . . . . 0.0 111.736 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -155.77 88.05 1.1 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.163 1.385 . . . . 0.0 108.989 158.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 177.38 178.61 0.28 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.512 1.925 . . . . 0.0 108.699 161.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.75 147.66 52.32 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.507 1.523 . . . . 0.0 110.818 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.68 99.87 4.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.433 2.293 . . . . 0.0 106.444 170.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.29 121.85 15.26 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -80.79 123.53 37.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -103.62 105.32 15.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.787 0.835 . . . . 0.0 108.849 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -27.09 113.0 0.24 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 128.704 2.801 . . . . 0.0 112.314 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.85 -34.2 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.73 1.62 . . . . 0.0 113.164 -164.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.18 165.65 20.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.486 1.914 . . . . 0.0 107.231 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -67.4 152.23 46.05 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 108.103 155.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.41 -167.59 31.95 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 132.3 23.4 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.66 143.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.83 -3.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.869 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.1 159.81 36.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.062 0.846 . . . . 0.0 109.978 166.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -141.16 152.23 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.913 1.685 . . . . 0.0 107.663 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -98.78 76.21 2.16 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.59 -11.66 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.856 1.662 . . . . 0.0 113.349 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -36.79 68.38 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.663 1.585 . . . . 0.0 112.86 167.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -10.39 59.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.51 1.05 . . . . 0.0 111.761 -165.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -41.81 -55.15 3.14 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 128.098 2.559 . . . . 0.0 111.93 155.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 79.2 p -118.69 -3.98 10.78 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.754 1.222 . . . . 0.0 111.863 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -132.04 56.45 23.63 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.324 1.45 . . . . 0.0 110.879 170.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 -28.42 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.507 2.138 . . . . 0.0 109.407 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.88 -17.41 64.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.529 1.132 . . . . 0.0 111.111 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -61.89 -21.92 65.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 120.619 1.554 . . . . 0.0 111.831 173.669 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.41 -14.8 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 120.167 -1.583 . . . . 0.0 110.538 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -84.86 -55.01 4.3 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 120.022 -1.674 . . . . 0.0 110.556 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 1.9 mmtp -62.98 -31.41 72.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.273 1.029 . . . . 0.0 112.091 -168.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -162.59 77.22 1.97 Allowed Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 123.907 0.883 . . . . 0.0 110.463 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.69 -18.06 45.94 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 113.194 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.489 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 4.2 mt-10 -123.43 11.84 9.33 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.829 0.852 . . . . 0.0 111.465 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.39 -108.4 2.07 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.15 -18.44 63.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.475 0.71 . . . . 0.0 112.644 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.44 27.04 4.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.225 1.393 . . . . 0.0 114.489 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -64.85 165.81 10.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.8 1.8 . . . . 0.0 110.164 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 mt -110.01 -60.91 1.73 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.76 168.83 21.87 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.3 -0.875 . . . . 0.0 110.88 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -123.59 141.68 51.77 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.318 1.447 . . . . 0.0 108.425 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.7 ptm -141.65 140.18 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.842 0.857 . . . . 0.0 110.275 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.27 136.42 40.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 34.3 pt -87.02 117.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 t -83.59 -18.22 38.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.857 167.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -143.12 86.57 1.92 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -157.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . 2.8 tt0 -74.22 -12.17 60.49 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 0.0 111.079 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.03 -57.66 18.11 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -69.43 -1.88 9.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.568 1.147 . . . . 0.0 113.019 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' ' 105' ' ' GLU . 14.9 mt -61.48 -38.44 87.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.312 -0.867 . . . . 0.0 110.115 164.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.59 -5.31 59.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.295 1.438 . . . . 0.0 111.323 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.07 -18.77 60.78 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.427 -0.796 . . . . 0.0 110.132 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.6 mt -87.18 -159.17 0.49 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.04 1.336 . . . . 0.0 112.477 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.9 mt -110.29 135.78 50.49 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.094 2.157 . . . . 0.0 109.761 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.3 172.65 1.84 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 162.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -63.32 -48.05 79.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.861 1.664 . . . . 0.0 110.086 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.28 -40.68 96.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.181 0.992 . . . . 0.0 111.644 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.23 75.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.77 0.828 . . . . 0.0 110.152 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.79 -43.42 69.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.858 0.863 . . . . 0.0 110.419 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -57.57 -48.74 78.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.189 0.596 . . . . 0.0 111.042 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -64.58 -26.54 68.45 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.232 0.539 . . . . 0.0 112.085 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -7.2 46.63 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.391 1.476 . . . . 0.0 112.806 172.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.93 -14.46 23.07 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.32 1.048 . . . . 0.0 112.125 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -87.76 -1.95 58.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.43 1.092 . . . . 0.0 112.75 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.245 0.835 0 CA-C-N 120.167 1.349 . . . . 0.0 112.166 -163.451 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 mtt . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm 176.43 134.86 0.05 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 128.53 2.732 . . . . 0.0 104.266 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ptm -162.31 158.3 23.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.103 0.865 . . . . 0.0 109.961 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -160.07 125.05 3.92 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 121.041 -1.037 . . . . 0.0 109.985 -167.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' A' ' 113' ' ' ASP . 6.6 mmtp -128.12 -177.45 4.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.334 1.054 . . . . 0.0 109.821 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 179.62 6.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.5 1.92 . . . . 0.0 111.042 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -138.4 173.32 11.73 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.711 1.596 . . . . 0.0 111.912 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.473 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -82.02 -2.89 53.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.253 2.221 . . . . 0.0 112.9 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -102.14 48.37 0.88 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 p80 45.54 57.01 5.25 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.431 168.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -132.64 152.73 51.58 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.618 1.167 . . . . 0.0 108.33 -167.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.511 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.1 p-90 -124.43 162.53 23.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.081 0.952 . . . . 0.0 111.699 170.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.81 161.72 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.85 2.46 . . . . 0.0 107.705 172.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.73 94.57 1.9 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.464 1.906 . . . . 0.0 107.469 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.7 mt -98.54 95.03 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -78.11 -49.89 13.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.898 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.07 -71.68 0.68 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.259 0.936 . . . . 0.0 110.128 -171.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -138.94 10.31 2.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.627 1.571 . . . . 0.0 111.85 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.32 121.13 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -162.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 119.31 22.68 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.4 m -68.17 137.06 54.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 152.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.41 142.7 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.256 1.422 . . . . 0.0 109.772 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.71 176.73 34.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.728 HD11 HG21 ' A' ' 87' ' ' ILE . 13.8 pt -97.14 156.57 3.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 121.531 0.682 . . . . 0.0 110.697 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 169.59 17.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 112.57 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -24.28 62.52 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.64 -1.288 . . . . 0.0 111.367 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.65 -30.42 71.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.958 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.99 66.06 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.037 -1.039 . . . . 0.0 112.468 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.3 pp0? -63.3 -19.82 64.94 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.66 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.01 -0.59 7.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.337 1.455 . . . . 0.0 113.434 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -115.04 -31.01 6.19 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 160.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.42 -46.49 54.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.44 -147.0 43.22 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.81 112.5 0.62 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.566 2.346 . . . . 0.0 110.51 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.711 HG22 ' H ' ' A' ' 36' ' ' VAL 0.345 9.0 p -108.31 165.7 4.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 123.309 1.528 . . . . 0.0 111.275 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.711 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -152.43 -28.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.839 -154.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -146.3 143.57 29.24 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.433 0.56 . . . . 0.0 110.846 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.57 125.91 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.656 1.582 . . . . 0.0 107.915 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.89 139.86 43.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.382 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.1 mt -133.04 139.25 33.82 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.73 1.212 . . . . 0.0 107.932 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.45 -179.63 5.36 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.269 2.646 . . . . 0.0 112.041 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.25 145.67 43.87 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.9 18.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 129.178 2.991 . . . . 0.0 115.36 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.17 13.46 0.46 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.183 1.849 . . . . 0.0 112.138 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -76.58 132.73 39.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.789 1.294 . . . . 0.0 108.96 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.98 152.41 33.14 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.983 0.81 . . . . 0.0 109.212 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.82 174.08 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 122.354 1.073 . . . . 0.0 111.07 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -112.28 170.2 8.34 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.317 2.247 . . . . 0.0 107.9 165.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.87 18.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.616 2.366 . . . . 0.0 115.221 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.08 59.14 0.24 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.2 131.12 56.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.742 1.217 . . . . 0.0 108.112 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 52' ' ' VAL 0.297 0.1 OUTLIER -77.69 27.51 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.877 2.871 . . . . 0.0 114.232 -168.032 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.06 12.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.76 54.26 1.17 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 171.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.83 159.3 2.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.513 HG22 HG21 ' A' ' 35' ' ' VAL . 1.6 mt -139.85 135.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -127.76 110.99 13.16 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -99.15 -164.24 1.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.456 1.902 . . . . 0.0 110.775 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -45.89 -34.86 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.338 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -165.91 15.87 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 160.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.33 138.37 31.57 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.4 124.66 52.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 161.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.06 92.49 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.126 0.97 . . . . 0.0 109.303 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -58.72 108.06 0.6 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 108.8 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.22 93.75 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -82.41 109.74 16.92 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.666 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.87 150.01 0.39 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.922 2.489 . . . . 0.0 114.329 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.23 -36.53 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.819 1.679 . . . . 0.0 115.801 -161.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -148.03 139.57 23.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.114 1.365 . . . . 0.0 108.806 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -51.17 129.4 24.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.404 0.621 . . . . 0.0 109.393 170.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.03 -174.52 44.79 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 107.061 -2.416 . . . . 0.0 107.061 -161.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -142.56 127.95 18.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -166.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -59.52 142.46 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -145.99 -2.51 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -147.24 156.66 43.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 121.097 1.771 . . . . 0.0 108.44 165.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.83 153.47 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.045 0.938 . . . . 0.0 109.168 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -104.73 78.83 1.47 Allowed 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.446 0.698 . . . . 0.0 109.398 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -57.03 -14.88 4.12 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.979 0.912 . . . . 0.0 112.76 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -50.68 -39.56 51.46 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.989 1.716 . . . . 0.0 111.955 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -3.25 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.56 0.744 . . . . 0.0 112.501 -170.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.86 -49.96 53.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.011 1.278 . . . . 0.0 109.16 160.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.0 p -92.34 -39.31 11.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.069 -162.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -117.33 67.39 4.86 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.097 1.759 . . . . 0.0 109.517 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.51 -44.83 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.953 3.769 . . . . 0.0 110.837 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 35' ' ' VAL . 14.7 tt0 -61.69 -4.45 1.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.125 1.37 . . . . 0.0 109.905 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -58.15 -13.58 5.19 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 121.426 1.921 . . . . 0.0 114.076 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 24' ' ' ILE . 4.2 mm -53.33 -39.68 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 118.619 0.645 . . . . 0.0 109.78 164.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -69.61 -55.79 9.11 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.046 1.339 . . . . 0.0 109.42 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.82 78.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 -164.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -153.32 74.01 6.76 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -57.32 -23.5 54.96 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.776 2.317 . . . . 0.0 112.381 -172.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.511 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.2 mp0 -118.67 9.42 12.16 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.263 1.025 . . . . 0.0 112.147 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.93 -110.29 2.7 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.244 1.878 . . . . 0.0 109.597 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.96 -28.29 69.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.458 1.129 . . . . 0.0 111.093 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.54 25.22 1.4 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-N 119.721 1.146 . . . . 0.0 115.76 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.422 ' CZ3' ' HG3' ' A' ' 99' ' ' LYS . 46.0 p-90 -67.57 163.06 22.05 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.288 1.544 . . . . 0.0 110.404 171.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mt -106.16 -66.96 0.96 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -140.92 175.95 9.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.569 1.147 . . . . 0.0 109.387 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.422 ' HG3' ' CZ3' ' A' ' 96' ' ' TRP . 65.9 mttt -131.88 152.45 51.03 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 124.307 1.043 . . . . 0.0 108.297 171.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.32 134.89 23.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.342 0.657 . . . . 0.0 110.04 -172.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.66 127.37 31.68 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 167.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 pt -76.53 109.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.1 m -65.97 -21.55 66.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.949 -0.47 . . . . 0.0 111.198 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -151.63 88.33 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -157.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -11.92 59.93 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.933 0.788 . . . . 0.0 111.662 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.78 -41.16 95.84 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.92 -22.66 66.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 117.416 -1.278 . . . . 0.0 111.928 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 111' ' ' LEU . 12.4 mt -52.62 -30.96 34.2 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -79.21 -11.38 59.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.596 0.635 . . . . 0.0 112.069 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -74.89 -34.44 62.19 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.815 -0.553 . . . . 0.0 110.928 168.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -72.65 158.98 34.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.743 1.259 . . . . 0.0 108.132 -173.495 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.469 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -74.42 130.85 40.42 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.476 ' OD1' ' HE2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -69.82 -167.81 0.16 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 164.17 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.14 -39.69 65.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 119.768 -1.832 . . . . 0.0 113.544 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.73 -48.44 31.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.45 81.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.139 0.274 . . . . 0.0 111.408 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -53.99 -54.77 34.48 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.101 0.961 . . . . 0.0 109.866 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -39.4 74.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.103 0.961 . . . . 0.0 111.652 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.86 -35.38 79.9 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.51 1.124 . . . . 0.0 111.677 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -72.76 -38.39 67.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.25 0.932 . . . . 0.0 110.592 167.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.6 t -69.18 5.07 1.34 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.214 1.805 . . . . 0.0 113.739 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.75 -42.91 11.04 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.357 1.063 . . . . 0.0 110.944 161.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -94.84 1.41 55.36 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.832 2.053 . . . . 0.0 113.868 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--O 1.246 0.917 0 C-N-CA 124.736 1.214 . . . . 0.0 109.077 174.116 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.1 tttp 50.11 72.9 0.29 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.607 1.563 . . . . 0.0 112.627 170.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.6 ttm -146.42 159.38 43.46 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.103 1.761 . . . . 0.0 107.168 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 116.8 13.96 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 119.977 -1.702 . . . . 0.0 110.842 157.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -112.99 -179.76 3.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -130.65 170.66 14.01 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 127.191 2.196 . . . . 0.0 110.855 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -117.79 -174.67 2.68 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.665 1.586 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -106.71 10.68 30.86 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.816 1.246 . . . . 0.0 112.271 163.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -105.64 17.7 23.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.477 1.111 . . . . 0.0 111.26 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 72.23 42.5 0.56 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.892 2.077 . . . . 0.0 111.379 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -131.82 139.36 48.84 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.898 1.679 . . . . 0.0 110.879 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 69.9 p-90 -103.24 164.36 11.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.765 1.626 . . . . 0.0 109.583 171.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.57 99.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -86.84 91.88 8.8 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.741 -1.224 . . . . 0.0 110.668 173.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.548 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.2 mp -72.54 119.17 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -97.83 -72.94 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -116.49 -105.65 0.39 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -93.62 14.04 20.19 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.51 1.124 . . . . 0.0 110.698 166.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.27 152.06 35.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -123.16 137.07 54.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.784 1.633 . . . . 0.0 108.521 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -77.84 138.31 38.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 160.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.409 HG11 ' HD3' ' A' ' 68' ' ' PRO . 3.3 t -119.2 143.79 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.951 0.9 . . . . 0.0 109.669 171.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -148.75 165.93 29.23 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.979 -2.049 . . . . 0.0 107.979 164.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.6 pt -76.6 160.1 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.806 -0.82 . . . . 0.0 109.576 168.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.2 p -84.58 166.51 17.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.07 0.948 . . . . 0.0 111.304 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -56.47 -34.63 67.07 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.652 -1.28 . . . . 0.0 111.267 175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -58.36 -23.4 56.79 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.955 -1.09 . . . . 0.0 112.724 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.78 -49.64 8.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.414 -1.429 . . . . 0.0 111.349 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -56.09 -28.54 58.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.116 0.871 . . . . 0.0 110.899 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -55.83 -23.29 29.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.821 1.648 . . . . 0.0 113.288 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -109.63 -11.63 14.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.96 1.304 . . . . 0.0 112.776 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.52 -43.86 11.71 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.097 0.862 . . . . 0.0 111.0 173.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.75 -149.65 51.61 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.85 114.7 2.43 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.023 1.329 . . . . 0.0 109.228 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.658 HG22 ' H ' ' A' ' 36' ' ' VAL 0.344 8.4 p -105.65 167.57 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 124.192 1.949 . . . . 0.0 110.36 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.658 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.29 -30.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 112.316 -2.22 . . . . 0.0 107.396 -148.202 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -149.08 153.81 38.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.782 0.719 . . . . 0.0 111.329 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.571 HG22 HG23 ' A' ' 56' ' ' ILE . 69.1 t -145.3 118.73 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 127.304 2.242 . . . . 0.0 106.579 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -69.29 140.06 54.39 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.73 136.55 29.32 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.05 -172.74 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.157 3.238 . . . . 0.0 111.391 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.83 156.28 19.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.53 0.732 . . . . 0.0 111.897 171.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.78 13.63 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.031 1.732 . . . . 0.0 113.34 -172.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.21 12.94 0.61 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.654 2.073 . . . . 0.0 111.566 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -66.13 119.75 11.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.85 141.99 40.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 174.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.24 157.32 25.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.978 0.911 . . . . 0.0 110.352 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -104.95 171.01 7.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.499 1.52 . . . . 0.0 109.446 167.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -65.38 13.88 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.39 25.93 0.68 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.55 1.072 . . . . 0.0 112.24 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.62 124.79 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 108.793 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.27 109.03 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.28 8.79 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.868 0.867 . . . . 0.0 111.646 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.28 51.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.806 -0.559 . . . . 0.0 110.173 -171.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.83 161.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.293 1.037 . . . . 0.0 112.709 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.571 HG23 HG22 ' A' ' 38' ' ' VAL . 2.9 mt -143.49 108.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.61 98.95 9.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.047 1.339 . . . . 0.0 107.924 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.5 ' HA ' HG23 ' A' ' 35' ' ' VAL . 24.2 p -84.55 -163.2 0.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.31 0.644 . . . . 0.0 110.487 174.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.01 -41.5 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.411 1.484 . . . . 0.0 112.538 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -167.6 20.53 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.009 0.923 . . . . 0.0 113.277 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.78 160.36 14.41 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 120.031 -1.668 . . . . 0.0 108.546 161.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.42 84.72 1.97 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 171.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.22 118.32 22.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -77.04 111.48 12.66 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 167.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG11 HD13 ' A' ' 97' ' ' LEU . 75.0 t -79.21 118.0 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 170.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -100.33 98.51 9.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.092 1.357 . . . . 0.0 111.759 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.75 135.62 1.25 Allowed Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.031 1.733 . . . . 0.0 113.301 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD3' HG11 ' A' ' 22' ' ' VAL . 55.9 Cg_endo -76.55 -37.47 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.486 2.124 . . . . 0.0 114.707 -161.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.42 164.59 16.88 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 m -69.12 137.16 53.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 155.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.61 33.79 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -135.27 129.55 33.76 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.9 145.74 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.49 -2.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.749 0.82 . . . . 0.0 113.07 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -154.3 153.79 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.62 150.35 30.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.44 85.74 5.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -16.35 51.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -51.62 -36.34 45.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.272 1.829 . . . . 0.0 111.79 168.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -10.43 59.79 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.721 0.809 . . . . 0.0 111.567 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.26 -42.26 79.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.915 1.234 . . . . 0.0 109.552 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.6 p -95.64 -41.03 9.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.704 0.802 . . . . 0.0 111.25 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.19 72.54 9.47 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.431 1.892 . . . . 0.0 109.72 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.13 -38.8 4.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.06 3.173 . . . . 0.0 110.38 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HA ' HG12 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -60.18 -13.46 12.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.574 1.15 . . . . 0.0 111.363 -175.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -19.83 41.1 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.261 1.391 . . . . 0.0 112.815 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.8 mt -63.88 -26.22 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 121.519 -0.738 . . . . 0.0 110.893 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.35 -57.14 13.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.299 1.047 . . . . 0.0 109.263 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.19 -64.08 0.95 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.623 2.769 . . . . 0.0 110.355 -165.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -136.88 60.66 30.86 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -165.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.96 -15.48 39.13 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.151 2.567 . . . . 0.0 113.682 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -125.5 7.57 7.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.632 2.373 . . . . 0.0 110.747 -170.33 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.42 -96.77 1.79 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 168.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.18 -20.28 32.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.204 0.602 . . . . 0.0 112.003 -171.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.0 32.85 4.19 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.43 1.014 . . . . 0.0 113.344 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -65.5 160.6 21.87 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 1.373 . . . . 0.0 109.859 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 2.8 mt -104.71 -62.0 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -141.82 167.63 21.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.503 0.721 . . . . 0.0 111.459 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -117.5 150.57 38.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.282 1.033 . . . . 0.0 108.67 165.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.3 ptm -145.32 140.69 27.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.351 0.661 . . . . 0.0 109.864 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -64.0 121.51 14.29 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.559 1.144 . . . . 0.0 107.921 168.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.0 pt -71.51 98.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -75.37 -10.03 59.09 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.81 -0.557 . . . . 0.0 111.59 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -151.49 95.14 2.1 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.379 1.871 . . . . 0.0 107.068 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -8.61 55.33 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.63 -1.294 . . . . 0.0 111.507 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.92 -40.44 98.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -67.05 -9.97 44.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.728 1.611 . . . . 0.0 112.049 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.15 -20.27 65.72 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.756 1.162 . . . . 0.0 110.557 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -72.29 -18.0 61.83 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.894 1.224 . . . . 0.0 111.537 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.19 -19.81 49.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.052 0.842 . . . . 0.0 111.091 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.52 175.17 8.78 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.951 1.301 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.3 mt -106.44 149.63 26.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.863 1.265 . . . . 0.0 110.823 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.99 169.12 10.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.383 1.073 . . . . 0.0 108.294 163.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.67 -49.65 61.73 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.948 1.299 . . . . 0.0 109.843 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -60.56 -41.79 95.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.705 0.802 . . . . 0.0 110.612 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.88 -37.18 83.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.121 0.568 . . . . 0.0 110.718 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.03 -39.09 86.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.548 0.739 . . . . 0.0 110.692 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -47.66 84.37 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.272 0.629 . . . . 0.0 110.694 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.17 -26.07 65.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.547 0.612 . . . . 0.0 111.421 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -65.86 -27.19 68.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.2 -0.938 . . . . 0.0 111.861 167.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.94 -48.44 68.58 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.056 -1.027 . . . . 0.0 109.018 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.17 -20.61 64.32 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.522 0.601 . . . . 0.0 112.578 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -83.78 -15.45 48.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.716 1.606 . . . . 0.0 112.79 172.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.324 -172.271 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp 65.18 158.0 0.1 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.138 1.775 . . . . 0.0 110.136 -168.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 ptp -160.41 168.44 25.17 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.246 -1.534 . . . . 0.0 111.502 -167.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -159.82 70.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 110.143 -170.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -81.42 176.72 9.47 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.71 -1.244 . . . . 0.0 112.956 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 12' ' ' TRP . 23.7 m-85 -132.91 161.68 33.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.555 2.342 . . . . 0.0 111.723 -171.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -103.4 177.23 4.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 123.181 1.467 . . . . 0.0 109.68 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -101.39 19.16 18.32 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.504 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -134.04 44.14 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.816 1.647 . . . . 0.0 109.894 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 p80 41.47 55.07 3.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.534 1.534 . . . . 0.0 113.118 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -143.81 134.39 24.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.751 2.021 . . . . 0.0 107.479 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 58.9 p-90 -92.65 172.72 8.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.234 1.414 . . . . 0.0 109.29 167.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.53 148.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.46 90.98 2.51 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.027 0.531 . . . . 0.0 111.696 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.0 mt -95.76 102.87 14.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.991 1.316 . . . . 0.0 107.468 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -79.02 -76.49 0.2 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.245 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -106.07 -82.71 0.53 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.081 0.855 . . . . 0.0 109.219 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.18 13.72 11.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.834 0.854 . . . . 0.0 111.339 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -137.41 126.08 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.45 154.86 20.03 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.938 0.875 . . . . 0.0 108.843 162.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.9 m -106.5 155.4 19.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.994 157.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.63 142.64 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.239 3.416 . . . . 0.0 104.765 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -160.37 32.66 0.4 Allowed Glycine 0 N--CA 1.477 1.376 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.541 HD11 ' CG2' ' A' ' 87' ' ' ILE . 27.6 pt 44.07 162.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 131.215 3.806 . . . . 0.0 114.663 -169.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.9 p -93.46 170.78 9.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.496 -2.003 . . . . 0.0 110.92 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -31.36 70.98 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.629 -1.294 . . . . 0.0 111.659 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -59.45 -24.21 63.35 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.043 0.937 . . . . 0.0 111.66 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.71 -54.22 6.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.945 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.11 -26.8 51.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.424 0.69 . . . . 0.0 111.947 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.56 -54.62 41.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.138 1.775 . . . . 0.0 110.928 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -62.18 -49.01 77.51 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.245 1.018 . . . . 0.0 110.63 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -67.82 -38.57 83.42 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.363 1.065 . . . . 0.0 109.515 179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.74 -118.77 10.14 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.192 1.853 . . . . 0.0 108.928 -168.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.6 159.59 21.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.685 0.755 . . . . 0.0 109.681 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.004 HG12 ' H ' ' A' ' 36' ' ' VAL . 6.4 t -132.74 -172.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.014 1.325 . . . . 0.0 107.914 171.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.004 ' H ' HG12 ' A' ' 35' ' ' VAL . 3.1 m -159.35 -34.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 129.307 3.043 . . . . 0.0 109.583 -168.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.445 ' H ' HG12 ' A' ' 35' ' ' VAL . 32.3 t80 -151.4 164.99 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.49 124.47 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 127.045 2.138 . . . . 0.0 107.379 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.68 140.17 38.4 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.807 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.6 mt -138.98 144.76 42.54 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.223 0.609 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.4 178.19 7.69 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.941 3.094 . . . . 0.0 111.454 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -86.58 160.41 18.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 0.0 110.581 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.11 17.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 127.177 2.191 . . . . 0.0 114.487 -167.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.4 11.4 0.47 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.977 2.227 . . . . 0.0 113.025 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -71.0 127.96 34.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.132 1.466 . . . . 0.0 109.929 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.69 146.21 46.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.762 1.165 . . . . 0.0 110.924 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.53 144.47 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.905 1.682 . . . . 0.0 108.991 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -83.25 172.31 12.72 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.109 -0.995 . . . . 0.0 111.414 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 12.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.254 2.221 . . . . 0.0 116.182 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.25 65.48 0.22 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.92 121.98 15.72 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.2 OUTLIER -72.76 35.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 132.003 4.121 . . . . 0.0 113.308 -166.834 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 m -70.12 6.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 118.827 -2.421 . . . . 0.0 115.291 -168.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.7 55.76 1.2 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.897 1.226 . . . . 0.0 111.465 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.69 163.81 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.769 1.271 . . . . 0.0 112.532 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 mt -131.91 114.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -166.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.53 126.52 51.69 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 167.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.469 ' HB3' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -108.0 -165.62 1.06 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.04 2.536 . . . . 0.0 108.388 178.336 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.26 -24.74 32.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 127.701 2.4 . . . . 0.0 112.375 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.23 12.6 0.19 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.604 1.093 . . . . 0.0 113.93 166.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.613 ' HB3' HD13 ' A' ' 32' ' ' LEU . . . -115.02 155.42 27.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.143 -0.973 . . . . 0.0 109.944 173.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.66 100.03 3.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.05 179.21 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.469 1.508 . . . . 0.0 111.078 -166.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.18 139.06 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.586 1.955 . . . . 0.0 108.475 -163.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.608 HG11 HD13 ' A' ' 97' ' ' LEU . 54.7 t -112.35 108.59 25.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 167.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.0 107.67 20.21 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.808 0.731 . . . . 0.0 109.895 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -43.48 142.39 1.77 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.451 1.101 . . . . 0.0 112.485 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.13 -28.1 2.6 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.85 2.366 . . . . 0.0 114.596 -158.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mt -153.19 145.34 23.83 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.496 2.718 . . . . 0.0 104.906 -162.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 m -68.11 128.03 35.04 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 103' ' ' SER . . . -175.01 -166.53 32.96 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 124.496 1.046 . . . . 0.0 111.559 -170.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -137.02 130.3 31.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.506 HD12 ' CD1' ' A' ' 98' ' ' PHE . 8.9 mm -58.78 144.63 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.515 1.126 . . . . 0.0 108.287 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.9 m -146.98 3.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -155.14 156.01 34.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.614 1.552 . . . . 0.0 108.535 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.09 157.68 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.788 1.235 . . . . 0.0 109.081 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -101.15 84.73 2.69 Favored 'General case' 0 C--O 1.23 0.057 0 C-N-CA 123.347 0.659 . . . . 0.0 109.455 -174.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -60.1 -3.38 0.57 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.803 1.241 . . . . 0.0 113.586 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -54.86 -52.77 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.301 -1.499 . . . . 0.0 109.982 160.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.53 ' CD1' HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -63.94 -25.39 68.12 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.018 1.727 . . . . 0.0 112.111 -163.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -59.72 -23.81 63.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.641 1.176 . . . . 0.0 111.827 173.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.2 p -125.69 -20.82 4.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.678 1.591 . . . . 0.0 112.107 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -133.62 70.01 76.13 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 126.304 1.841 . . . . 0.0 108.4 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.48 -4.75 15.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.576 3.517 . . . . 0.0 111.689 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.82 -8.44 43.56 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.091 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.7 mt -70.94 -22.97 62.16 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.06 -1.65 . . . . 0.0 111.543 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.541 ' CG2' HD11 ' A' ' 24' ' ' ILE . 8.5 mt -58.17 -26.29 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.297 169.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -72.11 -55.29 7.57 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.684 1.584 . . . . 0.0 110.585 164.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -35.22 80.46 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.115 0.966 . . . . 0.0 111.884 -161.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.35 78.72 1.1 Allowed Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.57 -34.45 95.37 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 CA-C-N 120.948 1.374 . . . . 0.0 110.328 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -100.09 -5.69 27.53 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.959 1.304 . . . . 0.0 111.946 -171.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.69 -69.19 0.96 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -119.68 -21.13 7.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.541 1.136 . . . . 0.0 112.769 -167.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.91 26.07 3.87 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.805 1.669 . . . . 0.0 115.351 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 45.0 p-90 -63.53 158.92 19.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 119.388 1.594 . . . . 0.0 111.642 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.608 HD13 HG11 ' A' ' 65' ' ' VAL . 1.1 mt -99.46 -67.43 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.506 ' CD1' HD12 ' A' ' 73' ' ' ILE . 15.2 p90 -142.22 166.1 25.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.264 1.826 . . . . 0.0 110.617 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -113.84 154.68 27.06 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.023 1.329 . . . . 0.0 108.933 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.0 ptm -145.48 143.32 29.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.084 0.553 . . . . 0.0 110.688 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.31 137.23 57.4 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.902 1.281 . . . . 0.0 107.881 168.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.5 pt -76.29 155.92 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 123.444 0.465 . . . . 0.0 109.96 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.505 ' HB2' ' HA2' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -133.53 -13.03 2.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.56 112.68 3.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 168.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -83.95 -15.68 46.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.089 1.755 . . . . 0.0 110.622 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.36 71.79 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.085 1.326 . . . . 0.0 111.437 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.61 -7.89 58.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 112.609 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.02 -41.23 82.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.442 1.474 . . . . 0.0 110.639 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.23 -19.09 63.95 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.493 0.588 . . . . 0.0 111.065 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -70.91 -17.11 62.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.097 1.359 . . . . 0.0 111.702 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.81 169.59 13.22 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.37 153.42 20.44 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.641 0.776 . . . . 0.0 109.89 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.63 171.14 6.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 163.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.78 -45.64 70.81 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.11 -40.11 96.66 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.651 1.18 . . . . 0.0 111.005 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.56 82.7 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.082 0.401 . . . . 0.0 111.308 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -64.48 -36.51 84.42 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.527 0.731 . . . . 0.0 111.766 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.04 -47.85 71.14 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.491 0.587 . . . . 0.0 110.343 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -62.0 -39.54 92.56 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 118.183 0.447 . . . . 0.0 110.149 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -62.15 -27.22 68.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.45 0.568 . . . . 0.0 111.862 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 55.5 m -82.66 -5.46 58.85 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.825 -1.172 . . . . 0.0 113.873 171.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.96 -2.24 53.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.949 1.249 . . . . 0.0 111.4 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.05 24.93 9.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.863 2.065 . . . . 0.0 108.986 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 127.2 2.2 . . . . 0.0 107.456 -175.505 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 tttp 30.86 77.36 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.818 2.447 . . . . 0.0 112.534 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.4 ttm -142.86 150.5 39.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -173.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 110.53 7.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -111.34 -179.94 3.86 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.415 1.086 . . . . 0.0 109.946 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.58 163.56 32.53 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.032 0.933 . . . . 0.0 110.361 -170.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.1 p -114.68 -179.79 3.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.552 1.644 . . . . 0.0 110.642 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HG2' ' H ' ' A' ' 8' ' ' LYS . 11.1 ptpt -63.63 -24.48 67.81 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.072 2.149 . . . . 0.0 115.226 160.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -84.05 24.01 0.98 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.732 1.151 . . . . 0.0 111.67 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.9 m80 52.89 56.42 7.6 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 125.391 1.476 . . . . 0.0 109.569 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -140.28 148.85 42.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.856 2.063 . . . . 0.0 108.236 -167.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -128.03 153.55 46.64 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.99 1.716 . . . . 0.0 110.956 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.14 151.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 C-N-CA 127.188 2.195 . . . . 0.0 106.499 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -141.4 72.3 1.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.282 1.433 . . . . 0.0 108.807 -178.368 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 15' ' ' ILE . 3.7 mp -70.57 134.1 30.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.064 2.145 . . . . 0.0 106.427 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -125.78 -61.44 1.25 Allowed 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.315 -0.866 . . . . 0.0 110.981 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.03 -76.65 0.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -126.79 4.44 6.66 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.041 1.336 . . . . 0.0 112.635 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.76 135.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.11 142.35 29.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 35.8 m -75.87 147.51 39.01 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 151.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.14 130.29 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 129.003 2.921 . . . . 0.0 107.187 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.41 172.68 26.92 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 167.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 87' ' ' ILE . 12.2 pt -91.66 152.54 3.37 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.38 0.672 . . . . 0.0 109.863 173.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.7 p -82.29 170.85 14.91 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.973 -1.08 . . . . 0.0 111.206 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -21.82 66.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.926 -1.109 . . . . 0.0 113.345 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -61.59 -29.46 70.05 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.0 -1.062 . . . . 0.0 111.56 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.412 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -72.4 -46.16 56.46 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.974 -1.079 . . . . 0.0 111.432 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -64.93 -24.25 67.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.198 0.599 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.49 -47.84 68.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.553 1.941 . . . . 0.0 108.389 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -70.7 -52.6 19.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mt -73.13 -33.03 65.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.286 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -133.46 15.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.46 147.71 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.694 1.198 . . . . 0.0 107.804 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.818 HG12 ' H ' ' A' ' 36' ' ' VAL . 21.4 t -121.48 -149.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.969 1.707 . . . . 0.0 106.559 178.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.818 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER 179.8 -40.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 130.34 3.456 . . . . 0.0 108.406 -166.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.456 ' H ' HG12 ' A' ' 35' ' ' VAL . 41.1 t80 -150.43 154.52 37.88 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.267 1.394 . . . . 0.0 113.776 -176.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.06 131.33 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 125.189 1.396 . . . . 0.0 107.767 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.9 147.76 26.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.686 2.394 . . . . 0.0 108.777 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -144.61 148.88 41.64 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.048 1.339 . . . . 0.0 109.6 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.06 179.98 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.212 2.608 . . . . 0.0 114.377 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 152.04 21.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.109 0.963 . . . . 0.0 110.518 170.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.93 11.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 128.349 2.66 . . . . 0.0 115.037 -168.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.16 10.83 1.36 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.111 1.815 . . . . 0.0 112.47 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.451 ' CZ ' HG12 ' A' ' 53' ' ' VAL . 72.2 ttt180 -70.14 128.68 37.12 Favored 'General case' 0 CA--C 1.527 0.088 0 O-C-N 121.288 -1.124 . . . . 0.0 108.027 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.85 153.79 30.31 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.405 HG12 HG11 ' A' ' 53' ' ' VAL . 35.3 m -142.94 170.88 10.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.893 1.277 . . . . 0.0 109.849 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -122.56 166.24 15.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.014 1.326 . . . . 0.0 109.597 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -62.13 7.87 0.05 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -155.34 75.61 0.22 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 167.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 114.36 13.73 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.579 1.151 . . . . 0.0 109.558 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.48 93.29 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.944 1.697 . . . . 0.0 108.145 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.451 HG12 ' CZ ' ' A' ' 45' ' ' ARG . 8.3 m -115.27 -3.5 10.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.852 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.99 53.21 1.21 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.763 0.664 . . . . 0.0 111.925 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.66 155.44 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.787 0.835 . . . . 0.0 111.348 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' CD1' HD13 ' A' ' 24' ' ' ILE . 8.4 mt -129.42 94.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.0 mt-10 -82.04 108.34 15.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 88.1 p -88.92 -169.52 2.56 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.604 1.162 . . . . 0.0 110.559 172.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.1 m -53.78 -29.35 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.684 1.193 . . . . 0.0 111.905 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -163.73 29.69 0.08 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -149.9 161.54 42.09 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.483 -0.761 . . . . 0.0 109.504 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.56 105.4 8.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.601 1.561 . . . . 0.0 107.606 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.01 119.78 22.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 131.03 38.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 163.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.49 106.72 21.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -99.72 107.4 19.48 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 110.629 -162.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -36.37 122.89 0.75 Allowed Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 126.747 2.019 . . . . 0.0 111.284 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 -23.55 7.27 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.637 1.558 . . . . 0.0 114.848 -161.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.74 161.61 32.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.418 1.887 . . . . 0.0 105.911 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.4 m -77.98 149.67 34.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.7 -162.97 34.39 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 120.101 -1.624 . . . . 0.0 110.167 -172.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -132.53 131.89 42.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.114 0.957 . . . . 0.0 109.844 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.49 HD12 ' CD1' ' A' ' 98' ' ' PHE . 13.3 mm -61.3 137.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.708 1.603 . . . . 0.0 108.167 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.71 1.12 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 123.955 0.784 . . . . 0.0 112.966 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -150.75 153.32 35.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 162.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.45 166.07 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.159 1.345 . . . . 0.0 109.827 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -110.4 82.01 1.53 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -59.86 -15.09 18.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.79 0.836 . . . . 0.0 112.255 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -55.87 -31.63 62.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.339 1.055 . . . . 0.0 112.416 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -13.93 62.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.191 0.905 . . . . 0.0 109.828 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.49 -16.91 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.87 1.268 . . . . 0.0 111.953 171.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -129.95 -17.85 3.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.773 0.829 . . . . 0.0 112.267 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.06 71.71 72.96 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.941 1.697 . . . . 0.0 107.904 167.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.52 -17.53 59.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 108.949 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.51 -4.75 59.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.268 1.027 . . . . 0.0 112.734 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.6 mt -66.08 -18.15 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.468 -1.395 . . . . 0.0 111.993 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.757 HG21 HD11 ' A' ' 24' ' ' ILE . 32.7 mt -62.94 -34.85 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.223 1.009 . . . . 0.0 109.561 171.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.08 -52.4 49.18 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.138 -1.602 . . . . 0.0 109.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -37.3 86.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.505 -162.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.18 79.92 0.52 Allowed Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.42 -14.95 41.22 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.135 1.89 . . . . 0.0 112.168 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -125.15 43.76 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.579 1.552 . . . . 0.0 108.316 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.34 -100.26 0.34 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 162.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -76.38 -26.57 55.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.96 -1.019 . . . . 0.0 112.505 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 39.52 2.92 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.347 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -69.39 164.02 23.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.871 1.336 . . . . 0.0 110.344 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.28 -65.16 0.98 Allowed 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.49 ' CD1' HD12 ' A' ' 73' ' ' ILE . 48.8 p90 -148.78 173.51 13.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.2 1.0 . . . . 0.0 110.04 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -127.21 153.8 45.63 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.658 1.183 . . . . 0.0 109.022 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.4 ptm -149.9 135.88 18.68 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.159 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.76 125.56 20.54 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.061 1.744 . . . . 0.0 107.357 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 21.4 pt -73.28 129.84 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.3 p -75.62 -41.92 53.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 166.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -142.83 90.53 2.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.981 0.913 . . . . 0.0 108.648 -160.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -10.1 0.98 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.319 1.048 . . . . 0.0 111.904 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -90.47 -15.97 56.05 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.571 1.558 . . . . 0.0 112.591 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.87 -16.29 60.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.561 1.181 . . . . 0.0 110.29 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.64 -29.17 69.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.437 0.695 . . . . 0.0 110.927 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -95.38 27.63 3.25 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.011 -1.056 . . . . 0.0 111.36 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -116.71 0.5 12.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.381 147.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -84.41 -177.62 6.68 Favored 'General case' 0 C--N 1.34 0.186 0 O-C-N 120.683 -1.261 . . . . 0.0 109.837 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -91.3 127.92 36.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 107.656 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.93 178.29 1.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.374 1.083 . . . . 0.0 109.472 160.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -69.65 -49.53 52.86 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.273 1.029 . . . . 0.0 112.02 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.28 -44.28 95.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.905 0.882 . . . . 0.0 109.037 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.71 90.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.138 0.575 . . . . 0.0 111.148 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.76 -41.72 78.48 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.242 -0.911 . . . . 0.0 111.118 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -44.01 68.04 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.649 1.58 . . . . 0.0 109.97 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -52.1 -56.54 13.81 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.094 0.957 . . . . 0.0 110.49 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.04 -46.21 78.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.558 0.343 . . . . 0.0 110.283 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 4.3 t -66.43 -13.95 61.5 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.912 -1.118 . . . . 0.0 113.074 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.94 15.12 18.57 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.21 1.404 . . . . 0.0 111.117 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -4.31 25.6 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.183 -0.948 . . . . 0.0 111.334 169.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 . . . . . 0 C--O 1.248 0.978 0 C-N-CA 124.948 1.299 . . . . 0.0 109.047 -166.68 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -161.17 124.69 3.31 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 159.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 ttp -136.03 162.14 33.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.6 1.56 . . . . 0.0 107.958 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 14' ' ' SER . 21.0 ttmt -145.09 148.2 33.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.669 -1.269 . . . . 0.0 107.733 155.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -127.01 176.1 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.43 168.08 20.62 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.549 1.94 . . . . 0.0 108.827 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 68' ' ' PRO . 7.7 p -130.53 177.16 7.57 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.938 1.352 . . . . 0.0 111.311 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -76.25 -25.46 55.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.518 1.527 . . . . 0.0 110.856 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 0.6 OUTLIER -82.28 17.33 1.71 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.68 1.127 . . . . 0.0 111.272 171.398 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 65.34 59.18 0.82 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.23 1.812 . . . . 0.0 110.663 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -111.58 165.45 12.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.167 0.987 . . . . 0.0 110.388 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.415 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 50.4 p-90 -131.37 152.81 50.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.865 1.666 . . . . 0.0 109.227 168.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 t -135.78 89.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.961 1.704 . . . . 0.0 107.407 -168.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 5.7 m -72.86 82.37 1.19 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.25 1.82 . . . . 0.0 112.986 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.789 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 13.5 mm -87.41 127.29 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -141.61 -21.57 0.74 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.124 -0.985 . . . . 0.0 112.945 -170.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -141.19 -105.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 157.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -111.49 9.66 21.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.82 1.648 . . . . 0.0 111.015 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.05 144.24 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 168.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . . . -109.06 141.88 40.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 108.565 160.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 m -85.67 136.06 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 156.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.5 124.18 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 130.249 3.42 . . . . 0.0 110.67 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.62 170.96 33.6 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.007 1.289 . . . . 0.0 110.49 168.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 pt -90.7 148.27 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.784 -0.833 . . . . 0.0 108.818 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.9 p -76.28 157.92 32.06 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.32 -0.862 . . . . 0.0 111.144 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.4 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 48.1 t30 -58.44 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 1 C-N-CA 135.451 5.5 . . . . 0.0 116.054 176.41 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -107.5 -40.08 5.45 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 127.566 2.346 . . . . 0.0 112.402 164.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.79 -51.66 21.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.215 2.206 . . . . 0.0 116.07 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.555 ' NE2' ' H ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -42.08 -45.7 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.385 3.074 . . . . 0.0 109.75 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.555 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -51.69 -48.07 63.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.271 1.428 . . . . 0.0 112.284 176.289 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -68.75 -23.13 64.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.571 1.148 . . . . 0.0 111.517 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -89.05 -28.48 20.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.607 0.64 . . . . 0.0 112.385 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.43 -137.36 37.39 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 126.178 1.847 . . . . 0.0 110.555 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.28 112.98 2.93 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -86.28 -171.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 122.596 1.189 . . . . 0.0 109.038 170.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.584 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.7 p -173.15 -40.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.267 2.227 . . . . 0.0 106.348 -150.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.505 ' H ' HG12 ' A' ' 35' ' ' VAL . 36.2 t80 -154.48 149.68 27.02 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.73 135.43 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.668 1.587 . . . . 0.0 107.967 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -91.54 143.99 26.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.551 2.341 . . . . 0.0 108.155 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -141.66 138.36 17.2 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.936 0.894 . . . . 0.0 109.031 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.75 175.71 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.088 2.525 . . . . 0.0 112.325 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.19 147.93 29.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.925 -1.11 . . . . 0.0 109.718 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.19 17.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 128.464 2.706 . . . . 0.0 115.528 -168.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.77 3.85 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.311 2.386 . . . . 0.0 112.319 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -60.71 138.87 58.05 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.571 1.186 . . . . 0.0 108.388 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.61 141.36 28.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.71 170.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.952 0.901 . . . . 0.0 110.182 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -127.57 159.75 33.67 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.996 0.918 . . . . 0.0 110.672 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 10.55 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.914 2.486 . . . . 0.0 115.151 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.12 68.19 0.19 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 173.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -140.42 129.28 23.22 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.2 t -79.35 110.7 15.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -173.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -2.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.767 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.35 45.29 0.72 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.417 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.3 m -48.29 145.86 3.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.246 1.419 . . . . 0.0 113.156 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.8 mt -122.2 107.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.3 128.84 41.04 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.3 p -105.03 -172.68 2.14 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.299 0.954 . . . . 0.0 109.967 172.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 m -52.36 -27.17 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.37 1.468 . . . . 0.0 112.616 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -158.29 29.77 0.24 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.918 1.235 . . . . 0.0 113.76 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.54 -179.31 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.007 -1.058 . . . . 0.0 109.993 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.34 44.43 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 126.746 2.018 . . . . 0.0 108.35 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.31 111.65 8.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.596 1.959 . . . . 0.0 107.01 160.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 114.95 7.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -77.78 101.44 3.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -68.15 124.15 22.66 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.08 132.95 30.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.995 0.918 . . . . 0.0 109.728 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HB3' HG21 ' A' ' 7' ' ' THR . 32.9 Cg_endo -81.01 -31.84 1.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.221 1.947 . . . . 0.0 114.285 -168.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.67 157.99 35.89 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.538 1.935 . . . . 0.0 106.981 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 m -77.16 153.62 33.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.45 -171.05 31.68 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -165.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -136.38 130.88 33.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -63.62 150.21 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.432 1.093 . . . . 0.0 108.374 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.68 3.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.689 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -156.73 160.12 38.99 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 121.373 1.897 . . . . 0.0 109.501 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.68 168.0 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.728 1.611 . . . . 0.0 109.59 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -117.71 78.71 1.26 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.641 1.177 . . . . 0.0 109.035 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.55 -11.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.169 0.987 . . . . 0.0 112.958 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -53.14 -31.68 43.68 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.683 -1.26 . . . . 0.0 111.042 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -21.36 59.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.241 1.017 . . . . 0.0 110.079 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.38 -5.95 16.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.549 1.939 . . . . 0.0 113.293 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -137.42 -34.35 0.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.552 -0.718 . . . . 0.0 110.229 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.1 62.07 19.19 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.323 2.249 . . . . 0.0 109.113 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.16 -20.49 28.34 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 124.177 3.251 . . . . 0.0 110.263 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.83 -17.32 49.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.699 1.2 . . . . 0.0 110.587 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.5 mt -67.86 -16.76 64.24 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.653 1.57 . . . . 0.0 114.383 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 mt -67.4 -23.72 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.26 0.936 . . . . 0.0 109.816 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -76.16 -53.73 7.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 119.967 -1.708 . . . . 0.0 109.918 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -59.99 -40.5 89.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.151 0.981 . . . . 0.0 112.084 -167.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.75 76.63 2.26 Favored Pre-proline 0 C--N 1.333 -0.136 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.15 -19.71 67.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.407 2.072 . . . . 0.0 113.315 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.3 mt-10 -124.19 22.32 8.66 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.43 1.013 . . . . 0.0 111.288 -171.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.06 -82.14 0.17 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 166.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -83.36 -38.83 21.5 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.49 46.32 3.24 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.793 1.179 . . . . 0.0 114.15 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -81.3 168.37 18.51 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.249 1.024 . . . . 0.0 109.704 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.63 -69.25 0.84 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -138.48 173.18 11.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.557 0.743 . . . . 0.0 111.349 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -128.38 150.36 50.14 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -144.84 148.69 34.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.054 0.542 . . . . 0.0 110.141 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.94 117.48 11.57 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.258 1.823 . . . . 0.0 107.778 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.412 HG21 ' CD1' ' A' ' 15' ' ' ILE . 2.9 pt -70.1 97.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.587 1.184 . . . . 0.0 107.963 163.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 m -60.67 -34.73 74.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.028 167.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -134.95 82.72 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -163.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.476 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -65.15 -12.81 55.0 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.464 -0.772 . . . . 0.0 110.235 172.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.31 73.19 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 117.549 -1.695 . . . . 0.0 112.202 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -80.43 -29.22 37.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.958 1.879 . . . . 0.0 110.61 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 105' ' ' GLU . 17.8 mt -41.81 -46.08 3.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.142 1.792 . . . . 0.0 111.83 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.49 -11.34 60.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.05 -35.62 59.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 165.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 108' ' ' LEU . 2.4 mm? -64.88 171.02 3.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 123.693 1.711 . . . . 0.0 110.979 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.7 mt -70.54 120.82 16.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.022 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.4 -179.47 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.266 1.426 . . . . 0.0 110.231 163.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.64 -37.96 70.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.271 -1.518 . . . . 0.0 110.986 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -69.73 -46.1 66.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.27 1.428 . . . . 0.0 109.024 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.44 66.5 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.013 0.925 . . . . 0.0 111.875 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -63.47 -48.14 78.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.573 1.149 . . . . 0.0 109.506 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.0 -41.85 79.23 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -56.17 -46.95 79.14 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.817 0.847 . . . . 0.0 110.084 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -61.46 -40.92 96.27 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.24 -0.913 . . . . 0.0 111.671 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.49 -14.89 8.95 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.56 -17.77 29.51 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 120.523 1.51 . . . . 0.0 111.757 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -115.81 32.35 6.14 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.701 2.401 . . . . 0.0 108.601 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.61 -1.662 . . . . 0.0 111.891 -175.812 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.7 mtt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.83 150.46 1.47 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 31.1 tpp -147.43 154.23 40.58 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.126 1.37 . . . . 0.0 108.767 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -142.09 112.47 7.1 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.964 -1.085 . . . . 0.0 109.892 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -105.63 -179.23 3.88 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.732 0.645 . . . . 0.0 111.56 162.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -136.69 176.75 8.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.408 1.883 . . . . 0.0 111.568 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -134.96 166.09 23.82 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.894 1.277 . . . . 0.0 111.512 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 10' ' ' HIS . 2.1 mtmt -71.91 -34.54 69.18 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.769 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -71.58 42.33 0.08 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.35 0.977 . . . . 0.0 109.611 165.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 8' ' ' LYS . 5.1 p80 38.97 63.97 0.85 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 127.726 2.411 . . . . 0.0 112.509 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 11.1 mt-10 -128.17 169.14 14.47 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.0 109.361 168.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -113.35 172.27 7.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.833 2.053 . . . . 0.0 109.435 161.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.3 t -136.4 142.89 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.757 2.423 . . . . 0.0 105.279 174.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.77 80.11 1.78 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 119.557 1.071 . . . . 0.0 110.893 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.4 mp -62.39 140.02 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 168.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -117.23 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 160.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.68 -94.83 0.44 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -123.22 33.35 5.4 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 128.152 2.581 . . . . 0.0 110.849 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.16 119.43 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 164.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -102.06 107.04 18.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.856 1.663 . . . . 0.0 107.607 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -70.23 126.39 29.52 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.824 0.85 . . . . 0.0 109.145 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.54 HG11 ' CE1' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -95.12 148.52 5.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 128.545 2.738 . . . . 0.0 112.618 169.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.19 161.39 32.0 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 157.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.434 ' CD1' HG21 ' A' ' 87' ' ' ILE . 3.3 pt -84.49 139.4 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 118.939 1.37 . . . . 0.0 108.6 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.7 p -73.51 172.99 10.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.564 -0.71 . . . . 0.0 111.466 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -59.19 -33.81 71.4 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.618 -1.301 . . . . 0.0 113.245 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -54.25 -24.1 17.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.893 1.277 . . . . 0.0 111.616 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.52 -48.75 10.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.264 1.025 . . . . 0.0 112.152 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.0 pp0? -62.45 -20.02 64.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.084 0.856 . . . . 0.0 110.302 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -58.67 -26.52 63.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.647 1.979 . . . . 0.0 112.958 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -90.04 -42.01 11.38 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 120.155 1.343 . . . . 0.0 113.387 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mt -89.14 -33.0 17.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -170.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.44 -118.78 7.26 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.848 1.69 . . . . 0.0 111.606 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.79 112.88 3.07 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.213 1.805 . . . . 0.0 107.81 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -98.11 -165.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.047 0.927 . . . . 0.0 109.849 179.461 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.669 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -172.85 -31.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 129.62 3.168 . . . . 0.0 109.545 -168.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' H ' HG12 ' A' ' 35' ' ' VAL . 37.0 t80 -150.12 147.41 27.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 111.326 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 56' ' ' ILE . 22.8 t -138.99 115.88 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.21 140.71 58.9 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.998 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.3 mt -134.17 137.01 27.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 125.486 1.515 . . . . 0.0 107.576 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.87 -163.69 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.546 2.831 . . . . 0.0 112.643 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -113.69 145.32 41.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.854 1.662 . . . . 0.0 108.288 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.41 16.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -165.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.54 13.84 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.92 1.724 . . . . 0.0 112.671 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -79.39 137.38 37.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.524 1.662 . . . . 0.0 109.491 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -77.13 154.48 33.19 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.996 0.816 . . . . 0.0 109.872 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.448 HG11 HD11 ' A' ' 73' ' ' ILE . 35.6 m -140.46 164.71 21.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.515 1.126 . . . . 0.0 110.566 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -111.08 165.45 11.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 126.427 1.891 . . . . 0.0 107.983 167.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -60.77 10.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.729 2.012 . . . . 0.0 115.78 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.3 92.13 0.12 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 162.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.07 126.83 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -72.27 20.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 126.47 1.908 . . . . 0.0 113.976 -166.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.03 11.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 127.118 2.167 . . . . 0.0 116.196 -165.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.1 49.08 0.84 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.899 1.28 . . . . 0.0 108.79 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.8 m -49.43 157.22 0.53 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.402 1.096 . . . . 0.0 111.123 169.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.458 HG23 HG22 ' A' ' 38' ' ' VAL . 5.3 mt -142.0 100.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -86.2 118.93 25.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -90.37 -167.94 1.97 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.484 1.514 . . . . 0.0 109.511 168.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -39.53 -52.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.054 1.742 . . . . 0.0 112.392 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -155.04 52.4 0.62 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.883 1.219 . . . . 0.0 111.81 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.3 177.37 10.64 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.179 -0.951 . . . . 0.0 109.194 163.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.19 114.04 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.506 1.523 . . . . 0.0 108.34 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.77 100.04 11.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.21 111.16 2.47 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.11 109.69 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -81.97 108.05 15.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.721 -0.612 . . . . 0.0 109.767 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -38.49 142.63 0.48 Allowed Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 126.826 2.05 . . . . 0.0 113.067 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.8 -35.9 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 119.617 0.899 . . . . 0.0 113.783 -161.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.537 HD11 HD23 ' A' ' 108' ' ' LEU . 4.5 mm? -123.46 160.32 27.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -80.67 151.61 28.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.54 -157.28 27.44 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -168.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -142.54 137.44 30.15 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.899 0.85 . . . . 0.0 109.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.52 HD12 ' CD1' ' A' ' 98' ' ' PHE . 11.0 mm -63.96 146.27 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 124.372 1.069 . . . . 0.0 108.817 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.4 -0.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.202 1.001 . . . . 0.0 111.116 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -161.43 157.64 25.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.22 146.13 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -173.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -86.51 74.73 9.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 118.57 0.623 . . . . 0.0 110.204 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.35 -15.11 14.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -54.51 -45.9 73.39 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.076 165.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.11 -18.88 64.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 0.0 112.281 -173.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -63.75 -15.66 59.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.207 1.403 . . . . 0.0 111.232 169.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 p -131.97 -27.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.67 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.23 64.55 61.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.143 1.777 . . . . 0.0 110.496 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.85 -10.25 27.65 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.146 3.231 . . . . 0.0 111.792 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.37 -14.16 61.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.197 -0.94 . . . . 0.0 112.908 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 86' ' ' LEU . 5.5 mt -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.113 1.324 . . . . 0.0 113.464 -169.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 87' ' ' ILE . 4.6 mp -63.83 -33.87 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.44 1.018 . . . . 0.0 110.667 169.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -59.07 -46.35 88.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.785 1.755 . . . . 0.0 109.965 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -72.73 -59.99 2.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 127.694 2.398 . . . . 0.0 110.579 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -140.54 65.07 25.24 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -167.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.78 -18.31 55.33 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 120.811 1.007 . . . . 0.0 111.475 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.33 28.18 7.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 109.021 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.6 -113.85 0.99 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.44 -14.33 62.83 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.269 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.71 32.48 2.15 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 120.678 1.581 . . . . 0.0 112.513 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.86 161.25 13.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.171 0.985 . . . . 0.0 108.741 165.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.46 -58.29 2.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.931 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CE1' HG11 ' A' ' 22' ' ' VAL . 42.7 p90 -140.03 -176.79 4.72 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 115.022 -2.671 . . . . 0.0 111.934 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -136.42 129.84 31.79 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 ptm -131.92 139.13 48.63 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.5 141.91 58.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.9 pt -95.91 149.97 4.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -133.65 -13.06 2.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.904 1.681 . . . . 0.0 112.391 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -146.27 74.36 1.36 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -66.52 -10.26 43.04 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.618 -1.301 . . . . 0.0 111.009 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.28 -39.26 95.82 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 120.531 -1.355 . . . . 0.0 110.703 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -63.85 -28.94 70.19 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.568 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 69' ' ' LEU . 15.0 mt -47.41 -36.67 10.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 120.184 1.356 . . . . 0.0 111.883 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.72 -16.62 55.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.887 1.676 . . . . 0.0 112.657 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.6 -31.24 66.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.346 1.459 . . . . 0.0 109.96 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -65.08 169.08 5.78 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.673 -0.642 . . . . 0.0 109.525 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.561 HD22 ' H ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -68.21 127.04 31.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.57 171.94 0.76 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 154.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -67.88 -36.57 80.47 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.509 -1.995 . . . . 0.0 112.126 -173.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.71 -51.55 58.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.21 71.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.255 0.222 . . . . 0.0 111.192 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -61.58 -52.37 64.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.728 1.211 . . . . 0.0 109.933 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -41.0 72.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.295 0.638 . . . . 0.0 109.651 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.97 -41.41 91.22 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.906 0.882 . . . . 0.0 110.968 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -68.11 -51.67 43.6 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.54 -0.725 . . . . 0.0 109.435 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.5 m -72.76 15.26 0.2 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.803 1.241 . . . . 0.0 113.404 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.34 -15.67 14.58 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.231 2.212 . . . . 0.0 112.266 164.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -114.21 -13.85 12.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.717 1.607 . . . . 0.0 112.664 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.465 1.906 . . . . 0.0 109.55 -174.862 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mtm . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.919 0.39 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.5 mttt 70.43 130.15 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 128.569 2.748 . . . . 0.0 111.43 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.519 ' SD ' ' HE2' ' A' ' 5' ' ' LYS . 3.8 ptp -165.61 178.28 6.78 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.44 1.496 . . . . 0.0 109.512 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 64.94 0.74 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.66 -1.275 . . . . 0.0 111.372 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HE2' ' SD ' ' A' ' 3' ' ' MET . 2.0 mptp? -66.9 -178.65 0.78 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.97 149.42 47.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.487 1.915 . . . . 0.0 110.003 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.0 p -93.14 171.21 9.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 123.518 1.628 . . . . 0.0 109.574 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -71.99 -33.4 68.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.016 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -89.84 43.53 1.15 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.63 2.372 . . . . 0.0 111.564 -176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p80 48.5 46.53 20.79 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.361 1.864 . . . . 0.0 114.234 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.0 mt-10 -121.25 158.21 28.61 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 109.275 170.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.43 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.8 p-90 -108.79 163.15 13.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.472 1.509 . . . . 0.0 107.358 165.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.18 154.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -143.34 80.66 1.68 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.122 1.369 . . . . 0.0 109.632 -172.425 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 20' ' ' ALA . 1.2 mt -80.56 117.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.454 1.502 . . . . 0.0 108.82 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.287 5.1 pt-20 -114.11 -101.18 0.42 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 116.732 -1.604 . . . . 0.0 108.988 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -64.08 1.1 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 122.321 2.328 . . . . 0.0 111.806 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -153.66 8.54 0.38 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.487 2.715 . . . . 0.0 109.873 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.5 t -127.92 126.45 66.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -90.71 141.81 28.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.695 0.398 . . . . 0.0 109.962 168.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 16.4 m -87.99 151.71 22.58 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.15 142.33 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.752 1.221 . . . . 0.0 109.327 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -158.47 170.39 35.11 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 163.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.782 HD11 HG21 ' A' ' 87' ' ' ILE . 30.7 pt -77.46 152.08 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 118.415 1.108 . . . . 0.0 110.695 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -80.8 171.81 14.54 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.916 -1.115 . . . . 0.0 112.508 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -21.52 62.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.37 1.068 . . . . 0.0 113.025 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -67.02 -31.21 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 119.765 -1.835 . . . . 0.0 111.859 169.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.504 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -81.2 -42.7 20.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.953 -1.092 . . . . 0.0 111.705 -172.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.655 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.9 pp0? -56.31 -22.32 29.72 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.372 0.533 . . . . 0.0 111.374 175.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -46.13 81.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.194 0.998 . . . . 0.0 109.371 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -81.01 -27.83 35.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.254 1.422 . . . . 0.0 112.515 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.508 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -78.02 -43.96 27.91 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.91 -150.03 51.6 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 124.517 1.056 . . . . 0.0 110.801 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -46.23 114.57 0.82 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.954 2.502 . . . . 0.0 108.081 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 36' ' ' VAL 0.276 8.9 p -111.08 173.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-O 122.774 1.273 . . . . 0.0 110.112 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.709 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.07 -23.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.413 -153.221 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.419 ' H ' ' H ' ' A' ' 36' ' ' VAL . 45.3 t80 -147.79 142.05 26.21 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.802 0.274 . . . . 0.0 111.237 175.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.25 132.47 55.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 159.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.5 137.63 42.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.805 168.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.2 mt -131.47 131.44 22.91 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.66 179.7 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.568 2.845 . . . . 0.0 113.149 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.39 156.77 24.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.549 -0.719 . . . . 0.0 111.146 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.99 19.21 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 0.0 113.457 -164.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.88 33.43 0.56 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -106.85 133.89 50.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.332 1.066 . . . . 0.0 110.829 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 150.72 48.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.378 0.99 . . . . 0.0 110.353 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -142.22 167.13 15.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.755 1.622 . . . . 0.0 110.624 169.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -116.85 170.49 8.58 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 127.758 2.423 . . . . 0.0 110.895 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 6.61 0.25 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.6 59.25 0.35 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -106.79 115.35 30.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.922 1.289 . . . . 0.0 108.994 -173.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.1 OUTLIER -70.28 33.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 127.736 2.414 . . . . 0.0 113.922 -173.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 53' ' ' VAL . 17.0 m -72.69 10.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 O-C-N 117.956 -2.965 . . . . 0.0 115.958 -167.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.85 51.85 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.221 0.918 . . . . 0.0 109.554 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.69 157.21 7.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.81 0.814 . . . . 0.0 111.034 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.452 HD12 HD13 ' A' ' 24' ' ' ILE . 15.2 mt -133.6 108.03 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -101.49 117.27 34.59 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 35' ' ' VAL . 56.2 p -99.61 -159.95 0.77 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.335 1.454 . . . . 0.0 111.7 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -43.55 -44.1 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.07 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -158.56 13.29 0.18 Allowed 'General case' 0 C--N 1.346 0.453 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 165.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.82 159.16 15.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.911 1.687 . . . . 0.0 108.148 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.32 96.59 3.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.385 1.474 . . . . 0.0 107.517 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -90.65 107.38 19.14 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.998 0.919 . . . . 0.0 110.311 176.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.31 117.33 4.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.238 1.815 . . . . 0.0 107.37 163.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.74 103.63 14.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -94.51 98.55 10.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -168.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.9 130.97 0.3 Allowed Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.924 2.09 . . . . 0.0 113.917 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.1 -29.68 39.54 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.279 2.653 . . . . 0.0 114.546 -167.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.9 mt -148.34 158.59 44.19 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.963 1.305 . . . . 0.0 108.079 -167.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -66.48 145.43 55.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.4 38.8 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -129.53 130.92 46.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.13 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.5 mm -63.66 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.2 m -145.71 -3.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.245 1.018 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -148.03 158.77 44.24 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.969 1.259 . . . . 0.0 107.845 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -142.45 158.38 19.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.333 1.453 . . . . 0.0 107.948 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -108.72 74.09 0.9 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.988 0.515 . . . . 0.0 110.141 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.65 -11.4 7.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -44.78 -42.34 7.71 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.313 1.445 . . . . 0.0 111.357 164.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -12.14 61.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.063 0.945 . . . . 0.0 110.893 -170.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.66 -11.21 57.75 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.707 1.203 . . . . 0.0 112.173 167.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -131.28 -36.18 1.31 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.828 . . . . 0.0 111.235 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -121.2 73.92 28.39 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.869 2.068 . . . . 0.0 107.233 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.89 -43.86 1.54 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.987 1.791 . . . . 0.0 107.657 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.617 ' HA ' HG12 ' A' ' 35' ' ' VAL . 96.4 mt-10 -56.07 -11.36 1.07 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.653 1.581 . . . . 0.0 112.285 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -57.43 -18.11 16.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.664 1.985 . . . . 0.0 111.99 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.782 HG21 HD11 ' A' ' 24' ' ' ILE . 3.8 mm -53.05 -37.95 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -68.02 -48.59 65.28 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 120.93 -1.106 . . . . 0.0 111.334 174.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 5.0 mtpt -77.74 -28.26 50.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 125.755 1.622 . . . . 0.0 113.126 -162.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.75 65.19 0.72 Allowed Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -177.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.98 -30.22 89.47 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.295 1.997 . . . . 0.0 112.756 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.1 mp0 -119.12 21.57 12.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.642 0.777 . . . . 0.0 110.046 177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.79 -121.53 4.86 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 105.874 -2.89 . . . . 0.0 105.874 157.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.54 -3.01 28.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.05 23.3 5.31 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 120.706 1.594 . . . . 0.0 112.7 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -63.2 162.02 12.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.722 1.761 . . . . 0.0 109.886 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.42 HD12 ' HA2' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -104.71 -56.16 2.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.132 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.03 173.81 12.12 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.209 -0.932 . . . . 0.0 112.014 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -124.72 152.54 43.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.788 0.835 . . . . 0.0 110.209 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -142.89 141.71 31.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.753 1.221 . . . . 0.0 110.493 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -64.63 133.51 52.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 pt -87.45 103.13 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 122.846 0.458 . . . . 0.0 110.322 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.5 m -66.86 -7.69 23.54 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -143.56 135.08 26.19 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -99.46 2.02 44.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.527 2.331 . . . . 0.0 108.158 162.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.81 -39.12 5.02 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.804 -1.185 . . . . 0.0 112.573 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -65.27 -24.13 67.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.42 1.11 . . . . 0.0 110.527 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 111' ' ' LEU . 2.7 mp -38.0 -44.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.533 2.733 . . . . 0.0 112.206 163.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -79.86 -7.34 58.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.272 1.396 . . . . 0.0 112.506 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -88.23 -12.75 42.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 111.639 168.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 108' ' ' LEU . 1.1 mm? -66.27 169.52 7.1 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.053 -1.655 . . . . 0.0 109.155 167.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.42 139.44 42.33 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.84 171.66 0.88 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.553 1.168 . . . . 0.0 109.232 159.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.13 -34.45 78.08 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.388 1.875 . . . . 0.0 111.251 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -80.55 -44.16 19.49 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.571 1.148 . . . . 0.0 109.514 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.16 72.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.106 0.479 . . . . 0.0 111.307 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -59.31 -39.9 84.55 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.175 0.99 . . . . 0.0 110.947 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.67 -45.32 72.02 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.178 0.591 . . . . 0.0 109.881 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -46.52 76.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.662 0.785 . . . . 0.0 110.45 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -53.82 -49.26 68.76 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.798 1.639 . . . . 0.0 110.895 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.3 t -66.5 -21.71 66.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.985 0.914 . . . . 0.0 112.346 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.88 -6.59 58.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.287 1.035 . . . . 0.0 112.721 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -103.21 -13.67 16.66 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.088 0.858 . . . . 0.0 111.902 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.895 -169.298 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 58.04 61.47 2.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.129 1.372 . . . . 0.0 111.21 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.6 ttm -115.85 157.81 23.88 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.437 1.095 . . . . 0.0 108.141 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -138.64 121.18 16.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.949 154.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -113.42 179.97 3.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.316 1.847 . . . . 0.0 110.011 172.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 117' ' ' TYR . 70.6 m-85 -150.55 167.94 25.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.0 1.32 . . . . 0.0 110.508 -164.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -136.74 170.08 16.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.23 1.377 . . . . 0.0 111.371 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.487 ' HG2' ' CZ ' ' A' ' 120' ' ' PHE . 0.7 OUTLIER -68.5 -14.64 63.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 176.158 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -89.33 34.89 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.151 -1.593 . . . . 0.0 108.282 175.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 p80 41.73 64.16 1.13 Allowed 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.173 2.589 . . . . 0.0 110.723 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.492 1.517 . . . . 0.0 107.562 -166.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.9 p-90 -116.92 150.69 38.09 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.19 1.796 . . . . 0.0 110.043 176.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.57 122.91 15.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -161.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -120.38 97.79 5.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.449 1.022 . . . . 0.0 111.295 -163.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -108.49 102.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.484 1.113 . . . . 0.0 109.529 -164.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.46 -74.5 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.885 0.874 . . . . 0.0 110.11 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -74.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 108.066 -170.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -126.93 7.85 6.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.233 0.924 . . . . 0.0 113.344 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -134.69 142.66 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.79 137.54 38.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.029 1.332 . . . . 0.0 109.187 163.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 5.8 m -78.94 132.02 36.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 155.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.49 132.05 49.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.683 1.993 . . . . 0.0 108.762 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.493 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -149.69 168.82 29.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.548 1.071 . . . . 0.0 110.904 159.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.601 HD12 ' HB1' ' A' ' 28' ' ' ALA . 16.4 pt -89.06 159.19 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.334 0.653 . . . . 0.0 109.875 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -90.72 175.08 7.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.711 -1.243 . . . . 0.0 112.049 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -39.52 62.45 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.01 -1.056 . . . . 0.0 111.599 171.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -58.18 -22.5 51.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.398 1.079 . . . . 0.0 111.85 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 24' ' ' ILE . . . -89.56 -46.65 8.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.751 1.62 . . . . 0.0 112.172 -175.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -64.03 -22.83 67.09 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.12 0.418 . . . . 0.0 111.396 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -27.52 69.0 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.193 1.397 . . . . 0.0 111.716 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -90.11 -43.78 10.24 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.733 -0.605 . . . . 0.0 110.967 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.58 -35.75 14.08 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.954 -170.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.2 -119.42 8.68 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 125.373 1.464 . . . . 0.0 111.043 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.73 91.63 0.63 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.405 1.882 . . . . 0.0 106.728 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -74.88 -162.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.8 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -165.6 -35.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 130.249 3.42 . . . . 0.0 109.37 -169.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.478 ' H ' HG12 ' A' ' 35' ' ' VAL . 59.7 t80 -158.17 161.21 37.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.128 0.876 . . . . 0.0 112.667 -174.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.45 132.37 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.574 1.15 . . . . 0.0 110.951 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.78 136.02 36.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 108.869 170.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 80' ' ' LEU . 68.3 mt -130.95 144.39 53.35 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.062 1.745 . . . . 0.0 109.135 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.72 -179.25 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.586 2.857 . . . . 0.0 112.658 -169.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -73.49 148.11 43.45 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 110.065 166.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.71 9.18 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.642 2.377 . . . . 0.0 114.743 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.19 12.17 0.92 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 126.76 2.124 . . . . 0.0 110.503 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -66.52 145.14 55.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.212 1.006 . . . . 0.0 108.921 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -84.33 150.48 25.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.429 1.585 . . . . 0.0 110.575 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.562 HG22 HG11 ' A' ' 53' ' ' VAL 0.377 11.6 t -142.58 173.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.174 0 C-N-CA 129.782 3.233 . . . . 0.0 108.621 -175.257 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -141.89 169.46 17.54 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 129.362 3.065 . . . . 0.0 103.831 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 14.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.68 92.57 0.1 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 103.9 -3.68 . . . . 0.0 103.9 162.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.26 142.45 31.37 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 52' ' ' VAL . 46.1 t -79.12 32.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 130.341 3.456 . . . . 0.0 111.344 -164.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG11 HG22 ' A' ' 47' ' ' VAL . 23.5 m -68.41 1.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 119.431 -2.043 . . . . 0.0 111.788 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.6 73.2 1.17 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.886 1.675 . . . . 0.0 110.015 172.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.99 164.33 6.74 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 120.028 -1.67 . . . . 0.0 110.592 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mt -135.24 151.88 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.0 123.68 21.1 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.835 -1.165 . . . . 0.0 108.286 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 61' ' ' ALA . 48.4 t -107.21 -169.61 1.57 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.957 1.303 . . . . 0.0 107.952 -172.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.93 -33.82 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.86 1.264 . . . . 0.0 111.794 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -169.13 18.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.96 1.704 . . . . 0.0 112.827 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 58' ' ' SER . . . -113.48 152.64 29.89 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.269 0.941 . . . . 0.0 111.361 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.83 129.58 15.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.119 1.368 . . . . 0.0 109.254 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.3 107.93 2.27 Favored 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.634 4.374 . . . . 0.0 105.27 -163.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -67.35 134.75 52.11 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -78.46 120.12 28.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 164.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -102.86 105.58 15.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.57 132.58 1.34 Allowed Pre-proline 0 N--CA 1.452 -0.36 0 O-C-N 124.488 1.117 . . . . 0.0 112.331 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.02 -26.0 31.5 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.711 2.274 . . . . 0.0 113.491 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.4 151.26 34.97 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.261 1.425 . . . . 0.0 107.568 -163.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -72.48 128.38 35.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.16 40.62 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.626 -0.671 . . . . 0.0 111.919 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -128.52 131.09 48.28 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.328 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.2 mm -57.78 148.31 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 120.132 1.333 . . . . 0.0 108.368 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.81 -4.27 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.029 0.932 . . . . 0.0 112.747 164.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -150.5 156.51 41.57 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.349 1.432 . . . . 0.0 107.796 171.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.0 m -133.55 165.44 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.765 1.226 . . . . 0.0 108.017 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.98 83.03 1.69 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.253 0.621 . . . . 0.0 110.617 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.1 1.9 0.4 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -62.53 -43.02 99.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 119.802 -1.811 . . . . 0.0 108.49 166.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.554 ' CD1' HD23 ' A' ' 97' ' ' LEU . 92.1 mt -57.09 -14.29 3.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 113.704 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.1 -36.85 78.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.832 2.053 . . . . 0.0 110.698 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 p -127.5 -11.84 5.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.518 1.127 . . . . 0.0 112.413 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -117.31 58.3 2.29 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.254 1.822 . . . . 0.0 111.235 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.45 -18.16 18.02 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.641 2.227 . . . . 0.0 110.222 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.04 -13.89 60.92 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.382 0.992 . . . . 0.0 111.6 171.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -24.91 66.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.725 -1.859 . . . . 0.0 110.863 -172.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 80' ' ' LEU . 3.5 mt -62.65 -18.27 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 O-C-N 120.557 -1.339 . . . . 0.0 110.507 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -74.3 -53.57 9.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 119.171 -2.206 . . . . 0.0 111.33 161.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -68.73 -52.6 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.296 1.439 . . . . 0.0 109.958 -159.551 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.4 70.72 12.93 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 125.803 1.641 . . . . 0.0 106.7 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.99 -23.35 72.69 Favored 'Trans proline' 0 CA--C 1.511 -0.63 0 C-N-CA 123.059 2.506 . . . . 0.0 112.351 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP 0.294 0.4 OUTLIER -119.1 31.54 6.58 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.773 1.629 . . . . 0.0 109.27 -175.256 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -110.87 0.85 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.256 1.884 . . . . 0.0 109.03 166.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -72.96 -9.17 58.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.828 0.851 . . . . 0.0 113.104 -175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.74 21.92 33.68 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.854 1.216 . . . . 0.0 113.567 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -57.66 169.12 0.74 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.126 1.463 . . . . 0.0 110.309 165.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.554 HD23 ' CD1' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -120.6 -52.58 2.13 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -152.05 170.09 20.77 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 121.557 -0.714 . . . . 0.0 110.144 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -129.84 141.13 50.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.59 142.29 39.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.845 0.858 . . . . 0.0 110.105 -171.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.56 125.69 27.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.89 2.076 . . . . 0.0 106.935 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -81.77 97.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 124.328 1.018 . . . . 0.0 108.69 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -72.15 -16.12 61.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.39 172.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -137.93 79.2 1.73 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.597 ' HA ' HD21 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -65.25 -15.61 62.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.62 -0.675 . . . . 0.0 111.609 176.261 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.55 4.64 77.48 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 116.925 -2.042 . . . . 0.0 114.067 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -97.81 -28.91 13.64 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.691 1.745 . . . . 0.0 112.614 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -62.95 -34.06 76.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.652 1.569 . . . . 0.0 112.135 -173.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -56.0 -29.29 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 124.841 1.257 . . . . 0.0 112.698 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -84.97 -17.16 38.51 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 111.36 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -76.68 -174.08 2.85 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.589 1.155 . . . . 0.0 109.623 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.58 128.1 32.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.96 169.93 0.2 Allowed 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 122.023 0.916 . . . . 0.0 109.957 160.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.01 -43.06 75.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.732 1.613 . . . . 0.0 110.995 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -65.31 -50.97 63.64 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.475 1.51 . . . . 0.0 109.107 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.84 70.19 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.592 -0.692 . . . . 0.0 111.824 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 4.3 t80 -63.16 -44.0 96.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.009 0.924 . . . . 0.0 110.407 174.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.38 71.91 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -45.6 86.55 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.981 0.42 . . . . 0.0 109.909 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.487 ' CZ ' ' HG2' ' A' ' 8' ' ' LYS . 34.3 t80 -66.18 -34.65 78.52 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.249 -0.907 . . . . 0.0 111.456 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 90.7 m -69.68 -12.6 61.76 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.237 -0.914 . . . . 0.0 113.337 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.94 9.65 42.59 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.199 1.8 . . . . 0.0 111.171 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -104.48 20.13 19.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.043 0.537 . . . . 0.0 110.234 160.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 C--O 1.243 0.72 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.189 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 mmm . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -74.83 129.15 37.17 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.665 -1.272 . . . . 0.0 108.511 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ptm -160.38 152.5 20.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.311 1.045 . . . . 0.0 108.93 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -125.9 88.4 2.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.278 0.944 . . . . 0.0 109.947 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -92.49 174.73 7.13 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.697 -0.627 . . . . 0.0 111.707 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.16 177.24 7.99 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.288 1.435 . . . . 0.0 112.035 -169.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -130.67 168.03 17.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.1 1.36 . . . . 0.0 110.882 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.474 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -77.27 18.21 0.42 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.019 1.328 . . . . 0.0 111.414 159.304 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -125.23 26.67 6.83 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.458 -1.401 . . . . 0.0 110.496 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.6 p80 45.02 50.97 9.03 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 111.506 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -121.97 143.22 49.61 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -99.51 159.53 14.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 160.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.26 107.9 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.35 74.79 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.495 1.118 . . . . 0.0 110.503 -170.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.0 mp -64.7 146.16 13.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.718 1.207 . . . . 0.0 108.501 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -139.06 -70.6 0.41 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.083 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.4 -62.47 1.26 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.984 1.266 . . . . 0.0 111.006 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.05 15.36 2.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.01 1.324 . . . . 0.0 110.526 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.45 150.89 33.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -123.07 133.43 54.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.736 1.614 . . . . 0.0 107.261 167.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -77.47 113.59 15.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 164.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.12 135.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.3 170.32 31.56 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 165.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.569 HD11 ' CG2' ' A' ' 87' ' ' ILE . 15.7 pt -90.33 153.35 3.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 117.974 0.887 . . . . 0.0 110.466 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 p -91.25 164.58 13.83 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.211 -1.555 . . . . 0.0 109.654 171.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.545 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 13.4 p-10 -50.9 -37.18 42.29 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 114.151 -2.833 . . . . 0.0 115.308 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -49.24 -34.52 15.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 121.604 2.002 . . . . 0.0 109.46 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' HB1' HD12 ' A' ' 24' ' ' ILE . . . -64.57 -68.9 0.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.26 1.824 . . . . 0.0 112.9 173.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.545 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 6.1 pm0 -66.04 -24.58 66.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.695 1.589 . . . . 0.0 110.699 -171.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.99 -40.29 96.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.272 17.8 pt20 -75.05 -56.69 4.48 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.328 0.651 . . . . 0.0 112.248 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -35.62 81.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.682 0.674 . . . . 0.0 111.926 -170.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.53 -137.07 36.86 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.85 110.73 0.77 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 128.39 2.676 . . . . 0.0 110.105 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -93.1 172.82 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 124.693 2.187 . . . . 0.0 109.649 171.361 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.715 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.5 m -151.2 -37.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 129.432 3.093 . . . . 0.0 109.201 -160.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.404 ' H ' HG12 ' A' ' 35' ' ' VAL . 46.3 t80 -155.52 153.61 30.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.759 0.424 . . . . 0.0 110.776 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.44 135.43 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.843 0.83 . . . . 0.0 109.602 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.93 122.74 23.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 163.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.33 141.83 31.34 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 124.626 1.17 . . . . 0.0 107.907 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -76.3 179.45 6.36 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.717 2.278 . . . . 0.0 111.97 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -79.59 157.93 27.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.29 1.036 . . . . 0.0 110.232 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.41 15.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.291 1.437 . . . . 0.0 113.317 -171.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.34 15.29 0.39 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 128.41 2.91 . . . . 0.0 111.41 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -73.38 128.17 34.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.11 1.455 . . . . 0.0 109.051 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.26 146.76 45.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 73' ' ' ILE . 34.2 m -142.21 168.41 14.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 110.391 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 26.3 mtpt -126.21 170.68 11.6 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.741 1.616 . . . . 0.0 108.427 172.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 24.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -152.16 15.17 0.77 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.931 1.253 . . . . 0.0 113.012 167.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.43 113.78 13.23 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.06 1.93 . . . . 0.0 110.679 -168.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.79 94.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.81 5.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.545 1.538 . . . . 0.0 112.153 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.37 38.96 1.16 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.786 0.435 . . . . 0.0 110.643 -168.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.33 151.98 6.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 123.183 1.468 . . . . 0.0 111.067 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.79 134.78 53.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -115.22 124.34 51.15 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 161.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.8 p -99.14 -173.84 2.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.191 0.996 . . . . 0.0 109.647 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 m -42.9 -48.6 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.997 0.919 . . . . 0.0 111.381 171.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -160.25 85.13 0.73 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.069 0.85 . . . . 0.0 109.55 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -178.47 147.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.878 2.471 . . . . 0.0 106.23 157.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.34 152.83 18.04 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.25 120.13 14.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 130.5 47.24 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.983 2.113 . . . . 0.0 107.392 165.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.82 116.15 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -106.27 100.71 10.23 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.893 0.877 . . . . 0.0 110.738 -166.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.54 127.09 0.5 Allowed Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 126.801 2.04 . . . . 0.0 112.584 -172.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.52 -27.71 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.569 1.513 . . . . 0.0 114.129 -159.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.481 HD21 HD11 ' A' ' 111' ' ' LEU . 3.5 mm? -133.23 172.44 12.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.485 1.914 . . . . 0.0 108.634 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 49.7 m -93.48 123.02 36.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.093 1.357 . . . . 0.0 110.862 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.33 -158.27 20.7 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -164.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -139.76 142.12 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.079 -1.247 . . . . 0.0 108.304 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.597 HD12 ' CD1' ' A' ' 98' ' ' PHE . 6.3 mm -62.17 148.66 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.693 1.197 . . . . 0.0 108.226 176.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -146.46 -5.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -156.36 140.79 16.74 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.51 147.67 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -89.02 81.64 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.1 -15.71 4.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.122 0.969 . . . . 0.0 113.193 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -53.34 -39.6 64.23 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.988 2.115 . . . . 0.0 112.692 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -11.17 60.56 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.377 1.444 . . . . 0.0 111.313 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -69.3 -38.3 78.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.358 1.463 . . . . 0.0 111.164 171.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.4 p -110.86 -25.99 9.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.32 1.448 . . . . 0.0 112.847 -171.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -132.09 61.79 59.83 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 128.513 2.725 . . . . 0.0 109.449 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.67 -30.07 84.82 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.021 3.148 . . . . 0.0 111.502 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.83 -11.42 27.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.87 2.068 . . . . 0.0 111.896 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 86' ' ' LEU . 6.6 mt -64.46 -15.7 61.15 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 120.281 1.401 . . . . 0.0 113.043 168.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.569 ' CG2' HD11 ' A' ' 24' ' ' ILE . 84.8 mt -58.6 -32.34 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.502 1.046 . . . . 0.0 110.054 167.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -73.86 -55.02 6.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 119.709 -1.87 . . . . 0.0 109.082 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.464 ' HB2' HD23 ' A' ' 86' ' ' LEU . 15.3 mmmt -63.85 -56.46 15.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.391 1.476 . . . . 0.0 110.722 -168.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -138.63 57.17 11.11 Favored Pre-proline 0 C--O 1.239 0.523 0 O-C-N 124.691 1.245 . . . . 0.0 110.459 -165.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.74 -13.74 36.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.147 2.565 . . . . 0.0 112.116 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -109.22 -0.8 19.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.574 2.35 . . . . 0.0 110.756 -163.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.79 -81.09 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 125.947 1.737 . . . . 0.0 110.719 -174.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.12 -24.8 20.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.847 1.324 . . . . 0.0 113.212 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.63 31.89 1.44 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.372 1.463 . . . . 0.0 111.996 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -67.97 155.15 40.09 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.343 1.072 . . . . 0.0 109.229 173.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.15 -72.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.597 ' CD1' HD12 ' A' ' 73' ' ' ILE . 25.4 p90 -143.82 149.63 37.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.258 1.423 . . . . 0.0 108.371 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -99.25 150.71 21.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.67 142.76 43.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.47 138.16 48.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.076 1.35 . . . . 0.0 107.444 169.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 pt -96.02 111.92 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.513 0.725 . . . . 0.0 110.703 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 m -70.36 -38.03 74.7 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.073 -0.392 . . . . 0.0 111.346 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.62 81.07 1.98 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.154 0.982 . . . . 0.0 109.032 -164.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -7.31 24.11 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.97 -1.081 . . . . 0.0 111.748 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.66 -31.76 23.47 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.778 -1.201 . . . . 0.0 111.583 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -66.42 -8.98 29.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.7 -28.03 69.62 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.242 0.928 . . . . 0.0 110.946 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.16 -14.25 60.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.979 1.263 . . . . 0.0 111.391 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.85 -10.31 58.9 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.828 0.851 . . . . 0.0 111.616 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.481 HD11 HD21 ' A' ' 69' ' ' LEU . 77.9 mt -78.95 176.43 9.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.457 1.122 . . . . 0.0 110.534 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.7 133.14 34.31 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.149 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.79 166.44 13.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.379 1.561 . . . . 0.0 108.651 153.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -68.89 -35.93 77.45 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 125.447 1.499 . . . . 0.0 111.154 -168.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -67.38 -40.19 85.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.14 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.848 -0.533 . . . . 0.0 110.621 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.85 -44.04 97.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.603 0.361 . . . . 0.0 110.198 171.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -47.0 81.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.855 0.862 . . . . 0.0 110.698 172.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -60.41 -46.34 90.35 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.145 0.43 . . . . 0.0 110.389 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -59.77 -39.18 84.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.301 0.641 . . . . 0.0 110.953 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 37.8 t -62.27 -29.25 70.28 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.26 -0.9 . . . . 0.0 112.494 176.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.61 -36.88 76.59 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.895 1.225 . . . . 0.0 110.729 173.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -77.63 -3.1 39.21 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.546 1.138 . . . . 0.0 113.07 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.227 -1.368 . . . . 0.0 107.744 173.01 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 mtt . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -168.26 116.33 0.72 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -153.42 140.49 19.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 83.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.267 -0.896 . . . . 0.0 110.119 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.531 ' H ' ' HE3' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -82.93 176.81 8.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 119.436 -0.905 . . . . 0.0 113.202 178.185 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -131.44 152.92 50.25 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.897 1.679 . . . . 0.0 109.222 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.8 p -101.84 -173.67 2.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.442 1.115 . . . . 0.0 109.716 -172.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -98.03 10.36 40.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.662 1.985 . . . . 0.0 111.244 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.0 p -119.92 32.73 5.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.726 1.61 . . . . 0.0 111.572 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.11 38.86 26.54 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.355 -1.466 . . . . 0.0 111.844 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.28 137.29 44.15 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.378 1.871 . . . . 0.0 108.724 -165.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.541 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 60.4 p-90 -106.25 166.48 10.49 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.62 1.168 . . . . 0.0 109.774 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.04 144.67 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 83.81 1.9 Allowed 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.351 1.061 . . . . 0.0 109.855 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.79 132.39 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 107.744 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -137.96 -12.92 1.45 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.82 -70.86 0.07 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 29.7 mttt -144.41 17.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.899 1.28 . . . . 0.0 111.225 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.0 t -143.56 128.34 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.96 131.34 34.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 158.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 99' ' ' LYS . 21.0 m -73.25 132.19 42.86 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 152.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.62 139.38 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 126.756 2.022 . . . . 0.0 107.656 171.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.21 164.69 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 163.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.583 HD11 HG21 ' A' ' 87' ' ' ILE . 6.9 pt -80.24 152.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 122.598 1.19 . . . . 0.0 109.168 167.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.1 p -77.32 166.07 23.64 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.519 1.128 . . . . 0.0 109.599 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -36.2 68.99 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.92 -33.24 61.93 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.644 -1.285 . . . . 0.0 112.381 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -67.87 -49.58 61.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.164 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.17 -27.11 68.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.512 1.051 . . . . 0.0 111.427 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -49.13 64.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.902 0.481 . . . . 0.0 109.867 -173.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -49.83 55.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.417 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -34.61 78.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.57 0.623 . . . . 0.0 110.169 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 -119.43 9.23 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.82 111.12 4.12 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.9 t -77.11 -168.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 152.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.595 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.6 p -176.75 -40.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -157.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -153.69 151.26 29.45 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.794 1.179 . . . . 0.0 110.832 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.748 HG22 HG23 ' A' ' 56' ' ' ILE . 84.5 t -134.13 133.59 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.66 137.32 32.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.361 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -136.28 149.18 67.14 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 124.319 1.048 . . . . 0.0 109.135 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HG2' HG21 ' A' ' 73' ' ' ILE . 37.0 Cg_endo -79.37 -174.02 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.821 3.014 . . . . 0.0 114.428 -172.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.46 162.03 20.07 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 119.837 -1.789 . . . . 0.0 112.928 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.27 16.13 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 126.997 2.119 . . . . 0.0 111.773 -171.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.75 10.26 0.79 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.764 2.126 . . . . 0.0 112.329 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.9 ttt85 -81.12 130.12 34.88 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.314 1.057 . . . . 0.0 108.678 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.8 151.23 37.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.609 HG11 HD11 ' A' ' 73' ' ' ILE . 15.8 m -143.25 165.77 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.768 1.227 . . . . 0.0 109.443 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -118.56 170.34 9.03 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.132 1.373 . . . . 0.0 107.599 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -62.82 15.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.36 86.62 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 166.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.54 128.58 25.47 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.96 1.704 . . . . 0.0 107.534 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 52' ' ' VAL . 26.8 t -72.01 38.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 127.56 2.344 . . . . 0.0 111.627 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.573 HG21 HG11 ' A' ' 47' ' ' VAL . 21.4 m -83.86 28.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 118.421 -2.674 . . . . 0.0 112.786 -170.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -167.72 66.54 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.41 1.004 . . . . 0.0 108.915 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.5 m -58.16 148.83 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.058 -1.026 . . . . 0.0 110.176 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.748 HG23 HG22 ' A' ' 38' ' ' VAL . 10.9 mt -122.37 109.03 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 124.37 34.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.569 ' HA ' HG12 ' A' ' 36' ' ' VAL . 80.4 p -102.47 -179.91 4.11 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.361 1.077 . . . . 0.0 109.532 171.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -48.32 -33.59 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.519 -1.673 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -148.19 5.67 0.75 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.92 170.41 9.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.627 1.558 . . . . 0.0 108.747 171.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.39 149.2 38.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 149.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.52 88.69 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -39.8 120.36 1.11 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 128.408 2.683 . . . . 0.0 107.999 161.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.43 136.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -113.39 98.73 7.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.416 0.686 . . . . 0.0 109.798 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -33.42 124.29 0.45 Allowed Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 124.765 1.29 . . . . 0.0 112.065 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.34 -23.96 11.19 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.653 1.568 . . . . 0.0 114.358 -157.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' O ' ' HE1' ' A' ' 100' ' ' MET . 4.2 mm? -141.36 156.98 45.77 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 127.505 2.322 . . . . 0.0 107.047 -174.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.6 m -74.23 138.43 43.68 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.316 1.417 . . . . 0.0 110.347 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.0 36.57 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.669 0.652 . . . . 0.0 111.803 -165.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -138.43 136.7 36.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.409 -1.054 . . . . 0.0 109.458 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.609 HD11 HG11 ' A' ' 47' ' ' VAL . 9.1 mm -65.3 146.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 108.941 176.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.39 4.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 110.909 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -162.25 151.1 15.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 41' ' ' PRO . 35.4 m -139.26 158.57 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.315 1.046 . . . . 0.0 108.46 175.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.72 76.78 1.41 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -57.91 -11.73 2.62 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.639 -0.663 . . . . 0.0 112.218 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -51.21 -31.55 20.87 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 111.699 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.5 HD12 HG21 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -80.16 -9.05 59.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.257 1.023 . . . . 0.0 110.514 -173.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.0 -30.41 70.52 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.41 1.084 . . . . 0.0 111.424 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.7 p -118.98 -20.36 8.14 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.732 0.813 . . . . 0.0 112.42 -171.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -136.85 67.14 56.99 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.759 2.023 . . . . 0.0 108.721 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.71 -26.17 60.94 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.345 2.697 . . . . 0.0 110.03 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.64 -15.66 53.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.332 1.053 . . . . 0.0 112.382 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -16.46 64.04 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.312 -1.493 . . . . 0.0 111.929 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 24' ' ' ILE . 37.7 mt -64.28 -28.89 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.978 0.808 . . . . 0.0 109.832 169.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -71.44 -55.19 8.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.083 -1.636 . . . . 0.0 108.972 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.01 -43.1 99.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.429 -169.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.33 87.14 2.95 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-O 119.178 -0.439 . . . . 0.0 110.234 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.1 -11.28 29.17 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.095 1.863 . . . . 0.0 112.737 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -125.98 8.42 7.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.407 1.483 . . . . 0.0 112.201 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -124.19 -71.15 0.22 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 124.397 0.998 . . . . 0.0 111.474 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.2 -25.36 7.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.341 1.056 . . . . 0.0 110.611 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.03 35.59 1.47 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.057 1.789 . . . . 0.0 112.865 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -64.98 159.29 23.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.214 1.507 . . . . 0.0 108.626 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 mt -99.32 -66.91 0.87 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -146.27 171.98 14.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.202 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 18.2 mttt -135.14 145.62 48.0 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 124.323 1.049 . . . . 0.0 109.392 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.484 ' HB3' HD13 ' A' ' 73' ' ' ILE . 1.6 ptm -149.07 140.11 22.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.029 -172.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 18' ' ' LYS . 33.0 tt0 -62.78 143.89 57.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.492 1.117 . . . . 0.0 109.412 172.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.9 pt -90.4 109.03 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 123.928 0.767 . . . . 0.0 109.139 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -67.38 -35.55 79.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.166 0.439 . . . . 0.0 110.558 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -135.42 70.73 1.43 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -156.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.536 ' HA ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -57.65 -17.62 15.75 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 172.651 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.46 -21.95 74.04 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.696 1.589 . . . . 0.0 113.294 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -72.43 -12.75 61.24 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 119.235 1.517 . . . . 0.0 111.338 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.536 HD13 ' HA ' ' A' ' 105' ' ' GLU . 0.6 OUTLIER -56.09 -36.13 67.79 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.881 173.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.23 -7.83 49.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.097 0.862 . . . . 0.0 112.34 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.96 -19.06 41.41 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.705 1.202 . . . . 0.0 109.983 172.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.95 161.32 23.1 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 123.32 1.534 . . . . 0.0 109.87 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.91 140.69 43.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.941 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.24 167.72 2.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 163.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.24 -47.02 78.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.544 1.537 . . . . 0.0 110.777 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -61.91 -50.8 70.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.84 -32.16 72.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.144 0.578 . . . . 0.0 110.2 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.73 -44.93 96.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.978 0.911 . . . . 0.0 111.26 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.32 -46.8 72.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.61 0.641 . . . . 0.0 109.992 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -53.65 -43.78 69.08 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.747 1.219 . . . . 0.0 111.141 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -58.02 -48.53 79.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.462 1.105 . . . . 0.0 111.339 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 61.4 m -70.17 -24.33 63.13 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.708 -0.62 . . . . 0.0 112.239 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.91 -31.59 63.16 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.613 0.642 . . . . 0.0 111.874 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -63.04 -10.74 15.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.249 1.42 . . . . 0.0 112.82 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 117.009 -1.472 . . . . 0.0 110.975 -175.798 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm 27.91 80.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.35 2.26 . . . . 0.0 114.628 151.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 tpp -137.24 145.71 43.9 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.658 1.183 . . . . 0.0 108.015 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -133.98 69.96 1.46 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.866 0.841 . . . . 0.0 109.204 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -80.87 175.59 10.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.895 171.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -137.57 169.08 18.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.741 2.417 . . . . 0.0 108.921 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -107.36 174.03 6.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.425 1.49 . . . . 0.0 108.955 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.54 ' HE3' ' CZ ' ' A' ' 120' ' ' PHE . 8.3 mtpt -77.22 -32.37 55.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.804 174.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -88.94 29.21 1.06 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.323 1.849 . . . . 0.0 113.229 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.02 41.89 3.49 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.224 -1.548 . . . . 0.0 112.59 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -124.8 150.29 46.5 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.445 1.098 . . . . 0.0 109.794 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.473 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 67.4 p-90 -105.08 172.54 6.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.863 0.839 . . . . 0.0 111.114 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.09 152.74 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.651 1.58 . . . . 0.0 107.071 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.29 81.47 1.71 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.649 1.179 . . . . 0.0 109.748 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 mp -65.99 150.07 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.662 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 3.4 pt-20 -142.71 -65.5 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.333 1.453 . . . . 0.0 108.797 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 13.3 t70 -126.52 -77.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.118 2.567 . . . . 0.0 108.222 -170.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.75 9.78 2.41 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 128.16 2.584 . . . . 0.0 110.963 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.63 155.68 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.755 1.622 . . . . 0.0 107.051 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.67 139.57 53.74 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 125.343 1.457 . . . . 0.0 108.294 165.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.1 m -83.97 143.57 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 t -122.11 143.03 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.54 2.336 . . . . 0.0 109.911 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.58 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -154.44 174.22 32.84 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 158.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 pt -74.2 165.12 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 117.837 0.819 . . . . 0.0 108.838 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -90.06 173.28 8.28 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.001 -1.062 . . . . 0.0 113.234 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.417 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -74.36 9.39 1.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 175.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -100.72 0.21 38.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.038 2.135 . . . . 0.0 112.624 167.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.43 -58.62 1.9 Allowed 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.571 -1.331 . . . . 0.0 110.573 -163.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.417 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -41.46 -42.17 2.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.72 2.808 . . . . 0.0 111.997 166.19 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.63 -52.99 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.394 3.078 . . . . 0.0 110.223 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -72.32 -35.47 68.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.719 -0.613 . . . . 0.0 111.453 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -65.13 -48.34 73.92 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.586 1.154 . . . . 0.0 110.162 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.79 -158.63 41.14 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.96 128.42 15.92 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.806 2.043 . . . . 0.0 109.147 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.595 HG22 ' H ' ' A' ' 36' ' ' VAL 0.446 6.0 p -123.89 154.88 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.595 ' H ' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -153.43 -31.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.632 -142.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -146.95 150.5 35.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.636 0.653 . . . . 0.0 111.843 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.27 133.02 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.514 1.15 . . . . 0.0 109.902 168.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.02 145.7 51.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.452 170.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.521 HD11 HD12 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -130.77 151.87 79.56 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 163.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.43 176.14 8.25 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.197 2.598 . . . . 0.0 111.702 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.16 141.88 35.28 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.41 22.06 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 129.024 2.929 . . . . 0.0 115.173 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.37 6.84 0.7 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.091 1.329 . . . . 0.0 113.308 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -79.84 141.86 35.8 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.829 1.815 . . . . 0.0 110.116 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -79.42 149.38 31.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.014 0.825 . . . . 0.0 109.098 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.0 171.0 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 110.062 -176.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -116.15 166.01 12.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.227 1.411 . . . . 0.0 110.537 174.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -64.82 14.82 0.02 OUTLIER 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.063 2.145 . . . . 0.0 116.131 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.66 67.07 0.23 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 173.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -134.13 128.07 33.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -175.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 52' ' ' VAL . 24.8 t -87.84 53.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 127.46 2.304 . . . . 0.0 110.042 -161.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -86.52 9.01 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 120.014 -1.679 . . . . 0.0 113.631 -158.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.35 50.26 0.28 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.879 0.872 . . . . 0.0 110.221 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 148.72 20.46 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.631 -0.668 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 mt -117.92 135.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.11 117.11 29.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.979 1.312 . . . . 0.0 107.925 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -99.18 -165.89 1.29 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.756 0.707 . . . . 0.0 110.679 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -46.75 -38.91 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.731 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.84 55.81 0.2 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.454 1.479 . . . . 0.0 111.559 155.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.79 167.8 16.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.512 -0.742 . . . . 0.0 109.961 165.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.2 151.45 39.11 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 152.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -131.39 112.9 13.13 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.964 1.706 . . . . 0.0 106.585 160.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -70.78 107.98 4.24 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 170.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -76.0 111.04 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -86.22 116.51 24.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.42 135.15 5.73 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.107 0.963 . . . . 0.0 110.078 169.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.55 -32.38 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.116 1.877 . . . . 0.0 113.845 -161.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.08 166.69 19.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.555 2.342 . . . . 0.0 106.397 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 m -81.46 134.39 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -171.94 44.9 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 120.759 -1.213 . . . . 0.0 111.132 -166.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -121.63 132.61 54.76 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 117.655 -1.164 . . . . 0.0 109.647 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -60.95 140.18 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -147.35 1.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.802 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -148.62 160.65 42.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.685 1.584 . . . . 0.0 109.066 162.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.7 155.69 14.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.369 1.468 . . . . 0.0 108.438 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -108.02 70.96 0.78 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.45 -15.16 15.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 112.477 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -53.28 -29.89 35.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 116.855 -1.545 . . . . 0.0 112.991 166.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 40' ' ' LEU . 76.3 mt -57.01 -14.7 3.9 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 121.186 1.812 . . . . 0.0 113.269 174.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.2 1.818 . . . . 0.0 112.903 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.0 p -124.13 -27.15 3.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.094 1.358 . . . . 0.0 110.858 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.34 64.21 14.19 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 128.042 2.537 . . . . 0.0 110.11 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -73.72 -52.08 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.728 2.952 . . . . 0.0 109.858 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -53.64 -17.63 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.179 1.791 . . . . 0.0 110.524 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -30.48 34.96 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.454 1.934 . . . . 0.0 111.518 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -58.6 -25.69 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 121.825 -0.547 . . . . 0.0 110.047 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -64.83 -53.51 45.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.444 -2.035 . . . . 0.0 110.814 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -49.31 70.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.777 . . . . 0.0 110.342 -164.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -148.73 79.62 8.56 Favored Pre-proline 0 N--CA 1.451 -0.393 0 O-C-N 123.899 0.75 . . . . 0.0 110.151 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.57 -17.44 59.97 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.802 1.668 . . . . 0.0 112.444 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.473 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 3.6 mp0 -114.75 14.4 17.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.264 0.626 . . . . 0.0 112.592 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.34 -89.95 0.28 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.81 -32.25 35.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 122.94 0.496 . . . . 0.0 111.899 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.41 36.34 2.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.245 0.926 . . . . 0.0 112.698 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -66.42 169.33 7.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.025 1.412 . . . . 0.0 109.452 166.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.58 HD12 ' HA2' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -119.88 -59.76 1.77 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.72 168.31 20.49 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.711 -1.243 . . . . 0.0 111.023 -171.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -125.72 155.32 41.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.288 1.035 . . . . 0.0 108.47 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -146.46 143.99 29.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.215 0.606 . . . . 0.0 110.727 -177.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.9 139.04 58.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.651 1.18 . . . . 0.0 108.025 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 pt -88.21 104.72 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 122.578 0.351 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -33.99 70.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.85 0.46 . . . . 0.0 110.391 171.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -147.36 103.39 3.56 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 125.931 1.692 . . . . 0.0 107.216 -171.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.538 ' HA ' HD13 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -71.46 -1.95 14.98 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.807 1.243 . . . . 0.0 109.712 160.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.1 -64.46 4.32 Favored Glycine 0 C--N 1.338 0.653 0 O-C-N 120.789 -1.194 . . . . 0.0 111.959 168.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -71.4 -10.04 59.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -164.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 105' ' ' GLU . 1.1 mp -46.48 -48.33 19.14 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.29 1.436 . . . . 0.0 110.455 163.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -75.82 -15.24 60.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.668 0.667 . . . . 0.0 111.024 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -86.66 -18.01 32.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.121 1.368 . . . . 0.0 110.943 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mt -80.32 -178.78 6.79 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.233 2.213 . . . . 0.0 110.975 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.3 mt -87.78 121.05 29.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.165 0.986 . . . . 0.0 110.249 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.99 166.8 15.07 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.112 0.965 . . . . 0.0 110.786 163.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.57 -57.72 4.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.184 1.794 . . . . 0.0 112.091 -160.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -50.21 -46.61 54.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.512 1.525 . . . . 0.0 110.01 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.58 -25.21 41.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.943 1.297 . . . . 0.0 111.901 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.91 -40.6 91.64 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 127.778 2.431 . . . . 0.0 109.844 167.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.42 -52.2 59.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -43.26 -46.7 6.32 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.083 1.353 . . . . 0.0 111.066 171.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.54 ' CZ ' ' HE3' ' A' ' 8' ' ' LYS . 9.0 t80 -51.17 -36.54 41.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.381 1.472 . . . . 0.0 112.8 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.09 -21.51 50.37 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.382 1.473 . . . . 0.0 113.844 -177.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.58 -43.27 23.29 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 166.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -73.85 26.64 0.07 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.428 2.291 . . . . 0.0 110.734 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.911 2.085 . . . . 0.0 107.929 -178.838 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt 42.83 100.0 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.963 2.505 . . . . 0.0 116.378 166.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ptp -150.68 168.82 23.21 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.804 1.641 . . . . 0.0 112.53 -165.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -142.78 114.82 8.27 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.519 1.128 . . . . 0.0 111.453 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -113.0 179.77 3.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.82 161.56 37.26 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.367 1.867 . . . . 0.0 110.194 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -125.62 173.38 9.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.437 1.113 . . . . 0.0 110.182 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HE3' ' CZ ' ' A' ' 120' ' ' PHE . 6.1 mmmt -89.91 17.01 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.898 1.679 . . . . 0.0 110.849 -169.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.438 HG21 ' HB2' ' A' ' 66' ' ' TYR . 15.1 t -135.53 57.72 1.78 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.5 p80 44.42 52.77 7.27 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.807 1.643 . . . . 0.0 112.984 172.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -128.99 149.96 50.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.425 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 54.5 p-90 -121.35 162.53 20.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.648 1.579 . . . . 0.0 110.19 170.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.494 HG12 ' HB1' ' A' ' 20' ' ' ALA . 1.8 t -141.77 126.15 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.477 1.511 . . . . 0.0 107.995 -166.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.43 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.4 m -117.01 75.47 0.97 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.7 2.4 . . . . 0.0 110.004 -170.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.9 mp -74.0 97.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.108 1.363 . . . . 0.0 108.485 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.05 -56.02 3.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 118.112 -0.946 . . . . 0.0 111.541 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.16 -76.15 0.45 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.41 0.55 . . . . 0.0 110.173 -166.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -125.52 2.95 7.64 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.834 1.254 . . . . 0.0 111.086 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.25 143.14 41.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.494 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -117.62 109.05 16.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.174 1.789 . . . . 0.0 108.971 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 41.0 m -68.76 143.75 54.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.5 OUTLIER -115.32 152.44 16.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 127.647 2.379 . . . . 0.0 112.512 176.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.18 161.09 32.25 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 160.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.588 HD11 HG21 ' A' ' 87' ' ' ILE . 7.1 pt -73.52 149.23 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.072 -1.252 . . . . 0.0 108.506 170.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 p -76.41 170.35 16.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.967 0.889 . . . . 0.0 111.657 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -62.63 -33.66 75.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.885 -1.134 . . . . 0.0 112.794 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -58.92 -25.7 63.69 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.264 -0.898 . . . . 0.0 112.056 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.27 -47.63 41.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.386 -0.822 . . . . 0.0 111.211 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -64.42 -27.79 69.24 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.837 -0.539 . . . . 0.0 110.56 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -63.43 -28.4 69.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.701 1.2 . . . . 0.0 111.47 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.75 -54.67 4.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.843 0.857 . . . . 0.0 111.959 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.81 -43.7 98.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.371 0.532 . . . . 0.0 110.118 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.52 -114.17 4.55 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.57 96.08 0.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.686 1.594 . . . . 0.0 109.057 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.749 HG12 ' H ' ' A' ' 36' ' ' VAL . 3.4 t -78.62 -178.77 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 162.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.749 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.8 p -169.2 -33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 126.431 1.892 . . . . 0.0 108.487 -146.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.431 ' H ' HG12 ' A' ' 35' ' ' VAL . 40.3 t80 -166.44 157.61 12.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.222 0.951 . . . . 0.0 111.008 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -138.15 146.93 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.86 148.11 22.71 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.176 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -137.72 142.98 38.52 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 123.897 0.879 . . . . 0.0 111.161 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.37 175.44 10.75 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.029 2.486 . . . . 0.0 111.077 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -87.85 147.67 25.01 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.348 0.659 . . . . 0.0 110.107 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.77 16.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 129.816 3.246 . . . . 0.0 116.436 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.72 6.32 0.87 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.655 1.598 . . . . 0.0 113.222 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -76.55 135.97 39.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.878 1.339 . . . . 0.0 110.487 -171.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -78.11 143.04 37.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.344 1.429 . . . . 0.0 108.902 167.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.07 -177.08 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.795 1.238 . . . . 0.0 108.645 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -131.55 160.75 34.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.062 1.345 . . . . 0.0 108.547 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 10.28 0.23 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.64 102.61 0.21 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 105.472 -3.051 . . . . 0.0 105.472 160.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.88 131.71 14.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.992 1.717 . . . . 0.0 107.097 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.628 HG13 ' HB3' ' A' ' 64' ' ' ASP . 55.1 t -69.92 16.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.805 2.042 . . . . 0.0 114.33 -169.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.38 -0.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 119.317 -2.114 . . . . 0.0 115.528 -163.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -142.51 60.08 1.44 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.677 1.126 . . . . 0.0 108.375 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 m -56.74 163.04 2.03 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.597 1.189 . . . . 0.0 111.346 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.8 mt -132.85 144.77 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 35' ' ' VAL . 16.4 mt-10 -122.27 165.86 15.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -139.62 -177.49 4.98 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.9 m -51.45 -23.83 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 125.504 1.522 . . . . 0.0 112.118 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.53 13.58 0.23 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.39 168.78 19.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.79 1.632 . . . . 0.0 110.04 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.78 164.94 27.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.205 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.65 118.44 5.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.77 1.228 . . . . 0.0 110.031 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.628 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -67.86 117.21 9.45 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 167.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.59 121.63 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.535 1.516 . . . . 0.0 106.976 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.438 ' HB2' HG21 ' A' ' 9' ' ' THR . 38.4 m-85 -88.98 111.16 21.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.692 0.678 . . . . 0.0 109.533 171.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.32 156.64 0.23 Allowed Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 128.078 2.551 . . . . 0.0 114.528 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -96.62 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 116.157 1.56 . . . . 0.0 116.157 -163.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' CD2' HG11 ' A' ' 13' ' ' VAL . 3.5 mm? -136.41 169.73 17.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.577 1.551 . . . . 0.0 107.606 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 m -101.26 65.56 1.07 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.839 1.256 . . . . 0.0 111.761 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.63 -165.84 12.54 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.199 1.857 . . . . 0.0 111.774 -164.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -119.17 123.69 44.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 118.1 0.95 . . . . 0.0 110.81 -176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.437 HD12 ' CD1' ' A' ' 98' ' ' PHE . 20.7 mm -59.77 142.01 15.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.3 m -146.75 -5.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.43 163.68 39.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.658 1.117 . . . . 0.0 108.792 169.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 m -149.83 144.18 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -95.12 81.2 3.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.76 1.618 . . . . 0.0 108.846 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.78 -11.52 27.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -26.79 65.91 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.375 1.07 . . . . 0.0 111.812 169.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -8.69 58.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.535 1.061 . . . . 0.0 109.941 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -80.09 -4.87 54.62 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 112.269 170.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -137.75 -25.07 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.595 0.758 . . . . 0.0 112.589 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.81 67.44 42.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.905 2.082 . . . . 0.0 109.512 168.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.81 -20.15 58.72 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.203 2.602 . . . . 0.0 111.186 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.97 -16.12 48.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.911 -1.042 . . . . 0.0 111.935 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 86' ' ' LEU . 5.3 mt -60.88 -20.63 62.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.972 1.715 . . . . 0.0 113.414 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.588 HG21 HD11 ' A' ' 24' ' ' ILE . 15.3 mt -59.71 -32.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -66.13 -47.46 74.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 122.654 1.216 . . . . 0.0 110.123 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -69.65 -47.37 63.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.604 -1.635 . . . . 0.0 111.425 -165.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.32 83.17 4.18 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 172.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -62.89 -20.64 71.89 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.179 1.253 . . . . 0.0 111.135 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 1.2 mt-10 -112.65 21.53 15.49 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.818 1.247 . . . . 0.0 111.58 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.92 -101.87 0.97 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -86.62 -20.86 27.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.5 0.72 . . . . 0.0 111.308 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.52 37.05 2.03 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-N 120.001 1.273 . . . . 0.0 113.658 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -68.62 157.5 36.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.83 1.252 . . . . 0.0 110.242 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.66 -67.36 0.87 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-O 116.904 -1.522 . . . . 0.0 108.486 176.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.522 ' O ' HG13 ' A' ' 22' ' ' VAL . 53.1 p90 -133.49 -176.94 4.32 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.191 2.269 . . . . 0.0 111.762 -175.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -136.87 141.58 42.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -141.71 138.32 32.31 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.278 0.631 . . . . 0.0 109.494 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -62.51 126.11 26.23 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.695 1.998 . . . . 0.0 106.243 168.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.9 pt -75.78 135.81 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.7 m -117.26 -11.12 10.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.017 1.727 . . . . 0.0 113.421 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -145.23 81.37 1.63 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -6.33 44.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.517 -1.364 . . . . 0.0 112.365 -177.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.51 66.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.02 -7.02 14.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.83 -42.1 98.62 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.209 0.913 . . . . 0.0 109.023 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -71.86 -0.2 10.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.398 0.679 . . . . 0.0 111.32 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -85.69 -19.15 31.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.87 0.759 . . . . 0.0 111.497 168.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.41 174.59 8.43 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.174 1.79 . . . . 0.0 111.413 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.46 142.97 38.89 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.418 1.087 . . . . 0.0 110.158 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -59.81 170.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 109.086 158.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -68.47 -51.36 44.37 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.046 -1.033 . . . . 0.0 110.187 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.37 -47.8 84.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.533 ' H ' ' HB2' ' A' ' 113' ' ' ASP . . . -63.96 -30.31 71.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.68 0.673 . . . . 0.0 112.09 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -67.29 -40.94 86.16 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.402 0.547 . . . . 0.0 110.956 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.64 -53.07 60.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.244 169.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -68.66 -24.66 64.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.176 1.353 . . . . 0.0 109.948 -172.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.478 ' CZ ' ' HE3' ' A' ' 8' ' ' LYS . 32.4 t80 -63.02 -29.75 71.07 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.996 -1.065 . . . . 0.0 111.698 171.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -31.66 72.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 118.425 0.557 . . . . 0.0 110.778 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.07 -18.71 65.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.224 0.609 . . . . 0.0 111.856 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -97.28 -0.03 47.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.238 2.215 . . . . 0.0 111.803 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.251 1.155 0 O-C-N 120.227 -1.546 . . . . 0.0 110.01 -178.105 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.66 119.4 5.24 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.536 0.734 . . . . 0.0 111.497 -175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ttp -131.8 145.54 51.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.704 1.202 . . . . 0.0 108.489 -173.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -140.71 100.24 3.8 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 113' ' ' ASP . 0.3 OUTLIER -101.76 179.3 4.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -143.54 174.98 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.686 1.594 . . . . 0.0 108.669 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.455 HG22 HD22 ' A' ' 111' ' ' LEU . 54.8 p -133.82 -165.14 1.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.129 0.966 . . . . 0.0 112.624 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -30.96 42.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.631 2.372 . . . . 0.0 111.135 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.13 30.21 0.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.249 -0.907 . . . . 0.0 111.502 -167.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 p80 45.33 27.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.121 1.769 . . . . 0.0 115.026 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.9 mt-10 -82.8 165.34 19.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.744 3.218 . . . . 0.0 112.628 160.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 61.2 p-90 -124.46 170.09 11.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.218 2.207 . . . . 0.0 109.014 163.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.12 142.39 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.59 88.33 2.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.479 1.112 . . . . 0.0 109.738 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.88 89.48 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -175.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -69.88 0.31 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.28 -98.32 0.39 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -122.23 11.01 10.06 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.235 1.414 . . . . 0.0 110.79 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.72 119.71 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.4 124.53 36.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 m -76.63 128.44 34.71 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 162.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.57 134.81 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 108.016 167.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.665 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -147.12 172.01 27.67 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 162.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HG21 ' A' ' 87' ' ' ILE . 6.1 pt -88.6 148.92 4.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 118.586 1.193 . . . . 0.0 109.367 169.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.1 p -77.04 169.6 18.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.062 0.945 . . . . 0.0 110.954 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.85 63.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.169 0.988 . . . . 0.0 111.883 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -59.33 -18.5 38.63 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.356 -0.84 . . . . 0.0 113.149 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -84.33 -51.0 7.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.997 -1.065 . . . . 0.0 111.189 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -60.89 -21.48 63.36 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.668 0.667 . . . . 0.0 111.574 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.13 -16.12 40.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.866 2.066 . . . . 0.0 113.731 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -112.22 -51.3 2.85 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.737 0.699 . . . . 0.0 110.022 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mt -65.01 -36.32 84.03 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.59 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.88 -125.45 27.87 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 125.339 1.447 . . . . 0.0 110.002 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.69 113.13 3.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -87.63 -164.0 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.693 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.2 p -173.19 -38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.22 1.808 . . . . 0.0 107.124 -153.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.473 ' H ' HG12 ' A' ' 35' ' ' VAL . 68.5 t80 -154.21 152.55 30.49 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 123.561 0.538 . . . . 0.0 111.524 -176.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.812 HG22 HG23 ' A' ' 56' ' ' ILE . 71.6 t -139.17 128.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -72.63 134.72 45.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.921 166.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.7 mt -128.88 138.7 33.73 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.08 179.18 6.01 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.387 2.725 . . . . 0.0 113.772 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.48 166.78 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.137 0.975 . . . . 0.0 110.119 169.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.62 21.38 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 124.484 2.088 . . . . 0.0 112.786 -162.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.57 10.86 0.52 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 129.269 3.318 . . . . 0.0 111.315 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -76.95 132.45 39.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.085 -1.244 . . . . 0.0 108.238 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -86.35 145.24 26.97 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 53' ' ' VAL . 30.7 m -131.67 164.22 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.563 1.545 . . . . 0.0 110.061 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' H ' ' HB2' ' A' ' 51' ' ' GLU . 59.3 mtmt -116.56 170.19 8.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.116 1.766 . . . . 0.0 108.401 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.72 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.023 2.929 . . . . 0.0 117.96 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.54 35.8 0.43 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.512 165.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -86.04 115.71 23.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.949 1.874 . . . . 0.0 109.683 -173.606 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' VAL 0.416 0.2 OUTLIER -63.43 25.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 129.962 3.305 . . . . 0.0 115.609 -175.703 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 47' ' ' VAL . 27.6 m -68.92 13.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 118.573 -2.58 . . . . 0.0 116.133 -169.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.36 43.93 0.61 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 120.517 1.508 . . . . 0.0 111.163 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -46.82 145.07 2.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.875 1.27 . . . . 0.0 112.223 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.812 HG23 HG22 ' A' ' 38' ' ' VAL . 7.3 mt -126.98 104.9 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -173.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.88 131.96 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -104.91 -173.7 2.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.893 0.877 . . . . 0.0 109.936 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 m -47.87 -27.82 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.62 15.45 0.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.54 -179.28 5.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.561 1.528 . . . . 0.0 110.504 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.11 137.61 27.64 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.53 107.38 7.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.882 1.673 . . . . 0.0 108.683 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB3' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -55.64 144.0 28.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.716 1.206 . . . . 0.0 107.946 170.383 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 97' ' ' LEU . 54.1 t -116.42 113.27 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -106.01 99.06 8.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.277 1.031 . . . . 0.0 110.297 -166.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.76 134.69 2.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 O-C-N 124.58 1.175 . . . . 0.0 111.718 -164.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.1 -24.85 16.69 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.365 1.376 . . . . 0.0 113.409 -165.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 108' ' ' LEU . 1.1 mp -142.58 166.86 23.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.193 1.397 . . . . 0.0 108.935 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -89.3 122.9 33.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.723 1.209 . . . . 0.0 108.262 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.15 -161.37 24.03 Favored Glycine 0 C--O 1.235 0.193 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -172.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -132.93 130.3 39.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.298 1.049 . . . . 0.0 109.686 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.514 HD12 ' CD1' ' A' ' 98' ' ' PHE . 8.9 mm -58.39 151.72 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 108.165 175.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -167.29 -14.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.192 -165.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -146.13 153.57 40.82 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 168.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.92 138.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.418 ' HB2' ' CD2' ' A' ' 96' ' ' TRP . 61.4 t30 -87.16 89.52 8.02 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.99 -9.24 9.26 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.708 0.803 . . . . 0.0 111.745 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -62.4 -45.28 93.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.024 1.33 . . . . 0.0 108.825 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.32 -14.6 63.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 120.249 1.386 . . . . 0.0 114.141 -170.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -62.17 -30.67 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.421 1.088 . . . . 0.0 111.529 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.8 p -134.38 -7.96 2.56 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.38 70.46 81.86 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.423 1.089 . . . . 0.0 108.238 159.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HB3' HG23 ' A' ' 38' ' ' VAL . 9.3 Cg_endo -63.15 -16.11 52.33 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.546 2.83 . . . . 0.0 110.086 169.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 -19.75 64.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 118.018 -0.992 . . . . 0.0 112.065 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.4 mt -65.4 -17.17 64.33 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 121.025 1.739 . . . . 0.0 112.787 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.509 HG21 HD11 ' A' ' 24' ' ' ILE . 2.8 mt -64.52 -29.13 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 118.801 -0.619 . . . . 0.0 110.724 169.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -70.29 -53.87 15.03 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 120.814 1.643 . . . . 0.0 109.779 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.427 ' HB2' HD23 ' A' ' 86' ' ' LEU . 1.2 mmtp -60.63 -43.49 97.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.825 1.65 . . . . 0.0 112.063 -171.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.91 74.75 5.04 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 124.39 1.076 . . . . 0.0 108.269 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -55.29 -29.64 68.33 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.822 1.681 . . . . 0.0 111.734 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 7.6 mp0 -104.62 3.43 31.68 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.358 1.463 . . . . 0.0 112.769 -169.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.89 -86.56 0.57 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -172.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.49 -7.48 38.0 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.751 -0.852 . . . . 0.0 111.848 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.66 25.53 18.42 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.416 1.484 . . . . 0.0 112.344 172.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.418 ' CD2' ' HB2' ' A' ' 77' ' ' ASN . 16.8 p-90 -60.98 159.54 11.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.595 1.198 . . . . 0.0 109.229 166.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.671 HD13 HG11 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -105.63 -54.07 2.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 109.681 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.514 ' CD1' HD12 ' A' ' 73' ' ' ILE . 41.3 p90 -148.43 168.15 23.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -128.3 151.5 49.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.6 ptm -143.48 145.86 32.94 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.069 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.52 128.76 37.3 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 160.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt -81.44 136.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.61 -21.56 14.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.76 1.224 . . . . 0.0 111.349 167.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -138.08 64.35 1.51 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.904 1.335 . . . . 0.0 111.595 -171.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -5.48 0.07 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.486 1.915 . . . . 0.0 112.846 160.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.87 -25.94 18.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.685 1.612 . . . . 0.0 112.065 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.76 -5.54 46.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.614 1.707 . . . . 0.0 111.122 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.442 HD23 HD21 ' A' ' 69' ' ' LEU . 74.8 mt -54.09 -21.87 9.57 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.528 0.731 . . . . 0.0 111.261 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.063 1.345 . . . . 0.0 113.188 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.95 -24.31 35.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.284 1.434 . . . . 0.0 110.423 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD22 HG22 ' A' ' 7' ' ' THR . 9.5 mt -85.1 156.18 21.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.363 1.078 . . . . 0.0 108.577 -175.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.49 ' H ' HD22 ' A' ' 112' ' ' LEU . 0.8 OUTLIER -75.75 134.6 40.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -176.536 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.414 ' HA ' ' HE2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -62.17 179.06 0.32 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 123.442 1.592 . . . . 0.0 110.386 155.365 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -73.35 -39.89 64.83 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.291 -168.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -67.16 -49.19 65.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.84 69.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.021 1.728 . . . . 0.0 111.421 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -61.83 -38.12 86.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.271 1.028 . . . . 0.0 112.692 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -73.59 -46.16 48.81 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -48.28 -46.9 36.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.105 1.362 . . . . 0.0 111.265 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -60.82 -43.42 98.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 122.8 0.44 . . . . 0.0 112.027 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.43 -17.42 64.77 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.692 -1.255 . . . . 0.0 112.951 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.52 -20.85 53.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.846 -1.159 . . . . 0.0 112.096 171.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.68 27.78 8.34 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.552 1.541 . . . . 0.0 112.056 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.116 1.766 . . . . 0.0 110.512 -179.523 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.528 0.204 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 tttt 50.85 51.51 16.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.595 2.358 . . . . 0.0 113.889 172.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.9 ttm -137.5 131.57 32.01 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.869 1.267 . . . . 0.0 111.981 -163.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.04 95.76 4.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -170.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.499 ' CE ' HD23 ' A' ' 108' ' ' LEU . 1.8 mppt? -75.49 179.93 4.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 110.399 165.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -142.23 178.5 7.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.25 1.42 . . . . 0.0 110.898 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 p -135.89 174.61 10.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.959 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -75.32 -35.23 61.25 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.88 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.25 51.71 2.03 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.77 1.623 . . . . 0.0 108.816 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 p80 42.85 52.28 5.13 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.8 -1.187 . . . . 0.0 113.423 165.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.8 mt-10 -114.21 154.37 27.99 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.337 1.455 . . . . 0.0 108.06 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 54.7 p-90 -108.11 162.41 14.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 157.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 69' ' ' LEU . 1.5 t -124.88 164.08 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -149.47 77.02 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.818 1.19 . . . . 0.0 109.508 -177.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.47 HG13 ' HB2' ' A' ' 20' ' ' ALA . 9.6 mt -72.37 93.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -71.56 -64.51 0.91 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.95 -86.49 0.42 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.159 0.584 . . . . 0.0 109.809 -169.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -119.47 -2.0 10.62 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.0 2.12 . . . . 0.0 110.073 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -116.25 141.58 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -102.25 161.7 13.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 162.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 16.3 m -111.19 148.91 31.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 163.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -112.92 145.83 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.1 3.36 . . . . 0.0 113.134 169.299 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.49 169.44 34.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 107.271 -2.331 . . . . 0.0 107.271 155.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.737 HD11 HG21 ' A' ' 87' ' ' ILE . 41.7 pt -81.69 157.16 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 O-C-N 121.837 -0.802 . . . . 0.0 109.829 170.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -78.16 166.4 22.8 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.219 0.533 . . . . 0.0 110.428 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -25.66 68.2 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.018 -1.051 . . . . 0.0 111.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -49.37 -47.88 47.27 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.807 -1.183 . . . . 0.0 110.537 165.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.526 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -67.65 -42.93 81.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.445 -1.409 . . . . 0.0 112.393 -170.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -62.43 -23.58 66.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.752 0.251 . . . . 0.0 111.084 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.58 -24.19 67.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.248 2.219 . . . . 0.0 112.035 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -98.37 -41.06 8.0 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.349 -0.844 . . . . 0.0 111.878 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.81 -27.55 28.71 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.753 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.59 -133.64 38.28 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 119.24 0.927 . . . . 0.0 111.28 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -62.4 117.43 6.14 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.6 t -87.39 -171.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.678 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.4 m -153.92 -35.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 130.485 3.514 . . . . 0.0 108.495 -169.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -155.85 156.61 35.0 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.231 0.469 . . . . 0.0 111.191 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.34 136.79 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.98 144.71 25.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.354 2.262 . . . . 0.0 108.451 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -138.77 154.48 73.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.784 0.834 . . . . 0.0 109.262 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -72.72 -171.23 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.154 2.569 . . . . 0.0 112.647 174.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -107.03 158.26 17.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.77 1.628 . . . . 0.0 110.685 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.52 9.42 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 126.946 2.099 . . . . 0.0 115.238 -165.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.25 11.68 1.81 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.028 1.775 . . . . 0.0 111.917 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -69.35 125.35 26.44 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.334 1.567 . . . . 0.0 108.957 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -76.15 145.6 39.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.7 m -142.39 163.12 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.014 1.326 . . . . 0.0 109.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -111.67 169.29 8.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.573 0.349 . . . . 0.0 110.858 168.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 49' ' ' LYS . 14.9 ttpt -57.55 17.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 1 C-N-CA 131.834 4.053 . . . . 0.0 114.944 178.093 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.35 23.76 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 120.045 -1.659 . . . . 0.0 114.856 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.63 143.86 32.2 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.254 2.027 . . . . 0.0 111.923 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 64' ' ' ASP . 52.3 t -77.65 38.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 129.241 3.016 . . . . 0.0 112.852 -168.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.59 4.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 118.472 -2.643 . . . . 0.0 115.048 -166.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.3 54.82 0.86 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.633 1.106 . . . . 0.0 111.542 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -61.85 165.48 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.194 0.997 . . . . 0.0 112.838 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.66 100.55 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.03 125.89 32.52 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.4 p -103.83 -174.8 2.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.213 1.405 . . . . 0.0 109.853 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 m -50.82 -32.09 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.142 1.377 . . . . 0.0 113.015 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.72 37.7 0.27 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 120.506 1.503 . . . . 0.0 113.289 168.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.03 170.58 19.02 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.44 -1.412 . . . . 0.0 109.832 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.46 122.4 24.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.596 1.558 . . . . 0.0 107.832 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.75 143.49 26.24 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 160.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.561 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -102.58 117.19 34.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.105 -2.924 . . . . 0.0 103.105 167.071 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.36 119.6 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 169.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.36 97.95 7.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.125 0.875 . . . . 0.0 109.624 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.09 0.46 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.664 1.985 . . . . 0.0 115.198 -157.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.06 -32.57 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 N-CA-C 114.593 0.959 . . . . 0.0 114.593 -159.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 13' ' ' VAL . 4.5 mm? -127.58 170.21 12.89 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.293 2.237 . . . . 0.0 104.975 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -86.03 157.56 20.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 157.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.47 -165.7 31.49 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 120.006 -1.684 . . . . 0.0 111.091 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -130.83 125.7 34.35 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.463 HD12 ' CD2' ' A' ' 98' ' ' PHE . 6.8 mm -63.29 140.07 20.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.1 m -149.63 6.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.858 0.863 . . . . 0.0 111.231 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -159.79 153.91 23.42 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 166.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.86 174.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.226 1.81 . . . . 0.0 108.25 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -118.37 84.06 2.11 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.706 0.685 . . . . 0.0 109.683 -172.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.9 -15.54 9.0 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.093 0.957 . . . . 0.0 112.123 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -54.52 -38.68 66.83 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.755 1.622 . . . . 0.0 111.105 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.866 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -68.96 -18.87 64.14 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.613 -0.679 . . . . 0.0 111.412 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 p -127.6 -16.44 4.79 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -129.59 71.62 82.07 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.182 1.793 . . . . 0.0 107.415 165.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -67.53 -22.75 44.27 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.219 1.946 . . . . 0.0 109.746 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.7 -9.75 58.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.087 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -17.87 63.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 122.5 2.409 . . . . 0.0 111.779 -177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.737 HG21 HD11 ' A' ' 24' ' ' ILE . 16.5 mt -60.68 -30.52 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.115 0.966 . . . . 0.0 109.654 171.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -69.47 -47.98 62.22 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 120.851 -1.156 . . . . 0.0 109.18 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -29.92 30.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.463 -160.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -160.06 65.06 2.4 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 120.414 1.461 . . . . 0.0 110.601 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.06 -19.6 49.54 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.9 2.4 . . . . 0.0 114.547 -167.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.2 mp0 -115.23 -1.57 12.91 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.849 0.86 . . . . 0.0 112.405 -173.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.64 -84.53 1.67 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -98.55 -26.64 14.35 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.557 1.143 . . . . 0.0 111.956 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.98 40.28 2.65 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.058 0.845 . . . . 0.0 111.594 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -73.78 164.92 26.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.652 1.581 . . . . 0.0 110.448 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.26 -66.5 1.0 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-O 116.468 -1.73 . . . . 0.0 108.845 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.494 ' O ' HG13 ' A' ' 22' ' ' VAL . 48.0 p90 -138.04 -177.62 4.9 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.016 -2.273 . . . . 0.0 112.703 -176.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -134.1 154.08 51.41 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 124.123 0.969 . . . . 0.0 109.321 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.72 138.72 21.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.246 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -58.66 126.63 28.41 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 162.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 pt -82.25 96.15 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 172.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -66.42 -29.69 69.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.021 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.81 79.84 1.64 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.931 1.348 . . . . 0.0 109.998 -167.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.746 ' HA ' ' CD1' ' A' ' 108' ' ' LEU 0.293 0.0 OUTLIER -81.44 26.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 124.582 2.134 . . . . 0.0 111.504 173.9 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.03 -22.07 31.31 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.511 -1.222 . . . . 0.0 114.052 155.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -76.32 -6.96 53.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.181 1.491 . . . . 0.0 112.678 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.746 ' CD1' ' HA ' ' A' ' 105' ' ' GLU . 4.8 mp -61.88 -21.94 65.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.219 1.008 . . . . 0.0 110.955 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.47 -20.42 58.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.111 . . . . 0.0 112.057 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -82.57 -15.88 50.61 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.238 0.926 . . . . 0.0 110.535 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.82 165.74 20.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.975 -1.078 . . . . 0.0 108.364 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.558 ' H ' HD22 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -77.57 125.07 28.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 172.049 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.86 171.68 7.61 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 152.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.48 -41.99 88.15 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 120.452 -1.405 . . . . 0.0 113.569 -156.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -62.49 -41.51 98.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.332 1.053 . . . . 0.0 110.114 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.72 -32.92 66.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.578 0.751 . . . . 0.0 111.034 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.5 -48.7 80.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 120.957 -1.089 . . . . 0.0 109.015 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.23 -47.92 71.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -51.7 -55.89 16.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.602 1.561 . . . . 0.0 111.805 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -65.12 -36.46 84.34 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.443 0.565 . . . . 0.0 111.282 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.85 -33.73 75.33 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.993 1.317 . . . . 0.0 110.833 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.73 -2.95 32.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.029 1.331 . . . . 0.0 111.767 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.23 -2.84 58.92 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.271 0.941 . . . . 0.0 111.729 166.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.242 0.682 0 CA-C-O 116.388 -1.768 . . . . 0.0 108.286 174.64 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtp . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -64.88 95.66 0.16 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.896 1.226 . . . . 0.0 108.646 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.403 ' HG2' ' HB ' ' A' ' 15' ' ' ILE . 5.7 ptm -154.93 152.94 30.32 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.467 1.107 . . . . 0.0 109.987 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.7 95.88 2.66 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.836 -0.54 . . . . 0.0 110.569 -162.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 109' ' ' GLU . 15.2 mmtm -93.53 174.26 7.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.68 0.792 . . . . 0.0 111.391 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.69 -173.09 2.66 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.772 2.429 . . . . 0.0 109.486 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -138.41 179.54 6.4 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.947 1.299 . . . . 0.0 109.918 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -82.3 7.53 13.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.424 1.089 . . . . 0.0 111.447 167.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -121.93 40.8 3.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.605 1.548 . . . . 0.0 109.909 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 p80 43.27 59.62 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.967 1.707 . . . . 0.0 111.908 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -152.21 133.25 14.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 108.612 -158.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.411 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.2 p-90 -110.62 160.69 16.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.361 1.465 . . . . 0.0 109.514 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 136.37 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.77 77.32 1.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.913 0.885 . . . . 0.0 109.462 -172.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.1 mp -71.47 139.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.7 pt-20 -126.46 -93.58 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.654 1.182 . . . . 0.0 110.101 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.484 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 9.1 t0 -83.4 -81.42 0.16 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -131.05 7.93 4.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.699 2.0 . . . . 0.0 110.426 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.77 149.78 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -113.05 140.83 47.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 159.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.3 m -79.78 137.02 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 153.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.9 t -103.11 136.62 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 128.0 2.52 . . . . 0.0 110.367 167.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.562 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -159.4 173.67 36.21 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.521 -0.737 . . . . 0.0 111.598 161.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 28' ' ' ALA . 9.0 pt -86.56 153.99 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 118.073 0.936 . . . . 0.0 110.683 177.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -84.06 171.91 12.48 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.677 0.791 . . . . 0.0 111.454 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.73 -35.94 71.37 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.408 0.623 . . . . 0.0 111.938 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -54.39 -33.74 59.86 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.734 -1.229 . . . . 0.0 112.279 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -74.8 -44.0 51.77 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.356 -0.84 . . . . 0.0 112.145 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.13 -25.81 68.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.497 0.59 . . . . 0.0 110.75 176.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.62 -21.09 66.63 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.115 1.366 . . . . 0.0 111.042 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -102.45 -41.58 6.25 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.763 0.711 . . . . 0.0 111.254 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 mt -82.99 -19.75 36.43 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.55 -123.13 29.25 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 119.45 1.023 . . . . 0.0 111.183 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -80.29 33.91 0.3 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.745 2.018 . . . . 0.0 116.212 -151.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 21.5 t -22.19 -115.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 115.121 -2.371 . . . . 0.0 111.428 -131.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.5 OUTLIER 170.93 -47.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 128.455 2.702 . . . . 0.0 110.813 -170.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -169.86 158.85 7.56 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.31 0.381 . . . . 0.0 111.446 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.755 HG22 HG23 ' A' ' 56' ' ' ILE . 4.5 t -144.09 144.05 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 125.561 1.544 . . . . 0.0 110.711 175.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.04 139.56 37.51 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.712 2.405 . . . . 0.0 108.984 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -135.79 155.9 77.71 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.973 0.909 . . . . 0.0 110.713 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -84.47 -179.05 3.63 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.374 3.382 . . . . 0.0 114.207 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -84.96 155.76 21.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 163.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.39 18.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 127.086 2.155 . . . . 0.0 113.927 -163.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.42 13.75 0.2 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 127.903 2.668 . . . . 0.0 111.938 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -73.92 135.89 43.31 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.067 -1.255 . . . . 0.0 109.564 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -82.88 139.16 33.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.03 175.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.238 1.415 . . . . 0.0 110.453 -174.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -118.66 169.67 9.62 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.417 1.487 . . . . 0.0 109.48 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HE2' HD21 ' A' ' 111' ' ' LEU . 24.9 tttt -62.99 14.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.27 2.228 . . . . 0.0 114.915 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.0 78.2 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.52 116.58 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -169.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.6 71.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 128.005 2.522 . . . . 0.0 108.835 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.51 6.42 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.502 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.24 59.8 0.9 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.551 1.069 . . . . 0.0 112.438 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 m -59.85 160.61 7.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.763 1.268 . . . . 0.0 111.324 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.755 HG23 HG22 ' A' ' 38' ' ' VAL . 1.6 mt -134.27 105.73 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.7 166.19 23.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 163.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.9 p -140.8 177.78 7.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.487 1.494 . . . . 0.0 107.89 164.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -49.04 -19.58 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 128.055 2.542 . . . . 0.0 115.978 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -160.65 41.6 0.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.934 1.697 . . . . 0.0 114.164 155.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -154.37 -172.32 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.216 -0.928 . . . . 0.0 109.188 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.91 14.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.994 0.918 . . . . 0.0 108.771 159.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.75 131.96 32.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 143.62 37.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 164.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.54 114.18 46.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.44 107.03 18.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -170.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.62 125.39 0.94 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.038 1.335 . . . . 0.0 113.551 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.9 -21.86 24.04 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.218 2.612 . . . . 0.0 115.187 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 49' ' ' LYS . 1.8 mm? -134.93 149.02 50.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 129.501 3.12 . . . . 0.0 108.644 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -66.49 149.72 50.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 158.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.67 -165.97 36.5 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -130.67 134.86 47.29 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.36 0.664 . . . . 0.0 109.43 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.429 ' HA ' ' HB3' ' A' ' 100' ' ' MET . 8.7 mm -60.22 143.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.93 1.292 . . . . 0.0 108.861 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.59 -8.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -153.18 150.52 29.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.588 1.54 . . . . 0.0 108.342 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.26 168.01 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.818 1.19 . . . . 0.0 110.21 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -119.86 73.98 1.0 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.72 -1.04 0.33 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.05 -0.407 . . . . 0.0 112.077 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -54.92 -43.77 73.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.128 -1.415 . . . . 0.0 110.2 162.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.439 HD12 HG11 ' A' ' 38' ' ' VAL . 43.7 mt -68.37 -9.81 50.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.639 1.563 . . . . 0.0 113.774 -177.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.8 -24.28 65.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.476 1.035 . . . . 0.0 111.636 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.2 p -129.18 -19.29 3.54 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.577 -0.702 . . . . 0.0 112.548 -172.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -122.03 59.86 11.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.351 2.66 . . . . 0.0 108.788 166.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.82 -19.04 47.32 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.691 1.594 . . . . 0.0 109.601 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.23 -11.54 59.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.464 1.906 . . . . 0.0 112.094 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -27.83 68.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 119.454 -2.029 . . . . 0.0 111.519 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.75 -19.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.157 0.583 . . . . 0.0 109.932 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -65.0 -56.02 15.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.3 1.048 . . . . 0.0 109.696 165.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -63.05 -53.89 46.73 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.067 2.547 . . . . 0.0 108.791 -162.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 85.79 5.5 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -59.11 -22.04 62.24 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.512 2.141 . . . . 0.0 112.455 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.411 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -127.41 9.01 6.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 127.858 2.463 . . . . 0.0 110.764 -163.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.33 -80.26 0.87 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 126.277 1.894 . . . . 0.0 109.716 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -93.6 -25.25 17.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.18 31.88 4.9 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.649 1.119 . . . . 0.0 113.367 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.564 ' CZ3' ' HE3' ' A' ' 99' ' ' LYS . 34.4 p-90 -70.06 159.4 33.91 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.562 HD12 ' HA2' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -108.89 -46.66 3.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.5 1.046 . . . . 0.0 109.136 -177.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.401 ' CD2' HD12 ' A' ' 73' ' ' ILE . 46.2 p90 -154.33 171.02 19.95 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.339 -0.851 . . . . 0.0 111.378 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.564 ' HE3' ' CZ3' ' A' ' 96' ' ' TRP . 77.1 mttt -131.59 152.49 50.76 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.504 1.522 . . . . 0.0 108.1 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.429 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 6.0 ptm -154.8 148.3 25.2 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.202 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -65.67 133.35 50.91 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.1 pt -79.23 103.41 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -73.77 -17.41 61.1 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.808 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -144.15 79.29 1.61 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.191 1.397 . . . . 0.0 107.364 -164.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.55 -10.46 55.91 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.767 -1.208 . . . . 0.0 113.298 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -81.97 -4.85 90.15 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.72 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 49' ' ' LYS . 49.0 mt-10 -81.38 -36.55 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.87 1.335 . . . . 0.0 112.169 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -35.41 80.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.656 1.116 . . . . 0.0 112.193 -170.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.468 ' HA ' ' HE2' ' A' ' 5' ' ' LYS . 17.6 mm-40 -62.51 -20.37 64.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -87.26 -11.0 50.94 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.588 0.755 . . . . 0.0 112.589 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.499 HD21 ' HE2' ' A' ' 49' ' ' LYS . 82.5 mt -75.04 -179.1 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.539 1.136 . . . . 0.0 110.252 167.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.9 mt -88.33 131.96 34.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.733 0.813 . . . . 0.0 109.996 -170.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.84 171.74 1.55 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.263 1.425 . . . . 0.0 109.846 163.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.74 -51.53 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.286 1.035 . . . . 0.0 111.151 -175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -56.7 -47.47 79.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.024 0.53 . . . . 0.0 109.776 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.48 67.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.332 0.653 . . . . 0.0 112.098 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -79.72 -43.35 22.81 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.656 0.662 . . . . 0.0 111.631 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 109.579 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -45.75 -49.13 15.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -68.36 -24.96 64.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.287 1.035 . . . . 0.0 112.061 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.6 m -87.38 -3.32 59.02 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.665 1.186 . . . . 0.0 112.738 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -112.75 3.24 16.39 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.35 1.46 . . . . 0.0 111.332 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.76 18.54 13.34 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.677 1.591 . . . . 0.0 110.73 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.203 1.401 . . . . 0.0 110.16 -166.274 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 ttm . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -169.02 127.75 1.03 Allowed 'General case' 0 C--O 1.231 0.121 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -167.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ttp -162.54 153.46 17.35 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.318 1.447 . . . . 0.0 107.973 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.27 101.73 3.75 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.442 -0.786 . . . . 0.0 109.763 -171.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -112.77 -178.6 3.43 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.97 153.49 43.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.373 1.069 . . . . 0.0 112.061 -167.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -101.33 171.39 7.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 123.306 1.527 . . . . 0.0 110.346 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HE3' ' CZ ' ' A' ' 120' ' ' PHE . 9.4 mtpt -83.59 -1.01 52.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.989 170.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 p -120.65 44.25 2.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.129 1.772 . . . . 0.0 109.376 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.2 p80 43.96 61.11 2.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 113.807 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.8 mt-10 -134.86 152.18 51.53 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.299 1.84 . . . . 0.0 109.155 171.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.476 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 64.0 p-90 -109.81 172.66 6.72 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.947 1.299 . . . . 0.0 109.373 169.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.1 134.45 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -116.43 84.92 2.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.269 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.3 mp -75.67 118.07 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -106.33 -120.82 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 167.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.61 -60.49 2.29 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.849 1.204 . . . . 0.0 110.666 -167.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.1 7.53 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.973 0.909 . . . . 0.0 111.523 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.4 t -130.38 140.79 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -110.33 134.22 52.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 163.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -77.15 142.05 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 158.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.72 139.86 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.083 1.353 . . . . 0.0 109.559 166.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.29 161.4 28.75 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 161.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 87' ' ' ILE . 2.6 pp -70.06 159.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -79.6 -172.31 3.22 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.493 -0.755 . . . . 0.0 111.726 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.04 19.74 13.48 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.896 2.478 . . . . 0.0 112.549 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -113.48 0.57 14.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 126.009 1.724 . . . . 0.0 113.999 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.288 . . -119.76 -52.26 2.23 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.823 3.249 . . . . 0.0 112.585 -156.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.91 -42.97 1.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.777 2.431 . . . . 0.0 110.178 158.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.28 -25.05 67.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.694 1.598 . . . . 0.0 113.722 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -75.02 -45.31 42.67 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.015 -1.053 . . . . 0.0 109.542 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -72.47 -57.51 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.31 -132.29 11.19 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.15 126.82 28.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 36' ' ' VAL . 3.1 t -97.83 -154.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 169.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.644 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.2 m -174.42 -38.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 129.582 3.153 . . . . 0.0 106.973 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.487 ' H ' HG12 ' A' ' 35' ' ' VAL . 53.9 t80 -144.93 145.6 31.62 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.553 0.615 . . . . 0.0 111.27 -176.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 56' ' ' ILE . 39.6 t -128.81 121.07 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 168.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.48 140.79 37.2 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.033 173.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.43 149.09 63.5 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -175.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -71.0 -175.52 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.18 2.587 . . . . 0.0 112.308 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.44 158.98 15.35 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.893 1.677 . . . . 0.0 109.918 162.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.13 19.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 126.378 1.871 . . . . 0.0 115.014 -167.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.33 9.34 0.6 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.627 2.06 . . . . 0.0 112.887 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -73.04 135.82 44.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.723 1.261 . . . . 0.0 109.678 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.415 ' HG2' ' CG ' ' A' ' 72' ' ' LYS . 22.0 mt-10 -89.01 157.95 18.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.315 1.055 . . . . 0.0 111.665 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.519 HG22 HG11 ' A' ' 53' ' ' VAL 0.331 11.1 t -146.22 171.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.29 0 C-N-CA 131.653 3.981 . . . . 0.0 108.852 -162.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' H ' HG12 ' A' ' 47' ' ' VAL . 64.9 mttm -146.13 166.11 27.12 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.768 4.027 . . . . 0.0 106.338 -171.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -74.73 27.85 0.09 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.85 57.78 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 126.469 1.985 . . . . 0.0 108.372 171.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.01 143.25 45.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 117.583 0.692 . . . . 0.0 110.491 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.1 t -92.72 103.89 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.519 HG11 HG22 ' A' ' 47' ' ' VAL . 27.4 m -118.76 -0.24 8.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 125.919 1.687 . . . . 0.0 109.9 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -166.95 66.51 0.09 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.488 1.115 . . . . 0.0 109.432 -163.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -65.23 166.59 9.56 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.515 -1.366 . . . . 0.0 110.963 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.445 HG23 HG22 ' A' ' 38' ' ' VAL . 6.2 mt -143.65 103.78 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 O-C-N 120.145 -1.597 . . . . 0.0 107.612 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.43 117.67 29.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.4 p -97.98 -168.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.187 1.795 . . . . 0.0 110.645 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -52.79 -28.84 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.473 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.11 40.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.393 1.451 . . . . 0.0 113.003 166.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.17 39.46 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 120.78 -1.2 . . . . 0.0 109.721 171.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.34 152.38 31.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.739 1.616 . . . . 0.0 106.7 168.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.73 76.1 1.42 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -33.01 107.49 0.05 OUTLIER 'General case' 0 C--O 1.237 0.439 0 C-N-CA 128.777 2.831 . . . . 0.0 108.928 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.79 120.53 30.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.18 94.77 6.13 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.696 0.398 . . . . 0.0 111.804 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.09 132.74 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.559 0 C-N-CA 125.947 1.699 . . . . 0.0 114.647 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.2 -32.74 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.068 1.845 . . . . 0.0 111.874 -165.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.24 160.93 37.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.235 1.814 . . . . 0.0 108.209 -175.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.14 132.18 46.75 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.226 1.811 . . . . 0.0 107.328 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -172.89 45.88 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.415 ' CG ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -133.2 131.23 40.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 100' ' ' MET . 27.2 mm -62.81 151.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.93 -11.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 124.044 0.937 . . . . 0.0 109.744 -167.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.58 152.07 39.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 163.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.68 152.38 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -99.99 84.66 2.91 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.27 -15.29 23.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.779 0.8 . . . . 0.0 111.859 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -59.56 -22.41 61.67 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.273 1.829 . . . . 0.0 113.24 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.29 -15.55 46.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.271 1.396 . . . . 0.0 112.113 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -62.66 -31.33 72.19 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 165.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.9 -20.36 12.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.113 -0.992 . . . . 0.0 111.9 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.11 74.95 76.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.79 1.236 . . . . 0.0 110.312 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -65.64 -25.55 54.35 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.633 2.222 . . . . 0.0 110.456 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.64 -16.84 64.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.938 0.79 . . . . 0.0 110.99 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -21.62 66.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.911 2.141 . . . . 0.0 112.204 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.672 ' CG2' HD11 ' A' ' 24' ' ' ILE . 3.0 mt -64.52 -28.78 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.353 0.661 . . . . 0.0 110.289 172.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -67.1 -55.31 14.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.22 -1.55 . . . . 0.0 108.527 167.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -51.13 68.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.25 -160.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.86 76.76 5.88 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.13 0.972 . . . . 0.0 108.427 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.51 -25.16 62.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.016 1.81 . . . . 0.0 113.028 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -116.0 15.09 16.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.064 0.945 . . . . 0.0 110.781 -175.019 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.4 -65.91 0.34 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.248 1.88 . . . . 0.0 111.289 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -124.86 -23.9 4.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.516 1.158 . . . . 0.0 114.072 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.51 2.65 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 111.879 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -67.59 152.58 45.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -93.63 -59.9 1.89 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' CD1' HD12 ' A' ' 73' ' ' ILE . 44.4 p90 -149.31 168.62 22.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.719 1.207 . . . . 0.0 109.857 -172.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -132.99 155.11 49.76 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.386 1.474 . . . . 0.0 107.545 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.465 ' HB3' HD13 ' A' ' 73' ' ' ILE . 1.8 ptm -148.58 144.59 27.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.388 -168.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.56 114.66 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.351 2.26 . . . . 0.0 107.912 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt -71.34 117.59 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.606 0.717 . . . . 0.0 111.472 -170.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -78.06 -25.85 47.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.371 -0.83 . . . . 0.0 112.718 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.08 84.76 1.59 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -8.55 36.27 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 173.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.53 -31.85 8.06 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.748 -1.029 . . . . 0.0 112.872 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.57 -5.47 11.56 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.085 1.443 . . . . 0.0 111.212 170.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.99 -34.57 73.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.45 1.023 . . . . 0.0 110.868 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.69 -20.74 61.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.253 1.421 . . . . 0.0 111.441 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -83.41 -6.08 59.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.886 0.874 . . . . 0.0 111.456 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.08 176.07 5.27 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.643 1.211 . . . . 0.0 111.915 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.97 143.78 41.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.8 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.75 171.98 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.395 162.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -73.9 -34.68 64.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.524 1.93 . . . . 0.0 111.903 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.82 -48.92 33.79 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.22 70.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.445 0.698 . . . . 0.0 110.839 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -53.48 -47.64 69.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.626 1.571 . . . . 0.0 111.884 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.61 -35.72 65.4 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.7 -0.625 . . . . 0.0 110.205 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.53 -46.03 90.04 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.807 . . . . 0.0 110.101 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.431 ' CZ ' ' HE3' ' A' ' 8' ' ' LYS . 31.4 t80 -57.19 -19.25 19.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.596 1.559 . . . . 0.0 112.918 175.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.4 t -87.89 -15.08 37.66 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.71 0.804 . . . . 0.0 112.7 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.5 -50.73 5.63 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.603 1.161 . . . . 0.0 109.08 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.52 45.54 0.68 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.969 0.89 . . . . 0.0 110.725 172.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 167.009 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.6 tpp . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.56 109.55 8.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.575 0.75 . . . . 0.0 110.075 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -104.81 178.09 4.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.046 0.938 . . . . 0.0 110.104 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -144.07 157.35 44.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.509 1.924 . . . . 0.0 108.891 -171.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 p -110.92 177.28 4.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 123.04 1.4 . . . . 0.0 109.463 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -78.64 -9.43 59.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.978 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -109.18 42.0 1.52 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.794 -1.191 . . . . 0.0 109.107 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 p80 44.87 54.47 6.75 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.084 1.353 . . . . 0.0 110.674 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 4.2 tt0 -130.21 145.25 51.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.212 2.205 . . . . 0.0 107.479 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.47 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.2 p-90 -117.87 159.89 22.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.56 1.944 . . . . 0.0 110.21 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.555 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.2 t -128.99 152.74 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.646 1.978 . . . . 0.0 107.468 -173.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.85 84.33 1.84 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 119.766 1.166 . . . . 0.0 112.771 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mp -70.37 132.39 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -120.15 -99.47 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 164.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.25 -88.65 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.911 2.084 . . . . 0.0 110.368 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -127.71 3.88 6.09 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.8 -1.188 . . . . 0.0 113.382 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.71 133.56 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -108.35 110.29 21.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.038 2.135 . . . . 0.0 109.529 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.5 m -75.96 116.51 16.73 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.653 1.181 . . . . 0.0 110.743 171.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.5 OUTLIER -87.99 149.85 3.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 112.415 174.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.98 163.64 31.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 156.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.407 ' CD1' HG21 ' A' ' 87' ' ' ILE . 2.3 pt -82.09 151.42 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.4 1.6 . . . . 0.0 109.511 169.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.3 p -82.05 174.48 11.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.705 1.202 . . . . 0.0 112.828 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.81 -41.81 71.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.2 -0.937 . . . . 0.0 112.3 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -57.85 -21.1 40.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.093 0.86 . . . . 0.0 112.935 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.28 -47.83 9.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.034 -1.041 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -64.18 -21.38 66.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.7 0.682 . . . . 0.0 111.806 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.09 -37.95 81.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.627 1.571 . . . . 0.0 110.888 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -88.21 -35.9 17.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.2 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.7 -70.99 0.47 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.703 1.138 . . . . 0.0 109.824 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.19 -130.25 10.11 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.19 0.9 . . . . 0.0 111.041 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -71.85 34.18 0.06 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.242 3.017 . . . . 0.0 117.029 -159.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 59' ' ' VAL . 14.2 t -21.97 -113.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 114.091 -2.861 . . . . 0.0 113.049 -135.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER 164.38 -41.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 128.924 2.89 . . . . 0.0 110.082 -170.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -157.39 164.4 37.56 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.644 0.656 . . . . 0.0 109.721 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -139.12 142.18 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 163.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.79 87.46 3.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.341 1.457 . . . . 0.0 107.218 -177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -90.28 153.1 46.4 Favored Pre-proline 0 C--O 1.234 0.245 0 O-C-N 121.656 -0.652 . . . . 0.0 109.885 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.96 174.7 12.32 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.448 2.099 . . . . 0.0 112.205 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.89 142.11 31.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.13 19.88 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 128.835 2.854 . . . . 0.0 114.839 -172.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.82 17.89 0.65 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.063 1.792 . . . . 0.0 112.501 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -90.18 142.63 27.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.889 1.345 . . . . 0.0 110.319 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.43 144.69 27.84 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.124 1.329 . . . . 0.0 110.669 170.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.44 HG11 HD11 ' A' ' 73' ' ' ILE . 20.3 m -137.17 177.98 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.793 1.237 . . . . 0.0 111.22 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -132.01 166.61 21.32 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.172 1.789 . . . . 0.0 108.821 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -72.94 37.21 0.08 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.076 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.56 76.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.01 120.34 7.86 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.696 1.598 . . . . 0.0 106.8 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.287 0.1 OUTLIER -69.84 33.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 127.716 2.406 . . . . 0.0 113.683 -171.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.17 8.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 118.501 -2.624 . . . . 0.0 114.804 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 48.01 1.77 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 121.063 1.756 . . . . 0.0 111.031 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 161.64 8.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.918 0.866 . . . . 0.0 110.767 -173.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mt -137.78 101.77 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.49 148.97 25.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 164.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -124.2 179.8 4.74 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.391 1.077 . . . . 0.0 110.167 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 35' ' ' VAL . 2.7 m -40.8 -35.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 126.172 1.789 . . . . 0.0 113.379 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -160.97 59.19 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.62 1.554 . . . . 0.0 113.655 156.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.93 -175.57 5.5 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.75 . . . . 0.0 109.48 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.64 166.5 23.41 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.865 1.666 . . . . 0.0 110.635 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.64 127.19 6.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.714 2.006 . . . . 0.0 106.902 167.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.3 118.05 28.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.67 93.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.53 106.88 9.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.655 0.382 . . . . 0.0 111.565 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.39 153.36 0.57 Allowed Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 127.606 2.362 . . . . 0.0 115.615 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -86.11 -41.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.343 1.362 . . . . 0.0 114.866 -162.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -129.93 168.17 17.07 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -76.94 168.95 19.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 156.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.95 -167.38 24.65 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -171.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -135.07 129.48 34.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -169.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.452 HD12 ' CD2' ' A' ' 98' ' ' PHE . 6.0 mm -62.47 141.76 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 107.585 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.79 -1.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 124.383 1.052 . . . . 0.0 112.828 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -151.99 157.08 41.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.583 1.538 . . . . 0.0 106.898 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.7 m -142.56 154.0 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.72 85.16 5.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.588 0.631 . . . . 0.0 110.722 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.23 -9.56 5.19 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -55.09 -46.24 75.46 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.654 -1.279 . . . . 0.0 110.463 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -13.03 60.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.23 1.012 . . . . 0.0 110.069 -168.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.65 -35.2 73.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.415 1.486 . . . . 0.0 110.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -123.59 -22.32 5.02 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.243 1.417 . . . . 0.0 112.854 -167.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -131.18 68.83 82.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 127.426 2.291 . . . . 0.0 107.847 171.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.69 -11.29 28.29 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.39 2.727 . . . . 0.0 111.588 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.65 -3.14 19.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.632 1.573 . . . . 0.0 112.675 171.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 86' ' ' LEU . 1.9 mt -70.37 -22.49 62.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.623 1.556 . . . . 0.0 113.527 -172.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.407 HG21 ' CD1' ' A' ' 24' ' ' ILE . 3.0 mt -65.34 -29.32 46.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.46 -52.03 60.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 120.42 1.464 . . . . 0.0 109.038 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -56.17 -55.59 31.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.727 2.411 . . . . 0.0 110.169 -169.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -151.95 89.7 3.97 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -57.36 -29.49 84.41 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.586 1.524 . . . . 0.0 111.934 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 13.1 mt-10 -122.73 31.21 6.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.624 1.969 . . . . 0.0 108.701 -167.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.38 -74.45 0.07 OUTLIER Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.409 1.481 . . . . 0.0 111.404 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -117.17 -11.3 10.7 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.129 -0.939 . . . . 0.0 113.307 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.84 29.6 1.55 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.449 1.022 . . . . 0.0 113.328 168.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 59.0 p-90 -60.31 149.6 33.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.579 1.189 . . . . 0.0 109.755 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.85 -69.4 0.76 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 116.589 -1.672 . . . . 0.0 106.814 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CD2' HD12 ' A' ' 73' ' ' ILE . 48.4 p90 -134.31 -174.95 3.71 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 122.114 2.234 . . . . 0.0 112.033 -172.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -135.86 153.53 51.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.831 167.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.07 139.15 25.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.847 0.859 . . . . 0.0 109.271 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.38 120.31 12.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 163.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -73.24 152.97 7.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 m -110.12 -31.93 7.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.699 0.8 . . . . 0.0 111.58 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 76.48 1.61 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -160.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -11.46 57.35 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.445 -0.784 . . . . 0.0 111.324 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.01 -15.17 81.22 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.927 -1.108 . . . . 0.0 112.586 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -86.34 -15.95 38.93 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.549 1.175 . . . . 0.0 111.572 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.22 -43.37 98.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.497 1.044 . . . . 0.0 109.543 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -60.65 -24.76 65.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 111.28 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.5 -4.52 58.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.247 1.019 . . . . 0.0 112.45 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.54 -171.95 2.5 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.591 1.956 . . . . 0.0 108.958 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -96.99 135.53 38.86 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.675 1.19 . . . . 0.0 108.215 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.38 179.93 3.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.828 0.823 . . . . 0.0 110.041 163.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.53 -47.53 72.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.612 1.965 . . . . 0.0 111.732 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -74.22 -39.99 62.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.191 0.596 . . . . 0.0 109.419 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.78 76.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.417 0.687 . . . . 0.0 111.262 172.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -70.7 -44.22 67.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.969 0.908 . . . . 0.0 111.187 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.27 -45.57 72.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.125 0.875 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 . . . . . 0 N--CA 1.437 -1.116 0 C-N-CA 123.815 0.846 . . . . 0.0 110.879 176.174 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.496 ' SD ' ' HE3' ' A' ' 5' ' ' LYS . 2.9 ptp . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.54 122.89 8.4 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 120.669 -1.27 . . . . 0.0 109.324 171.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.496 ' HE3' ' SD ' ' A' ' 3' ' ' MET . 22.2 mmtt -114.38 175.44 5.48 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.662 0.602 . . . . 0.0 109.864 168.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -133.36 154.22 50.92 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.654 1.581 . . . . 0.0 109.179 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -91.48 -176.92 4.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 122.226 1.013 . . . . 0.0 108.641 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -101.66 20.48 16.12 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 0.0 110.296 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -127.02 30.1 5.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.402 1.881 . . . . 0.0 110.817 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 59.72 40.69 19.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.801 -1.187 . . . . 0.0 112.193 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 24' ' ' ILE . 20.5 mt-10 -126.24 145.11 50.53 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.45 1.5 . . . . 0.0 107.887 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.418 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.1 p-90 -116.94 162.02 18.43 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.714 1.605 . . . . 0.0 109.534 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.5 t -142.35 100.79 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -167.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -82.15 89.12 6.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.74 -1.225 . . . . 0.0 109.034 173.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.2 mp -74.04 104.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 120.224 1.374 . . . . 0.0 107.595 174.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.3 tp10 -80.9 -138.78 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 167.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.414 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 1.2 t0 -64.69 -61.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.098 -1.001 . . . . 0.0 109.414 -172.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.5 2.21 2.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.031 0.933 . . . . 0.0 113.019 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.3 t -124.28 132.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -100.2 140.0 35.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 169.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -85.15 139.05 31.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 t -113.5 126.22 70.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.654 1.581 . . . . 0.0 107.584 170.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -134.97 168.55 23.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 160.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 87' ' ' ILE . 19.6 pt -85.62 156.57 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.8 p -82.55 179.09 7.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -39.52 94.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.408 -1.433 . . . . 0.0 111.541 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -61.02 -26.48 67.64 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.398 -1.439 . . . . 0.0 111.668 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.434 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -69.79 -56.43 7.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.977 -1.077 . . . . 0.0 110.088 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -55.14 -30.89 60.74 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.662 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.03 -42.43 94.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.381 0.672 . . . . 0.0 110.545 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -79.96 -24.26 41.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 113.202 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.68 -42.05 35.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.747 1.158 . . . . 0.0 110.346 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.9 53.27 Favored Glycine 0 N--CA 1.443 -0.859 0 O-C-N 124.188 0.93 . . . . 0.0 110.939 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.95 122.6 3.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.748 2.019 . . . . 0.0 108.515 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 36' ' ' VAL 0.425 9.8 p -118.47 158.07 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 122.493 1.139 . . . . 0.0 112.387 -177.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.584 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -146.85 -26.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 C-N-CA 126.148 1.779 . . . . 0.0 108.974 -150.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -150.53 151.93 33.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 123.741 0.651 . . . . 0.0 111.17 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 56' ' ' ILE . 60.0 t -145.46 127.81 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 136.42 38.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.606 171.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.8 mt -129.88 128.52 22.92 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.2 -178.95 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.44 2.76 . . . . 0.0 112.59 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -80.61 140.88 35.51 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.828 -1.17 . . . . 0.0 108.923 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.0 12.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 128.567 2.747 . . . . 0.0 115.71 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.2 9.16 1.1 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.044 1.783 . . . . 0.0 111.615 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -71.92 137.57 47.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.086 -1.243 . . . . 0.0 110.106 -171.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HG2' ' CG ' ' A' ' 72' ' ' LYS . 10.5 mt-10 -85.35 149.44 25.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.623 -0.673 . . . . 0.0 110.285 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.76 177.35 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.174 0.99 . . . . 0.0 109.527 -172.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -126.25 170.98 11.31 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 125.659 1.584 . . . . 0.0 109.589 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.81 10.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.77 66.74 0.24 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.55 115.81 13.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.06 114.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.476 1.111 . . . . 0.0 108.257 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -146.09 0.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.754 1.222 . . . . 0.0 112.718 -168.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.96 39.63 0.94 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.216 1.006 . . . . 0.0 108.385 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -50.66 165.66 0.1 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.992 1.717 . . . . 0.0 111.538 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.489 HG23 HG22 ' A' ' 38' ' ' VAL . 2.2 mt -139.45 145.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.99 116.6 17.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.936 1.694 . . . . 0.0 107.234 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' HG23 ' A' ' 35' ' ' VAL . 84.5 p -105.6 -167.71 1.36 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.615 1.566 . . . . 0.0 111.02 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 m -44.86 -39.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 114.152 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -165.75 72.57 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 149.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.07 167.24 22.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.8 154.85 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 159.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.26 109.02 4.37 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.255 1.022 . . . . 0.0 109.701 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.2 114.54 4.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.575 1.55 . . . . 0.0 108.371 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.622 HG11 HD13 ' A' ' 97' ' ' LEU . 53.2 t -87.46 104.31 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.33 105.55 17.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.954 0.797 . . . . 0.0 110.341 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.66 142.33 1.07 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.434 1.894 . . . . 0.0 112.876 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.08 -35.32 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.18 1.92 . . . . 0.0 113.259 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -138.84 145.75 40.4 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.958 2.103 . . . . 0.0 107.147 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -64.44 137.86 58.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 167.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.48 -177.91 44.09 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -155.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.42 ' CG ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -129.9 140.62 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 173.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.479 HD12 ' CD2' ' A' ' 98' ' ' PHE . 7.1 mm -65.67 145.46 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 174.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.51 -3.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 O-C-N 123.359 0.412 . . . . 0.0 111.753 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.14 151.47 30.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.2 m -141.54 149.6 20.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -99.47 75.8 1.98 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.0 -14.89 2.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -53.01 -34.64 57.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.066 1.347 . . . . 0.0 111.919 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -9.05 41.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 112.024 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.07 -28.68 69.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.786 1.634 . . . . 0.0 112.912 166.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -126.93 -27.55 3.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.947 1.699 . . . . 0.0 110.818 -167.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -125.94 65.03 53.82 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.202 1.801 . . . . 0.0 108.511 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -72.26 -51.62 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.594 2.863 . . . . 0.0 108.654 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -15.65 0.39 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.226 2.21 . . . . 0.0 111.322 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.04 41.23 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 122.632 2.469 . . . . 0.0 110.999 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.533 ' CG2' HD11 ' A' ' 24' ' ' ILE . 70.0 mt -51.33 -30.34 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 120.814 -1.179 . . . . 0.0 110.4 171.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -73.45 -51.73 16.16 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.71 -1.244 . . . . 0.0 111.581 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -70.23 -38.73 75.29 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.098 1.759 . . . . 0.0 110.76 -163.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -156.11 67.58 4.66 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 123.03 0.532 . . . . 0.0 111.332 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.88 -20.99 69.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.53 2.82 . . . . 0.0 113.535 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.418 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 5.1 mt-10 -123.11 20.05 9.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.593 0.757 . . . . 0.0 110.535 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -123.83 -93.0 1.04 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -79.92 -32.14 40.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.264 1.032 . . . . 0.0 112.869 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.35 37.73 2.03 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 120.23 1.377 . . . . 0.0 114.58 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -68.87 165.02 20.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.871 1.835 . . . . 0.0 109.732 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 65' ' ' VAL . 1.7 mt -108.93 -61.37 1.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.479 ' CD2' HD12 ' A' ' 73' ' ' ILE . 43.6 p90 -148.85 172.23 15.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.769 0.827 . . . . 0.0 111.068 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -134.95 152.32 51.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.48 1.512 . . . . 0.0 108.795 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.44 144.82 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.912 0.485 . . . . 0.0 110.68 -166.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.16 128.25 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.266 1.826 . . . . 0.0 107.029 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 pt -86.95 95.86 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.794 0.807 . . . . 0.0 109.987 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 m -81.67 -11.33 59.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.762 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.49 96.51 3.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 171.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -4.98 57.68 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.304 -0.248 . . . . 0.0 110.671 171.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.79 -55.22 9.92 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -18.4 47.0 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 125.822 1.649 . . . . 0.0 113.486 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 111' ' ' LEU . 13.7 mt -44.14 -37.16 2.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.893 1.679 . . . . 0.0 111.48 169.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.24 -13.23 60.42 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.601 0.637 . . . . 0.0 112.265 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.38 -35.22 68.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.299 1.04 . . . . 0.0 109.574 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -71.83 167.88 19.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.327 1.451 . . . . 0.0 108.256 -177.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 mt -77.82 131.59 37.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -55.55 171.64 0.19 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 122.491 1.138 . . . . 0.0 108.647 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.96 -39.45 79.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 111.414 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -64.57 -45.64 86.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.509 -0.745 . . . . 0.0 109.417 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.4 86.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.314 0.646 . . . . 0.0 111.038 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.1 -45.04 96.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.761 1.624 . . . . 0.0 110.832 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -48.16 73.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.972 0.509 . . . . 0.0 110.179 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 CA--C 1.541 0.602 0 O-C-N 122.034 -0.416 . . . . 0.0 111.479 -179.317 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.78 113.54 11.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.271 1.396 . . . . 0.0 110.545 169.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.07 174.34 5.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 167.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.93 179.0 5.41 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.722 2.809 . . . . 0.0 110.958 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -139.53 167.06 22.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.4 1.88 . . . . 0.0 109.214 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.73 -7.87 56.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.24 0.616 . . . . 0.0 112.489 168.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -94.37 19.12 9.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.481 -1.387 . . . . 0.0 112.173 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 58.32 43.94 19.29 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.289 1.836 . . . . 0.0 111.566 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -124.11 149.86 45.72 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.739 -1.226 . . . . 0.0 109.91 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.521 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.1 p-90 -111.55 163.76 13.72 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.3 1.84 . . . . 0.0 109.109 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.53 100.81 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -168.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -85.25 95.17 9.1 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 119.609 1.095 . . . . 0.0 109.441 172.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.9 mp -74.43 141.62 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 119.897 1.226 . . . . 0.0 107.834 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.54 -101.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.607 1.163 . . . . 0.0 108.147 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.24 -77.57 0.46 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -126.51 16.72 7.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.49 1.516 . . . . 0.0 111.095 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.84 155.36 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -129.43 136.57 50.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.989 1.316 . . . . 0.0 108.305 166.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.0 m -83.65 138.54 33.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.85 134.54 55.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.691 1.996 . . . . 0.0 108.632 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -147.78 164.62 28.83 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 163.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.542 HD12 ' HB3' ' A' ' 28' ' ' ALA . 8.6 pt -73.77 154.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 O-C-N 122.029 -0.689 . . . . 0.0 109.325 169.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 79.3 p -75.42 166.34 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.334 -0.854 . . . . 0.0 109.802 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.67 -34.43 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.939 -1.101 . . . . 0.0 112.674 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -59.89 -28.09 67.26 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.0 -1.063 . . . . 0.0 111.959 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.542 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -72.71 -57.31 4.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.546 0.738 . . . . 0.0 111.21 174.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -56.59 -27.88 59.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.693 1.133 . . . . 0.0 112.326 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.99 -32.26 61.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.039 1.336 . . . . 0.0 111.047 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -88.92 -46.52 8.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.906 -0.569 . . . . 0.0 109.787 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -34.92 78.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 118.158 -0.925 . . . . 0.0 113.176 -174.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.94 -126.58 41.1 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -169.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.69 34.05 0.33 Allowed 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -145.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 85' ' ' GLU 0.398 2.2 p -23.06 -111.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 115.683 -2.103 . . . . 0.0 112.846 -122.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.4 OUTLIER 166.38 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.112 2.165 . . . . 0.0 109.032 -168.227 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.433 ' H ' HG22 ' A' ' 35' ' ' VAL . 83.3 t80 -161.8 166.68 26.11 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.494 0.717 . . . . 0.0 110.165 -165.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.17 134.34 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.915 1.686 . . . . 0.0 107.757 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.64 143.18 28.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.416 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.11 151.5 70.0 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 123.671 0.789 . . . . 0.0 109.326 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -72.12 174.32 11.55 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.959 1.773 . . . . 0.0 111.396 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -78.64 150.9 32.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.81 17.2 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 127.713 2.405 . . . . 0.0 114.098 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.08 6.44 0.35 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 128.623 3.011 . . . . 0.0 111.922 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -67.18 125.73 26.96 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.019 1.41 . . . . 0.0 108.267 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.62 143.65 40.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 m -144.29 -176.73 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.667 0.787 . . . . 0.0 109.647 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -138.95 167.78 21.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.539 1.536 . . . . 0.0 109.772 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -67.83 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -172.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.9 66.5 0.24 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 161.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.48 123.19 47.93 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.184 1.393 . . . . 0.0 113.083 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 0.1 OUTLIER -65.5 21.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 129.149 2.98 . . . . 0.0 115.113 -174.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -62.84 8.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 119.142 -2.224 . . . . 0.0 116.273 -168.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.68 51.48 1.05 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.026 1.285 . . . . 0.0 110.706 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.19 148.29 36.87 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 123.155 1.455 . . . . 0.0 110.783 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.29 142.56 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -118.88 142.33 47.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 155.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.563 ' HB2' ' HA ' ' A' ' 35' ' ' VAL . 82.6 p -111.51 -173.85 2.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.237 1.381 . . . . 0.0 108.344 155.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -40.65 -37.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.99 1.716 . . . . 0.0 113.174 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.13 0.11 1.03 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 159.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.804 2.093 . . . . 0.0 110.464 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.4 162.56 35.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.097 1.359 . . . . 0.0 108.545 160.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.04 112.28 2.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.733 0.813 . . . . 0.0 109.919 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.56 127.92 33.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.033 1.733 . . . . 0.0 107.989 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.781 HG11 HD13 ' A' ' 97' ' ' LEU . 71.8 t -102.48 109.29 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 120.697 1.589 . . . . 0.0 106.996 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.32 99.47 10.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.465 1.03 . . . . 0.0 112.125 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -35.66 124.84 0.64 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.514 1.925 . . . . 0.0 112.843 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.54 -24.57 10.36 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.694 2.262 . . . . 0.0 114.845 -160.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -133.5 158.64 42.59 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.243 1.817 . . . . 0.0 108.619 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -75.57 153.85 37.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.886 0.85 . . . . 0.0 109.842 165.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.74 -174.54 30.04 Favored Glycine 0 C--O 1.237 0.293 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -160.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.49 141.35 51.68 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.451 HD12 ' CD1' ' A' ' 98' ' ' PHE . 18.7 mm -67.7 146.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 173.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.19 -11.28 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.0 151.6 42.65 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.6 159.99 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.384 1.474 . . . . 0.0 107.177 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.489 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 39.2 t30 -104.43 90.03 3.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -172.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.47 -14.6 30.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.924 1.29 . . . . 0.0 112.585 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HE2' ' OD1' ' A' ' 77' ' ' ASN . 25.4 mtmm -55.96 -42.09 75.7 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.802 1.241 . . . . 0.0 111.787 167.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -21.9 61.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.947 0.794 . . . . 0.0 109.937 -170.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -57.63 -49.51 76.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.634 1.574 . . . . 0.0 109.063 167.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.8 p -82.98 -30.83 27.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.645 0.778 . . . . 0.0 112.364 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -149.86 71.8 9.57 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.2 1.0 . . . . 0.0 109.048 -166.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.504 ' HB2' HG13 ' A' ' 35' ' ' VAL . 1.5 Cg_endo -50.82 -41.54 54.68 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.232 3.288 . . . . 0.0 112.651 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.74 ' HA ' HG12 ' A' ' 35' ' ' VAL . 11.1 pt-20 -65.54 -2.88 3.75 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.664 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -60.66 -22.61 64.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 123.657 2.935 . . . . 0.0 112.169 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -61.02 -23.83 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.292 0.637 . . . . 0.0 109.819 174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -71.77 -58.16 3.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.811 -1.181 . . . . 0.0 109.647 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -53.09 -35.31 59.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 126.397 1.879 . . . . 0.0 111.474 -172.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.16 100.43 0.49 Allowed Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 168.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.43 -12.45 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.317 1.345 . . . . 0.0 113.14 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.521 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -118.37 -19.54 8.85 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.662 1.119 . . . . 0.0 113.779 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -77.97 -90.24 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -99.05 -17.17 18.39 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.98 0.912 . . . . 0.0 111.738 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.66 30.94 3.37 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.043 1.306 . . . . 0.0 114.197 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -72.24 164.82 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.293 1.546 . . . . 0.0 110.559 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.781 HD13 HG11 ' A' ' 65' ' ' VAL . 3.9 mt -100.3 -66.93 0.88 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CD1' HD12 ' A' ' 73' ' ' ILE . 38.6 p90 -142.39 172.82 12.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.941 0.897 . . . . 0.0 110.789 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -124.98 154.62 40.94 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.843 0.857 . . . . 0.0 109.47 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.71 142.42 34.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.871 0.869 . . . . 0.0 110.442 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -81.32 113.95 19.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.231 1.812 . . . . 0.0 107.45 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 pt -76.44 103.0 3.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.965 0.906 . . . . 0.0 110.416 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -60.02 -37.78 80.75 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.123 0.569 . . . . 0.0 111.84 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.6 93.45 2.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.06 -12.48 55.65 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.839 0.828 . . . . 0.0 109.95 168.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.45 72.48 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 120.701 -1.249 . . . . 0.0 110.983 173.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -72.55 -7.79 51.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.424 1.112 . . . . 0.0 111.586 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.19 -26.94 66.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.382 1.446 . . . . 0.0 111.384 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -78.39 -29.14 47.12 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 110.38 -167.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.94 -19.22 64.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 129.135 2.974 . . . . 0.0 112.364 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.3 mt -73.2 -170.41 0.77 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.368 1.467 . . . . 0.0 109.673 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.34 132.59 54.29 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.343 -0.848 . . . . 0.0 108.943 -171.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -60.13 165.4 3.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 157.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.21 -46.87 72.55 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -62.8 -33.38 75.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.08 0.4 . . . . 0.0 111.487 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.84 77.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.471 0.708 . . . . 0.0 110.433 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.85 -32.5 73.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.648 -0.657 . . . . 0.0 112.111 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.0 -56.53 17.04 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.728 1.611 . . . . 0.0 108.806 168.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 N--CA 1.452 -0.371 0 C-N-CA 124.548 1.139 . . . . 0.0 110.161 -171.927 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.6 ttp . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -155.21 98.41 1.99 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.164 1.347 . . . . 0.0 113.295 -167.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -95.02 -177.03 4.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.314 0.578 . . . . 0.0 111.865 168.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -138.1 172.99 12.1 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 127.684 2.393 . . . . 0.0 109.867 -170.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.9 p -121.49 173.34 7.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.822 1.649 . . . . 0.0 108.733 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.65 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -78.65 -34.58 46.29 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.36 163.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 p -75.22 23.49 0.11 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.818 1.247 . . . . 0.0 112.541 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.273 0.0 OUTLIER 60.84 52.81 4.08 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 128.076 2.55 . . . . 0.0 112.799 165.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -125.15 140.97 52.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.517 1.927 . . . . 0.0 108.572 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.489 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 63.5 p-90 -94.85 159.83 14.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.13 100.32 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -85.03 85.67 7.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.945 -1.097 . . . . 0.0 109.55 175.154 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.2 mp -69.5 134.95 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 169.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -122.17 -68.76 0.87 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.851 0.46 . . . . 0.0 110.068 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -120.76 -83.95 0.66 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -125.82 12.84 7.93 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.712 1.205 . . . . 0.0 110.57 170.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.8 t -128.58 149.92 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -118.77 140.36 50.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 166.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.8 m -91.57 133.25 35.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 t -110.6 138.58 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.203 1.401 . . . . 0.0 109.946 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.34 169.03 29.01 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.05 2.262 . . . . 0.0 108.207 164.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.55 159.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.934 1.367 . . . . 0.0 110.256 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.0 p -85.18 167.51 15.64 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.297 -0.877 . . . . 0.0 112.683 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.28 -42.36 69.91 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.566 -1.334 . . . . 0.0 112.728 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -57.63 -9.36 1.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.321 1.048 . . . . 0.0 113.145 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.94 -46.79 4.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.553 -1.342 . . . . 0.0 111.53 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -58.94 -26.58 64.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.923 1.238 . . . . 0.0 110.862 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -38.4 75.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.42 1.088 . . . . 0.0 111.516 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -82.61 -19.92 37.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.048 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.68 -31.91 9.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.697 0.681 . . . . 0.0 111.51 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.53 -123.77 29.89 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.09 114.96 4.04 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.3 t -94.61 -170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 160.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.1 p -172.84 -30.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.78 1.232 . . . . 0.0 108.04 -147.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.442 ' H ' HG12 ' A' ' 35' ' ' VAL . 34.5 t80 -153.43 160.37 42.58 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.746 0.654 . . . . 0.0 112.3 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.75 145.88 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 156.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.64 150.21 22.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.993 -1.003 . . . . 0.0 108.749 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -134.68 155.46 79.46 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 120.708 1.595 . . . . 0.0 111.045 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.34 -163.63 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 125.231 3.954 . . . . 0.0 109.563 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -108.66 148.92 29.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.582 1.153 . . . . 0.0 110.972 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.29 11.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 131.47 3.908 . . . . 0.0 117.633 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.62 17.43 0.57 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.556 2.027 . . . . 0.0 112.178 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -79.16 141.31 37.34 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.318 -1.107 . . . . 0.0 108.218 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -82.06 156.01 24.81 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.4 m -139.08 160.74 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.401 1.48 . . . . 0.0 110.236 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -124.09 162.64 23.11 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.106 2.162 . . . . 0.0 107.095 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -74.99 23.33 0.1 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -159.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -152.54 18.44 0.78 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.731 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -78.17 143.31 37.33 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 120.162 1.981 . . . . 0.0 111.218 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.0 106.95 18.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.6 m -133.84 -2.71 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -163.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.07 46.31 0.24 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.427 0.691 . . . . 0.0 110.007 -162.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -51.27 160.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.854 0.862 . . . . 0.0 111.694 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mt -128.45 111.69 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -109.01 130.99 55.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.6 p -112.62 -172.45 2.05 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.95 1.3 . . . . 0.0 110.22 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -48.77 -43.76 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.107 1.363 . . . . 0.0 111.736 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -155.77 88.05 1.1 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.163 1.385 . . . . 0.0 108.989 158.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 177.38 178.61 0.28 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.512 1.925 . . . . 0.0 108.699 161.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.75 147.66 52.32 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.507 1.523 . . . . 0.0 110.818 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.68 99.87 4.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.433 2.293 . . . . 0.0 106.444 170.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.29 121.85 15.26 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -80.79 123.53 37.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -103.62 105.32 15.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.787 0.835 . . . . 0.0 108.849 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -27.09 113.0 0.24 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 128.704 2.801 . . . . 0.0 112.314 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.85 -34.2 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.73 1.62 . . . . 0.0 113.164 -164.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.18 165.65 20.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.486 1.914 . . . . 0.0 107.231 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -67.4 152.23 46.05 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 108.103 155.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.41 -167.59 31.95 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 132.3 23.4 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.66 143.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.83 -3.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.869 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.1 159.81 36.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.062 0.846 . . . . 0.0 109.978 166.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -141.16 152.23 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.913 1.685 . . . . 0.0 107.663 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -98.78 76.21 2.16 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.59 -11.66 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.856 1.662 . . . . 0.0 113.349 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -36.79 68.38 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.663 1.585 . . . . 0.0 112.86 167.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -10.39 59.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.51 1.05 . . . . 0.0 111.761 -165.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -41.81 -55.15 3.14 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 128.098 2.559 . . . . 0.0 111.93 155.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 79.2 p -118.69 -3.98 10.78 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.754 1.222 . . . . 0.0 111.863 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -132.04 56.45 23.63 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.324 1.45 . . . . 0.0 110.879 170.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 -28.42 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.507 2.138 . . . . 0.0 109.407 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.88 -17.41 64.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.529 1.132 . . . . 0.0 111.111 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -61.89 -21.92 65.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 120.619 1.554 . . . . 0.0 111.831 173.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.41 -14.8 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 120.167 -1.583 . . . . 0.0 110.538 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -84.86 -55.01 4.3 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 120.022 -1.674 . . . . 0.0 110.556 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 1.9 mmtp -62.98 -31.41 72.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.273 1.029 . . . . 0.0 112.091 -168.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -162.59 77.22 1.97 Allowed Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 123.907 0.883 . . . . 0.0 110.463 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.69 -18.06 45.94 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 113.194 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.489 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 4.2 mt-10 -123.43 11.84 9.33 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.829 0.852 . . . . 0.0 111.465 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.39 -108.4 2.07 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.15 -18.44 63.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.475 0.71 . . . . 0.0 112.644 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.44 27.04 4.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.225 1.393 . . . . 0.0 114.489 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -64.85 165.81 10.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.8 1.8 . . . . 0.0 110.164 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 mt -110.01 -60.91 1.73 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.76 168.83 21.87 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.3 -0.875 . . . . 0.0 110.88 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -123.59 141.68 51.77 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.318 1.447 . . . . 0.0 108.425 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.7 ptm -141.65 140.18 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.842 0.857 . . . . 0.0 110.275 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.27 136.42 40.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 34.3 pt -87.02 117.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 t -83.59 -18.22 38.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.857 167.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -143.12 86.57 1.92 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -157.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . 2.8 tt0 -74.22 -12.17 60.49 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 0.0 111.079 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.03 -57.66 18.11 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -69.43 -1.88 9.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.568 1.147 . . . . 0.0 113.019 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' ' 105' ' ' GLU . 14.9 mt -61.48 -38.44 87.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.312 -0.867 . . . . 0.0 110.115 164.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.59 -5.31 59.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.295 1.438 . . . . 0.0 111.323 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.07 -18.77 60.78 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.427 -0.796 . . . . 0.0 110.132 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.6 mt -87.18 -159.17 0.49 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.04 1.336 . . . . 0.0 112.477 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.9 mt -110.29 135.78 50.49 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.094 2.157 . . . . 0.0 109.761 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.3 172.65 1.84 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 162.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -63.32 -48.05 79.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.861 1.664 . . . . 0.0 110.086 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.28 -40.68 96.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.181 0.992 . . . . 0.0 111.644 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.23 75.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.77 0.828 . . . . 0.0 110.152 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.79 -43.42 69.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.858 0.863 . . . . 0.0 110.419 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 . . . . . 0 N--CA 1.449 -0.522 0 C-N-CA 123.189 0.596 . . . . 0.0 111.042 175.072 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ptm . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -160.07 125.05 3.92 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 121.041 -1.037 . . . . 0.0 109.985 -167.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' A' ' 113' ' ' ASP . 6.6 mmtp -128.12 -177.45 4.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.334 1.054 . . . . 0.0 109.821 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 179.62 6.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.5 1.92 . . . . 0.0 111.042 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -138.4 173.32 11.73 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.711 1.596 . . . . 0.0 111.912 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.473 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -82.02 -2.89 53.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.253 2.221 . . . . 0.0 112.9 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -102.14 48.37 0.88 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 p80 45.54 57.01 5.25 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.431 168.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -132.64 152.73 51.58 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.618 1.167 . . . . 0.0 108.33 -167.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.511 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.1 p-90 -124.43 162.53 23.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.081 0.952 . . . . 0.0 111.699 170.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.81 161.72 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.85 2.46 . . . . 0.0 107.705 172.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.73 94.57 1.9 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.464 1.906 . . . . 0.0 107.469 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.7 mt -98.54 95.03 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -78.11 -49.89 13.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.898 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.07 -71.68 0.68 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.259 0.936 . . . . 0.0 110.128 -171.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -138.94 10.31 2.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.627 1.571 . . . . 0.0 111.85 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.32 121.13 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -162.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 119.31 22.68 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.4 m -68.17 137.06 54.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 152.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.41 142.7 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.256 1.422 . . . . 0.0 109.772 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.71 176.73 34.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.728 HD11 HG21 ' A' ' 87' ' ' ILE . 13.8 pt -97.14 156.57 3.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 121.531 0.682 . . . . 0.0 110.697 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 169.59 17.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 112.57 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -24.28 62.52 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.64 -1.288 . . . . 0.0 111.367 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.65 -30.42 71.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.958 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.99 66.06 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.037 -1.039 . . . . 0.0 112.468 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.3 pp0? -63.3 -19.82 64.94 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.66 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.01 -0.59 7.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.337 1.455 . . . . 0.0 113.434 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -115.04 -31.01 6.19 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 160.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.42 -46.49 54.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.44 -147.0 43.22 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.81 112.5 0.62 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.566 2.346 . . . . 0.0 110.51 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.711 HG22 ' H ' ' A' ' 36' ' ' VAL 0.345 9.0 p -108.31 165.7 4.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 123.309 1.528 . . . . 0.0 111.275 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.711 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -152.43 -28.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.839 -154.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -146.3 143.57 29.24 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.433 0.56 . . . . 0.0 110.846 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.57 125.91 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.656 1.582 . . . . 0.0 107.915 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.89 139.86 43.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.382 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.1 mt -133.04 139.25 33.82 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.73 1.212 . . . . 0.0 107.932 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.45 -179.63 5.36 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.269 2.646 . . . . 0.0 112.041 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.25 145.67 43.87 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.9 18.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 129.178 2.991 . . . . 0.0 115.36 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.17 13.46 0.46 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.183 1.849 . . . . 0.0 112.138 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -76.58 132.73 39.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.789 1.294 . . . . 0.0 108.96 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.98 152.41 33.14 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.983 0.81 . . . . 0.0 109.212 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.82 174.08 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 122.354 1.073 . . . . 0.0 111.07 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -112.28 170.2 8.34 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.317 2.247 . . . . 0.0 107.9 165.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.87 18.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.616 2.366 . . . . 0.0 115.221 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.08 59.14 0.24 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.2 131.12 56.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.742 1.217 . . . . 0.0 108.112 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 52' ' ' VAL 0.297 0.1 OUTLIER -77.69 27.51 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.877 2.871 . . . . 0.0 114.232 -168.032 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.06 12.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.76 54.26 1.17 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 171.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.83 159.3 2.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.513 HG22 HG21 ' A' ' 35' ' ' VAL . 1.6 mt -139.85 135.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -127.76 110.99 13.16 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -99.15 -164.24 1.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.456 1.902 . . . . 0.0 110.775 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -45.89 -34.86 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.338 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -165.91 15.87 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 160.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.33 138.37 31.57 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.4 124.66 52.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 161.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.06 92.49 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.126 0.97 . . . . 0.0 109.303 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -58.72 108.06 0.6 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 108.8 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.22 93.75 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -82.41 109.74 16.92 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.666 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.87 150.01 0.39 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.922 2.489 . . . . 0.0 114.329 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.23 -36.53 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.819 1.679 . . . . 0.0 115.801 -161.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -148.03 139.57 23.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.114 1.365 . . . . 0.0 108.806 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -51.17 129.4 24.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.404 0.621 . . . . 0.0 109.393 170.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.03 -174.52 44.79 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 107.061 -2.416 . . . . 0.0 107.061 -161.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -142.56 127.95 18.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -166.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -59.52 142.46 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -145.99 -2.51 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -147.24 156.66 43.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 121.097 1.771 . . . . 0.0 108.44 165.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.83 153.47 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.045 0.938 . . . . 0.0 109.168 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -104.73 78.83 1.47 Allowed 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.446 0.698 . . . . 0.0 109.398 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -57.03 -14.88 4.12 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.979 0.912 . . . . 0.0 112.76 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -50.68 -39.56 51.46 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.989 1.716 . . . . 0.0 111.955 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -3.25 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.56 0.744 . . . . 0.0 112.501 -170.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.86 -49.96 53.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.011 1.278 . . . . 0.0 109.16 160.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.0 p -92.34 -39.31 11.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.069 -162.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -117.33 67.39 4.86 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.097 1.759 . . . . 0.0 109.517 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.51 -44.83 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.953 3.769 . . . . 0.0 110.837 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 35' ' ' VAL . 14.7 tt0 -61.69 -4.45 1.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.125 1.37 . . . . 0.0 109.905 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -58.15 -13.58 5.19 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 121.426 1.921 . . . . 0.0 114.076 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 24' ' ' ILE . 4.2 mm -53.33 -39.68 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 118.619 0.645 . . . . 0.0 109.78 164.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -69.61 -55.79 9.11 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.046 1.339 . . . . 0.0 109.42 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.82 78.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 -164.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -153.32 74.01 6.76 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -57.32 -23.5 54.96 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.776 2.317 . . . . 0.0 112.381 -172.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.511 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.2 mp0 -118.67 9.42 12.16 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.263 1.025 . . . . 0.0 112.147 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.93 -110.29 2.7 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.244 1.878 . . . . 0.0 109.597 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.96 -28.29 69.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.458 1.129 . . . . 0.0 111.093 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.54 25.22 1.4 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-N 119.721 1.146 . . . . 0.0 115.76 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.422 ' CZ3' ' HG3' ' A' ' 99' ' ' LYS . 46.0 p-90 -67.57 163.06 22.05 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.288 1.544 . . . . 0.0 110.404 171.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mt -106.16 -66.96 0.96 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -140.92 175.95 9.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.569 1.147 . . . . 0.0 109.387 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.422 ' HG3' ' CZ3' ' A' ' 96' ' ' TRP . 65.9 mttt -131.88 152.45 51.03 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 124.307 1.043 . . . . 0.0 108.297 171.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.32 134.89 23.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.342 0.657 . . . . 0.0 110.04 -172.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.66 127.37 31.68 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 167.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 pt -76.53 109.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.1 m -65.97 -21.55 66.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.949 -0.47 . . . . 0.0 111.198 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -151.63 88.33 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -157.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -11.92 59.93 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.933 0.788 . . . . 0.0 111.662 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.78 -41.16 95.84 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.92 -22.66 66.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 117.416 -1.278 . . . . 0.0 111.928 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 111' ' ' LEU . 12.4 mt -52.62 -30.96 34.2 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -79.21 -11.38 59.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.596 0.635 . . . . 0.0 112.069 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -74.89 -34.44 62.19 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.815 -0.553 . . . . 0.0 110.928 168.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -72.65 158.98 34.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.743 1.259 . . . . 0.0 108.132 -173.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.469 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -74.42 130.85 40.42 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.476 ' OD1' ' HE2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -69.82 -167.81 0.16 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 164.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.14 -39.69 65.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 119.768 -1.832 . . . . 0.0 113.544 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.73 -48.44 31.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.45 81.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.139 0.274 . . . . 0.0 111.408 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -53.99 -54.77 34.48 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.101 0.961 . . . . 0.0 109.866 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -39.4 74.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.103 0.961 . . . . 0.0 111.652 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 N--CA 1.448 -0.569 0 C-N-CA 124.51 1.124 . . . . 0.0 111.677 178.396 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.6 ttm . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 116.8 13.96 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 119.977 -1.702 . . . . 0.0 110.842 157.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -112.99 -179.76 3.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -130.65 170.66 14.01 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 127.191 2.196 . . . . 0.0 110.855 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -117.79 -174.67 2.68 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.665 1.586 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -106.71 10.68 30.86 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.816 1.246 . . . . 0.0 112.271 163.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -105.64 17.7 23.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.477 1.111 . . . . 0.0 111.26 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 72.23 42.5 0.56 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.892 2.077 . . . . 0.0 111.379 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -131.82 139.36 48.84 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.898 1.679 . . . . 0.0 110.879 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 69.9 p-90 -103.24 164.36 11.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.765 1.626 . . . . 0.0 109.583 171.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.57 99.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -86.84 91.88 8.8 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.741 -1.224 . . . . 0.0 110.668 173.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.548 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.2 mp -72.54 119.17 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -97.83 -72.94 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -116.49 -105.65 0.39 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -93.62 14.04 20.19 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.51 1.124 . . . . 0.0 110.698 166.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.27 152.06 35.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -123.16 137.07 54.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.784 1.633 . . . . 0.0 108.521 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -77.84 138.31 38.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 160.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.409 HG11 ' HD3' ' A' ' 68' ' ' PRO . 3.3 t -119.2 143.79 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.951 0.9 . . . . 0.0 109.669 171.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -148.75 165.93 29.23 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.979 -2.049 . . . . 0.0 107.979 164.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.6 pt -76.6 160.1 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.806 -0.82 . . . . 0.0 109.576 168.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.2 p -84.58 166.51 17.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.07 0.948 . . . . 0.0 111.304 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -34.63 67.07 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.652 -1.28 . . . . 0.0 111.267 175.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -58.36 -23.4 56.79 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.955 -1.09 . . . . 0.0 112.724 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.78 -49.64 8.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.414 -1.429 . . . . 0.0 111.349 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -56.09 -28.54 58.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.116 0.871 . . . . 0.0 110.899 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -55.83 -23.29 29.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.821 1.648 . . . . 0.0 113.288 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -109.63 -11.63 14.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.96 1.304 . . . . 0.0 112.776 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.52 -43.86 11.71 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.097 0.862 . . . . 0.0 111.0 173.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.75 -149.65 51.61 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.85 114.7 2.43 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.023 1.329 . . . . 0.0 109.228 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.658 HG22 ' H ' ' A' ' 36' ' ' VAL 0.344 8.4 p -105.65 167.57 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 124.192 1.949 . . . . 0.0 110.36 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.658 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.29 -30.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 112.316 -2.22 . . . . 0.0 107.396 -148.202 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -149.08 153.81 38.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.782 0.719 . . . . 0.0 111.329 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.571 HG22 HG23 ' A' ' 56' ' ' ILE . 69.1 t -145.3 118.73 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 127.304 2.242 . . . . 0.0 106.579 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -69.29 140.06 54.39 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.73 136.55 29.32 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.05 -172.74 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.157 3.238 . . . . 0.0 111.391 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.83 156.28 19.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.53 0.732 . . . . 0.0 111.897 171.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.78 13.63 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.031 1.732 . . . . 0.0 113.34 -172.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.21 12.94 0.61 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.654 2.073 . . . . 0.0 111.566 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -66.13 119.75 11.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.85 141.99 40.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 174.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.24 157.32 25.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.978 0.911 . . . . 0.0 110.352 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -104.95 171.01 7.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.499 1.52 . . . . 0.0 109.446 167.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -65.38 13.88 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.39 25.93 0.68 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.55 1.072 . . . . 0.0 112.24 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.62 124.79 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 108.793 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.27 109.03 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.28 8.79 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.868 0.867 . . . . 0.0 111.646 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.28 51.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.806 -0.559 . . . . 0.0 110.173 -171.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.83 161.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.293 1.037 . . . . 0.0 112.709 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.571 HG23 HG22 ' A' ' 38' ' ' VAL . 2.9 mt -143.49 108.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.61 98.95 9.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.047 1.339 . . . . 0.0 107.924 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.5 ' HA ' HG23 ' A' ' 35' ' ' VAL . 24.2 p -84.55 -163.2 0.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.31 0.644 . . . . 0.0 110.487 174.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.01 -41.5 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.411 1.484 . . . . 0.0 112.538 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -167.6 20.53 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.009 0.923 . . . . 0.0 113.277 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.78 160.36 14.41 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 120.031 -1.668 . . . . 0.0 108.546 161.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.42 84.72 1.97 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 171.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.22 118.32 22.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -77.04 111.48 12.66 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 167.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG11 HD13 ' A' ' 97' ' ' LEU . 75.0 t -79.21 118.0 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 170.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -100.33 98.51 9.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.092 1.357 . . . . 0.0 111.759 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.75 135.62 1.25 Allowed Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.031 1.733 . . . . 0.0 113.301 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD3' HG11 ' A' ' 22' ' ' VAL . 55.9 Cg_endo -76.55 -37.47 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.486 2.124 . . . . 0.0 114.707 -161.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.42 164.59 16.88 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 m -69.12 137.16 53.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 155.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.61 33.79 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -135.27 129.55 33.76 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.9 145.74 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.49 -2.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.749 0.82 . . . . 0.0 113.07 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -154.3 153.79 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.62 150.35 30.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.44 85.74 5.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -16.35 51.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -51.62 -36.34 45.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.272 1.829 . . . . 0.0 111.79 168.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -10.43 59.79 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.721 0.809 . . . . 0.0 111.567 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.26 -42.26 79.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.915 1.234 . . . . 0.0 109.552 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.6 p -95.64 -41.03 9.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.704 0.802 . . . . 0.0 111.25 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.19 72.54 9.47 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.431 1.892 . . . . 0.0 109.72 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.13 -38.8 4.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.06 3.173 . . . . 0.0 110.38 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HA ' HG12 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -60.18 -13.46 12.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.574 1.15 . . . . 0.0 111.363 -175.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -19.83 41.1 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.261 1.391 . . . . 0.0 112.815 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.8 mt -63.88 -26.22 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 121.519 -0.738 . . . . 0.0 110.893 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.35 -57.14 13.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.299 1.047 . . . . 0.0 109.263 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.19 -64.08 0.95 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.623 2.769 . . . . 0.0 110.355 -165.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -136.88 60.66 30.86 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -165.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.96 -15.48 39.13 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.151 2.567 . . . . 0.0 113.682 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -125.5 7.57 7.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.632 2.373 . . . . 0.0 110.747 -170.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.42 -96.77 1.79 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 168.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.18 -20.28 32.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.204 0.602 . . . . 0.0 112.003 -171.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.0 32.85 4.19 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.43 1.014 . . . . 0.0 113.344 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -65.5 160.6 21.87 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 1.373 . . . . 0.0 109.859 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 2.8 mt -104.71 -62.0 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -141.82 167.63 21.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.503 0.721 . . . . 0.0 111.459 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -117.5 150.57 38.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.282 1.033 . . . . 0.0 108.67 165.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.3 ptm -145.32 140.69 27.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.351 0.661 . . . . 0.0 109.864 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -64.0 121.51 14.29 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.559 1.144 . . . . 0.0 107.921 168.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.0 pt -71.51 98.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -75.37 -10.03 59.09 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.81 -0.557 . . . . 0.0 111.59 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -151.49 95.14 2.1 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.379 1.871 . . . . 0.0 107.068 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -8.61 55.33 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.63 -1.294 . . . . 0.0 111.507 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.92 -40.44 98.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -67.05 -9.97 44.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.728 1.611 . . . . 0.0 112.049 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.15 -20.27 65.72 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.756 1.162 . . . . 0.0 110.557 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -72.29 -18.0 61.83 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.894 1.224 . . . . 0.0 111.537 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.19 -19.81 49.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.052 0.842 . . . . 0.0 111.091 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.52 175.17 8.78 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.951 1.301 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.3 mt -106.44 149.63 26.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.863 1.265 . . . . 0.0 110.823 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.99 169.12 10.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.383 1.073 . . . . 0.0 108.294 163.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.67 -49.65 61.73 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.948 1.299 . . . . 0.0 109.843 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -60.56 -41.79 95.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.705 0.802 . . . . 0.0 110.612 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.88 -37.18 83.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.121 0.568 . . . . 0.0 110.718 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.03 -39.09 86.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.548 0.739 . . . . 0.0 110.692 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -47.66 84.37 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.272 0.629 . . . . 0.0 110.694 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 CA--C 1.54 0.574 0 CA-C-N 118.547 0.612 . . . . 0.0 111.421 -179.449 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.811 0.339 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -159.82 70.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 110.143 -170.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -81.42 176.72 9.47 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.71 -1.244 . . . . 0.0 112.956 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 12' ' ' TRP . 23.7 m-85 -132.91 161.68 33.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.555 2.342 . . . . 0.0 111.723 -171.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -103.4 177.23 4.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 123.181 1.467 . . . . 0.0 109.68 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -101.39 19.16 18.32 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.504 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -134.04 44.14 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.816 1.647 . . . . 0.0 109.894 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 p80 41.47 55.07 3.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.534 1.534 . . . . 0.0 113.118 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -143.81 134.39 24.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.751 2.021 . . . . 0.0 107.479 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 58.9 p-90 -92.65 172.72 8.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.234 1.414 . . . . 0.0 109.29 167.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.53 148.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.46 90.98 2.51 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.027 0.531 . . . . 0.0 111.696 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.0 mt -95.76 102.87 14.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.991 1.316 . . . . 0.0 107.468 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -79.02 -76.49 0.2 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.245 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -106.07 -82.71 0.53 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.081 0.855 . . . . 0.0 109.219 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.18 13.72 11.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.834 0.854 . . . . 0.0 111.339 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -137.41 126.08 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.45 154.86 20.03 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.938 0.875 . . . . 0.0 108.843 162.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.9 m -106.5 155.4 19.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.994 157.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.63 142.64 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.239 3.416 . . . . 0.0 104.765 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -160.37 32.66 0.4 Allowed Glycine 0 N--CA 1.477 1.376 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.541 HD11 ' CG2' ' A' ' 87' ' ' ILE . 27.6 pt 44.07 162.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 131.215 3.806 . . . . 0.0 114.663 -169.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.9 p -93.46 170.78 9.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.496 -2.003 . . . . 0.0 110.92 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -31.36 70.98 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.629 -1.294 . . . . 0.0 111.659 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -59.45 -24.21 63.35 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.043 0.937 . . . . 0.0 111.66 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.71 -54.22 6.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.945 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.11 -26.8 51.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.424 0.69 . . . . 0.0 111.947 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.56 -54.62 41.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.138 1.775 . . . . 0.0 110.928 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -62.18 -49.01 77.51 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.245 1.018 . . . . 0.0 110.63 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -67.82 -38.57 83.42 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.363 1.065 . . . . 0.0 109.515 179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.74 -118.77 10.14 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.192 1.853 . . . . 0.0 108.928 -168.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.6 159.59 21.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.685 0.755 . . . . 0.0 109.681 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.004 HG12 ' H ' ' A' ' 36' ' ' VAL . 6.4 t -132.74 -172.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.014 1.325 . . . . 0.0 107.914 171.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.004 ' H ' HG12 ' A' ' 35' ' ' VAL . 3.1 m -159.35 -34.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 129.307 3.043 . . . . 0.0 109.583 -168.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.445 ' H ' HG12 ' A' ' 35' ' ' VAL . 32.3 t80 -151.4 164.99 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.49 124.47 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 127.045 2.138 . . . . 0.0 107.379 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.68 140.17 38.4 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.807 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.6 mt -138.98 144.76 42.54 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.223 0.609 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.4 178.19 7.69 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.941 3.094 . . . . 0.0 111.454 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -86.58 160.41 18.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 0.0 110.581 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.11 17.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 127.177 2.191 . . . . 0.0 114.487 -167.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.4 11.4 0.47 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.977 2.227 . . . . 0.0 113.025 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -71.0 127.96 34.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.132 1.466 . . . . 0.0 109.929 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.69 146.21 46.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.762 1.165 . . . . 0.0 110.924 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.53 144.47 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.905 1.682 . . . . 0.0 108.991 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -83.25 172.31 12.72 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.109 -0.995 . . . . 0.0 111.414 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 12.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.254 2.221 . . . . 0.0 116.182 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.25 65.48 0.22 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.92 121.98 15.72 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.2 OUTLIER -72.76 35.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 132.003 4.121 . . . . 0.0 113.308 -166.834 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 m -70.12 6.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 118.827 -2.421 . . . . 0.0 115.291 -168.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.7 55.76 1.2 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.897 1.226 . . . . 0.0 111.465 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.69 163.81 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.769 1.271 . . . . 0.0 112.532 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 mt -131.91 114.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -166.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.53 126.52 51.69 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 167.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.469 ' HB3' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -108.0 -165.62 1.06 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.04 2.536 . . . . 0.0 108.388 178.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.26 -24.74 32.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 127.701 2.4 . . . . 0.0 112.375 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.23 12.6 0.19 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.604 1.093 . . . . 0.0 113.93 166.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.613 ' HB3' HD13 ' A' ' 32' ' ' LEU . . . -115.02 155.42 27.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.143 -0.973 . . . . 0.0 109.944 173.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.66 100.03 3.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.05 179.21 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.469 1.508 . . . . 0.0 111.078 -166.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.18 139.06 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.586 1.955 . . . . 0.0 108.475 -163.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.608 HG11 HD13 ' A' ' 97' ' ' LEU . 54.7 t -112.35 108.59 25.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 167.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.0 107.67 20.21 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.808 0.731 . . . . 0.0 109.895 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -43.48 142.39 1.77 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.451 1.101 . . . . 0.0 112.485 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.13 -28.1 2.6 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.85 2.366 . . . . 0.0 114.596 -158.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mt -153.19 145.34 23.83 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.496 2.718 . . . . 0.0 104.906 -162.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 m -68.11 128.03 35.04 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 103' ' ' SER . . . -175.01 -166.53 32.96 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 124.496 1.046 . . . . 0.0 111.559 -170.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -137.02 130.3 31.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.506 HD12 ' CD1' ' A' ' 98' ' ' PHE . 8.9 mm -58.78 144.63 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.515 1.126 . . . . 0.0 108.287 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.9 m -146.98 3.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -155.14 156.01 34.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.614 1.552 . . . . 0.0 108.535 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.09 157.68 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.788 1.235 . . . . 0.0 109.081 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -101.15 84.73 2.69 Favored 'General case' 0 C--O 1.23 0.057 0 C-N-CA 123.347 0.659 . . . . 0.0 109.455 -174.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -60.1 -3.38 0.57 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.803 1.241 . . . . 0.0 113.586 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -54.86 -52.77 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.301 -1.499 . . . . 0.0 109.982 160.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.53 ' CD1' HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -63.94 -25.39 68.12 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.018 1.727 . . . . 0.0 112.111 -163.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -59.72 -23.81 63.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.641 1.176 . . . . 0.0 111.827 173.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.2 p -125.69 -20.82 4.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.678 1.591 . . . . 0.0 112.107 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -133.62 70.01 76.13 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 126.304 1.841 . . . . 0.0 108.4 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.48 -4.75 15.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.576 3.517 . . . . 0.0 111.689 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.82 -8.44 43.56 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.091 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.7 mt -70.94 -22.97 62.16 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.06 -1.65 . . . . 0.0 111.543 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.541 ' CG2' HD11 ' A' ' 24' ' ' ILE . 8.5 mt -58.17 -26.29 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.297 169.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -72.11 -55.29 7.57 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.684 1.584 . . . . 0.0 110.585 164.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -35.22 80.46 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.115 0.966 . . . . 0.0 111.884 -161.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.35 78.72 1.1 Allowed Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.57 -34.45 95.37 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 CA-C-N 120.948 1.374 . . . . 0.0 110.328 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -100.09 -5.69 27.53 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.959 1.304 . . . . 0.0 111.946 -171.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.69 -69.19 0.96 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -119.68 -21.13 7.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.541 1.136 . . . . 0.0 112.769 -167.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.91 26.07 3.87 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.805 1.669 . . . . 0.0 115.351 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 45.0 p-90 -63.53 158.92 19.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 119.388 1.594 . . . . 0.0 111.642 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.608 HD13 HG11 ' A' ' 65' ' ' VAL . 1.1 mt -99.46 -67.43 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.506 ' CD1' HD12 ' A' ' 73' ' ' ILE . 15.2 p90 -142.22 166.1 25.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.264 1.826 . . . . 0.0 110.617 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -113.84 154.68 27.06 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.023 1.329 . . . . 0.0 108.933 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.0 ptm -145.48 143.32 29.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.084 0.553 . . . . 0.0 110.688 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.31 137.23 57.4 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.902 1.281 . . . . 0.0 107.881 168.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.5 pt -76.29 155.92 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 123.444 0.465 . . . . 0.0 109.96 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.505 ' HB2' ' HA2' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -133.53 -13.03 2.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.56 112.68 3.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 168.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -83.95 -15.68 46.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.089 1.755 . . . . 0.0 110.622 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.36 71.79 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.085 1.326 . . . . 0.0 111.437 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.61 -7.89 58.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 112.609 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.02 -41.23 82.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.442 1.474 . . . . 0.0 110.639 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.23 -19.09 63.95 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.493 0.588 . . . . 0.0 111.065 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -70.91 -17.11 62.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.097 1.359 . . . . 0.0 111.702 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.81 169.59 13.22 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.37 153.42 20.44 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.641 0.776 . . . . 0.0 109.89 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.63 171.14 6.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 163.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.78 -45.64 70.81 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.11 -40.11 96.66 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.651 1.18 . . . . 0.0 111.005 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.56 82.7 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.082 0.401 . . . . 0.0 111.308 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -64.48 -36.51 84.42 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.527 0.731 . . . . 0.0 111.766 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.04 -47.85 71.14 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.491 0.587 . . . . 0.0 110.343 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 N--CA 1.438 -1.051 0 CA-C-N 118.183 0.447 . . . . 0.0 110.149 177.77 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.4 ttm . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 110.53 7.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -111.34 -179.94 3.86 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.415 1.086 . . . . 0.0 109.946 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.58 163.56 32.53 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.032 0.933 . . . . 0.0 110.361 -170.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.1 p -114.68 -179.79 3.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.552 1.644 . . . . 0.0 110.642 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HG2' ' H ' ' A' ' 8' ' ' LYS . 11.1 ptpt -63.63 -24.48 67.81 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.072 2.149 . . . . 0.0 115.226 160.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -84.05 24.01 0.98 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.732 1.151 . . . . 0.0 111.67 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 52.89 56.42 7.6 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 125.391 1.476 . . . . 0.0 109.569 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -140.28 148.85 42.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.856 2.063 . . . . 0.0 108.236 -167.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -128.03 153.55 46.64 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.99 1.716 . . . . 0.0 110.956 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.14 151.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 C-N-CA 127.188 2.195 . . . . 0.0 106.499 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -141.4 72.3 1.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.282 1.433 . . . . 0.0 108.807 -178.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 15' ' ' ILE . 3.7 mp -70.57 134.1 30.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.064 2.145 . . . . 0.0 106.427 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -125.78 -61.44 1.25 Allowed 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.315 -0.866 . . . . 0.0 110.981 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.03 -76.65 0.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -126.79 4.44 6.66 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.041 1.336 . . . . 0.0 112.635 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.76 135.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.11 142.35 29.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 35.8 m -75.87 147.51 39.01 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 151.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.14 130.29 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 129.003 2.921 . . . . 0.0 107.187 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.41 172.68 26.92 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 167.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 87' ' ' ILE . 12.2 pt -91.66 152.54 3.37 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.38 0.672 . . . . 0.0 109.863 173.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.7 p -82.29 170.85 14.91 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.973 -1.08 . . . . 0.0 111.206 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -21.82 66.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.926 -1.109 . . . . 0.0 113.345 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -61.59 -29.46 70.05 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.0 -1.062 . . . . 0.0 111.56 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.412 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -72.4 -46.16 56.46 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.974 -1.079 . . . . 0.0 111.432 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -64.93 -24.25 67.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.198 0.599 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.49 -47.84 68.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.553 1.941 . . . . 0.0 108.389 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -70.7 -52.6 19.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mt -73.13 -33.03 65.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.286 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -133.46 15.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.46 147.71 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.694 1.198 . . . . 0.0 107.804 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.818 HG12 ' H ' ' A' ' 36' ' ' VAL . 21.4 t -121.48 -149.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.969 1.707 . . . . 0.0 106.559 178.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.818 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER 179.8 -40.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 130.34 3.456 . . . . 0.0 108.406 -166.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.456 ' H ' HG12 ' A' ' 35' ' ' VAL . 41.1 t80 -150.43 154.52 37.88 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.267 1.394 . . . . 0.0 113.776 -176.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.06 131.33 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 125.189 1.396 . . . . 0.0 107.767 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.9 147.76 26.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.686 2.394 . . . . 0.0 108.777 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -144.61 148.88 41.64 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.048 1.339 . . . . 0.0 109.6 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.06 179.98 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.212 2.608 . . . . 0.0 114.377 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 152.04 21.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.109 0.963 . . . . 0.0 110.518 170.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.93 11.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 128.349 2.66 . . . . 0.0 115.037 -168.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.16 10.83 1.36 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.111 1.815 . . . . 0.0 112.47 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.451 ' CZ ' HG12 ' A' ' 53' ' ' VAL . 72.2 ttt180 -70.14 128.68 37.12 Favored 'General case' 0 CA--C 1.527 0.088 0 O-C-N 121.288 -1.124 . . . . 0.0 108.027 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.85 153.79 30.31 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.405 HG12 HG11 ' A' ' 53' ' ' VAL . 35.3 m -142.94 170.88 10.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.893 1.277 . . . . 0.0 109.849 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -122.56 166.24 15.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.014 1.326 . . . . 0.0 109.597 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -62.13 7.87 0.05 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -155.34 75.61 0.22 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 167.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 114.36 13.73 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.579 1.151 . . . . 0.0 109.558 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.48 93.29 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.944 1.697 . . . . 0.0 108.145 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.451 HG12 ' CZ ' ' A' ' 45' ' ' ARG . 8.3 m -115.27 -3.5 10.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.852 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.99 53.21 1.21 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.763 0.664 . . . . 0.0 111.925 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.66 155.44 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.787 0.835 . . . . 0.0 111.348 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' CD1' HD13 ' A' ' 24' ' ' ILE . 8.4 mt -129.42 94.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.0 mt-10 -82.04 108.34 15.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 88.1 p -88.92 -169.52 2.56 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.604 1.162 . . . . 0.0 110.559 172.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.1 m -53.78 -29.35 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.684 1.193 . . . . 0.0 111.905 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -163.73 29.69 0.08 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -149.9 161.54 42.09 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.483 -0.761 . . . . 0.0 109.504 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.56 105.4 8.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.601 1.561 . . . . 0.0 107.606 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.01 119.78 22.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 131.03 38.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 163.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.49 106.72 21.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -99.72 107.4 19.48 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 110.629 -162.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -36.37 122.89 0.75 Allowed Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 126.747 2.019 . . . . 0.0 111.284 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 -23.55 7.27 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.637 1.558 . . . . 0.0 114.848 -161.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.74 161.61 32.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.418 1.887 . . . . 0.0 105.911 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.4 m -77.98 149.67 34.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.7 -162.97 34.39 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 120.101 -1.624 . . . . 0.0 110.167 -172.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -132.53 131.89 42.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.114 0.957 . . . . 0.0 109.844 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.49 HD12 ' CD1' ' A' ' 98' ' ' PHE . 13.3 mm -61.3 137.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.708 1.603 . . . . 0.0 108.167 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.71 1.12 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 123.955 0.784 . . . . 0.0 112.966 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -150.75 153.32 35.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 162.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.45 166.07 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.159 1.345 . . . . 0.0 109.827 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -110.4 82.01 1.53 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -59.86 -15.09 18.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.79 0.836 . . . . 0.0 112.255 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -55.87 -31.63 62.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.339 1.055 . . . . 0.0 112.416 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -13.93 62.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.191 0.905 . . . . 0.0 109.828 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.49 -16.91 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.87 1.268 . . . . 0.0 111.953 171.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -129.95 -17.85 3.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.773 0.829 . . . . 0.0 112.267 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.06 71.71 72.96 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.941 1.697 . . . . 0.0 107.904 167.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.52 -17.53 59.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 108.949 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.51 -4.75 59.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.268 1.027 . . . . 0.0 112.734 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.6 mt -66.08 -18.15 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.468 -1.395 . . . . 0.0 111.993 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.757 HG21 HD11 ' A' ' 24' ' ' ILE . 32.7 mt -62.94 -34.85 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.223 1.009 . . . . 0.0 109.561 171.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.08 -52.4 49.18 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.138 -1.602 . . . . 0.0 109.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -37.3 86.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.505 -162.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.18 79.92 0.52 Allowed Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.42 -14.95 41.22 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.135 1.89 . . . . 0.0 112.168 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -125.15 43.76 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.579 1.552 . . . . 0.0 108.316 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.34 -100.26 0.34 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 162.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -76.38 -26.57 55.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.96 -1.019 . . . . 0.0 112.505 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 39.52 2.92 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.347 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -69.39 164.02 23.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.871 1.336 . . . . 0.0 110.344 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.28 -65.16 0.98 Allowed 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.49 ' CD1' HD12 ' A' ' 73' ' ' ILE . 48.8 p90 -148.78 173.51 13.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.2 1.0 . . . . 0.0 110.04 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -127.21 153.8 45.63 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.658 1.183 . . . . 0.0 109.022 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.4 ptm -149.9 135.88 18.68 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.159 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.76 125.56 20.54 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.061 1.744 . . . . 0.0 107.357 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 21.4 pt -73.28 129.84 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.3 p -75.62 -41.92 53.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 166.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -142.83 90.53 2.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.981 0.913 . . . . 0.0 108.648 -160.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -10.1 0.98 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.319 1.048 . . . . 0.0 111.904 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -90.47 -15.97 56.05 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.571 1.558 . . . . 0.0 112.591 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.87 -16.29 60.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.561 1.181 . . . . 0.0 110.29 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.64 -29.17 69.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.437 0.695 . . . . 0.0 110.927 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -95.38 27.63 3.25 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.011 -1.056 . . . . 0.0 111.36 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -116.71 0.5 12.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.381 147.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -84.41 -177.62 6.68 Favored 'General case' 0 C--N 1.34 0.186 0 O-C-N 120.683 -1.261 . . . . 0.0 109.837 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -91.3 127.92 36.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 107.656 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.93 178.29 1.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.374 1.083 . . . . 0.0 109.472 160.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -69.65 -49.53 52.86 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.273 1.029 . . . . 0.0 112.02 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.28 -44.28 95.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.905 0.882 . . . . 0.0 109.037 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.71 90.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.138 0.575 . . . . 0.0 111.148 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.76 -41.72 78.48 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.242 -0.911 . . . . 0.0 111.118 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -44.01 68.04 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.649 1.58 . . . . 0.0 109.97 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 . . . . . 0 N--CA 1.441 -0.923 0 C-N-CA 124.094 0.957 . . . . 0.0 110.49 176.254 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 ttp . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 14' ' ' SER . 21.0 ttmt -145.09 148.2 33.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.669 -1.269 . . . . 0.0 107.733 155.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -127.01 176.1 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.43 168.08 20.62 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.549 1.94 . . . . 0.0 108.827 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 68' ' ' PRO . 7.7 p -130.53 177.16 7.57 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.938 1.352 . . . . 0.0 111.311 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -76.25 -25.46 55.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.518 1.527 . . . . 0.0 110.856 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 0.6 OUTLIER -82.28 17.33 1.71 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.68 1.127 . . . . 0.0 111.272 171.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 65.34 59.18 0.82 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.23 1.812 . . . . 0.0 110.663 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -111.58 165.45 12.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.167 0.987 . . . . 0.0 110.388 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.415 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 50.4 p-90 -131.37 152.81 50.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.865 1.666 . . . . 0.0 109.227 168.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 t -135.78 89.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.961 1.704 . . . . 0.0 107.407 -168.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 5.7 m -72.86 82.37 1.19 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.25 1.82 . . . . 0.0 112.986 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.789 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 13.5 mm -87.41 127.29 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -141.61 -21.57 0.74 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.124 -0.985 . . . . 0.0 112.945 -170.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -141.19 -105.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 157.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -111.49 9.66 21.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.82 1.648 . . . . 0.0 111.015 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.05 144.24 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 168.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . . . -109.06 141.88 40.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 108.565 160.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 m -85.67 136.06 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 156.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.5 124.18 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 130.249 3.42 . . . . 0.0 110.67 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.62 170.96 33.6 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.007 1.289 . . . . 0.0 110.49 168.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 pt -90.7 148.27 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.784 -0.833 . . . . 0.0 108.818 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.9 p -76.28 157.92 32.06 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.32 -0.862 . . . . 0.0 111.144 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.4 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 7.5 t-20 -58.44 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 1 C-N-CA 135.451 5.5 . . . . 0.0 116.054 176.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -107.5 -40.08 5.45 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 127.566 2.346 . . . . 0.0 112.402 164.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.79 -51.66 21.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.215 2.206 . . . . 0.0 116.07 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.555 ' NE2' ' H ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -42.08 -45.7 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.385 3.074 . . . . 0.0 109.75 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.555 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -51.69 -48.07 63.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.271 1.428 . . . . 0.0 112.284 176.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -68.75 -23.13 64.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.571 1.148 . . . . 0.0 111.517 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -89.05 -28.48 20.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.607 0.64 . . . . 0.0 112.385 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.43 -137.36 37.39 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 126.178 1.847 . . . . 0.0 110.555 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.28 112.98 2.93 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -86.28 -171.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 122.596 1.189 . . . . 0.0 109.038 170.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.584 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.7 p -173.15 -40.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.267 2.227 . . . . 0.0 106.348 -150.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.505 ' H ' HG12 ' A' ' 35' ' ' VAL . 36.2 t80 -154.48 149.68 27.02 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.73 135.43 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.668 1.587 . . . . 0.0 107.967 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -91.54 143.99 26.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.551 2.341 . . . . 0.0 108.155 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -141.66 138.36 17.2 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.936 0.894 . . . . 0.0 109.031 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.75 175.71 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.088 2.525 . . . . 0.0 112.325 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.19 147.93 29.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.925 -1.11 . . . . 0.0 109.718 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.19 17.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 128.464 2.706 . . . . 0.0 115.528 -168.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.77 3.85 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.311 2.386 . . . . 0.0 112.319 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -60.71 138.87 58.05 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.571 1.186 . . . . 0.0 108.388 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.61 141.36 28.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.71 170.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.952 0.901 . . . . 0.0 110.182 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -127.57 159.75 33.67 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.996 0.918 . . . . 0.0 110.672 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 10.55 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.914 2.486 . . . . 0.0 115.151 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.12 68.19 0.19 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 173.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -140.42 129.28 23.22 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.2 t -79.35 110.7 15.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -173.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -2.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.767 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.35 45.29 0.72 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.417 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.3 m -48.29 145.86 3.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.246 1.419 . . . . 0.0 113.156 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.8 mt -122.2 107.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.3 128.84 41.04 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.3 p -105.03 -172.68 2.14 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.299 0.954 . . . . 0.0 109.967 172.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 m -52.36 -27.17 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.37 1.468 . . . . 0.0 112.616 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -158.29 29.77 0.24 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.918 1.235 . . . . 0.0 113.76 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.54 -179.31 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.007 -1.058 . . . . 0.0 109.993 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.34 44.43 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 126.746 2.018 . . . . 0.0 108.35 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.31 111.65 8.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.596 1.959 . . . . 0.0 107.01 160.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 114.95 7.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -77.78 101.44 3.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -68.15 124.15 22.66 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.08 132.95 30.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.995 0.918 . . . . 0.0 109.728 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HB3' HG21 ' A' ' 7' ' ' THR . 32.9 Cg_endo -81.01 -31.84 1.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.221 1.947 . . . . 0.0 114.285 -168.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.67 157.99 35.89 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.538 1.935 . . . . 0.0 106.981 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 m -77.16 153.62 33.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.45 -171.05 31.68 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -165.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -136.38 130.88 33.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -63.62 150.21 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.432 1.093 . . . . 0.0 108.374 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.68 3.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.689 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -156.73 160.12 38.99 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 121.373 1.897 . . . . 0.0 109.501 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.68 168.0 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.728 1.611 . . . . 0.0 109.59 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -117.71 78.71 1.26 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.641 1.177 . . . . 0.0 109.035 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.55 -11.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.169 0.987 . . . . 0.0 112.958 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -53.14 -31.68 43.68 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.683 -1.26 . . . . 0.0 111.042 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -21.36 59.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.241 1.017 . . . . 0.0 110.079 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.38 -5.95 16.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.549 1.939 . . . . 0.0 113.293 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -137.42 -34.35 0.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.552 -0.718 . . . . 0.0 110.229 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.1 62.07 19.19 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.323 2.249 . . . . 0.0 109.113 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.16 -20.49 28.34 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 124.177 3.251 . . . . 0.0 110.263 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.83 -17.32 49.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.699 1.2 . . . . 0.0 110.587 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.5 mt -67.86 -16.76 64.24 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.653 1.57 . . . . 0.0 114.383 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 mt -67.4 -23.72 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.26 0.936 . . . . 0.0 109.816 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -76.16 -53.73 7.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 119.967 -1.708 . . . . 0.0 109.918 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -59.99 -40.5 89.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.151 0.981 . . . . 0.0 112.084 -167.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.75 76.63 2.26 Favored Pre-proline 0 C--N 1.333 -0.136 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.15 -19.71 67.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.407 2.072 . . . . 0.0 113.315 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.3 mt-10 -124.19 22.32 8.66 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.43 1.013 . . . . 0.0 111.288 -171.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.06 -82.14 0.17 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 166.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -83.36 -38.83 21.5 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.49 46.32 3.24 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.793 1.179 . . . . 0.0 114.15 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -81.3 168.37 18.51 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.249 1.024 . . . . 0.0 109.704 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.63 -69.25 0.84 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -138.48 173.18 11.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.557 0.743 . . . . 0.0 111.349 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -128.38 150.36 50.14 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -144.84 148.69 34.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.054 0.542 . . . . 0.0 110.141 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.94 117.48 11.57 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.258 1.823 . . . . 0.0 107.778 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.412 HG21 ' CD1' ' A' ' 15' ' ' ILE . 2.9 pt -70.1 97.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.587 1.184 . . . . 0.0 107.963 163.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 m -60.67 -34.73 74.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.028 167.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -134.95 82.72 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -163.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.476 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -65.15 -12.81 55.0 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.464 -0.772 . . . . 0.0 110.235 172.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.31 73.19 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 117.549 -1.695 . . . . 0.0 112.202 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -80.43 -29.22 37.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.958 1.879 . . . . 0.0 110.61 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 105' ' ' GLU . 17.8 mt -41.81 -46.08 3.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.142 1.792 . . . . 0.0 111.83 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.49 -11.34 60.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.05 -35.62 59.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 165.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 108' ' ' LEU . 2.4 mm? -64.88 171.02 3.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 123.693 1.711 . . . . 0.0 110.979 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.7 mt -70.54 120.82 16.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.022 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.4 -179.47 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.266 1.426 . . . . 0.0 110.231 163.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.64 -37.96 70.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.271 -1.518 . . . . 0.0 110.986 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -69.73 -46.1 66.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.27 1.428 . . . . 0.0 109.024 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.44 66.5 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.013 0.925 . . . . 0.0 111.875 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -63.47 -48.14 78.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.573 1.149 . . . . 0.0 109.506 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.0 -41.85 79.23 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 123.817 0.847 . . . . 0.0 110.084 175.784 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 31.1 tpp . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -142.09 112.47 7.1 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.964 -1.085 . . . . 0.0 109.892 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -105.63 -179.23 3.88 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.732 0.645 . . . . 0.0 111.56 162.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -136.69 176.75 8.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.408 1.883 . . . . 0.0 111.568 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -134.96 166.09 23.82 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.894 1.277 . . . . 0.0 111.512 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 10' ' ' HIS . 2.1 mtmt -71.91 -34.54 69.18 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.769 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -71.58 42.33 0.08 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.35 0.977 . . . . 0.0 109.611 165.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 8' ' ' LYS . 5.1 p80 38.97 63.97 0.85 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 127.726 2.411 . . . . 0.0 112.509 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 11.1 mt-10 -128.17 169.14 14.47 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.0 109.361 168.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -113.35 172.27 7.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.833 2.053 . . . . 0.0 109.435 161.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.3 t -136.4 142.89 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.757 2.423 . . . . 0.0 105.279 174.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.77 80.11 1.78 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 119.557 1.071 . . . . 0.0 110.893 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.4 mp -62.39 140.02 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 168.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -117.23 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 160.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.68 -94.83 0.44 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -123.22 33.35 5.4 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 128.152 2.581 . . . . 0.0 110.849 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.16 119.43 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 164.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -102.06 107.04 18.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.856 1.663 . . . . 0.0 107.607 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -70.23 126.39 29.52 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.824 0.85 . . . . 0.0 109.145 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.54 HG11 ' CE1' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -95.12 148.52 5.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 128.545 2.738 . . . . 0.0 112.618 169.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.19 161.39 32.0 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 157.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.434 ' CD1' HG21 ' A' ' 87' ' ' ILE . 3.3 pt -84.49 139.4 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 118.939 1.37 . . . . 0.0 108.6 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.7 p -73.51 172.99 10.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.564 -0.71 . . . . 0.0 111.466 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -59.19 -33.81 71.4 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.618 -1.301 . . . . 0.0 113.245 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -54.25 -24.1 17.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.893 1.277 . . . . 0.0 111.616 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.52 -48.75 10.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.264 1.025 . . . . 0.0 112.152 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.0 pp0? -62.45 -20.02 64.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.084 0.856 . . . . 0.0 110.302 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -58.67 -26.52 63.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.647 1.979 . . . . 0.0 112.958 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -90.04 -42.01 11.38 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 120.155 1.343 . . . . 0.0 113.387 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mt -89.14 -33.0 17.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -170.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.44 -118.78 7.26 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.848 1.69 . . . . 0.0 111.606 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.79 112.88 3.07 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.213 1.805 . . . . 0.0 107.81 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -98.11 -165.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.047 0.927 . . . . 0.0 109.849 179.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.669 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -172.85 -31.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 129.62 3.168 . . . . 0.0 109.545 -168.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' H ' HG12 ' A' ' 35' ' ' VAL . 37.0 t80 -150.12 147.41 27.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 111.326 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 56' ' ' ILE . 22.8 t -138.99 115.88 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.21 140.71 58.9 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.998 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.3 mt -134.17 137.01 27.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 125.486 1.515 . . . . 0.0 107.576 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.87 -163.69 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.546 2.831 . . . . 0.0 112.643 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -113.69 145.32 41.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.854 1.662 . . . . 0.0 108.288 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.41 16.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -165.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.54 13.84 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.92 1.724 . . . . 0.0 112.671 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -79.39 137.38 37.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.524 1.662 . . . . 0.0 109.491 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -77.13 154.48 33.19 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.996 0.816 . . . . 0.0 109.872 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.448 HG11 HD11 ' A' ' 73' ' ' ILE . 35.6 m -140.46 164.71 21.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.515 1.126 . . . . 0.0 110.566 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -111.08 165.45 11.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 126.427 1.891 . . . . 0.0 107.983 167.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -60.77 10.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.729 2.012 . . . . 0.0 115.78 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.3 92.13 0.12 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 162.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.07 126.83 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -72.27 20.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 126.47 1.908 . . . . 0.0 113.976 -166.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.03 11.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 127.118 2.167 . . . . 0.0 116.196 -165.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.1 49.08 0.84 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.899 1.28 . . . . 0.0 108.79 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.8 m -49.43 157.22 0.53 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.402 1.096 . . . . 0.0 111.123 169.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.458 HG23 HG22 ' A' ' 38' ' ' VAL . 5.3 mt -142.0 100.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -86.2 118.93 25.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -90.37 -167.94 1.97 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.484 1.514 . . . . 0.0 109.511 168.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -39.53 -52.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.054 1.742 . . . . 0.0 112.392 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -155.04 52.4 0.62 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.883 1.219 . . . . 0.0 111.81 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.3 177.37 10.64 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.179 -0.951 . . . . 0.0 109.194 163.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.19 114.04 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.506 1.523 . . . . 0.0 108.34 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.77 100.04 11.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.21 111.16 2.47 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.11 109.69 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -81.97 108.05 15.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.721 -0.612 . . . . 0.0 109.767 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -38.49 142.63 0.48 Allowed Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 126.826 2.05 . . . . 0.0 113.067 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.8 -35.9 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 119.617 0.899 . . . . 0.0 113.783 -161.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.537 HD11 HD23 ' A' ' 108' ' ' LEU . 4.5 mm? -123.46 160.32 27.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -80.67 151.61 28.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.54 -157.28 27.44 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -168.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -142.54 137.44 30.15 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.899 0.85 . . . . 0.0 109.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.52 HD12 ' CD1' ' A' ' 98' ' ' PHE . 11.0 mm -63.96 146.27 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 124.372 1.069 . . . . 0.0 108.817 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.4 -0.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.202 1.001 . . . . 0.0 111.116 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -161.43 157.64 25.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.22 146.13 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -173.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -86.51 74.73 9.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 118.57 0.623 . . . . 0.0 110.204 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.35 -15.11 14.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -54.51 -45.9 73.39 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.076 165.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.11 -18.88 64.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 0.0 112.281 -173.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -63.75 -15.66 59.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.207 1.403 . . . . 0.0 111.232 169.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 p -131.97 -27.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.67 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.23 64.55 61.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.143 1.777 . . . . 0.0 110.496 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.85 -10.25 27.65 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.146 3.231 . . . . 0.0 111.792 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.37 -14.16 61.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.197 -0.94 . . . . 0.0 112.908 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 86' ' ' LEU . 5.5 mt -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.113 1.324 . . . . 0.0 113.464 -169.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 87' ' ' ILE . 4.6 mp -63.83 -33.87 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.44 1.018 . . . . 0.0 110.667 169.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -59.07 -46.35 88.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.785 1.755 . . . . 0.0 109.965 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -72.73 -59.99 2.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 127.694 2.398 . . . . 0.0 110.579 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -140.54 65.07 25.24 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -167.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.78 -18.31 55.33 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 120.811 1.007 . . . . 0.0 111.475 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.33 28.18 7.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 109.021 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.6 -113.85 0.99 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.44 -14.33 62.83 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.269 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.71 32.48 2.15 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 120.678 1.581 . . . . 0.0 112.513 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.86 161.25 13.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.171 0.985 . . . . 0.0 108.741 165.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.46 -58.29 2.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.931 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CE1' HG11 ' A' ' 22' ' ' VAL . 42.7 p90 -140.03 -176.79 4.72 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 115.022 -2.671 . . . . 0.0 111.934 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -136.42 129.84 31.79 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 ptm -131.92 139.13 48.63 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.5 141.91 58.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.9 pt -95.91 149.97 4.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -133.65 -13.06 2.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.904 1.681 . . . . 0.0 112.391 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -146.27 74.36 1.36 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -66.52 -10.26 43.04 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.618 -1.301 . . . . 0.0 111.009 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.28 -39.26 95.82 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 120.531 -1.355 . . . . 0.0 110.703 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -63.85 -28.94 70.19 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.568 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 69' ' ' LEU . 15.0 mt -47.41 -36.67 10.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 120.184 1.356 . . . . 0.0 111.883 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.72 -16.62 55.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.887 1.676 . . . . 0.0 112.657 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.6 -31.24 66.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.346 1.459 . . . . 0.0 109.96 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -65.08 169.08 5.78 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.673 -0.642 . . . . 0.0 109.525 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.561 HD22 ' H ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -68.21 127.04 31.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.57 171.94 0.76 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 154.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -67.88 -36.57 80.47 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.509 -1.995 . . . . 0.0 112.126 -173.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.71 -51.55 58.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.21 71.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.255 0.222 . . . . 0.0 111.192 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -61.58 -52.37 64.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.728 1.211 . . . . 0.0 109.933 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -41.0 72.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.295 0.638 . . . . 0.0 109.651 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 . . . . . 0 N--CA 1.443 -0.803 0 C-N-CA 123.906 0.882 . . . . 0.0 110.968 -176.336 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.519 ' SD ' ' HE2' ' A' ' 5' ' ' LYS . 3.8 ptp . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 64.94 0.74 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.66 -1.275 . . . . 0.0 111.372 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HE2' ' SD ' ' A' ' 3' ' ' MET . 2.0 mptp? -66.9 -178.65 0.78 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.97 149.42 47.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.487 1.915 . . . . 0.0 110.003 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.0 p -93.14 171.21 9.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 123.518 1.628 . . . . 0.0 109.574 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -71.99 -33.4 68.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.016 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -89.84 43.53 1.15 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.63 2.372 . . . . 0.0 111.564 -176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p80 48.5 46.53 20.79 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.361 1.864 . . . . 0.0 114.234 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.0 mt-10 -121.25 158.21 28.61 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 109.275 170.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.43 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.8 p-90 -108.79 163.15 13.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.472 1.509 . . . . 0.0 107.358 165.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.18 154.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -143.34 80.66 1.68 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.122 1.369 . . . . 0.0 109.632 -172.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 20' ' ' ALA . 1.2 mt -80.56 117.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.454 1.502 . . . . 0.0 108.82 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.287 5.1 pt-20 -114.11 -101.18 0.42 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 116.732 -1.604 . . . . 0.0 108.988 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -64.08 1.1 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 122.321 2.328 . . . . 0.0 111.806 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -153.66 8.54 0.38 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.487 2.715 . . . . 0.0 109.873 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.5 t -127.92 126.45 66.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -90.71 141.81 28.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.695 0.398 . . . . 0.0 109.962 168.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 16.4 m -87.99 151.71 22.58 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.15 142.33 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.752 1.221 . . . . 0.0 109.327 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -158.47 170.39 35.11 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 163.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.782 HD11 HG21 ' A' ' 87' ' ' ILE . 30.7 pt -77.46 152.08 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 118.415 1.108 . . . . 0.0 110.695 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -80.8 171.81 14.54 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.916 -1.115 . . . . 0.0 112.508 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -21.52 62.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.37 1.068 . . . . 0.0 113.025 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -67.02 -31.21 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 119.765 -1.835 . . . . 0.0 111.859 169.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.504 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -81.2 -42.7 20.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.953 -1.092 . . . . 0.0 111.705 -172.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.655 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.9 pp0? -56.31 -22.32 29.72 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.372 0.533 . . . . 0.0 111.374 175.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -46.13 81.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.194 0.998 . . . . 0.0 109.371 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.627 ' HA ' HE21 ' A' ' 31' ' ' GLN . 0.1 OUTLIER -81.01 -27.83 35.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.254 1.422 . . . . 0.0 112.515 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.508 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -78.02 -43.96 27.91 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.91 -150.03 51.6 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 124.517 1.056 . . . . 0.0 110.801 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -46.23 114.57 0.82 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.954 2.502 . . . . 0.0 108.081 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 36' ' ' VAL 0.276 8.9 p -111.08 173.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-O 122.774 1.273 . . . . 0.0 110.112 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.709 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.07 -23.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.413 -153.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.419 ' H ' ' H ' ' A' ' 36' ' ' VAL . 45.3 t80 -147.79 142.05 26.21 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.802 0.274 . . . . 0.0 111.237 175.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.25 132.47 55.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 159.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.5 137.63 42.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.805 168.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.2 mt -131.47 131.44 22.91 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.66 179.7 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.568 2.845 . . . . 0.0 113.149 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.39 156.77 24.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.549 -0.719 . . . . 0.0 111.146 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.99 19.21 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 0.0 113.457 -164.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.88 33.43 0.56 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -106.85 133.89 50.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.332 1.066 . . . . 0.0 110.829 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 150.72 48.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.378 0.99 . . . . 0.0 110.353 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -142.22 167.13 15.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.755 1.622 . . . . 0.0 110.624 169.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -116.85 170.49 8.58 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 127.758 2.423 . . . . 0.0 110.895 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 6.61 0.25 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.6 59.25 0.35 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -106.79 115.35 30.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.922 1.289 . . . . 0.0 108.994 -173.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.1 OUTLIER -70.28 33.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 127.736 2.414 . . . . 0.0 113.922 -173.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 53' ' ' VAL . 17.0 m -72.69 10.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 O-C-N 117.956 -2.965 . . . . 0.0 115.958 -167.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.85 51.85 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.221 0.918 . . . . 0.0 109.554 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.69 157.21 7.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.81 0.814 . . . . 0.0 111.034 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.452 HD12 HD13 ' A' ' 24' ' ' ILE . 15.2 mt -133.6 108.03 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -101.49 117.27 34.59 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 35' ' ' VAL . 56.2 p -99.61 -159.95 0.77 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.335 1.454 . . . . 0.0 111.7 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -43.55 -44.1 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.07 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -158.56 13.29 0.18 Allowed 'General case' 0 C--N 1.346 0.453 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 165.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.82 159.16 15.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.911 1.687 . . . . 0.0 108.148 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.32 96.59 3.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.385 1.474 . . . . 0.0 107.517 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -90.65 107.38 19.14 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.998 0.919 . . . . 0.0 110.311 176.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.31 117.33 4.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.238 1.815 . . . . 0.0 107.37 163.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.74 103.63 14.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -94.51 98.55 10.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -168.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.9 130.97 0.3 Allowed Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.924 2.09 . . . . 0.0 113.917 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.1 -29.68 39.54 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.279 2.653 . . . . 0.0 114.546 -167.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.9 mt -148.34 158.59 44.19 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.963 1.305 . . . . 0.0 108.079 -167.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -66.48 145.43 55.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.4 38.8 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -129.53 130.92 46.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.13 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.5 mm -63.66 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.2 m -145.71 -3.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.245 1.018 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -148.03 158.77 44.24 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.969 1.259 . . . . 0.0 107.845 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -142.45 158.38 19.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.333 1.453 . . . . 0.0 107.948 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -108.72 74.09 0.9 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.988 0.515 . . . . 0.0 110.141 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.65 -11.4 7.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -44.78 -42.34 7.71 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.313 1.445 . . . . 0.0 111.357 164.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -12.14 61.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.063 0.945 . . . . 0.0 110.893 -170.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.66 -11.21 57.75 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.707 1.203 . . . . 0.0 112.173 167.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -131.28 -36.18 1.31 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.828 . . . . 0.0 111.235 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -121.2 73.92 28.39 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.869 2.068 . . . . 0.0 107.233 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.89 -43.86 1.54 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.987 1.791 . . . . 0.0 107.657 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.617 ' HA ' HG12 ' A' ' 35' ' ' VAL . 96.4 mt-10 -56.07 -11.36 1.07 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.653 1.581 . . . . 0.0 112.285 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -57.43 -18.11 16.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.664 1.985 . . . . 0.0 111.99 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.782 HG21 HD11 ' A' ' 24' ' ' ILE . 3.8 mm -53.05 -37.95 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -68.02 -48.59 65.28 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 120.93 -1.106 . . . . 0.0 111.334 174.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 5.0 mtpt -77.74 -28.26 50.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 125.755 1.622 . . . . 0.0 113.126 -162.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.75 65.19 0.72 Allowed Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -177.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.98 -30.22 89.47 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.295 1.997 . . . . 0.0 112.756 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.1 mp0 -119.12 21.57 12.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.642 0.777 . . . . 0.0 110.046 177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.79 -121.53 4.86 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 105.874 -2.89 . . . . 0.0 105.874 157.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.54 -3.01 28.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.05 23.3 5.31 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 120.706 1.594 . . . . 0.0 112.7 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -63.2 162.02 12.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.722 1.761 . . . . 0.0 109.886 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.42 HD12 ' HA2' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -104.71 -56.16 2.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.03 173.81 12.12 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.209 -0.932 . . . . 0.0 112.014 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -124.72 152.54 43.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.788 0.835 . . . . 0.0 110.209 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -142.89 141.71 31.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.753 1.221 . . . . 0.0 110.493 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -64.63 133.51 52.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 pt -87.45 103.13 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 122.846 0.458 . . . . 0.0 110.322 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.5 m -66.86 -7.69 23.54 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -143.56 135.08 26.19 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -99.46 2.02 44.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.527 2.331 . . . . 0.0 108.158 162.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.81 -39.12 5.02 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.804 -1.185 . . . . 0.0 112.573 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -65.27 -24.13 67.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.42 1.11 . . . . 0.0 110.527 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 111' ' ' LEU . 2.7 mp -38.0 -44.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.533 2.733 . . . . 0.0 112.206 163.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -79.86 -7.34 58.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.272 1.396 . . . . 0.0 112.506 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -88.23 -12.75 42.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 111.639 168.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 108' ' ' LEU . 1.1 mm? -66.27 169.52 7.1 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.053 -1.655 . . . . 0.0 109.155 167.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.42 139.44 42.33 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.84 171.66 0.88 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.553 1.168 . . . . 0.0 109.232 159.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.13 -34.45 78.08 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.388 1.875 . . . . 0.0 111.251 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -80.55 -44.16 19.49 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.571 1.148 . . . . 0.0 109.514 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.16 72.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.106 0.479 . . . . 0.0 111.307 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -59.31 -39.9 84.55 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.175 0.99 . . . . 0.0 110.947 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.67 -45.32 72.02 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.178 0.591 . . . . 0.0 109.881 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 123.662 0.785 . . . . 0.0 110.45 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.6 ttm . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -138.64 121.18 16.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.949 154.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -113.42 179.97 3.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.316 1.847 . . . . 0.0 110.011 172.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 117' ' ' TYR . 70.6 m-85 -150.55 167.94 25.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.0 1.32 . . . . 0.0 110.508 -164.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -136.74 170.08 16.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.23 1.377 . . . . 0.0 111.371 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -68.5 -14.64 63.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 176.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -89.33 34.89 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.151 -1.593 . . . . 0.0 108.282 175.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 p80 41.73 64.16 1.13 Allowed 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.173 2.589 . . . . 0.0 110.723 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.492 1.517 . . . . 0.0 107.562 -166.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.9 p-90 -116.92 150.69 38.09 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.19 1.796 . . . . 0.0 110.043 176.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.57 122.91 15.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -161.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -120.38 97.79 5.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.449 1.022 . . . . 0.0 111.295 -163.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -108.49 102.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.484 1.113 . . . . 0.0 109.529 -164.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.46 -74.5 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.885 0.874 . . . . 0.0 110.11 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -74.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 108.066 -170.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -126.93 7.85 6.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.233 0.924 . . . . 0.0 113.344 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -134.69 142.66 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.79 137.54 38.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.029 1.332 . . . . 0.0 109.187 163.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 5.8 m -78.94 132.02 36.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 155.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.49 132.05 49.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.683 1.993 . . . . 0.0 108.762 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.493 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -149.69 168.82 29.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.548 1.071 . . . . 0.0 110.904 159.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.601 HD12 ' HB1' ' A' ' 28' ' ' ALA . 16.4 pt -89.06 159.19 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.334 0.653 . . . . 0.0 109.875 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -90.72 175.08 7.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.711 -1.243 . . . . 0.0 112.049 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -39.52 62.45 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.01 -1.056 . . . . 0.0 111.599 171.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -58.18 -22.5 51.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.398 1.079 . . . . 0.0 111.85 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 24' ' ' ILE . . . -89.56 -46.65 8.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.751 1.62 . . . . 0.0 112.172 -175.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -64.03 -22.83 67.09 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.12 0.418 . . . . 0.0 111.396 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -27.52 69.0 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.193 1.397 . . . . 0.0 111.716 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -90.11 -43.78 10.24 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.733 -0.605 . . . . 0.0 110.967 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.58 -35.75 14.08 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.954 -170.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.2 -119.42 8.68 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 125.373 1.464 . . . . 0.0 111.043 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.73 91.63 0.63 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.405 1.882 . . . . 0.0 106.728 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -74.88 -162.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.8 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -165.6 -35.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 130.249 3.42 . . . . 0.0 109.37 -169.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.478 ' H ' HG12 ' A' ' 35' ' ' VAL . 59.7 t80 -158.17 161.21 37.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.128 0.876 . . . . 0.0 112.667 -174.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.45 132.37 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.574 1.15 . . . . 0.0 110.951 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.78 136.02 36.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 108.869 170.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 80' ' ' LEU . 68.3 mt -130.95 144.39 53.35 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.062 1.745 . . . . 0.0 109.135 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.72 -179.25 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.586 2.857 . . . . 0.0 112.658 -169.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -73.49 148.11 43.45 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 110.065 166.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.71 9.18 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.642 2.377 . . . . 0.0 114.743 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.19 12.17 0.92 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 126.76 2.124 . . . . 0.0 110.503 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -66.52 145.14 55.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.212 1.006 . . . . 0.0 108.921 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -84.33 150.48 25.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.429 1.585 . . . . 0.0 110.575 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.562 HG22 HG11 ' A' ' 53' ' ' VAL 0.377 11.6 t -142.58 173.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.174 0 C-N-CA 129.782 3.233 . . . . 0.0 108.621 -175.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -141.89 169.46 17.54 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 129.362 3.065 . . . . 0.0 103.831 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 14.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.68 92.57 0.1 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 103.9 -3.68 . . . . 0.0 103.9 162.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.26 142.45 31.37 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 52' ' ' VAL . 46.1 t -79.12 32.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 130.341 3.456 . . . . 0.0 111.344 -164.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG11 HG22 ' A' ' 47' ' ' VAL . 23.5 m -68.41 1.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 119.431 -2.043 . . . . 0.0 111.788 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.6 73.2 1.17 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.886 1.675 . . . . 0.0 110.015 172.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.99 164.33 6.74 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 120.028 -1.67 . . . . 0.0 110.592 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mt -135.24 151.88 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.0 123.68 21.1 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.835 -1.165 . . . . 0.0 108.286 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 61' ' ' ALA . 48.4 t -107.21 -169.61 1.57 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.957 1.303 . . . . 0.0 107.952 -172.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.93 -33.82 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.86 1.264 . . . . 0.0 111.794 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -169.13 18.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.96 1.704 . . . . 0.0 112.827 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 58' ' ' SER . . . -113.48 152.64 29.89 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.269 0.941 . . . . 0.0 111.361 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.83 129.58 15.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.119 1.368 . . . . 0.0 109.254 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.3 107.93 2.27 Favored 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.634 4.374 . . . . 0.0 105.27 -163.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -67.35 134.75 52.11 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -78.46 120.12 28.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 164.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -102.86 105.58 15.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.57 132.58 1.34 Allowed Pre-proline 0 N--CA 1.452 -0.36 0 O-C-N 124.488 1.117 . . . . 0.0 112.331 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.02 -26.0 31.5 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.711 2.274 . . . . 0.0 113.491 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.4 151.26 34.97 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.261 1.425 . . . . 0.0 107.568 -163.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -72.48 128.38 35.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.16 40.62 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.626 -0.671 . . . . 0.0 111.919 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -128.52 131.09 48.28 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.328 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.2 mm -57.78 148.31 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 120.132 1.333 . . . . 0.0 108.368 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.81 -4.27 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.029 0.932 . . . . 0.0 112.747 164.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -150.5 156.51 41.57 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.349 1.432 . . . . 0.0 107.796 171.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.0 m -133.55 165.44 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.765 1.226 . . . . 0.0 108.017 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.98 83.03 1.69 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.253 0.621 . . . . 0.0 110.617 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.1 1.9 0.4 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -62.53 -43.02 99.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 119.802 -1.811 . . . . 0.0 108.49 166.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.554 ' CD1' HD23 ' A' ' 97' ' ' LEU . 92.1 mt -57.09 -14.29 3.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 113.704 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.1 -36.85 78.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.832 2.053 . . . . 0.0 110.698 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 p -127.5 -11.84 5.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.518 1.127 . . . . 0.0 112.413 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -117.31 58.3 2.29 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.254 1.822 . . . . 0.0 111.235 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.45 -18.16 18.02 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.641 2.227 . . . . 0.0 110.222 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.04 -13.89 60.92 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.382 0.992 . . . . 0.0 111.6 171.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -24.91 66.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.725 -1.859 . . . . 0.0 110.863 -172.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 80' ' ' LEU . 3.5 mt -62.65 -18.27 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 O-C-N 120.557 -1.339 . . . . 0.0 110.507 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -74.3 -53.57 9.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 119.171 -2.206 . . . . 0.0 111.33 161.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -68.73 -52.6 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.296 1.439 . . . . 0.0 109.958 -159.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.4 70.72 12.93 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 125.803 1.641 . . . . 0.0 106.7 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.99 -23.35 72.69 Favored 'Trans proline' 0 CA--C 1.511 -0.63 0 C-N-CA 123.059 2.506 . . . . 0.0 112.351 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP 0.294 0.4 OUTLIER -119.1 31.54 6.58 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.773 1.629 . . . . 0.0 109.27 -175.256 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -110.87 0.85 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.256 1.884 . . . . 0.0 109.03 166.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -72.96 -9.17 58.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.828 0.851 . . . . 0.0 113.104 -175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.74 21.92 33.68 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.854 1.216 . . . . 0.0 113.567 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -57.66 169.12 0.74 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.126 1.463 . . . . 0.0 110.309 165.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.554 HD23 ' CD1' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -120.6 -52.58 2.13 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -152.05 170.09 20.77 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 121.557 -0.714 . . . . 0.0 110.144 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -129.84 141.13 50.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.59 142.29 39.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.845 0.858 . . . . 0.0 110.105 -171.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.56 125.69 27.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.89 2.076 . . . . 0.0 106.935 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -81.77 97.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 124.328 1.018 . . . . 0.0 108.69 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -72.15 -16.12 61.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.39 172.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -137.93 79.2 1.73 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.597 ' HA ' HD21 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -65.25 -15.61 62.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.62 -0.675 . . . . 0.0 111.609 176.261 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.55 4.64 77.48 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 116.925 -2.042 . . . . 0.0 114.067 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -97.81 -28.91 13.64 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.691 1.745 . . . . 0.0 112.614 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -62.95 -34.06 76.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.652 1.569 . . . . 0.0 112.135 -173.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -56.0 -29.29 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 124.841 1.257 . . . . 0.0 112.698 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -84.97 -17.16 38.51 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 111.36 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -76.68 -174.08 2.85 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.589 1.155 . . . . 0.0 109.623 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.58 128.1 32.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.96 169.93 0.2 Allowed 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 122.023 0.916 . . . . 0.0 109.957 160.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.01 -43.06 75.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.732 1.613 . . . . 0.0 110.995 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -65.31 -50.97 63.64 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.475 1.51 . . . . 0.0 109.107 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.84 70.19 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.592 -0.692 . . . . 0.0 111.824 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 4.3 t80 -63.16 -44.0 96.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.009 0.924 . . . . 0.0 110.407 174.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.38 71.91 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.981 0.42 . . . . 0.0 109.909 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ptm . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -125.9 88.4 2.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.278 0.944 . . . . 0.0 109.947 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -92.49 174.73 7.13 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.697 -0.627 . . . . 0.0 111.707 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.16 177.24 7.99 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.288 1.435 . . . . 0.0 112.035 -169.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -130.67 168.03 17.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.1 1.36 . . . . 0.0 110.882 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.474 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -77.27 18.21 0.42 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.019 1.328 . . . . 0.0 111.414 159.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -125.23 26.67 6.83 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.458 -1.401 . . . . 0.0 110.496 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.6 p80 45.02 50.97 9.03 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 111.506 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -121.97 143.22 49.61 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -99.51 159.53 14.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 160.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.26 107.9 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.35 74.79 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.495 1.118 . . . . 0.0 110.503 -170.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.0 mp -64.7 146.16 13.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.718 1.207 . . . . 0.0 108.501 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -139.06 -70.6 0.41 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.083 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.4 -62.47 1.26 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.984 1.266 . . . . 0.0 111.006 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.05 15.36 2.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.01 1.324 . . . . 0.0 110.526 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.45 150.89 33.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -123.07 133.43 54.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.736 1.614 . . . . 0.0 107.261 167.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -77.47 113.59 15.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 164.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.12 135.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.3 170.32 31.56 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 165.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.569 HD11 ' CG2' ' A' ' 87' ' ' ILE . 15.7 pt -90.33 153.35 3.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 117.974 0.887 . . . . 0.0 110.466 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 p -91.25 164.58 13.83 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.211 -1.555 . . . . 0.0 109.654 171.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.545 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 13.4 p-10 -50.9 -37.18 42.29 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 114.151 -2.833 . . . . 0.0 115.308 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -49.24 -34.52 15.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 121.604 2.002 . . . . 0.0 109.46 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' HB1' HD12 ' A' ' 24' ' ' ILE . . . -64.57 -68.9 0.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.26 1.824 . . . . 0.0 112.9 173.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.545 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 6.1 pm0 -66.04 -24.58 66.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.695 1.589 . . . . 0.0 110.699 -171.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.99 -40.29 96.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.272 6.3 pt20 -75.05 -56.69 4.48 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.328 0.651 . . . . 0.0 112.248 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -35.62 81.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.682 0.674 . . . . 0.0 111.926 -170.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.53 -137.07 36.86 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.85 110.73 0.77 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 128.39 2.676 . . . . 0.0 110.105 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -93.1 172.82 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 124.693 2.187 . . . . 0.0 109.649 171.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.715 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.5 m -151.2 -37.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 129.432 3.093 . . . . 0.0 109.201 -160.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.404 ' H ' HG12 ' A' ' 35' ' ' VAL . 46.3 t80 -155.52 153.61 30.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.759 0.424 . . . . 0.0 110.776 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.44 135.43 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.843 0.83 . . . . 0.0 109.602 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.93 122.74 23.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 163.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.33 141.83 31.34 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 124.626 1.17 . . . . 0.0 107.907 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -76.3 179.45 6.36 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.717 2.278 . . . . 0.0 111.97 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -79.59 157.93 27.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.29 1.036 . . . . 0.0 110.232 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.41 15.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.291 1.437 . . . . 0.0 113.317 -171.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.34 15.29 0.39 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 128.41 2.91 . . . . 0.0 111.41 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -73.38 128.17 34.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.11 1.455 . . . . 0.0 109.051 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.26 146.76 45.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 73' ' ' ILE . 34.2 m -142.21 168.41 14.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 110.391 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 26.3 mtpt -126.21 170.68 11.6 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.741 1.616 . . . . 0.0 108.427 172.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 24.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -152.16 15.17 0.77 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.931 1.253 . . . . 0.0 113.012 167.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.43 113.78 13.23 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.06 1.93 . . . . 0.0 110.679 -168.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.79 94.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.81 5.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.545 1.538 . . . . 0.0 112.153 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.37 38.96 1.16 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.786 0.435 . . . . 0.0 110.643 -168.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.33 151.98 6.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 123.183 1.468 . . . . 0.0 111.067 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.79 134.78 53.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -115.22 124.34 51.15 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 161.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.8 p -99.14 -173.84 2.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.191 0.996 . . . . 0.0 109.647 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 m -42.9 -48.6 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.997 0.919 . . . . 0.0 111.381 171.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -160.25 85.13 0.73 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.069 0.85 . . . . 0.0 109.55 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -178.47 147.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.878 2.471 . . . . 0.0 106.23 157.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.34 152.83 18.04 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.25 120.13 14.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 130.5 47.24 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.983 2.113 . . . . 0.0 107.392 165.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.82 116.15 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -106.27 100.71 10.23 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.893 0.877 . . . . 0.0 110.738 -166.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.54 127.09 0.5 Allowed Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 126.801 2.04 . . . . 0.0 112.584 -172.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.52 -27.71 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.569 1.513 . . . . 0.0 114.129 -159.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.481 HD21 HD11 ' A' ' 111' ' ' LEU . 3.5 mm? -133.23 172.44 12.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.485 1.914 . . . . 0.0 108.634 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 49.7 m -93.48 123.02 36.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.093 1.357 . . . . 0.0 110.862 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.33 -158.27 20.7 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -164.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -139.76 142.12 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.079 -1.247 . . . . 0.0 108.304 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.597 HD12 ' CD1' ' A' ' 98' ' ' PHE . 6.3 mm -62.17 148.66 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.693 1.197 . . . . 0.0 108.226 176.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -146.46 -5.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -156.36 140.79 16.74 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.51 147.67 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -89.02 81.64 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.1 -15.71 4.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.122 0.969 . . . . 0.0 113.193 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -53.34 -39.6 64.23 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.988 2.115 . . . . 0.0 112.692 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -11.17 60.56 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.377 1.444 . . . . 0.0 111.313 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -69.3 -38.3 78.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.358 1.463 . . . . 0.0 111.164 171.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.4 p -110.86 -25.99 9.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.32 1.448 . . . . 0.0 112.847 -171.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -132.09 61.79 59.83 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 128.513 2.725 . . . . 0.0 109.449 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.67 -30.07 84.82 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.021 3.148 . . . . 0.0 111.502 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.83 -11.42 27.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.87 2.068 . . . . 0.0 111.896 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 86' ' ' LEU . 6.6 mt -64.46 -15.7 61.15 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 120.281 1.401 . . . . 0.0 113.043 168.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.569 ' CG2' HD11 ' A' ' 24' ' ' ILE . 84.8 mt -58.6 -32.34 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.502 1.046 . . . . 0.0 110.054 167.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -73.86 -55.02 6.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 119.709 -1.87 . . . . 0.0 109.082 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.464 ' HB2' HD23 ' A' ' 86' ' ' LEU . 15.3 mmmt -63.85 -56.46 15.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.391 1.476 . . . . 0.0 110.722 -168.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -138.63 57.17 11.11 Favored Pre-proline 0 C--O 1.239 0.523 0 O-C-N 124.691 1.245 . . . . 0.0 110.459 -165.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.74 -13.74 36.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.147 2.565 . . . . 0.0 112.116 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -109.22 -0.8 19.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.574 2.35 . . . . 0.0 110.756 -163.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.79 -81.09 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 125.947 1.737 . . . . 0.0 110.719 -174.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.12 -24.8 20.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.847 1.324 . . . . 0.0 113.212 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.63 31.89 1.44 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.372 1.463 . . . . 0.0 111.996 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -67.97 155.15 40.09 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.343 1.072 . . . . 0.0 109.229 173.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.15 -72.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.597 ' CD1' HD12 ' A' ' 73' ' ' ILE . 25.4 p90 -143.82 149.63 37.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.258 1.423 . . . . 0.0 108.371 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -99.25 150.71 21.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.67 142.76 43.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.47 138.16 48.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.076 1.35 . . . . 0.0 107.444 169.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 pt -96.02 111.92 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.513 0.725 . . . . 0.0 110.703 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 m -70.36 -38.03 74.7 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.073 -0.392 . . . . 0.0 111.346 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.62 81.07 1.98 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.154 0.982 . . . . 0.0 109.032 -164.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -7.31 24.11 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.97 -1.081 . . . . 0.0 111.748 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.66 -31.76 23.47 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.778 -1.201 . . . . 0.0 111.583 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -66.42 -8.98 29.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.7 -28.03 69.62 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.242 0.928 . . . . 0.0 110.946 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.16 -14.25 60.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.979 1.263 . . . . 0.0 111.391 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.85 -10.31 58.9 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.828 0.851 . . . . 0.0 111.616 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.481 HD11 HD21 ' A' ' 69' ' ' LEU . 77.9 mt -78.95 176.43 9.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.457 1.122 . . . . 0.0 110.534 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.7 133.14 34.31 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.149 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.79 166.44 13.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.379 1.561 . . . . 0.0 108.651 153.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -68.89 -35.93 77.45 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 125.447 1.499 . . . . 0.0 111.154 -168.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -67.38 -40.19 85.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.14 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.848 -0.533 . . . . 0.0 110.621 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.85 -44.04 97.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.603 0.361 . . . . 0.0 110.198 171.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -47.0 81.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.855 0.862 . . . . 0.0 110.698 172.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 118.145 0.43 . . . . 0.0 110.389 -178.257 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 83.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.267 -0.896 . . . . 0.0 110.119 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.531 ' H ' ' HE3' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -82.93 176.81 8.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 119.436 -0.905 . . . . 0.0 113.202 178.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -131.44 152.92 50.25 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.897 1.679 . . . . 0.0 109.222 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.8 p -101.84 -173.67 2.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.442 1.115 . . . . 0.0 109.716 -172.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -98.03 10.36 40.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.662 1.985 . . . . 0.0 111.244 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.0 p -119.92 32.73 5.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.726 1.61 . . . . 0.0 111.572 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.11 38.86 26.54 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.355 -1.466 . . . . 0.0 111.844 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.28 137.29 44.15 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.378 1.871 . . . . 0.0 108.724 -165.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.541 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 60.4 p-90 -106.25 166.48 10.49 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.62 1.168 . . . . 0.0 109.774 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.04 144.67 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 83.81 1.9 Allowed 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.351 1.061 . . . . 0.0 109.855 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.79 132.39 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 107.744 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -137.96 -12.92 1.45 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.82 -70.86 0.07 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 29.7 mttt -144.41 17.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.899 1.28 . . . . 0.0 111.225 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.0 t -143.56 128.34 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.96 131.34 34.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 158.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 99' ' ' LYS . 21.0 m -73.25 132.19 42.86 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 152.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.62 139.38 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 126.756 2.022 . . . . 0.0 107.656 171.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.21 164.69 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 163.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.583 HD11 HG21 ' A' ' 87' ' ' ILE . 6.9 pt -80.24 152.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 122.598 1.19 . . . . 0.0 109.168 167.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.1 p -77.32 166.07 23.64 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.519 1.128 . . . . 0.0 109.599 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -36.2 68.99 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.92 -33.24 61.93 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.644 -1.285 . . . . 0.0 112.381 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -67.87 -49.58 61.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.164 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.17 -27.11 68.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.512 1.051 . . . . 0.0 111.427 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -49.13 64.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.902 0.481 . . . . 0.0 109.867 -173.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -49.83 55.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.417 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -34.61 78.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.57 0.623 . . . . 0.0 110.169 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 -119.43 9.23 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.82 111.12 4.12 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.9 t -77.11 -168.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 152.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.595 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.6 p -176.75 -40.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -157.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -153.69 151.26 29.45 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.794 1.179 . . . . 0.0 110.832 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.748 HG22 HG23 ' A' ' 56' ' ' ILE . 84.5 t -134.13 133.59 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.66 137.32 32.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.361 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -136.28 149.18 67.14 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 124.319 1.048 . . . . 0.0 109.135 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HG2' HG21 ' A' ' 73' ' ' ILE . 37.0 Cg_endo -79.37 -174.02 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.821 3.014 . . . . 0.0 114.428 -172.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.46 162.03 20.07 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 119.837 -1.789 . . . . 0.0 112.928 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.27 16.13 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 126.997 2.119 . . . . 0.0 111.773 -171.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.75 10.26 0.79 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.764 2.126 . . . . 0.0 112.329 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.9 ttt85 -81.12 130.12 34.88 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.314 1.057 . . . . 0.0 108.678 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.8 151.23 37.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.609 HG11 HD11 ' A' ' 73' ' ' ILE . 15.8 m -143.25 165.77 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.768 1.227 . . . . 0.0 109.443 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -118.56 170.34 9.03 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.132 1.373 . . . . 0.0 107.599 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -62.82 15.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.36 86.62 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 166.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.54 128.58 25.47 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.96 1.704 . . . . 0.0 107.534 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 52' ' ' VAL . 26.8 t -72.01 38.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 127.56 2.344 . . . . 0.0 111.627 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.573 HG21 HG11 ' A' ' 47' ' ' VAL . 21.4 m -83.86 28.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 118.421 -2.674 . . . . 0.0 112.786 -170.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -167.72 66.54 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.41 1.004 . . . . 0.0 108.915 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.5 m -58.16 148.83 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.058 -1.026 . . . . 0.0 110.176 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.748 HG23 HG22 ' A' ' 38' ' ' VAL . 10.9 mt -122.37 109.03 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 124.37 34.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.569 ' HA ' HG12 ' A' ' 36' ' ' VAL . 80.4 p -102.47 -179.91 4.11 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.361 1.077 . . . . 0.0 109.532 171.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -48.32 -33.59 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.519 -1.673 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -148.19 5.67 0.75 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.92 170.41 9.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.627 1.558 . . . . 0.0 108.747 171.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.39 149.2 38.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 149.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.52 88.69 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -39.8 120.36 1.11 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 128.408 2.683 . . . . 0.0 107.999 161.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.43 136.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -113.39 98.73 7.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.416 0.686 . . . . 0.0 109.798 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -33.42 124.29 0.45 Allowed Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 124.765 1.29 . . . . 0.0 112.065 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.34 -23.96 11.19 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.653 1.568 . . . . 0.0 114.358 -157.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' O ' ' HE1' ' A' ' 100' ' ' MET . 4.2 mm? -141.36 156.98 45.77 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 127.505 2.322 . . . . 0.0 107.047 -174.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.6 m -74.23 138.43 43.68 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.316 1.417 . . . . 0.0 110.347 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.0 36.57 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.669 0.652 . . . . 0.0 111.803 -165.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -138.43 136.7 36.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.409 -1.054 . . . . 0.0 109.458 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.609 HD11 HG11 ' A' ' 47' ' ' VAL . 9.1 mm -65.3 146.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 108.941 176.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.39 4.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 110.909 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -162.25 151.1 15.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 41' ' ' PRO . 35.4 m -139.26 158.57 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.315 1.046 . . . . 0.0 108.46 175.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.72 76.78 1.41 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -57.91 -11.73 2.62 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.639 -0.663 . . . . 0.0 112.218 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -51.21 -31.55 20.87 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 111.699 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.5 HD12 HG21 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -80.16 -9.05 59.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.257 1.023 . . . . 0.0 110.514 -173.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.0 -30.41 70.52 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.41 1.084 . . . . 0.0 111.424 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.7 p -118.98 -20.36 8.14 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.732 0.813 . . . . 0.0 112.42 -171.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -136.85 67.14 56.99 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.759 2.023 . . . . 0.0 108.721 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.71 -26.17 60.94 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.345 2.697 . . . . 0.0 110.03 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.64 -15.66 53.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.332 1.053 . . . . 0.0 112.382 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -16.46 64.04 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.312 -1.493 . . . . 0.0 111.929 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 24' ' ' ILE . 37.7 mt -64.28 -28.89 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.978 0.808 . . . . 0.0 109.832 169.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -71.44 -55.19 8.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.083 -1.636 . . . . 0.0 108.972 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.01 -43.1 99.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.429 -169.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.33 87.14 2.95 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-O 119.178 -0.439 . . . . 0.0 110.234 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.1 -11.28 29.17 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.095 1.863 . . . . 0.0 112.737 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -125.98 8.42 7.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.407 1.483 . . . . 0.0 112.201 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -124.19 -71.15 0.22 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 124.397 0.998 . . . . 0.0 111.474 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.2 -25.36 7.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.341 1.056 . . . . 0.0 110.611 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.03 35.59 1.47 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.057 1.789 . . . . 0.0 112.865 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -64.98 159.29 23.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.214 1.507 . . . . 0.0 108.626 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 mt -99.32 -66.91 0.87 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -146.27 171.98 14.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.202 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 18.2 mttt -135.14 145.62 48.0 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 124.323 1.049 . . . . 0.0 109.392 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.484 ' HB3' HD13 ' A' ' 73' ' ' ILE . 1.6 ptm -149.07 140.11 22.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.029 -172.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 18' ' ' LYS . 33.0 tt0 -62.78 143.89 57.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.492 1.117 . . . . 0.0 109.412 172.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.9 pt -90.4 109.03 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 123.928 0.767 . . . . 0.0 109.139 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -67.38 -35.55 79.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.166 0.439 . . . . 0.0 110.558 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -135.42 70.73 1.43 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -156.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.536 ' HA ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -57.65 -17.62 15.75 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 172.651 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.46 -21.95 74.04 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.696 1.589 . . . . 0.0 113.294 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -72.43 -12.75 61.24 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 119.235 1.517 . . . . 0.0 111.338 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.536 HD13 ' HA ' ' A' ' 105' ' ' GLU . 0.6 OUTLIER -56.09 -36.13 67.79 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.881 173.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.23 -7.83 49.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.097 0.862 . . . . 0.0 112.34 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.96 -19.06 41.41 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.705 1.202 . . . . 0.0 109.983 172.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.95 161.32 23.1 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 123.32 1.534 . . . . 0.0 109.87 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.91 140.69 43.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.941 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.24 167.72 2.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 163.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.24 -47.02 78.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.544 1.537 . . . . 0.0 110.777 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -61.91 -50.8 70.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.84 -32.16 72.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.144 0.578 . . . . 0.0 110.2 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.73 -44.93 96.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.978 0.911 . . . . 0.0 111.26 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.32 -46.8 72.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.61 0.641 . . . . 0.0 109.992 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 CA--C 1.535 0.379 0 C-N-CA 124.747 1.219 . . . . 0.0 111.141 175.47 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 tpp . . . . . 0 C--O 1.23 0.079 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -133.98 69.96 1.46 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.866 0.841 . . . . 0.0 109.204 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -80.87 175.59 10.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.895 171.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -137.57 169.08 18.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.741 2.417 . . . . 0.0 108.921 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -107.36 174.03 6.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.425 1.49 . . . . 0.0 108.955 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -77.22 -32.37 55.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.804 174.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -88.94 29.21 1.06 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.323 1.849 . . . . 0.0 113.229 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.02 41.89 3.49 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.224 -1.548 . . . . 0.0 112.59 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -124.8 150.29 46.5 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.445 1.098 . . . . 0.0 109.794 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.473 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 67.4 p-90 -105.08 172.54 6.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.863 0.839 . . . . 0.0 111.114 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.09 152.74 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.651 1.58 . . . . 0.0 107.071 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.29 81.47 1.71 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.649 1.179 . . . . 0.0 109.748 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 mp -65.99 150.07 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.662 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 3.4 pt-20 -142.71 -65.5 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.333 1.453 . . . . 0.0 108.797 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 13.3 t70 -126.52 -77.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.118 2.567 . . . . 0.0 108.222 -170.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.75 9.78 2.41 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 128.16 2.584 . . . . 0.0 110.963 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.63 155.68 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.755 1.622 . . . . 0.0 107.051 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.67 139.57 53.74 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 125.343 1.457 . . . . 0.0 108.294 165.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.1 m -83.97 143.57 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 t -122.11 143.03 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.54 2.336 . . . . 0.0 109.911 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.58 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -154.44 174.22 32.84 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 158.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 pt -74.2 165.12 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 117.837 0.819 . . . . 0.0 108.838 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -90.06 173.28 8.28 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.001 -1.062 . . . . 0.0 113.234 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.417 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -74.36 9.39 1.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 175.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -100.72 0.21 38.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.038 2.135 . . . . 0.0 112.624 167.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.43 -58.62 1.9 Allowed 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.571 -1.331 . . . . 0.0 110.573 -163.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.417 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -41.46 -42.17 2.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.72 2.808 . . . . 0.0 111.997 166.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.63 -52.99 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.394 3.078 . . . . 0.0 110.223 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -72.32 -35.47 68.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.719 -0.613 . . . . 0.0 111.453 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -65.13 -48.34 73.92 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.586 1.154 . . . . 0.0 110.162 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.79 -158.63 41.14 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.96 128.42 15.92 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.806 2.043 . . . . 0.0 109.147 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.595 HG22 ' H ' ' A' ' 36' ' ' VAL 0.446 6.0 p -123.89 154.88 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.595 ' H ' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -153.43 -31.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.632 -142.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -146.95 150.5 35.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.636 0.653 . . . . 0.0 111.843 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.27 133.02 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.514 1.15 . . . . 0.0 109.902 168.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.02 145.7 51.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.452 170.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.521 HD11 HD12 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -130.77 151.87 79.56 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 163.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.43 176.14 8.25 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.197 2.598 . . . . 0.0 111.702 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.16 141.88 35.28 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.41 22.06 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 129.024 2.929 . . . . 0.0 115.173 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.37 6.84 0.7 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.091 1.329 . . . . 0.0 113.308 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -79.84 141.86 35.8 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.829 1.815 . . . . 0.0 110.116 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -79.42 149.38 31.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.014 0.825 . . . . 0.0 109.098 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.0 171.0 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 110.062 -176.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -116.15 166.01 12.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.227 1.411 . . . . 0.0 110.537 174.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -64.82 14.82 0.02 OUTLIER 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.063 2.145 . . . . 0.0 116.131 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.66 67.07 0.23 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 173.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -134.13 128.07 33.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -175.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 52' ' ' VAL . 24.8 t -87.84 53.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 127.46 2.304 . . . . 0.0 110.042 -161.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -86.52 9.01 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 120.014 -1.679 . . . . 0.0 113.631 -158.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.35 50.26 0.28 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.879 0.872 . . . . 0.0 110.221 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 148.72 20.46 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.631 -0.668 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 mt -117.92 135.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.11 117.11 29.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.979 1.312 . . . . 0.0 107.925 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -99.18 -165.89 1.29 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.756 0.707 . . . . 0.0 110.679 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -46.75 -38.91 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.731 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.84 55.81 0.2 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.454 1.479 . . . . 0.0 111.559 155.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.79 167.8 16.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.512 -0.742 . . . . 0.0 109.961 165.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.2 151.45 39.11 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 152.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -131.39 112.9 13.13 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.964 1.706 . . . . 0.0 106.585 160.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -70.78 107.98 4.24 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 170.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -76.0 111.04 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -86.22 116.51 24.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.42 135.15 5.73 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.107 0.963 . . . . 0.0 110.078 169.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.55 -32.38 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.116 1.877 . . . . 0.0 113.845 -161.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.08 166.69 19.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.555 2.342 . . . . 0.0 106.397 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 m -81.46 134.39 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -171.94 44.9 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 120.759 -1.213 . . . . 0.0 111.132 -166.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -121.63 132.61 54.76 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 117.655 -1.164 . . . . 0.0 109.647 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -60.95 140.18 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -147.35 1.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.802 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -148.62 160.65 42.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.685 1.584 . . . . 0.0 109.066 162.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.7 155.69 14.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.369 1.468 . . . . 0.0 108.438 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -108.02 70.96 0.78 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.45 -15.16 15.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 112.477 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -53.28 -29.89 35.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 116.855 -1.545 . . . . 0.0 112.991 166.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 40' ' ' LEU . 76.3 mt -57.01 -14.7 3.9 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 121.186 1.812 . . . . 0.0 113.269 174.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.2 1.818 . . . . 0.0 112.903 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.0 p -124.13 -27.15 3.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.094 1.358 . . . . 0.0 110.858 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.34 64.21 14.19 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 128.042 2.537 . . . . 0.0 110.11 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -73.72 -52.08 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.728 2.952 . . . . 0.0 109.858 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -53.64 -17.63 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.179 1.791 . . . . 0.0 110.524 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -30.48 34.96 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.454 1.934 . . . . 0.0 111.518 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -58.6 -25.69 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 121.825 -0.547 . . . . 0.0 110.047 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -64.83 -53.51 45.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.444 -2.035 . . . . 0.0 110.814 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -49.31 70.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.777 . . . . 0.0 110.342 -164.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -148.73 79.62 8.56 Favored Pre-proline 0 N--CA 1.451 -0.393 0 O-C-N 123.899 0.75 . . . . 0.0 110.151 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.57 -17.44 59.97 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.802 1.668 . . . . 0.0 112.444 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.473 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 3.6 mp0 -114.75 14.4 17.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.264 0.626 . . . . 0.0 112.592 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.34 -89.95 0.28 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.81 -32.25 35.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 122.94 0.496 . . . . 0.0 111.899 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.41 36.34 2.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.245 0.926 . . . . 0.0 112.698 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -66.42 169.33 7.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.025 1.412 . . . . 0.0 109.452 166.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.58 HD12 ' HA2' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -119.88 -59.76 1.77 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.72 168.31 20.49 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.711 -1.243 . . . . 0.0 111.023 -171.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -125.72 155.32 41.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.288 1.035 . . . . 0.0 108.47 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -146.46 143.99 29.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.215 0.606 . . . . 0.0 110.727 -177.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.9 139.04 58.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.651 1.18 . . . . 0.0 108.025 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 pt -88.21 104.72 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 122.578 0.351 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -33.99 70.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.85 0.46 . . . . 0.0 110.391 171.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -147.36 103.39 3.56 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 125.931 1.692 . . . . 0.0 107.216 -171.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.538 ' HA ' HD13 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -71.46 -1.95 14.98 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.807 1.243 . . . . 0.0 109.712 160.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.1 -64.46 4.32 Favored Glycine 0 C--N 1.338 0.653 0 O-C-N 120.789 -1.194 . . . . 0.0 111.959 168.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -71.4 -10.04 59.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -164.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 105' ' ' GLU . 1.1 mp -46.48 -48.33 19.14 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.29 1.436 . . . . 0.0 110.455 163.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -75.82 -15.24 60.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.668 0.667 . . . . 0.0 111.024 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -86.66 -18.01 32.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.121 1.368 . . . . 0.0 110.943 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mt -80.32 -178.78 6.79 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.233 2.213 . . . . 0.0 110.975 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.3 mt -87.78 121.05 29.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.165 0.986 . . . . 0.0 110.249 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.99 166.8 15.07 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.112 0.965 . . . . 0.0 110.786 163.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.57 -57.72 4.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.184 1.794 . . . . 0.0 112.091 -160.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -50.21 -46.61 54.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.512 1.525 . . . . 0.0 110.01 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.58 -25.21 41.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.943 1.297 . . . . 0.0 111.901 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.91 -40.6 91.64 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 127.778 2.431 . . . . 0.0 109.844 167.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.42 -52.2 59.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 125.083 1.353 . . . . 0.0 111.066 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -142.78 114.82 8.27 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.519 1.128 . . . . 0.0 111.453 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -113.0 179.77 3.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.82 161.56 37.26 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.367 1.867 . . . . 0.0 110.194 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -125.62 173.38 9.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.437 1.113 . . . . 0.0 110.182 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -89.91 17.01 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.898 1.679 . . . . 0.0 110.849 -169.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.438 HG21 ' HB2' ' A' ' 66' ' ' TYR . 15.1 t -135.53 57.72 1.78 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.5 p80 44.42 52.77 7.27 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.807 1.643 . . . . 0.0 112.984 172.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -128.99 149.96 50.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.425 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 54.5 p-90 -121.35 162.53 20.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.648 1.579 . . . . 0.0 110.19 170.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.494 HG12 ' HB1' ' A' ' 20' ' ' ALA . 1.8 t -141.77 126.15 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.477 1.511 . . . . 0.0 107.995 -166.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.43 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.4 m -117.01 75.47 0.97 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.7 2.4 . . . . 0.0 110.004 -170.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.9 mp -74.0 97.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.108 1.363 . . . . 0.0 108.485 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.05 -56.02 3.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 118.112 -0.946 . . . . 0.0 111.541 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.16 -76.15 0.45 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.41 0.55 . . . . 0.0 110.173 -166.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -125.52 2.95 7.64 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.834 1.254 . . . . 0.0 111.086 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.25 143.14 41.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.494 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -117.62 109.05 16.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.174 1.789 . . . . 0.0 108.971 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 41.0 m -68.76 143.75 54.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.5 OUTLIER -115.32 152.44 16.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 127.647 2.379 . . . . 0.0 112.512 176.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.18 161.09 32.25 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 160.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.588 HD11 HG21 ' A' ' 87' ' ' ILE . 7.1 pt -73.52 149.23 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.072 -1.252 . . . . 0.0 108.506 170.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 p -76.41 170.35 16.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.967 0.889 . . . . 0.0 111.657 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -62.63 -33.66 75.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.885 -1.134 . . . . 0.0 112.794 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -58.92 -25.7 63.69 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.264 -0.898 . . . . 0.0 112.056 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.27 -47.63 41.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.386 -0.822 . . . . 0.0 111.211 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -64.42 -27.79 69.24 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.837 -0.539 . . . . 0.0 110.56 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -63.43 -28.4 69.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.701 1.2 . . . . 0.0 111.47 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.75 -54.67 4.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.843 0.857 . . . . 0.0 111.959 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.81 -43.7 98.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.371 0.532 . . . . 0.0 110.118 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.52 -114.17 4.55 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.57 96.08 0.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.686 1.594 . . . . 0.0 109.057 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.749 HG12 ' H ' ' A' ' 36' ' ' VAL . 3.4 t -78.62 -178.77 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 162.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.749 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.8 p -169.2 -33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 126.431 1.892 . . . . 0.0 108.487 -146.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.431 ' H ' HG12 ' A' ' 35' ' ' VAL . 40.3 t80 -166.44 157.61 12.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.222 0.951 . . . . 0.0 111.008 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -138.15 146.93 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.86 148.11 22.71 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.176 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -137.72 142.98 38.52 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 123.897 0.879 . . . . 0.0 111.161 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.37 175.44 10.75 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.029 2.486 . . . . 0.0 111.077 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -87.85 147.67 25.01 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.348 0.659 . . . . 0.0 110.107 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.77 16.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 129.816 3.246 . . . . 0.0 116.436 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.72 6.32 0.87 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.655 1.598 . . . . 0.0 113.222 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -76.55 135.97 39.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.878 1.339 . . . . 0.0 110.487 -171.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -78.11 143.04 37.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.344 1.429 . . . . 0.0 108.902 167.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.07 -177.08 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.795 1.238 . . . . 0.0 108.645 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -131.55 160.75 34.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.062 1.345 . . . . 0.0 108.547 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 10.28 0.23 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.64 102.61 0.21 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 105.472 -3.051 . . . . 0.0 105.472 160.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.88 131.71 14.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.992 1.717 . . . . 0.0 107.097 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.628 HG13 ' HB3' ' A' ' 64' ' ' ASP . 55.1 t -69.92 16.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.805 2.042 . . . . 0.0 114.33 -169.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.38 -0.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 119.317 -2.114 . . . . 0.0 115.528 -163.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -142.51 60.08 1.44 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.677 1.126 . . . . 0.0 108.375 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 m -56.74 163.04 2.03 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.597 1.189 . . . . 0.0 111.346 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.8 mt -132.85 144.77 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 35' ' ' VAL . 16.4 mt-10 -122.27 165.86 15.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -139.62 -177.49 4.98 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.9 m -51.45 -23.83 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 125.504 1.522 . . . . 0.0 112.118 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.53 13.58 0.23 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.39 168.78 19.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.79 1.632 . . . . 0.0 110.04 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.78 164.94 27.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.205 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.65 118.44 5.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.77 1.228 . . . . 0.0 110.031 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.628 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -67.86 117.21 9.45 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 167.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.59 121.63 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.535 1.516 . . . . 0.0 106.976 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.438 ' HB2' HG21 ' A' ' 9' ' ' THR . 38.4 m-85 -88.98 111.16 21.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.692 0.678 . . . . 0.0 109.533 171.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.32 156.64 0.23 Allowed Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 128.078 2.551 . . . . 0.0 114.528 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -96.62 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 116.157 1.56 . . . . 0.0 116.157 -163.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' CD2' HG11 ' A' ' 13' ' ' VAL . 3.5 mm? -136.41 169.73 17.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.577 1.551 . . . . 0.0 107.606 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 m -101.26 65.56 1.07 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.839 1.256 . . . . 0.0 111.761 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.63 -165.84 12.54 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.199 1.857 . . . . 0.0 111.774 -164.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -119.17 123.69 44.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 118.1 0.95 . . . . 0.0 110.81 -176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.437 HD12 ' CD1' ' A' ' 98' ' ' PHE . 20.7 mm -59.77 142.01 15.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.3 m -146.75 -5.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.43 163.68 39.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.658 1.117 . . . . 0.0 108.792 169.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 m -149.83 144.18 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -95.12 81.2 3.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.76 1.618 . . . . 0.0 108.846 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.78 -11.52 27.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -26.79 65.91 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.375 1.07 . . . . 0.0 111.812 169.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -8.69 58.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.535 1.061 . . . . 0.0 109.941 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -80.09 -4.87 54.62 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 112.269 170.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -137.75 -25.07 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.595 0.758 . . . . 0.0 112.589 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.81 67.44 42.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.905 2.082 . . . . 0.0 109.512 168.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.81 -20.15 58.72 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.203 2.602 . . . . 0.0 111.186 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.97 -16.12 48.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.911 -1.042 . . . . 0.0 111.935 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 86' ' ' LEU . 5.3 mt -60.88 -20.63 62.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.972 1.715 . . . . 0.0 113.414 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.588 HG21 HD11 ' A' ' 24' ' ' ILE . 15.3 mt -59.71 -32.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -66.13 -47.46 74.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 122.654 1.216 . . . . 0.0 110.123 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -69.65 -47.37 63.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.604 -1.635 . . . . 0.0 111.425 -165.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.32 83.17 4.18 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 172.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -62.89 -20.64 71.89 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.179 1.253 . . . . 0.0 111.135 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 1.2 mt-10 -112.65 21.53 15.49 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.818 1.247 . . . . 0.0 111.58 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.92 -101.87 0.97 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -86.62 -20.86 27.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.5 0.72 . . . . 0.0 111.308 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.52 37.05 2.03 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-N 120.001 1.273 . . . . 0.0 113.658 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -68.62 157.5 36.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.83 1.252 . . . . 0.0 110.242 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.66 -67.36 0.87 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-O 116.904 -1.522 . . . . 0.0 108.486 176.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.522 ' O ' HG13 ' A' ' 22' ' ' VAL . 53.1 p90 -133.49 -176.94 4.32 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.191 2.269 . . . . 0.0 111.762 -175.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -136.87 141.58 42.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -141.71 138.32 32.31 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.278 0.631 . . . . 0.0 109.494 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -62.51 126.11 26.23 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.695 1.998 . . . . 0.0 106.243 168.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.9 pt -75.78 135.81 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.7 m -117.26 -11.12 10.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.017 1.727 . . . . 0.0 113.421 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -145.23 81.37 1.63 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -6.33 44.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.517 -1.364 . . . . 0.0 112.365 -177.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.51 66.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.02 -7.02 14.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.83 -42.1 98.62 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.209 0.913 . . . . 0.0 109.023 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -71.86 -0.2 10.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.398 0.679 . . . . 0.0 111.32 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -85.69 -19.15 31.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.87 0.759 . . . . 0.0 111.497 168.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.41 174.59 8.43 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.174 1.79 . . . . 0.0 111.413 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.46 142.97 38.89 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.418 1.087 . . . . 0.0 110.158 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -59.81 170.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 109.086 158.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -68.47 -51.36 44.37 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.046 -1.033 . . . . 0.0 110.187 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.37 -47.8 84.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.533 ' H ' ' HB2' ' A' ' 113' ' ' ASP . . . -63.96 -30.31 71.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.68 0.673 . . . . 0.0 112.09 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -67.29 -40.94 86.16 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.402 0.547 . . . . 0.0 110.956 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.64 -53.07 60.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.244 169.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 120.176 1.353 . . . . 0.0 109.948 -172.211 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ttp . . . . . 0 C--O 1.23 0.051 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -140.71 100.24 3.8 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 113' ' ' ASP . 0.3 OUTLIER -101.76 179.3 4.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -143.54 174.98 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.686 1.594 . . . . 0.0 108.669 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.455 HG22 HD22 ' A' ' 111' ' ' LEU . 54.8 p -133.82 -165.14 1.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.129 0.966 . . . . 0.0 112.624 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -30.96 42.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.631 2.372 . . . . 0.0 111.135 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.13 30.21 0.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.249 -0.907 . . . . 0.0 111.502 -167.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 p80 45.33 27.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.121 1.769 . . . . 0.0 115.026 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.9 mt-10 -82.8 165.34 19.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.744 3.218 . . . . 0.0 112.628 160.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 61.2 p-90 -124.46 170.09 11.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.218 2.207 . . . . 0.0 109.014 163.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.12 142.39 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.59 88.33 2.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.479 1.112 . . . . 0.0 109.738 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.88 89.48 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -175.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -69.88 0.31 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.28 -98.32 0.39 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -122.23 11.01 10.06 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.235 1.414 . . . . 0.0 110.79 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.72 119.71 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.4 124.53 36.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 m -76.63 128.44 34.71 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 162.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.57 134.81 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 108.016 167.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.665 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -147.12 172.01 27.67 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 162.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HG21 ' A' ' 87' ' ' ILE . 6.1 pt -88.6 148.92 4.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 118.586 1.193 . . . . 0.0 109.367 169.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.1 p -77.04 169.6 18.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.062 0.945 . . . . 0.0 110.954 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.85 63.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.169 0.988 . . . . 0.0 111.883 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -59.33 -18.5 38.63 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.356 -0.84 . . . . 0.0 113.149 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -84.33 -51.0 7.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.997 -1.065 . . . . 0.0 111.189 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -60.89 -21.48 63.36 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.668 0.667 . . . . 0.0 111.574 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.13 -16.12 40.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.866 2.066 . . . . 0.0 113.731 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -112.22 -51.3 2.85 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.737 0.699 . . . . 0.0 110.022 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mt -65.01 -36.32 84.03 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.59 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.88 -125.45 27.87 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 125.339 1.447 . . . . 0.0 110.002 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.69 113.13 3.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -87.63 -164.0 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.693 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.2 p -173.19 -38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.22 1.808 . . . . 0.0 107.124 -153.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.473 ' H ' HG12 ' A' ' 35' ' ' VAL . 68.5 t80 -154.21 152.55 30.49 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 123.561 0.538 . . . . 0.0 111.524 -176.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.812 HG22 HG23 ' A' ' 56' ' ' ILE . 71.6 t -139.17 128.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -72.63 134.72 45.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.921 166.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.7 mt -128.88 138.7 33.73 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.08 179.18 6.01 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.387 2.725 . . . . 0.0 113.772 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.48 166.78 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.137 0.975 . . . . 0.0 110.119 169.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.62 21.38 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 124.484 2.088 . . . . 0.0 112.786 -162.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.57 10.86 0.52 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 129.269 3.318 . . . . 0.0 111.315 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -76.95 132.45 39.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.085 -1.244 . . . . 0.0 108.238 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -86.35 145.24 26.97 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 53' ' ' VAL . 30.7 m -131.67 164.22 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.563 1.545 . . . . 0.0 110.061 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' H ' ' HB2' ' A' ' 51' ' ' GLU . 59.3 mtmt -116.56 170.19 8.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.116 1.766 . . . . 0.0 108.401 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.72 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.023 2.929 . . . . 0.0 117.96 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.54 35.8 0.43 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.512 165.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -86.04 115.71 23.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.949 1.874 . . . . 0.0 109.683 -173.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' VAL 0.416 0.2 OUTLIER -63.43 25.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 129.962 3.305 . . . . 0.0 115.609 -175.703 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 47' ' ' VAL . 27.6 m -68.92 13.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 118.573 -2.58 . . . . 0.0 116.133 -169.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.36 43.93 0.61 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 120.517 1.508 . . . . 0.0 111.163 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -46.82 145.07 2.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.875 1.27 . . . . 0.0 112.223 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.812 HG23 HG22 ' A' ' 38' ' ' VAL . 7.3 mt -126.98 104.9 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -173.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.88 131.96 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -104.91 -173.7 2.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.893 0.877 . . . . 0.0 109.936 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 m -47.87 -27.82 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.62 15.45 0.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.54 -179.28 5.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.561 1.528 . . . . 0.0 110.504 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.11 137.61 27.64 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.53 107.38 7.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.882 1.673 . . . . 0.0 108.683 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB3' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -55.64 144.0 28.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.716 1.206 . . . . 0.0 107.946 170.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 97' ' ' LEU . 54.1 t -116.42 113.27 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -106.01 99.06 8.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.277 1.031 . . . . 0.0 110.297 -166.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.76 134.69 2.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 O-C-N 124.58 1.175 . . . . 0.0 111.718 -164.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.1 -24.85 16.69 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.365 1.376 . . . . 0.0 113.409 -165.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 108' ' ' LEU . 1.1 mp -142.58 166.86 23.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.193 1.397 . . . . 0.0 108.935 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -89.3 122.9 33.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.723 1.209 . . . . 0.0 108.262 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.15 -161.37 24.03 Favored Glycine 0 C--O 1.235 0.193 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -172.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -132.93 130.3 39.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.298 1.049 . . . . 0.0 109.686 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.514 HD12 ' CD1' ' A' ' 98' ' ' PHE . 8.9 mm -58.39 151.72 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 108.165 175.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -167.29 -14.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.192 -165.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -146.13 153.57 40.82 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 168.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.92 138.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.418 ' HB2' ' CD2' ' A' ' 96' ' ' TRP . 61.4 t30 -87.16 89.52 8.02 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.99 -9.24 9.26 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.708 0.803 . . . . 0.0 111.745 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -62.4 -45.28 93.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.024 1.33 . . . . 0.0 108.825 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.32 -14.6 63.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 120.249 1.386 . . . . 0.0 114.141 -170.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -62.17 -30.67 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.421 1.088 . . . . 0.0 111.529 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.8 p -134.38 -7.96 2.56 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.38 70.46 81.86 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.423 1.089 . . . . 0.0 108.238 159.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HB3' HG23 ' A' ' 38' ' ' VAL . 9.3 Cg_endo -63.15 -16.11 52.33 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.546 2.83 . . . . 0.0 110.086 169.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 -19.75 64.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 118.018 -0.992 . . . . 0.0 112.065 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.4 mt -65.4 -17.17 64.33 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 121.025 1.739 . . . . 0.0 112.787 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.509 HG21 HD11 ' A' ' 24' ' ' ILE . 2.8 mt -64.52 -29.13 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 118.801 -0.619 . . . . 0.0 110.724 169.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -70.29 -53.87 15.03 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 120.814 1.643 . . . . 0.0 109.779 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.427 ' HB2' HD23 ' A' ' 86' ' ' LEU . 1.2 mmtp -60.63 -43.49 97.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.825 1.65 . . . . 0.0 112.063 -171.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.91 74.75 5.04 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 124.39 1.076 . . . . 0.0 108.269 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -55.29 -29.64 68.33 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.822 1.681 . . . . 0.0 111.734 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 7.6 mp0 -104.62 3.43 31.68 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.358 1.463 . . . . 0.0 112.769 -169.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.89 -86.56 0.57 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -172.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.49 -7.48 38.0 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.751 -0.852 . . . . 0.0 111.848 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.66 25.53 18.42 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.416 1.484 . . . . 0.0 112.344 172.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.418 ' CD2' ' HB2' ' A' ' 77' ' ' ASN . 16.8 p-90 -60.98 159.54 11.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.595 1.198 . . . . 0.0 109.229 166.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.671 HD13 HG11 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -105.63 -54.07 2.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 109.681 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.514 ' CD1' HD12 ' A' ' 73' ' ' ILE . 41.3 p90 -148.43 168.15 23.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -128.3 151.5 49.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.6 ptm -143.48 145.86 32.94 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.069 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.52 128.76 37.3 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 160.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt -81.44 136.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.61 -21.56 14.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.76 1.224 . . . . 0.0 111.349 167.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -138.08 64.35 1.51 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.904 1.335 . . . . 0.0 111.595 -171.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -5.48 0.07 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.486 1.915 . . . . 0.0 112.846 160.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.87 -25.94 18.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.685 1.612 . . . . 0.0 112.065 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.76 -5.54 46.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.614 1.707 . . . . 0.0 111.122 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.442 HD23 HD21 ' A' ' 69' ' ' LEU . 74.8 mt -54.09 -21.87 9.57 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.528 0.731 . . . . 0.0 111.261 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.063 1.345 . . . . 0.0 113.188 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.95 -24.31 35.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.284 1.434 . . . . 0.0 110.423 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 HD22 HG22 ' A' ' 7' ' ' THR . 9.5 mt -85.1 156.18 21.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.363 1.078 . . . . 0.0 108.577 -175.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.49 ' H ' HD22 ' A' ' 112' ' ' LEU . 0.8 OUTLIER -75.75 134.6 40.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -176.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.414 ' HA ' ' HE2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -62.17 179.06 0.32 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 123.442 1.592 . . . . 0.0 110.386 155.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -73.35 -39.89 64.83 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.291 -168.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -67.16 -49.19 65.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.84 69.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.021 1.728 . . . . 0.0 111.421 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -61.83 -38.12 86.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.271 1.028 . . . . 0.0 112.692 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.46 ' HA ' HE21 ' A' ' 118' ' ' GLN . 0.0 OUTLIER -73.59 -46.16 48.81 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 125.105 1.362 . . . . 0.0 111.265 177.145 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 C--O 1.238 0.467 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.04 95.76 4.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -170.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.499 ' CE ' HD23 ' A' ' 108' ' ' LEU . 1.8 mppt? -75.49 179.93 4.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 110.399 165.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -142.23 178.5 7.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.25 1.42 . . . . 0.0 110.898 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 p -135.89 174.61 10.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.959 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -75.32 -35.23 61.25 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.88 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.25 51.71 2.03 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.77 1.623 . . . . 0.0 108.816 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 p80 42.85 52.28 5.13 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.8 -1.187 . . . . 0.0 113.423 165.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.8 mt-10 -114.21 154.37 27.99 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.337 1.455 . . . . 0.0 108.06 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 54.7 p-90 -108.11 162.41 14.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 157.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 69' ' ' LEU . 1.5 t -124.88 164.08 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -149.47 77.02 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.818 1.19 . . . . 0.0 109.508 -177.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.47 HG13 ' HB2' ' A' ' 20' ' ' ALA . 9.6 mt -72.37 93.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -71.56 -64.51 0.91 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.95 -86.49 0.42 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.159 0.584 . . . . 0.0 109.809 -169.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -119.47 -2.0 10.62 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.0 2.12 . . . . 0.0 110.073 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -116.25 141.58 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -102.25 161.7 13.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 162.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 16.3 m -111.19 148.91 31.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 163.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -112.92 145.83 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.1 3.36 . . . . 0.0 113.134 169.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.49 169.44 34.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 107.271 -2.331 . . . . 0.0 107.271 155.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.737 HD11 HG21 ' A' ' 87' ' ' ILE . 41.7 pt -81.69 157.16 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 O-C-N 121.837 -0.802 . . . . 0.0 109.829 170.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -78.16 166.4 22.8 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.219 0.533 . . . . 0.0 110.428 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -25.66 68.2 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.018 -1.051 . . . . 0.0 111.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -49.37 -47.88 47.27 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.807 -1.183 . . . . 0.0 110.537 165.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.526 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -67.65 -42.93 81.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.445 -1.409 . . . . 0.0 112.393 -170.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -62.43 -23.58 66.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.752 0.251 . . . . 0.0 111.084 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.58 -24.19 67.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.248 2.219 . . . . 0.0 112.035 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -98.37 -41.06 8.0 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.349 -0.844 . . . . 0.0 111.878 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.81 -27.55 28.71 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.753 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.59 -133.64 38.28 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 119.24 0.927 . . . . 0.0 111.28 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -62.4 117.43 6.14 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.6 t -87.39 -171.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.678 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.4 m -153.92 -35.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 130.485 3.514 . . . . 0.0 108.495 -169.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -155.85 156.61 35.0 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.231 0.469 . . . . 0.0 111.191 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.34 136.79 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.98 144.71 25.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.354 2.262 . . . . 0.0 108.451 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -138.77 154.48 73.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.784 0.834 . . . . 0.0 109.262 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -72.72 -171.23 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.154 2.569 . . . . 0.0 112.647 174.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -107.03 158.26 17.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.77 1.628 . . . . 0.0 110.685 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.52 9.42 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 126.946 2.099 . . . . 0.0 115.238 -165.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.25 11.68 1.81 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.028 1.775 . . . . 0.0 111.917 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -69.35 125.35 26.44 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.334 1.567 . . . . 0.0 108.957 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -76.15 145.6 39.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.7 m -142.39 163.12 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.014 1.326 . . . . 0.0 109.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -111.67 169.29 8.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.573 0.349 . . . . 0.0 110.858 168.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 49' ' ' LYS . 14.9 ttpt -57.55 17.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 1 C-N-CA 131.834 4.053 . . . . 0.0 114.944 178.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.35 23.76 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 120.045 -1.659 . . . . 0.0 114.856 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.63 143.86 32.2 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.254 2.027 . . . . 0.0 111.923 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 64' ' ' ASP . 52.3 t -77.65 38.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 129.241 3.016 . . . . 0.0 112.852 -168.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.59 4.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 118.472 -2.643 . . . . 0.0 115.048 -166.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.3 54.82 0.86 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.633 1.106 . . . . 0.0 111.542 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -61.85 165.48 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.194 0.997 . . . . 0.0 112.838 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.66 100.55 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.03 125.89 32.52 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.4 p -103.83 -174.8 2.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.213 1.405 . . . . 0.0 109.853 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 m -50.82 -32.09 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.142 1.377 . . . . 0.0 113.015 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.72 37.7 0.27 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 120.506 1.503 . . . . 0.0 113.289 168.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.03 170.58 19.02 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.44 -1.412 . . . . 0.0 109.832 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.46 122.4 24.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.596 1.558 . . . . 0.0 107.832 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.75 143.49 26.24 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 160.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.561 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -102.58 117.19 34.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.105 -2.924 . . . . 0.0 103.105 167.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.36 119.6 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 169.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.36 97.95 7.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.125 0.875 . . . . 0.0 109.624 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.09 0.46 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.664 1.985 . . . . 0.0 115.198 -157.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.06 -32.57 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 N-CA-C 114.593 0.959 . . . . 0.0 114.593 -159.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 13' ' ' VAL . 4.5 mm? -127.58 170.21 12.89 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.293 2.237 . . . . 0.0 104.975 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -86.03 157.56 20.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 157.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.47 -165.7 31.49 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 120.006 -1.684 . . . . 0.0 111.091 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -130.83 125.7 34.35 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.463 HD12 ' CD2' ' A' ' 98' ' ' PHE . 6.8 mm -63.29 140.07 20.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.1 m -149.63 6.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.858 0.863 . . . . 0.0 111.231 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -159.79 153.91 23.42 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 166.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.86 174.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.226 1.81 . . . . 0.0 108.25 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -118.37 84.06 2.11 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.706 0.685 . . . . 0.0 109.683 -172.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.9 -15.54 9.0 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.093 0.957 . . . . 0.0 112.123 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -54.52 -38.68 66.83 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.755 1.622 . . . . 0.0 111.105 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.866 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -68.96 -18.87 64.14 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.613 -0.679 . . . . 0.0 111.412 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 p -127.6 -16.44 4.79 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -129.59 71.62 82.07 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.182 1.793 . . . . 0.0 107.415 165.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -67.53 -22.75 44.27 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.219 1.946 . . . . 0.0 109.746 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.7 -9.75 58.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.087 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -17.87 63.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 122.5 2.409 . . . . 0.0 111.779 -177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.737 HG21 HD11 ' A' ' 24' ' ' ILE . 16.5 mt -60.68 -30.52 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.115 0.966 . . . . 0.0 109.654 171.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -69.47 -47.98 62.22 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 120.851 -1.156 . . . . 0.0 109.18 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -29.92 30.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.463 -160.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -160.06 65.06 2.4 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 120.414 1.461 . . . . 0.0 110.601 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.06 -19.6 49.54 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.9 2.4 . . . . 0.0 114.547 -167.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.2 mp0 -115.23 -1.57 12.91 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.849 0.86 . . . . 0.0 112.405 -173.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.64 -84.53 1.67 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -98.55 -26.64 14.35 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.557 1.143 . . . . 0.0 111.956 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.98 40.28 2.65 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.058 0.845 . . . . 0.0 111.594 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -73.78 164.92 26.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.652 1.581 . . . . 0.0 110.448 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.26 -66.5 1.0 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-O 116.468 -1.73 . . . . 0.0 108.845 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.494 ' O ' HG13 ' A' ' 22' ' ' VAL . 48.0 p90 -138.04 -177.62 4.9 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.016 -2.273 . . . . 0.0 112.703 -176.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -134.1 154.08 51.41 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 124.123 0.969 . . . . 0.0 109.321 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.72 138.72 21.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.246 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -58.66 126.63 28.41 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 162.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 pt -82.25 96.15 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 172.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -66.42 -29.69 69.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.021 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.81 79.84 1.64 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.931 1.348 . . . . 0.0 109.998 -167.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.746 ' HA ' ' CD1' ' A' ' 108' ' ' LEU 0.293 0.0 OUTLIER -81.44 26.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 124.582 2.134 . . . . 0.0 111.504 173.9 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.03 -22.07 31.31 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.511 -1.222 . . . . 0.0 114.052 155.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -76.32 -6.96 53.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.181 1.491 . . . . 0.0 112.678 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.746 ' CD1' ' HA ' ' A' ' 105' ' ' GLU . 4.8 mp -61.88 -21.94 65.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.219 1.008 . . . . 0.0 110.955 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.47 -20.42 58.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.111 . . . . 0.0 112.057 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -82.57 -15.88 50.61 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.238 0.926 . . . . 0.0 110.535 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.82 165.74 20.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.975 -1.078 . . . . 0.0 108.364 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.558 ' H ' HD22 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -77.57 125.07 28.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 172.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.86 171.68 7.61 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 152.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.48 -41.99 88.15 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 120.452 -1.405 . . . . 0.0 113.569 -156.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -62.49 -41.51 98.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.332 1.053 . . . . 0.0 110.114 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.72 -32.92 66.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.578 0.751 . . . . 0.0 111.034 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.5 -48.7 80.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 120.957 -1.089 . . . . 0.0 109.015 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.23 -47.92 71.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 125.602 1.561 . . . . 0.0 111.805 173.834 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.403 ' HG2' ' HB ' ' A' ' 15' ' ' ILE . 5.7 ptm . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.7 95.88 2.66 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.836 -0.54 . . . . 0.0 110.569 -162.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 109' ' ' GLU . 15.2 mmtm -93.53 174.26 7.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.68 0.792 . . . . 0.0 111.391 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.69 -173.09 2.66 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.772 2.429 . . . . 0.0 109.486 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -138.41 179.54 6.4 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.947 1.299 . . . . 0.0 109.918 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -82.3 7.53 13.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.424 1.089 . . . . 0.0 111.447 167.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -121.93 40.8 3.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.605 1.548 . . . . 0.0 109.909 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 p80 43.27 59.62 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.967 1.707 . . . . 0.0 111.908 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -152.21 133.25 14.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 108.612 -158.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.411 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.2 p-90 -110.62 160.69 16.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.361 1.465 . . . . 0.0 109.514 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 136.37 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.77 77.32 1.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.913 0.885 . . . . 0.0 109.462 -172.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.1 mp -71.47 139.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.7 pt-20 -126.46 -93.58 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.654 1.182 . . . . 0.0 110.101 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.484 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 9.1 t0 -83.4 -81.42 0.16 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -131.05 7.93 4.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.699 2.0 . . . . 0.0 110.426 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.77 149.78 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -113.05 140.83 47.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 159.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.3 m -79.78 137.02 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 153.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.9 t -103.11 136.62 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 128.0 2.52 . . . . 0.0 110.367 167.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.562 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -159.4 173.67 36.21 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.521 -0.737 . . . . 0.0 111.598 161.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 28' ' ' ALA . 9.0 pt -86.56 153.99 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 118.073 0.936 . . . . 0.0 110.683 177.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -84.06 171.91 12.48 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.677 0.791 . . . . 0.0 111.454 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.73 -35.94 71.37 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.408 0.623 . . . . 0.0 111.938 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -54.39 -33.74 59.86 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.734 -1.229 . . . . 0.0 112.279 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -74.8 -44.0 51.77 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.356 -0.84 . . . . 0.0 112.145 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.13 -25.81 68.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.497 0.59 . . . . 0.0 110.75 176.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.62 -21.09 66.63 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.115 1.366 . . . . 0.0 111.042 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -102.45 -41.58 6.25 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.763 0.711 . . . . 0.0 111.254 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 mt -82.99 -19.75 36.43 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.55 -123.13 29.25 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 119.45 1.023 . . . . 0.0 111.183 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -80.29 33.91 0.3 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.745 2.018 . . . . 0.0 116.212 -151.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 21.5 t -22.19 -115.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 115.121 -2.371 . . . . 0.0 111.428 -131.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.5 OUTLIER 170.93 -47.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 128.455 2.702 . . . . 0.0 110.813 -170.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -169.86 158.85 7.56 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.31 0.381 . . . . 0.0 111.446 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.755 HG22 HG23 ' A' ' 56' ' ' ILE . 4.5 t -144.09 144.05 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 125.561 1.544 . . . . 0.0 110.711 175.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.04 139.56 37.51 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.712 2.405 . . . . 0.0 108.984 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -135.79 155.9 77.71 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.973 0.909 . . . . 0.0 110.713 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -84.47 -179.05 3.63 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.374 3.382 . . . . 0.0 114.207 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -84.96 155.76 21.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 163.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.39 18.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 127.086 2.155 . . . . 0.0 113.927 -163.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.42 13.75 0.2 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 127.903 2.668 . . . . 0.0 111.938 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -73.92 135.89 43.31 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.067 -1.255 . . . . 0.0 109.564 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -82.88 139.16 33.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.03 175.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.238 1.415 . . . . 0.0 110.453 -174.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -118.66 169.67 9.62 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.417 1.487 . . . . 0.0 109.48 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HE2' HD21 ' A' ' 111' ' ' LEU . 24.9 tttt -62.99 14.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.27 2.228 . . . . 0.0 114.915 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.0 78.2 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.52 116.58 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -169.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.6 71.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 128.005 2.522 . . . . 0.0 108.835 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.51 6.42 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.502 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.24 59.8 0.9 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.551 1.069 . . . . 0.0 112.438 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 m -59.85 160.61 7.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.763 1.268 . . . . 0.0 111.324 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.755 HG23 HG22 ' A' ' 38' ' ' VAL . 1.6 mt -134.27 105.73 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.7 166.19 23.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 163.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.9 p -140.8 177.78 7.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.487 1.494 . . . . 0.0 107.89 164.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -49.04 -19.58 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 128.055 2.542 . . . . 0.0 115.978 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -160.65 41.6 0.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.934 1.697 . . . . 0.0 114.164 155.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -154.37 -172.32 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.216 -0.928 . . . . 0.0 109.188 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.91 14.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.994 0.918 . . . . 0.0 108.771 159.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.75 131.96 32.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 143.62 37.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 164.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.54 114.18 46.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.44 107.03 18.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -170.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.62 125.39 0.94 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.038 1.335 . . . . 0.0 113.551 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.9 -21.86 24.04 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.218 2.612 . . . . 0.0 115.187 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 49' ' ' LYS . 1.8 mm? -134.93 149.02 50.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 129.501 3.12 . . . . 0.0 108.644 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -66.49 149.72 50.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 158.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.67 -165.97 36.5 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -130.67 134.86 47.29 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.36 0.664 . . . . 0.0 109.43 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.429 ' HA ' ' HB3' ' A' ' 100' ' ' MET . 8.7 mm -60.22 143.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.93 1.292 . . . . 0.0 108.861 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.59 -8.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -153.18 150.52 29.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.588 1.54 . . . . 0.0 108.342 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.26 168.01 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.818 1.19 . . . . 0.0 110.21 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -119.86 73.98 1.0 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.72 -1.04 0.33 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.05 -0.407 . . . . 0.0 112.077 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -54.92 -43.77 73.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.128 -1.415 . . . . 0.0 110.2 162.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.439 HD12 HG11 ' A' ' 38' ' ' VAL . 43.7 mt -68.37 -9.81 50.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.639 1.563 . . . . 0.0 113.774 -177.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.8 -24.28 65.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.476 1.035 . . . . 0.0 111.636 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.2 p -129.18 -19.29 3.54 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.577 -0.702 . . . . 0.0 112.548 -172.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -122.03 59.86 11.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.351 2.66 . . . . 0.0 108.788 166.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.82 -19.04 47.32 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.691 1.594 . . . . 0.0 109.601 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.23 -11.54 59.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.464 1.906 . . . . 0.0 112.094 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -27.83 68.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 119.454 -2.029 . . . . 0.0 111.519 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.75 -19.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.157 0.583 . . . . 0.0 109.932 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -65.0 -56.02 15.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.3 1.048 . . . . 0.0 109.696 165.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -63.05 -53.89 46.73 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.067 2.547 . . . . 0.0 108.791 -162.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 85.79 5.5 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -59.11 -22.04 62.24 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.512 2.141 . . . . 0.0 112.455 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.411 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -127.41 9.01 6.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 127.858 2.463 . . . . 0.0 110.764 -163.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.33 -80.26 0.87 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 126.277 1.894 . . . . 0.0 109.716 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -93.6 -25.25 17.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.18 31.88 4.9 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.649 1.119 . . . . 0.0 113.367 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.564 ' CZ3' ' HE3' ' A' ' 99' ' ' LYS . 34.4 p-90 -70.06 159.4 33.91 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.562 HD12 ' HA2' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -108.89 -46.66 3.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.5 1.046 . . . . 0.0 109.136 -177.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.401 ' CD2' HD12 ' A' ' 73' ' ' ILE . 46.2 p90 -154.33 171.02 19.95 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.339 -0.851 . . . . 0.0 111.378 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.564 ' HE3' ' CZ3' ' A' ' 96' ' ' TRP . 77.1 mttt -131.59 152.49 50.76 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.504 1.522 . . . . 0.0 108.1 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.429 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 6.0 ptm -154.8 148.3 25.2 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.202 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -65.67 133.35 50.91 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.1 pt -79.23 103.41 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -73.77 -17.41 61.1 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.808 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -144.15 79.29 1.61 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.191 1.397 . . . . 0.0 107.364 -164.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.55 -10.46 55.91 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.767 -1.208 . . . . 0.0 113.298 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -81.97 -4.85 90.15 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.72 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 49' ' ' LYS . 49.0 mt-10 -81.38 -36.55 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.87 1.335 . . . . 0.0 112.169 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -35.41 80.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.656 1.116 . . . . 0.0 112.193 -170.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.468 ' HA ' ' HE2' ' A' ' 5' ' ' LYS . 17.6 mm-40 -62.51 -20.37 64.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -87.26 -11.0 50.94 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.588 0.755 . . . . 0.0 112.589 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.499 HD21 ' HE2' ' A' ' 49' ' ' LYS . 82.5 mt -75.04 -179.1 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.539 1.136 . . . . 0.0 110.252 167.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.9 mt -88.33 131.96 34.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.733 0.813 . . . . 0.0 109.996 -170.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.84 171.74 1.55 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.263 1.425 . . . . 0.0 109.846 163.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.74 -51.53 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.286 1.035 . . . . 0.0 111.151 -175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -56.7 -47.47 79.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.024 0.53 . . . . 0.0 109.776 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.48 67.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.332 0.653 . . . . 0.0 112.098 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -79.72 -43.35 22.81 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.656 0.662 . . . . 0.0 111.631 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 109.579 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 169.901 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ttp . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.27 101.73 3.75 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.442 -0.786 . . . . 0.0 109.763 -171.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -112.77 -178.6 3.43 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.97 153.49 43.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.373 1.069 . . . . 0.0 112.061 -167.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -101.33 171.39 7.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 123.306 1.527 . . . . 0.0 110.346 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -83.59 -1.01 52.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.989 170.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 p -120.65 44.25 2.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.129 1.772 . . . . 0.0 109.376 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.2 p80 43.96 61.11 2.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 113.807 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.8 mt-10 -134.86 152.18 51.53 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.299 1.84 . . . . 0.0 109.155 171.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.476 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 64.0 p-90 -109.81 172.66 6.72 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.947 1.299 . . . . 0.0 109.373 169.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.1 134.45 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -116.43 84.92 2.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.3 mp -75.67 118.07 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -106.33 -120.82 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 167.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.61 -60.49 2.29 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.849 1.204 . . . . 0.0 110.666 -167.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.1 7.53 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.973 0.909 . . . . 0.0 111.523 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.4 t -130.38 140.79 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -110.33 134.22 52.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 163.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -77.15 142.05 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 158.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.72 139.86 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.083 1.353 . . . . 0.0 109.559 166.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.29 161.4 28.75 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 161.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 87' ' ' ILE . 2.6 pp -70.06 159.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -79.6 -172.31 3.22 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.493 -0.755 . . . . 0.0 111.726 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.04 19.74 13.48 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.896 2.478 . . . . 0.0 112.549 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -113.48 0.57 14.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 126.009 1.724 . . . . 0.0 113.999 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.288 . . -119.76 -52.26 2.23 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.823 3.249 . . . . 0.0 112.585 -156.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.91 -42.97 1.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.777 2.431 . . . . 0.0 110.178 158.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.28 -25.05 67.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.694 1.598 . . . . 0.0 113.722 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -75.02 -45.31 42.67 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.015 -1.053 . . . . 0.0 109.542 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -72.47 -57.51 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.31 -132.29 11.19 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.15 126.82 28.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 36' ' ' VAL . 3.1 t -97.83 -154.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 169.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.644 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.2 m -174.42 -38.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 129.582 3.153 . . . . 0.0 106.973 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.487 ' H ' HG12 ' A' ' 35' ' ' VAL . 53.9 t80 -144.93 145.6 31.62 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.553 0.615 . . . . 0.0 111.27 -176.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 56' ' ' ILE . 39.6 t -128.81 121.07 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 168.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.48 140.79 37.2 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.033 173.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.43 149.09 63.5 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -175.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -71.0 -175.52 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.18 2.587 . . . . 0.0 112.308 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.44 158.98 15.35 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.893 1.677 . . . . 0.0 109.918 162.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.13 19.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 126.378 1.871 . . . . 0.0 115.014 -167.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.33 9.34 0.6 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.627 2.06 . . . . 0.0 112.887 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -73.04 135.82 44.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.723 1.261 . . . . 0.0 109.678 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.415 ' HG2' ' CG ' ' A' ' 72' ' ' LYS . 22.0 mt-10 -89.01 157.95 18.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.315 1.055 . . . . 0.0 111.665 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.519 HG22 HG11 ' A' ' 53' ' ' VAL 0.331 11.1 t -146.22 171.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.29 0 C-N-CA 131.653 3.981 . . . . 0.0 108.852 -162.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' H ' HG12 ' A' ' 47' ' ' VAL . 64.9 mttm -146.13 166.11 27.12 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.768 4.027 . . . . 0.0 106.338 -171.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -74.73 27.85 0.09 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.85 57.78 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 126.469 1.985 . . . . 0.0 108.372 171.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.01 143.25 45.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 117.583 0.692 . . . . 0.0 110.491 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.1 t -92.72 103.89 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.519 HG11 HG22 ' A' ' 47' ' ' VAL . 27.4 m -118.76 -0.24 8.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 125.919 1.687 . . . . 0.0 109.9 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -166.95 66.51 0.09 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.488 1.115 . . . . 0.0 109.432 -163.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -65.23 166.59 9.56 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.515 -1.366 . . . . 0.0 110.963 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.445 HG23 HG22 ' A' ' 38' ' ' VAL . 6.2 mt -143.65 103.78 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 O-C-N 120.145 -1.597 . . . . 0.0 107.612 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.43 117.67 29.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.4 p -97.98 -168.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.187 1.795 . . . . 0.0 110.645 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -52.79 -28.84 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.473 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.11 40.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.393 1.451 . . . . 0.0 113.003 166.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.17 39.46 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 120.78 -1.2 . . . . 0.0 109.721 171.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.34 152.38 31.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.739 1.616 . . . . 0.0 106.7 168.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.73 76.1 1.42 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -33.01 107.49 0.05 OUTLIER 'General case' 0 C--O 1.237 0.439 0 C-N-CA 128.777 2.831 . . . . 0.0 108.928 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.79 120.53 30.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.18 94.77 6.13 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.696 0.398 . . . . 0.0 111.804 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.09 132.74 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.559 0 C-N-CA 125.947 1.699 . . . . 0.0 114.647 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.2 -32.74 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.068 1.845 . . . . 0.0 111.874 -165.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.24 160.93 37.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.235 1.814 . . . . 0.0 108.209 -175.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.14 132.18 46.75 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.226 1.811 . . . . 0.0 107.328 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -172.89 45.88 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.415 ' CG ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -133.2 131.23 40.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 100' ' ' MET . 27.2 mm -62.81 151.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.93 -11.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 124.044 0.937 . . . . 0.0 109.744 -167.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.58 152.07 39.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 163.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.68 152.38 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -99.99 84.66 2.91 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.27 -15.29 23.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.779 0.8 . . . . 0.0 111.859 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -59.56 -22.41 61.67 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.273 1.829 . . . . 0.0 113.24 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.29 -15.55 46.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.271 1.396 . . . . 0.0 112.113 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -62.66 -31.33 72.19 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 165.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.9 -20.36 12.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.113 -0.992 . . . . 0.0 111.9 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.11 74.95 76.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.79 1.236 . . . . 0.0 110.312 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -65.64 -25.55 54.35 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.633 2.222 . . . . 0.0 110.456 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.64 -16.84 64.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.938 0.79 . . . . 0.0 110.99 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -21.62 66.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.911 2.141 . . . . 0.0 112.204 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.672 ' CG2' HD11 ' A' ' 24' ' ' ILE . 3.0 mt -64.52 -28.78 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.353 0.661 . . . . 0.0 110.289 172.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -67.1 -55.31 14.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.22 -1.55 . . . . 0.0 108.527 167.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -51.13 68.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.25 -160.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.86 76.76 5.88 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.13 0.972 . . . . 0.0 108.427 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.51 -25.16 62.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.016 1.81 . . . . 0.0 113.028 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -116.0 15.09 16.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.064 0.945 . . . . 0.0 110.781 -175.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.4 -65.91 0.34 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.248 1.88 . . . . 0.0 111.289 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -124.86 -23.9 4.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.516 1.158 . . . . 0.0 114.072 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.51 2.65 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 111.879 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -67.59 152.58 45.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -93.63 -59.9 1.89 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.441 ' CD1' HD12 ' A' ' 73' ' ' ILE . 44.4 p90 -149.31 168.62 22.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.719 1.207 . . . . 0.0 109.857 -172.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -132.99 155.11 49.76 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.386 1.474 . . . . 0.0 107.545 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.465 ' HB3' HD13 ' A' ' 73' ' ' ILE . 1.8 ptm -148.58 144.59 27.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.388 -168.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.56 114.66 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.351 2.26 . . . . 0.0 107.912 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt -71.34 117.59 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.606 0.717 . . . . 0.0 111.472 -170.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -78.06 -25.85 47.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.371 -0.83 . . . . 0.0 112.718 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.08 84.76 1.59 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -8.55 36.27 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 173.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.53 -31.85 8.06 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.748 -1.029 . . . . 0.0 112.872 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.57 -5.47 11.56 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.085 1.443 . . . . 0.0 111.212 170.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.99 -34.57 73.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.45 1.023 . . . . 0.0 110.868 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.69 -20.74 61.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.253 1.421 . . . . 0.0 111.441 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -83.41 -6.08 59.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.886 0.874 . . . . 0.0 111.456 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.08 176.07 5.27 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.643 1.211 . . . . 0.0 111.915 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.97 143.78 41.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.8 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.75 171.98 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.395 162.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -73.9 -34.68 64.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.524 1.93 . . . . 0.0 111.903 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.82 -48.92 33.79 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.22 70.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.445 0.698 . . . . 0.0 110.839 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -53.48 -47.64 69.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.626 1.571 . . . . 0.0 111.884 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.61 -35.72 65.4 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.7 -0.625 . . . . 0.0 110.205 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.807 . . . . 0.0 110.101 175.001 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.31 145.37 47.17 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 157.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.6 tpp -157.54 125.62 5.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -168.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.56 109.55 8.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.575 0.75 . . . . 0.0 110.075 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -104.81 178.09 4.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.046 0.938 . . . . 0.0 110.104 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -144.07 157.35 44.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.509 1.924 . . . . 0.0 108.891 -171.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.4 p -110.92 177.28 4.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 123.04 1.4 . . . . 0.0 109.463 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -78.64 -9.43 59.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.978 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -109.18 42.0 1.52 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.794 -1.191 . . . . 0.0 109.107 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 p80 44.87 54.47 6.75 Favored 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.084 1.353 . . . . 0.0 110.674 174.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 4.2 tt0 -130.21 145.25 51.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.212 2.205 . . . . 0.0 107.479 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.47 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.2 p-90 -117.87 159.89 22.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.56 1.944 . . . . 0.0 110.21 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.555 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.2 t -128.99 152.74 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.646 1.978 . . . . 0.0 107.468 -173.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.85 84.33 1.84 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 119.766 1.166 . . . . 0.0 112.771 177.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mp -70.37 132.39 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -120.15 -99.47 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 164.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.25 -88.65 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.911 2.084 . . . . 0.0 110.368 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -127.71 3.88 6.09 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.8 -1.188 . . . . 0.0 113.382 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.71 133.56 69.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -108.35 110.29 21.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.038 2.135 . . . . 0.0 109.529 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.5 m -75.96 116.51 16.73 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.653 1.181 . . . . 0.0 110.743 171.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.5 OUTLIER -87.99 149.85 3.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 112.415 174.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.98 163.64 31.92 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 156.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.407 ' CD1' HG21 ' A' ' 87' ' ' ILE . 2.3 pt -82.09 151.42 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.4 1.6 . . . . 0.0 109.511 169.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.3 p -82.05 174.48 11.2 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.705 1.202 . . . . 0.0 112.828 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.81 -41.81 71.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.2 -0.937 . . . . 0.0 112.3 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -57.85 -21.1 40.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.093 0.86 . . . . 0.0 112.935 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.28 -47.83 9.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.034 -1.041 . . . . 0.0 110.855 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -64.18 -21.38 66.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.7 0.682 . . . . 0.0 111.806 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.09 -37.95 81.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.627 1.571 . . . . 0.0 110.888 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -88.21 -35.9 17.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.2 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.7 -70.99 0.47 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.703 1.138 . . . . 0.0 109.824 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.19 -130.25 10.11 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.19 0.9 . . . . 0.0 111.041 -170.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -71.85 34.18 0.06 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.242 3.017 . . . . 0.0 117.029 -159.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 59' ' ' VAL . 14.2 t -21.97 -113.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 114.091 -2.861 . . . . 0.0 113.049 -135.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER 164.38 -41.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 128.924 2.89 . . . . 0.0 110.082 -170.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -157.39 164.4 37.56 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 118.644 0.656 . . . . 0.0 109.721 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -139.12 142.18 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 163.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.79 87.46 3.33 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.341 1.457 . . . . 0.0 107.218 -177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -90.28 153.1 46.4 Favored Pre-proline 0 C--O 1.234 0.245 0 O-C-N 121.656 -0.652 . . . . 0.0 109.885 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.96 174.7 12.32 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.448 2.099 . . . . 0.0 112.205 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.89 142.11 31.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.13 19.88 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 128.835 2.854 . . . . 0.0 114.839 -172.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.82 17.89 0.65 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.063 1.792 . . . . 0.0 112.501 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -90.18 142.63 27.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.889 1.345 . . . . 0.0 110.319 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.43 144.69 27.84 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 120.124 1.329 . . . . 0.0 110.669 170.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.44 HG11 HD11 ' A' ' 73' ' ' ILE . 20.3 m -137.17 177.98 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.793 1.237 . . . . 0.0 111.22 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -132.01 166.61 21.32 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.172 1.789 . . . . 0.0 108.821 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -72.94 37.21 0.08 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.076 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.56 76.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.01 120.34 7.86 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.696 1.598 . . . . 0.0 106.8 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.287 0.1 OUTLIER -69.84 33.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 127.716 2.406 . . . . 0.0 113.683 -171.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.17 8.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 118.501 -2.624 . . . . 0.0 114.804 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.36 48.01 1.77 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 121.063 1.756 . . . . 0.0 111.031 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 161.64 8.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.918 0.866 . . . . 0.0 110.767 -173.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mt -137.78 101.77 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -86.49 148.97 25.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 164.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -124.2 179.8 4.74 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.391 1.077 . . . . 0.0 110.167 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 35' ' ' VAL . 2.7 m -40.8 -35.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 126.172 1.789 . . . . 0.0 113.379 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -160.97 59.19 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.62 1.554 . . . . 0.0 113.655 156.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.93 -175.57 5.5 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.75 . . . . 0.0 109.48 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.64 166.5 23.41 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.865 1.666 . . . . 0.0 110.635 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.64 127.19 6.64 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.714 2.006 . . . . 0.0 106.902 167.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.3 118.05 28.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.67 93.01 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -77.53 106.88 9.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.655 0.382 . . . . 0.0 111.565 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.39 153.36 0.57 Allowed Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 127.606 2.362 . . . . 0.0 115.615 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -86.11 -41.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.343 1.362 . . . . 0.0 114.866 -162.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -129.93 168.17 17.07 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -76.94 168.95 19.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 156.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.95 -167.38 24.65 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -171.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -135.07 129.48 34.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -169.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.452 HD12 ' CD2' ' A' ' 98' ' ' PHE . 6.0 mm -62.47 141.76 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 125.445 1.498 . . . . 0.0 107.585 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.79 -1.83 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 124.383 1.052 . . . . 0.0 112.828 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -151.99 157.08 41.23 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.583 1.538 . . . . 0.0 106.898 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.7 m -142.56 154.0 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.72 85.16 5.57 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.588 0.631 . . . . 0.0 110.722 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.23 -9.56 5.19 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -55.09 -46.24 75.46 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.654 -1.279 . . . . 0.0 110.463 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -13.03 60.4 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.23 1.012 . . . . 0.0 110.069 -168.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.65 -35.2 73.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.415 1.486 . . . . 0.0 110.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -123.59 -22.32 5.02 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.243 1.417 . . . . 0.0 112.854 -167.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -131.18 68.83 82.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 127.426 2.291 . . . . 0.0 107.847 171.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.69 -11.29 28.29 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.39 2.727 . . . . 0.0 111.588 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -71.65 -3.14 19.99 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.632 1.573 . . . . 0.0 112.675 171.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 86' ' ' LEU . 1.9 mt -70.37 -22.49 62.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.623 1.556 . . . . 0.0 113.527 -172.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.407 HG21 ' CD1' ' A' ' 24' ' ' ILE . 3.0 mt -65.34 -29.32 46.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.46 -52.03 60.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 120.42 1.464 . . . . 0.0 109.038 173.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -56.17 -55.59 31.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.727 2.411 . . . . 0.0 110.169 -169.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -151.95 89.7 3.97 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -57.36 -29.49 84.41 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.586 1.524 . . . . 0.0 111.934 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 13.1 mt-10 -122.73 31.21 6.15 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.624 1.969 . . . . 0.0 108.701 -167.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.38 -74.45 0.07 OUTLIER Glycine 0 C--N 1.343 0.922 0 C-N-CA 125.409 1.481 . . . . 0.0 111.404 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -117.17 -11.3 10.7 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.129 -0.939 . . . . 0.0 113.307 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.84 29.6 1.55 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.449 1.022 . . . . 0.0 113.328 168.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 59.0 p-90 -60.31 149.6 33.07 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.579 1.189 . . . . 0.0 109.755 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.85 -69.4 0.76 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 116.589 -1.672 . . . . 0.0 106.814 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CD2' HD12 ' A' ' 73' ' ' ILE . 48.4 p90 -134.31 -174.95 3.71 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 122.114 2.234 . . . . 0.0 112.033 -172.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -135.86 153.53 51.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.831 167.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.07 139.15 25.83 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.847 0.859 . . . . 0.0 109.271 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.38 120.31 12.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 163.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -73.24 152.97 7.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.1 m -110.12 -31.93 7.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.699 0.8 . . . . 0.0 111.58 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 76.48 1.61 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -160.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -11.46 57.35 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.445 -0.784 . . . . 0.0 111.324 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.01 -15.17 81.22 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.927 -1.108 . . . . 0.0 112.586 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -86.34 -15.95 38.93 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.549 1.175 . . . . 0.0 111.572 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.22 -43.37 98.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.497 1.044 . . . . 0.0 109.543 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -60.65 -24.76 65.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 111.28 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.5 -4.52 58.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.247 1.019 . . . . 0.0 112.45 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.54 -171.95 2.5 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 126.591 1.956 . . . . 0.0 108.958 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -96.99 135.53 38.86 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.675 1.19 . . . . 0.0 108.215 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -73.38 179.93 3.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.828 0.823 . . . . 0.0 110.041 163.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -66.53 -47.53 72.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.612 1.965 . . . . 0.0 111.732 -171.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -74.22 -39.99 62.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.191 0.596 . . . . 0.0 109.419 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.78 76.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.417 0.687 . . . . 0.0 111.262 172.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -70.7 -44.22 67.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.969 0.908 . . . . 0.0 111.187 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.27 -45.57 72.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.125 0.875 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -63.4 -38.76 92.38 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.815 0.846 . . . . 0.0 110.879 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -59.14 -32.34 69.78 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.159 -0.963 . . . . 0.0 111.408 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.6 m -77.06 -26.04 53.09 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.078 -1.013 . . . . 0.0 112.982 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.9 0.56 17.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.446 1.098 . . . . 0.0 111.485 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.8 17.92 21.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.001 0.92 . . . . 0.0 110.202 169.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.669 164.129 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt 48.41 64.71 1.57 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 127.253 2.221 . . . . 0.0 112.464 157.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.496 ' SD ' ' HE3' ' A' ' 5' ' ' LYS . 2.9 ptp -152.66 -175.8 5.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.129 1.772 . . . . 0.0 109.027 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.54 122.89 8.4 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 120.669 -1.27 . . . . 0.0 109.324 171.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.496 ' HE3' ' SD ' ' A' ' 3' ' ' MET . 22.2 mmtt -114.38 175.44 5.48 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.662 0.602 . . . . 0.0 109.864 168.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -133.36 154.22 50.92 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.654 1.581 . . . . 0.0 109.179 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.5 p -91.48 -176.92 4.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 122.226 1.013 . . . . 0.0 108.641 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -101.66 20.48 16.12 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.494 1.518 . . . . 0.0 110.296 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -127.02 30.1 5.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.402 1.881 . . . . 0.0 110.817 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 59.72 40.69 19.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.801 -1.187 . . . . 0.0 112.193 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 24' ' ' ILE . 20.5 mt-10 -126.24 145.11 50.53 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.45 1.5 . . . . 0.0 107.887 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.418 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.1 p-90 -116.94 162.02 18.43 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.714 1.605 . . . . 0.0 109.534 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.5 t -142.35 100.79 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -167.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -82.15 89.12 6.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.74 -1.225 . . . . 0.0 109.034 173.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.2 mp -74.04 104.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 120.224 1.374 . . . . 0.0 107.595 174.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.3 tp10 -80.9 -138.78 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 167.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 1.2 t0 -64.69 -61.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.098 -1.001 . . . . 0.0 109.414 -172.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.5 2.21 2.44 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.031 0.933 . . . . 0.0 113.019 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.3 t -124.28 132.25 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -100.2 140.0 35.07 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 169.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -85.15 139.05 31.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 t -113.5 126.22 70.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 125.654 1.581 . . . . 0.0 107.584 170.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -134.97 168.55 23.63 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 160.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 87' ' ' ILE . 19.6 pt -85.62 156.57 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 171.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.8 p -82.55 179.09 7.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 111.632 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -39.52 94.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.408 -1.433 . . . . 0.0 111.541 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -61.02 -26.48 67.64 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.398 -1.439 . . . . 0.0 111.668 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.434 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -69.79 -56.43 7.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.977 -1.077 . . . . 0.0 110.088 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -55.14 -30.89 60.74 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.662 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.03 -42.43 94.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.381 0.672 . . . . 0.0 110.545 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -79.96 -24.26 41.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.717 1.207 . . . . 0.0 113.202 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.68 -42.05 35.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.747 1.158 . . . . 0.0 110.346 175.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.9 53.27 Favored Glycine 0 N--CA 1.443 -0.859 0 O-C-N 124.188 0.93 . . . . 0.0 110.939 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -45.95 122.6 3.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.748 2.019 . . . . 0.0 108.515 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 36' ' ' VAL 0.425 9.8 p -118.47 158.07 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 122.493 1.139 . . . . 0.0 112.387 -177.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.584 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -146.85 -26.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 C-N-CA 126.148 1.779 . . . . 0.0 108.974 -150.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -150.53 151.93 33.4 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 123.741 0.651 . . . . 0.0 111.17 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 56' ' ' ILE . 60.0 t -145.46 127.81 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 136.42 38.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.606 171.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.8 mt -129.88 128.52 22.92 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.2 -178.95 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.44 2.76 . . . . 0.0 112.59 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -80.61 140.88 35.51 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.828 -1.17 . . . . 0.0 108.923 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.0 12.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 128.567 2.747 . . . . 0.0 115.71 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.2 9.16 1.1 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.044 1.783 . . . . 0.0 111.615 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -71.92 137.57 47.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.086 -1.243 . . . . 0.0 110.106 -171.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HG2' ' CG ' ' A' ' 72' ' ' LYS . 10.5 mt-10 -85.35 149.44 25.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.623 -0.673 . . . . 0.0 110.285 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.1 m -147.76 177.35 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.174 0.99 . . . . 0.0 109.527 -172.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -126.25 170.98 11.31 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 125.659 1.584 . . . . 0.0 109.589 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.81 10.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.77 66.74 0.24 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.55 115.81 13.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -168.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.06 114.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.476 1.111 . . . . 0.0 108.257 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 m -146.09 0.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.754 1.222 . . . . 0.0 112.718 -168.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.96 39.63 0.94 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.216 1.006 . . . . 0.0 108.385 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -50.66 165.66 0.1 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.992 1.717 . . . . 0.0 111.538 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.489 HG23 HG22 ' A' ' 38' ' ' VAL . 2.2 mt -139.45 145.79 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.99 116.6 17.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.936 1.694 . . . . 0.0 107.234 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' HG23 ' A' ' 35' ' ' VAL . 84.5 p -105.6 -167.71 1.36 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.615 1.566 . . . . 0.0 111.02 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 m -44.86 -39.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 114.152 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -165.75 72.57 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 149.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.07 167.24 22.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.8 154.85 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 159.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.26 109.02 4.37 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.255 1.022 . . . . 0.0 109.701 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.2 114.54 4.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.575 1.55 . . . . 0.0 108.371 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.622 HG11 HD13 ' A' ' 97' ' ' LEU . 53.2 t -87.46 104.31 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 172.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.33 105.55 17.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.954 0.797 . . . . 0.0 110.341 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.66 142.33 1.07 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.434 1.894 . . . . 0.0 112.876 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.08 -35.32 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.18 1.92 . . . . 0.0 113.259 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -138.84 145.75 40.4 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.958 2.103 . . . . 0.0 107.147 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -64.44 137.86 58.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 167.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.48 -177.91 44.09 Favored Glycine 0 CA--C 1.509 -0.336 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -155.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' CG ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -129.9 140.62 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 173.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.479 HD12 ' CD2' ' A' ' 98' ' ' PHE . 7.1 mm -65.67 145.46 13.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 174.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.51 -3.8 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 O-C-N 123.359 0.412 . . . . 0.0 111.753 174.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.14 151.47 30.19 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.2 m -141.54 149.6 20.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -99.47 75.8 1.98 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.0 -14.89 2.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -53.01 -34.64 57.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.066 1.347 . . . . 0.0 111.919 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -9.05 41.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 112.024 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.07 -28.68 69.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.786 1.634 . . . . 0.0 112.912 166.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -126.93 -27.55 3.02 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.947 1.699 . . . . 0.0 110.818 -167.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -125.94 65.03 53.82 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.202 1.801 . . . . 0.0 108.511 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -72.26 -51.62 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.594 2.863 . . . . 0.0 108.654 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -15.65 0.39 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.226 2.21 . . . . 0.0 111.322 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.04 41.23 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 122.632 2.469 . . . . 0.0 110.999 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.533 ' CG2' HD11 ' A' ' 24' ' ' ILE . 70.0 mt -51.33 -30.34 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 120.814 -1.179 . . . . 0.0 110.4 171.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -73.45 -51.73 16.16 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.71 -1.244 . . . . 0.0 111.581 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -70.23 -38.73 75.29 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.098 1.759 . . . . 0.0 110.76 -163.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -156.11 67.58 4.66 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 123.03 0.532 . . . . 0.0 111.332 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.88 -20.99 69.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.53 2.82 . . . . 0.0 113.535 -170.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.418 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 5.1 mt-10 -123.11 20.05 9.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.593 0.757 . . . . 0.0 110.535 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -123.83 -93.0 1.04 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -79.92 -32.14 40.13 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.264 1.032 . . . . 0.0 112.869 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.35 37.73 2.03 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 120.23 1.377 . . . . 0.0 114.58 -174.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -68.87 165.02 20.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.871 1.835 . . . . 0.0 109.732 169.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 65' ' ' VAL . 1.7 mt -108.93 -61.37 1.62 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.479 ' CD2' HD12 ' A' ' 73' ' ' ILE . 43.6 p90 -148.85 172.23 15.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.769 0.827 . . . . 0.0 111.068 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -134.95 152.32 51.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.48 1.512 . . . . 0.0 108.795 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.44 144.82 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.912 0.485 . . . . 0.0 110.68 -166.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.16 128.25 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.266 1.826 . . . . 0.0 107.029 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 pt -86.95 95.86 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.794 0.807 . . . . 0.0 109.987 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 m -81.67 -11.33 59.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.762 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.49 96.51 3.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 171.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -4.98 57.68 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.304 -0.248 . . . . 0.0 110.671 171.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.79 -55.22 9.92 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -18.4 47.0 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 125.822 1.649 . . . . 0.0 113.486 -171.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 111' ' ' LEU . 13.7 mt -44.14 -37.16 2.96 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.893 1.679 . . . . 0.0 111.48 169.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.24 -13.23 60.42 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.601 0.637 . . . . 0.0 112.265 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -72.38 -35.22 68.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.299 1.04 . . . . 0.0 109.574 171.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -71.83 167.88 19.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.327 1.451 . . . . 0.0 108.256 -177.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 mt -77.82 131.59 37.64 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -55.55 171.64 0.19 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 122.491 1.138 . . . . 0.0 108.647 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.96 -39.45 79.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.188 1.395 . . . . 0.0 111.414 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -64.57 -45.64 86.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.509 -0.745 . . . . 0.0 109.417 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.4 86.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.314 0.646 . . . . 0.0 111.038 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.1 -45.04 96.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.761 1.624 . . . . 0.0 110.832 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -48.16 73.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.972 0.509 . . . . 0.0 110.179 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -64.51 -31.94 73.37 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.034 -0.416 . . . . 0.0 111.479 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -70.65 -32.89 70.34 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.727 -1.233 . . . . 0.0 110.622 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.3 t -66.13 -39.79 90.14 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.027 0.376 . . . . 0.0 110.272 171.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.13 -25.68 67.87 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.64 -0.662 . . . . 0.0 112.154 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -101.45 4.87 41.69 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.987 1.715 . . . . 0.0 111.511 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.248 1.013 0 CA-C-N 119.596 1.089 . . . . 0.0 109.959 -178.578 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.9 ttm . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 153.59 126.59 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 1 C-N-CA 133.485 4.714 . . . . 0.0 105.131 173.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 ttm -152.61 157.79 41.51 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.78 113.54 11.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.271 1.396 . . . . 0.0 110.545 169.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.07 174.34 5.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 167.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.93 179.0 5.41 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.722 2.809 . . . . 0.0 110.958 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 p -139.53 167.06 22.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.4 1.88 . . . . 0.0 109.214 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.73 -7.87 56.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.24 0.616 . . . . 0.0 112.489 168.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.3 p -94.37 19.12 9.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.481 -1.387 . . . . 0.0 112.173 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 58.32 43.94 19.29 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.289 1.836 . . . . 0.0 111.566 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -124.11 149.86 45.72 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.739 -1.226 . . . . 0.0 109.91 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.521 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 68.1 p-90 -111.55 163.76 13.72 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.3 1.84 . . . . 0.0 109.109 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.53 100.81 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -168.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -85.25 95.17 9.1 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 119.609 1.095 . . . . 0.0 109.441 172.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.9 mp -74.43 141.62 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 119.897 1.226 . . . . 0.0 107.834 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.54 -101.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.607 1.163 . . . . 0.0 108.147 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.24 -77.57 0.46 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -126.51 16.72 7.61 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.49 1.516 . . . . 0.0 111.095 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.84 155.36 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -129.43 136.57 50.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.989 1.316 . . . . 0.0 108.305 166.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.0 m -83.65 138.54 33.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.85 134.54 55.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.691 1.996 . . . . 0.0 108.632 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -147.78 164.62 28.83 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 163.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.542 HD12 ' HB3' ' A' ' 28' ' ' ALA . 8.6 pt -73.77 154.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 O-C-N 122.029 -0.689 . . . . 0.0 109.325 169.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 79.3 p -75.42 166.34 23.75 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.334 -0.854 . . . . 0.0 109.802 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.67 -34.43 62.25 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.939 -1.101 . . . . 0.0 112.674 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -59.89 -28.09 67.26 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.0 -1.063 . . . . 0.0 111.959 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.542 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -72.71 -57.31 4.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.546 0.738 . . . . 0.0 111.21 174.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -56.59 -27.88 59.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.693 1.133 . . . . 0.0 112.326 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -54.99 -32.26 61.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.039 1.336 . . . . 0.0 111.047 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -88.92 -46.52 8.84 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.906 -0.569 . . . . 0.0 109.787 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -34.92 78.14 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 118.158 -0.925 . . . . 0.0 113.176 -174.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.94 -126.58 41.1 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -169.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.69 34.05 0.33 Allowed 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -145.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 85' ' ' GLU 0.398 2.2 p -23.06 -111.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 115.683 -2.103 . . . . 0.0 112.846 -122.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.4 OUTLIER 166.38 -46.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.112 2.165 . . . . 0.0 109.032 -168.227 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.433 ' H ' HG22 ' A' ' 35' ' ' VAL . 83.3 t80 -161.8 166.68 26.11 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.494 0.717 . . . . 0.0 110.165 -165.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.17 134.34 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 C-N-CA 125.915 1.686 . . . . 0.0 107.757 170.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.64 143.18 28.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.416 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.2 mt -138.11 151.5 70.0 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 123.671 0.789 . . . . 0.0 109.326 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -72.12 174.32 11.55 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.959 1.773 . . . . 0.0 111.396 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -78.64 150.9 32.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.81 17.2 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 127.713 2.405 . . . . 0.0 114.098 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.08 6.44 0.35 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 128.623 3.011 . . . . 0.0 111.922 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -67.18 125.73 26.96 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 119.019 1.41 . . . . 0.0 108.267 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.62 143.65 40.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 m -144.29 -176.73 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.667 0.787 . . . . 0.0 109.647 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -138.95 167.78 21.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.539 1.536 . . . . 0.0 109.772 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -67.83 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -172.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.9 66.5 0.24 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 161.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.48 123.19 47.93 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.184 1.393 . . . . 0.0 113.083 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.338 0.1 OUTLIER -65.5 21.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 129.149 2.98 . . . . 0.0 115.113 -174.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -62.84 8.54 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 119.142 -2.224 . . . . 0.0 116.273 -168.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.68 51.48 1.05 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.026 1.285 . . . . 0.0 110.706 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.19 148.29 36.87 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 123.155 1.455 . . . . 0.0 110.783 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.29 142.56 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -118.88 142.33 47.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 155.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.563 ' HB2' ' HA ' ' A' ' 35' ' ' VAL . 82.6 p -111.51 -173.85 2.34 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.237 1.381 . . . . 0.0 108.344 155.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -40.65 -37.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.99 1.716 . . . . 0.0 113.174 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.13 0.11 1.03 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 159.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.804 2.093 . . . . 0.0 110.464 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.4 162.56 35.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.097 1.359 . . . . 0.0 108.545 160.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.04 112.28 2.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.733 0.813 . . . . 0.0 109.919 172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.56 127.92 33.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.033 1.733 . . . . 0.0 107.989 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.781 HG11 HD13 ' A' ' 97' ' ' LEU . 71.8 t -102.48 109.29 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 120.697 1.589 . . . . 0.0 106.996 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.32 99.47 10.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.465 1.03 . . . . 0.0 112.125 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -35.66 124.84 0.64 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.514 1.925 . . . . 0.0 112.843 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.54 -24.57 10.36 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.694 2.262 . . . . 0.0 114.845 -160.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -133.5 158.64 42.59 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.243 1.817 . . . . 0.0 108.619 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -75.57 153.85 37.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.886 0.85 . . . . 0.0 109.842 165.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.74 -174.54 30.04 Favored Glycine 0 C--O 1.237 0.293 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -160.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.49 141.35 51.68 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.451 HD12 ' CD1' ' A' ' 98' ' ' PHE . 18.7 mm -67.7 146.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 173.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.19 -11.28 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.0 151.6 42.65 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.6 159.99 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.384 1.474 . . . . 0.0 107.177 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.489 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 39.2 t30 -104.43 90.03 3.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -172.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -61.47 -14.6 30.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.924 1.29 . . . . 0.0 112.585 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HE2' ' OD1' ' A' ' 77' ' ' ASN . 25.4 mtmm -55.96 -42.09 75.7 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.802 1.241 . . . . 0.0 111.787 167.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -21.9 61.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.947 0.794 . . . . 0.0 109.937 -170.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -57.63 -49.51 76.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.634 1.574 . . . . 0.0 109.063 167.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.8 p -82.98 -30.83 27.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.645 0.778 . . . . 0.0 112.364 -170.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -149.86 71.8 9.57 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.2 1.0 . . . . 0.0 109.048 -166.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.504 ' HB2' HG13 ' A' ' 35' ' ' VAL . 1.5 Cg_endo -50.82 -41.54 54.68 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.232 3.288 . . . . 0.0 112.651 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.74 ' HA ' HG12 ' A' ' 35' ' ' VAL . 11.1 pt-20 -65.54 -2.88 3.75 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 116.688 -1.625 . . . . 0.0 113.664 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -60.66 -22.61 64.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 123.657 2.935 . . . . 0.0 112.169 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -61.02 -23.83 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.292 0.637 . . . . 0.0 109.819 174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -71.77 -58.16 3.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.811 -1.181 . . . . 0.0 109.647 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -53.09 -35.31 59.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 126.397 1.879 . . . . 0.0 111.474 -172.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.16 100.43 0.49 Allowed Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 168.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.43 -12.45 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.317 1.345 . . . . 0.0 113.14 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.521 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -118.37 -19.54 8.85 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.662 1.119 . . . . 0.0 113.779 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -77.97 -90.24 0.34 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -99.05 -17.17 18.39 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.98 0.912 . . . . 0.0 111.738 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.66 30.94 3.37 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.043 1.306 . . . . 0.0 114.197 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -72.24 164.82 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.293 1.546 . . . . 0.0 110.559 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.781 HD13 HG11 ' A' ' 65' ' ' VAL . 3.9 mt -100.3 -66.93 0.88 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CD1' HD12 ' A' ' 73' ' ' ILE . 38.6 p90 -142.39 172.82 12.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.941 0.897 . . . . 0.0 110.789 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -124.98 154.62 40.94 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.843 0.857 . . . . 0.0 109.47 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.71 142.42 34.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.871 0.869 . . . . 0.0 110.442 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -81.32 113.95 19.77 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.231 1.812 . . . . 0.0 107.45 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 pt -76.44 103.0 3.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.965 0.906 . . . . 0.0 110.416 -168.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -60.02 -37.78 80.75 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.123 0.569 . . . . 0.0 111.84 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -139.6 93.45 2.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.06 -12.48 55.65 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-O 121.839 0.828 . . . . 0.0 109.95 168.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.45 72.48 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 120.701 -1.249 . . . . 0.0 110.983 173.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -72.55 -7.79 51.9 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.424 1.112 . . . . 0.0 111.586 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.9 mt -67.19 -26.94 66.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.382 1.446 . . . . 0.0 111.384 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -78.39 -29.14 47.12 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.932 0.396 . . . . 0.0 110.38 -167.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.94 -19.22 64.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 129.135 2.974 . . . . 0.0 112.364 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.3 mt -73.2 -170.41 0.77 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.368 1.467 . . . . 0.0 109.673 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -111.34 132.59 54.29 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.343 -0.848 . . . . 0.0 108.943 -171.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -60.13 165.4 3.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 157.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.21 -46.87 72.55 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.189 -0.944 . . . . 0.0 109.704 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -62.8 -33.38 75.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.08 0.4 . . . . 0.0 111.487 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.84 77.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.471 0.708 . . . . 0.0 110.433 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.85 -32.5 73.81 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.648 -0.657 . . . . 0.0 112.111 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.0 -56.53 17.04 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.728 1.611 . . . . 0.0 108.806 168.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.63 -44.57 93.5 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.548 1.139 . . . . 0.0 110.161 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.31 -50.8 64.2 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.545 0.738 . . . . 0.0 110.509 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.3 t -60.05 -35.35 74.94 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.691 -0.631 . . . . 0.0 112.249 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.45 -23.6 66.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.315 0.646 . . . . 0.0 111.533 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -96.36 -3.66 43.34 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.126 1.37 . . . . 0.0 111.917 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.457 -176.177 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 tpp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.66 120.43 11.78 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 162.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.6 ttp -165.26 162.26 19.72 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -155.21 98.41 1.99 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.164 1.347 . . . . 0.0 113.295 -167.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -95.02 -177.03 4.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.314 0.578 . . . . 0.0 111.865 168.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -138.1 172.99 12.1 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 127.684 2.393 . . . . 0.0 109.867 -170.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.9 p -121.49 173.34 7.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.822 1.649 . . . . 0.0 108.733 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.65 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -78.65 -34.58 46.29 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.36 163.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 p -75.22 23.49 0.11 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.818 1.247 . . . . 0.0 112.541 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.273 0.0 OUTLIER 60.84 52.81 4.08 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 128.076 2.55 . . . . 0.0 112.799 165.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -125.15 140.97 52.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.517 1.927 . . . . 0.0 108.572 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.489 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 63.5 p-90 -94.85 159.83 14.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.13 100.32 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -85.03 85.67 7.46 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 120.945 -1.097 . . . . 0.0 109.55 175.154 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.2 mp -69.5 134.95 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 169.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -122.17 -68.76 0.87 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.851 0.46 . . . . 0.0 110.068 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -120.76 -83.95 0.66 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -125.82 12.84 7.93 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.712 1.205 . . . . 0.0 110.57 170.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.8 t -128.58 149.92 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -118.77 140.36 50.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 166.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.8 m -91.57 133.25 35.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 t -110.6 138.58 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.203 1.401 . . . . 0.0 109.946 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.34 169.03 29.01 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 127.05 2.262 . . . . 0.0 108.207 164.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.55 159.14 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 118.934 1.367 . . . . 0.0 110.256 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.0 p -85.18 167.51 15.64 Favored 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.297 -0.877 . . . . 0.0 112.683 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.28 -42.36 69.91 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.566 -1.334 . . . . 0.0 112.728 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -57.63 -9.36 1.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.321 1.048 . . . . 0.0 113.145 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -103.94 -46.79 4.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.553 -1.342 . . . . 0.0 111.53 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -58.94 -26.58 64.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.923 1.238 . . . . 0.0 110.862 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -38.4 75.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.42 1.088 . . . . 0.0 111.516 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -82.61 -19.92 37.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.048 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.68 -31.91 9.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.697 0.681 . . . . 0.0 111.51 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.53 -123.77 29.89 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -63.09 114.96 4.04 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.3 t -94.61 -170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 160.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.1 p -172.84 -30.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 124.78 1.232 . . . . 0.0 108.04 -147.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.442 ' H ' HG12 ' A' ' 35' ' ' VAL . 34.5 t80 -153.43 160.37 42.58 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.746 0.654 . . . . 0.0 112.3 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.75 145.88 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 156.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.64 150.21 22.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.993 -1.003 . . . . 0.0 108.749 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -134.68 155.46 79.46 Favored Pre-proline 0 N--CA 1.469 0.496 0 CA-C-N 120.708 1.595 . . . . 0.0 111.045 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.34 -163.63 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 125.231 3.954 . . . . 0.0 109.563 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -108.66 148.92 29.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.582 1.153 . . . . 0.0 110.972 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.29 11.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 131.47 3.908 . . . . 0.0 117.633 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.62 17.43 0.57 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.556 2.027 . . . . 0.0 112.178 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -79.16 141.31 37.34 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.318 -1.107 . . . . 0.0 108.218 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -82.06 156.01 24.81 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.4 m -139.08 160.74 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.401 1.48 . . . . 0.0 110.236 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -124.09 162.64 23.11 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.106 2.162 . . . . 0.0 107.095 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -74.99 23.33 0.1 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -159.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -152.54 18.44 0.78 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.731 171.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -78.17 143.31 37.33 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 120.162 1.981 . . . . 0.0 111.218 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.0 106.95 18.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.6 m -133.84 -2.71 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -163.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.07 46.31 0.24 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.427 0.691 . . . . 0.0 110.007 -162.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -51.27 160.04 0.59 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.854 0.862 . . . . 0.0 111.694 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mt -128.45 111.69 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -109.01 130.99 55.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.6 p -112.62 -172.45 2.05 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.95 1.3 . . . . 0.0 110.22 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -48.77 -43.76 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.107 1.363 . . . . 0.0 111.736 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -155.77 88.05 1.1 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.163 1.385 . . . . 0.0 108.989 158.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 177.38 178.61 0.28 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.512 1.925 . . . . 0.0 108.699 161.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.75 147.66 52.32 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.507 1.523 . . . . 0.0 110.818 169.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.68 99.87 4.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.433 2.293 . . . . 0.0 106.444 170.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.29 121.85 15.26 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -80.79 123.53 37.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -103.62 105.32 15.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.787 0.835 . . . . 0.0 108.849 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -27.09 113.0 0.24 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 128.704 2.801 . . . . 0.0 112.314 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.85 -34.2 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.73 1.62 . . . . 0.0 113.164 -164.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.18 165.65 20.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.486 1.914 . . . . 0.0 107.231 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -67.4 152.23 46.05 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 108.103 155.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.41 -167.59 31.95 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 132.3 23.4 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.9 mm -68.66 143.51 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -174.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.83 -3.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.869 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.1 159.81 36.65 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.062 0.846 . . . . 0.0 109.978 166.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -141.16 152.23 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.913 1.685 . . . . 0.0 107.663 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -98.78 76.21 2.16 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.59 -11.66 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.856 1.662 . . . . 0.0 113.349 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.03 -36.79 68.38 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.663 1.585 . . . . 0.0 112.86 167.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -10.39 59.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.51 1.05 . . . . 0.0 111.761 -165.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -41.81 -55.15 3.14 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 128.098 2.559 . . . . 0.0 111.93 155.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 79.2 p -118.69 -3.98 10.78 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.754 1.222 . . . . 0.0 111.863 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -132.04 56.45 23.63 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.324 1.45 . . . . 0.0 110.879 170.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 -28.42 19.76 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.507 2.138 . . . . 0.0 109.407 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -66.88 -17.41 64.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.529 1.132 . . . . 0.0 111.111 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -61.89 -21.92 65.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 120.619 1.554 . . . . 0.0 111.831 173.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.41 -14.8 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 120.167 -1.583 . . . . 0.0 110.538 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -84.86 -55.01 4.3 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 120.022 -1.674 . . . . 0.0 110.556 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 1.9 mmtp -62.98 -31.41 72.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 124.273 1.029 . . . . 0.0 112.091 -168.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -162.59 77.22 1.97 Allowed Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 123.907 0.883 . . . . 0.0 110.463 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.69 -18.06 45.94 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 113.194 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.489 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 4.2 mt-10 -123.43 11.84 9.33 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.829 0.852 . . . . 0.0 111.465 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -121.39 -108.4 2.07 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.15 -18.44 63.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.475 0.71 . . . . 0.0 112.644 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.44 27.04 4.81 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.225 1.393 . . . . 0.0 114.489 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -64.85 165.81 10.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.8 1.8 . . . . 0.0 110.164 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.0 mt -110.01 -60.91 1.73 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -148.76 168.83 21.87 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.3 -0.875 . . . . 0.0 110.88 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -123.59 141.68 51.77 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.318 1.447 . . . . 0.0 108.425 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.7 ptm -141.65 140.18 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.842 0.857 . . . . 0.0 110.275 -171.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.27 136.42 40.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 34.3 pt -87.02 117.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 t -83.59 -18.22 38.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.857 167.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -143.12 86.57 1.92 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -157.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . 2.8 tt0 -74.22 -12.17 60.49 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 0.0 111.079 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.03 -57.66 18.11 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -69.43 -1.88 9.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.568 1.147 . . . . 0.0 113.019 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' ' 105' ' ' GLU . 14.9 mt -61.48 -38.44 87.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.312 -0.867 . . . . 0.0 110.115 164.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.59 -5.31 59.29 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.295 1.438 . . . . 0.0 111.323 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.07 -18.77 60.78 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.427 -0.796 . . . . 0.0 110.132 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.6 mt -87.18 -159.17 0.49 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.04 1.336 . . . . 0.0 112.477 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.9 mt -110.29 135.78 50.49 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 127.094 2.157 . . . . 0.0 109.761 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.3 172.65 1.84 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 162.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -63.32 -48.05 79.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.861 1.664 . . . . 0.0 110.086 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.28 -40.68 96.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.181 0.992 . . . . 0.0 111.644 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.46 -34.23 75.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.77 0.828 . . . . 0.0 110.152 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.79 -43.42 69.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.858 0.863 . . . . 0.0 110.419 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -57.57 -48.74 78.52 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.189 0.596 . . . . 0.0 111.042 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -64.58 -26.54 68.45 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.232 0.539 . . . . 0.0 112.085 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -7.2 46.63 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.391 1.476 . . . . 0.0 112.806 172.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.93 -14.46 23.07 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.32 1.048 . . . . 0.0 112.125 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -87.76 -1.95 58.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.43 1.092 . . . . 0.0 112.75 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.245 0.835 0 CA-C-N 120.167 1.349 . . . . 0.0 112.166 -163.451 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 mtt . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm 176.43 134.86 0.05 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 128.53 2.732 . . . . 0.0 104.266 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ptm -162.31 158.3 23.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.103 0.865 . . . . 0.0 109.961 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -160.07 125.05 3.92 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 121.041 -1.037 . . . . 0.0 109.985 -167.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' A' ' 113' ' ' ASP . 6.6 mmtp -128.12 -177.45 4.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.334 1.054 . . . . 0.0 109.821 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -134.29 179.62 6.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.5 1.92 . . . . 0.0 111.042 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p -138.4 173.32 11.73 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.711 1.596 . . . . 0.0 111.912 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.473 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -82.02 -2.89 53.19 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.253 2.221 . . . . 0.0 112.9 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -102.14 48.37 0.88 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 p80 45.54 57.01 5.25 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.153 1.381 . . . . 0.0 111.431 168.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -132.64 152.73 51.58 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.618 1.167 . . . . 0.0 108.33 -167.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.511 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.1 p-90 -124.43 162.53 23.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.081 0.952 . . . . 0.0 111.699 170.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.81 161.72 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.85 2.46 . . . . 0.0 107.705 172.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.73 94.57 1.9 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.464 1.906 . . . . 0.0 107.469 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.7 mt -98.54 95.03 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -78.11 -49.89 13.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.898 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.07 -71.68 0.68 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.259 0.936 . . . . 0.0 110.128 -171.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -138.94 10.31 2.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.627 1.571 . . . . 0.0 111.85 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -141.32 121.13 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -162.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 119.31 22.68 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.4 m -68.17 137.06 54.57 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 152.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.41 142.7 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.256 1.422 . . . . 0.0 109.772 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.71 176.73 34.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.728 HD11 HG21 ' A' ' 87' ' ' ILE . 13.8 pt -97.14 156.57 3.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 121.531 0.682 . . . . 0.0 110.697 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 169.59 17.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 112.57 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -24.28 62.52 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.64 -1.288 . . . . 0.0 111.367 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.65 -30.42 71.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.958 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.33 -47.99 66.06 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.037 -1.039 . . . . 0.0 112.468 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.3 pp0? -63.3 -19.82 64.94 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.66 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.01 -0.59 7.81 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.337 1.455 . . . . 0.0 113.434 173.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -115.04 -31.01 6.19 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 160.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.42 -46.49 54.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.44 -147.0 43.22 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.81 112.5 0.62 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.566 2.346 . . . . 0.0 110.51 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.711 HG22 ' H ' ' A' ' 36' ' ' VAL 0.345 9.0 p -108.31 165.7 4.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 123.309 1.528 . . . . 0.0 111.275 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.711 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -152.43 -28.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 112.442 -2.163 . . . . 0.0 108.839 -154.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -146.3 143.57 29.24 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.433 0.56 . . . . 0.0 110.846 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.57 125.91 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.656 1.582 . . . . 0.0 107.915 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.89 139.86 43.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.382 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.1 mt -133.04 139.25 33.82 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.73 1.212 . . . . 0.0 107.932 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.45 -179.63 5.36 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.269 2.646 . . . . 0.0 112.041 -176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.25 145.67 43.87 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.9 18.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 129.178 2.991 . . . . 0.0 115.36 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.17 13.46 0.46 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.183 1.849 . . . . 0.0 112.138 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -76.58 132.73 39.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.789 1.294 . . . . 0.0 108.96 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.98 152.41 33.14 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.983 0.81 . . . . 0.0 109.212 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.82 174.08 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 122.354 1.073 . . . . 0.0 111.07 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -112.28 170.2 8.34 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.317 2.247 . . . . 0.0 107.9 165.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.87 18.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.616 2.366 . . . . 0.0 115.221 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.08 59.14 0.24 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.2 131.12 56.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.742 1.217 . . . . 0.0 108.112 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 52' ' ' VAL 0.297 0.1 OUTLIER -77.69 27.51 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.877 2.871 . . . . 0.0 114.232 -168.032 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.06 12.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.76 54.26 1.17 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 109.555 171.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.83 159.3 2.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 122.121 0.962 . . . . 0.0 110.586 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.513 HG22 HG21 ' A' ' 35' ' ' VAL . 1.6 mt -139.85 135.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -127.76 110.99 13.16 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 p -99.15 -164.24 1.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.456 1.902 . . . . 0.0 110.775 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -45.89 -34.86 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.506 -1.235 . . . . 0.0 113.338 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -165.91 15.87 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 160.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.33 138.37 31.57 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 168.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.4 124.66 52.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 161.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.06 92.49 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.126 0.97 . . . . 0.0 109.303 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -58.72 108.06 0.6 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 0.0 108.8 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.22 93.75 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -82.41 109.74 16.92 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.666 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.87 150.01 0.39 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.922 2.489 . . . . 0.0 114.329 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.23 -36.53 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.819 1.679 . . . . 0.0 115.801 -161.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -148.03 139.57 23.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.114 1.365 . . . . 0.0 108.806 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -51.17 129.4 24.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.404 0.621 . . . . 0.0 109.393 170.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.03 -174.52 44.79 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 107.061 -2.416 . . . . 0.0 107.061 -161.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -142.56 127.95 18.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -166.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -59.52 142.46 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.7 m -145.99 -2.51 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -147.24 156.66 43.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 121.097 1.771 . . . . 0.0 108.44 165.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.83 153.47 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.045 0.938 . . . . 0.0 109.168 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -104.73 78.83 1.47 Allowed 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.446 0.698 . . . . 0.0 109.398 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -57.03 -14.88 4.12 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.979 0.912 . . . . 0.0 112.76 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -50.68 -39.56 51.46 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.989 1.716 . . . . 0.0 111.955 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.34 -3.25 26.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.56 0.744 . . . . 0.0 112.501 -170.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.86 -49.96 53.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.011 1.278 . . . . 0.0 109.16 160.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.0 p -92.34 -39.31 11.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.069 -162.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -117.33 67.39 4.86 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.097 1.759 . . . . 0.0 109.517 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.51 -44.83 5.75 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.953 3.769 . . . . 0.0 110.837 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 35' ' ' VAL . 14.7 tt0 -61.69 -4.45 1.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.125 1.37 . . . . 0.0 109.905 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -58.15 -13.58 5.19 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 121.426 1.921 . . . . 0.0 114.076 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 24' ' ' ILE . 4.2 mm -53.33 -39.68 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 118.619 0.645 . . . . 0.0 109.78 164.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -69.61 -55.79 9.11 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.046 1.339 . . . . 0.0 109.42 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -44.82 78.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.172 0.989 . . . . 0.0 113.03 -164.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -153.32 74.01 6.76 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -57.32 -23.5 54.96 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.776 2.317 . . . . 0.0 112.381 -172.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.511 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.2 mp0 -118.67 9.42 12.16 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.263 1.025 . . . . 0.0 112.147 -174.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.93 -110.29 2.7 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.244 1.878 . . . . 0.0 109.597 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.96 -28.29 69.42 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.458 1.129 . . . . 0.0 111.093 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.54 25.22 1.4 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-N 119.721 1.146 . . . . 0.0 115.76 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.422 ' CZ3' ' HG3' ' A' ' 99' ' ' LYS . 46.0 p-90 -67.57 163.06 22.05 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.288 1.544 . . . . 0.0 110.404 171.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mt -106.16 -66.96 0.96 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -140.92 175.95 9.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.569 1.147 . . . . 0.0 109.387 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.422 ' HG3' ' CZ3' ' A' ' 96' ' ' TRP . 65.9 mttt -131.88 152.45 51.03 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 124.307 1.043 . . . . 0.0 108.297 171.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.32 134.89 23.3 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.342 0.657 . . . . 0.0 110.04 -172.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.66 127.37 31.68 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 167.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.6 pt -76.53 109.18 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.1 m -65.97 -21.55 66.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.949 -0.47 . . . . 0.0 111.198 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -151.63 88.33 1.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -157.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -11.92 59.93 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.933 0.788 . . . . 0.0 111.662 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.78 -41.16 95.84 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.92 -22.66 66.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 117.416 -1.278 . . . . 0.0 111.928 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 111' ' ' LEU . 12.4 mt -52.62 -30.96 34.2 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -79.21 -11.38 59.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.596 0.635 . . . . 0.0 112.069 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -74.89 -34.44 62.19 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.815 -0.553 . . . . 0.0 110.928 168.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -72.65 158.98 34.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.743 1.259 . . . . 0.0 108.132 -173.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.469 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -74.42 130.85 40.42 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.476 ' OD1' ' HE2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -69.82 -167.81 0.16 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 164.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.14 -39.69 65.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 119.768 -1.832 . . . . 0.0 113.544 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.73 -48.44 31.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.45 81.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.139 0.274 . . . . 0.0 111.408 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -53.99 -54.77 34.48 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.101 0.961 . . . . 0.0 109.866 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -39.4 74.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.103 0.961 . . . . 0.0 111.652 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.86 -35.38 79.9 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.51 1.124 . . . . 0.0 111.677 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -72.76 -38.39 67.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.25 0.932 . . . . 0.0 110.592 167.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.6 t -69.18 5.07 1.34 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.214 1.805 . . . . 0.0 113.739 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.75 -42.91 11.04 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.357 1.063 . . . . 0.0 110.944 161.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -94.84 1.41 55.36 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.832 2.053 . . . . 0.0 113.868 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--O 1.246 0.917 0 C-N-CA 124.736 1.214 . . . . 0.0 109.077 174.116 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.1 tttp 50.11 72.9 0.29 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.607 1.563 . . . . 0.0 112.627 170.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.6 ttm -146.42 159.38 43.46 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.103 1.761 . . . . 0.0 107.168 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.11 116.8 13.96 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 119.977 -1.702 . . . . 0.0 110.842 157.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -112.99 -179.76 3.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -130.65 170.66 14.01 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 127.191 2.196 . . . . 0.0 110.855 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -117.79 -174.67 2.68 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.665 1.586 . . . . 0.0 109.126 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -106.71 10.68 30.86 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.816 1.246 . . . . 0.0 112.271 163.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -105.64 17.7 23.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.477 1.111 . . . . 0.0 111.26 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 72.23 42.5 0.56 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.892 2.077 . . . . 0.0 111.379 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -131.82 139.36 48.84 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.898 1.679 . . . . 0.0 110.879 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 69.9 p-90 -103.24 164.36 11.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.765 1.626 . . . . 0.0 109.583 171.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.57 99.54 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -86.84 91.88 8.8 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.741 -1.224 . . . . 0.0 110.668 173.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.548 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.2 mp -72.54 119.17 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -97.83 -72.94 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -116.49 -105.65 0.39 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -93.62 14.04 20.19 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.51 1.124 . . . . 0.0 110.698 166.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.27 152.06 35.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -123.16 137.07 54.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.784 1.633 . . . . 0.0 108.521 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -77.84 138.31 38.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 160.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.409 HG11 ' HD3' ' A' ' 68' ' ' PRO . 3.3 t -119.2 143.79 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.951 0.9 . . . . 0.0 109.669 171.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -148.75 165.93 29.23 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.979 -2.049 . . . . 0.0 107.979 164.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.6 pt -76.6 160.1 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.806 -0.82 . . . . 0.0 109.576 168.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.2 p -84.58 166.51 17.11 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.07 0.948 . . . . 0.0 111.304 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -34.63 67.07 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.652 -1.28 . . . . 0.0 111.267 175.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -58.36 -23.4 56.79 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.955 -1.09 . . . . 0.0 112.724 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.78 -49.64 8.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.414 -1.429 . . . . 0.0 111.349 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -56.09 -28.54 58.1 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.116 0.871 . . . . 0.0 110.899 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -55.83 -23.29 29.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.821 1.648 . . . . 0.0 113.288 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -109.63 -11.63 14.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.96 1.304 . . . . 0.0 112.776 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.52 -43.86 11.71 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.097 0.862 . . . . 0.0 111.0 173.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.75 -149.65 51.61 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -170.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -57.85 114.7 2.43 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.023 1.329 . . . . 0.0 109.228 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.658 HG22 ' H ' ' A' ' 36' ' ' VAL 0.344 8.4 p -105.65 167.57 3.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 124.192 1.949 . . . . 0.0 110.36 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.658 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.29 -30.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 112.316 -2.22 . . . . 0.0 107.396 -148.202 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -149.08 153.81 38.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.782 0.719 . . . . 0.0 111.329 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.571 HG22 HG23 ' A' ' 56' ' ' ILE . 69.1 t -145.3 118.73 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 127.304 2.242 . . . . 0.0 106.579 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -69.29 140.06 54.39 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.73 136.55 29.32 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -78.05 -172.74 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 124.157 3.238 . . . . 0.0 111.391 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.83 156.28 19.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.53 0.732 . . . . 0.0 111.897 171.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.78 13.63 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.031 1.732 . . . . 0.0 113.34 -172.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.21 12.94 0.61 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.654 2.073 . . . . 0.0 111.566 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -66.13 119.75 11.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -76.85 141.99 40.41 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 174.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.24 157.32 25.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 123.978 0.911 . . . . 0.0 110.352 -171.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -104.95 171.01 7.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.499 1.52 . . . . 0.0 109.446 167.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -65.38 13.88 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.39 25.93 0.68 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.55 1.072 . . . . 0.0 112.24 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -82.62 124.79 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 108.793 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.27 109.03 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.28 8.79 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 123.868 0.867 . . . . 0.0 111.646 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.28 51.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.806 -0.559 . . . . 0.0 110.173 -171.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.83 161.42 0.1 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 124.293 1.037 . . . . 0.0 112.709 175.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.571 HG23 HG22 ' A' ' 38' ' ' VAL . 2.9 mt -143.49 108.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -100.61 98.95 9.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.047 1.339 . . . . 0.0 107.924 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.5 ' HA ' HG23 ' A' ' 35' ' ' VAL . 24.2 p -84.55 -163.2 0.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.31 0.644 . . . . 0.0 110.487 174.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.01 -41.5 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.411 1.484 . . . . 0.0 112.538 170.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -167.6 20.53 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.009 0.923 . . . . 0.0 113.277 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.78 160.36 14.41 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 120.031 -1.668 . . . . 0.0 108.546 161.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.42 84.72 1.97 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 171.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.22 118.32 22.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -77.04 111.48 12.66 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 167.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG11 HD13 ' A' ' 97' ' ' LEU . 75.0 t -79.21 118.0 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 170.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -100.33 98.51 9.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.092 1.357 . . . . 0.0 111.759 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.75 135.62 1.25 Allowed Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.031 1.733 . . . . 0.0 113.301 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD3' HG11 ' A' ' 22' ' ' VAL . 55.9 Cg_endo -76.55 -37.47 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.486 2.124 . . . . 0.0 114.707 -161.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.42 164.59 16.88 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 m -69.12 137.16 53.2 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 155.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -163.61 33.79 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -135.27 129.55 33.76 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.4 mm -57.9 145.74 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.8 m -146.49 -2.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.749 0.82 . . . . 0.0 113.07 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -154.3 153.79 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.62 150.35 30.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -92.44 85.74 5.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -16.35 51.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -175.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -51.62 -36.34 45.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.272 1.829 . . . . 0.0 111.79 168.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -10.43 59.79 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.721 0.809 . . . . 0.0 111.567 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.26 -42.26 79.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.915 1.234 . . . . 0.0 109.552 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.6 p -95.64 -41.03 9.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.704 0.802 . . . . 0.0 111.25 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.19 72.54 9.47 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.431 1.892 . . . . 0.0 109.72 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.13 -38.8 4.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.06 3.173 . . . . 0.0 110.38 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HA ' HG12 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -60.18 -13.46 12.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.574 1.15 . . . . 0.0 111.363 -175.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -19.83 41.1 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 120.261 1.391 . . . . 0.0 112.815 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.8 mt -63.88 -26.22 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 121.519 -0.738 . . . . 0.0 110.893 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.35 -57.14 13.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.299 1.047 . . . . 0.0 109.263 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.19 -64.08 0.95 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.623 2.769 . . . . 0.0 110.355 -165.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -136.88 60.66 30.86 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -165.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.96 -15.48 39.13 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.151 2.567 . . . . 0.0 113.682 -169.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -125.5 7.57 7.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.632 2.373 . . . . 0.0 110.747 -170.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.42 -96.77 1.79 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 168.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.18 -20.28 32.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.204 0.602 . . . . 0.0 112.003 -171.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.0 32.85 4.19 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.43 1.014 . . . . 0.0 113.344 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 39.3 p-90 -65.5 160.6 21.87 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 1.373 . . . . 0.0 109.859 168.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 2.8 mt -104.71 -62.0 1.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -141.82 167.63 21.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.503 0.721 . . . . 0.0 111.459 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -117.5 150.57 38.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.282 1.033 . . . . 0.0 108.67 165.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.3 ptm -145.32 140.69 27.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.351 0.661 . . . . 0.0 109.864 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -64.0 121.51 14.29 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.559 1.144 . . . . 0.0 107.921 168.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.0 pt -71.51 98.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -75.37 -10.03 59.09 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.81 -0.557 . . . . 0.0 111.59 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -151.49 95.14 2.1 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.379 1.871 . . . . 0.0 107.068 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -8.61 55.33 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.63 -1.294 . . . . 0.0 111.507 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.92 -40.44 98.31 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -67.05 -9.97 44.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.728 1.611 . . . . 0.0 112.049 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.15 -20.27 65.72 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.756 1.162 . . . . 0.0 110.557 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -72.29 -18.0 61.83 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.894 1.224 . . . . 0.0 111.537 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.19 -19.81 49.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.052 0.842 . . . . 0.0 111.091 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.52 175.17 8.78 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.951 1.301 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.3 mt -106.44 149.63 26.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.863 1.265 . . . . 0.0 110.823 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.99 169.12 10.56 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.383 1.073 . . . . 0.0 108.294 163.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.67 -49.65 61.73 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.948 1.299 . . . . 0.0 109.843 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -60.56 -41.79 95.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.705 0.802 . . . . 0.0 110.612 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.88 -37.18 83.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.121 0.568 . . . . 0.0 110.718 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.03 -39.09 86.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.548 0.739 . . . . 0.0 110.692 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -47.66 84.37 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.272 0.629 . . . . 0.0 110.694 173.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.17 -26.07 65.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.547 0.612 . . . . 0.0 111.421 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -65.86 -27.19 68.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.2 -0.938 . . . . 0.0 111.861 167.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.94 -48.44 68.58 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.056 -1.027 . . . . 0.0 109.018 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.17 -20.61 64.32 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.522 0.601 . . . . 0.0 112.578 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -83.78 -15.45 48.42 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.716 1.606 . . . . 0.0 112.79 172.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.324 -172.271 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp 65.18 158.0 0.1 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.138 1.775 . . . . 0.0 110.136 -168.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 ptp -160.41 168.44 25.17 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.246 -1.534 . . . . 0.0 111.502 -167.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -159.82 70.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 110.143 -170.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -81.42 176.72 9.47 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.71 -1.244 . . . . 0.0 112.956 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 12' ' ' TRP . 23.7 m-85 -132.91 161.68 33.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.555 2.342 . . . . 0.0 111.723 -171.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -103.4 177.23 4.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 123.181 1.467 . . . . 0.0 109.68 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -101.39 19.16 18.32 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 112.91 -1.95 . . . . 0.0 109.504 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p -134.04 44.14 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.816 1.647 . . . . 0.0 109.894 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.0 p80 41.47 55.07 3.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.534 1.534 . . . . 0.0 113.118 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -143.81 134.39 24.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.751 2.021 . . . . 0.0 107.479 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 58.9 p-90 -92.65 172.72 8.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.234 1.414 . . . . 0.0 109.29 167.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.53 148.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.46 90.98 2.51 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.027 0.531 . . . . 0.0 111.696 -177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.0 mt -95.76 102.87 14.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.991 1.316 . . . . 0.0 107.468 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -79.02 -76.49 0.2 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.245 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -106.07 -82.71 0.53 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.081 0.855 . . . . 0.0 109.219 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.18 13.72 11.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.834 0.854 . . . . 0.0 111.339 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -137.41 126.08 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.45 154.86 20.03 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.938 0.875 . . . . 0.0 108.843 162.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.9 m -106.5 155.4 19.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.994 157.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.63 142.64 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.239 3.416 . . . . 0.0 104.765 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -160.37 32.66 0.4 Allowed Glycine 0 N--CA 1.477 1.376 0 N-CA-C 119.021 2.368 . . . . 0.0 119.021 173.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.541 HD11 ' CG2' ' A' ' 87' ' ' ILE . 27.6 pt 44.07 162.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 131.215 3.806 . . . . 0.0 114.663 -169.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.9 p -93.46 170.78 9.35 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 119.496 -2.003 . . . . 0.0 110.92 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -31.36 70.98 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.629 -1.294 . . . . 0.0 111.659 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -59.45 -24.21 63.35 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.043 0.937 . . . . 0.0 111.66 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.71 -54.22 6.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.945 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.11 -26.8 51.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.424 0.69 . . . . 0.0 111.947 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.56 -54.62 41.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.138 1.775 . . . . 0.0 110.928 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -62.18 -49.01 77.51 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.245 1.018 . . . . 0.0 110.63 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -67.82 -38.57 83.42 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.363 1.065 . . . . 0.0 109.515 179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.74 -118.77 10.14 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.192 1.853 . . . . 0.0 108.928 -168.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.6 159.59 21.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.685 0.755 . . . . 0.0 109.681 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.004 HG12 ' H ' ' A' ' 36' ' ' VAL . 6.4 t -132.74 -172.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.014 1.325 . . . . 0.0 107.914 171.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.004 ' H ' HG12 ' A' ' 35' ' ' VAL . 3.1 m -159.35 -34.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 129.307 3.043 . . . . 0.0 109.583 -168.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.445 ' H ' HG12 ' A' ' 35' ' ' VAL . 32.3 t80 -151.4 164.99 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.49 124.47 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 127.045 2.138 . . . . 0.0 107.379 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.68 140.17 38.4 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.807 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.6 mt -138.98 144.76 42.54 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.223 0.609 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.4 178.19 7.69 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.941 3.094 . . . . 0.0 111.454 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -86.58 160.41 18.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 0.0 110.581 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.11 17.22 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 127.177 2.191 . . . . 0.0 114.487 -167.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.4 11.4 0.47 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.977 2.227 . . . . 0.0 113.025 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -71.0 127.96 34.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.132 1.466 . . . . 0.0 109.929 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.69 146.21 46.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.762 1.165 . . . . 0.0 110.924 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.53 144.47 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.905 1.682 . . . . 0.0 108.991 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -83.25 172.31 12.72 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.109 -0.995 . . . . 0.0 111.414 168.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 12.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.254 2.221 . . . . 0.0 116.182 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.25 65.48 0.22 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.92 121.98 15.72 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.2 OUTLIER -72.76 35.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 1 C-N-CA 132.003 4.121 . . . . 0.0 113.308 -166.834 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 m -70.12 6.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 118.827 -2.421 . . . . 0.0 115.291 -168.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.7 55.76 1.2 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.897 1.226 . . . . 0.0 111.465 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.69 163.81 3.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.769 1.271 . . . . 0.0 112.532 -178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 mt -131.91 114.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -166.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.53 126.52 51.69 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 167.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.469 ' HB3' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -108.0 -165.62 1.06 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.04 2.536 . . . . 0.0 108.388 178.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.26 -24.74 32.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 127.701 2.4 . . . . 0.0 112.375 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.23 12.6 0.19 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.604 1.093 . . . . 0.0 113.93 166.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.613 ' HB3' HD13 ' A' ' 32' ' ' LEU . . . -115.02 155.42 27.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.143 -0.973 . . . . 0.0 109.944 173.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.66 100.03 3.6 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.05 179.21 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.469 1.508 . . . . 0.0 111.078 -166.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.18 139.06 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.586 1.955 . . . . 0.0 108.475 -163.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.608 HG11 HD13 ' A' ' 97' ' ' LEU . 54.7 t -112.35 108.59 25.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 167.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.0 107.67 20.21 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.808 0.731 . . . . 0.0 109.895 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -43.48 142.39 1.77 Allowed Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.451 1.101 . . . . 0.0 112.485 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.13 -28.1 2.6 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.85 2.366 . . . . 0.0 114.596 -158.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mt -153.19 145.34 23.83 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.496 2.718 . . . . 0.0 104.906 -162.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 m -68.11 128.03 35.04 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 103' ' ' SER . . . -175.01 -166.53 32.96 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 124.496 1.046 . . . . 0.0 111.559 -170.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -137.02 130.3 31.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.506 HD12 ' CD1' ' A' ' 98' ' ' PHE . 8.9 mm -58.78 144.63 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.515 1.126 . . . . 0.0 108.287 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.9 m -146.98 3.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -155.14 156.01 34.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.614 1.552 . . . . 0.0 108.535 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 m -133.09 157.68 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.788 1.235 . . . . 0.0 109.081 170.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -101.15 84.73 2.69 Favored 'General case' 0 C--O 1.23 0.057 0 C-N-CA 123.347 0.659 . . . . 0.0 109.455 -174.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -60.1 -3.38 0.57 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.803 1.241 . . . . 0.0 113.586 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -54.86 -52.77 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.301 -1.499 . . . . 0.0 109.982 160.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.53 ' CD1' HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -63.94 -25.39 68.12 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 126.018 1.727 . . . . 0.0 112.111 -163.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -59.72 -23.81 63.48 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.641 1.176 . . . . 0.0 111.827 173.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.2 p -125.69 -20.82 4.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.678 1.591 . . . . 0.0 112.107 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -133.62 70.01 76.13 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 126.304 1.841 . . . . 0.0 108.4 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.48 -4.75 15.96 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.576 3.517 . . . . 0.0 111.689 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.82 -8.44 43.56 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.986 1.714 . . . . 0.0 112.091 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.7 mt -70.94 -22.97 62.16 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 120.06 -1.65 . . . . 0.0 111.543 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.541 ' CG2' HD11 ' A' ' 24' ' ' ILE . 8.5 mt -58.17 -26.29 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.297 169.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -72.11 -55.29 7.57 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.684 1.584 . . . . 0.0 110.585 164.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -35.22 80.46 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.115 0.966 . . . . 0.0 111.884 -161.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.35 78.72 1.1 Allowed Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 174.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.57 -34.45 95.37 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 CA-C-N 120.948 1.374 . . . . 0.0 110.328 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -100.09 -5.69 27.53 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.959 1.304 . . . . 0.0 111.946 -171.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.69 -69.19 0.96 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -119.68 -21.13 7.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.541 1.136 . . . . 0.0 112.769 -167.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.91 26.07 3.87 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.805 1.669 . . . . 0.0 115.351 -174.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 45.0 p-90 -63.53 158.92 19.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 119.388 1.594 . . . . 0.0 111.642 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.608 HD13 HG11 ' A' ' 65' ' ' VAL . 1.1 mt -99.46 -67.43 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.506 ' CD1' HD12 ' A' ' 73' ' ' ILE . 15.2 p90 -142.22 166.1 25.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.264 1.826 . . . . 0.0 110.617 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -113.84 154.68 27.06 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.023 1.329 . . . . 0.0 108.933 168.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.0 ptm -145.48 143.32 29.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.084 0.553 . . . . 0.0 110.688 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.31 137.23 57.4 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.902 1.281 . . . . 0.0 107.881 168.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.5 pt -76.29 155.92 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 O-C-N 123.444 0.465 . . . . 0.0 109.96 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.505 ' HB2' ' HA2' ' A' ' 71' ' ' GLY . 0.4 OUTLIER -133.53 -13.03 2.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.56 112.68 3.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 168.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -83.95 -15.68 46.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.089 1.755 . . . . 0.0 110.622 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.66 -29.36 71.79 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.085 1.326 . . . . 0.0 111.437 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.61 -7.89 58.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 112.609 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.02 -41.23 82.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.442 1.474 . . . . 0.0 110.639 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.23 -19.09 63.95 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.493 0.588 . . . . 0.0 111.065 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -70.91 -17.11 62.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.097 1.359 . . . . 0.0 111.702 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.81 169.59 13.22 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.186 1.794 . . . . 0.0 110.399 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.37 153.42 20.44 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.641 0.776 . . . . 0.0 109.89 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.63 171.14 6.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 163.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.78 -45.64 70.81 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.11 -40.11 96.66 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.651 1.18 . . . . 0.0 111.005 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.56 82.7 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.082 0.401 . . . . 0.0 111.308 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -64.48 -36.51 84.42 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.527 0.731 . . . . 0.0 111.766 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.04 -47.85 71.14 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.491 0.587 . . . . 0.0 110.343 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -62.0 -39.54 92.56 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 118.183 0.447 . . . . 0.0 110.149 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -62.15 -27.22 68.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.45 0.568 . . . . 0.0 111.862 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 55.5 m -82.66 -5.46 58.85 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.825 -1.172 . . . . 0.0 113.873 171.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.96 -2.24 53.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.949 1.249 . . . . 0.0 111.4 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -122.05 24.93 9.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.863 2.065 . . . . 0.0 108.986 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 127.2 2.2 . . . . 0.0 107.456 -175.505 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 tttp 30.86 77.36 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.818 2.447 . . . . 0.0 112.534 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.4 ttm -142.86 150.5 39.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -173.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 110.53 7.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -111.34 -179.94 3.86 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.415 1.086 . . . . 0.0 109.946 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.58 163.56 32.53 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.032 0.933 . . . . 0.0 110.361 -170.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.1 p -114.68 -179.79 3.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.552 1.644 . . . . 0.0 110.642 168.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HG2' ' H ' ' A' ' 8' ' ' LYS . 11.1 ptpt -63.63 -24.48 67.81 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.072 2.149 . . . . 0.0 115.226 160.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -84.05 24.01 0.98 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.732 1.151 . . . . 0.0 111.67 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 52.89 56.42 7.6 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 125.391 1.476 . . . . 0.0 109.569 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -140.28 148.85 42.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.856 2.063 . . . . 0.0 108.236 -167.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -128.03 153.55 46.64 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.99 1.716 . . . . 0.0 110.956 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.14 151.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 C-N-CA 127.188 2.195 . . . . 0.0 106.499 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -141.4 72.3 1.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.282 1.433 . . . . 0.0 108.807 -178.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 15' ' ' ILE . 3.7 mp -70.57 134.1 30.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 127.064 2.145 . . . . 0.0 106.427 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -125.78 -61.44 1.25 Allowed 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.315 -0.866 . . . . 0.0 110.981 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.03 -76.65 0.59 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -126.79 4.44 6.66 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.041 1.336 . . . . 0.0 112.635 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.76 135.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.11 142.35 29.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 35.8 m -75.87 147.51 39.01 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 151.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.14 130.29 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 129.003 2.921 . . . . 0.0 107.187 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.41 172.68 26.92 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 167.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 87' ' ' ILE . 12.2 pt -91.66 152.54 3.37 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.38 0.672 . . . . 0.0 109.863 173.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.7 p -82.29 170.85 14.91 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.973 -1.08 . . . . 0.0 111.206 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -21.82 66.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.926 -1.109 . . . . 0.0 113.345 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -61.59 -29.46 70.05 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.0 -1.062 . . . . 0.0 111.56 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.412 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -72.4 -46.16 56.46 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.974 -1.079 . . . . 0.0 111.432 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -64.93 -24.25 67.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.198 0.599 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.49 -47.84 68.87 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 126.553 1.941 . . . . 0.0 108.389 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -70.7 -52.6 19.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.833 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mt -73.13 -33.03 65.29 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.286 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -133.46 15.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.46 147.71 40.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.694 1.198 . . . . 0.0 107.804 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.818 HG12 ' H ' ' A' ' 36' ' ' VAL . 21.4 t -121.48 -149.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.969 1.707 . . . . 0.0 106.559 178.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.818 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER 179.8 -40.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 130.34 3.456 . . . . 0.0 108.406 -166.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.456 ' H ' HG12 ' A' ' 35' ' ' VAL . 41.1 t80 -150.43 154.52 37.88 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.267 1.394 . . . . 0.0 113.776 -176.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.06 131.33 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 125.189 1.396 . . . . 0.0 107.767 170.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.9 147.76 26.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.686 2.394 . . . . 0.0 108.777 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -144.61 148.88 41.64 Favored Pre-proline 0 N--CA 1.449 -0.481 0 C-N-CA 125.048 1.339 . . . . 0.0 109.6 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.06 179.98 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.212 2.608 . . . . 0.0 114.377 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 152.04 21.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.109 0.963 . . . . 0.0 110.518 170.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.93 11.91 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 128.349 2.66 . . . . 0.0 115.037 -168.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.16 10.83 1.36 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 126.111 1.815 . . . . 0.0 112.47 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.451 ' CZ ' HG12 ' A' ' 53' ' ' VAL . 72.2 ttt180 -70.14 128.68 37.12 Favored 'General case' 0 CA--C 1.527 0.088 0 O-C-N 121.288 -1.124 . . . . 0.0 108.027 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.85 153.79 30.31 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.405 HG12 HG11 ' A' ' 53' ' ' VAL . 35.3 m -142.94 170.88 10.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.893 1.277 . . . . 0.0 109.849 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -122.56 166.24 15.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 125.014 1.326 . . . . 0.0 109.597 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -62.13 7.87 0.05 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -155.34 75.61 0.22 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 167.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.22 114.36 13.73 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.579 1.151 . . . . 0.0 109.558 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.48 93.29 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.944 1.697 . . . . 0.0 108.145 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.451 HG12 ' CZ ' ' A' ' 45' ' ' ARG . 8.3 m -115.27 -3.5 10.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.852 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -144.99 53.21 1.21 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.763 0.664 . . . . 0.0 111.925 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.66 155.44 5.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.787 0.835 . . . . 0.0 111.348 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' CD1' HD13 ' A' ' 24' ' ' ILE . 8.4 mt -129.42 94.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.0 mt-10 -82.04 108.34 15.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 88.1 p -88.92 -169.52 2.56 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.604 1.162 . . . . 0.0 110.559 172.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.1 m -53.78 -29.35 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.684 1.193 . . . . 0.0 111.905 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -163.73 29.69 0.08 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -149.9 161.54 42.09 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.483 -0.761 . . . . 0.0 109.504 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.56 105.4 8.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.601 1.561 . . . . 0.0 107.606 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.01 119.78 22.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 131.03 38.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 163.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.49 106.72 21.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -99.72 107.4 19.48 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 110.629 -162.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -36.37 122.89 0.75 Allowed Pre-proline 0 C--O 1.224 -0.239 0 C-N-CA 126.747 2.019 . . . . 0.0 111.284 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.38 -23.55 7.27 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.637 1.558 . . . . 0.0 114.848 -161.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.74 161.61 32.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.418 1.887 . . . . 0.0 105.911 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.4 m -77.98 149.67 34.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.7 -162.97 34.39 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 120.101 -1.624 . . . . 0.0 110.167 -172.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -132.53 131.89 42.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.114 0.957 . . . . 0.0 109.844 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.49 HD12 ' CD1' ' A' ' 98' ' ' PHE . 13.3 mm -61.3 137.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.708 1.603 . . . . 0.0 108.167 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.71 1.12 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 123.955 0.784 . . . . 0.0 112.966 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -150.75 153.32 35.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 162.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.45 166.07 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.159 1.345 . . . . 0.0 109.827 172.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -110.4 82.01 1.53 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -59.86 -15.09 18.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.79 0.836 . . . . 0.0 112.255 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -55.87 -31.63 62.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.339 1.055 . . . . 0.0 112.416 169.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.87 -13.93 62.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.191 0.905 . . . . 0.0 109.828 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.49 -16.91 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.87 1.268 . . . . 0.0 111.953 171.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -129.95 -17.85 3.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.773 0.829 . . . . 0.0 112.267 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.06 71.71 72.96 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.941 1.697 . . . . 0.0 107.904 167.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.52 -17.53 59.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.759 2.306 . . . . 0.0 108.949 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.51 -4.75 59.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.268 1.027 . . . . 0.0 112.734 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.6 mt -66.08 -18.15 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.468 -1.395 . . . . 0.0 111.993 171.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.757 HG21 HD11 ' A' ' 24' ' ' ILE . 32.7 mt -62.94 -34.85 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.223 1.009 . . . . 0.0 109.561 171.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.08 -52.4 49.18 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.138 -1.602 . . . . 0.0 109.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -37.3 86.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.505 -162.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.18 79.92 0.52 Allowed Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.42 -14.95 41.22 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.135 1.89 . . . . 0.0 112.168 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -125.15 43.76 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.579 1.552 . . . . 0.0 108.316 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.34 -100.26 0.34 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 162.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -76.38 -26.57 55.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.96 -1.019 . . . . 0.0 112.505 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.5 39.52 2.92 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.347 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -69.39 164.02 23.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.871 1.336 . . . . 0.0 110.344 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.28 -65.16 0.98 Allowed 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.49 ' CD1' HD12 ' A' ' 73' ' ' ILE . 48.8 p90 -148.78 173.51 13.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.2 1.0 . . . . 0.0 110.04 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -127.21 153.8 45.63 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.658 1.183 . . . . 0.0 109.022 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.4 ptm -149.9 135.88 18.68 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.159 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -54.76 125.56 20.54 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.061 1.744 . . . . 0.0 107.357 167.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 21.4 pt -73.28 129.84 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 89.3 p -75.62 -41.92 53.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 166.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -142.83 90.53 2.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.981 0.913 . . . . 0.0 108.648 -160.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -10.1 0.98 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.319 1.048 . . . . 0.0 111.904 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -90.47 -15.97 56.05 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.571 1.558 . . . . 0.0 112.591 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.87 -16.29 60.08 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.561 1.181 . . . . 0.0 110.29 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.2 mt -60.64 -29.17 69.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.437 0.695 . . . . 0.0 110.927 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -95.38 27.63 3.25 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.011 -1.056 . . . . 0.0 111.36 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -116.71 0.5 12.6 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.381 147.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -84.41 -177.62 6.68 Favored 'General case' 0 C--N 1.34 0.186 0 O-C-N 120.683 -1.261 . . . . 0.0 109.837 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -91.3 127.92 36.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 107.656 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.93 178.29 1.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.374 1.083 . . . . 0.0 109.472 160.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -69.65 -49.53 52.86 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.273 1.029 . . . . 0.0 112.02 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.28 -44.28 95.49 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.905 0.882 . . . . 0.0 109.037 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.71 90.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.138 0.575 . . . . 0.0 111.148 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.76 -41.72 78.48 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.242 -0.911 . . . . 0.0 111.118 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -44.01 68.04 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.649 1.58 . . . . 0.0 109.97 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -52.1 -56.54 13.81 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.094 0.957 . . . . 0.0 110.49 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.04 -46.21 78.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.558 0.343 . . . . 0.0 110.283 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 4.3 t -66.43 -13.95 61.5 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.912 -1.118 . . . . 0.0 113.074 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.94 15.12 18.57 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.21 1.404 . . . . 0.0 111.117 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -4.31 25.6 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.183 -0.948 . . . . 0.0 111.334 169.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 . . . . . 0 C--O 1.248 0.978 0 C-N-CA 124.948 1.299 . . . . 0.0 109.047 -166.68 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -161.17 124.69 3.31 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 159.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 ttp -136.03 162.14 33.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.6 1.56 . . . . 0.0 107.958 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' HE3' ' HA ' ' A' ' 14' ' ' SER . 21.0 ttmt -145.09 148.2 33.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.669 -1.269 . . . . 0.0 107.733 155.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -127.01 176.1 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -139.43 168.08 20.62 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.549 1.94 . . . . 0.0 108.827 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 68' ' ' PRO . 7.7 p -130.53 177.16 7.57 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.938 1.352 . . . . 0.0 111.311 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -76.25 -25.46 55.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.518 1.527 . . . . 0.0 110.856 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 0.6 OUTLIER -82.28 17.33 1.71 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.68 1.127 . . . . 0.0 111.272 171.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 65.34 59.18 0.82 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.23 1.812 . . . . 0.0 110.663 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -111.58 165.45 12.0 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.167 0.987 . . . . 0.0 110.388 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.415 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 50.4 p-90 -131.37 152.81 50.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.865 1.666 . . . . 0.0 109.227 168.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 t -135.78 89.64 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.961 1.704 . . . . 0.0 107.407 -168.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HE3' ' A' ' 4' ' ' LYS . 5.7 m -72.86 82.37 1.19 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.25 1.82 . . . . 0.0 112.986 -175.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.789 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 13.5 mm -87.41 127.29 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -141.61 -21.57 0.74 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.124 -0.985 . . . . 0.0 112.945 -170.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -141.19 -105.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 157.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -111.49 9.66 21.32 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.82 1.648 . . . . 0.0 111.015 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.05 144.24 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 168.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . . . -109.06 141.88 40.58 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.454 1.102 . . . . 0.0 108.565 160.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 m -85.67 136.06 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 156.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.5 124.18 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 130.249 3.42 . . . . 0.0 110.67 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.62 170.96 33.6 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.007 1.289 . . . . 0.0 110.49 168.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 pt -90.7 148.27 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.784 -0.833 . . . . 0.0 108.818 172.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.9 p -76.28 157.92 32.06 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.32 -0.862 . . . . 0.0 111.144 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.4 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 7.5 t-20 -58.44 22.79 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 1 C-N-CA 135.451 5.5 . . . . 0.0 116.054 176.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -107.5 -40.08 5.45 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 127.566 2.346 . . . . 0.0 112.402 164.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.79 -51.66 21.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.215 2.206 . . . . 0.0 116.07 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.555 ' NE2' ' H ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -42.08 -45.7 4.03 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 129.385 3.074 . . . . 0.0 109.75 174.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.555 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -51.69 -48.07 63.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.271 1.428 . . . . 0.0 112.284 176.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -68.75 -23.13 64.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.571 1.148 . . . . 0.0 111.517 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -89.05 -28.48 20.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.607 0.64 . . . . 0.0 112.385 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.43 -137.36 37.39 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 126.178 1.847 . . . . 0.0 110.555 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.28 112.98 2.93 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -86.28 -171.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 122.596 1.189 . . . . 0.0 109.038 170.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.584 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.7 p -173.15 -40.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 127.267 2.227 . . . . 0.0 106.348 -150.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.505 ' H ' HG12 ' A' ' 35' ' ' VAL . 36.2 t80 -154.48 149.68 27.02 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.73 135.43 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 125.668 1.587 . . . . 0.0 107.967 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -91.54 143.99 26.02 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.551 2.341 . . . . 0.0 108.155 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -141.66 138.36 17.2 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.936 0.894 . . . . 0.0 109.031 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.75 175.71 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.088 2.525 . . . . 0.0 112.325 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.19 147.93 29.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.925 -1.11 . . . . 0.0 109.718 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.19 17.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 128.464 2.706 . . . . 0.0 115.528 -168.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.77 3.85 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.311 2.386 . . . . 0.0 112.319 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -60.71 138.87 58.05 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.571 1.186 . . . . 0.0 108.388 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.61 141.36 28.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.71 170.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.952 0.901 . . . . 0.0 110.182 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -127.57 159.75 33.67 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.996 0.918 . . . . 0.0 110.672 176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 10.55 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.914 2.486 . . . . 0.0 115.151 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.12 68.19 0.19 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 173.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -140.42 129.28 23.22 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.2 t -79.35 110.7 15.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -173.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -2.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.767 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.35 45.29 0.72 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.417 -176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.3 m -48.29 145.86 3.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.246 1.419 . . . . 0.0 113.156 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.8 mt -122.2 107.49 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -94.3 128.84 41.04 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.3 p -105.03 -172.68 2.14 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.299 0.954 . . . . 0.0 109.967 172.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 m -52.36 -27.17 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.37 1.468 . . . . 0.0 112.616 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -158.29 29.77 0.24 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.918 1.235 . . . . 0.0 113.76 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.54 -179.31 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 121.007 -1.058 . . . . 0.0 109.993 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.34 44.43 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 126.746 2.018 . . . . 0.0 108.35 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.31 111.65 8.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 126.596 1.959 . . . . 0.0 107.01 160.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.43 114.95 7.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -77.78 101.44 3.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -68.15 124.15 22.66 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.08 132.95 30.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.995 0.918 . . . . 0.0 109.728 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HB3' HG21 ' A' ' 7' ' ' THR . 32.9 Cg_endo -81.01 -31.84 1.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.221 1.947 . . . . 0.0 114.285 -168.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.67 157.99 35.89 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.538 1.935 . . . . 0.0 106.981 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 m -77.16 153.62 33.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.45 -171.05 31.68 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -165.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -136.38 130.88 33.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -63.62 150.21 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.432 1.093 . . . . 0.0 108.374 -173.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.68 3.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.689 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -156.73 160.12 38.99 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 121.373 1.897 . . . . 0.0 109.501 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.68 168.0 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.728 1.611 . . . . 0.0 109.59 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -117.71 78.71 1.26 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.641 1.177 . . . . 0.0 109.035 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.55 -11.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.169 0.987 . . . . 0.0 112.958 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -53.14 -31.68 43.68 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.683 -1.26 . . . . 0.0 111.042 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -21.36 59.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.241 1.017 . . . . 0.0 110.079 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.38 -5.95 16.82 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.549 1.939 . . . . 0.0 113.293 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -137.42 -34.35 0.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.552 -0.718 . . . . 0.0 110.229 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.1 62.07 19.19 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.323 2.249 . . . . 0.0 109.113 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.16 -20.49 28.34 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 124.177 3.251 . . . . 0.0 110.263 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.83 -17.32 49.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.699 1.2 . . . . 0.0 110.587 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.5 mt -67.86 -16.76 64.24 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.653 1.57 . . . . 0.0 114.383 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 mt -67.4 -23.72 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.26 0.936 . . . . 0.0 109.816 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -76.16 -53.73 7.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 119.967 -1.708 . . . . 0.0 109.918 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -59.99 -40.5 89.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.151 0.981 . . . . 0.0 112.084 -167.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.75 76.63 2.26 Favored Pre-proline 0 C--N 1.333 -0.136 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.15 -19.71 67.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.407 2.072 . . . . 0.0 113.315 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.3 mt-10 -124.19 22.32 8.66 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.43 1.013 . . . . 0.0 111.288 -171.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.06 -82.14 0.17 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 166.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -83.36 -38.83 21.5 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -80.49 46.32 3.24 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.793 1.179 . . . . 0.0 114.15 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -81.3 168.37 18.51 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.249 1.024 . . . . 0.0 109.704 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.63 -69.25 0.84 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -138.48 173.18 11.87 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.557 0.743 . . . . 0.0 111.349 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -128.38 150.36 50.14 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -144.84 148.69 34.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.054 0.542 . . . . 0.0 110.141 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.94 117.48 11.57 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.258 1.823 . . . . 0.0 107.778 168.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.412 HG21 ' CD1' ' A' ' 15' ' ' ILE . 2.9 pt -70.1 97.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.587 1.184 . . . . 0.0 107.963 163.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.1 m -60.67 -34.73 74.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.028 167.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -134.95 82.72 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -163.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.476 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -65.15 -12.81 55.0 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.464 -0.772 . . . . 0.0 110.235 172.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.77 -28.31 73.19 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 117.549 -1.695 . . . . 0.0 112.202 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -80.43 -29.22 37.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.958 1.879 . . . . 0.0 110.61 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 105' ' ' GLU . 17.8 mt -41.81 -46.08 3.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.142 1.792 . . . . 0.0 111.83 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.49 -11.34 60.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -76.05 -35.62 59.38 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 165.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 108' ' ' LEU . 2.4 mm? -64.88 171.02 3.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 123.693 1.711 . . . . 0.0 110.979 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.7 mt -70.54 120.82 16.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.022 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.4 -179.47 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.266 1.426 . . . . 0.0 110.231 163.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.64 -37.96 70.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.271 -1.518 . . . . 0.0 110.986 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -69.73 -46.1 66.66 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.27 1.428 . . . . 0.0 109.024 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.44 66.5 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.013 0.925 . . . . 0.0 111.875 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -63.47 -48.14 78.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.573 1.149 . . . . 0.0 109.506 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.0 -41.85 79.23 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -56.17 -46.95 79.14 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.817 0.847 . . . . 0.0 110.084 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -61.46 -40.92 96.27 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.24 -0.913 . . . . 0.0 111.671 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.49 -14.89 8.95 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 171.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.56 -17.77 29.51 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 120.523 1.51 . . . . 0.0 111.757 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -115.81 32.35 6.14 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.701 2.401 . . . . 0.0 108.601 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.61 -1.662 . . . . 0.0 111.891 -175.812 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.7 mtt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.83 150.46 1.47 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 31.1 tpp -147.43 154.23 40.58 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.126 1.37 . . . . 0.0 108.767 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -142.09 112.47 7.1 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.964 -1.085 . . . . 0.0 109.892 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -105.63 -179.23 3.88 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.732 0.645 . . . . 0.0 111.56 162.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -136.69 176.75 8.42 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.408 1.883 . . . . 0.0 111.568 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -134.96 166.09 23.82 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.894 1.277 . . . . 0.0 111.512 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 10' ' ' HIS . 2.1 mtmt -71.91 -34.54 69.18 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.769 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -71.58 42.33 0.08 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 119.35 0.977 . . . . 0.0 109.611 165.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 8' ' ' LYS . 5.1 p80 38.97 63.97 0.85 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 127.726 2.411 . . . . 0.0 112.509 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 11.1 mt-10 -128.17 169.14 14.47 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.081 0.952 . . . . 0.0 109.361 168.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -113.35 172.27 7.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.833 2.053 . . . . 0.0 109.435 161.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' A' ' 20' ' ' ALA . 2.3 t -136.4 142.89 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 127.757 2.423 . . . . 0.0 105.279 174.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.77 80.11 1.78 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 119.557 1.071 . . . . 0.0 110.893 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.4 mp -62.39 140.02 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 168.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -117.23 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 160.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.68 -94.83 0.44 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -123.22 33.35 5.4 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 128.152 2.581 . . . . 0.0 110.849 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.16 119.43 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 164.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -102.06 107.04 18.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.856 1.663 . . . . 0.0 107.607 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -70.23 126.39 29.52 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.824 0.85 . . . . 0.0 109.145 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.54 HG11 ' CE1' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -95.12 148.52 5.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 C-N-CA 128.545 2.738 . . . . 0.0 112.618 169.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.19 161.39 32.0 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 108.124 -1.99 . . . . 0.0 108.124 157.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.434 ' CD1' HG21 ' A' ' 87' ' ' ILE . 3.3 pt -84.49 139.4 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 118.939 1.37 . . . . 0.0 108.6 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.7 p -73.51 172.99 10.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.564 -0.71 . . . . 0.0 111.466 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -59.19 -33.81 71.4 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.618 -1.301 . . . . 0.0 113.245 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -54.25 -24.1 17.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.893 1.277 . . . . 0.0 111.616 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.52 -48.75 10.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.264 1.025 . . . . 0.0 112.152 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.0 pp0? -62.45 -20.02 64.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.084 0.856 . . . . 0.0 110.302 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -58.67 -26.52 63.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.647 1.979 . . . . 0.0 112.958 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -90.04 -42.01 11.38 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 120.155 1.343 . . . . 0.0 113.387 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mt -89.14 -33.0 17.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -170.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.44 -118.78 7.26 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.848 1.69 . . . . 0.0 111.606 -174.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.79 112.88 3.07 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.213 1.805 . . . . 0.0 107.81 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -98.11 -165.4 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.047 0.927 . . . . 0.0 109.849 179.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.669 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -172.85 -31.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 129.62 3.168 . . . . 0.0 109.545 -168.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' H ' HG12 ' A' ' 35' ' ' VAL . 37.0 t80 -150.12 147.41 27.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.526 1.057 . . . . 0.0 111.326 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 56' ' ' ILE . 22.8 t -138.99 115.88 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -63.21 140.71 58.9 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.998 165.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.3 mt -134.17 137.01 27.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 125.486 1.515 . . . . 0.0 107.576 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.87 -163.69 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.546 2.831 . . . . 0.0 112.643 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -113.69 145.32 41.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.854 1.662 . . . . 0.0 108.288 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.41 16.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -165.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.54 13.84 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.92 1.724 . . . . 0.0 112.671 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -79.39 137.38 37.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.524 1.662 . . . . 0.0 109.491 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -77.13 154.48 33.19 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.996 0.816 . . . . 0.0 109.872 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.448 HG11 HD11 ' A' ' 73' ' ' ILE . 35.6 m -140.46 164.71 21.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.515 1.126 . . . . 0.0 110.566 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -111.08 165.45 11.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 126.427 1.891 . . . . 0.0 107.983 167.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -60.77 10.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.729 2.012 . . . . 0.0 115.78 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.3 92.13 0.12 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 162.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.07 126.83 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -72.27 20.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 126.47 1.908 . . . . 0.0 113.976 -166.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.03 11.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 127.118 2.167 . . . . 0.0 116.196 -165.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.1 49.08 0.84 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.899 1.28 . . . . 0.0 108.79 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.8 m -49.43 157.22 0.53 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.402 1.096 . . . . 0.0 111.123 169.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.458 HG23 HG22 ' A' ' 38' ' ' VAL . 5.3 mt -142.0 100.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -86.2 118.93 25.96 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -90.37 -167.94 1.97 Allowed 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.484 1.514 . . . . 0.0 109.511 168.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -39.53 -52.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 126.054 1.742 . . . . 0.0 112.392 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -155.04 52.4 0.62 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.883 1.219 . . . . 0.0 111.81 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.3 177.37 10.64 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.179 -0.951 . . . . 0.0 109.194 163.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.19 114.04 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.506 1.523 . . . . 0.0 108.34 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.77 100.04 11.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.21 111.16 2.47 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.11 109.69 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -81.97 108.05 15.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 121.721 -0.612 . . . . 0.0 109.767 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -38.49 142.63 0.48 Allowed Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 126.826 2.05 . . . . 0.0 113.067 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.8 -35.9 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 119.617 0.899 . . . . 0.0 113.783 -161.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.537 HD11 HD23 ' A' ' 108' ' ' LEU . 4.5 mm? -123.46 160.32 27.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.1 m -80.67 151.61 28.87 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.54 -157.28 27.44 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -168.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -142.54 137.44 30.15 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.899 0.85 . . . . 0.0 109.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.52 HD12 ' CD1' ' A' ' 98' ' ' PHE . 11.0 mm -63.96 146.27 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 124.372 1.069 . . . . 0.0 108.817 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.4 -0.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.202 1.001 . . . . 0.0 111.116 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -161.43 157.64 25.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.22 146.13 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -173.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -86.51 74.73 9.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 118.57 0.623 . . . . 0.0 110.204 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.35 -15.11 14.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -54.51 -45.9 73.39 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.076 165.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.11 -18.88 64.84 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 0.0 112.281 -173.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -63.75 -15.66 59.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.207 1.403 . . . . 0.0 111.232 169.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 p -131.97 -27.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.67 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.23 64.55 61.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.143 1.777 . . . . 0.0 110.496 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.85 -10.25 27.65 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.146 3.231 . . . . 0.0 111.792 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.37 -14.16 61.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.197 -0.94 . . . . 0.0 112.908 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 86' ' ' LEU . 5.5 mt -65.21 -15.31 62.32 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.113 1.324 . . . . 0.0 113.464 -169.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 87' ' ' ILE . 4.6 mp -63.83 -33.87 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.44 1.018 . . . . 0.0 110.667 169.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -59.07 -46.35 88.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 123.785 1.755 . . . . 0.0 109.965 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -72.73 -59.99 2.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 127.694 2.398 . . . . 0.0 110.579 -168.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -140.54 65.07 25.24 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -167.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.78 -18.31 55.33 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 120.811 1.007 . . . . 0.0 111.475 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.33 28.18 7.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.77 1.228 . . . . 0.0 109.021 -175.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -142.6 -113.85 0.99 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.44 -14.33 62.83 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.269 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.71 32.48 2.15 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 120.678 1.581 . . . . 0.0 112.513 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.86 161.25 13.08 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.171 0.985 . . . . 0.0 108.741 165.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.46 -58.29 2.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 116.294 -1.813 . . . . 0.0 108.931 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CE1' HG11 ' A' ' 22' ' ' VAL . 42.7 p90 -140.03 -176.79 4.72 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 115.022 -2.671 . . . . 0.0 111.934 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -136.42 129.84 31.79 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 ptm -131.92 139.13 48.63 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -65.5 141.91 58.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.9 pt -95.91 149.97 4.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.8 m -133.65 -13.06 2.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.904 1.681 . . . . 0.0 112.391 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -146.27 74.36 1.36 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -66.52 -10.26 43.04 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.618 -1.301 . . . . 0.0 111.009 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.28 -39.26 95.82 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 120.531 -1.355 . . . . 0.0 110.703 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -63.85 -28.94 70.19 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.1 -1.428 . . . . 0.0 111.568 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 69' ' ' LEU . 15.0 mt -47.41 -36.67 10.15 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 120.184 1.356 . . . . 0.0 111.883 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.72 -16.62 55.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.887 1.676 . . . . 0.0 112.657 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.6 -31.24 66.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.346 1.459 . . . . 0.0 109.96 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 108' ' ' LEU . 0.8 OUTLIER -65.08 169.08 5.78 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.673 -0.642 . . . . 0.0 109.525 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.561 HD22 ' H ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -68.21 127.04 31.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.57 171.94 0.76 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 154.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -67.88 -36.57 80.47 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.509 -1.995 . . . . 0.0 112.126 -173.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.71 -51.55 58.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.21 71.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.255 0.222 . . . . 0.0 111.192 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -61.58 -52.37 64.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.728 1.211 . . . . 0.0 109.933 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -41.0 72.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.295 0.638 . . . . 0.0 109.651 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.97 -41.41 91.22 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.906 0.882 . . . . 0.0 110.968 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -68.11 -51.67 43.6 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.54 -0.725 . . . . 0.0 109.435 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.5 m -72.76 15.26 0.2 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.803 1.241 . . . . 0.0 113.404 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.34 -15.67 14.58 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.231 2.212 . . . . 0.0 112.266 164.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -114.21 -13.85 12.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.717 1.607 . . . . 0.0 112.664 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.465 1.906 . . . . 0.0 109.55 -174.862 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mtm . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.919 0.39 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.5 mttt 70.43 130.15 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 128.569 2.748 . . . . 0.0 111.43 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.519 ' SD ' ' HE2' ' A' ' 5' ' ' LYS . 3.8 ptp -165.61 178.28 6.78 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.44 1.496 . . . . 0.0 109.512 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 64.94 0.74 Allowed 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.66 -1.275 . . . . 0.0 111.372 -174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HE2' ' SD ' ' A' ' 3' ' ' MET . 2.0 mptp? -66.9 -178.65 0.78 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.97 149.42 47.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.487 1.915 . . . . 0.0 110.003 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.0 p -93.14 171.21 9.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 123.518 1.628 . . . . 0.0 109.574 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -71.99 -33.4 68.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.016 168.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -89.84 43.53 1.15 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.63 2.372 . . . . 0.0 111.564 -176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p80 48.5 46.53 20.79 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.361 1.864 . . . . 0.0 114.234 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.0 mt-10 -121.25 158.21 28.61 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 109.275 170.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.43 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.8 p-90 -108.79 163.15 13.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.472 1.509 . . . . 0.0 107.358 165.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.18 154.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -143.34 80.66 1.68 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.122 1.369 . . . . 0.0 109.632 -172.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 20' ' ' ALA . 1.2 mt -80.56 117.3 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.454 1.502 . . . . 0.0 108.82 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.287 5.1 pt-20 -114.11 -101.18 0.42 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 116.732 -1.604 . . . . 0.0 108.988 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -64.08 1.1 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 122.321 2.328 . . . . 0.0 111.806 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -153.66 8.54 0.38 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.487 2.715 . . . . 0.0 109.873 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.5 t -127.92 126.45 66.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -90.71 141.81 28.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.695 0.398 . . . . 0.0 109.962 168.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 16.4 m -87.99 151.71 22.58 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.15 142.33 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.752 1.221 . . . . 0.0 109.327 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -158.47 170.39 35.11 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 163.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.782 HD11 HG21 ' A' ' 87' ' ' ILE . 30.7 pt -77.46 152.08 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 118.415 1.108 . . . . 0.0 110.695 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -80.8 171.81 14.54 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.916 -1.115 . . . . 0.0 112.508 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -21.52 62.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.37 1.068 . . . . 0.0 113.025 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -67.02 -31.21 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 119.765 -1.835 . . . . 0.0 111.859 169.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.504 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -81.2 -42.7 20.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.953 -1.092 . . . . 0.0 111.705 -172.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.655 ' HB3' HG22 ' A' ' 87' ' ' ILE . 2.9 pp0? -56.31 -22.32 29.72 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.372 0.533 . . . . 0.0 111.374 175.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -46.13 81.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.194 0.998 . . . . 0.0 109.371 -174.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.627 ' HA ' HE21 ' A' ' 31' ' ' GLN . 0.1 OUTLIER -81.01 -27.83 35.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.254 1.422 . . . . 0.0 112.515 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.508 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -78.02 -43.96 27.91 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.91 -150.03 51.6 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 124.517 1.056 . . . . 0.0 110.801 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -46.23 114.57 0.82 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.954 2.502 . . . . 0.0 108.081 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 36' ' ' VAL 0.276 8.9 p -111.08 173.22 2.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-O 122.774 1.273 . . . . 0.0 110.112 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.709 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -160.07 -23.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.413 -153.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.419 ' H ' ' H ' ' A' ' 36' ' ' VAL . 45.3 t80 -147.79 142.05 26.21 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.802 0.274 . . . . 0.0 111.237 175.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.25 132.47 55.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 159.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.5 137.63 42.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.805 168.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.2 mt -131.47 131.44 22.91 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.66 179.7 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.568 2.845 . . . . 0.0 113.149 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.39 156.77 24.01 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.549 -0.719 . . . . 0.0 111.146 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.99 19.21 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 0.0 113.457 -164.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.88 33.43 0.56 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -106.85 133.89 50.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.332 1.066 . . . . 0.0 110.829 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 150.72 48.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.378 0.99 . . . . 0.0 110.353 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -142.22 167.13 15.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.755 1.622 . . . . 0.0 110.624 169.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -116.85 170.49 8.58 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 127.758 2.423 . . . . 0.0 110.895 175.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 6.61 0.25 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.6 59.25 0.35 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -106.79 115.35 30.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.922 1.289 . . . . 0.0 108.994 -173.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.321 0.1 OUTLIER -70.28 33.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 127.736 2.414 . . . . 0.0 113.922 -173.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 53' ' ' VAL . 17.0 m -72.69 10.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 O-C-N 117.956 -2.965 . . . . 0.0 115.958 -167.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.85 51.85 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.221 0.918 . . . . 0.0 109.554 -173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.69 157.21 7.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.81 0.814 . . . . 0.0 111.034 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.452 HD12 HD13 ' A' ' 24' ' ' ILE . 15.2 mt -133.6 108.03 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -101.49 117.27 34.59 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 35' ' ' VAL . 56.2 p -99.61 -159.95 0.77 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.335 1.454 . . . . 0.0 111.7 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -43.55 -44.1 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.07 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -158.56 13.29 0.18 Allowed 'General case' 0 C--N 1.346 0.453 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 165.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.82 159.16 15.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.911 1.687 . . . . 0.0 108.148 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.32 96.59 3.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.385 1.474 . . . . 0.0 107.517 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -90.65 107.38 19.14 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.998 0.919 . . . . 0.0 110.311 176.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.31 117.33 4.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.238 1.815 . . . . 0.0 107.37 163.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.74 103.63 14.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -94.51 98.55 10.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -168.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.9 130.97 0.3 Allowed Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.924 2.09 . . . . 0.0 113.917 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.1 -29.68 39.54 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.279 2.653 . . . . 0.0 114.546 -167.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.9 mt -148.34 158.59 44.19 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.963 1.305 . . . . 0.0 108.079 -167.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -66.48 145.43 55.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.4 38.8 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -129.53 130.92 46.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.13 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.5 mm -63.66 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.2 m -145.71 -3.17 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.245 1.018 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -148.03 158.77 44.24 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.969 1.259 . . . . 0.0 107.845 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.7 m -142.45 158.38 19.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.333 1.453 . . . . 0.0 107.948 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -108.72 74.09 0.9 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.988 0.515 . . . . 0.0 110.141 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -60.65 -11.4 7.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -44.78 -42.34 7.71 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.313 1.445 . . . . 0.0 111.357 164.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -12.14 61.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.063 0.945 . . . . 0.0 110.893 -170.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.66 -11.21 57.75 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.707 1.203 . . . . 0.0 112.173 167.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -131.28 -36.18 1.31 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.769 0.828 . . . . 0.0 111.235 -173.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -121.2 73.92 28.39 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.869 2.068 . . . . 0.0 107.233 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.89 -43.86 1.54 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.987 1.791 . . . . 0.0 107.657 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.617 ' HA ' HG12 ' A' ' 35' ' ' VAL . 96.4 mt-10 -56.07 -11.36 1.07 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.653 1.581 . . . . 0.0 112.285 -177.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -57.43 -18.11 16.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.664 1.985 . . . . 0.0 111.99 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.782 HG21 HD11 ' A' ' 24' ' ' ILE . 3.8 mm -53.05 -37.95 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -68.02 -48.59 65.28 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 120.93 -1.106 . . . . 0.0 111.334 174.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' A' ' 86' ' ' LEU . 5.0 mtpt -77.74 -28.26 50.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 125.755 1.622 . . . . 0.0 113.126 -162.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.75 65.19 0.72 Allowed Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -177.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -60.98 -30.22 89.47 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.295 1.997 . . . . 0.0 112.756 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.1 mp0 -119.12 21.57 12.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.642 0.777 . . . . 0.0 110.046 177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.79 -121.53 4.86 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 105.874 -2.89 . . . . 0.0 105.874 157.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.54 -3.01 28.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.05 23.3 5.31 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 120.706 1.594 . . . . 0.0 112.7 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -63.2 162.02 12.64 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.722 1.761 . . . . 0.0 109.886 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.42 HD12 ' HA2' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -104.71 -56.16 2.22 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -147.03 173.81 12.12 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.209 -0.932 . . . . 0.0 112.014 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -124.72 152.54 43.64 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.788 0.835 . . . . 0.0 110.209 166.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -142.89 141.71 31.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.753 1.221 . . . . 0.0 110.493 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -64.63 133.51 52.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.0 pt -87.45 103.13 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 122.846 0.458 . . . . 0.0 110.322 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.5 m -66.86 -7.69 23.54 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -143.56 135.08 26.19 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 172.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -99.46 2.02 44.62 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.527 2.331 . . . . 0.0 108.158 162.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.81 -39.12 5.02 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.804 -1.185 . . . . 0.0 112.573 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -65.27 -24.13 67.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.42 1.11 . . . . 0.0 110.527 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 111' ' ' LEU . 2.7 mp -38.0 -44.71 0.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.533 2.733 . . . . 0.0 112.206 163.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -79.86 -7.34 58.66 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 120.272 1.396 . . . . 0.0 112.506 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -88.23 -12.75 42.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 111.639 168.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 108' ' ' LEU . 1.1 mm? -66.27 169.52 7.1 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.053 -1.655 . . . . 0.0 109.155 167.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.42 139.44 42.33 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.84 171.66 0.88 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.553 1.168 . . . . 0.0 109.232 159.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.13 -34.45 78.08 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.388 1.875 . . . . 0.0 111.251 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -80.55 -44.16 19.49 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 124.571 1.148 . . . . 0.0 109.514 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.16 72.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.106 0.479 . . . . 0.0 111.307 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -59.31 -39.9 84.55 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.175 0.99 . . . . 0.0 110.947 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.67 -45.32 72.02 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.178 0.591 . . . . 0.0 109.881 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -46.52 76.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.662 0.785 . . . . 0.0 110.45 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -53.82 -49.26 68.76 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.798 1.639 . . . . 0.0 110.895 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.3 t -66.5 -21.71 66.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.985 0.914 . . . . 0.0 112.346 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.88 -6.59 58.74 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.287 1.035 . . . . 0.0 112.721 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -103.21 -13.67 16.66 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.088 0.858 . . . . 0.0 111.902 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.895 -169.298 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 58.04 61.47 2.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.129 1.372 . . . . 0.0 111.21 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.6 ttm -115.85 157.81 23.88 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.437 1.095 . . . . 0.0 108.141 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -138.64 121.18 16.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.949 154.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -113.42 179.97 3.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.316 1.847 . . . . 0.0 110.011 172.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 117' ' ' TYR . 70.6 m-85 -150.55 167.94 25.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.0 1.32 . . . . 0.0 110.508 -164.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.1 p -136.74 170.08 16.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.23 1.377 . . . . 0.0 111.371 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.487 ' HG2' ' CZ ' ' A' ' 120' ' ' PHE . 0.7 OUTLIER -68.5 -14.64 63.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 176.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.1 p -89.33 34.89 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.151 -1.593 . . . . 0.0 108.282 175.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 p80 41.73 64.16 1.13 Allowed 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.173 2.589 . . . . 0.0 110.723 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.492 1.517 . . . . 0.0 107.562 -166.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 55.9 p-90 -116.92 150.69 38.09 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.19 1.796 . . . . 0.0 110.043 176.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.57 122.91 15.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -161.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -120.38 97.79 5.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.449 1.022 . . . . 0.0 111.295 -163.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -108.49 102.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.484 1.113 . . . . 0.0 109.529 -164.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.46 -74.5 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.885 0.874 . . . . 0.0 110.11 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -74.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 108.066 -170.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -126.93 7.85 6.72 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.233 0.924 . . . . 0.0 113.344 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -134.69 142.66 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.79 137.54 38.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.029 1.332 . . . . 0.0 109.187 163.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 5.8 m -78.94 132.02 36.57 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 155.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.49 132.05 49.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.683 1.993 . . . . 0.0 108.762 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.493 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -149.69 168.82 29.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.548 1.071 . . . . 0.0 110.904 159.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.601 HD12 ' HB1' ' A' ' 28' ' ' ALA . 16.4 pt -89.06 159.19 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.334 0.653 . . . . 0.0 109.875 174.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -90.72 175.08 7.15 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.711 -1.243 . . . . 0.0 112.049 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -39.52 62.45 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.01 -1.056 . . . . 0.0 111.599 171.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -58.18 -22.5 51.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.398 1.079 . . . . 0.0 111.85 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 24' ' ' ILE . . . -89.56 -46.65 8.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.751 1.62 . . . . 0.0 112.172 -175.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -64.03 -22.83 67.09 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.12 0.418 . . . . 0.0 111.396 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -27.52 69.0 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.193 1.397 . . . . 0.0 111.716 174.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -90.11 -43.78 10.24 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.733 -0.605 . . . . 0.0 110.967 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.58 -35.75 14.08 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.954 -170.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.2 -119.42 8.68 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 125.373 1.464 . . . . 0.0 111.043 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.73 91.63 0.63 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.405 1.882 . . . . 0.0 106.728 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -74.88 -162.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.8 ' H ' HG12 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -165.6 -35.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 130.249 3.42 . . . . 0.0 109.37 -169.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.478 ' H ' HG12 ' A' ' 35' ' ' VAL . 59.7 t80 -158.17 161.21 37.84 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.128 0.876 . . . . 0.0 112.667 -174.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.45 132.37 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 124.574 1.15 . . . . 0.0 110.951 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.78 136.02 36.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 108.869 170.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 80' ' ' LEU . 68.3 mt -130.95 144.39 53.35 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.062 1.745 . . . . 0.0 109.135 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.72 -179.25 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.586 2.857 . . . . 0.0 112.658 -169.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -73.49 148.11 43.45 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 110.065 166.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.71 9.18 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 127.642 2.377 . . . . 0.0 114.743 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.19 12.17 0.92 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 126.76 2.124 . . . . 0.0 110.503 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -66.52 145.14 55.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.212 1.006 . . . . 0.0 108.921 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -84.33 150.48 25.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.429 1.585 . . . . 0.0 110.575 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.562 HG22 HG11 ' A' ' 53' ' ' VAL 0.377 11.6 t -142.58 173.07 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.174 0 C-N-CA 129.782 3.233 . . . . 0.0 108.621 -175.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -141.89 169.46 17.54 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 129.362 3.065 . . . . 0.0 103.831 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 14.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.68 92.57 0.1 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 103.9 -3.68 . . . . 0.0 103.9 162.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.26 142.45 31.37 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 171.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 52' ' ' VAL . 46.1 t -79.12 32.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 130.341 3.456 . . . . 0.0 111.344 -164.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG11 HG22 ' A' ' 47' ' ' VAL . 23.5 m -68.41 1.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 119.431 -2.043 . . . . 0.0 111.788 -169.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.6 73.2 1.17 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.886 1.675 . . . . 0.0 110.015 172.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.99 164.33 6.74 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 120.028 -1.67 . . . . 0.0 110.592 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mt -135.24 151.88 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.0 123.68 21.1 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.835 -1.165 . . . . 0.0 108.286 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 61' ' ' ALA . 48.4 t -107.21 -169.61 1.57 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.957 1.303 . . . . 0.0 107.952 -172.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.93 -33.82 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.86 1.264 . . . . 0.0 111.794 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -169.13 18.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.96 1.704 . . . . 0.0 112.827 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 58' ' ' SER . . . -113.48 152.64 29.89 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.269 0.941 . . . . 0.0 111.361 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.83 129.58 15.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.119 1.368 . . . . 0.0 109.254 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.3 107.93 2.27 Favored 'General case' 0 N--CA 1.447 -0.577 1 C-N-CA 132.634 4.374 . . . . 0.0 105.27 -163.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -67.35 134.75 52.11 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -78.46 120.12 28.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 164.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -102.86 105.58 15.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.57 132.58 1.34 Allowed Pre-proline 0 N--CA 1.452 -0.36 0 O-C-N 124.488 1.117 . . . . 0.0 112.331 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.02 -26.0 31.5 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.711 2.274 . . . . 0.0 113.491 -166.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.4 151.26 34.97 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.261 1.425 . . . . 0.0 107.568 -163.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.1 m -72.48 128.38 35.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.42 -171.16 40.62 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.626 -0.671 . . . . 0.0 111.919 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -128.52 131.09 48.28 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.328 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.2 mm -57.78 148.31 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 120.132 1.333 . . . . 0.0 108.368 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.81 -4.27 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.029 0.932 . . . . 0.0 112.747 164.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -150.5 156.51 41.57 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 120.349 1.432 . . . . 0.0 107.796 171.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.0 m -133.55 165.44 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.765 1.226 . . . . 0.0 108.017 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.98 83.03 1.69 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.253 0.621 . . . . 0.0 110.617 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.1 1.9 0.4 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -62.53 -43.02 99.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 119.802 -1.811 . . . . 0.0 108.49 166.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.554 ' CD1' HD23 ' A' ' 97' ' ' LEU . 92.1 mt -57.09 -14.29 3.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 113.704 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.1 -36.85 78.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.832 2.053 . . . . 0.0 110.698 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 p -127.5 -11.84 5.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.518 1.127 . . . . 0.0 112.413 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -117.31 58.3 2.29 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.254 1.822 . . . . 0.0 111.235 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.45 -18.16 18.02 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.641 2.227 . . . . 0.0 110.222 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.04 -13.89 60.92 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.382 0.992 . . . . 0.0 111.6 171.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -24.91 66.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.725 -1.859 . . . . 0.0 110.863 -172.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 80' ' ' LEU . 3.5 mt -62.65 -18.27 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 O-C-N 120.557 -1.339 . . . . 0.0 110.507 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -74.3 -53.57 9.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 119.171 -2.206 . . . . 0.0 111.33 161.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -68.73 -52.6 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.296 1.439 . . . . 0.0 109.958 -159.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.4 70.72 12.93 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 125.803 1.641 . . . . 0.0 106.7 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.99 -23.35 72.69 Favored 'Trans proline' 0 CA--C 1.511 -0.63 0 C-N-CA 123.059 2.506 . . . . 0.0 112.351 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP 0.294 0.4 OUTLIER -119.1 31.54 6.58 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.773 1.629 . . . . 0.0 109.27 -175.256 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.14 -110.87 0.85 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.256 1.884 . . . . 0.0 109.03 166.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -72.96 -9.17 58.42 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.828 0.851 . . . . 0.0 113.104 -175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.74 21.92 33.68 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.854 1.216 . . . . 0.0 113.567 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -57.66 169.12 0.74 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.126 1.463 . . . . 0.0 110.309 165.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.554 HD23 ' CD1' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -120.6 -52.58 2.13 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -152.05 170.09 20.77 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 121.557 -0.714 . . . . 0.0 110.144 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -129.84 141.13 50.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -138.59 142.29 39.17 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.845 0.858 . . . . 0.0 110.105 -171.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.56 125.69 27.47 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.89 2.076 . . . . 0.0 106.935 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.2 pt -81.77 97.0 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 124.328 1.018 . . . . 0.0 108.69 175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -72.15 -16.12 61.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.39 172.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -137.93 79.2 1.73 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.597 ' HA ' HD21 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -65.25 -15.61 62.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.62 -0.675 . . . . 0.0 111.609 176.261 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.55 4.64 77.48 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-O 116.925 -2.042 . . . . 0.0 114.067 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -97.81 -28.91 13.64 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.691 1.745 . . . . 0.0 112.614 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -62.95 -34.06 76.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.652 1.569 . . . . 0.0 112.135 -173.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -56.0 -29.29 60.1 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 124.841 1.257 . . . . 0.0 112.698 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -84.97 -17.16 38.51 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 111.36 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -76.68 -174.08 2.85 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.589 1.155 . . . . 0.0 109.623 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.58 128.1 32.97 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.96 169.93 0.2 Allowed 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 122.023 0.916 . . . . 0.0 109.957 160.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.01 -43.06 75.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 125.732 1.613 . . . . 0.0 110.995 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -65.31 -50.97 63.64 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.475 1.51 . . . . 0.0 109.107 170.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.18 -29.84 70.19 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.592 -0.692 . . . . 0.0 111.824 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 4.3 t80 -63.16 -44.0 96.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.009 0.924 . . . . 0.0 110.407 174.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -43.38 71.91 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -45.6 86.55 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.981 0.42 . . . . 0.0 109.909 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.487 ' CZ ' ' HG2' ' A' ' 8' ' ' LYS . 34.3 t80 -66.18 -34.65 78.52 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.249 -0.907 . . . . 0.0 111.456 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 90.7 m -69.68 -12.6 61.76 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.237 -0.914 . . . . 0.0 113.337 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.94 9.65 42.59 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.199 1.8 . . . . 0.0 111.171 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -104.48 20.13 19.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.043 0.537 . . . . 0.0 110.234 160.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 C--O 1.243 0.72 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.189 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 mmm . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -74.83 129.15 37.17 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.665 -1.272 . . . . 0.0 108.511 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ptm -160.38 152.5 20.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.311 1.045 . . . . 0.0 108.93 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -125.9 88.4 2.85 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.278 0.944 . . . . 0.0 109.947 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -92.49 174.73 7.13 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.697 -0.627 . . . . 0.0 111.707 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.16 177.24 7.99 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.288 1.435 . . . . 0.0 112.035 -169.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -130.67 168.03 17.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.1 1.36 . . . . 0.0 110.882 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.474 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -77.27 18.21 0.42 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.019 1.328 . . . . 0.0 111.414 159.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -125.23 26.67 6.83 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.458 -1.401 . . . . 0.0 110.496 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.6 p80 45.02 50.97 9.03 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 111.506 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -121.97 143.22 49.61 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -99.51 159.53 14.96 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 160.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.26 107.9 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.35 74.79 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.495 1.118 . . . . 0.0 110.503 -170.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.0 mp -64.7 146.16 13.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.718 1.207 . . . . 0.0 108.501 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -139.06 -70.6 0.41 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.083 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.4 -62.47 1.26 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.984 1.266 . . . . 0.0 111.006 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.05 15.36 2.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.01 1.324 . . . . 0.0 110.526 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.45 150.89 33.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -123.07 133.43 54.31 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.736 1.614 . . . . 0.0 107.261 167.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -77.47 113.59 15.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 164.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 t -86.12 135.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.3 170.32 31.56 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 165.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.569 HD11 ' CG2' ' A' ' 87' ' ' ILE . 15.7 pt -90.33 153.35 3.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 117.974 0.887 . . . . 0.0 110.466 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 p -91.25 164.58 13.83 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.211 -1.555 . . . . 0.0 109.654 171.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.545 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 13.4 p-10 -50.9 -37.18 42.29 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 114.151 -2.833 . . . . 0.0 115.308 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -49.24 -34.52 15.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 121.604 2.002 . . . . 0.0 109.46 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' HB1' HD12 ' A' ' 24' ' ' ILE . . . -64.57 -68.9 0.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.26 1.824 . . . . 0.0 112.9 173.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.545 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 6.1 pm0 -66.04 -24.58 66.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.695 1.589 . . . . 0.0 110.699 -171.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.99 -40.29 96.05 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -172.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.272 6.3 pt20 -75.05 -56.69 4.48 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.328 0.651 . . . . 0.0 112.248 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 -35.62 81.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.682 0.674 . . . . 0.0 111.926 -170.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.53 -137.07 36.86 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.85 110.73 0.77 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 128.39 2.676 . . . . 0.0 110.105 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -93.1 172.82 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 124.693 2.187 . . . . 0.0 109.649 171.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.715 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.5 m -151.2 -37.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 129.432 3.093 . . . . 0.0 109.201 -160.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.404 ' H ' HG12 ' A' ' 35' ' ' VAL . 46.3 t80 -155.52 153.61 30.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.759 0.424 . . . . 0.0 110.776 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.44 135.43 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 121.843 0.83 . . . . 0.0 109.602 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.93 122.74 23.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 163.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.33 141.83 31.34 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 124.626 1.17 . . . . 0.0 107.907 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -76.3 179.45 6.36 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.717 2.278 . . . . 0.0 111.97 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -79.59 157.93 27.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.29 1.036 . . . . 0.0 110.232 173.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.41 15.65 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.291 1.437 . . . . 0.0 113.317 -171.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.34 15.29 0.39 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 128.41 2.91 . . . . 0.0 111.41 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -73.38 128.17 34.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.11 1.455 . . . . 0.0 109.051 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.26 146.76 45.17 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 73' ' ' ILE . 34.2 m -142.21 168.41 14.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.625 1.17 . . . . 0.0 110.391 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 26.3 mtpt -126.21 170.68 11.6 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.741 1.616 . . . . 0.0 108.427 172.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 24.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -152.16 15.17 0.77 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.931 1.253 . . . . 0.0 113.012 167.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.43 113.78 13.23 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.06 1.93 . . . . 0.0 110.679 -168.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.79 94.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.81 5.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.545 1.538 . . . . 0.0 112.153 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.37 38.96 1.16 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.786 0.435 . . . . 0.0 110.643 -168.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.33 151.98 6.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 123.183 1.468 . . . . 0.0 111.067 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.79 134.78 53.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -115.22 124.34 51.15 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 161.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.8 p -99.14 -173.84 2.6 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.191 0.996 . . . . 0.0 109.647 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 m -42.9 -48.6 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.997 0.919 . . . . 0.0 111.381 171.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -160.25 85.13 0.73 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.069 0.85 . . . . 0.0 109.55 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -178.47 147.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 127.878 2.471 . . . . 0.0 106.23 157.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.34 152.83 18.04 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.25 120.13 14.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.35 130.5 47.24 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.983 2.113 . . . . 0.0 107.392 165.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.82 116.15 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 167.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -106.27 100.71 10.23 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.893 0.877 . . . . 0.0 110.738 -166.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.54 127.09 0.5 Allowed Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 126.801 2.04 . . . . 0.0 112.584 -172.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.52 -27.71 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.569 1.513 . . . . 0.0 114.129 -159.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.481 HD21 HD11 ' A' ' 111' ' ' LEU . 3.5 mm? -133.23 172.44 12.67 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.485 1.914 . . . . 0.0 108.634 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 49.7 m -93.48 123.02 36.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.093 1.357 . . . . 0.0 110.862 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.33 -158.27 20.7 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -164.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -139.76 142.12 36.79 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.079 -1.247 . . . . 0.0 108.304 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.597 HD12 ' CD1' ' A' ' 98' ' ' PHE . 6.3 mm -62.17 148.66 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.693 1.197 . . . . 0.0 108.226 176.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -146.46 -5.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -156.36 140.79 16.74 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.51 147.67 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -89.02 81.64 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.1 -15.71 4.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.122 0.969 . . . . 0.0 113.193 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -53.34 -39.6 64.23 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.988 2.115 . . . . 0.0 112.692 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -11.17 60.56 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.377 1.444 . . . . 0.0 111.313 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -69.3 -38.3 78.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.358 1.463 . . . . 0.0 111.164 171.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.4 p -110.86 -25.99 9.56 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.32 1.448 . . . . 0.0 112.847 -171.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -132.09 61.79 59.83 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 128.513 2.725 . . . . 0.0 109.449 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.67 -30.07 84.82 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.021 3.148 . . . . 0.0 111.502 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.83 -11.42 27.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.87 2.068 . . . . 0.0 111.896 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 86' ' ' LEU . 6.6 mt -64.46 -15.7 61.15 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 120.281 1.401 . . . . 0.0 113.043 168.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.569 ' CG2' HD11 ' A' ' 24' ' ' ILE . 84.8 mt -58.6 -32.34 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.502 1.046 . . . . 0.0 110.054 167.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -73.86 -55.02 6.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 119.709 -1.87 . . . . 0.0 109.082 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.464 ' HB2' HD23 ' A' ' 86' ' ' LEU . 15.3 mmmt -63.85 -56.46 15.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.391 1.476 . . . . 0.0 110.722 -168.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -138.63 57.17 11.11 Favored Pre-proline 0 C--O 1.239 0.523 0 O-C-N 124.691 1.245 . . . . 0.0 110.459 -165.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.74 -13.74 36.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.147 2.565 . . . . 0.0 112.116 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -109.22 -0.8 19.06 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.574 2.35 . . . . 0.0 110.756 -163.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.79 -81.09 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 125.947 1.737 . . . . 0.0 110.719 -174.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.12 -24.8 20.99 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.847 1.324 . . . . 0.0 113.212 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.63 31.89 1.44 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.372 1.463 . . . . 0.0 111.996 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -67.97 155.15 40.09 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.343 1.072 . . . . 0.0 109.229 173.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.15 -72.99 0.63 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -174.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.597 ' CD1' HD12 ' A' ' 73' ' ' ILE . 25.4 p90 -143.82 149.63 37.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.258 1.423 . . . . 0.0 108.371 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -99.25 150.71 21.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.67 142.76 43.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.47 138.16 48.77 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.076 1.35 . . . . 0.0 107.444 169.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 pt -96.02 111.92 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.513 0.725 . . . . 0.0 110.703 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.6 m -70.36 -38.03 74.7 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.073 -0.392 . . . . 0.0 111.346 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.62 81.07 1.98 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.154 0.982 . . . . 0.0 109.032 -164.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.41 -7.31 24.11 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.97 -1.081 . . . . 0.0 111.748 175.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.66 -31.76 23.47 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.778 -1.201 . . . . 0.0 111.583 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -66.42 -8.98 29.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.7 -28.03 69.62 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.242 0.928 . . . . 0.0 110.946 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.16 -14.25 60.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.979 1.263 . . . . 0.0 111.391 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.85 -10.31 58.9 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.828 0.851 . . . . 0.0 111.616 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.481 HD11 HD21 ' A' ' 69' ' ' LEU . 77.9 mt -78.95 176.43 9.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.457 1.122 . . . . 0.0 110.534 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.7 133.14 34.31 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.149 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.79 166.44 13.22 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.379 1.561 . . . . 0.0 108.651 153.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -68.89 -35.93 77.45 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 125.447 1.499 . . . . 0.0 111.154 -168.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -67.38 -40.19 85.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.14 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.848 -0.533 . . . . 0.0 110.621 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -62.85 -44.04 97.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.603 0.361 . . . . 0.0 110.198 171.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -47.0 81.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.855 0.862 . . . . 0.0 110.698 172.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -60.41 -46.34 90.35 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.145 0.43 . . . . 0.0 110.389 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -59.77 -39.18 84.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.301 0.641 . . . . 0.0 110.953 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 37.8 t -62.27 -29.25 70.28 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.26 -0.9 . . . . 0.0 112.494 176.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.61 -36.88 76.59 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.895 1.225 . . . . 0.0 110.729 173.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -77.63 -3.1 39.21 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.546 1.138 . . . . 0.0 113.07 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.227 -1.368 . . . . 0.0 107.744 173.01 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 mtt . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -168.26 116.33 0.72 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -153.42 140.49 19.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.69 83.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.267 -0.896 . . . . 0.0 110.119 -172.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.531 ' H ' ' HE3' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -82.93 176.81 8.99 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 119.436 -0.905 . . . . 0.0 113.202 178.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -131.44 152.92 50.25 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.897 1.679 . . . . 0.0 109.222 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.8 p -101.84 -173.67 2.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 122.442 1.115 . . . . 0.0 109.716 -172.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -98.03 10.36 40.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.662 1.985 . . . . 0.0 111.244 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.0 p -119.92 32.73 5.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.726 1.61 . . . . 0.0 111.572 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.11 38.86 26.54 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.355 -1.466 . . . . 0.0 111.844 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.28 137.29 44.15 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.378 1.871 . . . . 0.0 108.724 -165.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.541 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 60.4 p-90 -106.25 166.48 10.49 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.62 1.168 . . . . 0.0 109.774 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.04 144.67 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 83.81 1.9 Allowed 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.351 1.061 . . . . 0.0 109.855 -175.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.79 132.39 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 107.744 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -137.96 -12.92 1.45 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -160.82 -70.86 0.07 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 29.7 mttt -144.41 17.33 1.69 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.899 1.28 . . . . 0.0 111.225 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.0 t -143.56 128.34 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.96 131.34 34.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 158.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 99' ' ' LYS . 21.0 m -73.25 132.19 42.86 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 152.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -106.62 139.38 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 126.756 2.022 . . . . 0.0 107.656 171.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.21 164.69 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 163.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.583 HD11 HG21 ' A' ' 87' ' ' ILE . 6.9 pt -80.24 152.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 122.598 1.19 . . . . 0.0 109.168 167.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.1 p -77.32 166.07 23.64 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.519 1.128 . . . . 0.0 109.599 175.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -36.2 68.99 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.92 -33.24 61.93 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.644 -1.285 . . . . 0.0 112.381 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -67.87 -49.58 61.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.164 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.17 -27.11 68.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.512 1.051 . . . . 0.0 111.427 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -49.13 64.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.902 0.481 . . . . 0.0 109.867 -173.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -49.83 55.47 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.666 -0.683 . . . . 0.0 111.417 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -34.61 78.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.57 0.623 . . . . 0.0 110.169 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.54 -119.43 9.23 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.82 111.12 4.12 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.9 t -77.11 -168.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 152.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.595 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.6 p -176.75 -40.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -157.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -153.69 151.26 29.45 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.794 1.179 . . . . 0.0 110.832 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.748 HG22 HG23 ' A' ' 56' ' ' ILE . 84.5 t -134.13 133.59 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.66 137.32 32.46 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.361 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -136.28 149.18 67.14 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 124.319 1.048 . . . . 0.0 109.135 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HG2' HG21 ' A' ' 73' ' ' ILE . 37.0 Cg_endo -79.37 -174.02 2.11 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.821 3.014 . . . . 0.0 114.428 -172.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.46 162.03 20.07 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 119.837 -1.789 . . . . 0.0 112.928 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.27 16.13 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 126.997 2.119 . . . . 0.0 111.773 -171.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.75 10.26 0.79 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.764 2.126 . . . . 0.0 112.329 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.9 ttt85 -81.12 130.12 34.88 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.314 1.057 . . . . 0.0 108.678 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.8 151.23 37.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.609 HG11 HD11 ' A' ' 73' ' ' ILE . 15.8 m -143.25 165.77 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.768 1.227 . . . . 0.0 109.443 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -118.56 170.34 9.03 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 125.132 1.373 . . . . 0.0 107.599 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -62.82 15.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.36 86.62 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 166.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.54 128.58 25.47 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.96 1.704 . . . . 0.0 107.534 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 52' ' ' VAL . 26.8 t -72.01 38.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 127.56 2.344 . . . . 0.0 111.627 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.573 HG21 HG11 ' A' ' 47' ' ' VAL . 21.4 m -83.86 28.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 118.421 -2.674 . . . . 0.0 112.786 -170.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -167.72 66.54 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.41 1.004 . . . . 0.0 108.915 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.5 m -58.16 148.83 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.058 -1.026 . . . . 0.0 110.176 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.748 HG23 HG22 ' A' ' 38' ' ' VAL . 10.9 mt -122.37 109.03 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 124.37 34.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.569 ' HA ' HG12 ' A' ' 36' ' ' VAL . 80.4 p -102.47 -179.91 4.11 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.361 1.077 . . . . 0.0 109.532 171.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -48.32 -33.59 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.519 -1.673 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -148.19 5.67 0.75 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.92 170.41 9.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.627 1.558 . . . . 0.0 108.747 171.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.39 149.2 38.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 149.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.52 88.69 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -39.8 120.36 1.11 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 128.408 2.683 . . . . 0.0 107.999 161.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.43 136.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -113.39 98.73 7.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 123.416 0.686 . . . . 0.0 109.798 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -33.42 124.29 0.45 Allowed Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 124.765 1.29 . . . . 0.0 112.065 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.34 -23.96 11.19 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.653 1.568 . . . . 0.0 114.358 -157.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' O ' ' HE1' ' A' ' 100' ' ' MET . 4.2 mm? -141.36 156.98 45.77 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 127.505 2.322 . . . . 0.0 107.047 -174.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.6 m -74.23 138.43 43.68 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.316 1.417 . . . . 0.0 110.347 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.0 36.57 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 123.669 0.652 . . . . 0.0 111.803 -165.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -138.43 136.7 36.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.409 -1.054 . . . . 0.0 109.458 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.609 HD11 HG11 ' A' ' 47' ' ' VAL . 9.1 mm -65.3 146.29 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 108.941 176.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -149.39 4.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 110.909 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -162.25 151.1 15.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 41' ' ' PRO . 35.4 m -139.26 158.57 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.315 1.046 . . . . 0.0 108.46 175.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.72 76.78 1.41 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -57.91 -11.73 2.62 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.639 -0.663 . . . . 0.0 112.218 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -51.21 -31.55 20.87 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 111.699 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.5 HD12 HG21 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -80.16 -9.05 59.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.257 1.023 . . . . 0.0 110.514 -173.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.0 -30.41 70.52 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.41 1.084 . . . . 0.0 111.424 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.7 p -118.98 -20.36 8.14 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.732 0.813 . . . . 0.0 112.42 -171.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -136.85 67.14 56.99 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 126.759 2.023 . . . . 0.0 108.721 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.71 -26.17 60.94 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.345 2.697 . . . . 0.0 110.03 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.64 -15.66 53.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.332 1.053 . . . . 0.0 112.382 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -16.46 64.04 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.312 -1.493 . . . . 0.0 111.929 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 24' ' ' ILE . 37.7 mt -64.28 -28.89 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.978 0.808 . . . . 0.0 109.832 169.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -71.44 -55.19 8.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.083 -1.636 . . . . 0.0 108.972 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -61.01 -43.1 99.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.429 -169.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.33 87.14 2.95 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-O 119.178 -0.439 . . . . 0.0 110.234 170.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.1 -11.28 29.17 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.095 1.863 . . . . 0.0 112.737 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 1.0 OUTLIER -125.98 8.42 7.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.407 1.483 . . . . 0.0 112.201 -169.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -124.19 -71.15 0.22 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 124.397 0.998 . . . . 0.0 111.474 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.2 -25.36 7.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.341 1.056 . . . . 0.0 110.611 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -77.03 35.59 1.47 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.057 1.789 . . . . 0.0 112.865 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -64.98 159.29 23.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.214 1.507 . . . . 0.0 108.626 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 mt -99.32 -66.91 0.87 Allowed 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -146.27 171.98 14.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.202 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 18.2 mttt -135.14 145.62 48.0 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 124.323 1.049 . . . . 0.0 109.392 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.484 ' HB3' HD13 ' A' ' 73' ' ' ILE . 1.6 ptm -149.07 140.11 22.97 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.029 -172.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 18' ' ' LYS . 33.0 tt0 -62.78 143.89 57.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.492 1.117 . . . . 0.0 109.412 172.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.9 pt -90.4 109.03 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 123.928 0.767 . . . . 0.0 109.139 172.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.1 m -67.38 -35.55 79.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.166 0.439 . . . . 0.0 110.558 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -135.42 70.73 1.43 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -156.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.536 ' HA ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -57.65 -17.62 15.75 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 172.651 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.46 -21.95 74.04 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.696 1.589 . . . . 0.0 113.294 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -72.43 -12.75 61.24 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 119.235 1.517 . . . . 0.0 111.338 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.536 HD13 ' HA ' ' A' ' 105' ' ' GLU . 0.6 OUTLIER -56.09 -36.13 67.79 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.881 173.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.23 -7.83 49.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.097 0.862 . . . . 0.0 112.34 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.96 -19.06 41.41 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.705 1.202 . . . . 0.0 109.983 172.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.95 161.32 23.1 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 123.32 1.534 . . . . 0.0 109.87 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.91 140.69 43.95 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.941 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.24 167.72 2.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 163.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.24 -47.02 78.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.544 1.537 . . . . 0.0 110.777 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -61.91 -50.8 70.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.84 -32.16 72.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.144 0.578 . . . . 0.0 110.2 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.73 -44.93 96.03 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.978 0.911 . . . . 0.0 111.26 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.32 -46.8 72.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.61 0.641 . . . . 0.0 109.992 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -53.65 -43.78 69.08 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.747 1.219 . . . . 0.0 111.141 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -58.02 -48.53 79.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.462 1.105 . . . . 0.0 111.339 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 61.4 m -70.17 -24.33 63.13 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.708 -0.62 . . . . 0.0 112.239 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.91 -31.59 63.16 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.613 0.642 . . . . 0.0 111.874 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -63.04 -10.74 15.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.249 1.42 . . . . 0.0 112.82 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 117.009 -1.472 . . . . 0.0 110.975 -175.798 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm 27.91 80.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.35 2.26 . . . . 0.0 114.628 151.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.7 tpp -137.24 145.71 43.9 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.658 1.183 . . . . 0.0 108.015 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -133.98 69.96 1.46 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.866 0.841 . . . . 0.0 109.204 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -80.87 175.59 10.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.895 171.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -137.57 169.08 18.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.741 2.417 . . . . 0.0 108.921 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.1 p -107.36 174.03 6.07 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.425 1.49 . . . . 0.0 108.955 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.54 ' HE3' ' CZ ' ' A' ' 120' ' ' PHE . 8.3 mtpt -77.22 -32.37 55.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.804 174.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -88.94 29.21 1.06 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.323 1.849 . . . . 0.0 113.229 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.02 41.89 3.49 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.224 -1.548 . . . . 0.0 112.59 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -124.8 150.29 46.5 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.445 1.098 . . . . 0.0 109.794 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.473 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 67.4 p-90 -105.08 172.54 6.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.863 0.839 . . . . 0.0 111.114 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.09 152.74 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 125.651 1.58 . . . . 0.0 107.071 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.29 81.47 1.71 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.649 1.179 . . . . 0.0 109.748 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 mp -65.99 150.07 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.662 169.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 3.4 pt-20 -142.71 -65.5 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.333 1.453 . . . . 0.0 108.797 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 13.3 t70 -126.52 -77.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.118 2.567 . . . . 0.0 108.222 -170.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.75 9.78 2.41 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 128.16 2.584 . . . . 0.0 110.963 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -124.63 155.68 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.755 1.622 . . . . 0.0 107.051 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.67 139.57 53.74 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 125.343 1.457 . . . . 0.0 108.294 165.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.1 m -83.97 143.57 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 t -122.11 143.03 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.54 2.336 . . . . 0.0 109.911 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.58 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -154.44 174.22 32.84 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 158.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 pt -74.2 165.12 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 117.837 0.819 . . . . 0.0 108.838 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.2 p -90.06 173.28 8.28 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.001 -1.062 . . . . 0.0 113.234 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.417 ' HA ' ' CD ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -74.36 9.39 1.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 175.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -100.72 0.21 38.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.038 2.135 . . . . 0.0 112.624 167.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.43 -58.62 1.9 Allowed 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.571 -1.331 . . . . 0.0 110.573 -163.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.417 ' CD ' ' HA ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -41.46 -42.17 2.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.72 2.808 . . . . 0.0 111.997 166.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.63 -52.99 58.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.394 3.078 . . . . 0.0 110.223 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -72.32 -35.47 68.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.719 -0.613 . . . . 0.0 111.453 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -65.13 -48.34 73.92 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.586 1.154 . . . . 0.0 110.162 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.79 -158.63 41.14 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.96 128.42 15.92 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.806 2.043 . . . . 0.0 109.147 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.595 HG22 ' H ' ' A' ' 36' ' ' VAL 0.446 6.0 p -123.89 154.88 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.595 ' H ' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -153.43 -31.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.632 -142.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -146.95 150.5 35.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.636 0.653 . . . . 0.0 111.843 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.27 133.02 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.514 1.15 . . . . 0.0 109.902 168.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.02 145.7 51.56 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.452 170.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.521 HD11 HD12 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -130.77 151.87 79.56 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 163.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.43 176.14 8.25 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.197 2.598 . . . . 0.0 111.702 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -80.16 141.88 35.28 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.41 22.06 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 129.024 2.929 . . . . 0.0 115.173 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.37 6.84 0.7 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.091 1.329 . . . . 0.0 113.308 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -79.84 141.86 35.8 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.829 1.815 . . . . 0.0 110.116 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -79.42 149.38 31.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.014 0.825 . . . . 0.0 109.098 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.0 171.0 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 110.062 -176.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -116.15 166.01 12.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.227 1.411 . . . . 0.0 110.537 174.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -64.82 14.82 0.02 OUTLIER 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.063 2.145 . . . . 0.0 116.131 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.66 67.07 0.23 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 173.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -134.13 128.07 33.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -175.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 52' ' ' VAL . 24.8 t -87.84 53.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 127.46 2.304 . . . . 0.0 110.042 -161.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -86.52 9.01 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 120.014 -1.679 . . . . 0.0 113.631 -158.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.35 50.26 0.28 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.879 0.872 . . . . 0.0 110.221 -170.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 148.72 20.46 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.631 -0.668 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.9 mt -117.92 135.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.11 117.11 29.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.979 1.312 . . . . 0.0 107.925 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -99.18 -165.89 1.29 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.756 0.707 . . . . 0.0 110.679 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 m -46.75 -38.91 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 117.014 -1.469 . . . . 0.0 113.731 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.84 55.81 0.2 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.454 1.479 . . . . 0.0 111.559 155.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.79 167.8 16.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.512 -0.742 . . . . 0.0 109.961 165.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.2 151.45 39.11 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 152.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 32' ' ' LEU . . . -131.39 112.9 13.13 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.964 1.706 . . . . 0.0 106.585 160.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -70.78 107.98 4.24 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 170.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -76.0 111.04 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -86.22 116.51 24.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.42 135.15 5.73 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.107 0.963 . . . . 0.0 110.078 169.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.55 -32.38 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.116 1.877 . . . . 0.0 113.845 -161.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.08 166.69 19.65 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.555 2.342 . . . . 0.0 106.397 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 m -81.46 134.39 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.58 -171.94 44.9 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 120.759 -1.213 . . . . 0.0 111.132 -166.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -121.63 132.61 54.76 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 117.655 -1.164 . . . . 0.0 109.647 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.8 mm -60.95 140.18 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.6 m -147.35 1.12 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.802 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -148.62 160.65 42.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.685 1.584 . . . . 0.0 109.066 162.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.7 155.69 14.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.369 1.468 . . . . 0.0 108.438 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -108.02 70.96 0.78 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.45 -15.16 15.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.442 0.697 . . . . 0.0 112.477 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -53.28 -29.89 35.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 116.855 -1.545 . . . . 0.0 112.991 166.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD12 HD11 ' A' ' 40' ' ' LEU . 76.3 mt -57.01 -14.7 3.9 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 121.186 1.812 . . . . 0.0 113.269 174.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.2 1.818 . . . . 0.0 112.903 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.0 p -124.13 -27.15 3.89 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.094 1.358 . . . . 0.0 110.858 -171.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.34 64.21 14.19 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 128.042 2.537 . . . . 0.0 110.11 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -73.72 -52.08 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.728 2.952 . . . . 0.0 109.858 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -53.64 -17.63 2.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.179 1.791 . . . . 0.0 110.524 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -30.48 34.96 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.454 1.934 . . . . 0.0 111.518 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -58.6 -25.69 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 121.825 -0.547 . . . . 0.0 110.047 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -64.83 -53.51 45.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.444 -2.035 . . . . 0.0 110.814 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -49.31 70.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.144 1.777 . . . . 0.0 110.342 -164.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -148.73 79.62 8.56 Favored Pre-proline 0 N--CA 1.451 -0.393 0 O-C-N 123.899 0.75 . . . . 0.0 110.151 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.57 -17.44 59.97 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.802 1.668 . . . . 0.0 112.444 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.473 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 3.6 mp0 -114.75 14.4 17.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.264 0.626 . . . . 0.0 112.592 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.34 -89.95 0.28 Allowed Glycine 0 C--N 1.332 0.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.81 -32.25 35.32 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 122.94 0.496 . . . . 0.0 111.899 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.41 36.34 2.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.245 0.926 . . . . 0.0 112.698 172.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -66.42 169.33 7.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.025 1.412 . . . . 0.0 109.452 166.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.58 HD12 ' HA2' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -119.88 -59.76 1.77 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.72 168.31 20.49 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.711 -1.243 . . . . 0.0 111.023 -171.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -125.72 155.32 41.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.288 1.035 . . . . 0.0 108.47 172.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -146.46 143.99 29.36 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.215 0.606 . . . . 0.0 110.727 -177.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.9 139.04 58.72 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.651 1.18 . . . . 0.0 108.025 171.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 pt -88.21 104.72 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 122.578 0.351 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -33.99 70.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 122.85 0.46 . . . . 0.0 110.391 171.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -147.36 103.39 3.56 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 125.931 1.692 . . . . 0.0 107.216 -171.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.538 ' HA ' HD13 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -71.46 -1.95 14.98 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.807 1.243 . . . . 0.0 109.712 160.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.1 -64.46 4.32 Favored Glycine 0 C--N 1.338 0.653 0 O-C-N 120.789 -1.194 . . . . 0.0 111.959 168.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -71.4 -10.04 59.13 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -164.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.538 HD13 ' HA ' ' A' ' 105' ' ' GLU . 1.1 mp -46.48 -48.33 19.14 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.29 1.436 . . . . 0.0 110.455 163.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -75.82 -15.24 60.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.668 0.667 . . . . 0.0 111.024 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -86.66 -18.01 32.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.121 1.368 . . . . 0.0 110.943 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mt -80.32 -178.78 6.79 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.233 2.213 . . . . 0.0 110.975 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.3 mt -87.78 121.05 29.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.165 0.986 . . . . 0.0 110.249 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.99 166.8 15.07 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.112 0.965 . . . . 0.0 110.786 163.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.57 -57.72 4.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.184 1.794 . . . . 0.0 112.091 -160.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -50.21 -46.61 54.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.512 1.525 . . . . 0.0 110.01 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.58 -25.21 41.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 124.943 1.297 . . . . 0.0 111.901 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.91 -40.6 91.64 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 127.778 2.431 . . . . 0.0 109.844 167.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.42 -52.2 59.35 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -43.26 -46.7 6.32 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.083 1.353 . . . . 0.0 111.066 171.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.54 ' CZ ' ' HE3' ' A' ' 8' ' ' LYS . 9.0 t80 -51.17 -36.54 41.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.381 1.472 . . . . 0.0 112.8 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.09 -21.51 50.37 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.382 1.473 . . . . 0.0 113.844 -177.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.58 -43.27 23.29 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 166.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -73.85 26.64 0.07 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.428 2.291 . . . . 0.0 110.734 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.911 2.085 . . . . 0.0 107.929 -178.838 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt 42.83 100.0 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.963 2.505 . . . . 0.0 116.378 166.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ptp -150.68 168.82 23.21 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.804 1.641 . . . . 0.0 112.53 -165.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -142.78 114.82 8.27 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.519 1.128 . . . . 0.0 111.453 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -113.0 179.77 3.87 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -139.82 161.56 37.26 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.367 1.867 . . . . 0.0 110.194 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -125.62 173.38 9.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.437 1.113 . . . . 0.0 110.182 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.478 ' HE3' ' CZ ' ' A' ' 120' ' ' PHE . 6.1 mmmt -89.91 17.01 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.898 1.679 . . . . 0.0 110.849 -169.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.438 HG21 ' HB2' ' A' ' 66' ' ' TYR . 15.1 t -135.53 57.72 1.78 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 169.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.5 p80 44.42 52.77 7.27 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.807 1.643 . . . . 0.0 112.984 172.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -128.99 149.96 50.6 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.425 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 54.5 p-90 -121.35 162.53 20.19 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.648 1.579 . . . . 0.0 110.19 170.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.494 HG12 ' HB1' ' A' ' 20' ' ' ALA . 1.8 t -141.77 126.15 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.477 1.511 . . . . 0.0 107.995 -166.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.43 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 1.4 m -117.01 75.47 0.97 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.7 2.4 . . . . 0.0 110.004 -170.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 20' ' ' ALA . 4.9 mp -74.0 97.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.108 1.363 . . . . 0.0 108.485 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -89.05 -56.02 3.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 118.112 -0.946 . . . . 0.0 111.541 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.16 -76.15 0.45 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.41 0.55 . . . . 0.0 110.173 -166.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -125.52 2.95 7.64 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.834 1.254 . . . . 0.0 111.086 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.25 143.14 41.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.494 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -117.62 109.05 16.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.174 1.789 . . . . 0.0 108.971 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 41.0 m -68.76 143.75 54.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.5 OUTLIER -115.32 152.44 16.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 127.647 2.379 . . . . 0.0 112.512 176.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.18 161.09 32.25 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 160.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.588 HD11 HG21 ' A' ' 87' ' ' ILE . 7.1 pt -73.52 149.23 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 121.072 -1.252 . . . . 0.0 108.506 170.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.9 p -76.41 170.35 16.54 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.967 0.889 . . . . 0.0 111.657 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -62.63 -33.66 75.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.885 -1.134 . . . . 0.0 112.794 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -58.92 -25.7 63.69 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.264 -0.898 . . . . 0.0 112.056 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.27 -47.63 41.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.386 -0.822 . . . . 0.0 111.211 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -64.42 -27.79 69.24 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.837 -0.539 . . . . 0.0 110.56 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -63.43 -28.4 69.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.701 1.2 . . . . 0.0 111.47 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -88.75 -54.67 4.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.843 0.857 . . . . 0.0 111.959 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.81 -43.7 98.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.371 0.532 . . . . 0.0 110.118 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.52 -114.17 4.55 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.57 96.08 0.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.686 1.594 . . . . 0.0 109.057 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.749 HG12 ' H ' ' A' ' 36' ' ' VAL . 3.4 t -78.62 -178.77 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 162.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.749 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.8 p -169.2 -33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 126.431 1.892 . . . . 0.0 108.487 -146.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.431 ' H ' HG12 ' A' ' 35' ' ' VAL . 40.3 t80 -166.44 157.61 12.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.222 0.951 . . . . 0.0 111.008 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -138.15 146.93 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.86 148.11 22.71 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.176 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -137.72 142.98 38.52 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 123.897 0.879 . . . . 0.0 111.161 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.37 175.44 10.75 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.029 2.486 . . . . 0.0 111.077 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -87.85 147.67 25.01 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.348 0.659 . . . . 0.0 110.107 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.77 16.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 C-N-CA 129.816 3.246 . . . . 0.0 116.436 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.72 6.32 0.87 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.655 1.598 . . . . 0.0 113.222 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -76.55 135.97 39.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.878 1.339 . . . . 0.0 110.487 -171.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -78.11 143.04 37.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 120.344 1.429 . . . . 0.0 108.902 167.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.07 -177.08 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.795 1.238 . . . . 0.0 108.645 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -131.55 160.75 34.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.062 1.345 . . . . 0.0 108.547 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 10.28 0.23 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.64 102.61 0.21 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 105.472 -3.051 . . . . 0.0 105.472 160.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.88 131.71 14.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.992 1.717 . . . . 0.0 107.097 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.628 HG13 ' HB3' ' A' ' 64' ' ' ASP . 55.1 t -69.92 16.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.805 2.042 . . . . 0.0 114.33 -169.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.38 -0.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 119.317 -2.114 . . . . 0.0 115.528 -163.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -142.51 60.08 1.44 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.677 1.126 . . . . 0.0 108.375 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 m -56.74 163.04 2.03 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.597 1.189 . . . . 0.0 111.346 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.8 mt -132.85 144.77 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 35' ' ' VAL . 16.4 mt-10 -122.27 165.86 15.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -139.62 -177.49 4.98 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.9 m -51.45 -23.83 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 125.504 1.522 . . . . 0.0 112.118 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.53 13.58 0.23 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.39 168.78 19.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.79 1.632 . . . . 0.0 110.04 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.78 164.94 27.1 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.69 0.796 . . . . 0.0 111.205 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.65 118.44 5.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.77 1.228 . . . . 0.0 110.031 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.628 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -67.86 117.21 9.45 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 167.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.59 121.63 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 120.535 1.516 . . . . 0.0 106.976 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.438 ' HB2' HG21 ' A' ' 9' ' ' THR . 38.4 m-85 -88.98 111.16 21.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.692 0.678 . . . . 0.0 109.533 171.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.32 156.64 0.23 Allowed Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 128.078 2.551 . . . . 0.0 114.528 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -96.62 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 116.157 1.56 . . . . 0.0 116.157 -163.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' CD2' HG11 ' A' ' 13' ' ' VAL . 3.5 mm? -136.41 169.73 17.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.577 1.551 . . . . 0.0 107.606 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 m -101.26 65.56 1.07 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.839 1.256 . . . . 0.0 111.761 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.63 -165.84 12.54 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 126.199 1.857 . . . . 0.0 111.774 -164.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -119.17 123.69 44.97 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 118.1 0.95 . . . . 0.0 110.81 -176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.437 HD12 ' CD1' ' A' ' 98' ' ' PHE . 20.7 mm -59.77 142.01 15.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.3 m -146.75 -5.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.43 163.68 39.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.658 1.117 . . . . 0.0 108.792 169.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 m -149.83 144.18 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -95.12 81.2 3.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.76 1.618 . . . . 0.0 108.846 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -63.78 -11.52 27.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -26.79 65.91 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.375 1.07 . . . . 0.0 111.812 169.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -8.69 58.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.535 1.061 . . . . 0.0 109.941 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -80.09 -4.87 54.62 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.231 1.012 . . . . 0.0 112.269 170.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -137.75 -25.07 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.595 0.758 . . . . 0.0 112.589 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.81 67.44 42.49 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 126.905 2.082 . . . . 0.0 109.512 168.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.81 -20.15 58.72 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.203 2.602 . . . . 0.0 111.186 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.97 -16.12 48.89 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.911 -1.042 . . . . 0.0 111.935 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 86' ' ' LEU . 5.3 mt -60.88 -20.63 62.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.972 1.715 . . . . 0.0 113.414 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.588 HG21 HD11 ' A' ' 24' ' ' ILE . 15.3 mt -59.71 -32.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -66.13 -47.46 74.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 122.654 1.216 . . . . 0.0 110.123 173.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -69.65 -47.37 63.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.604 -1.635 . . . . 0.0 111.425 -165.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -154.32 83.17 4.18 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 172.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -62.89 -20.64 71.89 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.179 1.253 . . . . 0.0 111.135 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 1.2 mt-10 -112.65 21.53 15.49 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.818 1.247 . . . . 0.0 111.58 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.92 -101.87 0.97 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -86.62 -20.86 27.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.5 0.72 . . . . 0.0 111.308 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.52 37.05 2.03 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-N 120.001 1.273 . . . . 0.0 113.658 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -68.62 157.5 36.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.83 1.252 . . . . 0.0 110.242 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.66 -67.36 0.87 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-O 116.904 -1.522 . . . . 0.0 108.486 176.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.522 ' O ' HG13 ' A' ' 22' ' ' VAL . 53.1 p90 -133.49 -176.94 4.32 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.191 2.269 . . . . 0.0 111.762 -175.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -136.87 141.58 42.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -141.71 138.32 32.31 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.278 0.631 . . . . 0.0 109.494 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -62.51 126.11 26.23 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.695 1.998 . . . . 0.0 106.243 168.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.9 pt -75.78 135.81 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.7 m -117.26 -11.12 10.67 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.017 1.727 . . . . 0.0 113.421 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -145.23 81.37 1.63 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.83 -6.33 44.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.517 -1.364 . . . . 0.0 112.365 -177.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.51 66.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.02 -7.02 14.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.83 -42.1 98.62 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 119.209 0.913 . . . . 0.0 109.023 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -71.86 -0.2 10.69 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.398 0.679 . . . . 0.0 111.32 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -85.69 -19.15 31.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.87 0.759 . . . . 0.0 111.497 168.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.41 174.59 8.43 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.174 1.79 . . . . 0.0 111.413 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.46 142.97 38.89 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.418 1.087 . . . . 0.0 110.158 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -59.81 170.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 109.086 158.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -68.47 -51.36 44.37 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.046 -1.033 . . . . 0.0 110.187 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.37 -47.8 84.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.533 ' H ' ' HB2' ' A' ' 113' ' ' ASP . . . -63.96 -30.31 71.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.68 0.673 . . . . 0.0 112.09 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -67.29 -40.94 86.16 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.402 0.547 . . . . 0.0 110.956 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.64 -53.07 60.99 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.244 169.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -68.66 -24.66 64.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.176 1.353 . . . . 0.0 109.948 -172.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.478 ' CZ ' ' HE3' ' A' ' 8' ' ' LYS . 32.4 t80 -63.02 -29.75 71.07 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.996 -1.065 . . . . 0.0 111.698 171.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -31.66 72.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 118.425 0.557 . . . . 0.0 110.778 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.07 -18.71 65.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.224 0.609 . . . . 0.0 111.856 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -97.28 -0.03 47.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.238 2.215 . . . . 0.0 111.803 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.251 1.155 0 O-C-N 120.227 -1.546 . . . . 0.0 110.01 -178.105 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.66 119.4 5.24 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.536 0.734 . . . . 0.0 111.497 -175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ttp -131.8 145.54 51.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.704 1.202 . . . . 0.0 108.489 -173.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -140.71 100.24 3.8 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 113' ' ' ASP . 0.3 OUTLIER -101.76 179.3 4.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -143.54 174.98 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.686 1.594 . . . . 0.0 108.669 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.455 HG22 HD22 ' A' ' 111' ' ' LEU . 54.8 p -133.82 -165.14 1.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.129 0.966 . . . . 0.0 112.624 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -30.96 42.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.631 2.372 . . . . 0.0 111.135 173.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.13 30.21 0.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.249 -0.907 . . . . 0.0 111.502 -167.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 p80 45.33 27.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.121 1.769 . . . . 0.0 115.026 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.9 mt-10 -82.8 165.34 19.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.744 3.218 . . . . 0.0 112.628 160.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CE2' ' HA ' ' A' ' 92' ' ' GLU . 61.2 p-90 -124.46 170.09 11.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.218 2.207 . . . . 0.0 109.014 163.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.12 142.39 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.59 88.33 2.29 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.479 1.112 . . . . 0.0 109.738 -176.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.88 89.48 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -175.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -69.88 0.31 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.28 -98.32 0.39 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -122.23 11.01 10.06 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.235 1.414 . . . . 0.0 110.79 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.72 119.71 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.4 124.53 36.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 m -76.63 128.44 34.71 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 162.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.57 134.81 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 108.016 167.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.665 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -147.12 172.01 27.67 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 162.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HG21 ' A' ' 87' ' ' ILE . 6.1 pt -88.6 148.92 4.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-N 118.586 1.193 . . . . 0.0 109.367 169.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.1 p -77.04 169.6 18.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.062 0.945 . . . . 0.0 110.954 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.85 63.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.169 0.988 . . . . 0.0 111.883 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -59.33 -18.5 38.63 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.356 -0.84 . . . . 0.0 113.149 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -84.33 -51.0 7.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.997 -1.065 . . . . 0.0 111.189 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -60.89 -21.48 63.36 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.668 0.667 . . . . 0.0 111.574 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.13 -16.12 40.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.866 2.066 . . . . 0.0 113.731 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -112.22 -51.3 2.85 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.737 0.699 . . . . 0.0 110.022 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mt -65.01 -36.32 84.03 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.59 -173.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.88 -125.45 27.87 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 125.339 1.447 . . . . 0.0 110.002 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.69 113.13 3.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 36' ' ' VAL . 2.7 t -87.63 -164.0 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.693 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.2 p -173.19 -38.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.22 1.808 . . . . 0.0 107.124 -153.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.473 ' H ' HG12 ' A' ' 35' ' ' VAL . 68.5 t80 -154.21 152.55 30.49 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 123.561 0.538 . . . . 0.0 111.524 -176.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.812 HG22 HG23 ' A' ' 56' ' ' ILE . 71.6 t -139.17 128.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 171.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -72.63 134.72 45.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.921 166.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.7 mt -128.88 138.7 33.73 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.08 179.18 6.01 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.387 2.725 . . . . 0.0 113.772 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.48 166.78 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.137 0.975 . . . . 0.0 110.119 169.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.62 21.38 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 124.484 2.088 . . . . 0.0 112.786 -162.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.57 10.86 0.52 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 129.269 3.318 . . . . 0.0 111.315 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -76.95 132.45 39.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.085 -1.244 . . . . 0.0 108.238 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -86.35 145.24 26.97 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 53' ' ' VAL . 30.7 m -131.67 164.22 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.563 1.545 . . . . 0.0 110.061 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' H ' ' HB2' ' A' ' 51' ' ' GLU . 59.3 mtmt -116.56 170.19 8.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.116 1.766 . . . . 0.0 108.401 171.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.72 13.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.023 2.929 . . . . 0.0 117.96 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.54 35.8 0.43 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.512 165.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -86.04 115.71 23.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.949 1.874 . . . . 0.0 109.683 -173.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' VAL 0.416 0.2 OUTLIER -63.43 25.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 129.962 3.305 . . . . 0.0 115.609 -175.703 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 47' ' ' VAL . 27.6 m -68.92 13.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 118.573 -2.58 . . . . 0.0 116.133 -169.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.36 43.93 0.61 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 120.517 1.508 . . . . 0.0 111.163 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -46.82 145.07 2.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.875 1.27 . . . . 0.0 112.223 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.812 HG23 HG22 ' A' ' 38' ' ' VAL . 7.3 mt -126.98 104.9 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -173.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.88 131.96 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -104.91 -173.7 2.36 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.893 0.877 . . . . 0.0 109.936 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 m -47.87 -27.82 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.62 15.45 0.19 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 175.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.54 -179.28 5.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.561 1.528 . . . . 0.0 110.504 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.11 137.61 27.64 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.53 107.38 7.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.882 1.673 . . . . 0.0 108.683 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB3' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -55.64 144.0 28.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.716 1.206 . . . . 0.0 107.946 170.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 97' ' ' LEU . 54.1 t -116.42 113.27 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -106.01 99.06 8.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.277 1.031 . . . . 0.0 110.297 -166.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.76 134.69 2.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 O-C-N 124.58 1.175 . . . . 0.0 111.718 -164.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.1 -24.85 16.69 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.365 1.376 . . . . 0.0 113.409 -165.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 108' ' ' LEU . 1.1 mp -142.58 166.86 23.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.193 1.397 . . . . 0.0 108.935 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -89.3 122.9 33.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.723 1.209 . . . . 0.0 108.262 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -174.15 -161.37 24.03 Favored Glycine 0 C--O 1.235 0.193 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -172.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -132.93 130.3 39.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.298 1.049 . . . . 0.0 109.686 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.514 HD12 ' CD1' ' A' ' 98' ' ' PHE . 8.9 mm -58.39 151.72 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 108.165 175.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -167.29 -14.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.192 -165.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -146.13 153.57 40.82 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 168.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.92 138.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.418 ' HB2' ' CD2' ' A' ' 96' ' ' TRP . 61.4 t30 -87.16 89.52 8.02 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.99 -9.24 9.26 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.708 0.803 . . . . 0.0 111.745 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -62.4 -45.28 93.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.024 1.33 . . . . 0.0 108.825 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.32 -14.6 63.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 120.249 1.386 . . . . 0.0 114.141 -170.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -62.17 -30.67 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.421 1.088 . . . . 0.0 111.529 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.8 p -134.38 -7.96 2.56 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.38 70.46 81.86 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.423 1.089 . . . . 0.0 108.238 159.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HB3' HG23 ' A' ' 38' ' ' VAL . 9.3 Cg_endo -63.15 -16.11 52.33 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.546 2.83 . . . . 0.0 110.086 169.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.21 -19.75 64.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 118.018 -0.992 . . . . 0.0 112.065 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.4 mt -65.4 -17.17 64.33 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 121.025 1.739 . . . . 0.0 112.787 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.509 HG21 HD11 ' A' ' 24' ' ' ILE . 2.8 mt -64.52 -29.13 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 118.801 -0.619 . . . . 0.0 110.724 169.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -70.29 -53.87 15.03 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 120.814 1.643 . . . . 0.0 109.779 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.427 ' HB2' HD23 ' A' ' 86' ' ' LEU . 1.2 mmtp -60.63 -43.49 97.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.825 1.65 . . . . 0.0 112.063 -171.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.91 74.75 5.04 Favored Pre-proline 0 C--O 1.236 0.343 0 C-N-CA 124.39 1.076 . . . . 0.0 108.269 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -55.29 -29.64 68.33 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.822 1.681 . . . . 0.0 111.734 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.512 ' HA ' ' CE2' ' A' ' 12' ' ' TRP . 7.6 mp0 -104.62 3.43 31.68 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.358 1.463 . . . . 0.0 112.769 -169.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.89 -86.56 0.57 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -172.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.49 -7.48 38.0 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.751 -0.852 . . . . 0.0 111.848 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.66 25.53 18.42 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.416 1.484 . . . . 0.0 112.344 172.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.418 ' CD2' ' HB2' ' A' ' 77' ' ' ASN . 16.8 p-90 -60.98 159.54 11.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.595 1.198 . . . . 0.0 109.229 166.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.671 HD13 HG11 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -105.63 -54.07 2.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 109.681 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.514 ' CD1' HD12 ' A' ' 73' ' ' ILE . 41.3 p90 -148.43 168.15 23.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -128.3 151.5 49.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.6 ptm -143.48 145.86 32.94 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.069 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -63.52 128.76 37.3 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 160.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 pt -81.44 136.31 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.61 -21.56 14.67 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.76 1.224 . . . . 0.0 111.349 167.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -138.08 64.35 1.51 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.904 1.335 . . . . 0.0 111.595 -171.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -5.48 0.07 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.486 1.915 . . . . 0.0 112.846 160.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.87 -25.94 18.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.685 1.612 . . . . 0.0 112.065 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.76 -5.54 46.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.614 1.707 . . . . 0.0 111.122 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.442 HD23 HD21 ' A' ' 69' ' ' LEU . 74.8 mt -54.09 -21.87 9.57 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.528 0.731 . . . . 0.0 111.261 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.063 1.345 . . . . 0.0 113.188 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.95 -24.31 35.62 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.284 1.434 . . . . 0.0 110.423 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD22 HG22 ' A' ' 7' ' ' THR . 9.5 mt -85.1 156.18 21.17 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.363 1.078 . . . . 0.0 108.577 -175.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.49 ' H ' HD22 ' A' ' 112' ' ' LEU . 0.8 OUTLIER -75.75 134.6 40.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -176.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.414 ' HA ' ' HE2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -62.17 179.06 0.32 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 123.442 1.592 . . . . 0.0 110.386 155.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -73.35 -39.89 64.83 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.291 -168.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -67.16 -49.19 65.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.84 69.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.021 1.728 . . . . 0.0 111.421 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -61.83 -38.12 86.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.271 1.028 . . . . 0.0 112.692 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.46 ' HA ' HE21 ' A' ' 118' ' ' GLN . 0.0 OUTLIER -73.59 -46.16 48.81 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -48.28 -46.9 36.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.105 1.362 . . . . 0.0 111.265 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -60.82 -43.42 98.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 122.8 0.44 . . . . 0.0 112.027 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.43 -17.42 64.77 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.692 -1.255 . . . . 0.0 112.951 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.52 -20.85 53.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.846 -1.159 . . . . 0.0 112.096 171.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.68 27.78 8.34 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.552 1.541 . . . . 0.0 112.056 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.116 1.766 . . . . 0.0 110.512 -179.523 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptt? . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.528 0.204 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 tttt 50.85 51.51 16.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.595 2.358 . . . . 0.0 113.889 172.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.9 ttm -137.5 131.57 32.01 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.869 1.267 . . . . 0.0 111.981 -163.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.04 95.76 4.83 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.514 1.526 . . . . 0.0 112.442 -170.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.499 ' CE ' HD23 ' A' ' 108' ' ' LEU . 1.8 mppt? -75.49 179.93 4.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 110.399 165.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -142.23 178.5 7.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.25 1.42 . . . . 0.0 110.898 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 p -135.89 174.61 10.42 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.959 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -75.32 -35.23 61.25 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.88 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -83.25 51.71 2.03 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.77 1.623 . . . . 0.0 108.816 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 p80 42.85 52.28 5.13 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.8 -1.187 . . . . 0.0 113.423 165.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.8 mt-10 -114.21 154.37 27.99 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.337 1.455 . . . . 0.0 108.06 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 54.7 p-90 -108.11 162.41 14.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 157.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 69' ' ' LEU . 1.5 t -124.88 164.08 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -149.47 77.02 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.818 1.19 . . . . 0.0 109.508 -177.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.47 HG13 ' HB2' ' A' ' 20' ' ' ALA . 9.6 mt -72.37 93.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -71.56 -64.51 0.91 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.95 -86.49 0.42 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.159 0.584 . . . . 0.0 109.809 -169.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -119.47 -2.0 10.62 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.0 2.12 . . . . 0.0 110.073 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.4 t -116.25 141.58 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -102.25 161.7 13.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 162.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 16.3 m -111.19 148.91 31.76 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 163.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 98' ' ' PHE . 0.6 OUTLIER -112.92 145.83 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 130.1 3.36 . . . . 0.0 113.134 169.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.49 169.44 34.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 107.271 -2.331 . . . . 0.0 107.271 155.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.737 HD11 HG21 ' A' ' 87' ' ' ILE . 41.7 pt -81.69 157.16 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 O-C-N 121.837 -0.802 . . . . 0.0 109.829 170.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -78.16 166.4 22.8 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.219 0.533 . . . . 0.0 110.428 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -25.66 68.2 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.018 -1.051 . . . . 0.0 111.313 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -49.37 -47.88 47.27 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.807 -1.183 . . . . 0.0 110.537 165.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.526 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -67.65 -42.93 81.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.445 -1.409 . . . . 0.0 112.393 -170.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -62.43 -23.58 66.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.752 0.251 . . . . 0.0 111.084 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.58 -24.19 67.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.248 2.219 . . . . 0.0 112.035 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -98.37 -41.06 8.0 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.349 -0.844 . . . . 0.0 111.878 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.81 -27.55 28.71 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.753 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.59 -133.64 38.28 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 119.24 0.927 . . . . 0.0 111.28 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -62.4 117.43 6.14 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 36' ' ' VAL . 1.6 t -87.39 -171.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.678 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.4 m -153.92 -35.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 130.485 3.514 . . . . 0.0 108.495 -169.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -155.85 156.61 35.0 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.231 0.469 . . . . 0.0 111.191 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.34 136.79 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.98 144.71 25.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.354 2.262 . . . . 0.0 108.451 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -138.77 154.48 73.01 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.784 0.834 . . . . 0.0 109.262 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -72.72 -171.23 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.154 2.569 . . . . 0.0 112.647 174.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -107.03 158.26 17.19 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.77 1.628 . . . . 0.0 110.685 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.52 9.42 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 126.946 2.099 . . . . 0.0 115.238 -165.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.25 11.68 1.81 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.028 1.775 . . . . 0.0 111.917 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -69.35 125.35 26.44 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.334 1.567 . . . . 0.0 108.957 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -76.15 145.6 39.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 166.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.7 m -142.39 163.12 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.014 1.326 . . . . 0.0 109.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -111.67 169.29 8.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.573 0.349 . . . . 0.0 110.858 168.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 49' ' ' LYS . 14.9 ttpt -57.55 17.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 1 C-N-CA 131.834 4.053 . . . . 0.0 114.944 178.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.35 23.76 0.19 Allowed Glycine 0 CA--C 1.525 0.667 0 O-C-N 120.045 -1.659 . . . . 0.0 114.856 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.63 143.86 32.2 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.254 2.027 . . . . 0.0 111.923 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 64' ' ' ASP . 52.3 t -77.65 38.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 129.241 3.016 . . . . 0.0 112.852 -168.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.59 4.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 118.472 -2.643 . . . . 0.0 115.048 -166.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.3 54.82 0.86 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.633 1.106 . . . . 0.0 111.542 -172.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -61.85 165.48 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.194 0.997 . . . . 0.0 112.838 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.9 mt -141.66 100.55 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.03 125.89 32.52 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.4 p -103.83 -174.8 2.63 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.213 1.405 . . . . 0.0 109.853 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 m -50.82 -32.09 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.142 1.377 . . . . 0.0 113.015 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.72 37.7 0.27 Allowed 'General case' 0 C--N 1.348 0.539 0 CA-C-N 120.506 1.503 . . . . 0.0 113.289 168.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.03 170.58 19.02 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.44 -1.412 . . . . 0.0 109.832 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.46 122.4 24.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.596 1.558 . . . . 0.0 107.832 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.75 143.49 26.24 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 160.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.561 ' HB3' HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -102.58 117.19 34.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 103.105 -2.924 . . . . 0.0 103.105 167.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.36 119.6 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 169.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -103.36 97.95 7.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.125 0.875 . . . . 0.0 109.624 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -41.59 148.09 0.46 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.664 1.985 . . . . 0.0 115.198 -157.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.06 -32.57 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 N-CA-C 114.593 0.959 . . . . 0.0 114.593 -159.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 13' ' ' VAL . 4.5 mm? -127.58 170.21 12.89 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.293 2.237 . . . . 0.0 104.975 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -86.03 157.56 20.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 157.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.47 -165.7 31.49 Favored Glycine 0 C--N 1.331 0.305 0 O-C-N 120.006 -1.684 . . . . 0.0 111.091 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -130.83 125.7 34.35 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.463 HD12 ' CD2' ' A' ' 98' ' ' PHE . 6.8 mm -63.29 140.07 20.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.1 m -149.63 6.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.858 0.863 . . . . 0.0 111.231 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -159.79 153.91 23.42 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 166.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.86 174.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 126.226 1.81 . . . . 0.0 108.25 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -118.37 84.06 2.11 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.706 0.685 . . . . 0.0 109.683 -172.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.9 -15.54 9.0 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.093 0.957 . . . . 0.0 112.123 176.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -54.52 -38.68 66.83 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.755 1.622 . . . . 0.0 111.105 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.322 0.649 . . . . 0.0 109.866 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -68.96 -18.87 64.14 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.613 -0.679 . . . . 0.0 111.412 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.3 p -127.6 -16.44 4.79 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -129.59 71.62 82.07 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.182 1.793 . . . . 0.0 107.415 165.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -67.53 -22.75 44.27 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.219 1.946 . . . . 0.0 109.746 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.7 -9.75 58.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 117.528 -1.225 . . . . 0.0 113.087 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -17.87 63.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 122.5 2.409 . . . . 0.0 111.779 -177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.737 HG21 HD11 ' A' ' 24' ' ' ILE . 16.5 mt -60.68 -30.52 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.115 0.966 . . . . 0.0 109.654 171.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -69.47 -47.98 62.22 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 120.851 -1.156 . . . . 0.0 109.18 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -29.92 30.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.463 -160.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -160.06 65.06 2.4 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 120.414 1.461 . . . . 0.0 110.601 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.06 -19.6 49.54 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.9 2.4 . . . . 0.0 114.547 -167.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 2.2 mp0 -115.23 -1.57 12.91 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.849 0.86 . . . . 0.0 112.405 -173.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.64 -84.53 1.67 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -98.55 -26.64 14.35 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.557 1.143 . . . . 0.0 111.956 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.98 40.28 2.65 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.058 0.845 . . . . 0.0 111.594 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -73.78 164.92 26.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.652 1.581 . . . . 0.0 110.448 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.26 -66.5 1.0 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-O 116.468 -1.73 . . . . 0.0 108.845 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.494 ' O ' HG13 ' A' ' 22' ' ' VAL . 48.0 p90 -138.04 -177.62 4.9 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.016 -2.273 . . . . 0.0 112.703 -176.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.5 mtmt -134.1 154.08 51.41 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 124.123 0.969 . . . . 0.0 109.321 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.72 138.72 21.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.246 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -58.66 126.63 28.41 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 162.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 pt -82.25 96.15 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 172.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -66.42 -29.69 69.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.021 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.81 79.84 1.64 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.931 1.348 . . . . 0.0 109.998 -167.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.746 ' HA ' ' CD1' ' A' ' 108' ' ' LEU 0.293 0.0 OUTLIER -81.44 26.01 0.49 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 124.582 2.134 . . . . 0.0 111.504 173.9 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.03 -22.07 31.31 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.511 -1.222 . . . . 0.0 114.052 155.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -76.32 -6.96 53.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.181 1.491 . . . . 0.0 112.678 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.746 ' CD1' ' HA ' ' A' ' 105' ' ' GLU . 4.8 mp -61.88 -21.94 65.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.219 1.008 . . . . 0.0 110.955 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.47 -20.42 58.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.111 . . . . 0.0 112.057 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -82.57 -15.88 50.61 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.238 0.926 . . . . 0.0 110.535 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.82 165.74 20.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 120.975 -1.078 . . . . 0.0 108.364 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.558 ' H ' HD22 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -77.57 125.07 28.76 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 172.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.86 171.68 7.61 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 152.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.48 -41.99 88.15 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 120.452 -1.405 . . . . 0.0 113.569 -156.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -62.49 -41.51 98.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.332 1.053 . . . . 0.0 110.114 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.72 -32.92 66.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.578 0.751 . . . . 0.0 111.034 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.5 -48.7 80.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 120.957 -1.089 . . . . 0.0 109.015 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.23 -47.92 71.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -51.7 -55.89 16.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.602 1.561 . . . . 0.0 111.805 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -65.12 -36.46 84.34 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.443 0.565 . . . . 0.0 111.282 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.85 -33.73 75.33 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.993 1.317 . . . . 0.0 110.833 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.73 -2.95 32.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.029 1.331 . . . . 0.0 111.767 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -87.23 -2.84 58.92 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.271 0.941 . . . . 0.0 111.729 166.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.242 0.682 0 CA-C-O 116.388 -1.768 . . . . 0.0 108.286 174.64 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtp . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -64.88 95.66 0.16 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.896 1.226 . . . . 0.0 108.646 171.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.403 ' HG2' ' HB ' ' A' ' 15' ' ' ILE . 5.7 ptm -154.93 152.94 30.32 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.467 1.107 . . . . 0.0 109.987 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.7 95.88 2.66 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.836 -0.54 . . . . 0.0 110.569 -162.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 109' ' ' GLU . 15.2 mmtm -93.53 174.26 7.28 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.68 0.792 . . . . 0.0 111.391 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -123.69 -173.09 2.66 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.772 2.429 . . . . 0.0 109.486 175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -138.41 179.54 6.4 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.947 1.299 . . . . 0.0 109.918 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -82.3 7.53 13.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.424 1.089 . . . . 0.0 111.447 167.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -121.93 40.8 3.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.605 1.548 . . . . 0.0 109.909 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 p80 43.27 59.62 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.967 1.707 . . . . 0.0 111.908 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -152.21 133.25 14.24 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.857 1.663 . . . . 0.0 108.612 -158.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.411 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 66.2 p-90 -110.62 160.69 16.44 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.361 1.465 . . . . 0.0 109.514 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 136.37 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.77 77.32 1.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.913 0.885 . . . . 0.0 109.462 -172.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' ' 20' ' ' ALA . 5.1 mp -71.47 139.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 5.7 pt-20 -126.46 -93.58 0.48 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.654 1.182 . . . . 0.0 110.101 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.484 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 9.1 t0 -83.4 -81.42 0.16 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -131.05 7.93 4.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.699 2.0 . . . . 0.0 110.426 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.77 149.78 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB2' HG13 ' A' ' 15' ' ' ILE . . . -113.05 140.83 47.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 159.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.3 m -79.78 137.02 36.88 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 153.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.9 t -103.11 136.62 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 128.0 2.52 . . . . 0.0 110.367 167.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.562 ' HA2' HD12 ' A' ' 97' ' ' LEU . . . -159.4 173.67 36.21 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.521 -0.737 . . . . 0.0 111.598 161.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 28' ' ' ALA . 9.0 pt -86.56 153.99 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 118.073 0.936 . . . . 0.0 110.683 177.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -84.06 171.91 12.48 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.677 0.791 . . . . 0.0 111.454 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.73 -35.94 71.37 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.408 0.623 . . . . 0.0 111.938 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -54.39 -33.74 59.86 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.734 -1.229 . . . . 0.0 112.279 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 24' ' ' ILE . . . -74.8 -44.0 51.77 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.356 -0.84 . . . . 0.0 112.145 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.13 -25.81 68.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.497 0.59 . . . . 0.0 110.75 176.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.62 -21.09 66.63 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.115 1.366 . . . . 0.0 111.042 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -102.45 -41.58 6.25 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.763 0.711 . . . . 0.0 111.254 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 mt -82.99 -19.75 36.43 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.55 -123.13 29.25 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 119.45 1.023 . . . . 0.0 111.183 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -80.29 33.91 0.3 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.745 2.018 . . . . 0.0 116.212 -151.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 21.5 t -22.19 -115.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 115.121 -2.371 . . . . 0.0 111.428 -131.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 0.5 OUTLIER 170.93 -47.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 128.455 2.702 . . . . 0.0 110.813 -170.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -169.86 158.85 7.56 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.31 0.381 . . . . 0.0 111.446 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.755 HG22 HG23 ' A' ' 56' ' ' ILE . 4.5 t -144.09 144.05 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 125.561 1.544 . . . . 0.0 110.711 175.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.04 139.56 37.51 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.712 2.405 . . . . 0.0 108.984 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -135.79 155.9 77.71 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.973 0.909 . . . . 0.0 110.713 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -84.47 -179.05 3.63 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.374 3.382 . . . . 0.0 114.207 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -84.96 155.76 21.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 163.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.39 18.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 127.086 2.155 . . . . 0.0 113.927 -163.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.42 13.75 0.2 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 127.903 2.668 . . . . 0.0 111.938 -176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -73.92 135.89 43.31 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.067 -1.255 . . . . 0.0 109.564 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -82.88 139.16 33.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.03 175.54 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.238 1.415 . . . . 0.0 110.453 -174.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -118.66 169.67 9.62 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.417 1.487 . . . . 0.0 109.48 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HE2' HD21 ' A' ' 111' ' ' LEU . 24.9 tttt -62.99 14.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.27 2.228 . . . . 0.0 114.915 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.0 78.2 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.52 116.58 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -169.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.6 71.6 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 128.005 2.522 . . . . 0.0 108.835 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.51 6.42 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.502 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.24 59.8 0.9 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.551 1.069 . . . . 0.0 112.438 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 m -59.85 160.61 7.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.763 1.268 . . . . 0.0 111.324 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.755 HG23 HG22 ' A' ' 38' ' ' VAL . 1.6 mt -134.27 105.73 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.7 166.19 23.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 163.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.9 p -140.8 177.78 7.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 120.487 1.494 . . . . 0.0 107.89 164.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -49.04 -19.58 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 128.055 2.542 . . . . 0.0 115.978 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -160.65 41.6 0.17 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.934 1.697 . . . . 0.0 114.164 155.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -154.37 -172.32 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.216 -0.928 . . . . 0.0 109.188 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.57 170.91 14.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.994 0.918 . . . . 0.0 108.771 159.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.75 131.96 32.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 143.62 37.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 164.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.54 114.18 46.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 104.91 -2.255 . . . . 0.0 104.91 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -101.44 107.03 18.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -170.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.62 125.39 0.94 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.038 1.335 . . . . 0.0 113.551 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.9 -21.86 24.04 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.218 2.612 . . . . 0.0 115.187 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 49' ' ' LYS . 1.8 mm? -134.93 149.02 50.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 129.501 3.12 . . . . 0.0 108.644 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -66.49 149.72 50.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 158.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.67 -165.97 36.5 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -130.67 134.86 47.29 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.36 0.664 . . . . 0.0 109.43 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.429 ' HA ' ' HB3' ' A' ' 100' ' ' MET . 8.7 mm -60.22 143.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.93 1.292 . . . . 0.0 108.861 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.59 -8.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -153.18 150.52 29.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.588 1.54 . . . . 0.0 108.342 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.26 168.01 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.818 1.19 . . . . 0.0 110.21 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -119.86 73.98 1.0 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.72 -1.04 0.33 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.05 -0.407 . . . . 0.0 112.077 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -54.92 -43.77 73.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.128 -1.415 . . . . 0.0 110.2 162.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.439 HD12 HG11 ' A' ' 38' ' ' VAL . 43.7 mt -68.37 -9.81 50.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.639 1.563 . . . . 0.0 113.774 -177.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.8 -24.28 65.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.476 1.035 . . . . 0.0 111.636 169.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.2 p -129.18 -19.29 3.54 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.577 -0.702 . . . . 0.0 112.548 -172.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -122.03 59.86 11.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 128.351 2.66 . . . . 0.0 108.788 166.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.82 -19.04 47.32 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.691 1.594 . . . . 0.0 109.601 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -77.23 -11.54 59.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.464 1.906 . . . . 0.0 112.094 176.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -27.83 68.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 119.454 -2.029 . . . . 0.0 111.519 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mt -66.75 -19.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.157 0.583 . . . . 0.0 109.932 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -65.0 -56.02 15.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.3 1.048 . . . . 0.0 109.696 165.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -63.05 -53.89 46.73 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 128.067 2.547 . . . . 0.0 108.791 -162.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -149.89 85.79 5.5 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -59.11 -22.04 62.24 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.512 2.141 . . . . 0.0 112.455 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.411 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.8 OUTLIER -127.41 9.01 6.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 127.858 2.463 . . . . 0.0 110.764 -163.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.33 -80.26 0.87 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 126.277 1.894 . . . . 0.0 109.716 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -93.6 -25.25 17.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.18 31.88 4.9 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.649 1.119 . . . . 0.0 113.367 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.564 ' CZ3' ' HE3' ' A' ' 99' ' ' LYS . 34.4 p-90 -70.06 159.4 33.91 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.562 HD12 ' HA2' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -108.89 -46.66 3.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.5 1.046 . . . . 0.0 109.136 -177.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.401 ' CD2' HD12 ' A' ' 73' ' ' ILE . 46.2 p90 -154.33 171.02 19.95 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.339 -0.851 . . . . 0.0 111.378 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.564 ' HE3' ' CZ3' ' A' ' 96' ' ' TRP . 77.1 mttt -131.59 152.49 50.76 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.504 1.522 . . . . 0.0 108.1 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.429 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 6.0 ptm -154.8 148.3 25.2 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.202 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -65.67 133.35 50.91 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.1 pt -79.23 103.41 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 165.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -73.77 -17.41 61.1 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.808 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -144.15 79.29 1.61 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.191 1.397 . . . . 0.0 107.364 -164.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -68.55 -10.46 55.91 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.767 -1.208 . . . . 0.0 113.298 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -81.97 -4.85 90.15 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.72 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 49' ' ' LYS . 49.0 mt-10 -81.38 -36.55 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.87 1.335 . . . . 0.0 112.169 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -35.41 80.59 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 119.656 1.116 . . . . 0.0 112.193 -170.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.468 ' HA ' ' HE2' ' A' ' 5' ' ' LYS . 17.6 mm-40 -62.51 -20.37 64.54 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -87.26 -11.0 50.94 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.588 0.755 . . . . 0.0 112.589 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.499 HD21 ' HE2' ' A' ' 49' ' ' LYS . 82.5 mt -75.04 -179.1 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.539 1.136 . . . . 0.0 110.252 167.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.9 mt -88.33 131.96 34.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.733 0.813 . . . . 0.0 109.996 -170.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.84 171.74 1.55 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.263 1.425 . . . . 0.0 109.846 163.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.74 -51.53 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.286 1.035 . . . . 0.0 111.151 -175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -56.7 -47.47 79.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 123.024 0.53 . . . . 0.0 109.776 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.48 67.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.332 0.653 . . . . 0.0 112.098 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -79.72 -43.35 22.81 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.656 0.662 . . . . 0.0 111.631 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 109.579 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -45.75 -49.13 15.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.888 2.075 . . . . 0.0 111.501 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -68.36 -24.96 64.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.287 1.035 . . . . 0.0 112.061 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.6 m -87.38 -3.32 59.02 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.665 1.186 . . . . 0.0 112.738 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -112.75 3.24 16.39 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.35 1.46 . . . . 0.0 111.332 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.76 18.54 13.34 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.677 1.591 . . . . 0.0 110.73 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.203 1.401 . . . . 0.0 110.16 -166.274 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 ttm . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -169.02 127.75 1.03 Allowed 'General case' 0 C--O 1.231 0.121 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -167.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 ttp -162.54 153.46 17.35 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.318 1.447 . . . . 0.0 107.973 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.27 101.73 3.75 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.442 -0.786 . . . . 0.0 109.763 -171.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -112.77 -178.6 3.43 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.97 153.49 43.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.373 1.069 . . . . 0.0 112.061 -167.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.8 p -101.33 171.39 7.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 123.306 1.527 . . . . 0.0 110.346 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HE3' ' CZ ' ' A' ' 120' ' ' PHE . 9.4 mtpt -83.59 -1.01 52.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.989 170.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 p -120.65 44.25 2.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.129 1.772 . . . . 0.0 109.376 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.2 p80 43.96 61.11 2.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.287 1.835 . . . . 0.0 113.807 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 3.8 mt-10 -134.86 152.18 51.53 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.299 1.84 . . . . 0.0 109.155 171.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.476 ' CZ2' ' HA ' ' A' ' 92' ' ' GLU . 64.0 p-90 -109.81 172.66 6.72 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.947 1.299 . . . . 0.0 109.373 169.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.1 134.45 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -116.43 84.92 2.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.3 mp -75.67 118.07 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -106.33 -120.82 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 167.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.61 -60.49 2.29 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.849 1.204 . . . . 0.0 110.666 -167.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.1 7.53 2.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.973 0.909 . . . . 0.0 111.523 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.4 t -130.38 140.79 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -110.33 134.22 52.49 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 163.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.8 m -77.15 142.05 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 158.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.72 139.86 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.083 1.353 . . . . 0.0 109.559 166.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.29 161.4 28.75 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 161.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 87' ' ' ILE . 2.6 pp -70.06 159.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -79.6 -172.31 3.22 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.493 -0.755 . . . . 0.0 111.726 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.04 19.74 13.48 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.896 2.478 . . . . 0.0 112.549 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -113.48 0.57 14.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 126.009 1.724 . . . . 0.0 113.999 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.288 . . -119.76 -52.26 2.23 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.823 3.249 . . . . 0.0 112.585 -156.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -39.91 -42.97 1.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.777 2.431 . . . . 0.0 110.178 158.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.28 -25.05 67.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.694 1.598 . . . . 0.0 113.722 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -75.02 -45.31 42.67 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.015 -1.053 . . . . 0.0 109.542 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -72.47 -57.51 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.31 -132.29 11.19 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.15 126.82 28.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 36' ' ' VAL . 3.1 t -97.83 -154.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 169.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.644 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.2 m -174.42 -38.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 C-N-CA 129.582 3.153 . . . . 0.0 106.973 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.487 ' H ' HG12 ' A' ' 35' ' ' VAL . 53.9 t80 -144.93 145.6 31.62 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.553 0.615 . . . . 0.0 111.27 -176.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 56' ' ' ILE . 39.6 t -128.81 121.07 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 168.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.48 140.79 37.2 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.033 173.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.43 149.09 63.5 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -175.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -71.0 -175.52 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.18 2.587 . . . . 0.0 112.308 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.44 158.98 15.35 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.893 1.677 . . . . 0.0 109.918 162.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.13 19.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 126.378 1.871 . . . . 0.0 115.014 -167.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.33 9.34 0.6 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.627 2.06 . . . . 0.0 112.887 174.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -73.04 135.82 44.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.723 1.261 . . . . 0.0 109.678 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.415 ' HG2' ' CG ' ' A' ' 72' ' ' LYS . 22.0 mt-10 -89.01 157.95 18.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.315 1.055 . . . . 0.0 111.665 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.519 HG22 HG11 ' A' ' 53' ' ' VAL 0.331 11.1 t -146.22 171.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.29 0 C-N-CA 131.653 3.981 . . . . 0.0 108.852 -162.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' H ' HG12 ' A' ' 47' ' ' VAL . 64.9 mttm -146.13 166.11 27.12 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.768 4.027 . . . . 0.0 106.338 -171.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -74.73 27.85 0.09 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.85 57.78 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 126.469 1.985 . . . . 0.0 108.372 171.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.01 143.25 45.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 117.583 0.692 . . . . 0.0 110.491 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.1 t -92.72 103.89 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.519 HG11 HG22 ' A' ' 47' ' ' VAL . 27.4 m -118.76 -0.24 8.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 125.919 1.687 . . . . 0.0 109.9 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -166.95 66.51 0.09 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.488 1.115 . . . . 0.0 109.432 -163.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -65.23 166.59 9.56 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.515 -1.366 . . . . 0.0 110.963 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.445 HG23 HG22 ' A' ' 38' ' ' VAL . 6.2 mt -143.65 103.78 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 O-C-N 120.145 -1.597 . . . . 0.0 107.612 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.43 117.67 29.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.4 p -97.98 -168.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.187 1.795 . . . . 0.0 110.645 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -52.79 -28.84 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.473 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.11 40.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.393 1.451 . . . . 0.0 113.003 166.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.17 39.46 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 120.78 -1.2 . . . . 0.0 109.721 171.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.34 152.38 31.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.739 1.616 . . . . 0.0 106.7 168.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.73 76.1 1.42 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -33.01 107.49 0.05 OUTLIER 'General case' 0 C--O 1.237 0.439 0 C-N-CA 128.777 2.831 . . . . 0.0 108.928 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.79 120.53 30.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.18 94.77 6.13 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.696 0.398 . . . . 0.0 111.804 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -34.09 132.74 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.559 0 C-N-CA 125.947 1.699 . . . . 0.0 114.647 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.2 -32.74 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.068 1.845 . . . . 0.0 111.874 -165.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.24 160.93 37.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.235 1.814 . . . . 0.0 108.209 -175.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.14 132.18 46.75 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.226 1.811 . . . . 0.0 107.328 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.13 -172.89 45.88 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.415 ' CG ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -133.2 131.23 40.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 100' ' ' MET . 27.2 mm -62.81 151.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -163.93 -11.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 124.044 0.937 . . . . 0.0 109.744 -167.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.58 152.07 39.97 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 163.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.68 152.38 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -99.99 84.66 2.91 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.27 -15.29 23.63 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.779 0.8 . . . . 0.0 111.859 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -59.56 -22.41 61.67 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.273 1.829 . . . . 0.0 113.24 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.29 -15.55 46.28 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.271 1.396 . . . . 0.0 112.113 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -62.66 -31.33 72.19 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 165.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.9 -20.36 12.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.113 -0.992 . . . . 0.0 111.9 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.11 74.95 76.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.79 1.236 . . . . 0.0 110.312 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -65.64 -25.55 54.35 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.633 2.222 . . . . 0.0 110.456 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.64 -16.84 64.12 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.938 0.79 . . . . 0.0 110.99 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -21.62 66.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.911 2.141 . . . . 0.0 112.204 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.672 ' CG2' HD11 ' A' ' 24' ' ' ILE . 3.0 mt -64.52 -28.78 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.353 0.661 . . . . 0.0 110.289 172.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -67.1 -55.31 14.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.22 -1.55 . . . . 0.0 108.527 167.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -51.13 68.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.25 -160.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.86 76.76 5.88 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 124.13 0.972 . . . . 0.0 108.427 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.51 -25.16 62.92 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.016 1.81 . . . . 0.0 113.028 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' HA ' ' CZ2' ' A' ' 12' ' ' TRP . 0.6 OUTLIER -116.0 15.09 16.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.064 0.945 . . . . 0.0 110.781 -175.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -117.4 -65.91 0.34 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.248 1.88 . . . . 0.0 111.289 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -124.86 -23.9 4.2 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.516 1.158 . . . . 0.0 114.072 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.51 2.65 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 111.879 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -67.59 152.58 45.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -93.63 -59.9 1.89 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' CD1' HD12 ' A' ' 73' ' ' ILE . 44.4 p90 -149.31 168.62 22.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.719 1.207 . . . . 0.0 109.857 -172.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -132.99 155.11 49.76 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.386 1.474 . . . . 0.0 107.545 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.465 ' HB3' HD13 ' A' ' 73' ' ' ILE . 1.8 ptm -148.58 144.59 27.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.388 -168.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.56 114.66 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.351 2.26 . . . . 0.0 107.912 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.0 pt -71.34 117.59 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.606 0.717 . . . . 0.0 111.472 -170.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -78.06 -25.85 47.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.371 -0.83 . . . . 0.0 112.718 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.08 84.76 1.59 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -8.55 36.27 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.514 -0.741 . . . . 0.0 110.73 173.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -93.53 -31.85 8.06 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.748 -1.029 . . . . 0.0 112.872 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.57 -5.47 11.56 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.085 1.443 . . . . 0.0 111.212 170.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -59.99 -34.57 73.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.45 1.023 . . . . 0.0 110.868 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.69 -20.74 61.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.253 1.421 . . . . 0.0 111.441 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -83.41 -6.08 59.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.886 0.874 . . . . 0.0 111.456 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.08 176.07 5.27 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 122.643 1.211 . . . . 0.0 111.915 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -75.97 143.78 41.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.192 1.397 . . . . 0.0 109.8 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.75 171.98 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.395 162.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -73.9 -34.68 64.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.524 1.93 . . . . 0.0 111.903 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.82 -48.92 33.79 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.22 70.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.445 0.698 . . . . 0.0 110.839 -175.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -53.48 -47.64 69.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.626 1.571 . . . . 0.0 111.884 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.61 -35.72 65.4 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.7 -0.625 . . . . 0.0 110.205 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.53 -46.03 90.04 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.716 0.807 . . . . 0.0 110.101 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.431 ' CZ ' ' HE3' ' A' ' 8' ' ' LYS . 31.4 t80 -57.19 -19.25 19.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.596 1.559 . . . . 0.0 112.918 175.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 3.4 t -87.89 -15.08 37.66 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.71 0.804 . . . . 0.0 112.7 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.5 -50.73 5.63 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.603 1.161 . . . . 0.0 109.08 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.52 45.54 0.68 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.969 0.89 . . . . 0.0 110.725 172.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 167.009 . . . . . . . . 0 0 . 1 stop_ save_